,Date,Title,Url
0,2018-01-03,삼성바이오로직스CMO1위경쟁력바이오RD시장넘본다,http://news.mk.co.kr/newsRead.php?year=2018&no=4230
1,2018-01-03,다시금불거진삼성바이오로직스분식회계의혹,http://www.mdtoday.co.kr/mdtoday/index.html?no=306957
2,2018-01-03,코스피기관순매수카카오롯데지주삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018010316433804180
3,2018-01-04,김태한삼성바이오로직스의의약품수탁개발사업도속도전,http://www.businesspost.co.kr/BP?command=article_view&num=68789
4,2018-01-04,코스피외국인순매도아모레퍼시픽현대상선삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018010416392559856
5,2018-01-05,2018년주목받는기업20삼성바이오로직스3공장준공으로생산력세계1위,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=10660
6,2018-01-06,보호예수풀린삼성바이오로직스직원들은안팔아요,http://www.edaily.co.kr/news/newspath.asp?newsid=01177526619075096
7,2018-01-08,삼성바이오로직스제3공장8500억공격투자수익안정성아직,http://www.ceoscoredaily.com/news/article.html?no=36204
8,2018-01-08,삼성바이오로직스누적수주4조원돌파가시화,http://www.etnews.com/20180105000333
9,2018-01-09,기자수첩삼성바이오로직스분식회계의혹금감원조사에거는기대,http://www.kukinews.com/news/article.html?no=515287
10,2018-01-09,우리사주잭팟터진삼성바이오로직스임직원장기보유한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=307521
11,2018-01-09,유삼성바이오로직스장중신고가돌파414000→415000▲1000,http://www.sedaily.com/NewsView/1RUCZQSPW8
12,2018-01-09,fnRASSI삼성바이오로직스20794052주신고가375↑,http://www.fnnews.com/news/201801090945069992
13,2018-01-09,삼성바이오로직스사상최고가경신,http://www.sedaily.com/NewsView/1RUD04N6SL
14,2018-01-09,특징주삼성바이오로직스바이오주강세에신고가경신,http://www.edaily.co.kr/news/newspath.asp?newsid=02056566619076080
15,2018-01-09,특징주삼성바이오로직스사상최고가경신,http://www.sporbiz.co.kr/news/articleView.html?idxno=184285
16,2018-01-09,삼성바이오로직스사상최고가경신,http://www.mdtoday.co.kr/mdtoday/index.html?no=307609
17,2018-01-09,특징주삼성바이오로직스사흘째상승세신고가경신,http://biz.chosun.com/site/data/html_dir/2018/01/09/2018010901127.html
18,2018-01-09,특징주삼성바이오로직스사상최고가경신,http://www.newsis.com/view/?id=NISX20180109_0000198037&cID=10401&pID=10400
19,2018-01-09,상승세이어가는제약바이오株삼성바이오로직스사상최고가,http://www.mdtoday.co.kr/mdtoday/index.html?no=307622
20,2018-01-09,특징주삼성바이오로직스바이오주강세에40만원선재진입,http://www.newsway.co.kr/view.php?tp=1&ud=2018010913351025147
21,2018-01-09,특징주삼성바이오로직스상장이후최고가경신,http://www.asiatime.co.kr/news/articleView.html?idxno=162945
22,2018-01-10,2018신년기획바이오열풍셀트리온삼성바이오로직스앞장,http://www.polinews.co.kr/news/article.html?no=343185
23,2018-01-10,특징주삼성바이오로직스52주최고가경신4거래일연속상승세,http://www.g-enews.com/ko-kr/news/article/news_all/201801100930185000c16aa2f016_1/article.html
24,2018-01-12,셀트리온서정진제3공장미국으로삼성바이오로직스제치고세계1위로우뚝,http://www.updownnews.co.kr/news/articleView.html?idxno=81791
25,2018-01-12,기업분석삼성바이오로직스분식회계의혹에도주가탄탄눈에띄네,http://www.g-enews.com/ko-kr/news/article/news_all/201801081530569104581e5800d6_1/article.html
26,2018-01-12,삼성바이오로직스CMO바이오시밀러매력적현대차,http://news.hankyung.com/article/2018011212676
27,2018-01-12,클릭e종목삼성바이오로직스CMO바이오시밀러매력목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2018011207554569450
28,2018-01-12,현대차투자증권삼성바이오로직스공장정상가동시높은이익률유지외형성장가능”,http://www.g-enews.com/ko-kr/news/article/news_all/201801120819074399c642673384_1/article.html
29,2018-01-12,삼성바이오로직스목표주가상향생산능력확대로외형성장,http://www.businesspost.co.kr/BP?command=article_view&num=69632
30,2018-01-12,삼성바이오로직스주요파이프라인의약품성장률상향목표가↑현대차,http://www.edaily.co.kr/news/newspath.asp?newsid=01410406619077064
31,2018-01-12,오늘의종목삼성바이오로직스CMO수요증가매력적목표가UP,http://www.sedaily.com/NewsView/1RUEEB5F0B
32,2018-01-12,특징주삼성바이오로직스CMO바이오시밀러기대감에2대상승세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1583739
33,2018-01-12,삼성바이오로직스CMO바이오시밀러긍정적내년흑자전환현대차투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1583725
34,2018-01-12,특징주삼성바이오로직스CMO바이오시밀러매력4↑,http://www.asiae.co.kr/news/view.htm?idxno=2018011209534105407
35,2018-01-12,아주종목분석삼성바이오로직스위탁생산수요증가전망,http://www.ajunews.com/view/20180112095123047
36,2018-01-12,삼성바이오로직스CMO수요증가기대감강세,http://www.newsprime.co.kr/news/article.html?no=402352
37,2018-01-12,바이오열전세계최대CMO생산능력삼성바이오로직스지난해3분기영업흑자달성,http://www.polinews.co.kr/news/article.html?no=343506
38,2018-01-12,삼성바이오로직스CMO바이오시밀러매력에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=308049
39,2018-01-12,증권사모닝리포트삼성바이오로직스바이오CMO수요증가,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801120035
40,2018-01-12,삼성바이오로직스목표주가48만원으로상향CMO와바이오시밀러둘다좋다,http://www.nbntv.co.kr/news/view.php?idx=73357
41,2018-01-12,유삼성바이오로직스전일대비730상승일일회전율은085기록,http://www.sedaily.com/NewsView/1RUEEER7SX
42,2018-01-12,fnRASSI삼성바이오로직스20794052주신고가경신68↑,http://www.fnnews.com/news/201801121405023146
43,2018-01-12,유삼성바이오로직스장중신고가돌파426000→426500▲500,http://www.sedaily.com/NewsView/1RUEDW7X0G
44,2018-01-12,삼성바이오로직스CMO와바이오시밀러두다매력적,http://www.newsworks.co.kr/news/articleView.html?idxno=160715
45,2018-01-12,외국인삼성바이오로직스한미약품샀다코스피8p상승,http://www.choicenews.co.kr/news/articleView.html?idxno=38630
46,2018-01-12,코스피외국인순매수POSCOSK하이닉스삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018011216244538881
47,2018-01-12,코스피기관순매수삼성전자삼성바이오로직스롯데케미칼,http://www.newsway.co.kr/view.php?tp=1&ud=2018011217225309844
48,2018-01-14,단독삼성바이오로직스18만ℓ생산규모4공장세운다,http://news.mk.co.kr/newsRead.php?year=2018&no=30300
49,2018-01-14,단독삼성바이오로직스18만ℓ규모4공장세운다,http://news.mk.co.kr/newsRead.php?year=2018&no=30390
50,2018-01-14,삼성바이오로직스4공장증설은시기상조,http://news.hankyung.com/article/201801147163f
51,2018-01-15,특징주삼성바이오로직스추가공장신설계획에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=01653126619078048
52,2018-01-15,삼성바이오로직스장초반사상최고가경신,http://www.sedaily.com/NewsView/1RUFR6TD5G
53,2018-01-15,특징주삼성바이오로직스신규공장신설계획에강세,http://news.hankyung.com/article/2018011582196
54,2018-01-15,삼성바이오로직스내년공장신설검토소식에상승,http://www.newsprime.co.kr/news/article.html?no=402515
55,2018-01-15,특징주삼성바이오로직스공장증설보도에강세,http://www.ebn.co.kr/news/view/925745
56,2018-01-15,일신바이오삼성바이오로직스4공장증설에장초반강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=308201
57,2018-01-15,특징주삼성바이오로직스공장증설검토소식에최고가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180115041100008&did=1195m
58,2018-01-15,특징주삼성바이오로직스4공장신설기대에장중사상최고가경신,http://www.g-enews.com/ko-kr/news/article/news_all/201801150927368953581e5800d6_1/article.html
59,2018-01-15,삼성바이오로직스송도4공장신설계획에강세,http://news.heraldcorp.com/view.php?ud=20180115000197
60,2018-01-15,삼성바이오로직스송도신규공장증설계획에장초반상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=308204
61,2018-01-15,특징주삼성바이오로직스신규공장설립계획에상승세,http://www.dailian.co.kr/news/view/686803/?sc=naver
62,2018-01-15,삼성바이오로직스4공장신축관련결정된바없음,http://news.mt.co.kr/mtview.php?no=2018011510352445569
63,2018-01-15,삼성바이오로직스4공장신축관련결정된사항없어,http://www.asiae.co.kr/news/view.htm?idxno=2018011510384094162
64,2018-01-15,삼성바이오로직스4공장신축결정된것없어,http://www.etoday.co.kr/news/section/newsview.php?idxno=1584289
65,2018-01-15,공시삼성바이오로직스4공장신축결정된바없다”,http://www.newsway.co.kr/view.php?tp=1&ud=2018011510390044302
66,2018-01-15,삼성바이오로직스4공장신축관련결정사항없다,http://news.hankyung.com/article/2018011588576
67,2018-01-15,삼성바이오로직스당사4공장신축결정된사항없어,http://www.sisafocus.co.kr/news/articleView.html?idxno=172358
68,2018-01-15,삼성바이오로직스4공장신축결정된사항없다,http://www.mdtoday.co.kr/mdtoday/index.html?no=308218
69,2018-01-15,삼성바이오로직스4공장신축결정된사항없다”,http://news.heraldcorp.com/view.php?ud=20180115000417
70,2018-01-15,삼성바이오로직스4공장신축결정된사항없다,http://www.sedaily.com/NewsView/1RUFRHW94M
71,2018-01-15,삼성바이오로직스4공장신축결정된바없다,http://www.asiatoday.co.kr/view.php?key=20180115010007893
72,2018-01-15,삼성바이오로직스4공장신축결정된바없다,http://www.newsprime.co.kr/news/article.html?no=402556
73,2018-01-15,fnRASSI삼성바이오로직스20794052주신고가경신204↑,http://www.fnnews.com/news/201801151105207289
74,2018-01-15,삼성바이오로직스4공장신축결정된사항없다,http://www.edaily.co.kr/news/newspath.asp?newsid=02364886619078048
75,2018-01-15,삼성바이오로직스4공장신축관련결정된바없어,http://www.newspim.com/news/view/20180115000078
76,2018-01-15,특징주삼성바이오로직스연일신고가경신,http://www.newsis.com/view/?id=NISX20180115_0000203161&cID=10401&pID=10400
77,2018-01-15,삼성바이오로직스4공장신축결정된바없어,http://biz.chosun.com/site/data/html_dir/2018/01/15/2018011501248.html
78,2018-01-15,삼성바이오로직스4공장신축결정사항없다,http://daily.hankooki.com/lpage/economy/201801/dh20180115114746138080.htm
79,2018-01-15,삼성바이오로직스4공장신축결정된사항없다,http://www.newsis.com/view/?id=NISX20180115_0000203223&cID=10401&pID=10400
80,2018-01-15,삼성바이오로직스4공장신축결정된사항없다,http://news1.kr/articles/?3207170
81,2018-01-15,삼성바이오로직스4공장신축결정사항없다,http://www.newstomato.com/ReadNews.aspx?no=800256
82,2018-01-15,삼성바이오로직스4공장신축관련결정사항없다”,http://www.viva100.com/main/view.php?key=20180115010005349
83,2018-01-15,삼성바이오로직스4공장설립결정사항없다”,http://www.cstimes.com/?mod=news&act=articleView&idxno=265487
84,2018-01-15,삼성바이오로직스4공장신축결정된사항없어,http://news.einfomax.co.kr/news/articleView.html?idxno=3430032
85,2018-01-15,삼성바이오로직스4공장설립결정된사항없다,http://www.ebn.co.kr/news/view/925804
86,2018-01-15,삼성바이오로직스4공장신축관련결정된내용없다,http://www.businesspost.co.kr/BP?command=article_view&num=69829
87,2018-01-15,포춘클럽3공장시대연삼성바이오로직스CMO분야세계1위자리매김,http://www.fnnews.com/news/201801151506169254
88,2018-01-15,삼성바이오로직스송도4공장증설검토는맞지만확정無,http://www.ebn.co.kr/news/view/925828
89,2018-01-15,이종목은왜오늘의특징주가상화폐관련주삼성전자삼성바이오로직스대우조선해양내일톱픽은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018011517115185330
90,2018-01-15,코스피외국인순매도카카오SK하이닉스삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018011518142698871
91,2018-01-15,포춘클럽라운지삼성바이오로직스바이오의약품위탁생산세계1위로도약,http://www.fnnews.com/news/201801151917516588
92,2018-01-16,파죽지세셀트리온삼성바이오로직스공장규모확대4공장증설검토,http://www.newsis.com/view/?id=NISX20180115_0000203413&cID=13001&pID=13000
93,2018-01-16,한미셀트리온삼성바이오로직스등JP모건서비전발표,http://www.medigatenews.com/news/2170657448
94,2018-01-16,삼성바이오로직스셀트리온공장증설경쟁불붙을까,http://www.mdtoday.co.kr/mdtoday/index.html?no=308293
95,2018-01-16,CMO세계1위삼성바이오로직스2020년3공장본격생산,http://www.mdtoday.co.kr/mdtoday/index.html?no=308398
96,2018-01-18,서경스타즈IR3공장체제구축삼성바이오로직스매출쑥쑥,http://www.sedaily.com/NewsView/1RUH5X7W4C
97,2018-01-19,셀트리온왜나만갖고그래삼성바이오로직스는분식회계의혹에도굳건,http://www.ekn.kr/news/article.html?no=338431
98,2018-01-23,특징주삼성바이오로직스40만원회복,http://www.asiae.co.kr/news/view.htm?idxno=2018012315030493298
99,2018-01-26,JP모건삼성바이오로직스매수목표가49만5천원제시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180126071800008&did=1195m
100,2018-01-29,ET투자뉴스삼성바이오로직스_外人대량매수이후주가도탄력받아현재478,http://www.etnews.com/20180129000044
101,2018-01-29,특징주삼성바이오로직스JP모건매수의견에5대강세,http://www.asiae.co.kr/news/view.htm?idxno=2018012909470922971
102,2018-01-29,삼성바이오로직스JP모건매수의견소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=309741
103,2018-01-29,유삼성바이오로직스장중신고가돌파443000→443500▲500,http://www.sedaily.com/NewsView/1RUM7EIBBH
104,2018-01-29,fnRASSI삼성바이오로직스52주신고가562↑,http://www.fnnews.com/news/201801291035459517
105,2018-01-29,특징주삼성바이오로직스JP모건매수의견에강세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018012911078026450&outlink=1
106,2018-01-29,코스피삼성바이오로직스현대건설삼성물산껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=38977
107,2018-01-29,코스피외국인순매수삼성바이오로직스SK이노베이션삼성전자우선주,http://www.newsway.co.kr/view.php?tp=1&ud=2018012917245196451
108,2018-01-30,삼성바이오로직스4공장증설가능성목표가↑한국,http://news.hankyung.com/article/2018013022096
109,2018-01-30,클릭e종목삼성바이오로직스4공장증설따른이익성장기대목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2018013007311343991
110,2018-01-30,삼성바이오로직스4공장증설기대목표주가상향한국투자,http://www.ebn.co.kr/news/view/927753
111,2018-01-30,한국투자증권삼성바이오로직스바이오에피스올해흑자전환기대4공장증설가능성도주목”,http://www.g-enews.com/ko-kr/news/article/news_all/201801300820368036c642673384_1/article.html
112,2018-01-30,STOCK삼성바이오로직스4공장증설따른기대감목표가↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018013008298099288&outlink=1
113,2018-01-30,삼성바이오로직스4공장증설가능성에목표주가상향한투,http://biz.chosun.com/site/data/html_dir/2018/01/30/2018013000599.html
114,2018-01-30,ET투자뉴스삼성바이오로직스4공장증설에대한매수유지한국투자증권,http://www.etnews.com/20180130000006
115,2018-01-30,삼성바이오로직스4공장증설기대목표가상향한국투자,http://www.newstomato.com/ReadNews.aspx?no=803407
116,2018-01-30,특징주삼성바이오로직스4공장설립가능성신고가경신,http://news.mt.co.kr/mtview.php?no=2018013009060784498
117,2018-01-30,특징주삼성바이오로직스주가천정또뚫었다외인매수자회사바이오에피스흑자전환기대,http://www.g-enews.com/ko-kr/news/article/news_all/201801300904012436c642673384_1/article.html
118,2018-01-30,특징주삼성바이오로직스신고가4공장증설기대,http://news.hankyung.com/article/2018013025966
119,2018-01-30,유삼성바이오로직스장중신고가돌파444500→457500▲13000,http://www.sedaily.com/NewsView/1RUMNF8WQL
120,2018-01-30,fnRASSI삼성바이오로직스52주신고가398↑,http://www.fnnews.com/news/201801300914073394
121,2018-01-30,한국투자증권삼성바이오로직스4공장증설가능성에주목”,http://www.newsway.co.kr/view.php?tp=1&ud=2018013009162501971
122,2018-01-30,삼성바이오로직스4공장설립가능성대두52주신고가갱신,http://www.mdtoday.co.kr/mdtoday/index.html?no=309894
123,2018-01-30,삼성바이오로직스4공장증설에대한열린가능성주목,http://daily.hankooki.com/lpage/economy/201801/dh20180130091920138110.htm
124,2018-01-30,특징주삼성바이오로직스52주신고가4공장증설기대감,http://www.ebn.co.kr/news/view/927791
125,2018-01-30,삼성바이오로직스4공장증설가능성솔솔52주신고가,http://www.newsprime.co.kr/news/article.html?no=404572
126,2018-01-30,특징주삼성바이오로직스증설기대감45만원돌파,http://www.asiae.co.kr/news/view.htm?idxno=2018013009453583697
127,2018-01-30,특징주삼성바이오로직스4공장증설가능성에신고가,http://www.newsis.com/view/?id=NISX20180130_0000216924&cID=10401&pID=10400
128,2018-01-30,삼성바이오로직스4공장증설가능성에52주신고가,http://www.sedaily.com/NewsView/1RUMN2UZO7
129,2018-01-30,삼성바이오로직스CMO생산능력기준세계1위,http://www.asiatoday.co.kr/view.php?key=20180130010016614
130,2018-01-30,IR센터삼성바이오로직스매출액30증가예상,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801300187
131,2018-01-30,평가따로매매따로삼성바이오로직스잇단외국계증권사러브콜에도정작시장에선외국계매도셀트리온과정반대행보,http://www.news2day.co.kr/98388
132,2018-01-30,특징주삼성바이오로직스4공장증설로이익성장가능성제고,http://www.sisaon.co.kr/news/articleView.html?idxno=69109
133,2018-01-30,삼성바이오로직스바이오의약품수요에대응해4공장건설할수도,http://www.businesspost.co.kr/BP?command=article_view&num=71451
134,2018-01-30,삼성바이오로직스2019년4공장건설검토바이오의약품생산량1위보폭키운다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1589538
135,2018-01-31,삼성바이오로직스한미약품외국인기관쌍끌이매수세유입,http://www.mdtoday.co.kr/mdtoday/index.html?no=309955
136,2018-01-31,삼성바이오로직스매출4598억영업이익630억흑자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=03571926619083296
137,2018-01-31,삼성바이오로직스지난해4분기영업익4759억원흑전,http://news.mt.co.kr/mtview.php?no=2018013115425259742
138,2018-01-31,삼성바이오로직스작년4분기영업익475억전년대비흑자전환,http://www.sedaily.com/NewsView/1RUN51GTEA
139,2018-01-31,공시삼성바이오로직스작년영업익630억전년比흑자전환,http://www.newsway.co.kr/view.php?tp=1&ud=2018013115461658123
140,2018-01-31,삼성바이오로직스지난해4Q영업익476억원흑자전환1보,http://news1.kr/articles/?3222758
141,2018-01-31,삼성바이오로직스지난해매출액561증가한4598억원,http://www.fnnews.com/news/201801311552281555
142,2018-01-31,삼성바이오로직스지난해영업익630억흑자전환,http://www.asiatoday.co.kr/view.php?key=20180131010017964
143,2018-01-31,삼성바이오로직스영업익630억원전년比307↑흑전,http://view.asiae.co.kr/news/view.htm?idxno=2018013116041395931
144,2018-01-31,삼성바이오로직스2017년매출4598억영업익630억원,http://www.medigatenews.com/news/1878302251
145,2018-01-31,삼성바이오로직스2017년매출4598억영업익630억원,http://www.medigatenews.com/news/1878302251
146,2018-01-31,삼성바이오로직스4Q영업익476억원2분기째흑자,http://news.einfomax.co.kr/news/articleView.html?idxno=3432732
147,2018-01-31,삼성바이오로직스전년대비매출1652억원늘어,http://www.dailypharm.com/News/236295
148,2018-01-31,삼성바이오로직스지난해영업이익629억전년比흑자전환,http://news.hankyung.com/article/2018013198016
149,2018-01-31,삼성바이오로직스작년영업익630억원307증가,http://www.ciobiz.co.kr/news/article.html?id=20180131120024
150,2018-01-31,공시삼성바이오로직스지난해연결영업이익630억원전년대비307증가,http://www.g-enews.com/ko-kr/news/article/news_all/201801311610484597c642673384_1/article.html
151,2018-01-31,삼성바이오로직스지난해영업이익630억원흑자전환,http://www.sedaily.com/NewsView/1RUN4O1EE6
152,2018-01-31,삼성바이오로직스지난해영업이익630억원첫흑자전환,http://www.ebn.co.kr/news/view/928097
153,2018-01-31,삼성바이오로직스작년4Q영업익475억전년比흑자전환,http://www.mdtoday.co.kr/mdtoday/index.html?no=310110
154,2018-01-31,삼성바이오로직스흑자전환지난해영업이익630억원,http://biz.newdaily.co.kr/news/article.html?no=10152215
155,2018-01-31,삼성바이오로직스지난해영업익630억전년比307↑,http://www.newsis.com/view/?id=NISX20180131_0000218741&cID=13001&pID=13000
156,2018-01-31,삼성바이오로직스지난해영업익629억흑자전환,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180131161729
157,2018-01-31,삼성바이오로직스지난해영업익630억원전년비3배껑충상보,http://news1.kr/articles/?3222845
158,2018-01-31,삼성바이오로직스매출4598억원영업익307증가,http://www.dt.co.kr/contents.html?article_no=2018013102109976029003&ref=naver
159,2018-01-31,삼성바이오로직스작년영업익630억창사후첫흑자종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180131155051017&did=1195m
160,2018-01-31,삼성바이오로직스지난해영업익630억전년比307증가,http://daily.hankooki.com/lpage/economy/201801/dh20180131163226138080.htm
161,2018-01-31,삼성바이오로직스지난해영업익630억달성하며흑자전환,http://www.viva100.com/main/view.php?key=20180131010012287
162,2018-01-31,삼성바이오로직스창사7년만에첫연간흑자삼성바이오에피스는적자지속,http://biz.chosun.com/site/data/html_dir/2018/01/31/2018013102291.html
163,2018-01-31,삼성바이오로직스지난해영업흑자전환630억원,http://www.dailian.co.kr/news/view/690550/?sc=naver
164,2018-01-31,삼성바이오로직스매출4598억전년561↑,http://news.mt.co.kr/mtview.php?no=2018013116413229465
165,2018-01-31,삼성바이오로직스지난해4분기영업익4759억흑자전환,http://news.heraldcorp.com/view.php?ud=20180131000861
166,2018-01-31,삼성바이오로직스작년영업이익630억307증가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1151963
167,2018-01-31,삼성바이오로직스지난해매출4598억원영업익630억원전년대비증가,http://www.sisafocus.co.kr/news/articleView.html?idxno=173166
168,2018-01-31,삼성바이오로직스지난해영업익630억원흑자전환,http://www.newsway.co.kr/view.php?tp=1&ud=2018013116470723665
169,2018-01-31,삼성바이오로직스지난해영업익흑자전환630억원,http://www.cstimes.com/?mod=news&act=articleView&idxno=266971
170,2018-01-31,삼성바이오로직스지난해영업익300증가,http://www.m-i.kr/news/articleView.html?idxno=383467
171,2018-01-31,공시삼성바이오로직스지난해영업익630억흑자전환,http://www.fnnews.com/news/201801311700021291
172,2018-01-31,삼성바이오로직스4Q실적호조에흑전에피스는영업적자지속종합,http://view.asiae.co.kr/news/view.htm?idxno=2018013117043861608
173,2018-01-31,삼성바이오로직스지난해영업익630억흑자전환,http://www.metroseoul.co.kr/news/newsview?newscd=2018013100135
174,2018-01-31,삼성바이오로직스지난해영업익630억전년比307↑,http://www.newsprime.co.kr/news/article.html?no=404876
175,2018-01-31,공시삼성바이오로직스작년영업익630억흑자전환,http://www.viva100.com/main/view.php?key=20180131010012304
176,2018-01-31,삼성바이오로직스작년영업이익630억원,http://www.kpinews.co.kr/news/articleView.html?idxno=65300
177,2018-01-31,삼성바이오로직스2017년매출4598억원영업이익630억원기록,http://www.fnnews.com/news/201801311714501387
178,2018-01-31,삼성바이오로직스지난해영업익630억흑자전환,http://www.newstomato.com/ReadNews.aspx?no=803935
179,2018-01-31,삼성바이오로직스작년영업이익630억흑자전환,http://www.newsworks.co.kr/news/articleView.html?idxno=164785
180,2018-01-31,삼성바이오로직스작년영업익629억원흑자전환,http://view.asiae.co.kr/news/view.htm?idxno=2018013117243488644
181,2018-01-31,삼성바이오로직스작년영업이익630억,http://www.seoulfn.com/news/articleView.html?idxno=298392
182,2018-01-31,삼성바이오로직스창사이래첫영업흑자꿈이뤘다,http://www.ebn.co.kr/news/view/928122
183,2018-01-31,삼성바이오로직스지난해영업익630억원흑자전환,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801310577
184,2018-01-31,삼성바이오로직스창사첫흑자,http://news.mk.co.kr/newsRead.php?year=2018&no=72612
185,2018-01-31,삼성바이오로직스지난해영업익630억흑자전환,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018013117543917275
186,2018-01-31,삼성바이오로직스지난해영업이익630억원흑자전환성공,http://www.ceoscoredaily.com/news/article.html?no=37324
187,2018-01-31,삼성바이오로직스작년매출4598억달성,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1052090
188,2018-01-31,첫영업흑자삼성바이오로직스1000억육박순손실왜종합,http://www.newspim.com/news/view/20180131000328
189,2018-01-31,삼성바이오로직스창사뒤처음으로지난해영업이익흑자,http://www.businesspost.co.kr/BP?command=article_view&num=71701
190,2018-01-31,삼성바이오로직스지난해4분기영업익475억흑자전환,http://www.betanews.net:8080/article/804420.html
191,2018-01-31,삼성바이오로직스작년매출액4598억원영업이익은630억원,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=735537
192,2018-01-31,삼성바이오로직스영업익630억,http://www.kyeongin.com/main/view.php?key=20180201010010230
193,2018-02-01,삼성바이오로직스사상첫흑자전환,http://www.ajunews.com/view/20180131152905700
194,2018-02-01,삼성바이오로직스6년만에흑자돈벌일만남았다,http://www.edaily.co.kr/news/newspath.asp?newsid=01357926619106256
195,2018-02-01,삼성바이오로직스4분기어닝서프라이즈구현목표주가상향유안타증권,http://www.greened.kr/news/articleView.html?idxno=50056
196,2018-02-01,삼성바이오로직스CMO수요모멘텀목표가↑현대차투자證,http://news.mt.co.kr/mtview.php?no=2018020107582506850
197,2018-02-01,삼성바이오로직스4분기깜짝실적1분기는눈높이낮춰야NH,http://news.hankyung.com/article/2018020116586
198,2018-02-01,삼성바이오로직스목표주가높아져공장가동률좋아져성장세지속,http://www.businesspost.co.kr/BP?command=article_view&num=71737
199,2018-02-01,삼성바이오로직스어닝서프라이즈기록목표가↑현대차투자증권,http://www.dailian.co.kr/news/view/690625/?sc=naver
200,2018-02-01,대신증권삼성바이오로직스빠른CMO적응력목표가49만↑”,http://www.viva100.com/main/view.php?key=20180201010000028
201,2018-02-01,삼성바이오로직스예상보다빠른수익성증가투자의견목표가↑대신증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1590287
202,2018-02-01,STOCK삼성바이오로직스원가율개선에실적전망상향목표가↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018020108218048991&outlink=1
203,2018-02-01,주요공시삼성바이오로직스SOil넷게임즈등,http://www.intn.co.kr/news/articleView.html?idxno=866837
204,2018-02-01,삼성바이오로직스수익증가전망목표가상향대신증권,http://www.newstomato.com/ReadNews.aspx?no=804005
205,2018-02-01,현대차투자증권삼성바이오로직스4분기어닝서프라이즈공장정상가동시높은외형성장가능”,http://www.g-enews.com/ko-kr/news/article/news_all/20180201083326698c642673384_1/article.html
206,2018-02-01,삼성바이오로직스빠른경쟁력강화대신,http://www.cstimes.com/?mod=news&act=articleView&idxno=266997
207,2018-02-01,삼성바이오로직스CMO안정성성장기대매수대신,http://www.edaily.co.kr/news/newspath.asp?newsid=01725286619106256
208,2018-02-01,특징주삼성바이오로직스4분기영업이익흑전에상승세,http://news.mt.co.kr/mtview.php?no=2018020109041586802
209,2018-02-01,특징주삼성바이오로직스4분기깜짝실적강세,http://news.hankyung.com/article/2018020120006
210,2018-02-01,특징주삼성바이오로직스지난해흑자전환에강세,http://www.seoulfn.com/news/articleView.html?idxno=298419
211,2018-02-01,HotLine삼성바이오로직스창립후첫흑자전환소식에강세,http://news.mk.co.kr/newsRead.php?year=2018&no=73706
212,2018-02-01,삼성바이오로직스4분기영업익흑자전환에상승,http://www.newsprime.co.kr/news/article.html?no=404928
213,2018-02-01,삼성바이오로직스첫흑자영업이익307↑,http://www.kormedi.com/news/news/drug_dist/1226045_2906.html
214,2018-02-01,삼성바이오로직스2017년매출4598억영업이익630억기록,http://www.kukinews.com/news/article.html?no=521717
215,2018-02-01,삼성바이오로직스작년4분기영업이익흑자전환소식에도약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=310221
216,2018-02-01,삼성바이오로직스지난해첫흑자전환공장이살렸다,http://www.sisaweek.com/news/articleView.html?idxno=102479
217,2018-02-01,첫연간흑자삼성바이오로직스증권사목표주가잇따라상향,http://www.newsis.com/view/?id=NISX20180201_0000219425&cID=10401&pID=10400
218,2018-02-01,종목플러스흑자전환성공한삼성바이오로직스목표가줄상향,http://news.hankyung.com/article/2018020117336
219,2018-02-01,2월증시롱숏전략부각삼성바이오로직스삼성전기등사고KTG한국전력등팔아라,http://www.g-enews.com/ko-kr/news/article/news_all/201802011105199861c642673384_1/article.html
220,2018-02-01,특징주삼성바이오로직스2017년4분기어닝서프라이즈,http://www.sisaon.co.kr/news/articleView.html?idxno=69245
221,2018-02-01,ET투자뉴스삼성바이오로직스예상보다빠른경쟁매수상향대신증권,http://www.etnews.com/20180201000166
222,2018-02-01,ET투자뉴스삼성바이오로직스어닝서프라이즈매수현대차투자증권,http://www.etnews.com/20180201000211
223,2018-02-01,ET투자뉴스삼성바이오로직스2공장생산량증가매수유지유안타증권,http://www.etnews.com/20180201000335
224,2018-02-01,삼성바이오로직스1124억규모의약품위탁생산계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214770
225,2018-02-01,삼성바이오로직스1124억원규모의약품위탁생산계약,http://view.asiae.co.kr/news/view.htm?idxno=2018020115464902771
226,2018-02-01,삼성바이오로직스1124억규모바이오의약품위탁생산계약체결,http://www.asiatoday.co.kr/view.php?key=20180201010000626
227,2018-02-01,ET투자뉴스삼성바이오로직스207940수주공급계약아시아소재제약,http://www.etnews.com/20180201000438
228,2018-02-01,e2BOT삼성바이오로직스1124억원규모의기타판매공급계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1590579
229,2018-02-01,삼성바이오로직스1124억규모의약품위탁생산계약체결,http://news.mt.co.kr/mtview.php?no=2018020115493545440
230,2018-02-01,공시삼성바이오로직스1124억원규모의약품위탁생산계약체결,http://www.newsway.co.kr/view.php?tp=1&ud=2018020115503682908
231,2018-02-01,삼성바이오로직스1124억원규모의약품위탁생산계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=310282
232,2018-02-01,삼성바이오로직스1124억원대의약품위탁생산추가계약체결,http://biz.chosun.com/site/data/html_dir/2018/02/01/2018020102156.html
233,2018-02-01,삼성바이오로직스1124억원규모의약품생산계약체결,http://news1.kr/articles/?3224215
234,2018-02-01,삼성바이오로직스1124억규모의약품위탁생산추가계약,http://www.newsis.com/view/?id=NISX20180201_0000220098&cID=10401&pID=10400
235,2018-02-01,삼성바이오로직스1124억규모의약품위탁생산계약체결,http://www.newsworks.co.kr/news/articleView.html?idxno=165080
236,2018-02-01,삼성바이오로직스증권가눈높이일제히상향1124억규모생산계약체결도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1590655
237,2018-02-01,유가증권시장공시삼성바이오로직스디아이,http://news.mk.co.kr/newsRead.php?year=2018&no=76144
238,2018-02-02,삼성바이오로직스몸값올리는증권가,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=797385
239,2018-02-02,첫연간흑자삼성바이오로직스장기성장성낙관적”,http://www.mdtoday.co.kr/mdtoday/index.html?no=310333
240,2018-02-02,삼성바이오로직스지난해영업익흑자전환올해맑음,http://www.mdtoday.co.kr/mdtoday/index.html?no=310322
241,2018-02-02,주요공시삼성바이오로직스1124억원규모의약품위탁생산계약,http://www.cstimes.com/?mod=news&act=articleView&idxno=267105
242,2018-02-02,ET투자뉴스삼성바이오로직스207940수주공급계약아시아소재제약,http://www.etnews.com/20180202000009
243,2018-02-04,마켓포인트코스피개인순매도1위삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01804006619107240
244,2018-02-05,하락하는코스피시장어닝서프라이즈로빛난삼성바이오로직스상승,http://www.mdtoday.co.kr/mdtoday/index.html?no=310516
245,2018-02-05,제약바이오지각변동②꽃길걷는삼성바이오로직스,http://www.mdtoday.co.kr/mdtoday/index.html?no=310521
246,2018-02-05,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=804701
247,2018-02-06,셀트리온삼성바이오로직스수출확대로의약품해외수출증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=310702
248,2018-02-06,암흑탈출삼성SDI삼성바이오로직스성장세이어갈까,http://www.datanews.co.kr/news/article.html?no=100226
249,2018-02-06,삼성바이오로직스전일대비약5하락한403000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802060460
250,2018-02-07,메디포스트삼성바이오로직스2017년영업익흑자전환성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=310838
251,2018-02-07,삼성바이오로직스인천송도에공급사슬구축,http://www.joongboo.com/?mod=news&act=articleView&idxno=1227930
252,2018-02-08,삼성바이오로직스알랭베르세스위스대통령본사방문,http://www.fnnews.com/news/201802081601573628
253,2018-02-08,스위스대통령삼성바이오로직스방문,http://view.asiae.co.kr/news/view.htm?idxno=2018020816092766044
254,2018-02-08,삼성바이오로직스스위스대통령사절단방문,http://www.edaily.co.kr/news/newspath.asp?newsid=03739206619108552
255,2018-02-08,스위스대통령송도삼성바이오로직스찾은까닭,http://www.ebn.co.kr/news/view/929429
256,2018-02-08,스위스대통령삼성바이오로직스방문,http://www.dt.co.kr/contents.html?article_no=2018020802109976029008&ref=naver
257,2018-02-08,알랭베르세스위스대통령삼성바이오로직스방문,http://www.mdtoday.co.kr/mdtoday/index.html?no=311198
258,2018-02-08,포토스위스대통령에게제품설명하고있는김태한삼성바이오로직스사장,http://www.asiatoday.co.kr/view.php?key=20180208010005145
259,2018-02-08,알랭베르세스위스대통령삼성바이오로직스방문,http://www.dailian.co.kr/news/view/692566/?sc=naver
260,2018-02-08,베르세스위스대통령삼성바이오로직스송도본사방문,http://biz.chosun.com/site/data/html_dir/2018/02/08/2018020802326.html
261,2018-02-08,스위스대통령삼성바이오로직스방문협력확대기대,http://news.einfomax.co.kr/news/articleView.html?idxno=3434209
262,2018-02-08,알랭베르세스위스대통령삼성바이오로직스본사방문,http://daily.hankooki.com/lpage/economy/201802/dh20180208163804138080.htm
263,2018-02-08,스위스대통령삼성바이오로직스방문협력확대기대,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180208161200017&did=1195m
264,2018-02-08,스위스대통령삼성바이오로직스방문,http://news.mk.co.kr/newsRead.php?year=2018&no=92788
265,2018-02-08,알랭베르세스위스대통령삼성바이오로직스방문,http://www.newspim.com/news/view/20180208000276
266,2018-02-08,알랭베르세스위스대통령삼성바이오로직스방문,http://www.sedaily.com/NewsView/1RVMIQ4N1G
267,2018-02-08,스위스대통령삼성바이오로직스방문,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180208388300017&did=1196m
268,2018-02-08,스위스대통령삼성바이오로직스본사방문,http://www.enewstoday.co.kr/news/articleView.html?idxno=1155387
269,2018-02-08,베르세스위스대통령로슈협력사삼성바이오로직스방문,http://news1.kr/articles/?3231226
270,2018-02-08,스위스대통령삼성바이오로직스방문,http://www.ciobiz.co.kr/news/article.html?id=20180208120019
271,2018-02-08,스위스대통령삼성바이오로직스방문,http://www.sporbiz.co.kr/news/articleView.html?idxno=196836
272,2018-02-08,스위스대통령송도삼성바이오로직스방문,http://www.fnnews.com/news/201802081852299434
273,2018-02-08,스위스대통령삼성바이오로직스방문해긴밀히협력,http://www.m-i.kr/news/articleView.html?idxno=386037
274,2018-02-08,스위스대통령삼성바이오로직스방문해공장둘러봐,http://www.businesspost.co.kr/BP?command=article_view&num=72673
275,2018-02-08,스위스대통령송도삼성바이오로직스깜짝방문왜,http://www.viva100.com/main/view.php?key=20180208010003457
276,2018-02-08,스위스대통령삼성바이오로직스방문,http://www.medigatenews.com/news/2675433647
277,2018-02-08,포토스위스대통령송도삼성바이오로직스방문,http://www.kyeongin.com/main/view.php?key=20180208010003028
278,2018-02-09,스위스대통령삼성바이오로직스방문,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=798428
279,2018-02-09,스위스대통령삼성바이오로직스방문왜,http://www.sisaweek.com/news/articleView.html?idxno=102911
280,2018-02-09,뉴스투데이E스위스대통령삼성바이오로직스방문눈길,http://www.news2day.co.kr/98959
281,2018-02-09,스위스대통령삼성바이오로직스생산공장방문,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1052456
282,2018-02-09,스위스대통령삼성바이오로직스방문,http://www.munhwa.com/news/view.html?no=2018020901073603000001
283,2018-02-09,알랭베르세스위스대통령삼성바이오로직스본사방문,http://www.kukinews.com/news/article.html?no=524150
284,2018-02-11,스위스대통령일행삼성바이오로직스방문,http://www.kgnews.co.kr/news/articleView.html?idxno=506623
285,2018-02-12,알랭베르세AlainBerset스위스대통령삼성바이오로직스방문,http://www.anewsa.com/detail.php?number=1279759&thread=01r01
286,2018-02-12,스위스대통령삼성바이오로직스방문,http://www.anewsa.com/detail.php?number=1279758&thread=09r02
287,2018-02-12,코스피반등셀트리온삼성바이오로직스5대껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=39313
288,2018-02-12,코스피외국인순매수삼성전자삼성바이오로직스SK하이닉스,http://www.newsway.co.kr/view.php?tp=1&ud=2018021217000485716
289,2018-02-14,코스피외국인순매수삼성전자셀트리온삼성바이오로직스I,http://www.newsway.co.kr/view.php?tp=1&ud=2018021416545952671
290,2018-02-16,하락장이겨낸강세株③삼성바이오로직스창사이래첫흑자투자의견상향,http://www.metroseoul.co.kr/news/newsview?newscd=2018021600008
291,2018-02-20,삼성바이오로직스공장가동률상승과함께실적도UP유안타證,http://news.mt.co.kr/mtview.php?no=2018022007555480083
292,2018-02-20,삼성바이오로직스공장가동률상승과더불어실적상승,http://www.asiatoday.co.kr/view.php?key=20180220010010695
293,2018-02-20,유안타증권삼성바이오로직스바이오시밀러유럽시장진출로호실적전망,http://www.g-enews.com/ko-kr/news/article/news_all/201802200828011049c16aa2f016_1/article.html
294,2018-02-20,ET투자뉴스삼성바이오로직스공장가동률상승과매수유지유안타증권,http://www.etnews.com/20180220000007
295,2018-02-20,유안타증권삼성바이오로직스CDMO사업시작장기적수주에도움”,http://www.newsway.co.kr/view.php?tp=1&ud=2018022008532086943
296,2018-02-20,삼성바이오로직스주가더간다3공장가동률갈수록높아져,http://www.businesspost.co.kr/BP?command=article_view&num=73497
297,2018-02-20,삼성바이오로직스미래의고객유치를위한서비스CDMO,http://www.newsworks.co.kr/news/articleView.html?idxno=168401
298,2018-02-20,경인포토짙은안개에잠긴인천송도삼성바이오로직스,http://www.kyeongin.com/main/view.php?key=20180220010006666
299,2018-02-20,경인포토짙은안개에잠긴인천송도삼성바이오로직스,http://www.kyeongin.com/main/view.php?key=20180220010006667
300,2018-02-20,특징주삼성바이오로직스공장가동률상승에실적동반상승,http://www.sisaon.co.kr/news/articleView.html?idxno=70083
301,2018-02-21,판커지는CMO시장날개단삼성바이오로직스,http://www.ekn.kr/news/article.html?no=344744
302,2018-02-21,인사삼성바이오로직스,http://view.asiae.co.kr/news/view.htm?idxno=2018022110113033639
303,2018-02-21,인사삼성바이오로직스,http://news1.kr/articles/?3241063
304,2018-02-21,삼성바이오로직스2018년정기임원인사,http://www.medigatenews.com/board/people/view/589
305,2018-02-21,인사삼성바이오로직스,http://www.fnnews.com/news/201802211020220336
306,2018-02-21,인사삼성바이오로직스,http://www.seoulfn.com/news/articleView.html?idxno=299715
307,2018-02-21,인사삼성바이오로직스,http://news.einfomax.co.kr/news/articleView.html?idxno=3435594
308,2018-02-21,프로필제임스박삼성바이오로직스전무,http://www.asiatoday.co.kr/view.php?key=20180221010011684
309,2018-02-21,삼성바이오로직스3명승진시킨정기임원인사단행,http://news.mk.co.kr/newsRead.php?year=2018&no=119111
310,2018-02-21,프로필심병화삼성바이오로직스상무,http://www.asiatoday.co.kr/view.php?key=20180221010011698
311,2018-02-21,인사삼성바이오로직스,http://www.fnnews.com/news/201802211032357495
312,2018-02-21,프로필마이클가비삼성바이오로직스상무,http://www.asiatoday.co.kr/view.php?key=20180221010011713
313,2018-02-21,인사삼성바이오로직스,http://www.newspim.com/news/view/20180221000066
314,2018-02-21,인사삼성바이오에피스삼성바이오로직스,http://www.enewstoday.co.kr/news/articleView.html?idxno=1159550
315,2018-02-21,인사삼성바이오로직스,http://www.asiatime.co.kr/news/articleView.html?idxno=168797
316,2018-02-21,인사삼성바이오로직스,http://www.viva100.com/main/view.php?key=20180221010007284
317,2018-02-21,삼성바이오로직스정기임원인사전무에제임스박,http://daily.hankooki.com/lpage/economy/201802/dh20180221103912138080.htm
318,2018-02-21,인사삼성바이오로직스,http://www.newsis.com/view/?id=NISX20180221_0000233432&cID=10902&pID=16000
319,2018-02-21,삼성바이오로직스임원인사글로벌실적기여고려,http://www.dailypharm.com/News/236969
320,2018-02-21,인사삼성바이오로직스,http://www.dailian.co.kr/news/view/695254/?sc=naver
321,2018-02-21,인사삼성바이오로직스정기임원인사,http://www.sisajournal-e.com/biz/article/180493
322,2018-02-21,인사삼성바이오로직스,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1052772
323,2018-02-21,인사기술보증기금삼성바이오로직스삼성바이오에피스,http://www.businesspost.co.kr/BP?command=article_view&num=73631
324,2018-02-21,인사삼성바이오로직스,http://www.sisaon.co.kr/news/articleView.html?idxno=70149
325,2018-02-21,삼성바이오로직스정기임원인사단행,http://www.mdtoday.co.kr/mdtoday/index.html?no=312494
326,2018-02-21,인사삼성바이오로직스,http://www.kpinews.co.kr/news/articleView.html?idxno=66932
327,2018-02-21,인사삼성바이오로직스外,http://news.heraldcorp.com/view.php?ud=20180221000362
328,2018-02-21,인사삼성바이오로직스,http://www.ajunews.com/view/20180221111656085
329,2018-02-21,인사삼성바이오로직스,http://biz.chosun.com/site/data/html_dir/2018/02/21/2018022101195.html
330,2018-02-21,삼성바이오로직스2018년정기임원인사단행글로벌CMO사업실적고려,http://www.metroseoul.co.kr/news/newsview?newscd=2018022100053
331,2018-02-21,2월21일인사①삼성바이오에피스삼성바이오로직스外,http://www.news2day.co.kr/99432
332,2018-02-21,인사삼성바이오로직스2018년정기임원인사,http://www.m-i.kr/news/articleView.html?idxno=388960
333,2018-02-21,인사삼성바이오로직스,http://www.etnews.com/20180221000177
334,2018-02-21,삼성바이오로직스정기임원인사,http://www.bosa.co.kr/news/articleView.html?idxno=2078388
335,2018-02-21,인사삼성바이오로직스,http://www.dt.co.kr/contents.html?article_no=2018022102109976029004&ref=naver
336,2018-02-21,인사삼성바이오로직스,http://www.ceoscoredaily.com/news/article.html?no=38087
337,2018-02-21,인사삼성바이오로직스,http://www.ebn.co.kr/news/view/930877
338,2018-02-21,인사삼성바이오로직스,http://www.ciobiz.co.kr/news/article.html?id=20180221120016
339,2018-02-21,인사삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=02643686619112816
340,2018-02-21,인사삼성바이오로직스삼성바이오에피스,https://cnbc.sbs.co.kr/article_hub/10000892779?division=NAVER
341,2018-02-21,삼성바이오로직스2018년정기임원인사단행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022114555398665
342,2018-02-21,인사삼성바이오로직스,http://www.newstomato.com/ReadNews.aspx?no=807713
343,2018-02-21,삼성바이오로직스김태한고한승삼성바이오에피스사장유임,http://www.ekn.kr/news/article.html?no=345023
344,2018-02-21,인사키움증권;삼성바이오에피스;삼성바이오로직스등,http://news.hankyung.com/article/2018022153221
345,2018-02-21,인사삼성바이오로직스,http://www.ggilbo.com/news/articleView.html?idxno=445987
346,2018-02-21,삼성바이오로직스정기임원인사단행,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1446510
347,2018-02-21,인사안양시삼성바이오로직스삼성바이오에피스,http://www.kyeongin.com/main/view.php?key=20180221010007218
348,2018-02-22,삼성바이오로직스주가더오를듯,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=799708
349,2018-02-22,경제계인사삼성바이오로직스外,http://news.donga.com/3/all/20180221/88786600/1
350,2018-02-22,삼성바이오로직스美제약사와179억원규모계약,http://www.edaily.co.kr/news/newspath.asp?newsid=01321846619113144
351,2018-02-22,삼성바이오로직스美제약사와179억원규모계약,http://news.hankyung.com/article/2018022262066
352,2018-02-22,공시삼성바이오로직스178억원규모의약품위탁생산계약체결,http://www.newsway.co.kr/view.php?tp=1&ud=2018022207512397626
353,2018-02-22,삼성바이오로직스美제약사와의약품위탁생산계약체결,http://news.mt.co.kr/mtview.php?no=2018022207480579316
354,2018-02-22,삼성바이오로직스美제약사와의약품위탁생산계약,http://news1.kr/articles/?3242117
355,2018-02-22,삼성바이오로직스美제약사와의약품위탁생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180222027100008&did=1195m
356,2018-02-22,e2BOT삼성바이오로직스美제약사와179억규모의약품위탁생산계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1596918
357,2018-02-22,삼성바이오로직스美소재제약사에178억규모의약품위탁생산계약,http://www.newspim.com/news/view/20180222000029
358,2018-02-22,삼성바이오로직스美제약사와179억규모의약품위탁생산계약,http://view.asiae.co.kr/news/view.htm?idxno=2018022208174273617
359,2018-02-22,삼성바이오로직스미국제약사의임상시험용물질위탁생산키로,http://news.mk.co.kr/newsRead.php?year=2018&no=121794
360,2018-02-22,ET투자뉴스삼성바이오로직스207940수주공급계약미국소재제약사,http://www.etnews.com/20180222000003
361,2018-02-22,삼성바이오로직스美제약사와의약품위탁생산계약,http://www.asiatoday.co.kr/view.php?key=20180222010012382
362,2018-02-22,삼성바이오로직스미국제약사와178억규모위탁생산계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215331
363,2018-02-22,삼성바이오로직스美제약사와178억원규모계약,http://www.newstomato.com/ReadNews.aspx?no=807889
364,2018-02-22,삼성바이오로직스美제약사와1786억규모의약품위탁생산계약,http://news.heraldcorp.com/view.php?ud=20180222000052
365,2018-02-22,삼성바이오로직스3공장첫수주178억원규모,http://www.newspim.com/news/view/20180222000033
366,2018-02-22,공시삼성바이오로직스179억규모의약품위탁생산계약체결,http://www.viva100.com/main/view.php?key=20180222010007666
367,2018-02-22,삼성바이오로직스3공장첫수주계약체결178억원규모,http://www.fnnews.com/news/201802220848092569
368,2018-02-22,삼성바이오로직스美제약사와위탁생산계약3공장양산착수,http://www.edaily.co.kr/news/newspath.asp?newsid=01567846619113144
369,2018-02-22,삼성바이오로직스미제약사와3공장임상제품위탁생산계약,http://www.dt.co.kr/contents.html?article_no=2018022202109976029002&ref=naver
370,2018-02-22,삼성바이오로직스3공장첫수주美제약사와178억규모,http://www.ajunews.com/view/20180222083729766
371,2018-02-22,삼성바이오로직스미국제약사와178억규모의약품위탁생산계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=312638
372,2018-02-22,특징주삼성바이오로직스3공장첫수주계약에강세,http://news.mt.co.kr/mtview.php?no=2018022209085095423
373,2018-02-22,특징주삼성바이오로직스美제약사와의약품위탁생산계약↑,http://view.asiae.co.kr/news/view.htm?idxno=2018022209123099419
374,2018-02-22,삼성바이오로직스3공장첫위탁생산美제약사와계약상보,http://news1.kr/articles/?3242168
375,2018-02-22,ET투자뉴스삼성바이오로직스_돋보이는상승세현재282,http://www.etnews.com/20180222000029
376,2018-02-22,삼성바이오로직스美제약사와178억의약품위탁생산계약,http://www.newsis.com/view/?id=NISX20180222_0000234289&cID=10401&pID=10400
377,2018-02-22,삼성바이오로직스3공장첫의약품생산수주성공종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180222027151008&did=1195m
378,2018-02-22,삼성바이오로직스3공장첫수주美제약사와180억원규모계약,http://www.ebn.co.kr/news/view/930978
379,2018-02-22,인사삼성바이오로직스정기임원인사,http://www.econovill.com/news/articleView.html?idxno=332240
380,2018-02-22,특징주삼성바이오로직스178억규모CMO계약에강세3공장첫수주,http://news.hankyung.com/article/2018022265406
381,2018-02-22,특징주삼성바이오로직스3공장첫수주계약에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180222043700008&did=1195m
382,2018-02-22,삼성바이오로직스미국소재제약사와178억규모의약품위탁생산계약,http://biz.chosun.com/site/data/html_dir/2018/02/22/2018022200829.html
383,2018-02-22,삼성바이오로직스3공장완공후첫계약체결주가상승하며시작,http://www.sisafocus.co.kr/news/articleView.html?idxno=180911
384,2018-02-22,삼성바이오로직스3공장첫의약품생산수주,http://view.asiae.co.kr/news/view.htm?idxno=2018022209295572835
385,2018-02-22,삼성바이오로직스제3공장첫위탁생산돌입에3강세,http://news.heraldcorp.com/view.php?ud=20180222000133
386,2018-02-22,삼성바이오로직스3공장첫수주계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1160007
387,2018-02-22,특징주삼성바이오로직스3공장의약품수주신호탄에상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1596992
388,2018-02-22,인사삼성바이오로직스,http://www.econonews.co.kr/news/articleView.html?idxno=19210
389,2018-02-22,삼성바이오로직스美제약사와179억원규모위탁생산계약,http://www.ceoscoredaily.com/news/article.html?no=38118
390,2018-02-22,삼성바이오로직스세계최대규모3공장첫수주美제약사1660만달러,http://www.fnnews.com/news/201802220933550570
391,2018-02-22,특징주삼성바이오로직스미국제약사와위탁생산계약에강세,http://www.ebn.co.kr/news/view/930996
392,2018-02-22,특징주삼성바이오로직스美제약사와위탁생산계약에강세,http://www.newsis.com/view/?id=NISX20180222_0000234389&cID=10401&pID=10400
393,2018-02-22,특징주수주계약체결삼성바이오로직스상승에스피지하룻만에다시급등오스테오닉공모가2배등,http://www.news2day.co.kr/99498
394,2018-02-22,삼성바이오로직스의약품위탁생산계약체결소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=312649
395,2018-02-22,삼성바이오로직스작년준공한3공장첫생산물량수주,http://news.mk.co.kr/newsRead.php?year=2018&no=122124
396,2018-02-22,특징주삼성바이오로직스강세美에3공장첫의약품생산수주성공,http://www.g-enews.com/ko-kr/news/article/news_all/201802220932425314c16aa2f016_1/article.html
397,2018-02-22,삼성바이오로직스美제약사와179억원위탁생산계약,http://www.sedaily.com/NewsView/1RVSWE4JEP
398,2018-02-22,삼성바이오로직스3공장첫의약품생산수주,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003115285
399,2018-02-22,삼성바이오로직스3공장첫수주에주가방긋,http://www.newsprime.co.kr/news/article.html?no=407247
400,2018-02-22,삼성바이오로직스3공장첫수주계약,http://www.bosa.co.kr/news/articleView.html?idxno=2078439
401,2018-02-22,특징주삼성바이오로직스강세미국제약사와위탁생산계약,http://www.econonews.co.kr/news/articleView.html?idxno=19225
402,2018-02-22,삼성바이오로직스3공장첫위탁생산수주,http://www.seoulfn.com/news/articleView.html?idxno=299805
403,2018-02-22,삼성바이오로직스3공장첫수주계약체결,http://www.ekn.kr/news/article.html?no=345172
404,2018-02-22,삼성바이오로직스미국제약사와의약품위탁생산계약체결,http://www.cstimes.com/?mod=news&act=articleView&idxno=268772
405,2018-02-22,삼성바이오로직스3공장첫수주계약체결,http://www.metroseoul.co.kr/news/newsview?newscd=2018022200020
406,2018-02-22,특징주삼성바이오로직스3공장첫수주계약소식에강세,http://www.newsway.co.kr/view.php?tp=1&ud=2018022210222158403
407,2018-02-22,삼성바이오로직스美제약사와179억규모의약품위탁생산계약,http://www.newsworks.co.kr/news/articleView.html?idxno=168870
408,2018-02-22,특징주삼성바이오로직스179억생산계약에상승,http://www.viva100.com/main/view.php?key=20180222010007728
409,2018-02-22,삼성바이오로직스주가3공장첫수주계약에상승세,http://daily.hankooki.com/lpage/economy/201802/dh20180222104918138110.htm
410,2018-02-22,삼성바이오로직스미국제약사와의약품위탁생산계약,http://daily.hankooki.com/lpage/economy/201802/dh20180222105430138080.htm
411,2018-02-22,삼성바이오로직스3공장첫의약품생산수주성공,http://news.mk.co.kr/newsRead.php?year=2018&no=122392
412,2018-02-22,수급골든타임실시간수급시그널종목삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022211072220972
413,2018-02-22,특징주삼성바이오로직스수주계약소식에오름세,http://www.asiatime.co.kr/news/articleView.html?idxno=168975
414,2018-02-22,삼성바이오로직스美제약사와의약품위탁생산계약,http://www.wolyo.co.kr/news/articleView.html?idxno=54450
415,2018-02-22,삼성바이오로직스3공장첫의약품생산수주계약,http://www.newsis.com/view/?id=NISX20180222_0000234665&cID=13001&pID=13000
416,2018-02-22,코스피코스닥하락세삼성바이오로직스미제약사위탁생산계약소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=312681
417,2018-02-22,DailyBio삼성바이오로직스3공장첫위탁생산업무수주,http://www.econovill.com/news/articleView.html?idxno=332276
418,2018-02-22,삼성바이오로직스3공장첫수주계약체결,http://www.dailypop.kr/news/articleView.html?idxno=32195
419,2018-02-22,뉴스콕삼성바이오로직스3공장첫의약품생산수주성공,http://www.newstomato.com/ReadNews.aspx?no=807960
420,2018-02-22,공시앤리포트삼성바이오로직스미제약사와179억계약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003115688
421,2018-02-22,개미들의착각천장맞히기삼성바이오로직스3공장첫수주랠리신호탄,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022214282273202
422,2018-02-22,삼성바이오로직스3공장178억규모수주,http://www.kormedi.com/news/news/drug_dist/1226260_2906.html
423,2018-02-22,특징주삼성바이오로직스3공장첫수주계약에4대강세종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180222043751008&did=1195m
424,2018-02-22,삼성바이오로직스美제약사와3공장첫의약품위탁생산계약,http://www.sportsseoul.com/news/read/604911
425,2018-02-22,삼성바이오로직스미국제약사의약품위탁생산계약체결소식에강세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=312725
426,2018-02-22,종합특징주삼성바이오로직스美제약사와위탁생산계약에상승,http://www.newsis.com/view/?id=NISX20180222_0000235061&cID=10401&pID=10400
427,2018-02-22,코스피약세에도삼성바이오로직스한올바이오파마훨훨,http://www.choicenews.co.kr/news/articleView.html?idxno=39519
428,2018-02-22,삼성바이오로직스미국제약사와위탁생산계약소식에424상승마감,http://www.econonews.co.kr/news/articleView.html?idxno=19281
429,2018-02-22,코스피코스닥장중꾸준한약세삼성바이오로직스위탁생산체결소식에강세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=312736
430,2018-02-22,아주종목분석삼성바이오로직스의약품생산수주에4대강세,http://www.ajunews.com/view/20180222170726518
431,2018-02-22,수주약발받는삼성바이오로직스내가제일잘나가,http://www.sedaily.com/NewsView/1RVSY0ALJ8
432,2018-02-22,삼성바이오로직스3공장미국제약사위탁생산첫수주,http://news.hankyung.com/article/2018022294641
433,2018-02-22,삼성바이오로직스주가올라제3공장첫수주로매수몰려,http://www.businesspost.co.kr/BP?command=article_view&num=73874
434,2018-02-22,삼성바이오로직스3공장첫수주,http://www.fnnews.com/news/201802221900301731
435,2018-02-22,삼성바이오로직스3공장첫수주美제약사와의약품위탁생산계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1597359
436,2018-02-22,삼성바이오로직스3공장첫수주계약,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=738616
437,2018-02-22,삼성바이오로직스3공장첫의약품수주美제약사와178억계약체결,http://www.kyeongin.com/main/view.php?key=20180222010008130
438,2018-02-23,삼성바이오로직스3공장준공3개월만에첫의약품생산수주,http://news.heraldcorp.com/view.php?ud=20180223000035
439,2018-02-23,삼성바이오로직스3공장의약품생산수주성공에상승,http://www.sedaily.com/NewsView/1RVTCQPR9U
440,2018-02-23,지금이라도사라호평일색삼성바이오로직스셀트리온추격,http://news.heraldcorp.com/view.php?ud=20180223000106
441,2018-02-23,삼성바이오로직스3공장의약품생산수주에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=312822
442,2018-02-24,이번주외인은2주연속매수세SK하이닉스삼성바이오로직스사자,http://www.asiatoday.co.kr/view.php?key=20180224010013879
443,2018-02-25,삼성바이오로직스셀트리온바이오대장주1위쟁탈전,http://www.mdtoday.co.kr/mdtoday/index.html?no=312934
444,2018-02-25,마켓포인트코스피개인순매도1위삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01626886619114128
445,2018-02-25,미국FDA승인앞두고있는제약주셀트리온대웅제약삼성바이오로직스,http://news.hankyung.com/article/2018022569671
446,2018-02-26,삼성바이오로직스시총30조돌파원동력은,http://www.edaily.co.kr/news/newspath.asp?newsid=02095926619114456
447,2018-02-26,fnRASSI삼성바이오로직스52주신고가122↑,http://www.fnnews.com/news/201802260957497017
448,2018-02-26,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=808528
449,2018-02-26,코스피IT주춤vs셀트리온삼성바이오로직스상승,http://www.choicenews.co.kr/news/articleView.html?idxno=39584
450,2018-02-26,코스피외국인순매수LG화학삼성바이오로직스셀트리온,http://www.newsway.co.kr/view.php?tp=1&ud=2018022617375531236
451,2018-02-27,몸값30조넘어선삼성바이오로직스,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=800308
452,2018-02-27,DataScore삼성바이오로직스매출56늘고영업익흑자전환,http://www.ceoscoredaily.com/news/article.html?no=38120
453,2018-02-27,삼성바이오로직스시총30조돌파현대차POSCO에도전장,http://news.einfomax.co.kr/news/articleView.html?idxno=3436423
454,2018-02-27,fnRASSI삼성바이오로직스20794052주신고가011↑,http://www.fnnews.com/news/201802271054001254
455,2018-02-27,셀트리온vs삼성바이오로직스바이오대장주경쟁,http://www.fnnews.com/news/201802271915454630
456,2018-02-28,삼성바이오로직스내달22일정기주총소집,http://www.edaily.co.kr/news/newspath.asp?newsid=03627686619115112
457,2018-03-01,시총30조원벽허문삼성바이오로직스,http://www.mdtoday.co.kr/mdtoday/index.html?no=313507
458,2018-03-01,SK부터삼성바이오로직스까지공정위62개지주사수익구조들여다본다,http://view.asiae.co.kr/news/view.htm?idxno=2018030111445082177
459,2018-03-01,삼성바이오로직스셀트리온홀딩스등지주회사수익구조실태조사실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=313373
460,2018-03-02,삼성바이오로직스3월22일정기주주총회소집,http://www.mdtoday.co.kr/mdtoday/index.html?no=313591
461,2018-03-02,개장전특징주삼성바이오로직스207940,http://www.newstomato.com/ReadNews.aspx?no=809394
462,2018-03-02,삼성바이오로직스POSCO제치고코스피시총5위에,http://news.mt.co.kr/mtview.php?no=2018030213362385353
463,2018-03-02,트럼프發악재에포스코삼성바이오로직스에시총순위내줘,http://www.sedaily.com/NewsView/1RWTNZKUD8
464,2018-03-02,유삼성바이오로직스장중신고가돌파464500→465000▲500,http://www.sedaily.com/NewsView/1RWTO7PD42
465,2018-03-02,fnRASSI삼성바이오로직스52주신고가378↑,http://www.fnnews.com/news/201803021403024901
466,2018-03-02,삼성바이오로직스포스코제치고시가총액5위차지,http://www.mdtoday.co.kr/mdtoday/index.html?no=313622
467,2018-03-02,특징주삼성바이오로직스포스코밀어내고시총5위등극,http://biz.chosun.com/site/data/html_dir/2018/03/02/2018030201877.html
468,2018-03-02,특징주삼성바이오로직스POSCO제치고첫시총5위,http://view.asiae.co.kr/news/view.htm?idxno=2018030215310708117
469,2018-03-02,트럼프관세폭탄에한국증시출렁셀트리온삼성바이오로직스급등,http://www.choicenews.co.kr/news/articleView.html?idxno=39666
470,2018-03-02,해외악재에하락이어가는코스피삼성바이오로직스셀트리온강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=313638
471,2018-03-02,코스피외국인순매수SK하이닉스삼성바이오로직스롯데케미칼,http://www.newsway.co.kr/view.php?tp=1&ud=2018030216172318110
472,2018-03-02,삼성바이오로직스셀트리온코스피하락에도상승랠리,http://www.mdtoday.co.kr/mdtoday/index.html?no=313650
473,2018-03-04,삼성바이오로직스포스코밀어내며시총5위차지,http://www.insight.co.kr/news/143055
474,2018-03-05,삼성바이오로직스코스피시총6위로POSCO제쳤다,http://news.einfomax.co.kr/news/articleView.html?idxno=3437156
475,2018-03-05,삼성바이오로직스게섯거라사상최고가경신한셀트리온삼성바이오와의주가격차역전시킬까,http://www.news2day.co.kr/99960
476,2018-03-05,삼성바이오로직스465500원보합권마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803050490
477,2018-03-06,삼성바이오로직스가동률증가에주가쑥쑥시총그룹내2위껑충,http://www.ceoscoredaily.com/news/article.html?no=38482
478,2018-03-06,삼성바이오로직스가동률상승으로매출성장세가팔라KB,http://news.hankyung.com/article/2018030651006
479,2018-03-06,삼성바이오로직스신규설비가동률상승목표주가38만원,http://www.asiatoday.co.kr/view.php?key=20180306010001694
480,2018-03-06,제약바이오셀트리온삼성바이오로직스중심차별화된주가흐름점차완화예상,http://www.nspna.com/news/?mode=view&newsid=270529
481,2018-03-06,셀트리온삼성바이오로직스쏠림현상완화될것”신한금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1600650
482,2018-03-06,ET투자뉴스삼성바이오로직스삼성이만들어낸또HOLD신규KB증권,http://www.etnews.com/20180306000006
483,2018-03-06,KB증권삼성바이오로직스목표주가38만원제시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180306038800008&did=1195m
484,2018-03-06,삼성바이오로직스500원011오른466000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803060061
485,2018-03-06,아주종목분석삼성바이오로직스현주가보다낮은목표주가,http://www.ajunews.com/view/20180306091649996
486,2018-03-06,삼성바이오로직스전일대비약3하락한450500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803060158
487,2018-03-06,돌발수주삼성바이오로직스올해6천억매출돌파전망,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053277
488,2018-03-06,삼성바이오로직스16500원354내린449000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803060443
489,2018-03-07,삼성바이오로직스공장가동률상승으로올해매출6000억이상전망,http://www.mdtoday.co.kr/mdtoday/index.html?no=314016
490,2018-03-07,코스피외국인순매수삼성전자SK하이닉스삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018030717112834714
491,2018-03-08,이항영의딱이거셀트리온와삼성바이오로직스투자판단은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018030808490171845
492,2018-03-11,SK하이닉스삼성바이오로직스외국인이익커질종목만골라담는다,http://news.hankyung.com/article/2018031139101
493,2018-03-12,무림PP덴티움삼성바이오로직스업종대표주중많이올랐다,http://www.choicenews.co.kr/news/articleView.html?idxno=39840
494,2018-03-12,덴티움삼성바이오로직스등의약품의료정밀주가순항,http://www.mdtoday.co.kr/mdtoday/index.html?no=314602
495,2018-03-12,삼성바이오로직스3500원077오른458500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803120475
496,2018-03-13,삼성바이오로직스최고목표가등장신영證53만원,http://news.einfomax.co.kr/news/articleView.html?idxno=3438532
497,2018-03-13,삼성바이오로직스셀트리온發바이오시밀러업종수혜목표가53만원↑신영증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1602938
498,2018-03-13,삼성바이오로직스3500원076내린455000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803130077
499,2018-03-13,HotLine삼성바이오로직스바이오시밀러관심높아져목표가↑,http://news.mk.co.kr/newsRead.php?year=2018&no=162315
500,2018-03-13,삼성바이오로직스목표주가높아져바이오시밀러투자매력부각,http://www.businesspost.co.kr/BP?command=article_view&num=75607
501,2018-03-13,ET투자뉴스삼성바이오로직스바이오시밀러업종에매수유지신영증권,http://www.etnews.com/20180313000042
502,2018-03-13,삼성바이오로직스최고목표주가등장신영증권53만원,http://www.insight.co.kr/news/144686
503,2018-03-14,삼성바이오로직스엇갈린전망38만원VS53만원,http://www.mdtoday.co.kr/mdtoday/index.html?no=314868
504,2018-03-14,삼성바이오로직스신라젠등766사3월넷째주정기주총개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=314900
505,2018-03-15,코스피챔피언⑮삼성바이오로직스시가총액30조바이오CMO세계1위굳힌다,http://weekly.cnbnews.com/news/article.html?no=124212
506,2018-03-15,삼성바이오로직스매출4646억영업익흑전순익적자지속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216012
507,2018-03-16,특징주삼성바이오로직스외인순매수우위주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201803160919594576c642673384_1/article.html
508,2018-03-19,삼성바이오로직스448000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803190071
509,2018-03-21,인베스트조선국내선감당못한다맥킨지본사에평가맡긴삼성바이오로직스,http://www.investchosun.com/?p=3224061
510,2018-03-21,삼성바이오로직스500원011내린461500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803210075
511,2018-03-21,WhoIs김태한삼성바이오로직스대표이사사장,http://www.businesspost.co.kr/BP?command=article_view&num=76544
512,2018-03-21,제넥신삼성바이오로직스와의약품위탁생산계약체결,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803210421
513,2018-03-21,제넥신삼성바이오로직스에임상용항암신약생산위탁,http://news1.kr/articles/?3267076
514,2018-03-21,제넥신삼성바이오로직스에임상용의약품생산위탁,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180321118800017&did=1195m
515,2018-03-21,제넥신삼성바이오로직스HyLeukin7위탁제조계약,http://medipana.com/news/news_viewer.asp?NewsNum=217463&MainKind=A&NewsKind=5&vCount=12&vKind=1
516,2018-03-21,삼성바이오로직스1500원032내린460500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803210469
517,2018-03-21,제넥신삼성바이오로직스에임상용의약품생산위탁,http://www.dt.co.kr/contents.html?article_no=2018032102109976029009&ref=naver
518,2018-03-21,제넥신삼성바이오로직스460만달러하이루킨생산계약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053867
519,2018-03-21,제넥신삼성바이오로직스에임상용의약품생산위탁,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3484981
520,2018-03-22,삼성바이오로직스2500원054오른463000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803220085
521,2018-03-22,fnRASSI삼성바이오로직스52주신고가206↑,http://www.fnnews.com/news/201803220942381283
522,2018-03-22,삼성바이오로직스20794052주신고가,http://news.heraldcorp.com/view.php?ud=20180322000197
523,2018-03-22,특징주삼성바이오로직스사상최고가경신47만4000원,http://view.asiae.co.kr/news/view.htm?idxno=2018032209542676632
524,2018-03-22,유삼성바이오로직스장중신고가돌파469000→475500▲6500,http://www.sedaily.com/NewsView/1RX2UNJBH7
525,2018-03-22,삼성바이오로직스사상최고가경신47만원선돌파,http://www.mdtoday.co.kr/mdtoday/index.html?no=315808
526,2018-03-22,특징주삼성바이오로직스최고가경신,http://www.fnnews.com/news/201803221114379434
527,2018-03-22,특징주삼성바이오로직스장중신고가경신,http://www.ebn.co.kr/news/view/934668
528,2018-03-22,특징주삼성바이오로직스제3공장가동소식에급등,http://www.asiatime.co.kr/news/articleView.html?idxno=173078
529,2018-03-22,이종목은왜오늘시장의뜨거운감자삼성바이오로직스OCI그리고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018032213401298410
530,2018-03-22,삼성바이오로직스17000원369오른477500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803220479
531,2018-03-22,3월22일기관순매수상위종목거래소삼성전자삼성바이오로직스셀트리온등,http://news.heraldcorp.com/view.php?ud=20180322000797
532,2018-03-22,제넥신삼성바이오로직스에임상용항암신약생산위탁,http://www.mdtoday.co.kr/mdtoday/index.html?no=315874
533,2018-03-23,삼성바이오로직스바이오의약수탁생산이어개발까지확장,http://news.mk.co.kr/newsRead.php?year=2018&no=186439
534,2018-03-23,투데이포커스투명경영고집한김태한삼성바이오로직스사장세계1위바이오토탈솔루션기업은현재진행형,http://www.asiatoday.co.kr/view.php?key=20180322010012486
535,2018-03-23,삼성바이오로직스9500원199내린468000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803230069
536,2018-03-23,ET투자뉴스삼성바이오로직스_돋보이는상승세현재262,http://www.etnews.com/20180323000055
537,2018-03-23,삼성바이오로직스시총상위30종목中나홀로상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=315959
538,2018-03-23,코스피급락에도삼성바이오로직스23일오전또최고가,http://www.choicenews.co.kr/news/articleView.html?idxno=40118
539,2018-03-23,삼성바이오로직스4000원084오른481500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803230596
540,2018-03-23,검은금요일한국증시패닉삼성바이오로직스만방긋,http://www.choicenews.co.kr/news/articleView.html?idxno=40127
541,2018-03-24,셀트리온삼성바이오로직스등담은헬스케어펀드수익률껑충,http://www.mdtoday.co.kr/mdtoday/index.html?no=316047
542,2018-03-24,셀트리온삼성바이오로직스등바이오시밀러시장급성장,http://www.choicenews.co.kr/news/articleView.html?idxno=40131
543,2018-03-25,마켓포인트코스피개인순매도1위삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01341526619146928
544,2018-03-26,삼성바이오로직스1분기실적전망장밋빛영업익780↑,http://www.ceoscoredaily.com/news/article.html?no=39301
545,2018-03-26,삼성바이오로직스1000원021오른482500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803260067
546,2018-03-26,삼성바이오로직스10000원208오른491500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803260504
547,2018-03-26,이재용삼성외교관재개삼성전자삼성바이오로직스에힘보태나,http://www.businesspost.co.kr/BP?command=article_view&num=77060
548,2018-03-26,특징주삼성바이오로직스시총현대차에바짝다가서,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180326131100008&did=1195m
549,2018-03-26,코스피외국인순매수KODEX200TRKODEX200삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018032616422877407
550,2018-03-26,셀트리온주가제자리걸음삼성바이오로직스주가는올라,http://www.businesspost.co.kr/BP?command=article_view&num=77130
551,2018-03-26,삼성바이오로직스시총현대차에바짝다가서,http://www.mdtoday.co.kr/mdtoday/index.html?no=316295
552,2018-03-26,코스피미중무역분쟁우려속반등성공삼성바이오로직스강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=316305
553,2018-03-27,아주종목분석삼성바이오로직스1년새190급등장기성장성반영,http://www.ajunews.com/view/20180327084652670
554,2018-03-27,삼성바이오로직스7500원153오른499000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803270072
555,2018-03-27,특징주삼성바이오로직스또최고가50만원코앞,http://news.mt.co.kr/mtview.php?no=2018032709064591600
556,2018-03-27,국고처권태민종목상담삼성바이오로직스207940,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803240076
557,2018-03-27,삼성바이오로직스사상최고가경신,http://www.mdtoday.co.kr/mdtoday/index.html?no=316330
558,2018-03-27,특징주삼성바이오로직스50만원돌파장중최고가,http://www.ekn.kr/news/article.html?no=351805
559,2018-03-27,특징주삼성바이오로직스주가사상최고가갱신,http://www.kukinews.com/news/article.html?no=534697
560,2018-03-27,특징주삼성바이오로직스최고가경신50만원터치,http://www.newsis.com/view/?id=NISX20180327_0000263662&cID=10401&pID=10400
561,2018-03-27,fnRASSI삼성바이오로직스20794052주신고가122↑,http://www.fnnews.com/news/201803270945231113
562,2018-03-27,삼성바이오로직스50만원돌파52주신고가또달성코스닥코스피강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=316360
563,2018-03-27,특징주삼성바이오로직스상장1년4개월만에50만원돌파,http://www.ebn.co.kr/news/view/935306
564,2018-03-27,삼성바이오로직스8500원173오른500000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803270424
565,2018-03-27,50만원돌파한삼성바이오로직스고평가논란,http://news.mt.co.kr/mtview.php?no=2018032714364481778
566,2018-03-27,삼성바이오로직스4거래일연속상승사상최고가경신행진,http://www.newstomato.com/ReadNews.aspx?no=814349
567,2018-03-27,거침없는삼성바이오로직스시총4위눈앞,http://www.viva100.com/main/view.php?key=20180327010009950
568,2018-03-27,셀트리온3총사주가하락삼성바이오로직스는올라시총맹추격,http://www.businesspost.co.kr/BP?command=article_view&num=77277
569,2018-03-28,삼성바이오로직스7500원15내린492500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803280076
570,2018-03-28,삼성바이오로직스상장1년만에삼성그룹내시총2인자등극,http://www.mdtoday.co.kr/mdtoday/index.html?no=316500
571,2018-03-28,美증시급락여파28일SK하이닉스삼성바이오로직스등하락출발,http://www.choicenews.co.kr/news/articleView.html?idxno=40214
572,2018-03-28,대한민국100대CEO김태한삼성바이오로직스사장세계최대바이오의약품생산능력갖춰,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=197653
573,2018-03-28,삼성바이오로직스현대차바짝추격,http://view.asiae.co.kr/news/view.htm?idxno=2018032811110900927
574,2018-03-28,삼성바이오로직스전일대비약4하락한479500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803280312
575,2018-03-28,삼성바이오로직스임원들40만원대에줄매도,http://news.mt.co.kr/mtview.php?no=2018032814190838752
576,2018-03-28,삼성바이오로직스35000원7내린465000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803280512
577,2018-03-28,삼성바이오로직스주요임원들올해들어자사주식일제히매도,http://www.mdtoday.co.kr/mdtoday/index.html?no=316548
578,2018-03-28,장마감코스피코스닥외국인팔자에급락삼성바이오로직스7↓,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018032815388010291&outlink=1
579,2018-03-28,한국증시출렁셀트리온삼성바이오로직스도하락,http://www.choicenews.co.kr/news/articleView.html?idxno=40230
580,2018-03-28,투자세미나강양구현대차투자증권연구원셀트리온삼성바이오로직스ASP높아질것”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1608405
581,2018-03-28,셀트리온3총사주가계속하락삼성바이오로직스주가도급락,http://www.businesspost.co.kr/BP?command=article_view&num=77421
582,2018-03-29,급락삼성바이오로직스추가상승여력제한적,http://www.mdtoday.co.kr/mdtoday/index.html?no=316625
583,2018-03-29,삼성바이오로직스1500원032오른466500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803290071
584,2018-03-29,특징주삼성바이오로직스급락하루만에반등,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018032909238089313&outlink=1
585,2018-03-29,한국증시29일오전혼조셀트리온삼성바이오로직스반등출발,http://www.choicenews.co.kr/news/articleView.html?idxno=40243
586,2018-03-29,삼성바이오로직스하루만에반등상승그래프,http://www.mdtoday.co.kr/mdtoday/index.html?no=316705
587,2018-03-29,삼성바이오로직스현대차제치고코스피시총4위에,http://news.mt.co.kr/mtview.php?no=2018032913452259521
588,2018-03-29,특징주삼성바이오로직스고평가논란딛고반등시도,http://www.asiatime.co.kr/news/articleView.html?idxno=173983
589,2018-03-29,특징주삼성바이오로직스현대차제치고시총4위,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180329115600008&did=1195m
590,2018-03-29,삼성바이오로직스현대차꺾고코스피시총4등,http://www.mdtoday.co.kr/mdtoday/index.html?no=316735
591,2018-03-29,특징주삼성바이오로직스현대차제치고시총4위등극,http://www.ebn.co.kr/news/view/935669
592,2018-03-29,삼성바이오로직스시총순위현대차제쳤다,http://www.sedaily.com/NewsView/1RX62T8IWI
593,2018-03-29,특징주삼성바이오로직스시총4위등극바이오株강세,http://www.viva100.com/main/view.php?key=20180329010010934
594,2018-03-29,특징주삼성바이오로직스현대차제치고코스피시총4위,http://www.seoulfn.com/news/articleView.html?idxno=302464
595,2018-03-29,특징주삼성바이오로직스현대차제치고시총4위올라서,http://biz.chosun.com/site/data/html_dir/2018/03/29/2018032901854.html
596,2018-03-29,삼성바이오로직스21000원452오른486000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803290417
597,2018-03-29,특징주삼성바이오로직스현대차제치고시총4위종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180329115651008&did=1195m
598,2018-03-29,특징주삼성바이오로직스현대차시총제치고시총4위등극,http://www.newsway.co.kr/view.php?tp=1&ud=2018032915402969960
599,2018-03-29,코스피개인사자2430대회복삼성바이오로직스시총4위에,http://news.mt.co.kr/mtview.php?no=2018032915472956366
600,2018-03-29,삼성바이오로직스현대차제치고시총4위올라,http://view.asiae.co.kr/news/view.htm?idxno=2018032915520520143
601,2018-03-29,코스피하루만에반등해2430선회복삼성바이오로직스시총4위올라,http://news.hankyung.com/article/2018032936246
602,2018-03-29,특징주삼성바이오로직스현대차제치고시총4위올라,http://news.hankyung.com/article/2018032937506
603,2018-03-29,삼성바이오로직스현대차제치고시총4위로올라서,http://www.asiatoday.co.kr/view.php?key=20180329010016984
604,2018-03-29,삼성바이오로직스현대차시가총액제쳤다,http://www.choicenews.co.kr/news/articleView.html?idxno=40260
605,2018-03-29,아주종목분석삼성바이오로직스시총4위등극현대차5위,http://www.ajunews.com/view/20180329163308071
606,2018-03-29,삼성바이오로직스현대차누르고시총4위등극,http://www.newsis.com/view/?id=NISX20180329_0000267031&cID=10401&pID=10400
607,2018-03-29,특징주삼성바이오로직스시가총액4위현대차제쳤다,http://www.kukinews.com/news/article.html?no=535709
608,2018-03-29,삼성바이오로직스거침없는질주현대차제치고시총4위,http://www.etoday.co.kr/news/section/newsview.php?idxno=1608831
609,2018-03-29,셀트리온삼성바이오로직스주가급등미국바이오시밀러우대정책,http://www.businesspost.co.kr/BP?command=article_view&num=77556
610,2018-03-30,삼성바이오로직스4000원082오른490000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803300081
611,2018-03-30,삼성물산목표주가높아져삼성바이오로직스보유지분가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=77591
612,2018-03-30,특징주삼성바이오로직스이틀째강세시총4위굳히기,http://www.fnnews.com/news/201803300909200155
613,2018-03-30,증시삼성전자SK하이닉스상승출발vs셀트리온삼성바이오로직스하락출발,http://www.choicenews.co.kr/news/articleView.html?idxno=40272
614,2018-03-30,삼성바이오로직스현대차누르고시총4위바이오강세여전,http://www.sisaweek.com/news/articleView.html?idxno=105580
615,2018-03-30,분석플러스제약바이오株삼성바이오로직스타고오를까,http://news.hankyung.com/article/2018033073946
616,2018-03-30,삼성바이오로직스1000원021오른487000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803300484
617,2018-03-30,삼성바이오로직스강보합시총4위30일에도지켜,http://www.mdtoday.co.kr/mdtoday/index.html?no=316956
618,2018-03-30,셀트리온3총사주가떨어져삼성바이오로직스주가는소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=77696
619,2018-04-01,삼성바이오로직스분식회계의혹벗나,http://www.sedaily.com/NewsView/1RY35U7M9O
620,2018-04-02,삼성바이오로직스487000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804020081
621,2018-04-02,삼성바이오로직스1000원021내린486000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804020522
622,2018-04-02,김태한삼성바이오로직스사장지난해보수38억5900만원,http://www.asiatoday.co.kr/view.php?key=20180402010001281
623,2018-04-02,글로벌CMO정상오른삼성바이오로직스,http://www.sedaily.com/NewsView/1RY3MNGRRT
624,2018-04-02,셀트리온주가공매도에계속맥못춰삼성바이오로직스도하락,http://www.businesspost.co.kr/BP?command=article_view&num=77912
625,2018-04-02,김태한삼성바이오로직스사장연봉386억제약바이오업계1위,http://www.edaily.co.kr/news/newspath.asp?newsid=04572326619172184
626,2018-04-03,삼성바이오로직스2000원041내린484000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804030078
627,2018-04-03,화재보험협회삼성바이오로직스등27개건물화재안전우수건물선정,http://www.fntimes.com/html/view.php?ud=2018040309264796595e6e69892f_18
628,2018-04-03,美증시추락여파3일SK하이닉스삼성바이오로직스등약세출발,http://www.choicenews.co.kr/news/articleView.html?idxno=40345
629,2018-04-03,JOB리포트적자기업삼성바이오로직스의김태한사장2년째제약업계연봉킹고수한이유,http://www.news2day.co.kr/101650
630,2018-04-03,제약바이오연봉1위는김태한삼성바이오로직스사장39억원,http://news.mk.co.kr/newsRead.php?year=2018&no=212378
631,2018-04-03,김태한삼성바이오로직스대표제약바이오업계연봉1위차지,http://sports.khan.co.kr/news/sk_index.html?art_id=201804031357003&sec_id=561801&pt=nv
632,2018-04-03,삼성바이오로직스500원01내린485500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804030420
633,2018-04-03,화재보험협회삼성바이오로직스등화재안전우수건물인정,http://www.edaily.co.kr/news/newspath.asp?newsid=04073766619172512
634,2018-04-03,셀트리온3총사주가계속힘못써삼성바이오로직스도소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=78058
635,2018-04-03,화재보험협회삼성바이오로직스등화재안전우수건물27개소인정,http://www.insnews.co.kr/design_php/news_view.php?num=53936&firstsec=1&secondsec=13
636,2018-04-03,삼성물산증권사삼성바이오로직스지분매각할수있다”,http://www.g-enews.com/ko-kr/news/article/news_all/201804032046205143c642673384_1/article.html
637,2018-04-04,삼성김기식쇼크삼성바이오로직스라는구원투수,http://news1.kr/articles/?3279513
638,2018-04-04,삼성바이오로직스4500원093오른490000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804040067
639,2018-04-04,유삼성바이오로직스장중신고가돌파502000→504000▲2000,http://www.sedaily.com/NewsView/1RY4ILSJRS
640,2018-04-04,fnRASSI삼성바이오로직스52주신고가36↑,http://www.fnnews.com/news/201804041015146200
641,2018-04-04,특징주삼성바이오로직스5거래일만에50만원회복,http://www.newsway.co.kr/view.php?tp=1&ud=2018040410292347262
642,2018-04-04,삼성바이오로직스임상물질생산첫수주,http://www.dailypharm.com/News/238430
643,2018-04-04,코스피코스닥모두↓삼성바이오로직스52주신고가기록,http://www.mdtoday.co.kr/mdtoday/index.html?no=317354
644,2018-04-04,삼성바이오로직스17500원36오른503000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804040481&t=NN
645,2018-04-04,코스피외국인순매수삼성바이오로직스현대차현대모비스,http://www.newsway.co.kr/view.php?tp=1&ud=2018040415552184082
646,2018-04-04,코스피기관순매수현대차한국전력삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018040415575189374
647,2018-04-04,코스피추락한미약품삼성바이오로직스는껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=40394
648,2018-04-04,코스피코스닥약세마감제넥신삼성바이오로직스52주최고가경신,http://www.mdtoday.co.kr/mdtoday/index.html?no=317390
649,2018-04-04,셀트리온3총사주가계속하락삼성바이오로직스는강세,http://www.businesspost.co.kr/BP?command=article_view&num=78210
650,2018-04-05,유진투자삼성바이오로직스1분기실적기대치밑돌듯,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180405033200008&did=1195m
651,2018-04-05,삼성바이오로직스2000원04내린501000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804050074&t=NN
652,2018-04-05,최고가행진삼성바이오로직스그래도매수늦지않았다”,http://news.heraldcorp.com/view.php?ud=20180405000095
653,2018-04-05,아주종목분석삼성바이오로직스상반기실적기대치밑돌전망3분기개선,http://www.ajunews.com/view/20180405093010225
654,2018-04-05,삼성바이오로직스내년3공장가동으로수익성극적개선할것,http://www.asiatoday.co.kr/view.php?key=20180405010003063
655,2018-04-05,삼성바이오로직스거침없는하이킥,http://news.heraldcorp.com/view.php?ud=20180405000294
656,2018-04-05,삼성바이오로직스2026년까지전망밝다노무라,http://www.choicenews.co.kr/news/articleView.html?idxno=40408
657,2018-04-05,삼성바이오로직스1분기실적컨센서스추정치하회전망에약보합,http://www.mdtoday.co.kr/mdtoday/index.html?no=317477
658,2018-04-05,삼성바이오로직스공장가동률낮아져상반기실적부진불가피,http://www.businesspost.co.kr/BP?command=article_view&num=78268
659,2018-04-05,삼성바이오로직스바이오시밀러는팔방미인고평가지적지나쳐,http://www.m-i.kr/news/articleView.html?idxno=402670
660,2018-04-05,삼성바이오로직스1000원02내린502000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804050435&t=NN
661,2018-04-05,코스피외국인순매수NAVER삼성바이오로직스셀트리온,http://www.newsway.co.kr/view.php?tp=1&ud=2018040516155729473
662,2018-04-05,삼성바이오로직스삼성반도체DNA이식글로벌1위노린다,http://www.etnews.com/20180405000324
663,2018-04-05,노무라삼성바이오로직스에목표주가57만원제시,http://www.mdtoday.co.kr/mdtoday/index.html?no=317514
664,2018-04-05,셀트리온주가악재에도소폭상승삼성바이오로직스는숨고르기,http://www.businesspost.co.kr/BP?command=article_view&num=78328
665,2018-04-05,2018기업분석매출영업이익↑셀트리온삼성바이오로직스의질주,http://www.sisajournal-e.com/biz/article/182360
666,2018-04-05,코스피코스닥상승삼성바이오로직스약보합차바이오텍급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=317536
667,2018-04-06,삼성바이오로직스휴미라특허분쟁합의NH,http://news.hankyung.com/article/2018040604606
668,2018-04-06,NH투자증권삼성바이오로직스휴미라특허분쟁합의”,http://www.newsway.co.kr/view.php?tp=1&ud=2018040608262911270
669,2018-04-06,삼성바이오로직스휴미라특허분쟁합의임랄디10월유럽출시NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1611286
670,2018-04-06,HotLine삼성바이오로직스휴미라특허분쟁합의,http://news.mk.co.kr/newsRead.php?year=2018&no=219999
671,2018-04-06,삼성바이오로직스7000원139오른509000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804060081&t=NN
672,2018-04-06,특징주삼성바이오로직스특허분쟁합의소식에강세,http://news.mt.co.kr/mtview.php?no=2018040609030029390
673,2018-04-06,fnRASSI삼성바이오로직스20794052주신고가경신359↑,http://www.fnnews.com/news/201804060905159738
674,2018-04-06,특징주삼성바이오로직스4강세에최고가경신,http://view.asiae.co.kr/news/view.htm?idxno=2018040609101628361
675,2018-04-06,ET투자뉴스삼성바이오로직스_돋보이는상승세현재359,http://www.etnews.com/20180406000026
676,2018-04-06,특징주삼성바이오로직스신고가휴미라특허분쟁합의,http://news.hankyung.com/article/2018040608466
677,2018-04-06,특징주삼성바이오로직스특허분쟁합의오름세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018040609178035070&outlink=1
678,2018-04-06,특징주삼성바이오로직스휴미라특허분쟁합의에상승세,http://www.fnnews.com/news/201804060917056131
679,2018-04-06,특징주자회사특허분쟁합의에삼성바이오로직스신고가경신,http://www.newsis.com/view/?id=NISX20180406_0000274329&cID=10401&pID=10400
680,2018-04-06,특징주삼성바이오로직스주가사상최고치또뚫었다자회사특허분쟁종료,http://www.g-enews.com/ko-kr/news/article/news_all/20180406092023576c642673384_1/article.html
681,2018-04-06,HotLine삼성바이오로직스자회사특허분쟁합의소식에신고가,http://news.mk.co.kr/newsRead.php?year=2018&no=220205
682,2018-04-06,삼성바이오로직스특허분쟁합의소식에장초반강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=317585
683,2018-04-06,특징주삼성바이오로직스신고가자회사특허분쟁마무리,http://www.ebn.co.kr/news/view/936809
684,2018-04-06,삼성바이오로직스자회사특허분쟁해소에신고가경신,http://www.sedaily.com/NewsView/1RY5GF5INC
685,2018-04-06,특징주삼성바이오로직스자회사의특허분쟁합의에강세,http://www.seoulfn.com/news/articleView.html?idxno=303097
686,2018-04-06,특징주삼성바이오로직스자회사특허분쟁합의에신고가,http://www.cstimes.com/?mod=news&act=articleView&idxno=272541
687,2018-04-06,특징주삼성바이오로직스자회사특허분쟁합의에신고가,http://www.ekn.kr/news/article.html?no=354156
688,2018-04-06,특징주삼성바이오로직스휴미라특허분쟁합의에52주신고가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1611383
689,2018-04-06,아주종목분석삼성바이오로직스자회사특허분쟁종결소식에신고가경신,http://www.ajunews.com/view/20180406094901006
690,2018-04-06,6일한국증시반도체하락vs셀트리온삼성바이오로직스강세출발,http://www.choicenews.co.kr/news/articleView.html?idxno=40431
691,2018-04-06,특징주삼성바이오로직스자회사특허분쟁합의소식에상승세,http://www.newspim.com/news/view/20180406000061
692,2018-04-06,유삼성바이오로직스장중신고가돌파505000→524000▲19000,http://www.sedaily.com/NewsView/1RY5G8P5B1
693,2018-04-06,특징주삼성바이오로직스자회사특허분쟁합의에신고가,http://www.newsway.co.kr/view.php?tp=1&ud=2018040611022952808
694,2018-04-06,삼성바이오로직스17000원339오른519000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804060394&t=NN
695,2018-04-06,국내증시하락세에도삼성바이오로직스등제약바이오株굳건,http://www.mdtoday.co.kr/mdtoday/index.html?no=317643
696,2018-04-06,코스피외국인순매수삼성바이오로직스NAVERKTG,http://www.newsway.co.kr/view.php?tp=1&ud=2018040616075836748
697,2018-04-06,삼성바이오로직스코스피하락세에도신고가특허분쟁합의훨훨,http://www.mdtoday.co.kr/mdtoday/index.html?no=317646
698,2018-04-06,외국인투매SK하이닉스부진vs삼성바이오로직스파미셀신고가,http://www.choicenews.co.kr/news/articleView.html?idxno=40445
699,2018-04-06,삼성바이오로직스주가역대최고가셀트리온3총사는계속약세,http://www.businesspost.co.kr/BP?command=article_view&num=78471
700,2018-04-07,주간관심주삼성바이오로직스최고가행진셀트리온위협,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180406125200008&did=1195m
701,2018-04-07,셀트리온vs삼성바이오로직스바이오대장주경쟁격화,http://www.choicenews.co.kr/news/articleView.html?idxno=40455
702,2018-04-08,삼성바이오로직스특허분쟁우려해소하자주가훨훨,http://www.edaily.co.kr/news/newspath.asp?newsid=01705606619174152
703,2018-04-08,삼성바이오로직스자가면역질환치료제휴미라사상최고가기록,http://www.insight.co.kr/news/149175
704,2018-04-08,PB스타그램삼성바이오로직스여전히저평가꾸준히우상향할것,http://www.sedaily.com/NewsView/1RY6DZ0EQ5
705,2018-04-09,삼성바이오로직스반도체기술포함3공장이르면올해말가동,http://www.mdtoday.co.kr/mdtoday/index.html?no=317672
706,2018-04-09,삼성바이오로직스투자고용껑충삼성전자다음활기,http://www.ceoscoredaily.com/news/article.html?no=39897
707,2018-04-09,삼성바이오로직스바이오에피스흑자전환기대목표가↑한국투자증권,http://www.fntimes.com/html/view.php?ud=201804090747388332f09e13944d_18
708,2018-04-09,삼성바이오로직스바이오에피스가치재평가목표가↑한투,http://news.hankyung.com/article/2018040974916
709,2018-04-09,한국투자증권삼성바이오로직스자회사바이오에피스유럽진출로가치재평가전망,http://www.g-enews.com/ko-kr/news/article/news_all/201804090828359566c16aa2f016_1/article.html
710,2018-04-09,삼성바이오로직스9000원173오른528000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804090083&t=NN
711,2018-04-09,특징주삼성바이오로직스자회사실적기대신고가,http://news.hankyung.com/article/2018040978996
712,2018-04-09,특징주삼성바이오로직스자회사매출기대감속신고가경신,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018040909308037553&outlink=1
713,2018-04-09,삼성바이오로직스자회사실적기대감에52주신고가,http://www.inews24.com/php/news_view.php?g_serial=1087521&g_menu=022300&rrf=nv
714,2018-04-09,유삼성바이오로직스장중신고가돌파534000→541000▲7000,http://www.sedaily.com/NewsView/1RY6TF0VLE
715,2018-04-09,fnRASSI삼성바이오로직스20794052주신고가424↑,http://www.fnnews.com/news/201804091000034745
716,2018-04-09,삼성바이오로직스자회사실적개선기대감에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=317730
717,2018-04-09,ET투자뉴스삼성바이오로직스유럽Humira매수유지한국투자증권,http://www.etnews.com/20180409000073
718,2018-04-09,삼성바이오로직스고평가우려날리고시총4위굳히기,http://view.asiae.co.kr/news/view.htm?idxno=2018040911030978166
719,2018-04-09,특징주삼성바이오로직스장중11대상승시총3위오르기도,http://view.asiae.co.kr/news/view.htm?idxno=2018040911152725450
720,2018-04-09,코스피기관사자에상승세삼성바이오로직스유한양행등급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=317754
721,2018-04-09,삼성바이오로직스셀트리온제치고시총3위58만원터치최고가,http://news.mt.co.kr/mtview.php?no=2018040913485652305
722,2018-04-09,삼성바이오로직스급등장중58만원터치,http://www.mdtoday.co.kr/mdtoday/index.html?no=317765
723,2018-04-09,특징주삼성바이오로직스휴미라특허분쟁해결에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=03627686619174480
724,2018-04-09,특징주삼성바이오로직스장중11대상승한때시총3위셀트리온도제쳐,http://biz.chosun.com/site/data/html_dir/2018/04/09/2018040901699.html
725,2018-04-09,삼성전자가삼성물산의삼성바이오로직스지분사들일명분없어,http://www.businesspost.co.kr/BP?command=article_view&num=78592
726,2018-04-09,삼성바이오로직스43000원829오른562000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804090360&t=NN
727,2018-04-09,마감코스피기관사자에상승삼성바이오로직스8↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03837606619174480
728,2018-04-09,삼성바이오로직스셀트리온제치고바이오대장주등극하나,http://www.insightkorea.co.kr//news/articleView.html?idxno=24019
729,2018-04-09,삼성바이오로직스vs셀트리온바이오대장주나야나,http://news.mt.co.kr/mtview.php?no=2018040915483222530
730,2018-04-09,마감시황기관매수에코스피반등성공삼성바이오로직스등바이오株강세,http://www.newsis.com/view/?id=NISX20180409_0000276601&cID=10401&pID=10400
731,2018-04-09,마감코스피코스닥바이오주강세에동반상승삼성바이오로직스829↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018040915588093973&outlink=1
732,2018-04-09,한국증시반등셀트리온삼성바이오로직스파미셀질주,http://www.choicenews.co.kr/news/articleView.html?idxno=40497
733,2018-04-09,삼성바이오로직스거침없는상승세시가총액3위눈앞,http://www.edaily.co.kr/news/newspath.asp?newsid=04155766619174480
734,2018-04-09,아주종목분석삼성바이오로직스52주신고가경신,http://www.ajunews.com/view/20180409170411743
735,2018-04-09,코스피외국인순매수삼성바이오로직스현대모비스셀트리온,http://www.newsway.co.kr/view.php?tp=1&ud=2018040917243795814
736,2018-04-09,코스피바이오대장주싸움치열삼성바이오로직스VS셀트리온,http://www.mdtoday.co.kr/mdtoday/index.html?no=317801
737,2018-04-09,셀트리온삼성바이오로직스등코스피바이오대장주고공행진,http://www.mdtoday.co.kr/mdtoday/index.html?no=317807
738,2018-04-09,셀트리온삼성바이오로직스주가올라시총순위도엎치락뒤치락,http://www.businesspost.co.kr/BP?command=article_view&num=78656
739,2018-04-09,삼성물산이삼성바이오에피스사들이는이유삼성바이오로직스석달새37주가상승,http://news20.busan.com/controller/newsController.jsp?newsId=20180409000345
740,2018-04-09,삼성바이오로직스자회사삼성바이오에피스매출기대감에52주신고가갈아치워,http://www.segye.com/content/html/2018/04/09/20180409006508.html?OutUrl=naver
741,2018-04-10,삼성바이오로직스직무로알아보는삼성바이오로직스소개미생물분석부터공정기술까지,http://www.topstarnews.net/news/articleView.html?idxno=391402
742,2018-04-10,시총4위굳힌삼성바이오로직스셀트리온압박,http://www.mdtoday.co.kr/mdtoday/index.html?no=317816
743,2018-04-10,삼성바이오로직스2분기저점찍고회복목표가↑SK,http://news.mt.co.kr/mtview.php?no=2018041007560465358
744,2018-04-10,클릭e종목삼성바이오로직스불확실성해소목표가↑,http://view.asiae.co.kr/news/view.htm?idxno=2018041008034206433
745,2018-04-10,삼성바이오로직스올해4개바이오시밀러시판목표가↑SK,http://www.edaily.co.kr/news/newspath.asp?newsid=01626886619174808
746,2018-04-10,삼성바이오로직스하반기반등기대목표가↑SK증권,http://www.fntimes.com/html/view.php?ud=2018041008391644121d6f57e61a_18
747,2018-04-10,아주종목분석삼성바이오로직스목표주가↑2분기저점찍고회복,http://www.ajunews.com/view/20180410084144978
748,2018-04-10,삼성바이오로직스14000원249오른576000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804100070&t=NN
749,2018-04-10,ET투자뉴스삼성바이오로직스보릿고개를지나가는매수유지SK증권,http://www.etnews.com/20180410000015
750,2018-04-10,특징주삼성바이오로직스60만원눈앞시총3위로올라서,http://view.asiae.co.kr/news/view.htm?idxno=2018041009065576764
751,2018-04-10,특징주삼성바이오로직스셀트리온제치고장중시총3위로,http://news.hankyung.com/article/2018041017776
752,2018-04-10,유삼성바이오로직스장중신고가돌파580000→598000▲18000,http://www.sedaily.com/NewsView/1RY799F4PI
753,2018-04-10,특징주삼성바이오로직스삼성주력사업개편소식에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02027046619174808
754,2018-04-10,ET투자뉴스삼성바이오로직스_돋보이는상승세현재587,http://www.etnews.com/20180410000018
755,2018-04-10,특징주삼성바이오로직스셀트리온제치고장중시총3위60만터치도,http://www.fnnews.com/news/201804100907346590
756,2018-04-10,특징주삼성바이오로직스신고가행진에다시시총3위,http://news.mt.co.kr/mtview.php?no=2018041009114162116
757,2018-04-10,삼성바이오로직스5급등셀트리온제치고시총3위안착,http://news.heraldcorp.com/view.php?ud=20180410000113
758,2018-04-10,삼성바이오로직스바이오시밀러시판기대에60만원돌파눈앞,http://www.sedaily.com/NewsView/1RY7A489RH
759,2018-04-10,삼성바이오로직스임랄디유럽런칭이후실적반등일어날것,http://www.asiatoday.co.kr/view.php?key=20180410010005459
760,2018-04-10,코스피하락출발삼성바이오로직스는6↑,http://www.edaily.co.kr/news/newspath.asp?newsid=02122166619174808
761,2018-04-10,HotLine삼성바이오로직스사흘째사상최고가,http://news.mk.co.kr/newsRead.php?year=2018&no=227347
762,2018-04-10,특징주삼성바이오로직스연일신고가행진에셀트리온시총넘어,http://www.newsway.co.kr/view.php?tp=1&ud=2018041009201971372
763,2018-04-10,특징주삼성바이오로직스삼성그룹주력사업개편에급등,http://www.ekn.kr/news/article.html?no=354775
764,2018-04-10,특징주삼성바이오로직스최고가60만원터치시총3위껑충,http://www.ebn.co.kr/news/view/937215
765,2018-04-10,ET투자뉴스제약주테마삼성바이오로직스한미약품중심으로강세,http://www.etnews.com/20180410000034
766,2018-04-10,특징주삼성바이오로직스시총3위등극60만원선근접,http://www.cstimes.com/?mod=news&act=articleView&idxno=272835
767,2018-04-10,특징주삼성바이오로직스셀트리온누르고시총3위등극,http://www.newsis.com/view/?id=NISX20180410_0000277151&cID=10401&pID=10400
768,2018-04-10,특징주삼성바이오로직스바이오시밀러시판기대에시총3위셀트리온제쳐,http://www.g-enews.com/ko-kr/news/article/news_all/201804100930096763c16aa2f016_1/article.html
769,2018-04-10,특징주삼성바이오로직스신고가행진시총3위도약,http://www.seoulfn.com/news/articleView.html?idxno=303332
770,2018-04-10,특징주삼성바이오로직스바이오시밀러시판소식에급등시가총액3위등극,http://www.ezyeconomy.com/news/articleView.html?idxno=82488
771,2018-04-10,삼성바이오로직스60만원시총3위로껑충종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180410042451008&did=1195m
772,2018-04-10,fnRASSI삼성바이오로직스20794052주신고가경신445↑,http://www.fnnews.com/news/201804100959307303
773,2018-04-10,특징주삼성바이오로직스시총3위등극3거래일강세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018041010228018180&outlink=1
774,2018-04-10,특징주삼성바이오로직스60만원터치코스피시총3위로상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1612288
775,2018-04-10,삼성바이오로직스셀트리온밀어내고시총3위올라서,http://www.mdtoday.co.kr/mdtoday/index.html?no=317889
776,2018-04-10,삼성바이오로직스셀트리온제치고시총3위로올라서60만원돌파할듯,http://www.asiatoday.co.kr/view.php?key=20180410010005597
777,2018-04-10,삼성바이오로직스셀트리온제치고시총3위로껑충,http://www.sedaily.com/NewsView/1RY7AMK1PC
778,2018-04-10,삼성바이오로직스1년5개월새몸집4배불렸다,http://news.mt.co.kr/mtview.php?no=2018041010593507189
779,2018-04-10,삼성바이오로직스1분기매출액1361억원영업이익204억원전망,http://www.newsworks.co.kr/news/articleView.html?idxno=179031
780,2018-04-10,삼성바이오로직스내가바이오대장주”,http://news.heraldcorp.com/view.php?ud=20180410000360
781,2018-04-10,삼성바이오로직스60만원눈앞시총3위등극,http://www.m-i.kr/news/articleView.html?idxno=403855
782,2018-04-10,fnRASSI삼성바이오로직스20794052주신고가374↑,http://www.fnnews.com/news/201804101509489577
783,2018-04-10,삼성바이오로직스21000원374오른583000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804100410&t=NN
784,2018-04-10,바이오전쟁삼성바이오로직스vs셀트리온치열한시총3위다툼,http://www.metroseoul.co.kr/news/newsview?newscd=2018041000142
785,2018-04-10,삼성바이오로직스60만원최고가시총3위로껑충종합2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180410042452008&did=1195m
786,2018-04-10,삼성바이오로직스시가총액3위등극셀트리온제쳐바이오시밀러임랄디기대감,http://www.imaeil.com/sub_news/sub_news_view.php?news_id=15104&yy=2018
787,2018-04-10,삼성바이오로직스셀트리온제치고시총3위장중60만터치,http://www.fnnews.com/news/201804101559015305
788,2018-04-10,삼성바이오로직스셀트리온밀어내기시총3위우뚝,http://www.mdtoday.co.kr/mdtoday/index.html?no=317944
789,2018-04-10,종합특징주삼성바이오로직스장중60만원터치시총3위,http://www.newsis.com/view/?id=NISX20180410_0000277835&cID=10401&pID=10400
790,2018-04-10,아주종목분석삼성바이오로직스시총셀트리온제쳤다,http://www.ajunews.com/view/20180410164210558
791,2018-04-10,삼성바이오로직스사상최고가시총3위등극,http://www.ebn.co.kr/news/view/937299
792,2018-04-10,코스피외국인순매도삼성전자삼성바이오로직스셀트리온,http://www.newsway.co.kr/view.php?tp=1&ud=2018041017031415987
793,2018-04-10,中무역협상메시지에코스피직진시총3위굳힌삼성바이오로직스,http://www.mdtoday.co.kr/mdtoday/index.html?no=317954
794,2018-04-10,삼성바이오로직스시총에서셀트리온제쳐주주감정싸움양상도,http://www.businesspost.co.kr/BP?command=article_view&num=78757
795,2018-04-10,사상최고가삼성바이오로직스시총3위우뚝,http://www.newstomato.com/ReadNews.aspx?no=817387
796,2018-04-10,삼성바이오로직스바이오대장주등극,http://www.fnnews.com/news/201804101726437363
797,2018-04-10,삼성물산주가급등삼성바이오로직스보유지분가치부각,http://www.businesspost.co.kr/BP?command=article_view&num=78762
798,2018-04-10,삼성바이오로직스셀트리온제치고제약바이오株시총1위,http://daily.hankooki.com/lpage/life/201804/dh20180410175646138950.htm
799,2018-04-10,삼성바이오로직스셀트리온제치고시총3위우뚝,http://www.dailymedi.com/detail.php?number=829412&thread=22r05
800,2018-04-10,바이오로날개다나”삼성바이오로직스주력사업개편기대감,http://www.edaily.co.kr/news/newspath.asp?newsid=04644486619174808
801,2018-04-11,삼성바이오로직스최고몸값찍었다,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=806175
802,2018-04-11,삼성바이오로직스셀트리온시총제쳤다임랄디기대감,http://www.sportsseoul.com/news/read/622046
803,2018-04-11,삼성바이오로직스주가더간다3공장가동되면계속성장가능,http://www.businesspost.co.kr/BP?command=article_view&num=78811
804,2018-04-11,현대차투자증권삼성바이오로직스4분기3공장정상가동화모멘텀파이프라인부각목표가상향”,http://www.g-enews.com/ko-kr/news/article/news_all/20180411082700816c642673384_1/article.html
805,2018-04-11,STOCK삼성바이오로직스CMO위탁생산수요증가목표가↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018041108258048031&outlink=1
806,2018-04-11,HotLine삼성바이오로직스중장기적성장동력남아있어목표가↑,http://news.mk.co.kr/newsRead.php?year=2018&no=229854
807,2018-04-11,삼성바이오로직스중장기적모멘텀유효목표가↑–현대차,http://www.cstimes.com/?mod=news&act=articleView&idxno=272941
808,2018-04-11,삼성바이오로직스장기적관점으로지켜봐야현대차증권,http://www.sedaily.com/NewsView/1RY7PQY7YE
809,2018-04-11,삼성바이오로직스바이오의약품CMO수요증가주목목표가↑현대차투자증권,http://www.fntimes.com/html/view.php?ud=2018041108422362061d6f57e61a_18
810,2018-04-11,삼성바이오로직스임랄디시판으로성장성강화목표가68만원으로↑현대차투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1612629
811,2018-04-11,삼성바이오로직스내년하반기아키젠바이오텍파이프라인SAIT101시판허가가능,http://www.asiatoday.co.kr/view.php?key=20180411010006220
812,2018-04-11,삼성바이오로직스4분기3공장가동목표가↑현대차,http://www.newstomato.com/ReadNews.aspx?no=817465
813,2018-04-11,아주종목분석삼성바이오로직스바이오에피스유럽판매허가에목표주가상향,http://www.ajunews.com/view/20180411085627837
814,2018-04-11,삼성바이오로직스위탁생산복제약순항목표가51만→68만현대차,http://biz.chosun.com/site/data/html_dir/2018/04/11/2018041100612.html
815,2018-04-11,삼성바이오로직스4000원069오른587000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804110075&t=NN
816,2018-04-11,ET투자뉴스삼성바이오로직스장기적인관점으로매수현대차투자증권,http://www.etnews.com/20180411000028
817,2018-04-11,증권사들삼성바이오로직스띄우기사흘째최고목표가경신,http://news.einfomax.co.kr/news/articleView.html?idxno=3443303
818,2018-04-11,삼성바이오로직스전일대비약3하락한565000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804110222&t=NN
819,2018-04-11,삼성바이오로직스자회사삼성바이오에피스의주요파이프라인유럽판매허가,http://www.newsworks.co.kr/news/articleView.html?idxno=179351
820,2018-04-11,삼성바이오로직스바이오대장주등극,http://view.asiae.co.kr/news/view.htm?idxno=2018041111334994344
821,2018-04-11,삼성바이오로직스셀트리온꺾고승승장구코스피시가총액3위,http://www.sisafocus.co.kr/news/articleView.html?idxno=183838
822,2018-04-11,삼성바이오로직스1000원017오른584000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804110421&t=NN
823,2018-04-11,코스피기관순매도삼성전자KODEX200TR삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018041116482538733
824,2018-04-11,삼성바이오로직스주가오르고셀트리온내려시총격차더벌어져,http://www.businesspost.co.kr/BP?command=article_view&num=78914
825,2018-04-12,공염불김태한사장의기부금약속삼성바이오로직스영업이익흑자전환에도,http://www.asiatime.co.kr/news/articleView.html?idxno=175670
826,2018-04-12,삼성바이오로직스7000원12내린577000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804120070&t=NN
827,2018-04-12,아주종목분석삼성바이오로직스이달에만20상승증권가전망긍정적,http://www.ajunews.com/view/20180412091348707
828,2018-04-12,같은삼성다른운명삼성바이오로직스vs삼성증권명암교차,http://www.ebn.co.kr/news/view/937621
829,2018-04-12,삼성바이오로직스전일대비약3하락한566000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804120380&t=NN
830,2018-04-12,삼성바이오로직스19000원325내린565000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804120397&t=NN
831,2018-04-12,삼성바이오로직스주가내리고셀트리온올라시총격차다시좁혀져,http://www.businesspost.co.kr/BP?command=article_view&num=79051
832,2018-04-13,삼성바이오로직스9000원159내린556000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804130079&t=NN
833,2018-04-13,13일장초반반도체주오르고vs삼성바이오로직스셀트리온약세,http://www.choicenews.co.kr/news/articleView.html?idxno=40604
834,2018-04-13,삼성바이오로직스5000원088오른570000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804130438&t=NN
835,2018-04-13,김기식삼성바이오로직스분식회계특별감리내부적으로끝나”,http://news.kbs.co.kr/news/view.do?ncd=3634208&ref=A
836,2018-04-13,코스피기관순매도SK텔레콤삼성바이오로직스NAVER,http://www.newsway.co.kr/view.php?tp=1&ud=2018041316353382822
837,2018-04-13,셀트리온주가내리고삼성바이오로직스는올라시총격차더벌어져,http://www.businesspost.co.kr/BP?command=article_view&num=79220
838,2018-04-14,삼성바이오로직스셀트리온제치고바이오대장주등극앞과뒤,http://ilyo.co.kr/?ac=article_view&entry_id=294636
839,2018-04-15,인터뷰삼성바이오로직스분식회계는이재용승계목적”,http://www.mhj21.com/sub_read.html?uid=113215§ion=section5
840,2018-04-16,삼성바이오로직스6000원105내린564000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804160070&t=NN
841,2018-04-16,주가실적고공행진에도시름깊어가는삼성바이오로직스분식의혹에피스특혜논란등첩첩산중,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=240856
842,2018-04-16,삼성바이오로직스3000원053내린567000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804160425&t=NN
843,2018-04-16,삼성바이오로직스자회사단기차입금증가결정,http://www.cstimes.com/?mod=news&act=articleView&idxno=273417
844,2018-04-16,공시삼성바이오로직스자회사단기차입금535억증가,http://www.viva100.com/main/view.php?key=20180416010005830
845,2018-04-16,유가증권시장공시삼성바이오로직스엔케이,http://news.mk.co.kr/newsRead.php?year=2018&no=242770
846,2018-04-16,삼성바이오로직스주가고평가와회계논란에하락셀트리온은반등,http://www.businesspost.co.kr/BP?command=article_view&num=79411
847,2018-04-16,삼성바이오로직스드림플러스장학멘토링펼쳐,http://www.kgnews.co.kr/news/articleView.html?idxno=512558
848,2018-04-17,삼성바이오로직스자회사단기차입금535억원증가결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=318540
849,2018-04-17,삼성바이오로직스2000원035내린565000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804170076&t=NN
850,2018-04-17,뜨거운감자삼성바이오로직스분식의혹언제해결보나,http://www.mdtoday.co.kr/mdtoday/index.html?no=318521
851,2018-04-17,삼성바이오로직스전일대비약3하락한550000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804170343&t=NN
852,2018-04-17,삼성株들썩막내의반란삼성바이오로직스삼성전자제치고수익률1위,http://www.ekn.kr/news/article.html?no=356292
853,2018-04-17,삼성바이오로직스16000원282내린551000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804170459&t=NN
854,2018-04-17,삼성바이오로직스와셀트리온3총사주가모두하락,http://www.businesspost.co.kr/BP?command=article_view&num=79530
855,2018-04-17,文정부수립1년삼성바이오로직스뜨고한화테크윈지고,http://www.ebn.co.kr/news/view/938201
856,2018-04-18,삼성바이오로직스3000원054오른554000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804180066&t=NN
857,2018-04-18,특징주삼성바이오로직스셀트리온동반강세시총3위싸움치열,http://view.asiae.co.kr/news/view.htm?idxno=2018041809120742837
858,2018-04-18,삼성바이오로직스셀트리온동반강세시총3위다툼치열,http://www.sedaily.com/NewsView/1RYAY2TQQ9
859,2018-04-18,삼성바이오로직스셀트리온장초반상승세시총3위경쟁치열,http://www.mdtoday.co.kr/mdtoday/index.html?no=318682
860,2018-04-18,삼성바이오로직스12000원218내린539000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804180461&t=NN
861,2018-04-18,北리스크줄었다반도체껑충vs삼성바이오로직스셀트리온부진,http://www.choicenews.co.kr/news/articleView.html?idxno=40740
862,2018-04-18,코스피기관순매도SK텔레콤삼성바이오로직스고려아연,http://www.newsway.co.kr/view.php?tp=1&ud=2018041817010318344
863,2018-04-18,삼성바이오로직스와셀트리온주가모두하락시가총액격차줄어,http://www.businesspost.co.kr/BP?command=article_view&num=79702
864,2018-04-19,DataScore삼성바이오로직스흑자전환에투자3배로늘어,http://www.ceoscoredaily.com/news/article.html?no=39958
865,2018-04-19,삼성바이오로직스5000원093내린534000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804190063&t=NN
866,2018-04-19,삼성바이오로직스전일대비약3하락한523000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804190178&t=NN
867,2018-04-19,삼성바이오로직스32000원594내린507000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804190565&t=NN
868,2018-04-19,경협주떴다현대건설급등vs셀트리온삼성바이오로직스급락,http://www.choicenews.co.kr/news/articleView.html?idxno=40775
869,2018-04-19,삼성바이오로직스셀트리온주가하락시총에서현대차에밀려,http://www.businesspost.co.kr/BP?command=article_view&num=79829
870,2018-04-20,삼성바이오로직스1000원02내린506000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804200082&t=NN
871,2018-04-20,20일장초반삼성바이오로직스셀트리온신라젠반등vs반도체는약세,http://www.choicenews.co.kr/news/articleView.html?idxno=40788
872,2018-04-20,삼성바이오로직스등바이오주동반강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=318930
873,2018-04-20,삼성바이오로직스1000원02내린506000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804200480&t=NN
874,2018-04-20,셀트리온삼성바이오로직스주가하락언제까지,http://www.intn.co.kr/news/articleView.html?idxno=1046344
875,2018-04-20,버블경고삼성바이오로직스매집나선개미,http://www.cstimes.com/?mod=news&act=articleView&idxno=273837
876,2018-04-20,셀트리온주가오르고삼성바이오로직스내려시총순위다시역전,http://www.businesspost.co.kr/BP?command=article_view&num=79977
877,2018-04-21,이번주외인은1주만에매도세전환셀트리온삼성바이오로직스팔자,http://www.asiatoday.co.kr/view.php?key=20180421010012399
878,2018-04-23,삼성바이오로직스4000원079내린502000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804230081&t=NN
879,2018-04-23,특징주삼성바이오로직스40만원대로바이오버블논란영향,http://news.mt.co.kr/mtview.php?no=2018042309102011963
880,2018-04-23,삼성바이오로직스바이오주고평가논란에40만원대하락,http://news.heraldcorp.com/view.php?ud=20180423000193
881,2018-04-23,60만원찍었던삼성바이오로직스바이오거품논란에40만원대로,http://www.mdtoday.co.kr/mdtoday/index.html?no=319051
882,2018-04-23,삼성바이오로직스전일대비약5하락한482000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804230191&t=NN
883,2018-04-23,특징주셀트리온삼성바이오로직스외국인매도에5↓,http://view.asiae.co.kr/news/view.htm?idxno=2018042310582449726
884,2018-04-23,삼성바이오로직스33000원652내린473000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804230603&t=NN
885,2018-04-23,美국채금리파장외국인또투매셀트리온삼성바이오로직스곤두박질,http://www.choicenews.co.kr/news/articleView.html?idxno=40868
886,2018-04-23,코스피기관순매도현대건설LG전자삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018042316594039648
887,2018-04-23,셀트리온삼성바이오로직스주가동반급락바이오주거품론여진,http://www.businesspost.co.kr/BP?command=article_view&num=80185
888,2018-04-24,삼성바이오로직스3500원074오른476500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804240077&t=NN
889,2018-04-24,국고처권태민종목상담삼성바이오로직스207940,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804210084&t=NNv
890,2018-04-24,특징주삼성바이오로직스7일만에반등,http://www.sporbiz.co.kr/news/articleView.html?idxno=223662
891,2018-04-24,코스피반락불구삼성바이오로직스296셀트리온259등바이오주강세,http://www.updownnews.co.kr/news/articleView.html?idxno=89405
892,2018-04-24,삼성바이오로직스1000원021오른474000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804240484&t=NN
893,2018-04-24,삼성바이오로직스1분기영업익100억원193↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180424130500008&did=1195m
894,2018-04-24,삼성바이오로직스1분기영업익100억원전년比193↑,http://biz.chosun.com/site/data/html_dir/2018/04/24/2018042401958.html
895,2018-04-24,삼성바이오로직스1Q영업익100억전년比193↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03539126619179400
896,2018-04-24,공시삼성바이오로직스1분기영업익100억전년比1934↑,http://www.newsway.co.kr/view.php?tp=1&ud=2018042415442270535
897,2018-04-24,삼성바이오로직스1Q영업이익100억전년比193↑,http://news.mt.co.kr/mtview.php?no=2018042415461727084
898,2018-04-24,어닝쇼크삼성바이오로직스올해1Q영업익99억컨센비521↓,http://www.itooza.com/common/iview.php?no=2018042415370710721
899,2018-04-24,삼성바이오로직스1Q영업익100억순손실572억적자폭확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=319233
900,2018-04-24,삼성바이오로직스올해1분기연결영업익100억원전년比193↑,http://www.enewstoday.co.kr/news/articleView.html?idxno=1182816
901,2018-04-24,삼성바이오로직스1Q영업익100억원전년比194증가1보,http://news1.kr/articles/?3299092
902,2018-04-24,삼성바이오로직스1분기영업이익100억원전년대비1941↑,http://news.mk.co.kr/newsRead.php?year=2018&no=261287
903,2018-04-24,삼성바이오로직스1Q영업익100억3Q연속흑자,http://www.edaily.co.kr/news/newspath.asp?newsid=03611286619179400
904,2018-04-24,삼성바이오로직스1Q매출1310억원영업익100억원,http://www.ebn.co.kr/news/view/939001
905,2018-04-24,삼성바이오로직스1분기영업이익1941증가,http://www.dt.co.kr/contents.html?article_no=2018042402109976029009&ref=naver
906,2018-04-24,삼성바이오로직스1분기영업익100억전년比194↑,http://www.newspim.com/news/view/20180424000295
907,2018-04-24,삼성바이오로직스2018년1Q매출1310억영업익100억,http://www.medigatenews.com/news/3872567432
908,2018-04-24,삼성바이오로직스2018년1Q매출1310억영업익100억,http://www.medigatenews.com/news/3872567432
909,2018-04-24,삼성바이오로직스1분기매출1310억원2공장가동률증가전년동기대비매출↑,http://www.segye.com/content/html/2018/04/24/20180424004544.html?OutUrl=naver
910,2018-04-24,삼성바이오로직스1분기영업익100억원전년比1934↑,http://www.asiatoday.co.kr/view.php?key=20180424010014300
911,2018-04-24,삼성바이오로직스1Q영업익100억순손실572억달해,http://www.sporbiz.co.kr/news/articleView.html?idxno=223892
912,2018-04-24,삼성바이오로직스1분기영업익100억전년비1941증가,http://www.newstomato.com/ReadNews.aspx?no=820197
913,2018-04-24,삼성바이오로직스올1분기매출1310억영업이익100억,http://www.ekn.kr/news/article.html?no=357763
914,2018-04-24,삼성바이오로직스1Q영업익100억기대치하회,http://news.einfomax.co.kr/news/articleView.html?idxno=3445487
915,2018-04-24,삼성바이오로직스1분기영업이익100억원1934↑,http://www.cstimes.com/?mod=news&act=articleView&idxno=274140
916,2018-04-24,삼성바이오로직스1분기영업익194증가,http://www.ciobiz.co.kr/news/article.html?id=20180424120031
917,2018-04-24,삼성바이오로직스올해1Q매출1310억영업익100억,http://www.metroseoul.co.kr/news/newsview?newscd=2018042400169
918,2018-04-24,삼성바이오로직스1Q영업익100억기대치하회,http://news.einfomax.co.kr/news/articleView.html?idxno=3445487
919,2018-04-24,삼성바이오로직스바이오주하락세에도소폭상승,http://news20.busan.com/controller/newsController.jsp?newsId=20180424000149
920,2018-04-24,공시삼성바이오로직스1분기연결영업이익100억원전년대비1934증가,http://www.g-enews.com/ko-kr/news/article/news_all/201804241607592157c642673384_1/article.html
921,2018-04-24,삼성바이오로직스올1분기영업익100억1934↑,http://view.asiae.co.kr/news/view.htm?idxno=2018042416111165626
922,2018-04-24,삼성바이오로직스1분기영업익100억원193↑종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180424130551008&did=1195m
923,2018-04-24,삼성바이오로직스1분기영업익100억전년비1934↑,http://news.heraldcorp.com/view.php?ud=20180424000797
924,2018-04-24,삼성바이오로직스1분기매출1310억원영업이익100억원기록,http://www.fnnews.com/news/201804241617160098
925,2018-04-24,삼성바이오로직스1Q영업익100억원약3배증가,http://www.dailian.co.kr/news/view/709037/?sc=naver
926,2018-04-24,삼성바이오로직스1Q영업익217증가,http://www.sedaily.com/NewsView/1RYDQAO4PE
927,2018-04-24,외국인연일투매삼성전자SK하이닉스급락vs삼성바이오로직스반등,http://www.choicenews.co.kr/news/articleView.html?idxno=40902
928,2018-04-24,삼성바이오로직스1분기영업익100억전년비193↑,http://www.mediapen.com/news/view/349711
929,2018-04-24,삼성바이오로직스1분기영업익100억전분기比802↓,http://www.newsis.com/view/?id=NISX20180424_0000290586&cID=13001&pID=13000
930,2018-04-24,삼성바이오로직스1분기손순실증가왜놀라지마라생산제품구성변화탓,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180424.99099011448
931,2018-04-24,공시삼성바이오로직스1분기영업익100억전년比1934↑,http://www.viva100.com/main/view.php?key=20180424010008852
932,2018-04-24,공시삼성바이오로직스2018년영업익100억달성전년비1934증가,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018042416398037127&outlink=1
933,2018-04-24,삼성바이오로직스1Q실적순항최대CMO능력확보,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180424163711
934,2018-04-24,삼성바이오로직스1분기매출1310억영업이익100억,http://www.fnnews.com/news/201804241646034881
935,2018-04-24,삼성바이오로직스올해1분기매출1310억달성,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018042416460466683
936,2018-04-24,삼성바이오로직스1분기영업익100억전년比1934↑,http://www.betanews.net:8080/article/844417.html
937,2018-04-24,삼성바이오로직스1분기영업익100억원전년비193↑,http://www.ceoscoredaily.com/news/article.html?no=40607
938,2018-04-24,삼성바이오로직스1분기영업익100억원전년비193↑,http://www.ceoscoredaily.com/news/article.html?no=40607
939,2018-04-24,삼성바이오로직스실적쇼크삼성새대표주자맞나,http://www.choicenews.co.kr/news/articleView.html?idxno=40906
940,2018-04-24,삼성바이오로직스1분기매출영업익전년동기比↑2공장가동률증가영향,http://www.news2day.co.kr/102943
941,2018-04-24,삼성바이오로직스1Q영업익100억원전년比1934↑,http://www.wolyo.co.kr/news/articleView.html?idxno=59207
942,2018-04-24,삼성바이오로직스1분기매출1310억원영업이익100억원,http://www.newsworks.co.kr/news/articleView.html?idxno=182366
943,2018-04-24,삼성바이오로직스1분기영업이익100억전년比1934↑,http://www.newsworks.co.kr/news/articleView.html?idxno=182375
944,2018-04-24,삼성바이오로직스1분기매출1310억원전년比217증가,http://daily.hankooki.com/lpage/life/201804/dh20180424171012138950.htm
945,2018-04-24,삼성바이오로직스1분기영업익100억전년比193↑,http://www.ajunews.com/view/20180424171841140
946,2018-04-24,삼성바이오로직스1분기영업익100억원시장기대치하회,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804240502&t=NN
947,2018-04-24,삼성바이오로직스1분기영업익100억원전년比194↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1616842
948,2018-04-24,삼성바이오로직스1Q영업익100억,http://www.seoulfn.com/news/articleView.html?idxno=304460
949,2018-04-24,삼성바이오로직스주가약간올라셀트리온보다시가총액앞서,http://www.businesspost.co.kr/BP?command=article_view&num=80319
950,2018-04-24,삼성바이오로직스1분기성적표뒷걸음,http://www.kormedi.com/news/news/drug_dist/1227010_2906.html
951,2018-04-24,삼성바이오로직스1분기영업익100억,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1468347
952,2018-04-24,삼성바이오로직스1분기영업이익193증가,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=748013
953,2018-04-24,삼성바이오로직스1분기영업이익100억작년比1941↑,http://www.kyeongin.com/main/view.php?key=20180424010010489
954,2018-04-25,삼성바이오로직스1분기영업이익어닝쇼크전분기比80감소,http://www.asiatoday.co.kr/view.php?key=20180424010014393
955,2018-04-25,삼성바이오로직스예상된매출감소NH,http://news.hankyung.com/article/2018042556396
956,2018-04-25,퀵리포트삼성바이오로직스매수유지목표가66만원유지SK證,http://www.itooza.com/common/iview.php?no=2018042507381538480
957,2018-04-25,삼성바이오로직스예상된매출영업익감소NH,http://www.fnnews.com/news/201804250738064813
958,2018-04-25,퀵리포트삼성바이오로직스보유유지목표가5↑40만원KB證,http://www.itooza.com/common/iview.php?no=2018042507401723154
959,2018-04-25,퀵리포트삼성바이오로직스매수유지목표가61만원유지한투證,http://www.itooza.com/common/iview.php?no=2018042507435011939
960,2018-04-25,삼성바이오로직스국내외제약바이오섹터조정추세목표가↓현대차,http://news.hankyung.com/article/2018042556656
961,2018-04-25,퀵리포트삼성바이오로직스매수유지목표가57만원유지유진證,http://www.itooza.com/common/iview.php?no=2018042507492224088
962,2018-04-25,퀵리포트삼성바이오로직스매수유지목표가4↓65만원현대차證,http://www.itooza.com/common/iview.php?no=2018042507525727674
963,2018-04-25,삼성바이오로직스1분기부진예상중장기전망변동없어유진,http://news.hankyung.com/article/2018042556806
964,2018-04-25,삼성바이오로직스하반기실적회복전망투자의견매수SK증권,http://www.fntimes.com/html/view.php?ud=201804250802416579f09e13944d_18
965,2018-04-25,삼성바이오로직스저조한1Q실적하반기회복전망SK,http://news.mt.co.kr/mtview.php?no=2018042507555777268
966,2018-04-25,삼성바이오로직스내년영업이익급증기대투자의견매수한국투자증권,http://www.fntimes.com/html/view.php?ud=201804250810207219f09e13944d_18
967,2018-04-25,삼성바이오로직스1Q영업익컨센하회목표가↓,http://www.edaily.co.kr/news/newspath.asp?newsid=01810566619179728
968,2018-04-25,아주종목분석삼성바이오로직스하반기실적회복전망,http://www.ajunews.com/view/20180425081915326
969,2018-04-25,삼성바이오로직스3공장수주기대감한국투자증권,http://www.ebn.co.kr/news/view/939061
970,2018-04-25,ET투자뉴스삼성바이오로직스1공장품목다변화HOLD유지KB증권,http://www.etnews.com/20180425000008
971,2018-04-25,삼성바이오로직스목표주가낮아져바이오주투자심리둔화,http://www.businesspost.co.kr/BP?command=article_view&num=80345
972,2018-04-25,삼성바이오로직스국내외바이오투자심리위축목표가↓현대차투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1616950
973,2018-04-25,삼성바이오로직스국내최초BIS위기대응시스템구축,http://www.asiatoday.co.kr/view.php?key=20180425010014538
974,2018-04-25,SK증권삼성바이오로직스실적아쉽지만기대감여전,http://www.newsprime.co.kr/news/article.html?no=414572
975,2018-04-25,삼성바이오로직스9000원19내린465000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804250083&t=NN
976,2018-04-25,삼성바이오로직스전일대비약4하락한457000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804250096&t=NN
977,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180425085433
978,2018-04-25,특징주삼성바이오로직스바이오투심악화로하락,http://news.mt.co.kr/mtview.php?no=2018042509045664471
979,2018-04-25,특징주삼성바이오로직스1분기실적부진에하락,http://www.edaily.co.kr/news/newspath.asp?newsid=02177926619179728
980,2018-04-25,삼성바이오로직스국내제약기업첫위기대응글로벌인증,http://www.newsis.com/view/?id=NISX20180425_0000291114&cID=13001&pID=13000
981,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증획득,http://www.dailian.co.kr/news/view/709155/?sc=naver
982,2018-04-25,특징주삼성바이오로직스1분기실적부진으로약세,http://www.newspim.com/news/view/20180425000070
983,2018-04-25,특징주삼성바이오로직스실적부진에주가도뚝,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180425041100008&did=1195m
984,2018-04-25,삼성바이오로직스ISO22301인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2082206
985,2018-04-25,삼성바이오로직스1Q실적부진에하락세,http://www.sedaily.com/NewsView/1RYE6NOB5S
986,2018-04-25,특징주삼성바이오로직스1분기실적부진에3대↓,http://www.newsprime.co.kr/news/article.html?no=414576
987,2018-04-25,삼성바이오로직스기대이하실적에장초반급락,http://news.heraldcorp.com/view.php?ud=20180425000143
988,2018-04-25,삼성바이오로직스업계최초위기대응시스템글로벌인증획득,http://www.fnnews.com/news/201804250922150613
989,2018-04-25,특징주삼성바이오로직스컨센서스밑도는실적에5가량↓,http://www.newsis.com/view/?id=NISX20180425_0000291157&cID=10401&pID=10400
990,2018-04-25,특징주삼성바이오로직스14분기실적부진에하락세,http://www.fnnews.com/news/201804250925240355
991,2018-04-25,특징주삼성바이오로직스부진한수익성에하락세,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018042509278092568&outlink=1
992,2018-04-25,삼성바이오로직스1분기매출영업익감소예상NH,http://www.cstimes.com/?mod=news&act=articleView&idxno=274188
993,2018-04-25,특징주삼성바이오로직스1Q실적부진에약세시총6위로하락,http://view.asiae.co.kr/news/view.htm?idxno=2018042509343813420
994,2018-04-25,삼성바이오로직스국내제약기업첫위기대응시스템글로벌인증,http://www.etoday.co.kr/news/section/newsview.php?idxno=1616976
995,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증업계최초,http://view.asiae.co.kr/news/view.htm?idxno=2018042509394849345
996,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180425046100017&did=1195m
997,2018-04-25,HotLinePOSCO삼성바이오로직스제치고시총5위로,http://news.mk.co.kr/newsRead.php?year=2018&no=262841
998,2018-04-25,25일증시초반외국인투매지속SK하이닉스삼성바이오로직스등부진,http://www.choicenews.co.kr/news/articleView.html?idxno=40918
999,2018-04-25,특징주삼성바이오로직스1분기실적부진약세,http://www.inews24.com/php/news_view.php?g_serial=1090726&g_menu=022300&rrf=nv
1000,2018-04-25,삼성바이오로직스BSI서ISO22301인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1183050
1001,2018-04-25,특징주삼성바이오로직스1분기실적부진에약세,http://www.seoulfn.com/news/articleView.html?idxno=304495
1002,2018-04-25,삼성바이오로직스바이오의약품생산안정성국제적수준이뤄,http://www.ajunews.com/view/20180425095822453
1003,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://www.ceoscoredaily.com/news/article.html?no=40630
1004,2018-04-25,삼성바이오로직스위기대응국제규격ISO22301인증,http://news1.kr/articles/?3299682
1005,2018-04-25,삼성바이오로직스ISO22301획득비즈니스연속성증명,http://www.newsworks.co.kr/news/articleView.html?idxno=182471
1006,2018-04-25,삼성바이오로직스상승반전,http://www.sedaily.com/NewsView/1RYE5VCU8B
1007,2018-04-25,삼성바이오로직스1분기매출1310억원2공장가동률증가,http://www.sisaweek.com/news/articleView.html?idxno=106993
1008,2018-04-25,삼성바이오로직스기대에못미치는영업이익이지만상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=319321
1009,2018-04-25,ET투자뉴스삼성바이오로직스장기적관점에서지매수유지한국투자증권,http://www.etnews.com/20180425000081
1010,2018-04-25,삼성바이오로직스ISO22301인증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=72317
1011,2018-04-25,삼성바이오로직스제약기업최초위기대응시스템글로벌인증,http://www.ebn.co.kr/news/view/939113
1012,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증획득,http://www.newspim.com/news/view/20180425000048
1013,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://www.dt.co.kr/contents.html?article_no=2018042502109976029004&ref=naver
1014,2018-04-25,사업연속성확인삼성바이오로직스위기관리인증,http://www.edaily.co.kr/news/newspath.asp?newsid=02804406619179728
1015,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://www.sisajournal-e.com/biz/article/183194
1016,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증획득,http://www.viva100.com/main/view.php?key=20180425010009133
1017,2018-04-25,노무라삼성바이오로직스1분기실적은부진전망은긍정적,http://www.choicenews.co.kr/news/articleView.html?idxno=40925
1018,2018-04-25,삼성바이오로직스비즈니스연속성ISO22301인증획득,http://news.mt.co.kr/mtview.php?no=2018042509404497038
1019,2018-04-25,삼성바이오로직스1분기부진에바이오투심위축까지주가는,http://news.hankyung.com/article/2018042568576
1020,2018-04-25,삼성바이오로직스위기대응시스템국제인증,http://www.sedaily.com/NewsView/1RYE6ASE6M
1021,2018-04-25,삼성바이오로직스국내제약기업최초위기대응시스템글로벌인증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018042500065
1022,2018-04-25,삼성바이오로직스위기대응국제표준획득,http://news.hankyung.com/article/201804256222f
1023,2018-04-25,취준생을위하여30삼성바이오로직스의리스크관리3가지포인트,http://www.news2day.co.kr/102985
1024,2018-04-25,ET투자뉴스삼성바이오로직스보릿고개넘기기는매수유지SK증권,http://www.etnews.com/20180425000148
1025,2018-04-25,ET투자뉴스삼성바이오로직스회계기준변경으로매수유지유진투자증권,http://www.etnews.com/20180425000152
1026,2018-04-25,삼성바이오로직스제약사최초ISO22301인증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055250
1027,2018-04-25,삼성바이오로직스올해1분기매출1천3백억돌파,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055251
1028,2018-04-25,삼성바이오로직스국제표준위기대응경영시스템ISO22301획득,http://news.mk.co.kr/newsRead.php?year=2018&no=263598
1029,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://news.mk.co.kr/newsRead.php?year=2018&no=263782
1030,2018-04-25,ET투자뉴스삼성바이오로직스기대치가높았을뿐매수현대차투자증권,http://www.etnews.com/20180425000297
1031,2018-04-25,오마이스탁삼성바이오로직스207940코스모화학005420外종목상담,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018042514372131637
1032,2018-04-25,삼성바이오로직스국내제약사최초위기대응시스템인증획득,http://news.heraldcorp.com/view.php?ud=20180425000709
1033,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180425155300013&did=1196m
1034,2018-04-25,삼성바이오로직스올해실적은쉬어가지만관건은3공장수주,http://www.newsworks.co.kr/news/articleView.html?idxno=182588
1035,2018-04-25,삼성바이오로직스4500원095오른478500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804250463&t=NN
1036,2018-04-25,NH투자증권삼성바이오로직스1분기예상된순손실발생임랄디등바이오시밀러유럽진출기대,http://www.g-enews.com/ko-kr/news/article/news_all/20180425085934477c16aa2f016_1/article.html
1037,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증획득,http://www.whosaeng.com/sub_read.html?uid=100950§ion=sc5
1038,2018-04-25,삼성바이오로직스국내제약기업최초위기대응시스템글로벌인증획득,http://www.mediapen.com/news/view/350013
1039,2018-04-25,삼성바이오로직스위기대응시스템글로벌인증획득,http://www.ciobiz.co.kr/news/article.html?id=20180425120027
1040,2018-04-25,외국인나흘째투매IT부진vs셀트리온삼성바이오로직스는올라,http://www.choicenews.co.kr/news/articleView.html?idxno=40938
1041,2018-04-25,1분기기대못미친삼성바이오로직스제약바이오후폭풍부나,http://www.ekn.kr/news/article.html?no=358033
1042,2018-04-25,삼성바이오로직스국내제약사최초위기대응시스템글로벌인증획득,http://www.ekn.kr/news/article.html?no=358055
1043,2018-04-25,삼성지배구조개편놓고삼성바이오로직스주가에시선몰려,http://www.businesspost.co.kr/BP?command=article_view&num=80426
1044,2018-04-25,삼성바이오로직스국내제약기업최초IOS22301인증획득,http://daily.hankooki.com/lpage/life/201804/dh20180425185003138950.htm
1045,2018-04-25,삼성바이오로직스와셀트리온주가동반상승해대장주경쟁치열,http://www.businesspost.co.kr/BP?command=article_view&num=80458
1046,2018-04-25,삼성바이오로직스국내제약기업최초위기대응시스템글로벌인증획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1468810
1047,2018-04-25,삼성바이오로직스국내제약기업첫위기대응시스템글로벌인증,http://www.insight.co.kr/news/152013
1048,2018-04-25,삼성바이오로직스국제규격ISO22301인증받아,http://www.businesspost.co.kr/BP?command=article_view&num=80464
1049,2018-04-25,삼성바이오로직스위기대응경영시스템글로벌인증획득,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=748141
1050,2018-04-25,삼성바이오로직스BSI국제인증국내바이오제약기업중첫획득,http://www.kyeongin.com/main/view.php?key=20180425010010922
1051,2018-04-25,삼성바이오로직스안정적인바이오생산공급에앞장,http://www.joongboo.com/?mod=news&act=articleView&idxno=1246589
1052,2018-04-26,기업톡톡삼성바이오로직스국내제약기업최초위기대응시스템글로벌인증획득,http://www.segye.com/content/html/2018/04/25/20180425006036.html?OutUrl=naver
1053,2018-04-26,기자수첩삼성바이오로직스가나스닥에상장했다면,http://www.kukinews.com/news/article.html?no=543458
1054,2018-04-26,더벨삼성바이오로직스바이오젠콜옵션행사영향은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201804250100051030003164
1055,2018-04-26,삼성바이오로직스셀트리온신라젠반등할까거품론에바이오주급락,http://weekly.cnbnews.com/news/article.html?no=124477
1056,2018-04-26,삼성바이오로직스9500원199오른488000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804260081&t=NN
1057,2018-04-26,특징주삼성바이오로직스최초위기대응시스템인증획득소식에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=02184486619180056
1058,2018-04-26,삼성바이오로직스위기대응인증획득에장초반상승흐름,http://www.sedaily.com/NewsView/1RYEM37K15
1059,2018-04-26,특징주삼성바이오로직스최초위기대응시스템인증획득소식에상승세,http://www.fnnews.com/news/201804260909529111
1060,2018-04-26,특징주삼성바이오로직스상승최초위기대응시스템인증획득영향,http://www.ebn.co.kr/news/view/939283
1061,2018-04-26,삼성바이오로직스위기대응시스템인증획득소식에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=319427
1062,2018-04-26,특징주삼성바이오로직스바이오젠콜옵션행사에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=224719
1063,2018-04-26,공시앤리포트삼성바이오로직스1Q실적영업이익100억원,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003184258
1064,2018-04-26,삼성바이오로직스20000원418오른498500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804260431&t=NN
1065,2018-04-26,삼성바이오로직스순이익적자지속연이은CMO계약에기대감여전,http://biz.newdaily.co.kr/news/article.html?no=10159372
1066,2018-04-26,코스피외국인순매도삼성바이오로직스LG디스플레이현대산업,http://www.newsway.co.kr/view.php?tp=1&ud=2018042617535379635
1067,2018-04-26,삼성바이오로직스셀트리온주가동반상승대장주경쟁치열,http://www.businesspost.co.kr/BP?command=article_view&num=80596
1068,2018-04-27,삼성바이오로직스7500원15오른506000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804270075&t=NN
1069,2018-04-27,fn마켓워치삼성바이오로직스사모채1900억원어치발행,http://www.fnnews.com/news/201804270922102569
1070,2018-04-27,삼성바이오로직스운영자금마련위해1900억규모사모채발행,http://www.mdtoday.co.kr/mdtoday/index.html?no=319553
1071,2018-04-27,삼성바이오로직스7500원15오른506000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804270380&t=NN
1072,2018-04-27,셀트리온주가급등시가총액에서삼성바이오로직스다시제쳐,http://www.businesspost.co.kr/BP?command=article_view&num=80760
1073,2018-04-30,삼성바이오로직스셀트리온삼성물산코스피시총10위권진입,http://www.ebn.co.kr/news/view/939564
1074,2018-04-30,코스피지각변동삼성바이오로직스∙셀트리온10위권진입,http://www.fntimes.com/html/view.php?ud=2018042717474299441d6f57e61a_18
1075,2018-04-30,삼성바이오로직스시가총액상위사중주가상승률1위,http://www.newsway.co.kr/view.php?tp=1&ud=2018042822345623111
1076,2018-04-30,30일증시삼성전자SK하이닉스이슈삼성바이오로직스이슈현대차수소전기차이슈부각,http://www.choicenews.co.kr/news/articleView.html?idxno=41035
1077,2018-04-30,삼성바이오로직스5000원099내린501000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804300064&t=NN
1078,2018-04-30,바이오주쭉쭉삼성바이오로직스셀트리온코스피시총10위권,http://www.newsworks.co.kr/news/articleView.html?idxno=183524
1079,2018-04-30,삼성바이오로직스등제약바이오주급락에코스닥수치↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=319697
1080,2018-04-30,삼성바이오로직스전일대비약3하락한490500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804300382&t=NN
1081,2018-04-30,삼성바이오로직스18000원356내린488000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804300603&t=NN
1082,2018-04-30,코스피시총톱10에삼성바이오로직스셀트리온등바이오종목진입,http://www.munhwa.com/news/view.html?no=20180430MW154113346936
1083,2018-04-30,삼성바이오로직스신라젠등제약바이오관련주급락끝내코스닥약세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=319731
1084,2018-04-30,삼성바이오로직스스위스제약사와계약금500억증액,http://www.newspim.com/news/view/20180430000321
1085,2018-04-30,셀트리온과삼성바이오로직스주가동반하락시총격차더벌어져,http://www.businesspost.co.kr/BP?command=article_view&num=80984
1086,2018-04-30,삼성바이오로직스스위스제약사와계약금4110억대로증액,http://news1.kr/articles/?3305094
1087,2018-04-30,삼성바이오로직스스위스계제약사와기존계약497억증액,http://www.edaily.co.kr/news/newspath.asp?newsid=05087286619181368
1088,2018-04-30,삼성바이오로직스vs셀트리온엎치락뒤치락바이오대장주전쟁,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000047552
1089,2018-05-01,제약업계는지금1분기실적GC녹십자종근당맑음유한양행삼성바이오로직스흐림,http://www.etoday.co.kr/news/section/newsview.php?idxno=1618871
1090,2018-05-01,삼성바이오로직스스위스제약사와계약금497억원증액,http://www.medisobizanews.com/news/articleView.html?idxno=52951
1091,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://news1.kr/articles/?3305496
1092,2018-05-01,삼성바이오로직스스위스제약사수출계약금497억증가,http://www.kormedi.com/news/news/drug_dist/1227100_2906.html
1093,2018-05-01,금감원삼성바이오로직스회계처리위반으로결론,http://www.edaily.co.kr/news/newspath.asp?newsid=01685926619204656
1094,2018-05-01,금감원삼성바이오로직스회계처리는위반잠정결론,http://biz.chosun.com/site/data/html_dir/2018/05/01/2018050101130.html
1095,2018-05-01,금감원삼성바이오로직스분식회계논란에회계위반결론,http://www.newsis.com/view/?id=NISX20180501_0000296872&cID=10401&pID=10400
1096,2018-05-01,금감원삼성바이오로직스회계위반판단,http://www.newsway.co.kr/view.php?tp=1&ud=2018050112050625553
1097,2018-05-01,금감원삼성바이오로직스회계처리위반사실통보”,http://www.fntimes.com/html/view.php?ud=201805011211034042f09e13944d_18
1098,2018-05-01,삼성바이오로직스스위스계제약사와기존계약금증액,http://www.mdtoday.co.kr/mdtoday/index.html?no=319816
1099,2018-05-01,금감원삼성바이오로직스회계처리위반으로결론,http://news.einfomax.co.kr/news/articleView.html?idxno=3446635
1100,2018-05-01,삼성바이오로직스2015년분식회계금감원조치사전통지,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805010086&t=NN
1101,2018-05-01,금감원삼성바이오로직스분식회계논란에회계위반,https://cnbc.sbs.co.kr/article_hub/10000900545?division=NAVER
1102,2018-05-01,금감원삼성바이오로직스회계처리위반으로결론,http://www.sporbiz.co.kr/news/articleView.html?idxno=226747
1103,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180501053300008&did=1195m
1104,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://view.asiae.co.kr/news/view.htm?idxno=2018050113070020368
1105,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.fnnews.com/news/201805011303499557
1106,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.kyeongin.com/main/view.php?key=20180501010000152
1107,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://news.sbs.co.kr/news/endPage.do?news_id=N1004738746&plink=ORI&cooper=NAVER
1108,2018-05-01,삼성바이오로직스분식회계의혹금감원회계처리위반결론,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050113282162150
1109,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.ytn.co.kr/_ln/0102_201805011331106962
1110,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://news.kbs.co.kr/news/view.do?ncd=3642951&ref=A
1111,2018-05-01,금감원삼성바이오로직스회계처리부적격판단,http://www.etnews.com/20180501000114
1112,2018-05-01,금감원삼성바이오로직스특별감리완료조치사전통보,http://www.ebn.co.kr/news/view/939878
1113,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://news.mk.co.kr/newsRead.php?year=2018&no=277053
1114,2018-05-01,금감원삼성바이오로직스분식회계논란에회계위반잠정결론,http://news.hankyung.com/article/2018050179467
1115,2018-05-01,금감원삼성바이오로직스회계처리위반지분가치부풀렸나,http://moneys.mt.co.kr/news/mwView.php?no=2018050113498058803
1116,2018-05-01,금감원삼성바이오로직스분식회계회계처리위반결론,http://www.ezyeconomy.com/news/articleView.html?idxno=82951
1117,2018-05-01,삼성바이오로직스스위스계제약사와계약금4110억4356만원으로변경지난해매출액대비885,http://www.sedaily.com/NewsView/1RZD36K0BS
1118,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.cstimes.com/?mod=news&act=articleView&idxno=274726
1119,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.kukinews.com/news/article.html?no=545005
1120,2018-05-01,금감원삼성바이오로직스의회계처리위반결론내려,http://www.businesspost.co.kr/BP?command=article_view&num=81052
1121,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.viva100.com/main/view.php?key=20180501010000264
1122,2018-05-01,금융감독원삼성바이오로직스특별감리회계처리위반,http://www.topstarnews.net/news/articleView.html?idxno=403546
1123,2018-05-01,금감원삼성바이오로직스회계처리위반사측회계처리문제없어치열한공방예상,http://www.segye.com/content/html/2018/05/01/20180501002878.html?OutUrl=naver
1124,2018-05-01,삼성바이오로직스글로벌제약사와계약금4110억4356만원으로변경,http://sports.khan.co.kr/news/sk_index.html?art_id=201805011453013&sec_id=561801&pt=nv
1125,2018-05-01,삼성바이오로직스에피스회계처리문제없다입장고수,http://news.mt.co.kr/mtview.php?no=2018050113574667837
1126,2018-05-01,금감원삼성바이오로직스회계위반잠정결론,http://www.m-i.kr/news/articleView.html?idxno=411045
1127,2018-05-01,근로자의날주식시장쉬는데삼성바이오로직스공시왜,http://www.topdaily.kr/news/articleView.html?idxno=50375
1128,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://imnews.imbc.com/news/2018/econo/article/4594633_22671.html
1129,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://imnews.imbc.com/news/2018/econo/article/4594633_22671.html
1130,2018-05-01,삼성바이오로직스어떤기업이길래,http://moneys.mt.co.kr/news/mwView.php?no=2018050114468047491
1131,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론내려,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520002
1132,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.shinailbo.co.kr/news/articleView.html?idxno=1068283
1133,2018-05-01,금감원삼성바이오로직스감리결과회계위반,http://www.ftoday.co.kr/news/articleView.html?idxno=87395
1134,2018-05-01,삼성바이오로직스스위스제약사위탁계약금변경작년매출대비885,http://www.dt.co.kr/contents.html?article_no=2018050102109976029004&ref=naver
1135,2018-05-01,삼성바이오로직스심상정참여연대문제제기通회계처리위반,http://www.topdaily.kr/news/articleView.html?idxno=50377
1136,2018-05-01,금감원삼성바이오로직스회계위반결론,http://news.kmib.co.kr/article/view.asp?arcid=0012322872&code=61141311&cp=nv
1137,2018-05-01,금융감독원삼성바이오로직스회계처리위반잠정결론,http://www.joongboo.com/?mod=news&act=articleView&idxno=1247971
1138,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.ebn.co.kr/news/view/939886
1139,2018-05-01,금감원삼성바이오로직스분식회계잠정결론,http://www.segye.com/content/html/2018/05/01/20180501002866.html?OutUrl=naver
1140,2018-05-01,금감원삼성바이오로직스회계위반결론제재어떻게주가에도관심,http://wikileaks-kr.org/%EA%B8%88%EA%B0%90%EC%9B%90-%EC%82%BC%EC%84%B1%EB%B0%94%EC%9D%B4%EC%98%A4%EB%A1%9C%EC%A7%81%EC%8A%A4-%ED%9A%8C%EA%B3%84-%EC%9C%84%EB%B0%98-%EA%B2%B0%EB%A1%A0-%EC%A0%9C%EC%9E%AC-%EC%96%B4%EB%96%BB
1141,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.newstomato.com/ReadNews.aspx?no=821657
1142,2018-05-01,금감원삼성바이오로직스회계처리위반했다잠정결론내려,http://daily.hankooki.com/lpage/economy/201805/dh20180501154922138100.htm
1143,2018-05-01,금감원이특별감리한삼성바이오로직스는어떤기업,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520028
1144,2018-05-01,삼성바이오로직스회계처리위반잠정결론에최선의소명을할것,http://www.fnnews.com/news/201805011550406290
1145,2018-05-01,금감원삼성바이오로직스회계처리위반”,http://www.seoul.co.kr/news/newsView.php?id=20180501500080&wlog_tag3=naver
1146,2018-05-01,삼성바이오로직스회계처리위반분식회계공방예상,http://www.seoulfn.com/news/articleView.html?idxno=305103
1147,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.joseilbo.com/news/news_read.php?uid=352003&class=18&grp=
1148,2018-05-01,삼성바이오로직스회계기준위반시민단체가제기한부분이맞다고금감원은판단했다”,http://www.hkbs.co.kr/news/articleView.html?idxno=466668
1149,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://news20.busan.com/controller/newsController.jsp?newsId=20180501000087
1150,2018-05-01,삼성바이오로직스회계기준위반언론에알리지않으면미공개정보이용위험이있는점을감안했다”,http://www.nextdaily.co.kr/news/article.html?id=20180501800026
1151,2018-05-01,금감원삼성바이오로직스회계처리위반,http://www.segyefn.com/newsView/20180501002797?OutUrl=naver
1152,2018-05-01,금감원회계처리위반삼성바이오로직스위법없었다반박,http://www.edaily.co.kr/news/newspath.asp?newsid=02154966619204656
1153,2018-05-01,금융감독원삼성바이오로직스회계처리위반잠정결론,http://www.ajunews.com/view/20180501160855501
1154,2018-05-01,금감원삼성바이오로직스회계위반잠정결론,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180501.99099000343
1155,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.greened.kr/news/articleView.html?idxno=60536
1156,2018-05-01,금감원삼성바이오로직스회계위반잠정결론,http://www.dailypharm.com/News/239390
1157,2018-05-01,금감원회계위반결론에삼성바이오로직스위법없다반박상보,http://www.edaily.co.kr/news/newspath.asp?newsid=02181206619204656
1158,2018-05-01,금융당국삼성바이오로직스회계처리위반잠정결론,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1470866
1159,2018-05-01,금감원삼성바이오로직스회계처리위반,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805010119&t=NN
1160,2018-05-01,회계위반삼성바이오로직스최악경우거래정지도,http://news.mt.co.kr/mtview.php?no=2018050114463367106
1161,2018-05-01,금감원삼성바이오로직스회계위반”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805011700001&code=920301
1162,2018-05-01,금융당국회계기준위반했다삼성바이오로직스국제기준지켰다종합,http://www.edaily.co.kr/news/newspath.asp?newsid=02200886619204656
1163,2018-05-01,단독금감원삼성바이오로직스분식회계증거있다,http://www.sporbiz.co.kr/news/articleView.html?idxno=226877
1164,2018-05-01,금감원삼성바이오로직스회계처리위반조치사전통지,http://www.breaknews.com/sub_read.html?uid=576017§ion=sc3
1165,2018-05-01,삼성바이오로직스회계위반에국민청원시작삼성정신차리게해달라,http://news20.busan.com/controller/newsController.jsp?newsId=20180501000115
1166,2018-05-01,삼성바이오로직스대규모순익회계처리위반,http://www.yonhapnewstv.co.kr/MYH20180501012200038/?did=1825m
1167,2018-05-01,삼성바이오로직스회계처리위반논란에입장소명에최선다하겠다,http://www.fnnews.com/news/201805011729349237
1168,2018-05-01,금감원삼성바이오로직스회계위반통지,http://www.g-enews.com/ko-kr/news/article/news_all/20180501173234324878c769af4f_1/article.html
1169,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.newscj.com/news/articleView.html?idxno=517060
1170,2018-05-01,분식회계삼성바이오로직스에여론분노불법과탈법의종합체삼성,http://www.munhwanews.com/news/articleView.html?idxno=136989
1171,2018-05-01,금감원삼성바이오로직스에회계처리위반결론,http://www.ekn.kr/news/article.html?no=359415
1172,2018-05-01,금감원삼성바이오로직스회계위반인정,http://it.chosun.com/news/article.html?no=2850927
1173,2018-05-01,삼성바이오로직스삼성바이오에피스회계처리에문제없다반박,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050117400775021
1174,2018-05-01,금감원삼성바이오로직스특별감리결과회계위반결론,https://cnbc.sbs.co.kr/article_hub/10000900549?division=NAVER
1175,2018-05-01,금융감독원삼성바이오로직스회계기준위반사실통보,http://www.enewstoday.co.kr/news/articleView.html?idxno=1185401
1176,2018-05-01,삼성바이오로직스회계처리위반결론무슨일이있었길래,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20180501.99099000424
1177,2018-05-01,삼성바이오로직스스위스제약사수출계약금497억증가,http://www.insight.co.kr/news/152989
1178,2018-05-01,삼성바이오로직스진퇴양난규제리스크에콜옵션까지,http://news1.kr/articles/?3305781
1179,2018-05-01,금감원삼성바이오로직스회계처리위반,http://news.mk.co.kr/newsRead.php?year=2018&no=277535
1180,2018-05-01,꿈의제약주삼성바이오로직스거래정지위기금감원회계잘못,http://www.nocutnews.co.kr/news/4963545
1181,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.weeklytoday.com/news/articleView.html?idxno=65596
1182,2018-05-01,회계위반삼성바이오로직스주식시장에파장,http://www.newsway.co.kr/view.php?tp=1&ud=2018050118254315852
1183,2018-05-01,금감원삼성바이오로직스회계처리위반”왜,http://www.sedaily.com/NewsView/1RZD4OAGHN
1184,2018-05-01,금감원삼성바이오로직스회계처리위반판단,http://biz.newdaily.co.kr/news/article.html?no=10159724
1185,2018-05-01,삼성바이오로직스회계위반삼성물산제일모직합병의혹에불똥,https://cnbc.sbs.co.kr/article_hub/10000900573?division=NAVER
1186,2018-05-01,삼성바이오로직스회계처리위반”,http://news.kmib.co.kr/article/view.asp?arcid=0923942977&code=11151400&cp=nv
1187,2018-05-01,삼성바이오로직스스위스글로벌제약사와계약4110억원대로확대,http://www.kukinews.com/news/article.html?no=545087
1188,2018-05-01,금감원삼성바이오로직스분식회계혐의인정”,http://www.hani.co.kr/arti/economy/finance/842879.html
1189,2018-05-01,삼성바이오로직스분식회계맞다주식매매중단까지,http://imnews.imbc.com/replay/2018/nwdesk/article/4594942_22663.html
1190,2018-05-01,금감원삼성바이오로직스회계처리위반놓고공방,http://www.asiatime.co.kr/news/articleView.html?idxno=178100
1191,2018-05-01,금감원삼성바이오로직스상장앞두고회계처리위반,http://news.sbs.co.kr/news/endPage.do?news_id=N1004739210&plink=ORI&cooper=NAVER
1192,2018-05-01,금감원삼성바이오로직스회계위반으로징계착수,http://www.inews24.com/php/news_view.php?g_serial=1092016&g_menu=022300&rrf=nv
1193,2018-05-01,금감원삼성바이오로직스분식회계논란회계위반결론,http://www.ceoscoredaily.com/news/article.html?no=40849
1194,2018-05-01,삼성바이오로직스회계처리과정위반,http://www.kyeongin.com/main/view.php?key=20180501010000248
1195,2018-05-01,금감원삼성바이오로직스에피스가치부풀려,http://news.hankyung.com/article/2018050185141
1196,2018-05-01,금감원삼성바이오로직스회계처리위반잠정결론,http://www.joongboo.com/?mod=news&act=articleView&idxno=1248084
1197,2018-05-01,오늘이슈전남영암버스사고8명사망성추행의혹현응스님홍준표과태료2천만원노동을새로쓰자2018세계노동절삼성바이오로직스분식회계이재명측조폭연루설제기함진규의원고,http://www.econovill.com/news/articleView.html?idxno=337003
1198,2018-05-01,금감원삼성바이오로직스회계처리위반결론,http://www.econovill.com/news/articleView.html?idxno=337005
1199,2018-05-01,삼성바이오로직스향후제재는어떻게치열한논리대결을벌일것,http://www.sporbiz.co.kr/news/articleView.html?idxno=226988
1200,2018-05-01,삼성바이오로직스일부주식투자가들투자주의경고하기도해,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065624499269218
1201,2018-05-01,삼성바이오로직스증권가에투자주의경고있었다,http://www.sisunnews.co.kr/news/articleView.html?idxno=81347
1202,2018-05-02,금감원삼성바이오로직스회계위반잠정결론,http://www.segye.com/content/html/2018/05/01/20180501005509.html?OutUrl=naver
1203,2018-05-02,금감원삼성바이오로직스회계위반결론통지서전달,http://www.ccdn.co.kr/news/articleView.html?idxno=517133
1204,2018-05-02,금감원삼성바이오로직스회계위반판단통지서발송,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=749094
1205,2018-05-02,금감원삼성바이오로직스회계처리위반”,http://www.seoul.co.kr/news/newsView.php?id=20180502019024&wlog_tag3=naver
1206,2018-05-02,삼성바이오로직스분식회계사건우려와전망,http://news20.busan.com/controller/newsController.jsp?newsId=20180502000013
1207,2018-05-02,금감원삼성바이오로직스상장앞두고분식회계,http://www.dailymedi.com/detail.php?number=830156&thread=22r12
1208,2018-05-02,금감원삼성바이오로직스회계기준위반잠정결론,http://www.mdtoday.co.kr/mdtoday/index.html?no=319822
1209,2018-05-02,삼성바이오로직스투자자들삼성브랜드믿고투자했는데한숨주가폭락우려에좌불안석,http://www.g-enews.com/ko-kr/news/article/news_all/2018050207141515434e4869c120_1/article.html
1210,2018-05-02,삼성바이오로직스실적부풀렸나금감원회계처리위반”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055432
1211,2018-05-02,그때는맞고지금은틀리다삼성바이오로직스분식회계논란2년전과정반대결론,http://www.news2day.co.kr/103296
1212,2018-05-02,삼성바이오로직스대규모순익회계처리위반,http://www.yonhapnewstv.co.kr/MYH20180502002100038/?did=1825m
1213,2018-05-02,금감원삼성바이오로직스회계처리위반잠정결론,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180502.99099000512
1214,2018-05-02,금감원삼성바이오로직스분식회계결론,http://www.betanews.net:8080/article/848035.html
1215,2018-05-02,분식회계논란삼성바이오로직스는어떤기업주가폭등셀트리온과바이오대장주경쟁,http://news20.busan.com/controller/newsController.jsp?newsId=20180502000029
1216,2018-05-02,금감원삼성바이오로직스회계기준위반,http://news.sbs.co.kr/news/endPage.do?news_id=N1004739678&plink=ORI&cooper=NAVER
1217,2018-05-02,금감원삼성바이오로직스분식회계잠정결론,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520417
1218,2018-05-02,금감원삼성바이오로직스회계처리위반잠정결론통보,http://www.newspim.com/news/view/20180502000042
1219,2018-05-02,속보삼성바이오로직스금감원감리적극소명할것,http://view.asiae.co.kr/news/view.htm?idxno=2018050208392139861
1220,2018-05-02,전문삼성바이오로직스국제회계기준따랐다,http://view.asiae.co.kr/news/view.htm?idxno=2018050208414671065
1221,2018-05-02,속보삼성바이오로직스금감원감리적극소명할것”,http://www.kukinews.com/news/article.html?no=545110
1222,2018-05-02,금감원삼성바이오로직스회계처리위반잠정결론,https://cnbc.sbs.co.kr/article_hub/10000900596?division=NAVER
1223,2018-05-02,삼성바이오로직스국제회계기준따라적정하게처리”금감원감리에반박전문,http://www.kukinews.com/news/article.html?no=545115
1224,2018-05-02,특징주삼성바이오로직스회계처리부적격15급락,http://news.mt.co.kr/mtview.php?no=2018050208514206789
1225,2018-05-02,특징주삼성바이오로직스금감원회계처리위반잠정결론16급락,http://view.asiae.co.kr/news/view.htm?idxno=2018050209034379770
1226,2018-05-02,특징주삼성바이오로직스회계처리위반결론에급락,http://www.ekn.kr/news/article.html?no=359485
1227,2018-05-02,삼성바이오로직스16하락전일보다77000원내린411000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020017&t=NN
1228,2018-05-02,특징주삼성바이오로직스정적VI발동왜금감원회계위반결론에주가추락,http://www.g-enews.com/ko-kr/news/article/news_all/201805020903193703c642673384_1/article.html
1229,2018-05-02,특징주삼성바이오로직스분식회계우려속급락,http://biz.chosun.com/site/data/html_dir/2018/05/02/2018050200628.html
1230,2018-05-02,특징주바이오株삼성바이오로직스회계위반에줄줄이하락,http://news.hankyung.com/article/2018050295206
1231,2018-05-02,특징주삼성물산삼성바이오로직스급락여파6↓,http://view.asiae.co.kr/news/view.htm?idxno=2018050209080403994
1232,2018-05-02,특징주삼성바이오로직스회계처리위반잠정결론급락출발,http://www.newspim.com/news/view/20180502000067
1233,2018-05-02,특징주삼성바이오로직스분식회계논란에폭락,http://www.sporbiz.co.kr/news/articleView.html?idxno=227086
1234,2018-05-02,삼성바이오로직스회계부정의혹에두자릿수급락출발,http://news.einfomax.co.kr/news/articleView.html?idxno=3446732
1235,2018-05-02,특징주삼성바이오로직스급락바이오주함께와르르,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180502040000008&did=1195m
1236,2018-05-02,삼성바이오로직스회계처리부적격판단에개장과함께16폭락,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520477
1237,2018-05-02,특징주삼성바이오로직스회계처리위반결론에급락,http://www.edaily.co.kr/news/newspath.asp?newsid=02059846619204984
1238,2018-05-02,특징주삼성바이오로직스회계처리위반으로19급락,http://www.viva100.com/main/view.php?key=20180502010000501
1239,2018-05-02,삼성바이오로직스대규모순이익발생국제회계기준따라처리했다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180502.99099000531
1240,2018-05-02,특징주삼성물산삼성바이오로직스회계위반급락,http://news.hankyung.com/article/2018050295476
1241,2018-05-02,특징주삼성바이오로직스장초반급락분식회계잠정결론,http://www.mediapen.com/news/view/351595
1242,2018-05-02,특징주삼성물산삼성바이오로직스회계위반급락,http://news.hankyung.com/article/2018050295476
1243,2018-05-02,삼성바이오로직스조치사전통지서수령소명예정”,http://news.hankyung.com/article/2018050296666
1244,2018-05-02,삼성바이오로직스회계문제우려주가부정적영향KB증권,http://www.ebn.co.kr/news/view/939945
1245,2018-05-02,특징주삼성바이오로직스회계처리위반의혹에급락,http://www.ebn.co.kr/news/view/939941
1246,2018-05-02,특징주회계위반삼성바이오로직스약18급락,http://www.fntimes.com/html/view.php?ud=20180502091429705f09e13944d_18
1247,2018-05-02,특징주삼성바이오로직스급락회계처리위반,http://www.inews24.com/php/news_view.php?g_serial=1092060&g_menu=022300&rrf=nv
1248,2018-05-02,삼성바이오로직스금감원분식회계결론에20폭락,http://news.heraldcorp.com/view.php?ud=20180502000143
1249,2018-05-02,특징주삼성바이오로직스회계처리위반결론에급락,http://www.newsway.co.kr/view.php?tp=1&ud=2018050209161696841
1250,2018-05-02,회계위반삼성바이오로직스시총6조원증발코스닥도급락,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050209110783655
1251,2018-05-02,회계위반불거진삼성바이오로직스증시서19급락,http://news1.kr/articles/?3306119
1252,2018-05-02,삼성바이오로직스회계부정의혹에두자릿수급락상보,http://news.einfomax.co.kr/news/articleView.html?idxno=3446738
1253,2018-05-02,삼성바이오로직스에게잠정결론내려진분식회계란무엇,http://www.interview365.com/news/articleView.html?idxno=80232
1254,2018-05-02,금감원삼성바이오로직스분식회계맞다회계위반결론,http://www.topstarnews.net/news/articleView.html?idxno=404080
1255,2018-05-02,특징주삼성물산삼성바이오로직스사태에유탄5↓,http://www.newsway.co.kr/view.php?tp=1&ud=2018050209183781031
1256,2018-05-02,코스피삼성바이오로직스충격에2510선턱걸이,http://www.edaily.co.kr/news/newspath.asp?newsid=02145126619204984
1257,2018-05-02,금감원삼성바이오로직스회계기준위반맞다”,http://www.whosaeng.com/sub_read.html?uid=101080§ion=sc5
1258,2018-05-02,삼성바이오로직스입장은종속회사에서관계회사로변경한것적정하다는의견받아”코스피상장기업,http://www.sedaily.com/NewsView/1RZDIWV5L5
1259,2018-05-02,삼성바이오로직스회계처리기준위반,http://www.medisobizanews.com/news/articleView.html?idxno=52959
1260,2018-05-02,특징주삼성바이오로직스금감원회계처리위반잠정결론에17급락,http://www.seoulfn.com/news/articleView.html?idxno=305136
1261,2018-05-02,특징주삼성바이오로직스금감원분식회계지적에급락바이오주덩달아↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619090
1262,2018-05-02,삼성바이오로직스회계처리위반”최악엔거래정지도,https://cnbc.sbs.co.kr/article_hub/10000900609?division=NAVER
1263,2018-05-02,특징주삼성바이오로직스금감원분식회계잠정결론으로주가급락바이오주와르르,http://www.kyeongin.com/main/view.php?key=20180502010000484
1264,2018-05-02,삼성바이오로직스금감원회계위반결론분식회계란,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180502.99099000536
1265,2018-05-02,특징주삼성바이오로직스금융당국회계위반결론에급락,http://www.newstomato.com/ReadNews.aspx?no=821708
1266,2018-05-02,공시삼성바이오로직스조치사전통지서통보받아소명할예정”,http://www.newsway.co.kr/view.php?tp=1&ud=2018050209270922426
1267,2018-05-02,HotLine삼성바이오로직스분식회계잠정결론에급락,http://news.mk.co.kr/newsRead.php?year=2018&no=278404
1268,2018-05-02,특징주삼성바이오로직스회계처리위반잠정결론에급락,http://moneys.mt.co.kr/news/mwView.php?no=2018050209268023652
1269,2018-05-02,삼성바이오로직스회계문제단기적으로주가에부정적,http://www.newsprime.co.kr/news/article.html?no=415300
1270,2018-05-02,금감원삼성바이오로직스분식회계결론업체문제없다반박,http://www.sisajournal-e.com/biz/article/183498
1271,2018-05-02,삼성바이오로직스조치사전통지서통보받아소명예정,http://www.newsis.com/view/?id=NISX20180502_0000297534&cID=10401&pID=10400
1272,2018-05-02,삼성바이오로직스조치사전통지서통보받아소명예정,http://www.newsis.com/view/?id=NISX20180502_0000297534&cID=10401&pID=10400
1273,2018-05-02,삼성바이오로직스급락바이오주도함께동반하락,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520507
1274,2018-05-02,삼성바이오로직스6조증발회계처리위반의혹에국제회계기준따랐다”반박,http://www.sedaily.com/NewsView/1RZDJQITDJ
1275,2018-05-02,삼성바이오로직스회계처리위반잠정결론소식에급락,http://www.mdtoday.co.kr/mdtoday/index.html?no=319863
1276,2018-05-02,특징주삼성바이오로직스분식회계혐의에19대급락,http://www.ezyeconomy.com/news/articleView.html?idxno=82957
1277,2018-05-02,삼성바이오로직스국제회계기준으로자회사변경적정평가,http://www.biospectator.com/view/news_view.php?varAtcId=5412
1278,2018-05-02,개장시황코스피삼성바이오로직스급락에지수출렁2510선약보합,http://www.ezyeconomy.com/news/articleView.html?idxno=82959
1279,2018-05-02,삼성바이오로직스회계위반논란주가급락,http://www.medicaltimes.com/News/1118407
1280,2018-05-02,삼성바이오로직스금감원감리관련조치사전통지,http://www.edaily.co.kr/news/newspath.asp?newsid=02361606619204984
1281,2018-05-02,2일장초반한국증시주춤삼성바이오로직스곤두박질,http://www.choicenews.co.kr/news/articleView.html?idxno=41090
1282,2018-05-02,삼성바이오로직스주가급락금감원의회계위반결론에신음,http://www.businesspost.co.kr/BP?command=article_view&num=81096
1283,2018-05-02,삼성바이오로직스회계처리위반분식회계가뭐길래,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520546
1284,2018-05-02,삼성바이오로직스국제회계기준대로처리했다기존입장고수,http://www.asiatoday.co.kr/view.php?key=20180502010000716
1285,2018-05-02,분식회계의혹삼성바이오로직스오늘오후긴급기자회견연다,http://www.ajunews.com/view/20180502093023775
1286,2018-05-02,삼성바이오로직스무슨일,http://moneys.mt.co.kr/news/mwView.php?no=2018050209478018762
1287,2018-05-02,특징주삼성바이오로직스금감원회계처리위반결론에급락,http://www.cstimes.com/?mod=news&act=articleView&idxno=274760
1288,2018-05-02,특징주삼성물산삼성바이오로직스분식회계혐의에하락,http://www.ebn.co.kr/news/view/939964
1289,2018-05-02,회계처리위반잠정결론삼성바이오로직스주가뚝정적변동성완화장치발동,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180502.99099000587
1290,2018-05-02,특징주삼성바이오로직스회계부적격논란폭락세,http://www.nspna.com/news/?mode=view&newsid=281953
1291,2018-05-02,분식회계충격삼성바이오로직스조정길어질듯,http://news.heraldcorp.com/view.php?ud=20180502000261
1292,2018-05-02,삼성바이오로직스에피스관계사처리문제없다,http://www.dailypharm.com/News/239405
1293,2018-05-02,특징주삼성바이오로직스회계위반에급락당분간약세지속,http://www.metroseoul.co.kr/news/newsview?newscd=2018050200033
1294,2018-05-02,특징주삼성물산삼성바이오로직스분식회계논란여파에하락세,http://moneys.mt.co.kr/news/mwView.php?no=2018050210048052510
1295,2018-05-02,삼성바이오로직스여파코스피2510선수성안간힘,http://news1.kr/articles/?3306185
1296,2018-05-02,분식회계의혹삼성바이오로직스급락바이오주도동반하락,http://sports.khan.co.kr/news/sk_index.html?art_id=201805021006013&sec_id=564001&pt=nv
1297,2018-05-02,속보삼성바이오로직스오후대한상의에서금감원감리결과관련긴급기자회견,http://www.kyeongin.com/main/view.php?key=20180502010000505
1298,2018-05-02,삼성바이오로직스분식회계의혹에국제회계기준에따라처리,http://www.newsrep.co.kr/news/articleView.html?idxno=50055
1299,2018-05-02,삼성바이오로직스회계처리위반사실과달라적정하다,http://www.newsis.com/view/?id=NISX20180502_0000297587&cID=13001&pID=13000
1300,2018-05-02,특징주삼성바이오로직스분식회계잠정결론에10이상폭락,http://www.kukinews.com/news/article.html?no=545173
1301,2018-05-02,증권가삼성바이오로직스최대20과징금가능,http://www.dailypharm.com/News/239408
1302,2018-05-02,삼성바이오로직스회계부적격판단에외부감사인에게적정하다는의견도받았다”,http://www.hkbs.co.kr/news/articleView.html?idxno=466771
1303,2018-05-02,삼성바이오로직스금감원감리결과긴급기자회견,http://www.newsis.com/view/?id=NISX20180502_0000297635&cID=13001&pID=13000
1304,2018-05-02,삼성바이오로직스회계부적격판단에모든절차에충실하게임하도록하겠다”,http://www.nextdaily.co.kr/news/article.html?id=20180502800015
1305,2018-05-02,삼성바이오로직스바이오젠콜옵션행사가관건,http://www.inews24.com/php/news_view.php?g_serial=1092093&g_menu=022300&rrf=nv
1306,2018-05-02,삼성바이오로직스국제회계기준준수회계처리문제없다,http://www.etnews.com/20180502000062
1307,2018-05-02,삼성바이오로직스회계위반논란에바이오株우수수,http://news1.kr/articles/?3306223
1308,2018-05-02,삼성바이오로직스회계위반이슈에주가급락,http://www.sisajournal-e.com/biz/article/183502
1309,2018-05-02,특징주삼성바이오로직스금감원회계처리위반결론에급락,http://www.asiatoday.co.kr/view.php?key=20180502010000773
1310,2018-05-02,공시삼성바이오로직스금감원으로부터감리관련조치사전통지서받아소명예정,http://www.fnnews.com/news/201805021033109907
1311,2018-05-02,특징주바이오株삼성바이오로직스회계위반에털썩,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020088&t=NN
1312,2018-05-02,열린시장이슈IN금감원삼성바이오로직스회계처리위반,http://www.newstomato.com/ReadNews.aspx?no=821731
1313,2018-05-02,더벨삼성바이오로직스역대급사모채깜깜이금리,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201804270100056410003502
1314,2018-05-02,삼성바이오로직스조치사전통지서수령회계기준적절성소명예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=319875
1315,2018-05-02,속보삼성바이오로직스오후기자회견회계처리적정의견받아”,http://www.kukinews.com/news/article.html?no=545205
1316,2018-05-02,삼성물산자회사삼성바이오로직스회계위반주가불똥튀나,http://www.g-enews.com/ko-kr/news/article/news_all/201805021013456940c16aa2f016_1/article.html
1317,2018-05-02,삼성바이오로직스분식회계논란으로바이오주급감추세,http://www.sportsseoul.com/news/read/629952
1318,2018-05-02,회계부정의혹삼성바이오로직스증시서어떻게되나,http://news.einfomax.co.kr/news/articleView.html?idxno=3446783
1319,2018-05-02,회계위반논란삼성바이오로직스적극소명외부감사인은적정의견,http://www.newspim.com/news/view/20180502000077
1320,2018-05-02,삼성바이오로직스금감원서감리관련조치사전통지서통보받아소명예정,http://www.viva100.com/main/view.php?key=20180502010000594
1321,2018-05-02,특징주분식회계잠정결론에삼성바이오로직스급락바이오株내리막,http://www.m-i.kr/news/articleView.html?idxno=411268
1322,2018-05-02,인베스트조선회계처리위반삼성바이오로직스상장폐지도가능,http://www.investchosun.com/?p=3225534
1323,2018-05-02,삼성바이오로직스분식논란금감원회계위반결론물산제일모직합병불똥,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619135
1324,2018-05-02,삼성바이오로직스분식논란①금감원과온도차,http://news.bizwatch.co.kr/article/market/2018/05/02/0004/naver
1325,2018-05-02,﻿금융감독원vs삼성바이오로직스회계처리위반두고논란진실은,http://medicalworldnews.co.kr/news/view.php?idx=1510925477
1326,2018-05-02,삼성바이오로직스분식회계논란으로최악경우거래정지까지,http://www.polinews.co.kr/news/article.html?no=354411
1327,2018-05-02,바이오株삼성바이오로직스회계위반에줄줄이털썩,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020101&t=NNv
1328,2018-05-02,삼성바이오로직스IFRS기준따라적정하게회계처리,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180502110151
1329,2018-05-02,긴급진단금융당국회계처리위반결론삼성바이오로직스국제회계기준대로처리,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050210381192133
1330,2018-05-02,삼성바이오로직스금감원회계처리위반잠정결론에급락,http://daily.hankooki.com/lpage/economy/201805/dh20180502111323138110.htm
1331,2018-05-02,엘리엇소송삼성바이오로직스분식회계에삼성주울상,http://www.fntimes.com/html/view.php?ud=201805021114406354f09e13944d_18
1332,2018-05-02,회계위반논란삼성바이오로직스입장문게재적정하다,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520687
1333,2018-05-02,삼성바이오로직스감리위심의증선위의결등절차충실하게임할것,http://www.ekn.kr/news/article.html?no=359550
1334,2018-05-02,삼성바이오로직스분식회계논란그땐맞고지금은틀린회계판단,http://view.asiae.co.kr/news/view.htm?idxno=2018050211194864639
1335,2018-05-02,코스피기관외국인매도에하락삼성바이오로직스급락,http://news.hankyung.com/article/2018050205906
1336,2018-05-02,바이오대장주삼성바이오로직스분식회계충격투자심리꽁꽁,http://news.heraldcorp.com/view.php?ud=20180502000487
1337,2018-05-02,삼성바이오로직스회계처리위반논란쟁점은,http://news.einfomax.co.kr/news/articleView.html?idxno=3446804
1338,2018-05-02,삼성바이오로직스회계처리위반관련외부감사받았다,http://moneys.mt.co.kr/news/mwView.php?no=2018050211378067536
1339,2018-05-02,분식회계충격삼성바이오로직스주가급락의약품주도약세,https://cnbc.sbs.co.kr/article_hub/10000900637?division=NAVER
1340,2018-05-02,삼성바이오로직스회계처리문제없어”2일오후긴급기자회견,http://www.newsway.co.kr/view.php?tp=1&ud=2018050211311071071
1341,2018-05-02,삼성바이오로직스회계처리적정소명하겠다홈페이지에입장문올려,http://www.ftoday.co.kr/news/articleView.html?idxno=87430
1342,2018-05-02,삼성바이오로직스회계처리위반반박국제회계기준따라적정하게처리했다”,http://www.mdtoday.co.kr/mdtoday/index.html?no=319883
1343,2018-05-02,특징주삼성물산삼성바이오로직스회계위반하락세,http://www.fnnews.com/news/201805021144338427
1344,2018-05-02,삼성바이오로직스분식회계논란후폭풍어디까지촉각,http://www.00news.co.kr/news/articleView.html?idxno=52943
1345,2018-05-02,코스피2500선유지삼성바이오로직스따라바이오주폭락,https://cnbc.sbs.co.kr/article_hub/10000900643?division=NAVER
1346,2018-05-02,부자들은경제신문을읽는다회계위반삼성바이오로직스최악의경우거래정지도外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050211565111356
1347,2018-05-02,삼성바이오로직스회계위반바이오주급락,http://www.dailymedi.com/detail.php?number=830173&thread=22r05
1348,2018-05-02,분식회계논란삼성바이오로직스오늘2일긴급기자회견실시,http://www.topstarnews.net/news/articleView.html?idxno=404247
1349,2018-05-02,분식회계삼성바이오로직스에바이오주휘청,http://www.skyedaily.com/news/news_view.html?ID=73287
1350,2018-05-02,삼성바이오로직스금감원감리결과소명국제회계기준따른것,http://www.techholic.co.kr/news/articleView.html?idxno=175781
1351,2018-05-02,삼성바이오로직스회계처리외부감사인으로부터적정하다의견받아,http://www.sisafocus.co.kr/news/articleView.html?idxno=184994
1352,2018-05-02,금감원1년만에삼성바이오로직스회계위반결론,http://www.naeil.com/news_view/?id_art=274455
1353,2018-05-02,분식회계논란삼성바이오로직스쟁점은,http://www.ajunews.com/view/20180502123439952
1354,2018-05-02,삼성바이오로직스회계처리금감원대응오락가락,http://www.kukinews.com/news/article.html?no=545267
1355,2018-05-02,삼성바이오로직스분식회계논란회계기준위반VS국제회계기준따랐다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180502.99099000730
1356,2018-05-02,삼성바이오로직스회계처리위반가열되는상장폐지논란,http://www.viva100.com/main/view.php?key=20180502010000676
1357,2018-05-02,삼성바이오로직스분식회계최종결론시행정소송1보,http://news.mt.co.kr/mtview.php?no=2018050213323299157
1358,2018-05-02,삼성바이오로직스긴급기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502111700013&did=1196m
1359,2018-05-02,삼성바이오로직스회계위반최종결정시행정소송1보,http://news1.kr/articles/?3306528
1360,2018-05-02,삼성바이오로직스당시바이오젠콜옵션행사하겠다레터송부2보,http://news.mt.co.kr/mtview.php?no=2018050213420022298
1361,2018-05-02,삼성바이오로직스긴급기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502111600013&did=1196m
1362,2018-05-02,삼성바이오로직스부당이득아니므로분식회계아냐2보,http://news1.kr/articles/?3306535
1363,2018-05-02,삼성바이오로직스회계처리로얻은실익없어3보,http://news.mt.co.kr/mtview.php?no=2018050213453119758
1364,2018-05-02,속보삼성바이오로직스회계기준위반없다행정소송도불사,http://www.sporbiz.co.kr/news/articleView.html?idxno=227231
1365,2018-05-02,삼성바이오로직스긴급기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502112200013&did=1196m
1366,2018-05-02,삼성바이오로직스증선위감리위원회등에서회계위반결정시행정소송불사할것속보,http://www.asiatoday.co.kr/view.php?key=20180502010001033
1367,2018-05-02,삼성바이오로직스회계기준위반없다행정소송도불사,http://www.mediapen.com/news/view/351725
1368,2018-05-02,엘리엇삼성물산제일모직합병부당정부상대소송금감위분식회계논란삼성바이오로직스특별감리,http://www.weeklytoday.com/news/articleView.html?idxno=65614
1369,2018-05-02,삼성바이오로직스금감원회계처리위반결론에반박,http://www.koreaittimes.com/news/articleView.html?idxno=82626
1370,2018-05-02,삼성바이오로직스금감원감리조치사전통지서통보받아,http://www.newspim.com/news/view/20180502000105
1371,2018-05-02,포토대화하는삼성바이오로직스임원진,http://www.edaily.co.kr/news/newspath.asp?newsid=03627686619204984
1372,2018-05-02,포토삼성바이오로직스임원진의대화,http://www.edaily.co.kr/news/newspath.asp?newsid=03630966619204984
1373,2018-05-02,속보삼성바이오로직스회계처리로얻은실익없어사기를협의해서치나,http://www.sporbiz.co.kr/news/articleView.html?idxno=227248
1374,2018-05-02,포토취재진질문답하는김동중삼성바이오로직스전무,http://www.edaily.co.kr/news/newspath.asp?newsid=03644086619204984
1375,2018-05-02,포토답변하는심병화삼성바이오로직스상무,http://www.edaily.co.kr/news/newspath.asp?newsid=03650646619204984
1376,2018-05-02,포토답변하는김동중삼성바이오로직스전무,http://www.edaily.co.kr/news/newspath.asp?newsid=03647366619204984
1377,2018-05-02,회계처리위반삼성바이오로직스분식회계아니다,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180502107200017&did=1195m
1378,2018-05-02,포토삼성바이오로직스분식회계관련입장발표,http://view.asiae.co.kr/news/view.htm?idxno=2018050214141280931
1379,2018-05-02,포토삼성바이오로직스어떤대화,http://www.edaily.co.kr/news/newspath.asp?newsid=03673606619204984
1380,2018-05-02,포토기자회견가진삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=03670326619204984
1381,2018-05-02,삼성바이오로직스자회사회계처리문제없다분식혐의부인,http://www.newsworks.co.kr/news/articleView.html?idxno=184025
1382,2018-05-02,삼성바이오로직스상무긴급기자회견분식회계아니다”,http://sports.khan.co.kr/news/sk_index.html?art_id=201805021417003&sec_id=564001&pt=nv
1383,2018-05-02,삼성바이오로직스행정소송불사기자회견에도낙폭키워,http://www.sedaily.com/NewsView/1RZDKSKBV3
1384,2018-05-02,삼성바이오로직스주식거래정지될수있다”회계처리기준위반및금액쟁점,http://www.g-enews.com/ko-kr/news/article/news_all/201805021414515459c642673384_1/article.html
1385,2018-05-02,삼성바이오로직스긴급기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502122300013&did=1196m
1386,2018-05-02,긴급기자회견갖는삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502123200013&did=1196m
1387,2018-05-02,삼성바이오로직스긴급기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502123500013&did=1196m
1388,2018-05-02,머니S포토삼성바이오로직스금감원회계처리위반결론반박,http://moneys.mt.co.kr/news/mwView.php?no=2018050214138043015
1389,2018-05-02,머니S포토금감원반박입장발표한삼성바이오로직스,http://moneys.mt.co.kr/news/mwView.php?no=2018050214198044327
1390,2018-05-02,삼성바이오로직스회계위반관련결과따라행정소송도불사1보,http://www.newspim.com/news/view/20180502000225
1391,2018-05-02,대화하는삼성바이오로직스임원진,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180502123800013&did=1196m
1392,2018-05-02,삼성바이오로직스분식회계의혹부인행정소송도불사,http://www.businesspost.co.kr/BP?command=article_view&num=81137
1393,2018-05-02,삼성바이오로직스긴급기자회견,http://news1.kr/photos/view/?3091561
1394,2018-05-02,포토눈감은삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=03729366619204984
1395,2018-05-02,포토김동중삼성바이오로직스전무회계위반아냐,http://www.edaily.co.kr/news/newspath.asp?newsid=03726086619204984
1396,2018-05-02,포토생각에잠긴김동중삼성바이오로직스전무,http://www.edaily.co.kr/news/newspath.asp?newsid=03735926619204984
1397,2018-05-02,머니S포토삼성바이오로직스윤호열상무회계기준위반없어,http://moneys.mt.co.kr/news/mwView.php?no=2018050214218088483
1398,2018-05-02,삼성바이오로직스분식회계관련입장발표,http://news1.kr/photos/view/?3091595
1399,2018-05-02,삼성바이오로직스금감원감리결과관련긴급기자회견,http://news1.kr/photos/view/?3091596
1400,2018-05-02,속보삼성바이오로직스콜옵션으로관계사변경사례없어정권과의관련성은,http://www.sporbiz.co.kr/news/articleView.html?idxno=227259
1401,2018-05-02,삼성바이오로직스금감원감리결과관련긴급기자회견,http://news1.kr/photos/view/?3091574
1402,2018-05-02,삼성바이오로직스회계위반최종결정시행정소송,http://news1.kr/photos/view/?3091594
1403,2018-05-02,삼성바이오로직스분식회계아니다,http://news1.kr/photos/view/?3091598
1404,2018-05-02,머니S포토금감원결론반박삼성바이오로직스분식회계아니다,http://moneys.mt.co.kr/news/mwView.php?no=2018050214268013694
1405,2018-05-02,포토답변하는심병화삼성바이오로직스상무,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619274
1406,2018-05-02,포토삼성바이오로직스회계처리로부당한이득취한바없다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619272
1407,2018-05-02,포토삼성바이오로직스분식회계의혹관련긴급기자회견,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619275
1408,2018-05-02,포토삼성바이오로직스긴급기자회견열려,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619271
1409,2018-05-02,포토삼성바이오로직스회계기준인식적용에대한차이,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619273
1410,2018-05-02,회계처리위반삼성바이오로직스긴급기자회견분식회계아니다,http://www.kyeongin.com/main/view.php?key=20180502010000696
1411,2018-05-02,머니S포토삼성바이오로직스입장발표하는심병화상무,http://moneys.mt.co.kr/news/mwView.php?no=2018050214288016662
1412,2018-05-02,심각한표정의삼성바이오로직스,http://www.nocutnews.co.kr/news/4963895
1413,2018-05-02,모두발언하는삼성바이오로직스윤호열상무,http://www.nocutnews.co.kr/news/4963897
1414,2018-05-02,주요쟁점및진행결과발표하는삼성바이오로직스심병화상무,http://www.nocutnews.co.kr/news/4963896
1415,2018-05-02,삼성바이오로직스긴급기자회견,http://www.nocutnews.co.kr/news/4963891
1416,2018-05-02,삼성바이오로직스금감원감리결과기자회견,http://www.nocutnews.co.kr/news/4963889
1417,2018-05-02,답변준비하는삼성바이오로직스관계자들,http://www.nocutnews.co.kr/news/4963892
1418,2018-05-02,기자회견참석한삼성바이오로직스관계자,http://www.nocutnews.co.kr/news/4963890
1419,2018-05-02,삼성바이오로직스금감원회계처리위반사실아니다외부회계법인조언에따른것,http://www.fnnews.com/news/201805021430538413
1420,2018-05-02,삼성바이오로직스분식회계이슈에주가급락사실아냐행정소송도불사,http://www.seoulwire.com/news/articleView.html?idxno=13745
1421,2018-05-02,취재진질문에답하는삼성바이오로직스김동중전무,http://www.nocutnews.co.kr/news/4963894
1422,2018-05-02,삼성바이오로직스회계처리위반아냐기준따른것”,http://news.kbs.co.kr/news/view.do?ncd=3643533&ref=A
1423,2018-05-02,삼성바이오로직스금감원결정은인식적용차이부당이득취한바없어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1185709
1424,2018-05-02,삼성바이오로직스분식회계아니다소명예정,http://www.segyefn.com/newsView/20180502003692?OutUrl=naver
1425,2018-05-02,포토심병화삼성바이오로직스상무회계위반아니다,http://www.edaily.co.kr/news/newspath.asp?newsid=03781846619204984
1426,2018-05-02,삼성바이오로직스분식회계아니다고의회계조작동기실익없어”,http://news.kmib.co.kr/article/view.asp?arcid=0012325416&code=61141111&cp=nv
1427,2018-05-02,포토삼성바이오로직스분식회계관련입장발표,http://view.asiae.co.kr/news/view.htm?idxno=2018050214391012580
1428,2018-05-02,포토삼성바이오로직스기자회견,http://view.asiae.co.kr/news/view.htm?idxno=2018050214392124645
1429,2018-05-02,포토김동중전무삼성바이오로직스분식회계아니,http://view.asiae.co.kr/news/view.htm?idxno=2018050214385404248
1430,2018-05-02,포토발표하는심병화삼성바이오로직스상무,http://www.edaily.co.kr/news/newspath.asp?newsid=03778566619204984
1431,2018-05-02,포토의견나누는삼성바이오로직스관계자들,http://view.asiae.co.kr/news/view.htm?idxno=2018050214391821242
1432,2018-05-02,행정소송까지검토삼성바이오로직스회계처리로부당이득취한바없다,http://daily.hankooki.com/lpage/economy/201805/dh20180502143605138060.htm
1433,2018-05-02,삼성바이오로직스분식회계아니다,http://news1.kr/photos/view/?3091624
1434,2018-05-02,삼성바이오로직스분식회계아니다주장,http://www.ytn.co.kr/_ln/0102_201805021441548244
1435,2018-05-02,삼성바이오로직스분식회계관련입장발표,http://news1.kr/photos/view/?3091634
1436,2018-05-02,삼성바이오로직스분식회계관련입장은,http://news1.kr/photos/view/?3091627
1437,2018-05-02,모두발언하는윤호열삼성바이오로직스상무,http://news1.kr/photos/view/?3091625
1438,2018-05-02,삼성바이오로직스분식회계아니다주장,http://www.ytn.co.kr/_ln/0102_201805021441548244
1439,2018-05-02,삼성바이오로직스금감원감리결과관련긴급기자회견,http://news1.kr/photos/view/?3091626
1440,2018-05-02,삼성바이오로직스금감원감리결과관련긴급기자회견,http://news1.kr/photos/view/?3091630
1441,2018-05-02,포토발언하는윤호열삼성바이오로직스상무,http://www.edaily.co.kr/news/newspath.asp?newsid=03801526619204984
1442,2018-05-02,삼성바이오로직스금감원감리결과관련긴급기자회견,http://news1.kr/photos/view/?3091626
1443,2018-05-02,고민에빠진삼성바이오로직스,http://news1.kr/photos/view/?3091635
1444,2018-05-02,삼성바이오로직스분식회계아니다,http://news1.kr/photos/view/?3091631
1445,2018-05-02,삼성바이오로직스분식회계고심,http://news1.kr/photos/view/?3091629
1446,2018-05-02,포토취재진바라보는삼성바이오로직스임원진,http://www.edaily.co.kr/news/newspath.asp?newsid=03837606619204984
1447,2018-05-02,삼성바이오로직스분식회계논의,http://news1.kr/photos/view/?3091633
1448,2018-05-02,포토김동중삼성바이오로직스전무골똘,http://www.edaily.co.kr/news/newspath.asp?newsid=03850726619204984
1449,2018-05-02,포토윤호열삼성바이오로직스상무심각,http://www.edaily.co.kr/news/newspath.asp?newsid=03854006619204984
1450,2018-05-02,삼성바이오로직스분식회계있었다이재용승계설기정사실화,http://www.mhj21.com/sub_read.html?uid=113576§ion=sc243
1451,2018-05-02,뉴스콕금감원삼성바이오로직스회계처리위반잠정결론,http://www.newstomato.com/ReadNews.aspx?no=821758
1452,2018-05-02,특징주삼성바이오로직스행정소송불사방침에도낙폭커져,http://news.mt.co.kr/mtview.php?no=2018050214430429104
1453,2018-05-02,금감원삼성바이오로직스향후치열한법적공방예정,http://news.kmib.co.kr/article/view.asp?arcid=0012325435&code=61141111&cp=nv
1454,2018-05-02,삼성바이오로직스실익없어분식회계의혹부인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3520901
1455,2018-05-02,머니S포토자료살피는삼성바이오로직스,http://moneys.mt.co.kr/news/mwView.php?no=2018050214318038815
1456,2018-05-02,포토안경고쳐쓰는윤호열삼성바이오로직스CCC센,http://view.asiae.co.kr/news/view.htm?idxno=2018050214465392484
1457,2018-05-02,김관영의원삼성바이오로직스회계분식국회차원청문회진행하자”,http://www.kukinews.com/news/article.html?no=545317
1458,2018-05-02,머니S포토삼성바이오로직스긴급기자회견,http://moneys.mt.co.kr/news/mwView.php?no=2018050214338043649
1459,2018-05-02,포토모두발언마친윤호열삼성바이오로직스CCC센,http://view.asiae.co.kr/news/view.htm?idxno=2018050214470398503
1460,2018-05-02,포토삼성바이오로직스분식회계금감원발표관련,http://view.asiae.co.kr/news/view.htm?idxno=2018050214471613134
1461,2018-05-02,포토삼성바이오로직스분식회계금감원발표관련,http://view.asiae.co.kr/news/view.htm?idxno=2018050214470195562
1462,2018-05-02,포토삼성바이오로직스분식회계관련입장발표기자,http://view.asiae.co.kr/news/view.htm?idxno=2018050214471007991
1463,2018-05-02,포토삼성바이오로직스분식회계금감원발표관련,http://view.asiae.co.kr/news/view.htm?idxno=2018050214470195562
1464,2018-05-02,머니S포토긴급기자회견개최한삼성바이오로직스,http://moneys.mt.co.kr/news/mwView.php?no=2018050214408053258
1465,2018-05-02,삼성바이오로직스금감원감리통보에긴급기자회견분식회계아닌회계처리상이점,http://www.g-enews.com/ko-kr/news/article/news_all/201805021439238169e6a49afa8d_1/article.html
1466,2018-05-02,머니S포토의견나누는삼성바이오로직스임원들,http://moneys.mt.co.kr/news/mwView.php?no=2018050214368022589
1467,2018-05-02,김관영삼성바이오로직스국회청문회진상규명필요,http://www.inews24.com/php/news_view.php?g_serial=1092200&g_menu=022300&rrf=nv
1468,2018-05-02,포토삼성바이오로직스긴급기자회견의견나누는임원들,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619291
1469,2018-05-02,삼성바이오로직스분식회계최종결론시행정소송상보,http://news.mt.co.kr/mtview.php?no=2018050214454086997
1470,2018-05-02,삼성바이오로직스분식회계아니다,http://news.sbs.co.kr/news/endPage.do?news_id=N1004740521&plink=ORI&cooper=NAVER
1471,2018-05-02,삼성바이오로직스분식회계25넘으면거래정지금감원감리결과따라행정소송,http://www.ltn.kr/news/articleView.html?idxno=9442
1472,2018-05-02,삼성바이오로직스분식회계아니다최악의경우행정소송불사,http://news.hankyung.com/article/2018050216746
1473,2018-05-02,종합삼성바이오로직스분식회계아냐필요하면행정소송검토,http://www.newsis.com/view/?id=NISX20180502_0000298053&cID=13001&pID=13000
1474,2018-05-02,삼성바이오로직스회계처리문제없다행정소송도불사할것,http://biz.chosun.com/site/data/html_dir/2018/05/02/2018050201681.html
1475,2018-05-02,삼성바이오로직스분식회계아니다인식적용에대한차이,http://www.metroseoul.co.kr/news/newsview?newscd=2018050200132
1476,2018-05-02,삼성바이오로직스논란금감원엘리엇ISD소송과관련없다,http://view.asiae.co.kr/news/view.htm?idxno=2018050215051768683
1477,2018-05-02,회계처리위반삼성바이오로직스분식회계아니다종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180502107251017&did=1195m
1478,2018-05-02,생각에잠긴윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045811
1479,2018-05-02,금감원발표에대한입장밝히는윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045816
1480,2018-05-02,입장발표위해이동하는윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045819
1481,2018-05-02,취재진질문받는삼성바이오로직스,http://www.newsis.com/view/?id=NISI20180502_0014045812
1482,2018-05-02,삼성바이오로직스금감원회계논란행정소송불사할것,http://www.ceoscoredaily.com/news/article.html?no=40904
1483,2018-05-02,삼성바이오로직스금감원발표관련기자회견,http://www.newsis.com/view/?id=NISI20180502_0014045813
1484,2018-05-02,금감원발표에대한입장밝히는윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045816
1485,2018-05-02,생각에잠긴윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045811
1486,2018-05-02,입장발표위해이동하는윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045819
1487,2018-05-02,취재진질문받는삼성바이오로직스,http://www.newsis.com/view/?id=NISI20180502_0014045812
1488,2018-05-02,삼성바이오로직스금감원발표관련기자회견,http://www.newsis.com/view/?id=NISI20180502_0014045806
1489,2018-05-02,자료확인하는윤호열삼성바이오로직스상무,http://www.newsis.com/view/?id=NISI20180502_0014045805
1490,2018-05-02,삼성바이오로직스주주및고객분들께드리는말씀,http://www.newsis.com/view/?id=NISI20180502_0014045798
1491,2018-05-02,삼성바이오로직스금감원발표관련기자회견,http://www.newsis.com/view/?id=NISI20180502_0014045799
1492,2018-05-02,삼성바이오로직스고의로회계조작할동기없다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050215065129571
1493,2018-05-02,종합삼성바이오로직스회계기준위반없다행정소송도불사,http://www.sporbiz.co.kr/news/articleView.html?idxno=227283
1494,2018-05-02,금감원삼성바이오로직스분식회계는엘리엇ISD소송과무관,http://biz.chosun.com/site/data/html_dir/2018/05/02/2018050201718.html
1495,2018-05-02,포토오늘삼성바이오로직스금감원결론관련긴급기자회견,http://www.sisaon.co.kr/news/articleView.html?idxno=72707
1496,2018-05-02,금융당국삼성바이오로직스분식사기규정행정소송불가피,http://www.m-i.kr/news/articleView.html?idxno=411444
1497,2018-05-02,삼성바이오로직스쇼크바이오주엎친데덮쳤다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020138&t=NNv
1498,2018-05-02,공시앤리포트삼성바이오로직스금감원회계처리위반결론,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003190261
1499,2018-05-02,삼성바이오로직스분식회계아니다불리한판단나오면행정소송불사,http://www.medigatenews.com/news/294047979
1500,2018-05-02,삼성바이오로직스회계처리위반상장시회계처리철저히검증했다”,http://news.heraldcorp.com/view.php?ud=20180502000757
1501,2018-05-02,삼성바이오로직스회계위반아냐행정소송도강행상보,http://news1.kr/articles/?3306655
1502,2018-05-02,심상정삼성바이오로직스관련특별기자간담회,http://www.newsis.com/view/?id=NISI20180502_0014045947
1503,2018-05-02,심상정삼성바이오로직스관련특별기자간담회,http://www.newsis.com/view/?id=NISI20180502_0014045942
1504,2018-05-02,심상정삼성바이오로직스관련특별기자간담회,http://www.newsis.com/view/?id=NISI20180502_0014045943
1505,2018-05-02,회계처리위반의혹삼성바이오로직스분식회계아냐행정소송도불사,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619296
1506,2018-05-02,삼성바이오로직스분식회계아닌회계처리상이점행정소송도불사,http://www.asiatoday.co.kr/view.php?key=20180502010001127
1507,2018-05-02,금감원에날세운삼성바이오로직스분식회계아니다”,http://www.mhj21.com/sub_read.html?uid=113579§ion=sc243
1508,2018-05-02,현장에서임소현기자실소만자아낸삼성바이오로직스,http://www.g-enews.com/ko-kr/news/article/news_all/201805021516539163e6a49afa8d_1/article.html
1509,2018-05-02,금감원삼성바이오로직스감리삼성물산합병과관계없다,http://news.einfomax.co.kr/news/articleView.html?idxno=3446871
1510,2018-05-02,삼성바이오로직스분식회계아니다”행정소송까지고려중,http://www.polinews.co.kr/news/article.html?no=354448
1511,2018-05-02,삼성바이오로직스분식회계아냐행정소송도불사상보,http://www.newspim.com/news/view/20180502000226
1512,2018-05-02,삼성바이오로직스분식회계아니다금감원상대행정소송도준비”,http://www.econovill.com/news/articleView.html?idxno=337058
1513,2018-05-02,삼성바이오로직스금감원회계처리위반결론에분식회계아니다반박,http://www.joongboo.com/?mod=news&act=articleView&idxno=1248272
1514,2018-05-02,삼성바이오로직스분식회계아니다동기실익없어”,http://www.cstimes.com/?mod=news&act=articleView&idxno=274816
1515,2018-05-02,금감원삼성바이오로직스엘리엇ISD소송과무관,http://www.inews24.com/php/news_view.php?g_serial=1092217&g_menu=022300&rrf=nv
1516,2018-05-02,금감원삼성바이오로직스분식회계결론엘리엇ISD소송과관련없다,http://news.hankyung.com/article/2018050218696
1517,2018-05-02,삼성바이오로직스회계처리적절행정소송불사할것,http://www.inews24.com/php/news_view.php?g_serial=1092215&g_menu=022620&rrf=nv
1518,2018-05-02,바이오업계테마감리공포삼성바이오로직스분식회계결론에얼음,http://www.seoulwire.com/news/articleView.html?idxno=13750
1519,2018-05-02,fnRASSI장마감거래소하락종목삼성바이오로직스1721↓,http://www.fnnews.com/news/201805021536571171
1520,2018-05-02,삼성바이오로직스분식회계아냐행정소송검토,http://news.einfomax.co.kr/news/articleView.html?idxno=3446873
1521,2018-05-02,삼성바이오로직스분식회계아냐불리하면행정소송도불사,http://biz.newdaily.co.kr/news/article.html?no=10159821
1522,2018-05-02,김관영삼성바이오로직스사태국회청문회필요,http://www.kntimes.co.kr/news/articleView.html?idxno=25240
1523,2018-05-02,금감원삼성바이오로직스감리엘리엇ISD와관계없어,http://www.newsis.com/view/?id=NISX20180502_0000298145&cID=10401&pID=10400
1524,2018-05-02,금감원삼성바이오로직스분식회계결과엘리엇ISD소송과무관,http://www.ebn.co.kr/news/view/940045
1525,2018-05-02,삼성바이오로직스분식회계아냐금감원과소송가나,http://news.bbsi.co.kr/news/articleView.html?idxno=878256
1526,2018-05-02,삼성바이오로직스회계쇼크바이오株로전이되나,http://www.inews24.com/php/news_view.php?g_serial=1092229&g_menu=022300&rrf=nv
1527,2018-05-02,삼성바이오로직스분식회계전면부인행정소송검토,http://www.ezyeconomy.com/news/articleView.html?idxno=82983
1528,2018-05-02,삼성바이오로직스회계위반여파로바이오기업ETF와르르,http://news.hankyung.com/article/2018050219926
1529,2018-05-02,금감원2015년시행된삼성바이오로직스감리와무관,http://news.mk.co.kr/newsRead.php?year=2018&no=279947
1530,2018-05-02,삼성바이오로직스분식회계아니다금감원감리결과반박,http://www.dailian.co.kr/news/view/710775/?sc=naver
1531,2018-05-02,코스피외국인순매수호텔신라삼성바이오로직스넷마블,http://www.newsway.co.kr/view.php?tp=1&ud=2018050215543002847
1532,2018-05-02,삼성바이오로직스회계기준위반아냐행정소송도불사,http://www.etnews.com/20180502000422
1533,2018-05-02,fn마켓워치금융당국제동에삼성바이오로직스자금조달빨간불,http://www.fnnews.com/news/201805021545595353
1534,2018-05-02,삼성바이오로직스금감원분식회계지적에도당당한이유는,http://www.econovill.com/news/articleView.html?idxno=337066
1535,2018-05-02,삼성바이오로직스분식회계논란회계사들에물어보니,http://www.sporbiz.co.kr/news/articleView.html?idxno=227313
1536,2018-05-02,삼성바이오로직스회계처리로회사부당이익없다”,http://www.kukinews.com/news/article.html?no=545361
1537,2018-05-02,마감시황삼성바이오로직스여파에하락코스피2500선턱걸이,http://www.newsis.com/view/?id=NISX20180502_0000298183&cID=10401&pID=10400
1538,2018-05-02,기자수첩삼성바이오로직스에대한금융당국이중잣대,http://www.edaily.co.kr/news/newspath.asp?newsid=04208246619204984
1539,2018-05-02,인베스트조선삼성바이오로직스법과절차에따라상장행정소송도불사”,http://www.investchosun.com/?p=3225557
1540,2018-05-02,마감시황코스피삼성바이오로직스쇼크에하락전환2500선후퇴,http://www.ezyeconomy.com/news/articleView.html?idxno=82984
1541,2018-05-02,삼성바이오로직스후폭풍제약株와르르,http://www.tfnews.co.kr/news/article.html?no=46416
1542,2018-05-02,삼성바이오로직스쇼크한국증시출렁셀트리온등바이오주추락,http://www.choicenews.co.kr/news/articleView.html?idxno=41117
1543,2018-05-02,회계위반논란삼성바이오로직스행정소송불사,http://www.edaily.co.kr/news/newspath.asp?newsid=04241046619204984
1544,2018-05-02,더벨삼성바이오로직스회계처리독단적판단없었다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805020100001980000118
1545,2018-05-02,증시마감코스피약보합삼성바이오로직스이슈에제약바이오株↓,http://www.newspim.com/news/view/20180502000280
1546,2018-05-02,분식회계결론에삼성바이오로직스주가17급락거래정지우려,http://www.fnnews.com/news/201805021608044193
1547,2018-05-02,금감원삼성바이오로직스감리결과엘리엇ISD추진과무관,http://www.mediapen.com/news/view/351808
1548,2018-05-02,종합삼성바이오로직스회계처리위반파문에바이오株우수수,http://www.newsis.com/view/?id=NISX20180502_0000298199&cID=10401&pID=10400
1549,2018-05-02,분식회계논란금감원VS삼성바이오로직스논쟁격화,http://www.monews.co.kr/news/articleView.html?idxno=114218
1550,2018-05-02,삼성바이오로직스분식회계결론시행정소송불사종합,http://news.mt.co.kr/mtview.php?no=2018050215410929974
1551,2018-05-02,삼성바이오로직스회계처리위반에강하게반박분식회계아니다,http://www.asiatime.co.kr/news/articleView.html?idxno=178250
1552,2018-05-02,삼성바이오로직스회계처리위반에강하게반박분식회계아니다,http://www.asiatime.co.kr/news/articleView.html?idxno=178250
1553,2018-05-02,분식회계논란삼성바이오로직스부당이득없었다,http://www.ebn.co.kr/news/view/940058
1554,2018-05-02,금감원분식잠정결론에삼성바이오로직스반박,http://www.nocutnews.co.kr/news/4964031
1555,2018-05-02,NW포토삼성바이오로직스금감원의회계위반결론관련긴급기자회견,http://www.newsway.co.kr/view.php?tp=1&ud=2018050216270971086
1556,2018-05-02,금감원엘리엇ISD소송삼성바이오로직스분식회계결론과무관,http://www.weeklytoday.com/news/articleView.html?idxno=65621
1557,2018-05-02,금감원삼성바이오로직스감리엘리엇ISD와무관,http://www.ezyeconomy.com/news/articleView.html?idxno=82985
1558,2018-05-02,회계기준위반삼성바이오로직스주가1721하락,http://www.nocutnews.co.kr/news/4964038
1559,2018-05-02,삼성바이오로직스분식회계아냐행정소송검토,http://www.nocutnews.co.kr/news/4964041
1560,2018-05-02,종합마감시황삼성바이오로직스여파코스피2500선턱걸이,http://www.newsis.com/view/?id=NISX20180502_0000298247&cID=10401&pID=10400
1561,2018-05-02,NW포토삼성바이오로직스분식회계아니다”행정소송도고려,http://www.newsway.co.kr/view.php?tp=1&ud=2018050216301184690
1562,2018-05-02,삼성바이오로직스회계처리문제없다행정소송불사,http://www.seoulfn.com/news/articleView.html?idxno=305249
1563,2018-05-02,NW포토모두발언하는윤호열삼성바이오로직스상무,http://www.newsway.co.kr/view.php?tp=1&ud=2018050216444503009
1564,2018-05-02,삼성바이오로직스분식회계결정나면행정소송할것,http://moneys.mt.co.kr/news/mwView.php?no=2018050216058059743
1565,2018-05-02,분식회계논란삼성바이오로직스고의성없어행정소송불사,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055471
1566,2018-05-02,NW포토귀엣말나누는삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018050216494698138
1567,2018-05-02,분식회계논란삼성바이오로직스위법아니다”반박결론따라행정소송불사”,http://ilyo.co.kr/?ac=article_view&entry_id=296395
1568,2018-05-02,삼성바이오로직스시총하루새46조증발바이오株앗뜨거,http://www.edaily.co.kr/news/newspath.asp?newsid=04372246619204984
1569,2018-05-02,삼성바이오로직스금감원분식회계의혹사실아냐”,http://www.ajunews.com/view/20180502132441973
1570,2018-05-02,김관영의원삼성바이오로직스회계분식국회차원청문회진행해야”,http://www.mdtoday.co.kr/mdtoday/index.html?no=319929
1571,2018-05-02,삼성바이오로직스논란확산불안한헬스케어펀드,http://www.edaily.co.kr/news/newspath.asp?newsid=04395206619204984
1572,2018-05-02,삼성바이오로직스분식회계아니다행정소송검토,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180502143713
1573,2018-05-02,마감시황삼성바이오로직스분식회계에코스피2510선내줘,http://news.heraldcorp.com/view.php?ud=20180502000889
1574,2018-05-02,5년만에흑자된삼성바이오로직스회계의마술인가vs분식인가,http://www.edaily.co.kr/news/newspath.asp?newsid=04434566619204984
1575,2018-05-02,삼성바이오로직스단숨에흑자”분식회계논란왜,http://news.kbs.co.kr/news/view.do?ncd=3643614&ref=A
1576,2018-05-02,삼성바이오로직스편법분식회계사실아니다,http://imnews.imbc.com/news/2018/econo/article/4595884_22671.html
1577,2018-05-02,삼성바이오로직스분식회계아니다행정소송도불사할것,http://www.greened.kr/news/articleView.html?idxno=60661
1578,2018-05-02,삼성바이오로직스분식논란②지금은틀리다,http://news.bizwatch.co.kr/article/consumer/2018/05/02/0018/naver
1579,2018-05-02,삼성바이오로직스분식회계논란삼성바이오관계사라시장가반영금감원지배권판단안돼,http://www.fnnews.com/news/201805021706513669
1580,2018-05-02,삼성바이오로직스분식회계논란대기업사주등역외탈세혐의39명세무조사,http://www.fnnews.com/news/201805021706309848
1581,2018-05-02,삼성바이오로직스분식회계논란하루만에시총5조5000억사라져,http://www.fnnews.com/news/201805021706403328
1582,2018-05-02,삼성바이오로직스금감원측분식회계주장전면반박필요하면행정소송도,http://www.news2day.co.kr/103355
1583,2018-05-02,삼성바이오로직스투자금조달막히나,http://www.fnnews.com/news/201805021708566228
1584,2018-05-02,NW포토답변준비하는삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018050216544640448
1585,2018-05-02,삼성바이오로직스분식회계논란상장전적정의견받았다소명후행정소송도불사,http://www.fnnews.com/news/201805021709400054
1586,2018-05-02,삼성바이오로직스분식논란금감원엘리엇ISD소송과무관,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619402
1587,2018-05-02,SR공정운영삼성바이오로직스기준따랐다vs금감원회계처리위반,http://www.srtimes.kr/news/articleView.html?idxno=18861
1588,2018-05-02,삼성바이오로직스행정소송불사방침에도급락,http://www.mdtoday.co.kr/mdtoday/index.html?no=319940
1589,2018-05-02,금감원삼성바이오로직스감리결과삼성물산관련ISD소송연관없어,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=525391
1590,2018-05-02,삼성바이오로직스분식회계논란행정소송까지가나,http://www.sisajournal-e.com/biz/article/183544
1591,2018-05-02,삼성바이오로직스분식회계아냐행정소송도불사,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003190529
1592,2018-05-02,삼성바이오로직스삼성물산합병정당성위해회계기준바꿨나,http://www.businesspost.co.kr/BP?command=article_view&num=81167
1593,2018-05-02,금감원고의적분식회계vs삼성바이오로직스분식아니다종합2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180502107252017&did=1195m
1594,2018-05-02,삼성바이오로직스모든회계처리검증받아분식아니다해명,http://www.sportsseoul.com/news/read/630141
1595,2018-05-02,금감원회계법인도문제없다판단삼성바이오로직스행정소송도불사,http://www.sedaily.com/NewsView/1RZDKP5EHW
1596,2018-05-02,회계논란삼성바이오로직스거래정지우려,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020262&t=NNv
1597,2018-05-02,금감원삼성바이오로직스와엘리엇매니지먼트소송은관련없다,http://www.businesspost.co.kr/BP?command=article_view&num=81193
1598,2018-05-02,삼성바이오로직스분식회계논란바이오株동반약세,http://www.wolyo.co.kr/news/articleView.html?idxno=60064
1599,2018-05-02,코스피하락2505선마감삼성바이오로직스17급락,https://cnbc.sbs.co.kr/article_hub/10000900687?division=NAVER
1600,2018-05-02,생생경제엘리엇정부상대소송삼성바이오로직스분식회계에엎친데덮쳤다,http://www.ytn.co.kr/_ln/0102_201805021755054282
1601,2018-05-02,김관영삼성바이오로직스회계분식국회청문회로진상규명해야,http://www.sejungilbo.com/news/articleView.html?idxno=12667
1602,2018-05-02,생생인터뷰엘리엇정부상대소송삼성바이오로직스분식회계에엎친데덮쳤다,http://radio.ytn.co.kr/program/?f=2&id=55694&s_mcd=0206&s_hcd=15
1603,2018-05-02,금감원엘리엇소송삼성바이오로직스감리와관련없어”,http://www.fntimes.com/html/view.php?ud=201805021758281060f09e13944d_18
1604,2018-05-02,삼성바이오로직스쇼크행정소송도불사”,https://cnbc.sbs.co.kr/article_hub/10000900693?division=NAVER
1605,2018-05-02,삼성바이오로직스주가뇌관터지나,http://www.insightkorea.co.kr//news/articleView.html?idxno=24603
1606,2018-05-02,삼성바이오로직스분식회계할이유없어행정소송검토,http://www.sisaweek.com/news/articleView.html?idxno=107446
1607,2018-05-02,삼성바이오로직스회계위반결론시행정소송불사,http://www.kbanker.co.kr/news/articleView.html?idxno=72939
1608,2018-05-02,회계처리위반삼성바이오로직스당국고강도제재나서나,http://www.newsis.com/view/?id=NISX20180502_0000298385&cID=10401&pID=10400
1609,2018-05-02,삼성바이오로직스한국에서의사기의기준은도대체뭔가자세한건금감원에가서취재하라,http://www.weeklytoday.com/news/articleView.html?idxno=65623
1610,2018-05-02,삼성바이오로직스회계처리위반파장바이오株악영향,http://www.mdtoday.co.kr/mdtoday/index.html?no=319957
1611,2018-05-02,삼성바이오로직스분식회계의혹으로상장폐지로내몰리나,http://www.businesspost.co.kr/BP?command=article_view&num=81170
1612,2018-05-02,람기자의3시40분삼성바이오로직스분식회계논란바이오주투심어디로,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050215174133313
1613,2018-05-02,분식회계논란삼성바이오로직스행정소송불사,http://www.kpinews.co.kr/news/articleView.html?idxno=72820
1614,2018-05-02,삼성바이오로직스회계기준위반아냐적극반박,http://www.ntoday.co.kr/news/articleView.html?idxno=61413
1615,2018-05-02,금감원고의적분식회계VS삼성바이오로직스분식아니다행정소송불사,http://www.sisafocus.co.kr/news/articleView.html?idxno=185025
1616,2018-05-02,삼성바이오로직스분식회계아니다행정소송검토할것,http://www.viva100.com/main/view.php?key=20180502010000933
1617,2018-05-02,금감원명백한분식회계vs삼성바이오로직스국제회계기준충실히따랐다,http://biz.chosun.com/site/data/html_dir/2018/05/02/2018050202402.html
1618,2018-05-02,분식회계논란삼성바이오로직스시총56조증발삼성그룹주동반하락,http://www.kyeongin.com/main/view.php?key=20180502010000888
1619,2018-05-02,심상정분식회계안했다는삼성바이오로직스주장반박,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180502154600001&did=1195m
1620,2018-05-02,심상정삼성바이오로직스분식회계이재용경영권승계일환,http://www.newsprime.co.kr/news/article.html?no=415420
1621,2018-05-02,삼성바이오로직스분식회계받아들이기힘든표현행정소송도불사,http://www.starseoultv.com/news/articleView.html?idxno=494844
1622,2018-05-02,코스피코스닥동반하락삼성바이오로직스분식회계논란여파,http://www.businesspost.co.kr/BP?command=article_view&num=81183
1623,2018-05-02,마감시황삼성바이오로직스분식회계여파에코스피2510선내줘,http://www.betanews.net:8080/article/848622.html
1624,2018-05-02,일문일답삼성바이오로직스분식회계판단유감행정소송불사”,http://www.ajunews.com/view/20180502161518244
1625,2018-05-02,삼성물산주가급락삼성바이오로직스회계논란에발목잡혀,http://www.businesspost.co.kr/BP?command=article_view&num=81214
1626,2018-05-02,삼성바이오로직스셀트리온주가동반급락회계논란에된서리,http://www.businesspost.co.kr/BP?command=article_view&num=81208
1627,2018-05-02,심상정분식회계안했다는삼성바이오로직스에이재용경영권승계와도연관,http://www.kyeongin.com/main/view.php?key=20180502010000911
1628,2018-05-02,심상정삼성바이오로직스분식회계이재용경영권승계와도연관,http://www.fnnews.com/news/201805021850264442
1629,2018-05-02,금감원삼성바이오로직스고의적분식회계통보삼성물산합병논란재점화,http://www.sisafocus.co.kr/news/articleView.html?idxno=185022
1630,2018-05-02,심상정삼성바이오로직스분식회계부정반박,http://www.inews24.com/php/news_view.php?g_serial=1092301&g_menu=050200&rrf=nv
1631,2018-05-02,심상정분식회계논란삼성바이오로직스주장반박,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020539&t=NN
1632,2018-05-02,삼성바이오로직스소송불사”분식회계부인,http://www.hani.co.kr/arti/economy/finance/843044.html
1633,2018-05-02,심상정삼성바이오로직스분식회계로성장성부각→특혜상장,http://www.ebn.co.kr/news/view/940089
1634,2018-05-02,분식회계안했다삼성바이오로직스주장에심상정정면반박이재용경영권승계연관,http://www.joongboo.com/?mod=news&act=articleView&idxno=1248429
1635,2018-05-02,심상정분식회계안했다는삼성바이오로직스반박,http://news.sbs.co.kr/news/endPage.do?news_id=N1004741172&plink=ORI&cooper=NAVER
1636,2018-05-02,심상정의원삼성바이오로직스해명사실아냐”반박,http://www.edaily.co.kr/news/newspath.asp?newsid=04703526619204984
1637,2018-05-02,심상정삼성바이오로직스주장은허위이재용경영승계재검토돼야,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002430459&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
1638,2018-05-02,회계악재에삼성바이오로직스시총5조증발,http://www.seoul.co.kr/news/newsView.php?id=20180503020011&wlog_tag3=naver
1639,2018-05-02,심상정삼성바이오로직스분식회계부인에정면반박,http://www.mdtoday.co.kr/mdtoday/index.html?no=319978
1640,2018-05-02,삼성바이오로직스부당이득취한바없다”,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1471400
1641,2018-05-02,삼성바이오로직스시총하루새56조증발상폐우려까지투심뚝,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619433
1642,2018-05-02,삼성바이오로직스논란회계처리위반”vs분식회계아냐”,https://cnbc.sbs.co.kr/article_hub/10000900701?division=NAVER
1643,2018-05-02,EBN오늘2일이슈종합분식회계논란삼성바이오로직스부당이득없었다현대모비스6000억원규모자사주소각美수출한국철강쿼터배분등,http://www.ebn.co.kr/news/view/940090
1644,2018-05-02,삼성바이오로직스분식회계의혹합병사후합리화,http://imnews.imbc.com/replay/2018/nwdesk/article/4596194_22663.html
1645,2018-05-02,금감원삼성바이오로직스회계처리위반으로잠정결론,http://www.wsobi.com/news/articleView.html?idxno=60204
1646,2018-05-02,삼성바이오로직스시총56조증발분식회계아니다,http://news.sbs.co.kr/news/endPage.do?news_id=N1004741046&plink=ORI&cooper=NAVER
1647,2018-05-02,심상정의원감사조서에바이오시밀러관련내용없어삼성바이오로직스주장반박,http://www.kukinews.com/news/article.html?no=545463
1648,2018-05-02,심상정삼성바이오로직스해명사실아냐반박,http://www.newspim.com/news/view/20180502000361
1649,2018-05-02,사설분식회계혐의삼성바이오로직스엄중한책임물어야,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805022049025&code=990101
1650,2018-05-02,삼성바이오로직스분식회계잠정결론이재용승계연관의혹,http://news.jtbc.co.kr/html/439/NB11628439.html
1651,2018-05-02,심상정삼성바이오로직스분식회계의혹이재용경영권승계재검토해야”,http://www.sedaily.com/NewsView/1RZDKR2CB4
1652,2018-05-02,JTBC뉴스룸분식회계논란삼성바이오로직스이재용부회장승계위한작업과거최대주주제일모직,http://www.topstarnews.net/news/articleView.html?idxno=404634
1653,2018-05-02,회계위반삼성바이오로직스소송불사”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805022128005&code=920100
1654,2018-05-02,회계기준위반의혹삼성바이오로직스행정소송도불사하겠다,http://www.insight.co.kr/news/153184
1655,2018-05-02,바이오株삼성바이오로직스춘풍낙과금감원제약바이오기업10곳특별감리,http://www.updownnews.co.kr/news/articleView.html?idxno=89978
1656,2018-05-02,삼성바이오로직스분식회계아니다,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=749211
1657,2018-05-02,마감삼성바이오로직스분식회계논란에급락현대로템급등,http://www.sporbiz.co.kr/news/articleView.html?idxno=227472
1658,2018-05-02,삼성바이오로직스파동지배구조개편시나리오흔들,http://www.econovill.com/news/articleView.html?idxno=337096
1659,2018-05-02,분식회계의혹삼성바이오로직스고의로회계조작할이유가없다,http://www.kyeongin.com/main/view.php?key=20180502010000829
1660,2018-05-03,분식회계논란삼성바이오로직스심상정의원금감원주장맞불,http://www.g-enews.com/ko-kr/news/article/news_all/201805022105228652c16aa2f016_1/article.html
1661,2018-05-03,삼성바이오로직스회계처리논란의중심은,http://www.kukinews.com/news/article.html?no=545419
1662,2018-05-03,회계처리위반잠정결론삼성바이오로직스주가뚝분식회계아니다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180503.99099000836
1663,2018-05-03,삼성바이오로직스CEO직원연봉격차얼마544배,http://sports.hankooki.com/lpage/sisa/201805/sp20180503001019137040.htm
1664,2018-05-03,삼성바이오로직스분식회계털어내고주가상승할까,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180503.99099001080
1665,2018-05-03,삼성바이오로직스발끈하게만든분식회계는무엇,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180503.99099001074
1666,2018-05-03,삼성바이오로직스국제회계기준따랐다VS금감원회계처리위반,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180503.99099000981
1667,2018-05-03,삼성바이오로직스분식회계논란하루새시가총액5조5000억증발,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=809519
1668,2018-05-03,삼성바이오로직스분식회계안했다”금감원정면반박,http://news.donga.com/3/all/20180503/89908938/1
1669,2018-05-03,삼성바이오로직스분식논란금융위회계법인등관련기관후폭풍,http://www.kukinews.com/news/article.html?no=545393
1670,2018-05-03,삼성바이오로직스분식회계논란에바이오젠콜옵션주목,http://www.medigatenews.com/news/971413544
1671,2018-05-03,취재뒷담화한국거래소또불거진삼성바이오로직스상장특혜논란,http://www.asiatoday.co.kr/view.php?key=20180502010001191
1672,2018-05-03,분식회계의혹삼성바이오로직스합병적정성상장특혜논란도,http://www.nocutnews.co.kr/news/4964176
1673,2018-05-03,분식회계안했다”는삼성바이오로직스합병적정성상장특혜논란도,http://news.kmib.co.kr/article/view.asp?arcid=0012327264&code=61141111&cp=nv
1674,2018-05-03,심상정삼성바이오로직스분식회계는사실상이재용경영권승계의일환,http://www.gwangnam.co.kr/read.php3?aid=1525298700289848015
1675,2018-05-03,양재준기자의알투바이오삼성바이오로직스VS금융당국관전포인트3가지,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805020320&t=NN
1676,2018-05-03,분식회계의혹삼성바이오로직스회계기준위반아냐,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1182146
1677,2018-05-03,퀵리포트삼성바이오로직스매수유지목표가61만원유지한투證,http://www.itooza.com/common/iview.php?no=2018050307474716290
1678,2018-05-03,거액을투자했는데망했다삼성바이오로직스분식회계투자자들분통,http://www.g-enews.com/ko-kr/news/article/news_all/2018050307460653784e4869c120_1/article.html
1679,2018-05-03,삼성바이오로직스단기간불확실성해소어려워,http://news.mt.co.kr/mtview.php?no=2018050307533712450
1680,2018-05-03,금감원삼성바이오로직스감리결과엘리엇의ISD소송과무관,http://www.mdtoday.co.kr/mdtoday/index.html?no=319953
1681,2018-05-03,삼성바이오로직스상폐위기벗어나면저가매수기회한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01695766619205312
1682,2018-05-03,하루5조원날린삼성바이오로직스투자자회사감독당국회계법인상대로줄줄이소송대란예고,http://www.news2day.co.kr/103387
1683,2018-05-03,더벨삼성바이오로직스7년간노력에사형선고라니,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805020100002500000149
1684,2018-05-03,클릭e종목삼성바이오로직스회계불확실에주가당분간약세,http://view.asiae.co.kr/news/view.htm?idxno=2018050308163035409
1685,2018-05-03,한국투자증권삼성바이오로직스상장폐지가능성낮아”,http://www.newsway.co.kr/view.php?tp=1&ud=2018050308192539733
1686,2018-05-03,삼성바이오로직스상장폐지가능성낮아저가매수기회한국투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050308155577532
1687,2018-05-03,분식회계논란에침통한삼성바이오로직스주가당분간약세,http://www.fntimes.com/html/view.php?ud=201805030820563962f09e13944d_18
1688,2018-05-03,대신증권삼성바이오로직스회계처리위반지적우려는주가에충분히반영”,http://www.g-enews.com/ko-kr/news/article/news_all/201805030821547201c642673384_1/article.html
1689,2018-05-03,대신증권삼성바이오로직스단기간불확실성해소어려워,http://www.newsway.co.kr/view.php?tp=1&ud=2018050308294934779
1690,2018-05-03,분식회계의혹삼성바이오로직스고강도제재들어갈지관심검찰고발까지가능,http://www.topstarnews.net/news/articleView.html?idxno=404768
1691,2018-05-03,한국투자證삼성바이오로직스상폐가능성낮아매수유지,http://www.fnnews.com/news/201805030834495781
1692,2018-05-03,삼성바이오로직스회계의혹에연기금매도리스크피하자,http://news.einfomax.co.kr/news/articleView.html?idxno=3446999
1693,2018-05-03,삼성바이오로직스상장폐지가능성낮아한국투자,http://www.newstomato.com/ReadNews.aspx?no=821983
1694,2018-05-03,뉴투분석금감원삼성바이오로직스분식회계공방열쇠쥔바이오에피스기업가치,http://www.news2day.co.kr/103374
1695,2018-05-03,삼성바이오로직스단기불확실성확대대신증권,http://www.fnnews.com/news/201805030846267344
1696,2018-05-03,삼성바이오로직스불확실성단기간해소어려워대신증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050308502730587
1697,2018-05-03,사기의기준이뭔가요항변한삼성바이오로직스,http://news.hankyung.com/article/201805023140A
1698,2018-05-03,장용혁의마켓시그널삼성바이오로직스가던진고민말그대로고민,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050308073119164
1699,2018-05-03,오늘의종목삼성바이오로직스주가불확실성확대업황호조는긍정적,http://www.sedaily.com/NewsView/1RZDZQTVMX
1700,2018-05-03,삼성바이오로직스분식논란③삼바쇼크관건은,http://news.bizwatch.co.kr/article/market/2018/05/02/0023/naver
1701,2018-05-03,특징주회계위반지적삼성바이오로직스이틀연속미끌,http://view.asiae.co.kr/news/view.htm?idxno=2018050309060707082
1702,2018-05-03,특징주삼성바이오로직스회계처리위반충격서진정되나주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201805030903237761c642673384_1/article.html
1703,2018-05-03,특징주삼성바이오로직스하락폭크게줄어상장폐지가능성작다,http://www.sporbiz.co.kr/news/articleView.html?idxno=227593
1704,2018-05-03,STOCK삼성바이오로직스상폐가능성낮아저가매수기회,http://moneys.mt.co.kr/news/mwView.php?no=2018050309058074043
1705,2018-05-03,특징주삼성바이오로직스논란지속3일연속하락,http://www.edaily.co.kr/news/newspath.asp?newsid=02161526619205312
1706,2018-05-03,특징주바이오주반등시도삼성바이오로직스는하락,http://news.hankyung.com/article/2018050341126
1707,2018-05-03,특징주회계처리위반삼성바이오로직스하락세지속,http://www.newstomato.com/ReadNews.aspx?no=821996
1708,2018-05-03,퀵리포트삼성바이오로직스매수유지목표가51만원유지유안타證,http://www.itooza.com/common/iview.php?no=2018050309175011350
1709,2018-05-03,특징주분식회계논란삼성바이오로직스40만원선무너져,http://www.newsprime.co.kr/news/article.html?no=415439
1710,2018-05-03,특징주삼성바이오로직스회계처리논란에이틀연속약세,http://www.viva100.com/main/view.php?key=20180503010001039
1711,2018-05-03,특징주삼성바이오로직스분식회계의혹에연일하락,http://www.ebn.co.kr/news/view/940133
1712,2018-05-03,삼성바이오로직스논란후폭풍삼성물산합병논란재점화,https://cnbc.sbs.co.kr/article_hub/10000900753?division=NAVER
1713,2018-05-03,회계처리위반삼성바이오로직스상장폐지가능성낮아”,http://www.mdtoday.co.kr/mdtoday/index.html?no=319997
1714,2018-05-03,특징주회계처리위반삼성바이오로직스장초반하락세,http://www.newspim.com/news/view/20180503000063
1715,2018-05-03,HotLine회계논란삼성바이오로직스사흘째약세,http://news.mk.co.kr/newsRead.php?year=2018&no=281359
1716,2018-05-03,특징주삼성바이오로직스회계위반논란지속에내림세,http://www.seoulfn.com/news/articleView.html?idxno=305307
1717,2018-05-03,특징주삼성바이오로직스3거래일연속하락,http://www.fnnews.com/news/201805030925163247
1718,2018-05-03,특징주회계위반삼성바이오로직스3일째약세,http://www.inews24.com/php/news_view.php?g_serial=1092365&g_menu=022300&rrf=nv
1719,2018-05-03,특징주분식회계논란삼성바이오로직스사흘연속미끄럼,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180503048100008&did=1195m
1720,2018-05-03,삼성바이오로직스상장폐지가능성낮다한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619506
1721,2018-05-03,특징주삼성바이오로직스분식회계논란에3거래일연속하락,http://moneys.mt.co.kr/news/mwView.php?no=2018050309318067989
1722,2018-05-03,특징주회계처리문제삼성바이오로직스1대상승세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050309223341853
1723,2018-05-03,삼성바이오로직스회계논란촉각곤두세우는운용사는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050219140341193
1724,2018-05-03,회계의혹삼성바이오로직스주가장중상승전환,http://news1.kr/articles/?3307335
1725,2018-05-03,이데일리N삼성바이오로직스분식회계아니다행정소송불사外,http://www.edaily.co.kr/news/newspath.asp?newsid=02318966619205312
1726,2018-05-03,삼성바이오로직스소폭상승하며다시41만원선회복,http://www.sedaily.com/NewsView/1RZDZDH5FS
1727,2018-05-03,이슈진단삼성바이오로직스회계사기혐의확정될경우파장은,https://cnbc.sbs.co.kr/article_hub/10000900755?division=NAVER
1728,2018-05-03,삼성바이오로직스로이슈된분식회계적발체크포인트는,http://www.newsworks.co.kr/news/articleView.html?idxno=184192
1729,2018-05-03,3일장초반삼성바이오로직스쇼크다소진정셀트리온등바이오주반등,http://www.choicenews.co.kr/news/articleView.html?idxno=41132
1730,2018-05-03,삼성바이오로직스최악의시나리오는최종결정지연유안타,http://www.edaily.co.kr/news/newspath.asp?newsid=02397686619205312
1731,2018-05-03,특징주삼성바이오로직스회계위반지적하루만에반등,http://news.hankyung.com/article/2018050344026
1732,2018-05-03,삼성바이오로직스단기간불확실성해소어려워대신증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619535
1733,2018-05-03,삼성바이오로직스분식회계논란①삼바의당혹왜회계처리변경이물벼락됐나,http://news.heraldcorp.com/view.php?ud=20180503000246
1734,2018-05-03,아주종목분석삼성바이오로직스저가매수기회,http://www.ajunews.com/view/20180503100004582
1735,2018-05-03,삼성바이오로직스분식회계논란②삼성바이오정당한절차였다상황에따라행정소송도”,http://news.heraldcorp.com/view.php?ud=20180503000218
1736,2018-05-03,특징주삼성바이오로직스회계위반여파급락하루만에반등,http://moneys.mt.co.kr/news/mwView.php?no=2018050310028095971
1737,2018-05-03,ET투자뉴스삼성바이오로직스이번사안은5월매수유지한국투자증권,http://www.etnews.com/20180503000061
1738,2018-05-03,삼성바이오로직스불확실성대두가능성시기에따라주의필요”유안타증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619548
1739,2018-05-03,KB증권삼성물산삼성바이오로직스우려과도하다”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619556
1740,2018-05-03,특징주전날17급락한삼성바이오로직스2대상승반전,http://biz.chosun.com/site/data/html_dir/2018/05/03/2018050301060.html
1741,2018-05-03,인터뷰제1공장삼성바이오로직스분식회계이재용승계작업의후속판,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10278583
1742,2018-05-03,특징주삼성바이오로직스너무떨어졌나바이오주반등시도,http://www.fntimes.com/html/view.php?ud=201805031018451564f09e13944d_18
1743,2018-05-03,회계처리논란삼성바이오로직스하루만에반등숨돌리기,http://www.mdtoday.co.kr/mdtoday/index.html?no=320010
1744,2018-05-03,오전시황코스피이틀째하락세삼성바이오로직스는반등,http://news.heraldcorp.com/view.php?ud=20180503000356
1745,2018-05-03,삼성바이오로직스3일오전반등노무라의진단은,http://www.choicenews.co.kr/news/articleView.html?idxno=41137
1746,2018-05-03,금융당국삼성바이오로직스책임론그때는맞고지금은틀리다”,http://news.heraldcorp.com/view.php?ud=20180503000364
1747,2018-05-03,단독금감원삼성바이오로직스2015년재무제표수정해라”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619601
1748,2018-05-03,삼성바이오로직스분식논란삼성바이오에피스DCF콜옵션가치쟁점부각,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619580
1749,2018-05-03,단독삼성바이오로직스2015년감사조서공란신약바이오시밀러가치평가허위논란,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619578
1750,2018-05-03,단독삼성바이오로직스2015년감사조서공란신약바이오시밀러가치평가허위논란,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619578
1751,2018-05-03,특징주삼성바이오로직스분식회계논란에도16상승세,http://www.m-i.kr/news/articleView.html?idxno=411753
1752,2018-05-03,삼성바이오로직스해명에도분식회계특혜상장논란확산,http://www.sisajournal-e.com/biz/article/183565
1753,2018-05-03,삼성바이오로직스분식회계논란핵심쟁점은,http://www.newsis.com/view/?id=NISX20180503_0000298979&cID=13001&pID=13000
1754,2018-05-03,연결고리2삼성바이오로직스불똥어디까지튈까,http://www.newstomato.com/ReadNews.aspx?no=822006
1755,2018-05-03,특징주삼성바이오로직스불확실성악재발생불구반등세,http://www.sisaon.co.kr/news/articleView.html?idxno=72737
1756,2018-05-03,코스피2500선에서등락거듭삼성바이오로직스상승전환,https://cnbc.sbs.co.kr/article_hub/10000900781?division=NAVER
1757,2018-05-03,삼성바이오로직스5월분수령상폐가능성낮아,http://www.medicaltimes.com/News/1118439
1758,2018-05-03,분식회계논란삼성바이오로직스주가더떨어질까,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055509
1759,2018-05-03,공시앤리포트삼성바이오로직스회계기준적절성에대해소명예정,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003191408
1760,2018-05-03,삼성바이오로직스특혜상장의혹다시커진다,http://www.naeil.com/news_view/?id_art=274631
1761,2018-05-03,ET투자뉴스삼성바이오로직스향후진행사항에매수유지유안타증권,http://www.etnews.com/20180503000212
1762,2018-05-03,THE이슈삼성바이오로직스분식회논란향후전망은,http://www.newstomato.com/ReadNews.aspx?no=822071
1763,2018-05-03,삼성바이오로직스이재용승계작업에어떤역할을했길래,http://news.kbs.co.kr/news/view.do?ncd=3644156&ref=A
1764,2018-05-03,삼성바이오로직스VS금융당국피말리는공방예고,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805030094&t=NNv
1765,2018-05-03,삼성바이오로직스논란이재용3심에큰영향없을듯,http://www.sisajournal-e.com/biz/article/183582
1766,2018-05-03,삼성바이오로직스회계사기논란개인투자자안절부절,http://www.m-i.kr/news/articleView.html?idxno=411922
1767,2018-05-03,안승현의여의도톡삼성바이오로직스논란유감,http://www.fnnews.com/news/201805031402211555
1768,2018-05-03,연합시론삼성바이오로직스분식회계여부엄정심의바란다,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180503127400022&did=1195m
1769,2018-05-03,fn마켓워치삼성바이오로직스회계논란까지삼성지배구조재편험로,http://www.fnnews.com/news/201805031526369597
1770,2018-05-03,삼성바이오로직스사태바이오주하락도화선되나,http://www.mediapen.com/news/view/352066
1771,2018-05-03,특징주분식회계논란삼성바이오로직스사흘연속미끄럼종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180503048151008&did=1195m
1772,2018-05-03,삼성바이오로직스회계논란에바이오株연일하락,http://www.sedaily.com/NewsView/1RZE0JLKUR
1773,2018-05-03,UAE라스알카이마국왕삼성바이오로직스방문,http://www.newsworks.co.kr/news/articleView.html?idxno=184425
1774,2018-05-03,포토아랍에미리트국왕삼성바이오로직스방문,http://www.asiatoday.co.kr/view.php?key=20180503010001991
1775,2018-05-03,UAE라스알카이마국왕삼성바이오로직스방문해김태한사장과환담나눠,http://www.segye.com/content/html/2018/05/03/20180503004857.html?OutUrl=naver
1776,2018-05-03,금감원과삼성바이오로직스분식회계의혹에창과방패대결,http://www.businesspost.co.kr/BP?command=article_view&num=81311
1777,2018-05-03,특혜논란불똥튄KRX삼성바이오로직스딜레마,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180503.99099001464
1778,2018-05-03,회계처리논란삼성바이오로직스결국40만원밀려나,http://www.mdtoday.co.kr/mdtoday/index.html?no=320052
1779,2018-05-03,사기기준이뭔가항변하기바빴던삼성바이오로직스기자회견,http://www.ekn.kr/news/article.html?no=359990
1780,2018-05-03,외국인투매삼성바이오로직스연일하락vs셀트리온반등,http://www.choicenews.co.kr/news/articleView.html?idxno=41152
1781,2018-05-03,삼성바이오로직스분식회계논란금투업계반응은,http://www.metroseoul.co.kr/news/newsview?newscd=2018050300148
1782,2018-05-03,삼성바이오로직스회계분식파장확산,http://www.m-i.kr/news/articleView.html?idxno=411897
1783,2018-05-03,삼성바이오로직스분식논란확산조짐,http://www.m-i.kr/news/articleView.html?idxno=411932
1784,2018-05-03,금감원은왜삼성바이오로직스저격했나,http://www.insightkorea.co.kr//news/articleView.html?idxno=24632
1785,2018-05-03,삼성바이오로직스회계처리논란에바이오주도뚝뚝,http://www.mdtoday.co.kr/mdtoday/index.html?no=320054
1786,2018-05-03,삼성바이오로직스주가이틀연속하락반등가능할까,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180503.99099001532
1787,2018-05-03,삼성바이오로직스쟁점은종속회사VS관계회사,http://www.inews24.com/php/news_view.php?g_serial=1092559&g_menu=022300&rrf=nv
1788,2018-05-03,아랍에미레이트라스알카이마국왕삼성바이오로직스방문,http://daily.hankooki.com/lpage/economy/201805/dh20180503165934138060.htm
1789,2018-05-03,삼성바이오로직스분식회계논란에제약바이오주휘청,http://www.ebn.co.kr/news/view/940259
1790,2018-05-03,금융당국삼성바이오로직스회계처리오락가락결정에투자자만불똥,http://www.ekn.kr/news/article.html?no=360001
1791,2018-05-03,삼성바이오로직스논란증폭투자자피해확산우려,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805030245&t=NNv
1792,2018-05-03,삼성바이오로직스분식회계논란상폐가능성작고오히려저점매수기회목표가유지한증권업계,http://www.fnnews.com/news/201805031715122802
1793,2018-05-03,삼성바이오로직스분식회계논란바이오로직스지분묶인삼성물산그룹지배구조재편작업빨간불,http://www.fnnews.com/news/201805031715032047
1794,2018-05-03,삼성바이오로직스회계논란후폭풍어디까지,http://www.newsis.com/view/?id=NISX20180502_0000298272&cID=13001&pID=13000
1795,2018-05-03,경제이슈삼성바이오로직스회계사기의혹,http://imnews.imbc.com/replay/2018/nw1800/article/4597350_22625.html
1796,2018-05-03,반등못하고주저앉은삼성바이오로직스40만원선깨졌다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619839
1797,2018-05-03,코스피금리인상우려에약세삼성바이오로직스347하락,https://cnbc.sbs.co.kr/article_hub/10000900824?division=NAVER
1798,2018-05-03,아주종목분석삼성바이오로직스분식회계논란에3거래일새23하락,http://www.ajunews.com/view/20180503183100101
1799,2018-05-03,셀트리온주가상승삼성바이오로직스는회계논란에하락,http://www.businesspost.co.kr/BP?command=article_view&num=81343
1800,2018-05-03,삼성바이오로직스주관사한투證종합검사받는다,http://www.sedaily.com/NewsView/1RZE1SNC0S
1801,2018-05-03,뉴투분석금융감독원과참여연대의황당한삼성바이오로직스공격법,http://www.news2day.co.kr/103465
1802,2018-05-03,UAE사우드빈알카시미국왕삼성바이오로직스를방문,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1471956
1803,2018-05-03,삼성바이오로직스와금감원정면충돌에회계법인들도노심초사,http://www.businesspost.co.kr/BP?command=article_view&num=81350
1804,2018-05-03,금감원한투증권종합검사실시삼성바이오로직스상장과는무관,http://biz.chosun.com/site/data/html_dir/2018/05/03/2018050302987.html
1805,2018-05-03,금감원삼성바이오로직스상장주관사한국투자증권종합검사실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=320110
1806,2018-05-03,금감원한투증권종합검사삼성바이오로직스논란무관,http://news1.kr/articles/?3308330
1807,2018-05-03,삼성바이오로직스사흘연속하락바이오주도뚝뚝,http://www.segyefn.com/newsView/20180503007629?OutUrl=naver
1808,2018-05-03,부풀려진가치원위치로삼성바이오로직스분식회계파장,http://news.jtbc.co.kr/html/036/NB11629036.html
1809,2018-05-03,삼성바이오로직스자산4조이상급증주가후폭풍,http://news.kbs.co.kr/news/view.do?ncd=3644386&ref=A
1810,2018-05-03,박영선금융계의우병우상장요건바꿔삼성바이오로직스특혜상장의혹수사해야,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=9&seq_800=10278692
1811,2018-05-03,금감원삼성바이오로직스도운한국투자증권종합검사상장의혹때문아냐”,http://www.kukinews.com/news/article.html?no=545865
1812,2018-05-03,삼성바이오로직스계속커지는논란누가잘못인가,http://www.sporbiz.co.kr/news/articleView.html?idxno=228033
1813,2018-05-03,마감삼성바이오로직스사흘연속하락세삼성전자내일거래재개,http://www.sporbiz.co.kr/news/articleView.html?idxno=228040
1814,2018-05-03,아랍에미리트알카시미국왕일행삼성바이오로직스방문공장시설견학,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=749445
1815,2018-05-03,금감원한국투자증권종합검사삼성바이오로직스와무관”,http://www.fntimes.com/html/view.php?ud=201805032223184147f09e13944d_18
1816,2018-05-03,삼성바이오로직스쇼크바이오업계전체로번지나,http://www.edaily.co.kr/news/newspath.asp?newsid=04362406619205312
1817,2018-05-04,사진사우드빈알카시미UAE라스알카이마국왕삼성바이오로직스본사방문,http://www.ekn.kr/news/article.html?no=360003
1818,2018-05-04,주간한국삼성바이오로직스회계부정의혹드러나는쟁점과모순,http://daily.hankooki.com/lpage/economy/201805/dh20180504005520138060.htm
1819,2018-05-04,UAE국왕송도삼성바이오로직스방문,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=809698
1820,2018-05-04,삼성바이오로직스에피스회계처리에이중잣대,http://news.mt.co.kr/mtview.php?no=2018050315065268179
1821,2018-05-04,카페24에있고삼성바이오로직스에없는투자자보호옵션,http://www.kukinews.com/news/article.html?no=545718
1822,2018-05-04,삼성바이오로직스회계논란증폭상장폐지우려까지,http://www.mdtoday.co.kr/mdtoday/index.html?no=320107
1823,2018-05-04,사설삼성바이오로직스의분식회계논란,http://www.edaily.co.kr/news/newspath.asp?newsid=01226726619205640
1824,2018-05-04,인베스트조선코스피대형성장유망요건상장삼성바이오로직스1곳뿐,http://www.investchosun.com/?p=3225676
1825,2018-05-04,인베스트조선삼성바이오로직스사태회계부정프레임이가지는한계,http://www.investchosun.com/?p=3225670
1826,2018-05-04,tbs김어준의뉴스공장시장에사기친것그게삼성바이오로직스사건본질,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0500&key=20180504.99099001767
1827,2018-05-04,특징주삼성바이오로직스분식회계논란에사흘째하락세,http://news.mt.co.kr/mtview.php?no=2018050409110256657
1828,2018-05-04,특징주삼성바이오로직스나흘연속하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=228158
1829,2018-05-04,삼성바이오로직스전일대비약5하락한370500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805040118&t=NN
1830,2018-05-04,특징주삼성바이오로직스분식회계논란주가나흘째흔들,http://www.g-enews.com/ko-kr/news/article/news_all/2018050409195580c642673384_1/article.html
1831,2018-05-04,특징주삼성바이오로직스나흘째약세,http://www.newstomato.com/ReadNews.aspx?no=822319
1832,2018-05-04,특징주삼성바이오로직스금감원회계위반지적사흘째하락,http://news.hankyung.com/article/2018050491746
1833,2018-05-04,특징주삼성바이오로직스회계처리위반에나흘째하락,http://www.newsis.com/view/?id=NISX20180504_0000299903&cID=10401&pID=10400
1834,2018-05-04,특징주분식회계논란삼성바이오로직스나흘연속하락세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180504044000008&did=1195m
1835,2018-05-04,HotLine삼성바이오로직스회계논란에나흘째약세시총8위로하락,http://news.mk.co.kr/newsRead.php?year=2018&no=284616
1836,2018-05-04,4일장초반삼성전자약세삼성바이오로직스등바이오주부진,http://www.choicenews.co.kr/news/articleView.html?idxno=41164
1837,2018-05-04,특징주분식회계논란삼성바이오로직스나흘째약세,http://biz.chosun.com/site/data/html_dir/2018/05/04/2018050400774.html
1838,2018-05-04,삼성바이오로직스분식회계논란에4일연속하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=320135
1839,2018-05-04,특징주삼성바이오로직스나흘연속하락세,http://www.seoulfn.com/news/articleView.html?idxno=305478
1840,2018-05-04,특징주분식회계논란삼성바이오로직스나흘연속추락,http://www.newsprime.co.kr/news/article.html?no=415606
1841,2018-05-04,특징주삼성바이오로직스분식회계논란에4거래일연속약세,http://www.viva100.com/main/view.php?key=20180504010001555
1842,2018-05-04,특징주삼성바이오로직스분식회계논란에사흘째하락,http://www.ebn.co.kr/news/view/940321
1843,2018-05-04,특징주분식회계논란삼성바이오로직스4거래일연속약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620077
1844,2018-05-04,삼성바이오로직스삼성바이오에피스지배력높아졌다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805040101&t=NN
1845,2018-05-04,삼성바이오로직스분식논란에피스가치평가적정성논란48조vs이익불가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620109
1846,2018-05-04,특징주삼성바이오로직스분식회계논란속나흘째하락,http://moneys.mt.co.kr/news/mwView.php?no=2018050410338096741
1847,2018-05-04,특징주삼성바이오로직스4거래일연속하락바이오주동반약세,http://www.mediapen.com/news/view/352315
1848,2018-05-04,삼성바이오로직스관련금융당국책임론청와대국민청원에오르다,http://www.mdtoday.co.kr/mdtoday/index.html?no=320148
1849,2018-05-04,아주종목분석삼성바이오로직스분식회계논란에시총9위로하락,http://www.ajunews.com/view/20180504112537383
1850,2018-05-04,뉴스후삼성바이오로직스분식회계논란금감원삼성대립각,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050410415243126
1851,2018-05-04,입장번복한금감원폐지vs삼성바이오로직스처벌청와대게시판3일새관련청원34건봇물,http://www.news2day.co.kr/103504
1852,2018-05-04,삼성바이오로직스시총3일새8兆증발소액투자자들금융당국에손배소검토”,http://www.munhwa.com/news/view.html?no=2018050401070203325001
1853,2018-05-04,삼성바이오로직스주가40만원선붕괴,http://www.dailymedi.com/detail.php?number=830260&thread=22r05
1854,2018-05-04,삼성바이오로직스회계논란타격바이오주추락,http://medipana.com/news/news_viewer.asp?NewsNum=219625&MainKind=A&NewsKind=5&vCount=12&vKind=1
1855,2018-05-04,코스피코스닥하락삼성바이오로직스회계위반여파4일연속하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=320162
1856,2018-05-04,삼바삼성바이오로직스투자자소송예고,http://www.naeil.com/news_view/?id_art=274770
1857,2018-05-04,삼성바이오로직스후폭풍삼성금산분리압박하던금융당국의4차원딴죽걸기,http://www.news2day.co.kr/103507
1858,2018-05-04,특징주삼성바이오로직스분식회계논란에나흘연속약세,http://www.inews24.com/php/news_view.php?g_serial=1092820&g_menu=022300&rrf=nv
1859,2018-05-04,세계최대공장어쩌나삼성바이오로직스회계논란에울상,http://news.mk.co.kr/newsRead.php?year=2018&no=285606
1860,2018-05-04,삼성바이오로직스사태커지는금융당국책임론청와대청원봇물,http://www.kukinews.com/news/article.html?no=546080
1861,2018-05-04,뉴스줌인삼성바이오로직스사태한국투자증권의의리보고서,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805040292&t=NN
1862,2018-05-04,금융감독원한국투자증권㈜종합검사삼성바이오로직스상장의혹과는무관,http://www.fntoday.co.kr/news/articleView.html?idxno=161718
1863,2018-05-04,삼성바이오로직스10하락전일보다39000원내린351000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805040455&t=NN
1864,2018-05-04,단독삼성바이오로직스바이오젠과52주총의결권비밀계약,http://www.fnnews.com/news/201805041138346822
1865,2018-05-04,삼성바이오로직스주식투자자집단소송나서나,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050415023162261
1866,2018-05-04,종합삼성바이오로직스나흘간시총10조증발,http://www.newsis.com/view/?id=NISX20180504_0000300534&cID=10401&pID=10400
1867,2018-05-04,코스피외국인순매수SK하이닉스삼성전기삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018050416250144017
1868,2018-05-04,한국증시출렁삼성전자삼성바이오로직스추락vs현대중공업껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=41183
1869,2018-05-04,특징주분식회계논란삼성바이오로직스나흘째하락세종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180504044051008&did=1195m
1870,2018-05-04,삼성바이오로직스위반없다vs금감원분식회계이견팽팽,http://www.intn.co.kr/news/articleView.html?idxno=2000090
1871,2018-05-04,코스피하락삼성바이오로직스회계분식여파시총11위로밀려나다,http://www.mdtoday.co.kr/mdtoday/index.html?no=320190
1872,2018-05-04,삼성바이오로직스바이오젠과52주총의결권비밀계약,http://www.fnnews.com/news/201805041730384934
1873,2018-05-04,삼성바이오로직스바이오젠과52주총의결권비밀계약,http://www.fnnews.com/news/201805041737497005
1874,2018-05-04,금융위삼성바이오로직스처리금감원이독단결정,http://news.hankyung.com/article/2018050421271
1875,2018-05-04,마켓인사이트삼성바이오로직스개인투자자들소송나설까,http://news.hankyung.com/article/201805042161u
1876,2018-05-04,삼성바이오로직스셀트리온주가동반급락회계논란위력강력,http://www.businesspost.co.kr/BP?command=article_view&num=81488
1877,2018-05-04,삼성바이오로직스바이오젠콜옵션Letter주장참여연대앞뒤안맞는다,http://www.sisafocus.co.kr/news/articleView.html?idxno=185182
1878,2018-05-04,금감원삼성바이오로직스분식회계건금융위에알렸다”해명,http://www.nspna.com/news/?mode=view&newsid=282580
1879,2018-05-04,삼성바이오로직스책임공방전투자자불만국민청원봇물,http://www.segye.com/content/html/2018/05/04/20180504005444.html?OutUrl=naver
1880,2018-05-04,삼성물산주가계속떨어져삼성바이오로직스회계논란여파,http://www.businesspost.co.kr/BP?command=article_view&num=81493
1881,2018-05-04,금감원”삼성바이오로직스회계감리결과금융위에지난달말알렸다”,http://www.newsway.co.kr/view.php?tp=1&ud=2018050418451408549
1882,2018-05-04,금융위금감원삼성바이오로직스분식회계파열음네탓공방,http://www.newsis.com/view/?id=NISX20180504_0000300724&cID=10401&pID=10400
1883,2018-05-04,마감삼성전자액면분할첫날하락삼성바이오로직스시총11위로밀려,http://www.sporbiz.co.kr/news/articleView.html?idxno=228395
1884,2018-05-04,삼성바이오로직스투자자보호대책아직없어성실히조사임할것”,http://www.kukinews.com/news/article.html?no=546295
1885,2018-05-04,이건희새로운먹거리발굴해야삼성바이오로직스수상한흑자전환분식회계의혹,http://www.ltn.kr/news/articleView.html?idxno=9507
1886,2018-05-04,삼성바이오로직스자회사가치뻥튀기의혹꼼수상장,http://news.jtbc.co.kr/html/932/NB11629932.html
1887,2018-05-05,삼성바이오로직스상장주관사한투증권보고서로지원사격,http://www.ebn.co.kr/news/view/940443
1888,2018-05-05,삼성바이오로직스분식회계의혹이재용재판변수되나,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180504145100004&did=1195m
1889,2018-05-05,삼성바이오로직스분식회계의혹이재용재판변수되나,http://news.hankyung.com/article/2018050531257
1890,2018-05-05,삼성바이오로직스분식회계의혹이재용부회장재판에영향,http://view.asiae.co.kr/news/view.htm?idxno=2018050509145290905
1891,2018-05-05,삼성바이오로직스사흘간시총8조5000억원증발,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620404
1892,2018-05-05,삼성바이오로직스분식회계의혹이재용재판변수되나,http://news.sbs.co.kr/news/endPage.do?news_id=N1004745051&plink=ORI&cooper=NAVER
1893,2018-05-05,삼성바이오로직스시총8조5000억증발,http://www.edaily.co.kr/news/newspath.asp?newsid=01344806619205968
1894,2018-05-05,분식회계논란삼성바이오로직스시총8조5000억원증발,http://www.cstimes.com/?mod=news&act=articleView&idxno=275082
1895,2018-05-05,삼성바이오로직스사태는어떻게일어났는가,https://www.huffingtonpost.kr/entry/story_kr_5aead086e4b00f70f0ef77b8?utm_id=naver
1896,2018-05-05,삼성바이오로직스분식회계논란에시총85조증발,http://www.ebn.co.kr/news/view/940452
1897,2018-05-05,25년족집게애널리스트가보는삼성바이오로직스사태는,http://www.sporbiz.co.kr/news/articleView.html?idxno=228405
1898,2018-05-05,금감원6일삼성바이오로직스조치안금융위에보고,http://www.edaily.co.kr/news/newspath.asp?newsid=01728566619205968
1899,2018-05-05,삼성바이오로직스조치안6일금융위보고,http://www.newspim.com/news/view/20180505000034
1900,2018-05-05,금감원분식회계의혹삼성바이오로직스조치안금융위에6일보고,http://moneys.mt.co.kr/news/mwView.php?no=2018050514448021709
1901,2018-05-05,금융위삼성바이오로직스징계속도6일금감원보고,http://biz.chosun.com/site/data/html_dir/2018/05/05/2018050500851.html
1902,2018-05-05,삼성바이오로직스분식회계의혹국정농단재판변수되나종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180504145151004&did=1195m
1903,2018-05-05,금감원내일삼성바이오로직스조치안금융위에보고,http://www.ytn.co.kr/_ln/0102_201805051517512453
1904,2018-05-05,금감원금융위에삼성바이오로직스조치안보고예정,http://news.einfomax.co.kr/news/articleView.html?idxno=3447435
1905,2018-05-05,금융위삼성바이오로직스조치에속도6일금감원보고,http://www.fntimes.com/html/view.php?ud=20180505151527511179ad43907_18
1906,2018-05-05,금융위6일삼성바이오로직스조치보고받기로,http://www.fnnews.com/news/201805051525093713
1907,2018-05-05,금감원내일6일삼성바이오로직스조치안금융위에보고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050515331125114
1908,2018-05-05,금감원내일삼성바이오로직스조치안금융위에보고,http://www.ytn.co.kr/_ln/0102_201805051558175452
1909,2018-05-05,금융위삼성바이오로직스논란신속처리나선다,http://view.asiae.co.kr/news/view.htm?idxno=2018050516030538190
1910,2018-05-05,삼성바이오로직스분식회계의혹이재용재판에변수로작용,http://www.sisajournal-e.com/biz/article/183689
1911,2018-05-05,EBN오늘5일이슈종합이달22일한미정상회담삼성바이오로직스분식회계논란에시총85조증발남북시계통일北평양시30분앞당겨등,http://www.ebn.co.kr/news/view/940459
1912,2018-05-05,금융위삼성바이오로직스분식회계논란신속한결론내기로,http://www.viva100.com/main/view.php?key=20180505010001901
1913,2018-05-05,금융위삼성바이오로직스논란신속히결론내기로,http://www.sporbiz.co.kr/news/articleView.html?idxno=228617
1914,2018-05-05,금융위6일오전11시삼성바이오로직스분식회계의혹보고받아”,http://daily.hankooki.com/lpage/economy/201805/dh20180505164340138080.htm
1915,2018-05-05,금융위삼성바이오로직스분식회계논란처리속도,http://www.cstimes.com/?mod=news&act=articleView&idxno=275088
1916,2018-05-05,삼성바이오로직스나흘간시총10조허공으로날아갔다적정의견받았다,http://www.econonews.co.kr/news/articleView.html?idxno=24546
1917,2018-05-05,금융위삼성바이오로직스분식회계논란결론조만간내릴듯,http://wikileaks-kr.org/%EA%B8%88%EC%9C%B5%EC%9C%84-%EC%82%BC%EC%84%B1%EB%B0%94%EC%9D%B4%EC%98%A4%EB%A1%9C%EC%A7%81%EC%8A%A4-%EB%B6%84%EC%8B%9D%ED%9A%8C%EA%B3%84-%EB%85%BC%EB%9E%80-%EA%B2%B0%EB%A1%A0
1918,2018-05-05,금감원삼성바이오로직스조치안6일금융위에보고,http://www.kukinews.com/news/article.html?no=546419
1919,2018-05-05,삼성바이오로직스분식회계논란종지부빨라지나,http://www.ajunews.com/view/20180505211555812
1920,2018-05-06,여의도까톡삼성바이오로직스회계논란왜지금일까,http://www.ebn.co.kr/news/view/940453
1921,2018-05-06,금융위삼성바이오로직스분식회계논란일정조율나서,http://www.ftoday.co.kr/news/articleView.html?idxno=87588
1922,2018-05-06,WIKI칼럼금융당국은삼성바이오로직스논란잠재울확실하고빠른결단내려야,http://wikileaks-kr.org/WIKI-%EC%B9%BC%EB%9F%BC-%EA%B8%88%EC%9C%B5%EB%8B%B9%EA%B5%AD%EC%9D%80-%EC%82%BC%EC%84%B1%EB%B0%94%EC%9D%B4%EC%98%A4%EB%A1%9C%EC%A7%81%EC%8A%A4-%EB%85%BC%EB%9E%80-%EC%9E%A0%EC%9E%AC%EC%9A%B8
1923,2018-05-06,윤석헌신임금감원장삼성바이오로직스의혹규명흔들려선안된다,http://www.choicenews.co.kr/news/articleView.html?idxno=41199
1924,2018-05-06,삼성바이오로직스회계위반에금감원왜논란자초했나,http://www.newsis.com/view/?id=NISX20180506_0000301042&cID=10401&pID=10400
1925,2018-05-06,주간펀드동향삼성바이오로직스등제약바이오株부진투자심리위축,http://www.m-i.kr/news/articleView.html?idxno=412335
1926,2018-05-06,금감원의한국투자증권종합검사삼성바이오로직스문제도철저히검증해야,http://www.choicenews.co.kr/news/articleView.html?idxno=41200
1927,2018-05-06,시총9조증발삼성바이오로직스날개없는추락어디까지,http://www.edaily.co.kr/news/newspath.asp?newsid=01184086619206296
1928,2018-05-06,금감원오늘삼성바이오로직스조치안금융위에보고,http://www.ytn.co.kr/_ln/0102_201805060900522041
1929,2018-05-06,삼성바이오로직스분식회계논란시계추빨라진다,http://www.asiatime.co.kr/news/articleView.html?idxno=178634
1930,2018-05-06,금감원삼성바이오로직스조치안금융위에보고,http://news.heraldcorp.com/view.php?ud=20180506000017
1931,2018-05-06,금감원삼성바이오로직스조치안오늘금융위에보고,http://www.inews24.com/php/news_view.php?g_serial=1093062&g_menu=022300&rrf=nv
1932,2018-05-06,금융당국삼성바이오로직스분식회계논란신속히결론내리기로,http://www.betanews.net:8080/article/850117.html
1933,2018-05-06,박권추삼성바이오로직스특별감리결과보고합니다,http://news1.kr/photos/view/?3097518
1934,2018-05-06,금융위삼성바이오로직스분식회계논란보고,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180506029500013&did=1196m
1935,2018-05-06,금융위삼성바이오로직스분식회계논란보고,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180506029400013&did=1196m
1936,2018-05-06,삼성바이오로직스분식회계논란금융위보고,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180506029700013&did=1196m
1937,2018-05-06,삼성바이오로직스분식회계논란금융위보고,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180506029600013&did=1196m
1938,2018-05-06,분식회계논란삼성바이오로직스결론은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180506030200013&did=1196m
1939,2018-05-06,제약바이오주삼성바이오로직스회계논란에하락세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050611391549966
1940,2018-05-06,금감원삼성바이오로직스조치안금융위에보고,http://news.kbs.co.kr/news/view.do?ncd=3645352&ref=A
1941,2018-05-06,금감원삼성바이오로직스조치안금융위에보고,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050612165592209
1942,2018-05-06,종합삼성바이오로직스미리알린금감원진실공방,http://www.newsis.com/view/?id=NISX20180506_0000301138&cID=10401&pID=10400
1943,2018-05-06,휴일잊은금융위삼성바이오로직스회계처리제재딜레마자기부정하는꼴,http://www.news2day.co.kr/103563
1944,2018-05-06,삼성바이오로직스분식회계논란금감원보고받은김용범부위원장,http://news1.kr/photos/view/?3097576
1945,2018-05-06,금감원삼성바이오로직스분식회계관련보고받은김용범부위원장,http://news1.kr/photos/view/?3097586
1946,2018-05-06,삼성바이오로직스된서리에IPO눈치보는바이오,http://news.mt.co.kr/mtview.php?no=2018050611594834218
1947,2018-05-06,삼성바이오로직스감리위17일개최증선위23일열듯,http://news1.kr/articles/?3310006
1948,2018-05-06,김용범삼성바이오로직스사태시장충격크다이르면23일증선위상정,http://news.hankyung.com/article/2018050648446
1949,2018-05-06,김용범삼성바이오로직스사태빠르면23일증선위상정”,http://www.newsway.co.kr/view.php?tp=1&ud=2018050613554448670
1950,2018-05-06,금융위삼성바이오로직스감리위신속개최,http://www.newsis.com/view/?id=NISX20180506_0000301204&cID=10401&pID=10400
1951,2018-05-06,삼성바이오로직스사태17일감리위원회에올라온다,http://www.sporbiz.co.kr/news/articleView.html?idxno=228807
1952,2018-05-06,금융위삼성바이오로직스사전통지시장충격혼란있다,http://www.inews24.com/php/news_view.php?g_serial=1093087&g_menu=022300&rrf=nv
1953,2018-05-06,금융위삼성바이오로직스감리위신속개최17일예정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050614243166630
1954,2018-05-06,라인뉴스금감원삼성바이오로직스조치안금융위에보고,http://news.kbs.co.kr/news/view.do?ncd=3645379&ref=A
1955,2018-05-06,삼성바이오로직스분식회계논란감리위17일개최,http://news.kbs.co.kr/news/view.do?ncd=3645381&ref=A
1956,2018-05-06,분식회계논란삼성바이오로직스감리위17일열기로,http://www.cpbc.co.kr/CMS/news/view_body.php?cid=719750&path=201805
1957,2018-05-06,삼성바이오로직스감리위17일개최증선위는빠르면23일,http://www.fntimes.com/html/view.php?ud=201805061439092912179ad43907_18
1958,2018-05-06,분식회계논란삼성바이오로직스17일감리위개최,http://www.edaily.co.kr/news/newspath.asp?newsid=01558006619206296
1959,2018-05-06,삼성바이오로직스회계논란감리위17일개최,http://www.ebn.co.kr/news/view/940475
1960,2018-05-06,분식회계논란삼성바이오로직스감리위17일신속개최,http://www.ekn.kr/news/article.html?no=360380
1961,2018-05-06,삼성바이오로직스의삼성바이오에피스가치5조평가는정당한가,http://www.businesspost.co.kr/BP?command=article_view&num=81554
1962,2018-05-06,김용범증권선물위원장삼성바이오로직스감리위조속히개최,http://www.viva100.com/main/view.php?key=20180506010001997
1963,2018-05-06,삼성바이오로직스분식회계의혹감리위17일로확정,http://news.einfomax.co.kr/news/articleView.html?idxno=3447444
1964,2018-05-06,삼성바이오로직스감리위원회오는17일열린다,http://www.ajunews.com/view/20180506145742899
1965,2018-05-06,분식회계논란삼성바이오로직스감리위17일개최,http://www.cstimes.com/?mod=news&act=articleView&idxno=275109
1966,2018-05-06,금감원삼성바이오로직스금융위보고17일감리위,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=88731
1967,2018-05-06,금융위분식회계논란삼성바이오로직스감리위17일개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620487
1968,2018-05-06,삼성바이오로직스분식회계논란이르면이달내결론,http://www.segye.com/content/html/2018/05/06/20180506000866.html?OutUrl=naver
1969,2018-05-06,삼성바이오로직스논란감리위17일개최,http://www.nocutnews.co.kr/news/4965773
1970,2018-05-06,삼성바이오로직스분식회계논란감리위17일개최,http://www.segyefn.com/newsView/20180506000863?OutUrl=naver
1971,2018-05-06,삼성바이오로직스회계부정이재용승계작업뒷받침의혹,http://sports.khan.co.kr/news/sk_index.html?art_id=201805061528003&sec_id=560101&pt=nv
1972,2018-05-06,삼성바이오로직스분식회계감리위17일개최,http://www.newsworks.co.kr/news/articleView.html?idxno=184921
1973,2018-05-06,삼성바이오로직스분식회계논란17일심의,http://www.ytn.co.kr/_ln/0102_201805061540340623
1974,2018-05-06,분식회계논란삼성바이오로직스감리위17일개최,http://view.asiae.co.kr/news/view.htm?idxno=2018050615462977742
1975,2018-05-06,금융위삼성바이오로직스분식회계논란감리위17일개최,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10279046
1976,2018-05-06,삼성바이오로직스분식회계감리위17일열려,http://it.chosun.com/news/article.html?no=2851181
1977,2018-05-06,삼성바이오로직스감리위17일개최이르면23일증선위상정,http://news.kmib.co.kr/article/view.asp?arcid=0012334496&code=61141111&cp=nv
1978,2018-05-06,삼성바이오로직스감리위원회17일개최,http://www.econovill.com/news/articleView.html?idxno=337318
1979,2018-05-06,금융위삼성바이오로직스분식회계논란서둘러결론낸다,http://www.businesspost.co.kr/BP?command=article_view&num=81558
1980,2018-05-06,삼성바이오로직스분식회계논란감리위17일개최,http://news.kbs.co.kr/news/view.do?ncd=3645400&ref=A
1981,2018-05-06,금융위삼성바이오로직스분식회계의혹규명속도낸다,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805061727001&code=920100
1982,2018-05-06,삼성바이오로직스감리위원회17일개최,http://www.fnnews.com/news/201805061728276898
1983,2018-05-06,종합삼성바이오로직스감리위17일개최이르면23일증선위상정,http://www.sporbiz.co.kr/news/articleView.html?idxno=228859
1984,2018-05-06,금감원초강경삼성바이오로직스제재안,http://news.hankyung.com/article/2018050653421
1985,2018-05-06,금융위삼성바이오로직스사태신속한처리강조17일첫일정,http://www.news2day.co.kr/103568
1986,2018-05-06,삼성바이오로직스분식회계논란17일감리위에서판가름,http://www.kyeongin.com/main/view.php?key=20180506010001940
1987,2018-05-06,오늘이슈북미정상회담장소는어디한중일정상회담정세균국회의장김성태자유한국당원대대표방문이명희일우재단이사장입건삼성바이오로직스감리위원회17일열려우천으로야구3경기취소골,http://www.econovill.com/news/articleView.html?idxno=337322
1988,2018-05-06,분식회계논란삼성바이오로직스감리위17일개최,http://www.seoulwire.com/news/articleView.html?idxno=13927
1989,2018-05-06,천지일보주간SNS핫이슈5김성태폭행근로장려금삼성바이오로직스광주집단폭행백상예술대상,http://www.newscj.com/news/articleView.html?idxno=518559
1990,2018-05-06,삼성바이오로직스분식회계논란17일심의,http://www.ytn.co.kr/_ln/0102_201805062231421444
1991,2018-05-06,삼성바이오로직스사태칼뽑은금융당국빠르면이달결론,http://www.newstomato.com/ReadNews.aspx?no=822541
1992,2018-05-06,삼성바이오로직스분식회계이르면23일결론난다,http://www.hani.co.kr/arti/economy/finance/843525.html
1993,2018-05-07,분식회계혐의삼성바이오로직스대표해임권고60억과징금검토,http://news.donga.com/3/all/20180506/89959293/1
1994,2018-05-07,STOCK갈림길에선삼성바이오로직스,http://moneys.mt.co.kr/news/mwView.php?no=2018050304128095872
1995,2018-05-07,삼성바이오로직스분식회계논란감리위17일개최,http://news.kbs.co.kr/news/view.do?ncd=3645496&ref=A
1996,2018-05-07,금감원금융위에삼성바이오로직스구체적조치내용보고사실없어,http://www.nspna.com/news/?mode=view&newsid=282728
1997,2018-05-07,분식회계논란삼성바이오로직스오는23일쯤최종결론,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10279099
1998,2018-05-07,삼성바이오로직스분식회계당국최종판단은언제,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=525479
1999,2018-05-07,서경펀드닥터삼성바이오로직스분식회계이슈에국내주식형151하락,http://www.sedaily.com/NewsView/1RZFTZEZ3H
2000,2018-05-07,삼성바이오로직스분식논란처리금융개혁시험대될수도,http://www.choicenews.co.kr/news/articleView.html?idxno=41210
2001,2018-05-07,삼성바이오로직스분식회계본격심의이르면23일결론,http://news.jtbc.co.kr/html/583/NB11630583.html
2002,2018-05-07,분식회계혐의삼성바이오로직스감리위17일열린다,http://www.sportsseoul.com/news/read/631671
2003,2018-05-07,휴일한입뉴스한미정상회담22일워싱턴DC개최주택담보대출금리5돌파삼성바이오로직스분식회계발표정보사전유출의심삼성전자SK하이닉스중국반도체굴기에위기설美금리인상,http://www.econovill.com/news/articleView.html?idxno=337328
2004,2018-05-07,삼성바이오로직스분식회계논란17일심의이달말다음달초최종결론,http://www.kukinews.com/news/article.html?no=546527
2005,2018-05-07,삼성바이오로직스리스크에도증권사는잠잠,http://www.newstomato.com/ReadNews.aspx?no=822423
2006,2018-05-07,삼성바이오로직스의삼성바이오에피스나스닥상장어떻게됐나,http://www.businesspost.co.kr/BP?command=article_view&num=81572
2007,2018-05-07,분식회계삼성바이오로직스공매도타깃되나,http://www.ekn.kr/news/article.html?no=360413
2008,2018-05-07,뉴스초점삼성바이오로직스회계논란후폭풍어디까지,http://www.yonhapnewstv.co.kr/MYH20180507004100038/?did=1825m
2009,2018-05-07,윤석헌신임금융감독원장8일본격취임삼성바이오로직스현안수습부터,http://www.kyeongin.com/main/view.php?key=20180507010002011
2010,2018-05-07,이르면23일삼성바이오로직스부정회계논란결론,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180507100759
2011,2018-05-07,증권가삼성바이오로직스시총8조증발에도판단유보,http://www.inews24.com/php/news_view.php?g_serial=1092899&g_menu=022300&rrf=nv
2012,2018-05-07,이종무의눈삼성바이오로직스바이오시밀러는말이없다,http://www.ekn.kr/news/article.html?no=360472
2013,2018-05-07,삼성바이오로직스분식회계논란첨예하게대립하는금감원vs삼성,http://www.metroseoul.co.kr/news/newsview?newscd=2018050700076
2014,2018-05-07,문재인정부1년증시코스닥거품만키우고삼성바이오로직스대란까지,http://www.sporbiz.co.kr/news/articleView.html?idxno=229091
2015,2018-05-07,금융위삼성바이오로직스분식회계본격심의이르면23일결론,http://sports.khan.co.kr/news/sk_index.html?art_id=201805071547003&sec_id=560101&pt=nv
2016,2018-05-07,삼성바이오로직스논란에입닫고속앓이하는삼성,http://news.mt.co.kr/mtview.php?no=2018050715345649765
2017,2018-05-07,삼성바이오로직스분식회계심의최종징계수준6월결정될듯,http://news.hankyung.com/article/2018050769637
2018,2018-05-07,삼성바이오로직스고강도징계가능성에투자자불안갈수록커져,http://www.businesspost.co.kr/BP?command=article_view&num=81606
2019,2018-05-07,분식회계논란삼성바이오로직스최종징계수준관심,http://www.kyeongin.com/main/view.php?key=20180507010002277
2020,2018-05-07,삼성바이오로직스분식회계논란에제약바이오주먹구름,http://www.ajunews.com/view/20180507161235221
2021,2018-05-07,삼성바이오로직스과징금5억넘으면내달금융위서최종징계수준결정,http://biz.chosun.com/site/data/html_dir/2018/05/07/2018050701123.html
2022,2018-05-07,오늘이슈1삼성증권배당오류직원형사고소2윤석헌금감원장8일취임3신한금융ING생명인수단독협상종료4김성태폭행범구속단독범행가닥5삼성바이오로직스6월최종징계결정,http://www.econovill.com/news/articleView.html?idxno=337349
2023,2018-05-07,jtbc뉴스룸삼성장충기사장삼성바이오로직스직접챙겨문자금감원,http://www.topstarnews.net/news/articleView.html?idxno=406925
2024,2018-05-07,JTBC뉴스룸삼성바이오로직스의혹조명장충기문자안종범수첩에서관련내용발견,http://www.slist.kr/news/articleView.html?idxno=33130
2025,2018-05-07,삼성바이오로직스분식회계검토착수공방예상,http://news.sbs.co.kr/news/endPage.do?news_id=N1004746916&plink=ORI&cooper=NAVER
2026,2018-05-07,삼성바이오로직스분식회계논란감리위17일개최빠르면23일증선위운명의날,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1472672
2027,2018-05-07,삼성바이오로직스잘못된정보유통되는것막겠다8일성명서발표,http://www.asiatoday.co.kr/view.php?key=20180507010003124
2028,2018-05-07,윤석헌금감원장삼성바이오로직스사태어떻게풀까,http://www.sporbiz.co.kr/news/articleView.html?idxno=229193
2029,2018-05-08,삼성전자삼성바이오로직스주식을바라보는상반된시선,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180508.99099002594
2030,2018-05-08,김현주의일상톡톡금융당국해석그때그때달라요삼성바이오로직스회계처리논란,http://www.segye.com/content/html/2018/05/07/20180507000712.html?OutUrl=naver
2031,2018-05-08,혼돈의삼성바이오로직스17일감리위서운명가른다,http://news.mt.co.kr/mtview.php?no=2018050713142511407
2032,2018-05-08,삼성바이오로직스회계위반에바이오주집단하락세,http://www.asiatoday.co.kr/view.php?key=20180507010003079
2033,2018-05-08,삼성바이오로직스회계논란에바이오제약주허우적,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055581
2034,2018-05-08,분식회계논란삼성바이오로직스김태한대표해임등금감원최고수준제재내릴까,http://www.newsworker.co.kr/news/articleView.html?idxno=17782
2035,2018-05-08,더벨삼성바이오로직스신용등급공개왜꺼렸을까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805030100004590000282
2036,2018-05-08,인베스트조선삼성바이오로직스유탄튈까전전긍긍하는회계법인,http://www.investchosun.com/?p=3225727
2037,2018-05-08,인베스트조선바이오젠콜옵션행사의사숨긴삼성바이오로직스,http://www.investchosun.com/?p=3225734
2038,2018-05-08,더벨삼성바이오로직스에피스종속기업유지했다면,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805040100007800000476
2039,2018-05-08,삼성바이오로직스분식회계파문이르면23일결론,http://news.sbs.co.kr/news/endPage.do?news_id=N1004747258&plink=ORI&cooper=NAVER
2040,2018-05-08,분식회계논란삼성바이오로직스3일간시총약8조증발,http://www.mdtoday.co.kr/mdtoday/index.html?no=320255
2041,2018-05-08,삼성바이오로직스금감원의감리내용공개유감”표명,http://news.heraldcorp.com/view.php?ud=20180508000061
2042,2018-05-08,삼성바이오로직스금감원에감리정보공개노출유감”,http://news.kbs.co.kr/news/view.do?ncd=3645990&ref=A
2043,2018-05-08,분식회계논란삼성바이오로직스17일감리위열린다,http://www.mdtoday.co.kr/mdtoday/index.html?no=320258
2044,2018-05-08,삼성바이오로직스민감한정보무분별하게노출유감이다,http://www.newsis.com/view/?id=NISX20180508_0000301928&cID=13001&pID=13000
2045,2018-05-08,삼성바이오로직스금감원조치사전통지서내용공개자제해야,http://www.newspim.com/news/view/20180508000050
2046,2018-05-08,특징주삼성바이오로직스나흘만에반등,http://news.mt.co.kr/mtview.php?no=2018050809031905472
2047,2018-05-08,삼성바이오로직스금감원미공개정보유출유감표명,http://www.edaily.co.kr/news/newspath.asp?newsid=02023766619206952
2048,2018-05-08,제약바이오주가삼성바이오로직스논란으로당분간약세불가피,http://www.businesspost.co.kr/BP?command=article_view&num=81643
2049,2018-05-08,특징주삼성바이오로직스회계조작의혹지속주가는나흘만에반등세,http://www.g-enews.com/ko-kr/news/article/news_all/201805080909278493c16aa2f016_1/article.html
2050,2018-05-08,삼성바이오로직스측민감한정보무분별하게공개유감,http://www.mdtoday.co.kr/mdtoday/index.html?no=320262
2051,2018-05-08,특징주32급락한삼성바이오로직스5거래일만에반등,http://www.ekn.kr/news/article.html?no=360556
2052,2018-05-08,특징주너무떨어졌나삼성바이오로직스나흘만에반등,http://www.newsprime.co.kr/news/article.html?no=415779
2053,2018-05-08,삼성바이오로직스금감원통한감리정보유출유감,http://www.asiatoday.co.kr/view.php?key=20180508010003225
2054,2018-05-08,특징주삼성바이오로직스2거래일연속반등6↑,http://view.asiae.co.kr/news/view.htm?idxno=2018050809290768270
2055,2018-05-08,HotLine분식회계논란삼성바이오로직스5거래일만에반등,http://news.mk.co.kr/newsRead.php?year=2018&no=290541
2056,2018-05-08,삼성바이오로직스금감원감리내용사전에공개돼유감”,http://www.businesspost.co.kr/BP?command=article_view&num=81646
2057,2018-05-08,금감원에유감표명삼성바이오로직스장초반6대강세,http://www.sedaily.com/NewsView/1RZGAV79X9
2058,2018-05-08,특징주삼성바이오로직스금감원회계위반지적나흘만에반등,http://news.hankyung.com/article/2018050881756
2059,2018-05-08,삼성바이오로직스5대상승5거래일만에반등,http://news1.kr/articles/?3310840
2060,2018-05-08,특징주삼성바이오로직스반격나흘만에반등,http://www.edaily.co.kr/news/newspath.asp?newsid=02210726619206952
2061,2018-05-08,특징주분식회계논란삼성바이오로직스닷새만에반등,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180508047500008&did=1195m
2062,2018-05-08,특징주삼성바이오로직스분식회계논란닷새만에반등,http://www.newstomato.com/ReadNews.aspx?no=822705
2063,2018-05-08,삼성바이오로직스미공개감리정보유출유감표명,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050809302136247
2064,2018-05-08,특징주분식회계논란삼성바이오로직스닷새만에반등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620690
2065,2018-05-08,분식회계논란삼성바이오로직스금감원대한반발수위높인다,https://cnbc.sbs.co.kr/article_hub/10000901109?division=NAVER
2066,2018-05-08,삼성바이오로직스감리정보무분별한노출유감성명서발표,http://www.ekn.kr/news/article.html?no=360568
2067,2018-05-08,특징주회계위반삼성바이오로직스닷새만에반등,http://biz.chosun.com/site/data/html_dir/2018/05/08/2018050800689.html
2068,2018-05-08,특징주분식회계논란삼성바이오로직스나흘만에반등,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805080158&t=NN
2069,2018-05-08,8일장초반한국증시상승삼성전자삼성바이오로직스반등,http://www.choicenews.co.kr/news/articleView.html?idxno=41230
2070,2018-05-08,삼성바이오로직스민감한사안의정보공개유감,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003195942
2071,2018-05-08,특징주삼성바이오로직스분식회계논란딛고나흘만반등,http://www.fntimes.com/html/view.php?ud=201805080943492034f09e13944d_18
2072,2018-05-08,삼성바이오로직스나흘만에주가반등542％↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=320273
2073,2018-05-08,특징주삼성바이오로직스나흘만에반등,http://moneys.mt.co.kr/news/mwView.php?no=2018050809478086594
2074,2018-05-08,삼성바이오로직스고의분식잠정결론파장예고,http://news.jtbc.co.kr/html/832/NB11630832.html
2075,2018-05-08,삼성바이오로직스민감한정보무분별하게공개유감,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10279254
2076,2018-05-08,특징주분식회계논란삼성바이오로직스5일만에↑,http://www.ebn.co.kr/news/view/940563
2077,2018-05-08,삼성바이오로직스금감원에유감표명민감정보무분별공개,http://www.ebn.co.kr/news/view/940553
2078,2018-05-08,삼성바이오로직스금감원정보노출유감스럽다,http://news.mt.co.kr/mtview.php?no=2018050809544949165
2079,2018-05-08,보도참고한국경제55일자「금융위삼성바이오로직스처리금감원이독단결정”」제하의기사관련,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156268361
2080,2018-05-08,보도참고김용범증선위원장삼성바이오로직스감리결과를보고받고신속하고공정한심의를감리위원장에게당부,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156268363
2081,2018-05-08,삼성바이오로직스금감원에민감한정보무분별하게노출유감반격,http://www.m-i.kr/news/articleView.html?idxno=412716
2082,2018-05-08,삼성바이오로직스금감원겨냥민감한정보무분별공개하는상황우려”,http://www.kukinews.com/news/article.html?no=546710
2083,2018-05-08,회계논란삼성바이오로직스금감원이미공개정보유출유감”,http://biz.chosun.com/site/data/html_dir/2018/05/08/2018050800847.html
2084,2018-05-08,ISSUEINSIDE삼성바이오로직스분식회계논란2라운드증선위최종판단상폐까지는안갈듯,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=290788
2085,2018-05-08,경제플러스김미희기자삼성바이오로직스논란에개인투자자반발,http://www.cpbc.co.kr/CMS/news/view_body.php?cid=719853&path=201805
2086,2018-05-08,분식회계논란삼성바이오로직스금감원상대로유감표명민감한사안무분별노출에투자자불안가중,http://www.kyeongin.com/main/view.php?key=20180508010002476
2087,2018-05-08,지배력잃고2조원이득삼성바이오로직스의이상한해명,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002431664&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
2088,2018-05-08,삼성바이오로직스금감원충돌양상회계위반파장확산,http://www.newsis.com/view/?id=NISX20180508_0000301995&cID=10401&pID=10400
2089,2018-05-08,긴급진단바이오주삼성바이오로직스향후방향증권가시각은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620726
2090,2018-05-08,삼성바이오로직스금감원민감한회계사안무분별공개유감,http://www.seoulfn.com/news/articleView.html?idxno=305671
2091,2018-05-08,삼성바이오로직스금감원이민감한정보유출시장투자자불안가중시켜”,http://moneys.mt.co.kr/news/mwView.php?no=2018050811008096065
2092,2018-05-08,삼성바이오로직스금감원미확인정보유출유감,http://www.mediapen.com/news/view/353038
2093,2018-05-08,삼성바이오로직스초강경제재금감원삼성손보기총대매나,http://www.mediapen.com/news/view/353042
2094,2018-05-08,삼성바이오로직스감리정보무분별한노출우려와유감,http://biz.newdaily.co.kr/news/article.html?no=10160170
2095,2018-05-08,삼성바이오로직스분식회계맞다,http://www.finomy.com/news/articleView.html?idxno=54283
2096,2018-05-08,삼성바이오로직스금감원에감리진행민감정보무분별공개유출유감,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620776
2097,2018-05-08,특징주삼성바이오로직스5거래일만에상승세,http://www.mediapen.com/news/view/353064
2098,2018-05-08,삼성바이오로직스회계위반에입장표명,http://www.nbntv.co.kr/news/articleView.html?idxno=103331
2099,2018-05-08,제약바이오株주가상승세삼성바이오로직스도나흘만에반등,http://www.mdtoday.co.kr/mdtoday/index.html?no=320292
2100,2018-05-08,삼성바이오로직스금감원민감한정보노출에유감,http://moneys.mt.co.kr/news/mwView.php?no=2018050811248063579
2101,2018-05-08,삼성바이오로직스금감원유감,http://www.monews.co.kr/news/articleView.html?idxno=114369
2102,2018-05-08,삼성바이오로직스금감원정보무분별공개유감,http://www.dailymedi.com/detail.php?number=830334&thread=22r12
2103,2018-05-08,삼성바이오로직스에서윤석헌까지흔들리는금융위금감원공조,http://www.kukinews.com/news/article.html?no=546767
2104,2018-05-08,삼성바이오로직스분식회계논란금융위최종심의,http://www.koreaittimes.com/news/articleView.html?idxno=82771
2105,2018-05-08,회계정보무분별공개로시장불안가중”삼성바이오로직스금감원에유감표명,http://www.munhwa.com/news/view.html?no=2018050801070203324001
2106,2018-05-08,금감원VS삼성바이오로직스힘겨루기양상시총10조날아간삼성바이오로직스주가5일만에오름세,http://www.topstarnews.net/news/articleView.html?idxno=407271
2107,2018-05-08,삼성바이오로직스회계기준논란고의성여부로판가름날까,http://www.naeil.com/news_view/?id_art=274982
2108,2018-05-08,삼성바이오로직스회계기준해석놓고입장차팽팽,http://www.naeil.com/news_view/?id_art=274922
2109,2018-05-08,분식회계삼성바이오로직스금감원과갈등고조,http://www.skyedaily.com/news/news_view.html?ID=73470
2110,2018-05-08,삼성바이오로직스반격에도굳건한금융당국주가행방오리무중,http://www.g-enews.com/ko-kr/news/article/news_all/20180508114610907c16aa2f016_1/article.html
2111,2018-05-08,삼성바이오로직스금감원민감한사안공개유감,http://www.econovill.com/news/articleView.html?idxno=337406
2112,2018-05-08,삼성바이오로직스금감원민감한정보공개노출유감,http://www.newscj.com/news/articleView.html?idxno=518902
2113,2018-05-08,점입가경삼성바이오로직스분식회계의혹,http://www.intn.co.kr/news/articleView.html?idxno=2000100
2114,2018-05-08,삼성바이오로직스금감원언론플레이의3가지문제점제기,http://www.news2day.co.kr/103616
2115,2018-05-08,특징주너무떨어졌나삼성바이오로직스5거래일만에반등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1620866
2116,2018-05-08,원승연부원장삼성바이오로직스분식회계감리정권과무관,http://www.sporbiz.co.kr/news/articleView.html?idxno=229447
2117,2018-05-08,삼성바이오로직스금감원의정보공개노출에크나큰우려와유감,http://www.greened.kr/news/articleView.html?idxno=61159
2118,2018-05-08,금감원삼성바이오로직스감리결과증선위까지기밀유지할것,http://www.newsis.com/view/?id=NISX20180508_0000302499&cID=10401&pID=10400
2119,2018-05-08,분식회계불편한심경드러낸삼성바이오로직스,http://www.kormedi.com/news/news/drug_dist/1227187_2906.html
2120,2018-05-08,원승연삼성바이오로직스회계위반발표투자자보호위한것”,http://www.newsway.co.kr/view.php?tp=1&ud=2018050815432248067
2121,2018-05-08,분식회계논란반격나선삼성바이오로직스주가반등성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=320325
2122,2018-05-08,금감원삼성바이오로직스에대한입장바뀐것없다”,http://moneys.mt.co.kr/news/mwView.php?no=2018050815398049534
2123,2018-05-08,금감원삼성바이오로직스관련정보공개투자자보호목적”,http://moneys.mt.co.kr/news/mwView.php?no=2018050815488054704
2124,2018-05-08,D9반격나선삼성바이오로직스진화나선금감원,http://news.mt.co.kr/mtview.php?no=2018050815162388012
2125,2018-05-08,삼성바이오로직스끙끙앓는속내진실은,http://www.asiatime.co.kr/news/articleView.html?idxno=178889
2126,2018-05-08,삼성바이오로직스회계논란에바이오젠의콜옵션놓고여러의문,http://www.businesspost.co.kr/BP?command=article_view&num=81697
2127,2018-05-08,특징주바이오주대거하락삼성바이오로직스는반등종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180508047551008&did=1195m
2128,2018-05-08,한국증시휘청삼성전자삼성바이오로직스삼성중공업은상승,http://www.choicenews.co.kr/news/articleView.html?idxno=41255
2129,2018-05-08,금감원vs삼성바이오로직스감리결과공개두고티격태격,http://www.insightkorea.co.kr//news/articleView.html?idxno=24797
2130,2018-05-08,5스타투자전략_카드뉴스삼성바이오로직스충격바이오테마주영향은,https://cnbc.sbs.co.kr/article_hub/10000901169?division=NAVER
2131,2018-05-08,금감원삼성바이오로직스회계논란의역풍맞을수도,http://www.businesspost.co.kr/BP?command=article_view&num=81701
2132,2018-05-08,삼성바이오로직스VS금감원진흙탕싸움금융당국이중잣대논란,http://www.foodtvnews.com/news/article.html?no=7244
2133,2018-05-08,UpDown트럼프vs삼성바이오로직스,http://www.sisajournal.com/article/175231
2134,2018-05-08,삼성바이오로직스통지서내용유출투자자보호위한결정,http://www.seoulwire.com/news/articleView.html?idxno=14001
2135,2018-05-08,삼성바이오로직스논란에바이오주된서리,http://www.econovill.com/news/articleView.html?idxno=337426
2136,2018-05-08,금감원VS삼성바이오로직스2차신경전승부향방은,http://moneys.mt.co.kr/news/mwView.php?no=2018050817098031352
2137,2018-05-08,금감원삼성바이오로직스감리결과발표두고공방,http://www.fntimes.com/html/view.php?ud=201805081728002536f09e13944d_18
2138,2018-05-08,삼성바이오로직스vs금감원정보공개갈등고조,http://www.ytn.co.kr/_ln/0102_201805081732171646
2139,2018-05-08,삼성바이오로직스분식회계의혹이재용재판에미치는영향,http://news.kbs.co.kr/news/view.do?ncd=3646273&ref=A
2140,2018-05-08,특징주바이오주대거하락삼성바이오로직스는반등종합2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180508047552008&did=1195m
2141,2018-05-08,삼성바이오로직스가금감원을성토한진짜이유,http://www.kntimes.co.kr/news/articleView.html?idxno=25336
2142,2018-05-08,삼성바이오로직스주가어렵게반등셀트리온은급락,http://www.businesspost.co.kr/BP?command=article_view&num=81733
2143,2018-05-08,퇴근길경제삼성바이오로직스나흘만에반등주식시장전망은,http://news.donga.com/3/all/20180508/89982586/1
2144,2018-05-08,삼성바이오로직스금감원감리내용공개유감”,http://www.ajunews.com/view/20180508165355950
2145,2018-05-08,진퇴양난삼성바이오로직스김태한사장사퇴로이어지나,http://www.wolyo.co.kr/news/articleView.html?idxno=60440
2146,2018-05-08,시총8조원증발삼성바이오로직스징계여부불확실에주가도갈팡질팡,http://daily.hankooki.com/lpage/economy/201805/dh20180508183621138110.htm
2147,2018-05-08,국내바이오주고평가논란에줄줄이급락삼성바이오로직스는반등,http://www.insight.co.kr/news/154259
2148,2018-05-08,삼성바이오로직스어떻게3천억에서4조로뻥튀기됐나,http://www.nocutnews.co.kr/news/4966683
2149,2018-05-08,언론공개유감VS금감원투자자위한것삼성바이오로직스금감원충돌,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1182517
2150,2018-05-08,삼성바이오로직스정보공개유감”금감원투자자보호”,https://cnbc.sbs.co.kr/article_hub/10000901192?division=NAVER
2151,2018-05-08,마감삼성바이오로직스5일만에반등셀트리온신라젠등다른바이오주는급락,http://www.sporbiz.co.kr/news/articleView.html?idxno=229647
2152,2018-05-09,나흘만에삼성바이오로직스株반등,http://news.donga.com/3/all/20180508/89986187/1
2153,2018-05-09,삼성바이오로직스상장주역들승승장구투자자들마음부글부글,http://www.kukinews.com/news/article.html?no=546973
2154,2018-05-09,회계논란정면돌파나선삼성바이오로직스17일새국면맞이하나,http://www.asiatoday.co.kr/view.php?key=20180508010003571
2155,2018-05-09,기업분석삼성바이오로직스3공장모멘텀임박분식회계불확실성극복할까,http://www.g-enews.com/ko-kr/news/article/news_all/201805081727147150c642673384_1/article.html
2156,2018-05-09,전세계제약바이오시총20위권오른셀트리온삼성바이오로직스,http://www.medigatenews.com/news/3857388662
2157,2018-05-09,언론공개유감VS금감원투자자위한것삼성바이오로직스금감원충돌,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1182577
2158,2018-05-09,인베스트조선삼성바이오로직스직원들작년말3달간4000억원벌었다,http://www.investchosun.com/?p=3225806
2159,2018-05-09,강공택한삼성바이오로직스그속사정살펴보니,http://news.heraldcorp.com/view.php?ud=20180509000043
2160,2018-05-09,속보김동연부총리삼성바이오로직스분식회계논란은삼성이어서그렇다,http://www.ajunews.com/view/20180509080937178
2161,2018-05-09,모닝브리핑신한금융투자유가상승과삼성바이오로직스사태코스닥에악재됐다”,http://www.sedaily.com/NewsView/1RZGQEA13U
2162,2018-05-09,삼성바이오로직스시총급락지배구조개편깊은시름,http://www.datanews.co.kr/news/article.html?no=100643
2163,2018-05-09,특징주삼성바이오로직스이틀연속오름세금감원증거없어,http://www.sporbiz.co.kr/news/articleView.html?idxno=229740
2164,2018-05-09,삼성바이오로직스대심제요청금융위원회받아들일까,http://www.mdtoday.co.kr/mdtoday/index.html?no=320359
2165,2018-05-09,특징주삼성바이오로직스이틀연속반등중,http://news.mt.co.kr/mtview.php?no=2018050909174427499
2166,2018-05-09,특징주삼성바이오로직스이틀째상승장초반4↑,http://view.asiae.co.kr/news/view.htm?idxno=2018050909251690322
2167,2018-05-09,아주종목분석삼성바이오로직스장초반4대상승이틀연속강세,http://www.ajunews.com/view/20180509092209279
2168,2018-05-09,특징주삼성바이오로직스등바이오주장초반일제히강세,http://www.ekn.kr/news/article.html?no=360828
2169,2018-05-09,유삼성바이오로직스전일대비729상승일일회전율은079기록,http://www.sedaily.com/NewsView/1RZGR9UDGB
2170,2018-05-09,김동연삼성바이오로직스논란에시장혼란야기과정관리필요,http://www.newsis.com/view/?id=NISX20180509_0000303186&cID=10401&pID=10400
2171,2018-05-09,삼성바이오로직스분식회계대심제열린다,http://news.sbs.co.kr/news/endPage.do?news_id=N1004749300&plink=ORI&cooper=NAVER
2172,2018-05-09,분식회계논란삼성바이오로직스초강력대응에주가급등,http://www.sedaily.com/NewsView/1RZGQTQNFH
2173,2018-05-09,fnRASSI삼성바이오로직스207940전일대비999상승,http://www.fnnews.com/news/201805090941012932
2174,2018-05-09,김성준의시사전망대분식회계논란삼성바이오로직스거래정지불가피,http://news.sbs.co.kr/news/endPage.do?news_id=N1004748784&plink=ORI&cooper=NAVER
2175,2018-05-09,삼성바이오로직스바이오젠과52주총의결권계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=320358
2176,2018-05-09,삼성바이오로직스2거래일연속상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=320427
2177,2018-05-09,특징주삼성바이오로직스이틀연속강세,http://www.newstomato.com/ReadNews.aspx?no=822979
2178,2018-05-09,특징주삼성바이오로직스강경대응시사에연이틀반등,http://www.fnnews.com/news/201805090951519333
2179,2018-05-09,특징주삼성바이오로직스분식회계논란불구이틀째상승세,http://moneys.mt.co.kr/news/mwView.php?no=2018050909548094745
2180,2018-05-09,삼성바이오로직스개인투자자들소송걸까,http://www.mdtoday.co.kr/mdtoday/index.html?no=320355
2181,2018-05-09,김동연삼성바이오로직스논란에금융위증권선물위결정지켜봐달라,http://www.wsobi.com/news/articleView.html?idxno=60362
2182,2018-05-09,삼성바이오로직스분식회계논란감리위대심제예정,http://news.kbs.co.kr/news/view.do?ncd=3646631&ref=A
2183,2018-05-09,특징주삼성바이오로직스6대반등장중40만원선복구,http://www.etoday.co.kr/news/section/newsview.php?idxno=1621129
2184,2018-05-09,김동연삼성바이오로직스문제아쉽다최종결정지켜보자”,http://news.kmib.co.kr/article/view.asp?arcid=0012340319&code=61121111&cp=nv
2185,2018-05-09,특징주삼성바이오로직스외국인매수로이틀째상승세,http://www.newsprime.co.kr/news/article.html?no=415976
2186,2018-05-09,특징주삼성바이오로직스연일급등김부총리결과지켜보자,http://www.ebn.co.kr/news/view/940745
2187,2018-05-09,삼성바이오로직스분식회계對審制로진실가린다,http://view.asiae.co.kr/news/view.htm?idxno=2018050910421943677
2188,2018-05-09,김동연부총리삼성바이오로직스삼성이라논란균형있게지켜봐야”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1621195
2189,2018-05-09,삼성바이오로직스분식회계논란대심제열린다금감원삼성상호공방예상”,http://ilyo.co.kr/?ac=article_view&entry_id=296961
2190,2018-05-09,삼성바이오로직스회계부정논란본질은이재용승계문제,http://www.ftoday.co.kr/news/articleView.html?idxno=87666
2191,2018-05-09,분식회계의혹삼성바이오로직스공모가고평가논란,http://news.einfomax.co.kr/news/articleView.html?idxno=3447856
2192,2018-05-09,삼성바이오로직스회계처리논란주식시장파장은,https://cnbc.sbs.co.kr/article_hub/10000901276?division=NAVER
2193,2018-05-09,시장은금감원보다삼성바이오로직스에베팅17일감리위원회앞두고연이틀오름세,http://www.news2day.co.kr/103687
2194,2018-05-09,금감원삼성바이오로직스분식회계논란두고힘겨루기,http://www.koreaittimes.com/news/articleView.html?idxno=82840
2195,2018-05-09,심상정삼성바이오로직스회계기준변경은어떤근거도없는분식”,http://www.businesspost.co.kr/BP?command=article_view&num=81796
2196,2018-05-09,삼성바이오로직스민감한정보무분별하게노출됐다고입장표명,http://www.nbnnews.co.kr/news/articleView.html?idxno=141207
2197,2018-05-09,삼성바이오로직스주식투자자집단소송제기한다,http://www.newstomato.com/ReadNews.aspx?no=823051
2198,2018-05-09,삼성저격수박영선의원삼성바이오로직스상장의혹밝혀야,http://www.newsfreezone.co.kr/news/articleView.html?idxno=57280
2199,2018-05-09,분식회계논란삼성바이오로직스대심제적용,http://www.ebn.co.kr/news/view/940791
2200,2018-05-09,삼성바이오로직스대심제보다원하는건사전미팅금융당국언론플레이마라,http://www.sporbiz.co.kr/news/articleView.html?idxno=229907
2201,2018-05-09,삼성바이오로직스분식회계논란두번째대심제적용,http://sports.chosun.com/news/ntype.htm?id=201805100100079020005796&servicedate=20180509
2202,2018-05-09,이슈다시보기이재용삼성전자부회장과삼성바이오로직스분식회계의연결고리,http://www.polinews.co.kr/news/article.html?no=355082
2203,2018-05-09,삼성바이오로직스대심제적용대우조선해야이후두번째,http://www.mdtoday.co.kr/mdtoday/index.html?no=320482
2204,2018-05-09,삼성바이오로직스분식회계의혹진짜대심제로가려질까,http://www.intn.co.kr/news/articleView.html?idxno=2000130
2205,2018-05-09,김동연부총리삼성바이오로직스분식회계예단은,http://www.etnews.com/20180509000337
2206,2018-05-09,김동연삼성바이오로직스발표관련금감원관리좀더잘했으면좋았을것”이라고사실상질책,http://www.munhwa.com/news/view.html?no=20180509MW154836347676
2207,2018-05-09,코스피외국인순매수삼성전기삼성바이오로직스삼성SDI,http://www.newsway.co.kr/view.php?tp=1&ud=2018050915552184122
2208,2018-05-09,최종구삼성바이오로직스분식회계가핵심사전통지관련개선방안찾겠다,http://www.dailian.co.kr/news/view/712112/?sc=naver
2209,2018-05-09,최종구금감원삼성바이오로직스사전통지공개적법성검토,http://news.hankyung.com/article/2018050951576
2210,2018-05-09,최종구금융위원장삼성바이오로직스분식회계판단이핵심,http://biz.newdaily.co.kr/news/article.html?no=10160353
2211,2018-05-09,최종구삼성바이오로직스감리위대심제로운영,http://www.newspim.com/news/view/20180509000249
2212,2018-05-09,삼성바이오로직스분식회계대심제로심사한다,http://news.mt.co.kr/mtview.php?no=2018050915494093572
2213,2018-05-09,취재파일금융감독원vs삼성바이오로직스메가톤급파장예고,https://cnbc.sbs.co.kr/article_hub/10000901265?division=NAVER
2214,2018-05-09,외국인또투매셀트리온삼성바이오로직스는급등,http://www.choicenews.co.kr/news/articleView.html?idxno=41287
2215,2018-05-09,삼성바이오로직스분식회계공방대심제채택일반재판처럼진행,http://www.mediapen.com/news/view/353459
2216,2018-05-09,삼성바이오로직스분식회계논란대심제적용한다,http://www.cstimes.com/?mod=news&act=articleView&idxno=275346
2217,2018-05-09,최종구금감원의삼성바이오로직스조치시장혼란초래,http://www.kukinews.com/news/article.html?no=547317
2218,2018-05-09,삼성바이오로직스분식회계감리위에대심제적용,http://www.ajunews.com/view/20180509164214809
2219,2018-05-09,삼성바이오로직스금융당국회계논란속도전에지구전으로대응,http://www.businesspost.co.kr/BP?command=article_view&num=81836
2220,2018-05-09,시황코스피외국인팔자에5일연속약세셀트리온삼성바이오로직스는급등,http://daily.hankooki.com/lpage/economy/201805/dh20180509171921138110.htm
2221,2018-05-09,삼성바이오로직스소송준비하는개인투자자들,http://news.mt.co.kr/mtview.php?no=2018050917245662305
2222,2018-05-09,셀트리온실적앞세워주가급등삼성바이오로직스도반등이어가,http://www.businesspost.co.kr/BP?command=article_view&num=81867
2223,2018-05-09,삼성바이오로직스개인투자자들회사회계법인소송할듯,http://www.ebn.co.kr/news/view/940841
2224,2018-05-09,삼성바이오로직스분식회계논란최종구위원장의속내는,http://www.asiatime.co.kr/news/articleView.html?idxno=179085
2225,2018-05-09,스텝꼬인금감원삼성바이오로직스회계위반몰아가기,http://news1.kr/articles/?3312686
2226,2018-05-09,보도참고최종구금융위원장삼성바이오로직스와이해관계가있는인사는감리위증선위심의과정에서배제할것을지시,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156268763
2227,2018-05-09,최종구삼성바이오로직스조치사전통지공개적절성도검토”,http://www.businesspost.co.kr/BP?command=article_view&num=81877
2228,2018-05-09,최종구금융위원장삼성바이오로직스공정심의지시,http://www.kukinews.com/news/article.html?no=547452
2229,2018-05-09,최종구삼성바이오로직스이해관계자감리위증선위서배제,http://www.fntimes.com/html/view.php?ud=20180509205706906179ad43907_18
2230,2018-05-09,인천시장후보에게듣는다삼성바이오로직스분식회계논란후폭풍바이오산업미래방향은,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=750175
2231,2018-05-10,빅3줄줄이걸린삼성바이오로직스감사회계업계논란확대,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201805091502424290367
2232,2018-05-10,삼성바이오로직스계속된분식회계논란에도주가회복,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055677
2233,2018-05-10,뉴스줌인같은듯다른삼성바이오로직스와에버랜드의가치평가,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805090544&t=NN
2234,2018-05-10,삼성바이오로직스금감원과의날카로운신경전향후결과는,http://www.mdtoday.co.kr/mdtoday/index.html?no=320536
2235,2018-05-10,삼성바이오로직스논란코스닥에영향금융위금융산업정책제동,http://www.mdtoday.co.kr/mdtoday/index.html?no=320535
2236,2018-05-10,삼성바이오로직스시총전세계20위권탈락했다,http://news.heraldcorp.com/view.php?ud=20180510000102
2237,2018-05-10,특징주삼성바이오로직스금융당국과감리위서공방전예고외인러브콜에강세,http://www.g-enews.com/ko-kr/news/article/news_all/201805100909418909c16aa2f016_1/article.html
2238,2018-05-10,특징주삼성바이오로직스분식회계논란속사흘째강세,http://www.newstomato.com/ReadNews.aspx?no=823258
2239,2018-05-10,카드뉴스삼성바이오로직스논란분식회계란무엇인가,http://premium.mk.co.kr/view.php?no=22275
2240,2018-05-10,특징주삼성바이오로직스3일만에하락전환개인투자자소송준비,http://www.sporbiz.co.kr/news/articleView.html?idxno=230276
2241,2018-05-10,금감원삼성바이오로직스바이오젠에콜옵션먼저요청했다”,http://www.kukinews.com/news/article.html?no=547522
2242,2018-05-10,삼성바이오로직스분식회계대심제적용치열한공방예상,http://www.insight.co.kr/news/154415
2243,2018-05-10,뉴스더읽기삼성바이오로직스發바이오업계회계처리논란의모든것,http://www.etoday.co.kr/news/section/newsview.php?idxno=1621623
2244,2018-05-10,삼성바이오로직스등계열사악재에삼성그룹주펀드도휘청,http://www.ekn.kr/news/article.html?no=361092
2245,2018-05-10,삼성바이오로직스시총전세계20위권밖으로밀려나,http://www.nbnnews.co.kr/news/articleView.html?idxno=141818
2246,2018-05-10,삼성바이오로직스회계감리발표기폭제금감위금감원불협화음어디까지,http://www.iminju.net/news/articleView.html?idxno=35539
2247,2018-05-10,대심제로열리는삼성바이오로직스분식회계치열한공방예상,http://www.newsis.com/view/?id=NISX20180510_0000304578&cID=13001&pID=13000
2248,2018-05-10,삼성바이오로직스사전통지가시장혼란불러잇딴지적,http://www.koreaittimes.com/news/articleView.html?idxno=82866
2249,2018-05-10,코스닥흔드는제약바이오주삼성바이오로직스등약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=320613
2250,2018-05-10,삼성바이오로직스사태로금융위제도개선도마위에,http://www.naeil.com/news_view/?id_art=275250
2251,2018-05-10,국민연금삼성바이오로직스투자손떼나깊어지는고민,http://www.newsis.com/view/?id=NISX20180510_0000304990&cID=10401&pID=10400
2252,2018-05-10,집단소송나서는개미들삼성바이오로직스도,http://www.inews24.com/php/news_view.php?g_serial=1093899&g_menu=022300&rrf=nv
2253,2018-05-10,옵션만기일SK하이닉스삼성중공업껑충vs삼성바이오로직스하락,http://www.choicenews.co.kr/news/articleView.html?idxno=41322
2254,2018-05-10,삼성바이오로직스회계논란중심콜옵션행사조건은,http://www.edaily.co.kr/news/newspath.asp?newsid=04159046619207608
2255,2018-05-10,삼성바이오로직스사외이사로회계업계거물영입한배경논란,http://www.businesspost.co.kr/BP?command=article_view&num=81979
2256,2018-05-10,삼성바이오로직스등제약바이오대장주끝내약세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=320662
2257,2018-05-10,삼성바이오로직스주가정상화조짐대심제준비사활,http://www.ebn.co.kr/news/view/941016
2258,2018-05-10,금융inIT삼성바이오로직스분식회계논란의배경은,http://news.donga.com/3/all/20180510/90021503/1
2259,2018-05-10,악재에도버티는삼성바이오로직스,http://www.fnnews.com/news/201805101720018289
2260,2018-05-10,기자수첩금감원과삼성바이오로직스의분식회계논란설전을바라보며,http://www.ebn.co.kr/news/view/941018
2261,2018-05-10,셀트리온주가제자리삼성바이오로직스는회계논란에하락,http://www.businesspost.co.kr/BP?command=article_view&num=82016
2262,2018-05-10,삼성바이오로직스분식회계의혹뒤에숨은이재용,http://www.mhj21.com/sub_read.html?uid=113733§ion=sc243
2263,2018-05-10,금감원삼성바이오로직스분식회계입증할증거들고있나,http://www.businesspost.co.kr/BP?command=article_view&num=82011
2264,2018-05-11,김어준의블랙하우스이조명한삼성바이오로직스국민연금이투자손뗄수있어왜,http://www.topstarnews.net/news/articleView.html?idxno=409138
2265,2018-05-11,인베스트조선자금통로좁아진삼성바이오로직스삼성바이오에피스까지여파커졌다,http://www.investchosun.com/?p=3225927
2266,2018-05-11,삼성바이오로직스분식회계논란바이오젠이결론내리나,http://weekly.cnbnews.com/news/article.html?no=124574
2267,2018-05-11,특징주삼성바이오로직스이틀째하락세금감원증거확보했나,http://www.sporbiz.co.kr/news/articleView.html?idxno=230826
2268,2018-05-11,11일장초반한국증시후끈IT셀트리온상승vs삼성바이오로직스부진,http://www.choicenews.co.kr/news/articleView.html?idxno=41336
2269,2018-05-11,삼성바이오로직스분식회계의혹조직적공모가능성있다,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10279852
2270,2018-05-11,금감원공보국장4개월만에교체삼성바이오로직스관련문책인사아니다,http://www.sporbiz.co.kr/news/articleView.html?idxno=230878
2271,2018-05-11,고무줄같은삼성바이오로직스평가액을믿으라고,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002433229&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
2272,2018-05-11,삼성바이오로직스지수이틀째하락세금감원증거확보했을까,http://www.nbntv.co.kr/news/articleView.html?idxno=103520
2273,2018-05-11,거수기벗어난국민연금삼성바이오로직스배제하나,http://www.econovill.com/news/articleView.html?idxno=337671
2274,2018-05-11,삼성바이오로직스사태①삼성은왜삼성바이로직스회계기준을변경했을까,http://www.iminju.net/news/articleView.html?idxno=35569
2275,2018-05-11,삼성바이오로직스사태②삼성바이오에피스에적용한DCF회계기준놓고뒷말무성,http://www.iminju.net/news/articleView.html?idxno=35570
2276,2018-05-11,삼성바이오로직스사태③ 1년간특별감리나선금감원회계오류결론냈나,http://www.iminju.net/news/articleView.html?idxno=35571
2277,2018-05-11,삼성바이오로직스사태④완성단계치닫는삼성이재용후계구도뇌관될까,http://www.iminju.net/news/articleView.html?idxno=35572
2278,2018-05-11,외국인돌아왔다SK하이닉스셀트리온상승vs삼성바이오로직스부진,http://www.choicenews.co.kr/news/articleView.html?idxno=41357
2279,2018-05-11,셀트리온주가오르고삼성바이오로직스는내려,http://www.businesspost.co.kr/BP?command=article_view&num=82165
2280,2018-05-11,주간한국삼성바이오로직스금감원승부에걸린이재용운명,http://daily.hankooki.com/lpage/economy/201805/dh20180511215404138060.htm
2281,2018-05-11,박영선의원적자내던삼성바이오로직스상장위해규정변경한배경철저히밝혀야”,http://weeklytrade.co.kr/news/view.html?section=1&category=160&item=&no=40485
2282,2018-05-12,분식회계논란빠진삼성바이오로직스집단소송움직임,http://www.mdtoday.co.kr/mdtoday/index.html?no=320810
2283,2018-05-12,삼성바이오로직스美바이오젠에콜옵션요청한진짜속내는,http://www.mdtoday.co.kr/mdtoday/index.html?no=320807
2284,2018-05-12,삼성바이오로직스사태금감원이보유한스모킹건은,http://www.econovill.com/news/articleView.html?idxno=337728
2285,2018-05-13,17일삼성바이오로직스이슈바이오주변동성커질까금주변수는,http://www.choicenews.co.kr/news/articleView.html?idxno=41374
2286,2018-05-13,삼성바이오로직스분식회계감리위비밀서약서제출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051311135673119
2287,2018-05-13,삼성바이오로직스분식회계감리위원비밀서약서제출,http://www.sporbiz.co.kr/news/articleView.html?idxno=231670
2288,2018-05-14,금융위삼성바이오로직스와감리위증선위위원이해관계없어”,http://www.mdtoday.co.kr/mdtoday/index.html?no=320783
2289,2018-05-14,DataScore삼성바이오로직스흑자전환에고용383늘어,http://www.ceoscoredaily.com/news/article.html?no=40882
2290,2018-05-14,삼성그룹주공매도비중상승폭1위삼성바이오로직스,http://news.mk.co.kr/newsRead.php?year=2018&no=304243
2291,2018-05-14,삼성바이오로직스삼성계열사중공매도거래비중상승폭1위,http://www.viva100.com/main/view.php?key=20180514010004398
2292,2018-05-14,삼성바이오로직스삼성그룹주공매도비중상승폭1위,http://www.cstimes.com/?mod=news&act=articleView&idxno=275637
2293,2018-05-14,삼성그룹株공매도비중상승폭1위삼성바이오로직스,http://www.seoulfn.com/news/articleView.html?idxno=306192
2294,2018-05-14,삼성종합화학은웃돈없이넘기더니삼성바이오로직스회계처리논란,http://ilyo.co.kr/?ac=article_view&entry_id=297035
2295,2018-05-14,삼성바이오로직스공매도비중삼성그룹株중최대상승,http://www.m-i.kr/news/articleView.html?idxno=414445
2296,2018-05-14,ISSUEINSIDE혼란가중되는삼성바이오로직스분식회계결론나면주식거래정지가능,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=304629
2297,2018-05-14,삼성바이오로직스전일대비약5하락한367500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805140177&t=NN
2298,2018-05-14,삼성바이오로직스삼성그룹주공매도비중상승폭1위,http://www.mdtoday.co.kr/mdtoday/index.html?no=320862
2299,2018-05-14,삼성바이오로직스삼성그룹주중공매도거래비중상승폭1위,http://www.sporbiz.co.kr/news/articleView.html?idxno=231941
2300,2018-05-14,삼성바이오로직스52주공매도최대치금감원삼바분식회계부정적결과先반영됐나,http://www.sisafocus.co.kr/news/articleView.html?idxno=185608
2301,2018-05-14,삼성바이오로직스장외공방뜨거워,http://www.naeil.com/news_view/?id_art=275640
2302,2018-05-14,삼성바이오로직스분식회계혐의관련간담회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514109600013&did=1196m
2303,2018-05-14,삼성바이오로직스분식회계혐의관련간담회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514109300013&did=1196m
2304,2018-05-14,삼성바이오로직스분식회계혐의관련간담회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514109700013&did=1196m
2305,2018-05-14,삼성바이오로직스분식회계혐의관련간담회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514109500013&did=1196m
2306,2018-05-14,삼성바이오로직스분식회계혐의관련간담회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514109400013&did=1196m
2307,2018-05-14,삼성바이오로직스분식회계의혹의핵심은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514110000013&did=1196m
2308,2018-05-14,삼성바이오로직스분식회계의혹의핵심은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514109800013&did=1196m
2309,2018-05-14,삼성바이오로직스분식회계의혹의핵심은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514110100013&did=1196m
2310,2018-05-14,삼성바이오로직스분식회계의혹의핵심은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514110400013&did=1196m
2311,2018-05-14,삼성바이오로직스분식회계의혹의핵심은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180514110200013&did=1196m
2312,2018-05-14,포토참여연대삼성바이오로직스분식회계혐의관련기자간담회,http://www.dailian.co.kr/news/view/713118/?sc=naver
2313,2018-05-14,포토삼성바이오로직스분식회계혐의관련기자간담회가지는참여연대,http://www.dailian.co.kr/news/view/713119/?sc=naver
2314,2018-05-14,포토삼성바이오로직스분식회계관련기자간담회,http://www.dailian.co.kr/news/view/713122/?sc=naver
2315,2018-05-14,포토참여연대삼성바이오로직스분식회계의혹의핵심은,http://www.dailian.co.kr/news/view/713124/?sc=naver
2316,2018-05-14,포토삼성바이오로직스분식회계혐의관련기자간담회,http://www.dailian.co.kr/news/view/713127/?sc=naver
2317,2018-05-14,삼성그룹株공매도1위는삼성바이오로직스,http://www.newspim.com/news/view/20180514000206
2318,2018-05-14,참여연대삼성바이오로직스감리위명단이력공개돼야,http://view.asiae.co.kr/news/view.htm?idxno=2018051415191637256
2319,2018-05-14,참여연대회계법인삼성바이오로직스이례적고평가삼성합병도움”,http://news.kbs.co.kr/news/view.do?ncd=3649092&ref=A
2320,2018-05-14,삼성바이오로직스논란결국공매도세력만배불렸네,http://www.sporbiz.co.kr/news/articleView.html?idxno=232085
2321,2018-05-14,美훈풍에현대로템현대건설질주삼성바이오로직스또하락,http://www.choicenews.co.kr/news/articleView.html?idxno=41411
2322,2018-05-14,아주종목분석삼성바이오로직스4대하락,http://www.ajunews.com/view/20180514170351322
2323,2018-05-14,삼성바이오로직스감리위앞두고불공정게임지적,http://news.heraldcorp.com/view.php?ud=20180514000871
2324,2018-05-14,삼성바이오로직스분식회계혐의두고장외공방가열,https://cnbc.sbs.co.kr/article_hub/10000901787?division=NAVER
2325,2018-05-14,특징주주가급락삼성바이오로직스분식회계의혹전대비2448↓,http://www.kukinews.com/news/article.html?no=548795
2326,2018-05-14,삼성바이오로직스주가3거래일째하락셀트리온도약세,http://www.businesspost.co.kr/BP?command=article_view&num=82353
2327,2018-05-14,삼성바이오로직스감리위민간위원1명제척,http://www.fnnews.com/news/201805141859354196
2328,2018-05-14,삼성바이오로직스감리위민간위원1명제척,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180514166900008&did=1195m
2329,2018-05-14,참여연대회계법인삼성바이오로직스이례적고평가,http://imnews.imbc.com/news/2018/society/article/4607396_22673.html
2330,2018-05-14,삼성바이오로직스감리위민간위원1명제척,http://www.asiatoday.co.kr/view.php?key=20180514010007037
2331,2018-05-14,금융위삼성바이오로직스감리위서민간위원1명제척,http://www.newstomato.com/ReadNews.aspx?no=824129
2332,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,http://www.m-i.kr/news/articleView.html?idxno=414810
2333,2018-05-14,삼성바이오로직스감리위민간위원1명제척,http://news.kbs.co.kr/news/view.do?ncd=3649208&ref=A
2334,2018-05-14,삼성바이오로직스감리위민간위원1명제척,http://www.fntimes.com/html/view.php?ud=201805141917257503179ad43907_18
2335,2018-05-14,금융위삼성바이오로직스감리위민간위원1명배제,http://www.newsway.co.kr/view.php?tp=1&ud=2018051419242352634
2336,2018-05-14,금융위삼성바이오로직스감리위민간위원1명배제,http://biz.chosun.com/site/data/html_dir/2018/05/14/2018051402651.html
2337,2018-05-14,참여연대삼성바이오로직스분식회계심의할감리위원공개해야,http://www.businesspost.co.kr/BP?command=article_view&num=82371
2338,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,http://www.etnews.com/20180514000506
2339,2018-05-14,참여연대삼성바이오로직스감리위원전원명단이력공개가해법,http://www.mdtoday.co.kr/mdtoday/index.html?no=320937
2340,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,https://cnbc.sbs.co.kr/article_hub/10000901814?division=NAVER
2341,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,http://www.newsis.com/view/?id=NISX20180514_0000308320&cID=10401&pID=10400
2342,2018-05-14,금융위삼성바이오로직스감리위민간위원1명배제,http://www.etoday.co.kr/news/section/newsview.php?idxno=1622886
2343,2018-05-14,마켓인사이트금융위삼성바이오로직스감리위원1명제척,http://news.hankyung.com/article/201805142770u
2344,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,http://www.cstimes.com/?mod=news&act=articleView&idxno=275723
2345,2018-05-14,금융위삼성바이오로직스감리위민간위원1명배제,http://news.einfomax.co.kr/news/articleView.html?idxno=3448638
2346,2018-05-14,참여연대삼성바이오로직스고평가이재용부회장승계작업일환주장,http://view.asiae.co.kr/news/view.htm?idxno=2018051420181614524
2347,2018-05-14,금융위삼성바이오로직스감리위원회민간위원1명배제,http://www.ekn.kr/news/article.html?no=361988
2348,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,http://www.segyefn.com/newsView/20180514004891?OutUrl=naver
2349,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805142056001&code=920100
2350,2018-05-14,삼성바이오로직스감리위민간위원1명제외,http://news.kmib.co.kr/article/view.asp?arcid=0923949096&code=11151400&cp=nv
2351,2018-05-14,참여연대삼성바이오로직스회계논란맞불,http://news.heraldcorp.com/view.php?ud=20180514000919
2352,2018-05-14,참여연대합병도우려삼성바이오로직스이례적고평가,http://news.sbs.co.kr/news/endPage.do?news_id=N1004757500&plink=ORI&cooper=NAVER
2353,2018-05-14,금융위삼성바이오로직스심의에서민간감리위원1명배제,http://www.businesspost.co.kr/BP?command=article_view&num=82385
2354,2018-05-14,금융위삼성바이오로직스감리위민간위원1명배제,http://www.fnnews.com/news/201805142227289603
2355,2018-05-14,삼성바이오로직스감리위민간위원1명제척,http://www.sporbiz.co.kr/news/articleView.html?idxno=232224
2356,2018-05-14,금융위삼성바이오로직스감리위민간위원1명제척,http://www.enewstoday.co.kr/news/articleView.html?idxno=1189738
2357,2018-05-15,삼성바이오로직스논란최대쟁점콜옵션감리위서공방예고,http://www.newsis.com/view/?id=NISX20180514_0000307483&cID=10401&pID=10400
2358,2018-05-15,인베스트조선주요정보늑장공개삼성바이오로직스경영독립성갖춘상장사맞나,http://www.investchosun.com/?p=3226042
2359,2018-05-15,삼성바이오로직스감리위민간위원1명제척,http://www.ebn.co.kr/news/view/941422
2360,2018-05-15,삼성바이오로직스감리위민간위원1명제척,http://www.yonhapnewstv.co.kr/MYH20180515003200038/?did=1825m
2361,2018-05-15,금융위17일삼성바이오로직스감리위개최,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003203583
2362,2018-05-15,삼성바이오로직스감리위민간위원1명제척,http://imnews.imbc.com/news/2018/econo/article/4607564_22671.html
2363,2018-05-15,특징주삼성바이오로직스나흘만에반등,http://www.sporbiz.co.kr/news/articleView.html?idxno=232321
2364,2018-05-15,美바이오훈풍15일장초반셀트리온삼성바이오로직스껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=41427
2365,2018-05-15,삼성바이오로직스후폭풍에바이오휘청바이오주하락거품붕괴일까성장통일까,http://news.mk.co.kr/newsRead.php?year=2018&no=307324
2366,2018-05-15,시장보호냐신뢰회복이냐삼성바이오로직스감리위정보공개될까,http://view.asiae.co.kr/news/view.htm?idxno=2018051510510098616
2367,2018-05-15,삼성바이오로직스관련발언하는박용진,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515069700013&did=1196m
2368,2018-05-15,삼성바이오로직스관련발언하는박용진,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515069800013&did=1196m
2369,2018-05-15,삼성바이오로직스분식회계국정조사청문회필요,http://www.newsprime.co.kr/news/article.html?no=416611
2370,2018-05-15,분식회계판단근거공개하라삼성바이오로직스금감원에공문발송,http://www.sedaily.com/NewsView/1RZJIG2DW7
2371,2018-05-15,삼성바이오로직스국정조사필요하다,http://news1.kr/photos/view/?3111051
2372,2018-05-15,삼성바이오로직스국정조사필요,http://news1.kr/photos/view/?3111047
2373,2018-05-15,삼성바이오로직스분식회계건처리하라,http://news1.kr/photos/view/?3111044
2374,2018-05-15,삼성바이오로직스관련발언하는박용진,http://www.newsis.com/view/?id=NISI20180515_0014081580
2375,2018-05-15,삼성바이오로직스관련발언하는박용진,http://www.newsis.com/view/?id=NISI20180515_0014081578
2376,2018-05-15,박용진삼성바이오로직스분식회계논점은회사의고의성여부”주장,http://www.nspna.com/news/?mode=view&newsid=284030
2377,2018-05-15,삼성바이오로직스국정조사필요,http://www.fntoday.co.kr/news/articleView.html?idxno=162148
2378,2018-05-15,삼성바이오로직스금감원에회계처리위반근거알려달라”,http://news.kmib.co.kr/article/view.asp?arcid=0012355941&code=61141111&cp=nv
2379,2018-05-15,특징주삼성바이오로직스분식회계지적적극대응나흘만에반등,http://moneys.mt.co.kr/news/mwView.php?no=2018051513248097895
2380,2018-05-15,삼성바이오로직스분식회계신속공정하게처리,http://medipana.com/news/news_viewer.asp?NewsNum=220055&MainKind=A&NewsKind=5&vCount=12&vKind=1
2381,2018-05-15,삼성바이오로직스회계위반근거밝혀라금감원에공문발송,http://news1.kr/articles/?3317704
2382,2018-05-15,삼성바이오로직스금감원에회계처리규정위반근거요구,http://www.sporbiz.co.kr/news/articleView.html?idxno=232518
2383,2018-05-15,금융위삼성바이오로직스감리위공정약속,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515136500013&did=1196m
2384,2018-05-15,삼성바이오로직스금감원회계위반근거대라,http://news.mt.co.kr/mtview.php?no=2018051514152668512
2385,2018-05-15,금융위김용범부위원장삼성바이오로직스공정하게처리,http://www.newsis.com/view/?id=NISI20180515_0014082058
2386,2018-05-15,김용범부위원장삼성바이오로직스공정하게처리,http://www.newsis.com/view/?id=NISI20180515_0014082059
2387,2018-05-15,금융위부위원장삼성바이오로직스공정하게처리,http://www.newsis.com/view/?id=NISI20180515_0014082057
2388,2018-05-15,김용범부위원장삼성바이오로직스심의투명공정하게,http://news1.kr/photos/view/?3111536
2389,2018-05-15,김용범부위원장삼성바이오로직스심의투명공정하게,http://news1.kr/photos/view/?3111535
2390,2018-05-15,김용범삼성바이오로직스관련전사안검토감리위속기록남길것,http://www.dailian.co.kr/news/view/713385/?sc=naver
2391,2018-05-15,김용범삼성바이오로직스분식회계심의공정하게,http://news1.kr/photos/view/?3111558
2392,2018-05-15,김용범부위원장삼성바이오로직스관련브리핑,http://news1.kr/photos/view/?3111559
2393,2018-05-15,금융위삼성바이오로직스회계감리위속기록남기겠다,http://www.etnews.com/20180515000258
2394,2018-05-15,김용범부위원장삼성바이오로직스관련브리핑,http://news1.kr/photos/view/?3111555
2395,2018-05-15,김용범삼성바이오로직스심의투명공정하게,http://news1.kr/photos/view/?3111554
2396,2018-05-15,김용범삼성바이오로직스심의투명공정하게,http://news1.kr/photos/view/?3111556
2397,2018-05-15,삼성바이오로직스브리핑마친김용범,http://news1.kr/photos/view/?3111576
2398,2018-05-15,삼성바이오로직스회계위반근거알려달라금감원에공문발송,http://www.asiatoday.co.kr/view.php?key=20180515010007560
2399,2018-05-15,삼성바이오로직스조치결정브리핑,http://www.newsis.com/view/?id=NISI20180515_0014082118
2400,2018-05-15,금융위삼성바이오로직스공정하게처리,http://www.newsis.com/view/?id=NISI20180515_0014082121
2401,2018-05-15,금융위삼성바이오로직스공정하게처리할것,http://www.newsis.com/view/?id=NISI20180515_0014082120
2402,2018-05-15,금융위삼성바이오로직스공정하게처리할것,http://www.newsis.com/view/?id=NISI20180515_0014082119
2403,2018-05-15,삼성바이오로직스공정하게처리할것,http://www.newsis.com/view/?id=NISI20180515_0014082115
2404,2018-05-15,삼성바이오로직스조치결정브리핑,http://www.newsis.com/view/?id=NISI20180515_0014082117
2405,2018-05-15,금융위삼성바이오로직스공정하게처리할것,http://www.newsis.com/view/?id=NISI20180515_0014082116
2406,2018-05-15,김용범금융위부위원장삼성바이오로직스전과정속기록으로남길것,http://www.asiatoday.co.kr/view.php?key=20180515010007588
2407,2018-05-15,삼성바이오로직스관련속기록작성키로,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515149600013&did=1196m
2408,2018-05-15,삼성바이오로직스관련속기록작성키로,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515149700013&did=1196m
2409,2018-05-15,김용범삼성바이오로직스감리위투명공정한절차속기록작성,http://www.asiatime.co.kr/news/articleView.html?idxno=179761
2410,2018-05-15,삼성바이오로직스관련속기록작성키로,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515149500013&did=1196m
2411,2018-05-15,금융위삼성바이오로직스처리공정약속,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515151800013&did=1196m
2412,2018-05-15,금융위삼성바이오로직스처리공정약속,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515152000013&did=1196m
2413,2018-05-15,금융위삼성바이오로직스처리공정약속,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515151900013&did=1196m
2414,2018-05-15,삼성바이오로직스관련속기록작성키로,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180515152200013&did=1196m
2415,2018-05-15,삼성바이오로직스금감원회계처리규정위반근거밝혀야”,http://www.fntimes.com/html/view.php?ud=201805151456113494f09e13944d_18
2416,2018-05-15,금융위삼성바이오로직스감리위모든내용속기록남길것,http://www.fntimes.com/html/view.php?ud=201805151439498050179ad43907_18
2417,2018-05-15,금융위삼성바이오로직스감리위명단공개불가대신속기록남길것,http://moneys.mt.co.kr/news/mwView.php?no=2018051514368056847
2418,2018-05-15,삼성바이오로직스삼성바이오에피스이중잣대논란법따로회계따로,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805150366&t=NN
2419,2018-05-15,삼성바이오로직스금감원분식회계판단근거공개하라,http://www.newspim.com/news/view/20180515000269
2420,2018-05-15,분식회계근거공개하라삼성바이오로직스자신감에주가반등,http://www.seoulwire.com/news/articleView.html?idxno=14339
2421,2018-05-15,삼성바이오로직스회계규정위반근거공개요구분식회계논란정면승부,http://www.fnnews.com/news/201805151509271543
2422,2018-05-15,특징주삼성바이오로직스4거래일만에상승마감543↑,http://www.econonews.co.kr/news/articleView.html?idxno=25102
2423,2018-05-15,김용범삼성바이오로직스국민신뢰얻으려면절차적정당성확보필요”,http://www.kukinews.com/news/article.html?no=549082
2424,2018-05-15,김태한금감원은삼성바이오로직스분식회계판단근거공개해야,http://www.businesspost.co.kr/BP?command=article_view&num=82441
2425,2018-05-15,분식회계논란삼성바이오로직스4거래일만에간신히반등,http://www.mdtoday.co.kr/mdtoday/index.html?no=321051
2426,2018-05-15,삼성바이오로직스감리앞두고신경전치열,http://news.bizwatch.co.kr/article/market/2018/05/15/0020/naver
2427,2018-05-15,금융위삼성바이오로직스감리위공정진행할것,http://www.ktv.go.kr/content/view?content_id=553897
2428,2018-05-15,더벨금융위삼성바이오로직스분식회계감리위결과비공개,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805150100024060001478
2429,2018-05-15,김용범부위원장삼성바이오로직스투명공정진행,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180515155414
2430,2018-05-15,금융위삼성바이오로직스감리위속기록남긴다”,http://www.cstimes.com/?mod=news&act=articleView&idxno=275808
2431,2018-05-15,외국인투매IT하락vs셀트리온삼성바이오로직스5대급등,http://www.choicenews.co.kr/news/articleView.html?idxno=41450
2432,2018-05-15,공시삼성바이오로직스1Q영업익100억원전년동기比19336증가,http://www.newsway.co.kr/view.php?tp=1&ud=2018051516393876453
2433,2018-05-15,김태한삼성바이오로직스대표금감원회계처리규정위반근거알려달라,http://www.inews24.com/php/news_view.php?g_serial=1094782&g_menu=022600&rrf=nv
2434,2018-05-15,실적속보삼성바이오로직스1Q영업이익99억전년비193↑,http://www.itooza.com/common/iview.php?no=2018051516452797333
2435,2018-05-15,삼성바이오로직스금감원의분식회계결정적증거탐색치열,http://www.businesspost.co.kr/BP?command=article_view&num=82467
2436,2018-05-15,보도참고삼성바이오로직스조치결정의공정성확보관련,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156269665
2437,2018-05-15,삼성바이오로직스금감원회계규정위반근거밝혀라”,http://www.ajunews.com/view/20180515163439030
2438,2018-05-15,금융위삼성바이오로직스감리위명단비공개,http://www.kbanker.co.kr/news/articleView.html?idxno=73157
2439,2018-05-15,금융위부담됐나삼성바이오로직스감리위원회명단내용공개안해,http://www.news2day.co.kr/104027
2440,2018-05-15,금융위삼성바이오로직스감리위속기록작성혈투예고,https://cnbc.sbs.co.kr/article_hub/10000901933?division=NAVER
2441,2018-05-15,셀트리온삼성바이오로직스주가동반급등시총순위도올라,http://www.businesspost.co.kr/BP?command=article_view&num=82493
2442,2018-05-15,참여연대삼성바이오로직스사태경영승계위한큰그림,http://news.sbs.co.kr/news/endPage.do?news_id=N1004758985&plink=ORI&cooper=NAVER
2443,2018-05-15,금융위삼성바이오로직스감리위속기록남기겠다,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1475720
2444,2018-05-15,참여연대삼성바이오로직스가치3개월만에3배차이문제제기,http://www.mdtoday.co.kr/mdtoday/index.html?no=321080
2445,2018-05-15,박용진삼성바이오로직스분식회계의혹해소안되면청문회해야”,http://www.businesspost.co.kr/BP?command=article_view&num=82496
2446,2018-05-15,김용범감리위의삼성바이오로직스회의내용속기록작성”,http://www.businesspost.co.kr/BP?command=article_view&num=82497
2447,2018-05-16,딜로이트삼성바이오로직스바이오주RD비회계처리논란끝낸다,http://www.sporbiz.co.kr/news/articleView.html?idxno=232689
2448,2018-05-16,삼성바이오로직스감리위임박바이오에피스콜옵션뜨거운감자,http://www.g-enews.com/ko-kr/news/article/news_all/201805151302192630c16aa2f016_1/article.html
2449,2018-05-16,삼성바이오로직스회계위반근거밝혀라금감원에요청,http://www.edaily.co.kr/news/newspath.asp?newsid=01987686619209576
2450,2018-05-16,삼성바이오로직스논란스모킹건은무엇결정적증거,http://www.topstarnews.net/news/articleView.html?idxno=412111
2451,2018-05-16,전일외국인거래소에서엔씨소프트552삼성바이오로직스543등순매수,http://news.hankyung.com/article/201805168056L
2452,2018-05-16,전일기관거래소에서셀트리온51삼성바이오로직스543등순매수,http://news.hankyung.com/article/201805168055L
2453,2018-05-16,특징주삼성바이오로직스감리위원회임박외인사자에주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201805160911005129c642673384_1/article.html
2454,2018-05-16,삼성바이오로직스내일첫감리위앞두고소폭오름세,http://www.sedaily.com/NewsView/1RZJZEH6EP
2455,2018-05-16,특징주삼성바이오로직스감리위하루앞두고장초반1↑,http://view.asiae.co.kr/news/view.htm?idxno=2018051609243782082
2456,2018-05-16,삼성바이오로직스감리위내일첫회의첨예한대립치열한공방에쏠리는눈,http://news.heraldcorp.com/view.php?ud=20180516000175
2457,2018-05-16,특징주삼성바이오로직스내일감리위앞두고이틀째강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=232932
2458,2018-05-16,특징주삼성바이오로직스감리위앞두고오름세,http://www.newsprime.co.kr/news/article.html?no=416683
2459,2018-05-16,이데일리N금융위삼성바이오로직스감리위속기록남길것外,http://www.edaily.co.kr/news/newspath.asp?newsid=02624006619209576
2460,2018-05-16,매일장보는남녀삼성바이오로직스207940,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003204976
2461,2018-05-16,혼돈에싸인삼성바이오로직스,http://weekly.khan.co.kr/khnm.html?mode=view&code=114&artid=201805141354141&pt=nv
2462,2018-05-16,삼성바이오로직스감리위내일첫회의분식회계심의,http://www.newsway.co.kr/view.php?tp=1&ud=2018051610082571915
2463,2018-05-16,특징주삼성바이오로직스감리위앞두고2대강세,http://www.seoulfn.com/news/articleView.html?idxno=306448
2464,2018-05-16,삼성바이오로직스감리위원회앞두고소폭상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321168
2465,2018-05-16,삼성바이오로직스분식회계논란내일첫감리위열린다,http://www.medigatenews.com/news/855714729
2466,2018-05-16,삼성바이오로직스17일감리위에김태한사장출석성실히조사임할것,http://www.newsis.com/view/?id=NISX20180516_0000309959&cID=13001&pID=13000
2467,2018-05-16,삼성바이오로직스김태한사장감리위직접출석해소명,http://www.edaily.co.kr/news/newspath.asp?newsid=03112726619209576
2468,2018-05-16,김태한삼성바이오로직스대표17일감리위출석,http://news.mt.co.kr/mtview.php?no=2018051610480518461
2469,2018-05-16,삼성바이오로직스17일감리위서분식회계혐의소명,http://www.wolyo.co.kr/news/articleView.html?idxno=61021
2470,2018-05-16,김태한삼성바이오로직스사장17일감리위출석소명다할것”,http://www.newsway.co.kr/view.php?tp=1&ud=2018051611002485173
2471,2018-05-16,삼성바이오로직스17일감리위에김태환사장출석성실히조사임할것,http://www.ezyeconomy.com/news/articleView.html?idxno=83218
2472,2018-05-16,삼성바이오로직스김태한사장17일감리위출석,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805160284&t=NN
2473,2018-05-16,삼성바이오로직스17일감리위서분식회계의혹풀겠다”,http://biz.chosun.com/site/data/html_dir/2018/05/16/2018051601267.html
2474,2018-05-16,삼성바이오로직스감리위서소명다할것김태한사장출석,http://www.newspim.com/news/view/20180516000163
2475,2018-05-16,김태한삼성바이오로직스대표17일감리위출석성실히조사임할것,http://www.etoday.co.kr/news/section/newsview.php?idxno=1623578
2476,2018-05-16,삼성바이오로직스감리위직접출석해소명할것,http://www.mediapen.com/news/view/355060
2477,2018-05-16,삼성바이오로직스김태한사장17일감리위출석,http://www.ebn.co.kr/news/view/941695
2478,2018-05-16,삼성바이오로직스회계논란감리위서소명해명예회복,http://news1.kr/articles/?3318830
2479,2018-05-16,김태한삼성바이오로직스대표17일감리위출석성실히조사임할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051611330422428
2480,2018-05-16,삼성바이오로직스감리위내일첫회의치열한공방에쏠린눈,http://news.heraldcorp.com/view.php?ud=20180516000386
2481,2018-05-16,김태한삼성바이오로직스사장17일감리위원회서입장소명할것,http://www.asiatoday.co.kr/view.php?key=20180516010008192
2482,2018-05-16,삼성바이오로직스오는17일감리위김태한대표등임원총출동,http://www.mdtoday.co.kr/mdtoday/index.html?no=321178
2483,2018-05-16,김태한삼성바이오로직스대표17일감리위출석회계위반사항소명,http://www.inews24.com/php/news_view.php?g_serial=1094966&g_menu=022620&rrf=nv
2484,2018-05-16,삼성바이오로직스17일감리위에김태한사장출석,http://www.dailian.co.kr/news/view/713620/?sc=naver
2485,2018-05-16,삼성바이오로직스감리위서입장소명명예회복할것,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180516115147
2486,2018-05-16,삼성바이오로직스김태한사장감리위참석해소명상보,http://www.edaily.co.kr/news/newspath.asp?newsid=04027846619209576
2487,2018-05-16,삼바삼성바이오로직스분식회계논란사활건접전예고,http://www.naeil.com/news_view/?id_art=275957
2488,2018-05-16,심상정삼성바이오로직스심의끝까지눈부릅뜨고지켜보겠다,http://www.goodmorningcc.com/news/articleView.html?idxno=89487
2489,2018-05-16,삼성바이오로직스분식회계심의앞두고심상정삼성언론플레이하지마라,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002434782&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
2490,2018-05-16,특징주북한몽니에대북관련주우수수파미셀과셀트리온삼성바이오로직스등은올라,http://www.news2day.co.kr/104091
2491,2018-05-16,삼성바이오로직스감리위출석명예회복에최선”,http://www.dt.co.kr/contents.html?article_no=2018051602109976029004&ref=naver
2492,2018-05-16,심상정삼성바이오로직스분식회계감리금융위공정원칙대응하라,http://www.sisafocus.co.kr/news/articleView.html?idxno=185759
2493,2018-05-16,삼성바이오로직스17일감리위출석회사입장소명,http://www.enewstoday.co.kr/news/articleView.html?idxno=1190452
2494,2018-05-16,삼성바이오로직스김태한대표포함핵심임원17일감리위심의출석,http://daily.hankooki.com/lpage/economy/201805/dh20180516142742138060.htm
2495,2018-05-16,분식회계의혹삼성바이오로직스내일첫감리위앞뒀다,http://www.nbnnews.co.kr/news/articleView.html?idxno=142915
2496,2018-05-16,삼성바이오로직스17일감리위핵심임원총출동,http://www.ciobiz.co.kr/news/article.html?id=20180516120024
2497,2018-05-16,삼성바이오로직스감리위에김태한대표이사등핵심임원총출동,http://www.fnnews.com/news/201805161325585683
2498,2018-05-16,삼성바이오로직스17일감리위스모킹건이관건,http://www.metroseoul.co.kr/news/newsview?newscd=2018051600127
2499,2018-05-16,삼성바이오로직스김태한사장17일감리회출석,http://www.metroseoul.co.kr/news/newsview?newscd=2018051600132
2500,2018-05-16,이데일리N삼성바이오로직스내일감리위에김태한대표출석外,http://www.edaily.co.kr/news/newspath.asp?newsid=04828166619209576
2501,2018-05-16,김태한삼성바이오로직스대표17일감리위참석,http://www.fnnews.com/news/201805161455417743
2502,2018-05-16,감리위하루앞두고삼성바이오로직스급등40만원선회복,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051615583724117
2503,2018-05-16,최종구삼성바이오로직스조치사전통지공개는금융위책임질일”,http://www.businesspost.co.kr/BP?command=article_view&num=82616
2504,2018-05-16,北이슈현대로템현대건설추락vs삼성바이오로직스껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=41484
2505,2018-05-16,삼성바이오로직스9거래일만에40만원대복귀,http://www.mdtoday.co.kr/mdtoday/index.html?no=321208
2506,2018-05-16,김태한삼성바이오로직스대표감리위원회참석한다,http://www.fnnews.com/news/201805161701194788
2507,2018-05-16,삼성바이오로직스17일감리위서입장소명,http://www.kpinews.co.kr/news/articleView.html?idxno=73922
2508,2018-05-16,최종구금융위원장삼성바이오로직스내용공개는내책임,http://www.fnnews.com/news/201805161709036217
2509,2018-05-16,삼성바이오로직스오늘감리위①에피스관계사전환고의성이관건국제회계기준따른듯,http://www.sedaily.com/NewsView/1RZK089K9A
2510,2018-05-16,삼성바이오로직스김태한사장17일감리회출석,http://www.sporbiz.co.kr/news/articleView.html?idxno=233247
2511,2018-05-16,삼성바이오로직스내일첫감리위자회사기업가치쟁점,http://www.inews24.com/php/news_view.php?g_serial=1095069&g_menu=022620&rrf=nv
2512,2018-05-16,최종구삼성바이오로직스감리위원자격론에결과에영향줄의도언급,http://news.sbs.co.kr/news/endPage.do?news_id=N1004761090&plink=ORI&cooper=NAVER
2513,2018-05-16,아주종목분석감리위앞둔삼성바이오로직스6대반등,http://www.ajunews.com/view/20180516172408830
2514,2018-05-16,감리위앞둔삼성바이오로직스모든사안적법하게처리밝혀,http://www.dailian.co.kr/news/view/713762/?sc=naver
2515,2018-05-16,삼성바이오로직스감리위하루앞두고급등40만원선복귀,http://daily.hankooki.com/lpage/economy/201805/dh20180516175730138110.htm
2516,2018-05-16,마켓인사이트삼성바이오로직스분식회계논란에신용도휘청,http://news.hankyung.com/article/201805160708u
2517,2018-05-16,오늘Who삼성바이오로직스논란에최종구무기는공정성뿐,http://www.businesspost.co.kr/BP?command=article_view&num=82633
2518,2018-05-16,삼성바이오로직스감리위에임원진총출동해소명,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1476275
2519,2018-05-16,삼성바이오로직스주가이틀째급등셀트리온도소폭상승,http://www.businesspost.co.kr/BP?command=article_view&num=82675
2520,2018-05-16,김태한삼성바이오로직스분식회계논란다룰감리위에직접출석,http://www.businesspost.co.kr/BP?command=article_view&num=82678
2521,2018-05-16,삼성바이오로직스감리위원명단공개공정성믿을수있나,http://www.sporbiz.co.kr/news/articleView.html?idxno=233344
2522,2018-05-16,삼성바이오로직스회계처리위반해명오늘금감원에출석,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=751223
2523,2018-05-17,삼성바이오로직스감리위원회오늘첫회의,http://www.ytn.co.kr/_ln/0102_201805170003183394
2524,2018-05-17,주간한국삼성바이오로직스감리위미리보는정곡과맹점,http://daily.hankooki.com/lpage/economy/201805/dh20180517012508138060.htm
2525,2018-05-17,송도삼성바이오로직스VIP견학코스로,http://news.donga.com/3/all/20180516/90115583/1
2526,2018-05-17,삼성바이오로직스회계논란감리위쟁점은,http://www.edaily.co.kr/news/newspath.asp?newsid=01167686619209904
2527,2018-05-17,삼성바이오로직스운명의날분식회계의혹해명총력,http://www.newsis.com/view/?id=NISX20180516_0000310486&cID=13001&pID=13000
2528,2018-05-17,삼성바이오로직스분식회계여부오늘첫심의,http://imnews.imbc.com/replay/2018/nwtoday/article/4608484_22669.html
2529,2018-05-17,삼성바이오로직스감리위DDay관전포인트는,http://www.ekn.kr/news/article.html?no=362404
2530,2018-05-17,삼성바이오로직스결전의날감리위쟁점은,http://www.newsis.com/view/?id=NISX20180516_0000310632&cID=10401&pID=10400
2531,2018-05-17,삼성바이오로직스오늘감리위개최분식회계여부심의,http://www.cstimes.com/?mod=news&act=articleView&idxno=275948
2532,2018-05-17,특징주삼성바이오로직스감리위앞두고약세,http://news.mt.co.kr/mtview.php?no=2018051709022189919
2533,2018-05-17,특징주운명의날삼성바이오로직스하락,http://www.inews24.com/php/news_view.php?g_serial=1095173&g_menu=022300&rrf=nv
2534,2018-05-17,삼성바이오로직스첫감리위앞두고약세,http://www.sedaily.com/NewsView/1RZKEXIR9V
2535,2018-05-17,특징주삼성바이오로직스감리위앞두고약세,http://www.newstomato.com/ReadNews.aspx?no=824673
2536,2018-05-17,특징주삼성바이오로직스감리위앞두고약세,http://www.newsis.com/view/?id=NISX20180517_0000311044&cID=10401&pID=10400
2537,2018-05-17,특징주삼성바이오로직스감리위DDay주가는약세,http://www.ekn.kr/news/article.html?no=362485
2538,2018-05-17,특징주삼성바이오로직스첫감리위하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=233469
2539,2018-05-17,특징주삼성바이오로직스첫감리위앞두고하락,http://news.hankyung.com/article/2018051731286
2540,2018-05-17,특징주삼성바이오로직스감리위심의착수에약세,http://www.viva100.com/main/view.php?key=20180517010005839
2541,2018-05-17,오늘의경제일정금융위삼성바이오로직스분식회계감리위개최,http://www.asiatime.co.kr/news/articleView.html?idxno=180044
2542,2018-05-17,삼성바이오로직스감리위원회첫회의치열한논쟁예상,http://www.viva100.com/main/view.php?key=20180517010005838
2543,2018-05-17,특징주삼성바이오로직스감리위앞두고약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1623957
2544,2018-05-17,특징주삼성바이오로직스감리위앞두고하락세,http://www.newsprime.co.kr/news/article.html?no=416848
2545,2018-05-17,삼성바이오로직스감리위앞두고장초반하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321285
2546,2018-05-17,HotLine삼성바이오로직스감리위앞두고약세,http://news.mk.co.kr/newsRead.php?year=2018&no=313093
2547,2018-05-17,특징주삼성바이오로직스감리위첫회의앞두고약세,http://www.fnnews.com/news/201805170925495430
2548,2018-05-17,특징주삼성바이오로직스3거래일만에약세첫감리위영향,http://moneys.mt.co.kr/news/mwView.php?no=2018051709288065293
2549,2018-05-17,금융위삼성바이오로직스감리위원회오늘오후첫회의,http://www.kukinews.com/news/article.html?no=549566
2550,2018-05-17,삼성바이오로직스결전의날첫감리위어떻게진행되나,http://news.einfomax.co.kr/news/articleView.html?idxno=3449229
2551,2018-05-17,특징주삼성바이오로직스감리위첫회의앞두고약세,http://www.ebn.co.kr/news/view/941820
2552,2018-05-17,특징주삼성바이오로직스감리위앞두고약세,http://www.fntimes.com/html/view.php?ud=201805170940278031f09e13944d_18
2553,2018-05-17,특징주감리위앞둔삼성바이오로직스하락세,http://www.polinews.co.kr/news/article.html?no=355872
2554,2018-05-17,삼성바이오로직스감리위DDAY철저히비공개,http://www.inews24.com/php/news_view.php?g_serial=1095205&g_menu=022300&rrf=nv
2555,2018-05-17,삼성바이오로직스감리위첫회의자회사가치부풀렸나,http://www.newsworks.co.kr/news/articleView.html?idxno=187373
2556,2018-05-17,삼성바이오로직스감리위첫날핵심임원총출동치열한공방전망,http://www.sisaweek.com/news/articleView.html?idxno=108158
2557,2018-05-17,분식회계의혹삼성바이오로직스첫감리위철저한비공개진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=321297
2558,2018-05-17,삼성바이오로직스감리위D데이논의내용비공개,http://www.fntimes.com/html/view.php?ud=201805171008141473179ad43907_18
2559,2018-05-17,회계의혹삼성바이오로직스오늘금융위감리위출석,http://www.sisajournal-e.com/biz/article/184067
2560,2018-05-17,브리핑최석대변인강남역여성살인사건2주기금융위삼성바이오로직스분식회계감리위개최관련,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=426&aid=0000006341
2561,2018-05-17,삼성바이오로직스감리위오늘첫회의분식회계여부심의,http://moneys.mt.co.kr/news/mwView.php?no=2018051710398040731
2562,2018-05-17,특징주삼성바이오로직스운명의날감리위첫회의앞두고약세,http://biz.chosun.com/site/data/html_dir/2018/05/17/2018051700988.html
2563,2018-05-17,금융위삼성바이오로직스감리위위원1명제척,http://www.mdtoday.co.kr/mdtoday/index.html?no=321209
2564,2018-05-17,삼성바이오로직스오후2시에금감원과분식회계쟁점담판,http://www.econovill.com/news/articleView.html?idxno=338075
2565,2018-05-17,삼성바이오로직스금감원벼랑끝대결시작금감원의스모킹건은,http://www.news2day.co.kr/104141
2566,2018-05-17,삼성바이오로직스감리Dday제약바이오주휘청,http://medipana.com/news/news_viewer.asp?NewsNum=220173&MainKind=A&NewsKind=5&vCount=12&vKind=1
2567,2018-05-17,삼성바이오로직스즉각적인입장표명있을까,http://www.ebn.co.kr/news/view/941841
2568,2018-05-17,열린시장이슈IN삼성바이오로직스회계논란첫감리위,http://www.newstomato.com/ReadNews.aspx?no=824692
2569,2018-05-17,삼성바이오로직스분식회계첫감리위개최,http://www.dailymedi.com/detail.php?number=830644&thread=22r05
2570,2018-05-17,삼성바이오로직스감리위콜옵션둘러싼공방,http://www.naeil.com/news_view/?id_art=276069
2571,2018-05-17,분식회계논란삼성바이오로직스결론은,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055988
2572,2018-05-17,투데이뉴스콕삼성바이오로직스감리위원회오늘첫회의,http://www.newstomato.com/ReadNews.aspx?no=824703
2573,2018-05-17,삼성바이오로직스금감원결전지로의혹밝혀질까,http://www.fntimes.com/html/view.php?ud=201805171333214496f09e13944d_18
2574,2018-05-17,특징주삼성바이오로직스감리위코앞2대하락세,http://view.asiae.co.kr/news/view.htm?idxno=2018051713413191982
2575,2018-05-17,삼성바이오로직스심의감리위첫회의시작,http://imnews.imbc.com/news/2018/econo/article/4608741_22671.html
2576,2018-05-17,삼성바이오로직스자회사가치부풀려공모액수조원조달논란,http://www.joseilbo.com/news/news_read.php?uid=353218&class=53&grp=
2577,2018-05-17,금감원의외로운싸움삼성바이오로직스분식회계공방전,http://www.ebn.co.kr/news/view/941853
2578,2018-05-17,사진삼성바이오로직스분식회계첫감리위시작,http://www.newspim.com/news/view/20180517000225
2579,2018-05-17,특징주감리위첫회의앞둔삼성바이오로직스2대하락세,http://www.mediapen.com/news/view/355420
2580,2018-05-17,삼성바이오로직스는분식회계인가아닌가,http://www.fnnews.com/news/201805171445036474
2581,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517136000013&did=1196m
2582,2018-05-17,삼성바이오로직스감리위원회들어가는김학수위원장,http://www.fnnews.com/news/201805171445238171
2583,2018-05-17,삼성바이오로직스분식회계가릴김학수감리위원장,http://www.fnnews.com/news/201805171445346946
2584,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517135600013&did=1196m
2585,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517138800013&did=1196m
2586,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517138900013&did=1196m
2587,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517139000013&did=1196m
2588,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517139100013&did=1196m
2589,2018-05-17,삼성바이오로직스감리위첫회의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517139200013&did=1196m
2590,2018-05-17,삼성바이오로직스분식회계감리위개최,http://news1.kr/photos/view/?3115731
2591,2018-05-17,삼성바이오로직스분식회계감리위개최,http://news1.kr/photos/view/?3115739
2592,2018-05-17,삼성바이오로직스감리위원회첫회의,http://news1.kr/photos/view/?3115740
2593,2018-05-17,삼성바이오로직스결전의날,http://news1.kr/photos/view/?3115733
2594,2018-05-17,삼성바이오로직스분식회계감리위원회운명의날,http://news1.kr/photos/view/?3115734
2595,2018-05-17,삼성바이오로직스첫감리위들어서는김학수위원장,http://news1.kr/photos/view/?3115735
2596,2018-05-17,삼성바이오로직스감리위참석하는김학수위원장,http://news1.kr/photos/view/?3115738
2597,2018-05-17,삼성바이오로직스결전의날감리위쟁점은삼성경영권승계관련여부까지논의,http://www.topstarnews.net/news/articleView.html?idxno=413102
2598,2018-05-17,분식회계의혹삼성바이오로직스감리위시작진실드러날까,http://www.mdtoday.co.kr/mdtoday/index.html?no=321325
2599,2018-05-17,김기식전금감원장삼성바이오로직스분식회계근거있다,http://www.sporbiz.co.kr/news/articleView.html?idxno=233644
2600,2018-05-17,머니S포토삼성바이오로직스감리위참석하는김학수위원장,http://moneys.mt.co.kr/news/mwView.php?no=2018051714368061216
2601,2018-05-17,오늘17일삼성바이오로직스분식회계의혹첫감리위개최,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180517.99099007896
2602,2018-05-17,머니S포토삼성바이오로직스감리위결과는,http://moneys.mt.co.kr/news/mwView.php?no=2018051714398023736
2603,2018-05-17,머니S포토삼성바이오로직스운명의날,http://moneys.mt.co.kr/news/mwView.php?no=2018051714438028464
2604,2018-05-17,머니S포토삼성바이오로직스감리위원회에이목집중,http://moneys.mt.co.kr/news/mwView.php?no=2018051714528049606
2605,2018-05-17,삼성바이오로직스감리위시작대심제없이의견진술만,http://view.asiae.co.kr/news/view.htm?idxno=2018051715302389747
2606,2018-05-17,삼성바이오로직스대심제다음감리위로,http://www.fnnews.com/news/201805171448529546
2607,2018-05-17,삼성바이오로직스감리위차기회의부터대심제적용,http://news.hankyung.com/article/2018051757226
2608,2018-05-17,삼성바이오로직스오늘감리위대심제적용안한다,http://www.ebn.co.kr/news/view/941886
2609,2018-05-17,금융위삼성바이오로직스첫감리위대심제적용안한다,http://news.einfomax.co.kr/news/articleView.html?idxno=3449341
2610,2018-05-17,삼성바이오로직스감리위차기회의부터대심제적용,http://www.asiatoday.co.kr/view.php?key=20180517010009116
2611,2018-05-17,김태한삼성바이오로직스대표결론전사기분식공개당사자책임묻겠다,http://www.etnews.com/20180517000341
2612,2018-05-17,삼성바이오로직스감리위첫회의날주가하락세40만원선붕괴,http://www.mdtoday.co.kr/mdtoday/index.html?no=321337
2613,2018-05-17,삼성바이오로직스감리위시작대심제는다음으로,http://www.sporbiz.co.kr/news/articleView.html?idxno=233683
2614,2018-05-17,삼성바이오로직스감리위원회출석하는김학수위원장,http://news.kmib.co.kr/article/view.asp?arcid=0012363842&code=61141111&cp=nv
2615,2018-05-17,삼성바이오로직스감리위에쏠리는눈불공정논란향방은,http://www.dailian.co.kr/news/view/713989/?sc=naver
2616,2018-05-17,삼성바이오로직스감리위원회회의첫날3↓,http://view.asiae.co.kr/news/view.htm?idxno=2018051715590535587
2617,2018-05-17,종합삼성바이오로직스감리위심의에약세3급락,http://www.viva100.com/main/view.php?key=20180517010006086
2618,2018-05-17,삼성바이오로직스분식회계심의첫날주가하락,http://www.ggilbo.com/news/articleView.html?idxno=509859
2619,2018-05-17,굳게입다문김학수감리위원장삼성바이오로직스분식심의개시,http://www.kukinews.com/news/article.html?no=549771
2620,2018-05-17,취재진의질문에상기된표정으로답하는김태한삼성바이오로직스대표,http://www.fnnews.com/news/201805171606512012
2621,2018-05-17,상기된표정의김태한삼성바이오로직스대표,http://www.fnnews.com/news/201805171607150212
2622,2018-05-17,감리위원회소명하러온김태한삼성바이오로직스대표,http://www.fnnews.com/news/201805171607076596
2623,2018-05-17,굳은표정의삼성바이오로직스대표,http://www.fnnews.com/news/201805171607305910
2624,2018-05-17,핸드폰도안된다”삼엄경계속막오른삼성바이오로직스감리위,http://www.etoday.co.kr/news/section/newsview.php?idxno=1624214
2625,2018-05-17,금융위삼성바이오로직스대심제두번째감리위부터적용,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180517151432
2626,2018-05-17,아주종목분석삼성바이오로직스감리위첫날약세,http://www.ajunews.com/view/20180517161327480
2627,2018-05-17,특징주삼성바이오로직스감리위첫회의에주가도출렁,http://www.ekn.kr/news/article.html?no=362671
2628,2018-05-17,포토기자들질문에답하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716185411034
2629,2018-05-17,특징주삼성바이오로직스감리위첫날급락,http://www.cstimes.com/?mod=news&act=articleView&idxno=276010
2630,2018-05-17,포토취재진들에게소명하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716190217228
2631,2018-05-17,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517186700013&did=1196m
2632,2018-05-17,감리위참석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517187200013&did=1196m
2633,2018-05-17,감리위참석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517187100013&did=1196m
2634,2018-05-17,김태한삼성바이오로직스대표이사항변,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517187000013&did=1196m
2635,2018-05-17,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517186800013&did=1196m
2636,2018-05-17,김태한삼성바이오로직스대표이사항변,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517186900013&did=1196m
2637,2018-05-17,사진보안검색받는김태한삼성바이오로직스대표,http://news.mt.co.kr/mtview.php?no=2018051716203686480
2638,2018-05-17,사진감리위원회참석하는김태한삼성바이오로직스대표,http://news.mt.co.kr/mtview.php?no=2018051716214568463
2639,2018-05-17,포토보안검색받는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716233185410
2640,2018-05-17,사진입장표명하는김태한삼성바이오로직스대표,http://news.mt.co.kr/mtview.php?no=2018051716223053664
2641,2018-05-17,감리위원회소명하러온김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116070
2642,2018-05-17,취재진의질문에답하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116068
2643,2018-05-17,취재진의질문에답하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116068
2644,2018-05-17,상기된표정으로답하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116071
2645,2018-05-17,감리위참석앞서취재진만난김태한삼성바이오로직스대표이사,http://news1.kr/photos/view/?3116069
2646,2018-05-17,특징주삼성바이오로직스감리위첫심의받은날약세,http://www.kyeongin.com/main/view.php?key=20180517010006671
2647,2018-05-17,취재진질문에답하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116075
2648,2018-05-17,입장밝히는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517189600013&did=1196m
2649,2018-05-17,취재진질문에답하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3116099
2650,2018-05-17,입장밝히는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517189400013&did=1196m
2651,2018-05-17,사진굳은표정의김태한삼성바이오로직스대표,http://www.newspim.com/news/view/20180517000312
2652,2018-05-17,금융위감리위원회참석하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116102
2653,2018-05-17,금융위감리위원회참석하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116102
2654,2018-05-17,사진굳은표정의김태한삼성바이오로직스대표,http://www.newspim.com/news/view/20180517000312
2655,2018-05-17,입장밝히는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180517189300013&did=1196m
2656,2018-05-17,입장밝히는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116104
2657,2018-05-17,포토입술깨문김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716293125469
2658,2018-05-17,포토입장밝히는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716292420134
2659,2018-05-17,상기된표정의김태한삼성바이오로직스사장,http://www.newscj.com/news/articleView.html?idxno=521797
2660,2018-05-17,김태한삼성바이오로직스대표팩트변한것없어결정전공개책임끝까지묻겠다,http://www.fnnews.com/news/201805171633061126
2661,2018-05-17,감리위원회회의장향하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116174
2662,2018-05-17,감리위원회참석하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116175
2663,2018-05-17,감리위원회회의장향하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116174
2664,2018-05-17,굳은표정김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116135
2665,2018-05-17,포토입술깨무는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716363462350
2666,2018-05-17,감리위원회참석하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116175
2667,2018-05-17,삼성바이오로직스회계부정입장은,http://news1.kr/photos/view/?3116182
2668,2018-05-17,금융위감리위참석하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116136
2669,2018-05-17,감리위참석하는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116176
2670,2018-05-17,감리위참석위해정부청사들어서는김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116179
2671,2018-05-17,오늘Who김태한삼성바이오로직스명운놓고배수진을치다,http://www.businesspost.co.kr/BP?command=article_view&num=82751
2672,2018-05-17,삼성바이오로직스감리위심의착수대심제는차기회의적용,http://www.m-i.kr/news/articleView.html?idxno=416070
2673,2018-05-17,삼성바이오로직스감리위심의착수대심제는차기회의적용,http://www.m-i.kr/news/articleView.html?idxno=416070
2674,2018-05-17,감리위소명하러온김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3116180
2675,2018-05-17,포토오늘굳은표정김태한삼성바이오로직스대표,http://www.sisaon.co.kr/news/articleView.html?idxno=73181
2676,2018-05-17,김태한삼성바이오로직스대표이사감리위원회참석,http://news1.kr/photos/view/?3116202
2677,2018-05-17,정부청사들어온김태한삼성바이오로직스대표이사,http://news1.kr/photos/view/?3116197
2678,2018-05-17,감리위원회참석하는김태한삼성바이오로직스대표이사,http://news1.kr/photos/view/?3116199
2679,2018-05-17,감리위원회소명하러온김태한삼성바이오로직스대표이사,http://news1.kr/photos/view/?3116198
2680,2018-05-17,삼성바이오로직스감리위참석하는김태한대표,http://news1.kr/photos/view/?3116207
2681,2018-05-17,굳은표정의김태한삼성바이오로직스대표,http://ilyo.co.kr/?ac=article_view&entry_id=297801
2682,2018-05-17,람기자의3시40분삼성바이오로직스분식회계대립각상장폐지여부는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051715535231730
2683,2018-05-17,취재진질문에답하는김태한삼성바이오로직스대표이사,http://ilyo.co.kr/?ac=article_view&entry_id=297798
2684,2018-05-17,삼성바이오로직스에대한제7차감리위원회,http://ilyo.co.kr/?ac=article_view&entry_id=297799
2685,2018-05-17,포토분식회계논란반박하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716453391340
2686,2018-05-17,김태한삼성바이오로직스대표이사,http://www.nocutnews.co.kr/news/4971533
2687,2018-05-17,정부서울청사들어서는김태한삼성바이오로직스대표이사,http://www.nocutnews.co.kr/news/4971532
2688,2018-05-17,취재진질문답하는김태한삼성바이오로직스대표이사,http://www.nocutnews.co.kr/news/4971534
2689,2018-05-17,김태한삼성바이오로직스대표이사금융위원회감리위참석,http://www.nocutnews.co.kr/news/4971528
2690,2018-05-17,굳은표정의김태한삼성바이오로직스대표이사,http://www.nocutnews.co.kr/news/4971527
2691,2018-05-17,감리위원회참석하는김태한삼성바이오로직스대표이사,http://www.nocutnews.co.kr/news/4971531
2692,2018-05-17,금융위감리위원회참석하는김태한삼성바이오로직스대표이사,http://www.nocutnews.co.kr/news/4971530
2693,2018-05-17,삼성바이오로직스김태한대표이사금융위감리위원회참석,http://www.nocutnews.co.kr/news/4971535
2694,2018-05-17,포토검색받는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716522620945
2695,2018-05-17,포토감리위원회참석하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716523426319
2696,2018-05-17,김태한삼성바이오로직스대표상장과정서아무문제없어,http://www.sedaily.com/NewsView/1RZKHCLKPT
2697,2018-05-17,삼성바이오로직스감리위원회차기회의서대심제적용,http://www.ceoscoredaily.com/news/article.html?no=41443
2698,2018-05-17,몸수색받는김태한삼성바이오로직스대표이사,http://news1.kr/photos/view/?3116245
2699,2018-05-17,머니S포토검색받는김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018051716378069841
2700,2018-05-17,취재진들에게소명하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3116249
2701,2018-05-17,특징주삼성바이오로직스감리위첫날주당40만원선붕괴,http://www.m-i.kr/news/articleView.html?idxno=416059
2702,2018-05-17,머니S포토입장밝히는김태한삼성바이오로직스대표,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018051716418067956&outlink=1
2703,2018-05-17,포토감리위원회향하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018051716593558131
2704,2018-05-17,머니S포토승강기기다리는김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018051716508022260
2705,2018-05-17,머니S포토열변토하는김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018051716528013869
2706,2018-05-17,머니S포토김태한삼성바이오로직스대표정부청사방문,http://moneys.mt.co.kr/news/mwView.php?no=2018051716558021333
2707,2018-05-17,삼성바이오로직스감리위다음회의부터대심제적용,http://www.viva100.com/main/view.php?key=20180517010006091
2708,2018-05-17,삼성바이오로직스첫감리위핵심쟁점은콜옵션,http://www.viva100.com/main/view.php?key=20180517010006033
2709,2018-05-17,삼성바이오로직스회계처리첫감리위개최,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805170444&t=NNv
2710,2018-05-17,감리위분식회계의혹삼성바이오로직스첫심의,http://news.mk.co.kr/newsRead.php?year=2018&no=314880
2711,2018-05-17,삼성바이오로직스분식회계논란금감원과마찰불가피,http://www.kpinews.co.kr/news/articleView.html?idxno=74029
2712,2018-05-17,감리위원회삼성바이오로직스분식회계문제심의나서,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1476753
2713,2018-05-17,김태한삼성바이오로직스대표분식회계말도안돼금감원책임묻겠다,http://www.newsis.com/view/?id=NISX20180517_0000311861&cID=10401&pID=10400
2714,2018-05-17,삼성바이오로직스첫감리위대심제다음회의부터적용,http://moneys.mt.co.kr/news/mwView.php?no=2018051717158053656
2715,2018-05-17,김태한사장삼성바이오로직스분식회계논란으로명예실추진실밝힐것,http://www.newspim.com/news/view/20180517000319
2716,2018-05-17,삼성바이오로직스분식회계여부가린다감리위첫회의,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10280919
2717,2018-05-17,삼성바이오로직스첫감리위분식회계의혹풀리나,http://www.sedaily.com/NewsView/1RZKHFYVC5
2718,2018-05-17,삼성바이오로직스분식회계판단첫번째감리위열려,http://www.polinews.co.kr/news/article.html?no=355982
2719,2018-05-17,삼성바이오로직스주가다시급락셀트리온도소폭내려,http://www.businesspost.co.kr/BP?command=article_view&num=82799
2720,2018-05-17,정의당삼성바이오로직스분식회계엄중한책임물어야,http://daily.hankooki.com/lpage/politics/201805/dh20180517175854137490.htm
2721,2018-05-17,김태한삼성바이오로직스인내심갖고진실밝힐것”,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180517165554
2722,2018-05-17,삼성바이오로직스사장분식회계말안된다책임물을것,http://news.einfomax.co.kr/news/articleView.html?idxno=3449364
2723,2018-05-17,삼성바이오로직스분식회계감리위첫회의철통보안,http://www.sisafocus.co.kr/news/articleView.html?idxno=185842
2724,2018-05-17,김태한삼성바이오로직스대표투명하게밝히고명예회복할것”,http://www.newsway.co.kr/view.php?tp=1&ud=2018051718122935962
2725,2018-05-17,삼성바이오로직스감리위대심제다음회의때적용,http://www.cstimes.com/?mod=news&act=articleView&idxno=276042
2726,2018-05-17,김태한삼성바이오로직스사장상장관련팩트변한것이없다강변,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805170529&t=NN
2727,2018-05-17,삼성바이오로직스제재심의스타트시험대오르는최종구금융팀,http://www.newsway.co.kr/view.php?tp=1&ud=2018051718032800709
2728,2018-05-17,특징주분식회계감리첫날삼성바이오로직스주가하락마감,http://www.kukinews.com/news/article.html?no=549901
2729,2018-05-17,삼성바이오로직스감리위원회열려대심제는다음회의부터,http://www.businesspost.co.kr/BP?command=article_view&num=82798
2730,2018-05-17,김태한삼성바이오로직스논란만든금감원책임끝까지묻겠다,http://www.businesspost.co.kr/BP?command=article_view&num=82804
2731,2018-05-17,삼성바이오로직스감리위,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=751374
2732,2018-05-17,EBN오늘17일이슈종합현대차투기세력결집에긴장삼성바이오로직스분식회계공방전SM상선명실상부한국적원양선사,http://www.ebn.co.kr/news/view/941955
2733,2018-05-17,삼성바이오로직스분식회계의혹첫심의보안철저,http://news.sbs.co.kr/news/endPage.do?news_id=N1004763127&plink=ORI&cooper=NAVER
2734,2018-05-17,삼성바이오로직스감리위개최분식회계공방,http://www.obsnews.co.kr/news/articleView.html?idxno=1096747
2735,2018-05-17,삼성바이오로직스감리위7시간째치열한공방중,http://www.inews24.com/php/news_view.php?g_serial=1095408&g_menu=022300&rrf=nv
2736,2018-05-17,삼성바이오로직스25일감리위서대심제시행,http://www.fnnews.com/news/201805172250362416
2737,2018-05-17,김태한삼성바이오로직스사장美바이오젠콜옵션반드시행사할것,http://news.hankyung.com/article/201805177262i
2738,2018-05-17,김태한삼성바이오로직스사장대심제시행안돼아쉬워끝까지해결해나갈것,http://www.asiatoday.co.kr/view.php?key=20180517010009246
2739,2018-05-17,삼성바이오로직스감리위2차회의25일개최대심제적용,http://news.hankyung.com/article/2018051772576
2740,2018-05-17,삼성바이오로직스2차감리위25일에열린다,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180517225353
2741,2018-05-17,삼성바이오로직스차기감리위25일대심제시행,http://www.fntimes.com/html/view.php?ud=201805172314569178179ad43907_18
2742,2018-05-18,삼성바이오로직스분식회계의혹첫공방,http://www.ytn.co.kr/_ln/0102_201805180132006917
2743,2018-05-18,삼성바이오로직스첫감리위밤늦게공방차기회의는25일대심제로,http://www.segye.com/content/html/2018/05/17/20180517005835.html?OutUrl=naver
2744,2018-05-18,삼성바이오로직스금감원감리위서공방전벌여차기회의부터대심제적용,http://www.asiatoday.co.kr/view.php?key=20180517010009164
2745,2018-05-18,삼성바이오로직스바이오젠으로부터콜옵션행사관련서신수령,http://view.asiae.co.kr/news/view.htm?idxno=2018051807134532506
2746,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180518022100017&did=1195m
2747,2018-05-18,바이오젠삼성바이오로직스에콜옵션행사예고서신발송1보,http://news1.kr/articles/?3320808
2748,2018-05-18,삼성바이오로직스첫감리위차기회의는25일대심제로,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10280976
2749,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사밝혀,http://news.hankyung.com/article/2018051875706
2750,2018-05-18,삼성바이오로직스바이오젠에피스콜옵션행사의사밝혀,http://news.mt.co.kr/mtview.php?no=2018051807325209329
2751,2018-05-18,삼성바이오로직스바이오젠콜옵션내달29일까지행사서신발송,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051807305049093
2752,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명,http://news.mk.co.kr/newsRead.php?year=2018&no=315780
2753,2018-05-18,삼성바이오로직스美바이오젠콜옵션행사관련서신수령,http://www.newspim.com/news/view/20180518000031
2754,2018-05-18,삼성바이오로직스바이오젠콜옵션행사서한받아상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01443206619210232
2755,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명,http://imnews.imbc.com/news/2018/econo/article/4609148_22671.html
2756,2018-05-18,삼성바이오로직스바이오젠콜옵션행사결정,http://www.dailypharm.com/News/239966
2757,2018-05-18,공시삼성바이오로직스바이오젠콜옵션행사의사표명”,http://www.newsway.co.kr/view.php?tp=1&ud=2018051807493368498
2758,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명”,http://news.kbs.co.kr/news/view.do?ncd=3651371&ref=A
2759,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사밝혀”,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180518080240
2760,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명,http://www.fnnews.com/news/201805180807270217
2761,2018-05-18,삼성바이오로직스콜옵션콜옵션의정확한뜻은무엇,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180518.99099008136
2762,2018-05-18,공시삼성바이오로직스바이오젠의콜옵션행사관련서신수령”,http://www.viva100.com/main/view.php?key=20180518010006235
2763,2018-05-18,삼성바이오로직스바이오젠에피스콜옵션행사의사표명,http://www.dailian.co.kr/news/view/714068/?sc=naver
2764,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명”,https://cnbc.sbs.co.kr/article_hub/10000902277?division=NAVER
2765,2018-05-18,바이오젠삼성바이오에피스콜옵션행사삼성바이오로직스주장에힘실릴까,http://news.hankyung.com/article/2018051877256
2766,2018-05-18,삼성바이오로직스바이오젠콜옵션행사서신받아”,http://biz.chosun.com/site/data/html_dir/2018/05/18/2018051800703.html
2767,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사밝혀,http://www.newstomato.com/ReadNews.aspx?no=824939
2768,2018-05-18,공시바이오젠삼성바이오로직스에삼성바이오에피스콜옵션행사의사밝혀,http://moneys.mt.co.kr/news/mwView.php?no=2018051808348077679
2769,2018-05-18,바이오젠콜옵션행사서신발송삼성바이오로직스힘받나상보,http://news1.kr/articles/?3320853
2770,2018-05-18,삼성바이오로직스바이오젠으로부터콜옵션서신받아,http://www.newsis.com/view/?id=NISX20180518_0000312235&cID=13001&pID=13000
2771,2018-05-18,삼성바이오로직스바이오젠서콜옵션행사의사밝혀,http://news.mt.co.kr/mtview.php?no=2018051808270789712
2772,2018-05-18,삼성바이오로직스바이오젠다음달말까지콜옵션행사의사표명,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00004&news_seq_no=3534639
2773,2018-05-18,삼성바이오로직스바이오젠에피스콜옵션의사밝혀,http://www.inews24.com/php/news_view.php?g_serial=1095429&g_menu=022300&rrf=nv
2774,2018-05-18,바이오젠삼성바이오로직스에콜옵션행사서신전달,http://www.kukinews.com/news/article.html?no=549959
2775,2018-05-18,바이오젠삼성바이오로직스에콜옵션행사의사전달,http://www.dt.co.kr/contents.html?article_no=2018051802109976029001&ref=naver
2776,2018-05-18,인베스트조선삼성바이오로직스바이오젠바이오에피스콜옵션행사의사표명,http://www.investchosun.com/?p=3226208
2777,2018-05-18,삼성바이오로직스파트너바이오젠이콜옵션행사하겠다고통보,http://www.businesspost.co.kr/BP?command=article_view&num=82845
2778,2018-05-18,오늘의종목삼성바이오로직스바이오젠다음달콜옵션행사,http://www.sedaily.com/NewsView/1RZKVFCZ5S
2779,2018-05-18,삼성바이오로직스전일대비약8상승한430000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805180088&t=NN
2780,2018-05-18,특징주삼성바이오로직스에낭보안긴미국바이오젠의콜옵션행사서한개장초큰폭올라,http://www.news2day.co.kr/104203
2781,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사에급등,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180518042200008&did=1195m
2782,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사에급등,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180518042200008&did=1195m
2783,2018-05-18,삼성바이오로직스5이상상승외국인3일연속순매수60만주,http://news.hankyung.com/article/201805187962L
2784,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사에급등,http://www.ebn.co.kr/news/view/941978
2785,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에강세,http://news.hankyung.com/article/2018051879076
2786,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1624329
2787,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에강세,http://www.newsprime.co.kr/news/article.html?no=416976
2788,2018-05-18,특징주삼성바이오로직스美바이오젠내달콜옵션행사발표에급등세,http://www.newsis.com/view/?id=NISX20180518_0000312259&cID=10401&pID=10400
2789,2018-05-18,삼성바이오로직스바이오젠콜옵션행사서신수령,http://www.whosaeng.com/sub_read.html?uid=101460§ion=sc5
2790,2018-05-18,HotLine삼성바이오로직스바이오젠콜옵션행사에상승,http://news.mk.co.kr/newsRead.php?year=2018&no=316088
2791,2018-05-18,삼성바이오로직스바이오젠콜옵션행사소식에8급등,http://news.heraldcorp.com/view.php?ud=20180518000091
2792,2018-05-18,삼성바이오로직스바이오젠콜옵션행사소식에8급등,http://news.heraldcorp.com/view.php?ud=20180518000091
2793,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에급등,http://www.fnnews.com/news/201805180917379504
2794,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2018051809208034869
2795,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사에8급등,http://www.ekn.kr/news/article.html?no=362781
2796,2018-05-18,이데일리N삼성바이오로직스감리위치열한공방25일2차회의外,http://www.edaily.co.kr/news/newspath.asp?newsid=01895846619210232
2797,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에급등,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805180107&t=NN
2798,2018-05-18,코스피외국인사자에상승삼성바이오로직스급등,http://news.hankyung.com/article/2018051881596
2799,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사소식에8반등,http://www.viva100.com/main/view.php?key=20180518010006268
2800,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사확정에급등,http://biz.chosun.com/site/data/html_dir/2018/05/18/2018051800896.html
2801,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사공시에급등,http://www.edaily.co.kr/news/newspath.asp?newsid=01935206619210232
2802,2018-05-18,삼성바이오로직스美바이오젠콜옵션에6대급등세,http://news1.kr/articles/?3320920
2803,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사전해,http://www.enewstoday.co.kr/news/articleView.html?idxno=1191252
2804,2018-05-18,종합삼성바이오로직스바이오젠콜옵션행사의사표명,http://www.newsis.com/view/?id=NISX20180518_0000312271&cID=13001&pID=13000
2805,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사에오름세,http://www.seoulfn.com/news/articleView.html?idxno=306687
2806,2018-05-18,삼성바이오로직스바이오젠으로부터콜옵션행사서신받아”,http://www.fntimes.com/html/view.php?ud=201805180934138749f09e13944d_18
2807,2018-05-18,美바이오젠콜옵션행사삼성바이오로직스18일장초반급등,http://www.choicenews.co.kr/news/articleView.html?idxno=41532
2808,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사7↑,http://view.asiae.co.kr/news/view.htm?idxno=2018051809385340197
2809,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명”,http://www.cstimes.com/?mod=news&act=articleView&idxno=276059
2810,2018-05-18,유삼성바이오로직스전일대비704상승일일회전율은049기록,http://www.sedaily.com/NewsView/1RZKVNFK3F
2811,2018-05-18,특징주삼성바이오로직스6대급등바이오젠콜옵션행사,http://www.mediapen.com/news/view/355611
2812,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사나타내,http://www.ceoscoredaily.com/news/article.html?no=41457
2813,2018-05-18,삼성바이오로직스주가급등바이오젠501주콜옵션행사소식영향,http://www.insightkorea.co.kr//news/articleView.html?idxno=25109
2814,2018-05-18,삼성바이오로직스분식회계첫감리위금감원VS삼바공방치열,http://news.bbsi.co.kr/news/articleView.html?idxno=880522
2815,2018-05-18,삼성바이오로직스바이오젠콜옵션행사에급등,http://www.nbnnews.co.kr/news/articleView.html?idxno=143293
2816,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사의사표명에상승세,http://www.polinews.co.kr/news/article.html?no=356010
2817,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션에급등6↑,http://www.fntimes.com/html/view.php?ud=201805181022566939f09e13944d_18
2818,2018-05-18,공시삼성바이오로직스바이오젠콜옵션행사뜻밝혀,http://www.ajunews.com/view/20180518102051793
2819,2018-05-18,특징주삼성바이오로직스바이오젠콜옵션행사서신수령소식에강세,http://www.newspim.com/news/view/20180518000075
2820,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사공시,http://www.medigatenews.com/news/2878844586
2821,2018-05-18,바이오젠콜옵션행사삼성바이오로직스분식회계의혹벗나,http://www.newsis.com/view/?id=NISX20180518_0000312304&cID=13001&pID=13000
2822,2018-05-18,바이오젠콜옵션행사에삼성바이오로직스주장힘실려,http://www.inews24.com/php/news_view.php?g_serial=1095462&g_menu=022620&rrf=nv
2823,2018-05-18,열린시장이슈IN삼성바이오로직스바이오젠에피스콜옵션의사밝혀,http://www.newstomato.com/ReadNews.aspx?no=824978
2824,2018-05-18,삼성바이오로직스미국바이오젠콜옵션행사서신수령소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321432
2825,2018-05-18,삼성바이오로직스회계논란바이오젠콜옵션행사로새국면,http://www.ftoday.co.kr/news/articleView.html?idxno=87963
2826,2018-05-18,삼성바이오로직스바이오젠콜옵션행사서신수령,http://view.asiae.co.kr/news/view.htm?idxno=2018051811184115941
2827,2018-05-18,삼성바이오로직스신라젠등제약바이오주강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321436
2828,2018-05-18,삼성바이오로직스장초반급등美바이오젠콜옵션행사호재,http://www.seoulwire.com/news/articleView.html?idxno=14542
2829,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명에강세,http://daily.hankooki.com/lpage/economy/201805/dh20180518113222138110.htm
2830,2018-05-18,삼성바이오로직스美바이오젠콜옵션의지표명”,https://cnbc.sbs.co.kr/article_hub/10000902308?division=NAVER
2831,2018-05-18,삼성바이오로직스분식회계감리위17일철통보안속진행,http://it.chosun.com/news/article.html?no=2851837
2832,2018-05-18,최종구삼성바이오로직스언론플레이얘기나온다,http://www.ajunews.com/view/20180518115133848
2833,2018-05-18,삼성바이오로직스바이오젠콜옵션행사소식에강세,https://cnbc.sbs.co.kr/article_hub/10000902317?division=NAVER
2834,2018-05-18,삼성바이오로직스언론플레이과도최종구많은얘기나온다,http://www.choicenews.co.kr/news/articleView.html?idxno=41546
2835,2018-05-18,삼성바이오로직스회계처리위반감리위12시간동안진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=321445
2836,2018-05-18,윤석헌금감원장삼성바이오로직스사전공개금융위원회와교감을시도했었다”종합,http://biz.chosun.com/site/data/html_dir/2018/05/18/2018051801445.html
2837,2018-05-18,이데일리N삼성바이오로직스바이오젠콜옵션행사의사표명外,http://www.edaily.co.kr/news/newspath.asp?newsid=02591206619210232
2838,2018-05-18,삼성바이오로직스셀트리온3대장등제약바이오관련주강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321446
2839,2018-05-18,감리위삼바삼성바이오로직스분식회계의혹내부검토착수,http://www.naeil.com/news_view/?id_art=276247
2840,2018-05-18,바이오젠콜옵션행사삼성바이오로직스분식회계의혹벗나,http://www.topstarnews.net/news/articleView.html?idxno=413754
2841,2018-05-18,삼성바이오로직스美바이오젠콜옵션행사예정”,http://news.donga.com/3/all/20180518/90142797/2
2842,2018-05-18,삼성바이오로직스바이오젠으로부터콜옵션행사서한받았다,http://www.nbnnews.co.kr/news/articleView.html?idxno=143361
2843,2018-05-18,美바이오젠콜옵션행사분식회계논란삼성바이오로직스새국면가나,http://www.sisafocus.co.kr/news/articleView.html?idxno=185869
2844,2018-05-18,삼성바이오로직스바이오젠콜옵션행사,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805180320&t=NN
2845,2018-05-18,삼성바이오로직스바이오젠삼성바이오에피스콜옵션행사의사표명,http://daily.hankooki.com/lpage/economy/201805/dh20180518134216138060.htm
2846,2018-05-18,부자들은경제신문을읽는다삼성바이오로직스바이오젠서콜옵션행사의사밝혀外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051813373125503
2847,2018-05-18,Live영상삼성바이오로직스김태한사장의격정토로,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051810332914823
2848,2018-05-18,삼성바이오로직스바이오젠콜옵션행사공시새국면맞나,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180518110855
2849,2018-05-18,바이오젠삼성바이오로직스콜옵션행사표명금감원궁지몰려,http://www.news2day.co.kr/104236
2850,2018-05-18,바이오젠콜옵션행사밝혀삼성바이오로직스사태판세바뀌나,http://www.wolyo.co.kr/news/articleView.html?idxno=61179
2851,2018-05-18,윤석헌금감원장삼성바이오로직스분식회계감리위분석지켜봐야,http://www.m-i.kr/news/articleView.html?idxno=416345
2852,2018-05-18,윤석헌금감원장삼성바이오로직스문제감리위평가지켜봐야,http://www.mediapen.com/news/view/355720
2853,2018-05-18,바이오젠콜옵션금감원스모킹건에서삼성바이오로직스스모킹건으로,http://www.newsway.co.kr/view.php?tp=1&ud=2018051813573959304
2854,2018-05-18,바이오젠이삼성바이오로직스에콜옵션을행사하겠다고밝혔다,https://www.huffingtonpost.kr/entry/story_kr_5afe652fe4b07309e0567217?utm_id=naver
2855,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사표명,http://www.ciobiz.co.kr/news/article.html?id=20180518120016
2856,2018-05-18,삼성바이오로직스바이오젠콜옵션행사소식에2대상승40만원회복,http://www.viva100.com/main/view.php?key=20180518010006421
2857,2018-05-18,최종구금융위원장삼성바이오로직스문제첫감리위로쟁점파악됐을것,http://www.mediapen.com/news/view/355739
2858,2018-05-18,삼성바이오로직스바이오젠콜옵션행사소식에끝내강세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=321468
2859,2018-05-18,윤석헌삼성바이오로직스논란은금감원나름대로잘대처하겠다,http://www.businesspost.co.kr/BP?command=article_view&num=82903
2860,2018-05-18,삼성바이오로직스바이오젠콜옵션행사”서신수령,http://www.econovill.com/news/articleView.html?idxno=338182
2861,2018-05-18,삼성바이오로직스셀트리온3대장강세마감코스닥코스피모두↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=321470
2862,2018-05-18,삼성바이오로직스바이오젠콜옵션행사공시분식회계논란공수전환,http://it.chosun.com/news/article.html?no=2851861
2863,2018-05-18,바이오젠궁지몰린삼성바이오로직스백기사로급부상,http://news1.kr/articles/?3321264
2864,2018-05-18,삼성바이오로직스바이오젠콜옵션행사의사밝혀,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805180095&t=NNv
2865,2018-05-18,삼성바이오로직스2라운드바이오젠콜옵션변수,http://www.kpinews.co.kr/news/articleView.html?idxno=74086
2866,2018-05-18,바이오젠콜옵션행사삼성바이오로직스회계논란새국면맞나,http://www.businesspost.co.kr/BP?command=article_view&num=82910
2867,2018-05-18,삼성바이오로직스회계논란공방전장기화가능성높아져,http://www.businesspost.co.kr/BP?command=article_view&num=82913
2868,2018-05-18,삼성바이오로직스주가다시반등셀트리온3총사도올라,http://www.businesspost.co.kr/BP?command=article_view&num=82945
2869,2018-05-18,삼성바이오로직스비롯바이오주일제상승불확실성해소될까,http://www.fntimes.com/html/view.php?ud=201805181914412284f09e13944d_18
2870,2018-05-18,삼성바이오로직스바이오젠콜옵션행사한다”,http://www.hani.co.kr/arti/economy/finance/845324.html
2871,2018-05-18,미국바이오젠바이오에피스콜옵션행사”삼성바이오로직스분식회계논란변수되나,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805182219015&code=920509
2872,2018-05-19,롤러코스터삼성바이오로직스불확실성에망설이는투자자들,http://www.g-enews.com/ko-kr/news/article/news_all/201805192125079849c16aa2f016_1/article.html
2873,2018-05-20,알기쉬운경제삼성바이오로직스분식회계감리수당얼마받나,http://www.kukinews.com/news/article.html?no=550248
2874,2018-05-20,바이오젠콜옵션행사삼성바이오로직스구원투수되나,http://www.mediapen.com/news/view/355908
2875,2018-05-20,삼성바이오로직스감리위늦어도31일결론,http://www.cstimes.com/?mod=news&act=articleView&idxno=276183
2876,2018-05-20,삼성바이오로직스감리위원회늦어도31일결론,http://news.hankyung.com/article/2018052031707
2877,2018-05-20,휴일한입뉴스국민연금현대자동차지배구조개편에캐스팅보트역할LG세대교체가속화젊은총수시대열려삼성바이오로직스감리위이달끝낼예정발암물질라돈Rn침대파문확산경제성,http://www.econovill.com/news/articleView.html?idxno=338240
2878,2018-05-20,삼성바이오로직스감리위늦어도31일결론바이오젠콜옵션공시변수될까,http://www.ekn.kr/news/article.html?no=363009
2879,2018-05-20,이슈추적①삼성바이오로직스문제2년전이미경고했다,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805201031011&code=920100
2880,2018-05-20,이슈추적②인터뷰˝삼성바이오로직스분식회계의혹공방자체가말이안돼˝,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805201052001&code=920100
2881,2018-05-20,삼성바이오로직스감리위이달안으로결론낼까,http://www.ajunews.com/view/20180520111948285
2882,2018-05-20,삼성바이오로직스감리위이달안에결론낸다,http://www.ebn.co.kr/news/view/942110
2883,2018-05-20,김어준의뉴스공장하이라이트삼성바이오로직스감리위구성부터잘못됐다,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10281108
2884,2018-05-20,삼성바이오로직스감리위늦어도31일까지결론,http://www.etnews.com/20180520000052
2885,2018-05-20,삼성바이오로직스감리위늦어도31일결론,http://www.sporbiz.co.kr/news/articleView.html?idxno=234632
2886,2018-05-20,금감원콜옵션존재안알렸다”VS삼성바이오로직스알렸다”,http://news.donga.com/3/all/20180520/90168694/1
2887,2018-05-20,삼성바이오로직스바이오젠콜옵션행사의사표명,http://www.mdtoday.co.kr/mdtoday/index.html?no=321488
2888,2018-05-21,더벨삼성바이오로직스바이오젠콜옵션시재무변화는,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805180100030960001910
2889,2018-05-21,코스피코스닥18일주요공시삼성바이오로직스바이오젠콜옵션행사의사표명등,http://www.betanews.net:8080/article/856204.html
2890,2018-05-21,삼성바이오로직스극단적우려해소주가긍정적흐름예상”KB증권,http://www.fntimes.com/html/view.php?ud=201805210803159852f09e13944d_18
2891,2018-05-21,특징주삼성바이오로직스감리위분식회계혐의조기결론외인은매도vs주가는탄력,http://www.g-enews.com/ko-kr/news/article/news_all/201805210910272604c642673384_1/article.html
2892,2018-05-21,특징주삼성바이오로직스또강세거래정지상폐가능성↓,http://www.newsis.com/view/?id=NISX20180521_0000314013&cID=10401&pID=10400
2893,2018-05-21,삼성바이오로직스거래정지상폐가능성↓소식에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321557
2894,2018-05-21,삼성바이오로직스또강세거래정지상폐가능성낮다,http://www.nbnnews.co.kr/news/articleView.html?idxno=143625
2895,2018-05-21,삼성바이오로직스바이오젠콜옵션의사표명핵심쟁점영향미미,http://www.mdtoday.co.kr/mdtoday/index.html?no=321575
2896,2018-05-21,제약상장기업5월브랜드평판1위셀트리온2위삼성바이오로직스3위셀트리온헬스케어,http://www.cnbnews.com/news/article.html?no=375167
2897,2018-05-21,삼성바이오로직스주가소폭올라셀트리온은제자리,http://www.businesspost.co.kr/BP?command=article_view&num=83121
2898,2018-05-21,삼성바이오로직스감리위늦어도이달내결론,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1477883
2899,2018-05-22,삼성바이오로직스논란금융위vs금감원확전내막,http://ilyo.co.kr/?ac=article_view&entry_id=297685
2900,2018-05-23,셀트리온소액주주삼성바이오로직스를비난하면안되는이유,http://www.sporbiz.co.kr/news/articleView.html?idxno=235779
2901,2018-05-23,美훈풍삼성전자SK하이닉스껑충vs현대차삼성바이오로직스부진,http://www.choicenews.co.kr/news/articleView.html?idxno=41649
2902,2018-05-23,셀트리온3총사와삼성바이오로직스주가모두하락,http://www.businesspost.co.kr/BP?command=article_view&num=83276
2903,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.newsway.co.kr/view.php?tp=1&ud=2018052408471235735
2904,2018-05-24,삼성바이오로직스2공장FDA추가인증,http://www.newsis.com/view/?id=NISX20180524_0000316727&cID=13001&pID=13000
2905,2018-05-24,삼성바이오로직스2공장FDA인증추가획득,http://www.dt.co.kr/contents.html?article_no=2018052402109976029002&ref=naver
2906,2018-05-24,삼성바이오로직스2공장FDA서세번째제품제조승인받아,http://news.mk.co.kr/newsRead.php?year=2018&no=327952
2907,2018-05-24,삼성바이오로직스2공장의약품美FDA추가인증,http://www.edaily.co.kr/news/newspath.asp?newsid=01771206619212200
2908,2018-05-24,삼성바이오로직스2공장美FDA추가인증획득,http://www.medigatenews.com/news/3077565784
2909,2018-05-24,특징주삼성바이오로직스2차감리위원회임박외인매수에주가는단비,http://www.g-enews.com/ko-kr/news/article/news_all/201805240903522960c642673384_1/article.html
2910,2018-05-24,삼성바이오로직스2공장美FDA추가인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=321853
2911,2018-05-24,특징주셀트리온삼성바이오로직스동반오름세,http://www.sporbiz.co.kr/news/articleView.html?idxno=236040
2912,2018-05-24,삼성바이오로직스송도2공장미FDA인증추가획득,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180524043600017&did=1195m
2913,2018-05-24,삼성바이오로직스2공장美FDA추가인증획득,http://news1.kr/articles/?3325329
2914,2018-05-24,삼성바이오로직스2공장美FDA추가제조인증획득,http://biz.chosun.com/site/data/html_dir/2018/05/24/2018052400919.html
2915,2018-05-24,특징주삼성바이오로직스美FDA의2공장제품인증에오름세,http://www.fnnews.com/news/201805240937261597
2916,2018-05-24,삼성바이오로직스2공장FDA추가인증,http://www.sporbiz.co.kr/news/articleView.html?idxno=236050
2917,2018-05-24,특징주2공장美FDA생산인증추가획득삼성바이오로직스↑,http://www.newsis.com/view/?id=NISX20180524_0000316826&cID=10401&pID=10400
2918,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://news.heraldcorp.com/view.php?ud=20180524000246
2919,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://news.mk.co.kr/newsRead.php?year=2018&no=328267
2920,2018-05-24,삼성바이오로직스2공장미FDA추가인증획득,http://www.fnnews.com/news/201805240952528294
2921,2018-05-24,삼성바이오로직스2공장생산제품FDA추가인증,http://www.wolyo.co.kr/news/articleView.html?idxno=61371
2922,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018052409250137262
2923,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1192897
2924,2018-05-24,삼성바이오로직스2공장FAD인증추가획득,http://news.einfomax.co.kr/news/articleView.html?idxno=3450196
2925,2018-05-24,삼성바이오로직스2공장美FDA추가인증소식에장초반상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321870
2926,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.mediapen.com/news/view/356862
2927,2018-05-24,삼성바이오로직스송도2공장미FDA인증추가획득,http://daily.hankooki.com/lpage/ittech/201805/dh20180524101816138240.htm
2928,2018-05-24,특징주2공장美FDA생산인증추가획득삼성바이오로직스상승,http://www.ebn.co.kr/news/view/942544
2929,2018-05-24,FDA삼성바이오로직스2공장생산제품추가승인,http://www.dailypharm.com/News/240119
2930,2018-05-24,삼성바이오로직스2공장생산제품美FDA추가인증획득,http://www.sisaon.co.kr/news/articleView.html?idxno=73349
2931,2018-05-24,삼성바이오로직스2공장美FDA추가인증획득,http://biz.newdaily.co.kr/news/article.html?no=10161525
2932,2018-05-24,삼성바이오로직스2공장FDA서제조승인획득,http://www.asiatoday.co.kr/view.php?key=20180524010011712
2933,2018-05-24,삼성바이오로직스제2공장생산제품FDA인증획득,http://www.newsworks.co.kr/news/articleView.html?idxno=188830
2934,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.newspim.com/news/view/20180524000062
2935,2018-05-24,삼성바이오로직스바이오약공장해외서우수성입증,http://www.ajunews.com/view/20180524104426618
2936,2018-05-24,삼성바이오로직스2공장미국FDA추가인증획득,http://www.sisaweek.com/news/articleView.html?idxno=108500
2937,2018-05-24,특징주삼성바이오로직스2공장FDA추가인증획득에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02673206619212200
2938,2018-05-24,삼성바이오로직스2공장미국FDA추가인증,http://www.seoulfn.com/news/articleView.html?idxno=307110
2939,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.m-i.kr/news/articleView.html?idxno=417541
2940,2018-05-24,삼성바이오로직스미국식품의약국의2공장제조승인추가획득,http://www.businesspost.co.kr/BP?command=article_view&num=83333
2941,2018-05-24,6월초개막보스톤바이오USA삼성바이오로직스대웅제약등전세계바이오기업들총집결,http://www.news2day.co.kr/104459
2942,2018-05-24,삼성바이오로직스2공장美FDA인증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1056211
2943,2018-05-24,삼성바이오로직스2공장美FDA추가인증,http://www.kormedi.com/news/news/drug_dist/1227407_2906.html
2944,2018-05-24,특징주삼성바이오로직스2공장美FDA추가인증획득소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2018052413478081062
2945,2018-05-24,한경로보뉴스삼성바이오로직스5이상상승전일보다거래량증가전일117수준,http://news.hankyung.com/article/201805248155L
2946,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://news.mt.co.kr/mtview.php?no=2018052413593954522
2947,2018-05-24,삼성바이오로직스2공장FDA인증획득,http://www.newstomato.com/ReadNews.aspx?no=825876
2948,2018-05-24,삼성바이오로직스송도2공장미FDA인증추가획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018052400097
2949,2018-05-24,코스피기관순매수SK하이닉스삼성바이오로직스셀트리온,http://www.newsway.co.kr/view.php?tp=1&ud=2018052416045172503
2950,2018-05-24,삼성바이오로직스송도2공장미FDA인증추가획득,http://www.ciobiz.co.kr/news/article.html?id=20180524120029
2951,2018-05-24,北美리스크경협주현대차추락vs삼성바이오로직스셀트리온껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=41681
2952,2018-05-24,삼성바이오로직스2공장FDA인증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=74522
2953,2018-05-24,삼성바이오로직스2공장FDA서추가인증,http://www.fnnews.com/news/201805241702095891
2954,2018-05-24,셀트리온삼총사와삼성바이오로직스호재덕에주가동반상승,http://www.businesspost.co.kr/BP?command=article_view&num=83414
2955,2018-05-24,내일의경제일정금감원삼성바이오로직스2차감리위원회진행,http://www.asiatime.co.kr/news/articleView.html?idxno=181064
2956,2018-05-24,삼성바이오로직스송도2공장美FDA추가인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1626014
2957,2018-05-24,삼성바이오로직스감리委2라운드25일승부갈리나,http://news.hankyung.com/article/2018052493851
2958,2018-05-24,이데일리내일의경제일정삼성바이오로직스2차감리위,http://www.edaily.co.kr/news/newspath.asp?newsid=04201686619212200
2959,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1479141
2960,2018-05-24,삼성바이오로직스2공장FDA추가인증획득,http://www.ekn.kr/news/article.html?no=363896
2961,2018-05-24,삼성바이오로직스2공장美FDA인증획득,http://www.kgnews.co.kr/news/articleView.html?idxno=516119
2962,2018-05-24,삼성바이오로직스2공장제품美식품의약국인증추가획득,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=752428
2963,2018-05-25,삼성바이오로직스2공장FDA추가인증,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=812139
2964,2018-05-25,이데일리오늘의경제일정삼성바이오로직스2차감리위,http://www.edaily.co.kr/news/newspath.asp?newsid=01318566619212528
2965,2018-05-25,삼성바이오로직스2차감리위바이오젠콜옵션행사변수,http://www.edaily.co.kr/news/newspath.asp?newsid=01377606619212528
2966,2018-05-25,분식회계의혹삼성바이오로직스25일감리위임박주가영향은,http://www.mdtoday.co.kr/mdtoday/index.html?no=321967
2967,2018-05-25,삼성바이오로직스오늘2차감리콜옵션공방치열할듯,http://news1.kr/articles/?3326290
2968,2018-05-25,삼성바이오로직스김태한대표증선위일정겹쳐8년공들인보스톤바이오USA참석못할듯,http://www.news2day.co.kr/104484
2969,2018-05-25,오늘의증시5월25일지역난방공사주주총회삼성바이오로직스감리위등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1626101
2970,2018-05-25,삼성바이오로직스전일대비약3상승한431500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805250097&t=NN
2971,2018-05-25,삼성바이오로직스2차감리위시작대심제로치열한공방예상,http://www.sporbiz.co.kr/news/articleView.html?idxno=236560
2972,2018-05-25,특징주삼성바이오로직스2차감리위원회시선집중외인순매수강화에주가는탄력,http://www.g-enews.com/ko-kr/news/article/news_all/201805250909363217c642673384_1/article.html
2973,2018-05-25,특징주삼성바이오로직스장초반강세대심제2차감리위결과주목,http://www.mediapen.com/news/view/357136
2974,2018-05-25,특징주삼성바이오로직스감리위2차회의강세,http://www.ekn.kr/news/article.html?no=363955
2975,2018-05-25,특징주삼성바이오로직스2차감리위에상승세,http://www.fnnews.com/news/201805250920542080
2976,2018-05-25,HotLine삼성바이오로직스2차감리위당일강세,http://news.mk.co.kr/newsRead.php?year=2018&no=331256
2977,2018-05-25,특징주삼성바이오로직스감리위대심제앞두고강세,http://www.seoulfn.com/news/articleView.html?idxno=307224
2978,2018-05-25,삼성바이오로직스2차감리위필요시3자간대심진행,http://www.newstomato.com/ReadNews.aspx?no=826087
2979,2018-05-25,특징주삼성바이오로직스2차감리위당일주가상승,http://www.inews24.com/php/news_view.php?g_serial=1096715&g_menu=022300&rrf=nv
2980,2018-05-25,김학수2차삼성바이오로직스감리위차분하게논의하겠다,http://news.hankyung.com/article/2018052513096
2981,2018-05-25,삼성바이오로직스2차감리위바이오젠콜옵션관건 ,http://www.seoulfn.com/news/articleView.html?idxno=307228
2982,2018-05-25,특징주삼성바이오로직스2차감리위당일상승세,http://www.newsprime.co.kr/news/article.html?no=417611
2983,2018-05-25,취재진질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525051400013&did=1196m
2984,2018-05-25,감리위출석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525051600013&did=1196m
2985,2018-05-25,묵묵부답김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525052700013&did=1196m
2986,2018-05-25,특징주삼성바이오로직스2차감리위원회당일주가강세,http://www.newsway.co.kr/view.php?tp=1&ud=2018052509515228313
2987,2018-05-25,매일장보는남녀삼성바이오로직스207940,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003215281
2988,2018-05-25,손사래치는인터뷰거절하는김태한삼성바이오로직스이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525052000013&did=1196m
2989,2018-05-25,감리위출석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525054200013&did=1196m
2990,2018-05-25,김태한삼성바이오로직스사장질문은다음에,http://news1.kr/photos/view/?3126945
2991,2018-05-25,입굳게닫은김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180525_0014112811
2992,2018-05-25,질문세례받는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180525_0014112812
2993,2018-05-25,삼성바이오로직스2차감리위대심제적용,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180525092648
2994,2018-05-25,김태한삼성바이오로직스사장험난한출석,http://news1.kr/photos/view/?3126964
2995,2018-05-25,포토굳은표정의김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510005904461
2996,2018-05-25,묵묵부답김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525052600013&did=1196m
2997,2018-05-25,김태한사장삼성바이오로직스회계처리위반감리위원회참석,http://news1.kr/photos/view/?3126968
2998,2018-05-25,감리위원회참석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525058600013&did=1196m
2999,2018-05-25,포토감리위원회출석하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510012920648
3000,2018-05-25,포토굳은표정의김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510010808526
3001,2018-05-25,포토김태한삼성바이오로직스사장취재진질문뒤로한채,http://view.asiae.co.kr/news/view.htm?idxno=2018052510020029482
3002,2018-05-25,포토감리위원회출석하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510025946483
3003,2018-05-25,포토김태한삼성바이오로직스사장취재진질문뒤로한채,http://view.asiae.co.kr/news/view.htm?idxno=2018052510022233854
3004,2018-05-25,포토질문거절하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510034960023
3005,2018-05-25,포토감리위원회출석하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510033457942
3006,2018-05-25,포토감리위원회출석하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510031351455
3007,2018-05-25,포토감리위원회출석하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510032354988
3008,2018-05-25,포토질문거절하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510035667409
3009,2018-05-25,포토묵묵부답굳은표정의김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510042178113
3010,2018-05-25,포토입굳게닫은김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510044081551
3011,2018-05-25,포토삼성바이오로직스의분식회계관련감리위원회참석하는김태한대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02460006619212528
3012,2018-05-25,포토묵묵부답굳은표정의김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018052510041673829
3013,2018-05-25,포토금융위입장하는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02463286619212528
3014,2018-05-25,사진김태한대표이사삼성바이오로직스2차감리위출석,http://news.mt.co.kr/mtview.php?no=2018052510035277552
3015,2018-05-25,사진삼성바이오로직스2차감리위출석하는김태한대표이사,http://news.mt.co.kr/mtview.php?no=2018052510054075157
3016,2018-05-25,포토금융위온김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02469846619212528
3017,2018-05-25,포토금융위감리위원회온김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02479686619212528
3018,2018-05-25,포토금융위감리위원회참석하는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02482966619212528
3019,2018-05-25,포토김태한삼성바이오로직스대표질문안받습니다,http://www.edaily.co.kr/news/newspath.asp?newsid=02486246619212528
3020,2018-05-25,삼성바이오로직스감리위원회2차회의25일오늘개최치열한공방예상,http://www.topstarnews.net/news/articleView.html?idxno=417551
3021,2018-05-25,감리위원회향하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525063000013&did=1196m
3022,2018-05-25,포토취재진질문받는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02496086619212528
3023,2018-05-25,포토김태한삼성바이오로직스대표금융위감리위원회참석,http://www.edaily.co.kr/news/newspath.asp?newsid=02492806619212528
3024,2018-05-25,포토금융위2차감리위참석하는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02502646619212528
3025,2018-05-25,포토굳은표정으로감리위참석하는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02505926619212528
3026,2018-05-25,감리위원회향하는김태한삼성바이오로직스이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525062300013&did=1196m
3027,2018-05-25,삼성바이오로직스2차감리위오늘대질심문,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805251011001&code=920100
3028,2018-05-25,포토굳은표정으로금융위원회감리위참석하는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02512486619212528
3029,2018-05-25,승강기탄김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525063600013&did=1196m
3030,2018-05-25,김태한대표이사삼성바이오로직스의운명은,http://www.newsis.com/view/?id=NISI20180525_0014112859
3031,2018-05-25,삼성바이오로직스2차감리위진행저녁전끝날듯,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10282119
3032,2018-05-25,포토손사레치는김태한삼성바이오로직스대표,http://www.edaily.co.kr/news/newspath.asp?newsid=02519046619212528
3033,2018-05-25,감리위출석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525065200013&did=1196m
3034,2018-05-25,삼성바이오로직스2차감리위콜옵션거센공방,http://www.fnnews.com/news/201805251011467114
3035,2018-05-25,삼성바이오로직스2차감리위3자간대심도진행가능,http://view.asiae.co.kr/news/view.htm?idxno=2018052510183825124
3036,2018-05-25,감리위원회향하는김태한삼성바이오로직스대표,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525065500013&did=1196m
3037,2018-05-25,손사래치는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180525_0014112909
3038,2018-05-25,특징주삼성바이오로직스운명의날주가는강세,http://biz.chosun.com/site/data/html_dir/2018/05/25/2018052501274.html
3039,2018-05-25,포토감리위원회출석하는김태환삼성바이오로직스대표이사,http://www.enewstoday.co.kr/news/articleView.html?idxno=1193449
3040,2018-05-25,포토삼성바이오로직스2차감리위탈탈떨릴까,http://www.dailian.co.kr/news/view/715428/?sc=naver
3041,2018-05-25,포토2차감리위출석하는김태한삼성바이오로직스대표이사,http://www.dailian.co.kr/news/view/715432/?sc=naver
3042,2018-05-25,NW포토김태한대표삼성바이오로직스감리위원회2차회의참석,http://www.newsway.co.kr/view.php?tp=1&ud=2018052510271162688
3043,2018-05-25,NW포토김태한삼성바이오로직스대표취재진의질문에묵묵부답,http://www.newsway.co.kr/view.php?tp=1&ud=2018052510290150906
3044,2018-05-25,포토묵묵부답손사레치는김태한삼성바이오로직스대표이사,http://www.dailian.co.kr/news/view/715436/?sc=naver
3045,2018-05-25,NW포토조사받는삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018052510300263518
3046,2018-05-25,삼성바이오로직스오늘2차감리위콜옵션쟁점될듯,http://moneys.mt.co.kr/news/mwView.php?no=2018052510088066817
3047,2018-05-25,머니S포토삼성바이오로직스오늘2차감리,http://moneys.mt.co.kr/news/mwView.php?no=2018052510158016973
3048,2018-05-25,포토무거운표정의김태한삼성바이오로직스대표이사,http://www.dailian.co.kr/news/view/715439/?sc=naver
3049,2018-05-25,NW포토감리위원회참석하는김태한삼성바이오로직스대표,http://www.newsway.co.kr/view.php?tp=1&ud=2018052510305839296
3050,2018-05-25,머니S포토감리위2차회의참석한김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018052510178058363
3051,2018-05-25,머니S포토2차감리위출석하는김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018052510268088967
3052,2018-05-25,NW포토거부의사밝히는김태한삼성바이오로직스대표,http://www.newsway.co.kr/view.php?tp=1&ud=2018052510330192729
3053,2018-05-25,머니S포토2차감리위출석하는김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018052510268088967
3054,2018-05-25,NW포토엘리베이터에오른김태한삼성바이오로직스대표,http://www.newsway.co.kr/view.php?tp=1&ud=2018052510343854531
3055,2018-05-25,머니S포토삼성바이오로직스감리위얼굴맞대고대심제진행,http://moneys.mt.co.kr/news/mwView.php?no=2018052510228062429
3056,2018-05-25,머니S포토취재진외면하는김태한삼성바이오로직스대표,http://moneys.mt.co.kr/news/mwView.php?no=2018052510258056465
3057,2018-05-25,삼성바이오로직스2차감리위감사인과3자대면하나,http://www.inews24.com/php/news_view.php?g_serial=1096747&g_menu=022300&rrf=nv
3058,2018-05-25,분식회계혐의삼성바이오로직스2차감리위열려콜옵션행사공방,http://www.kyeongin.com/main/view.php?key=20180525010009602
3059,2018-05-25,경협주추락속셀트리온삼성바이오로직스껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=41704
3060,2018-05-25,삼성바이오로직스2차감리위열려바이오젠콜옵션행사영향은,http://www.econovill.com/news/articleView.html?idxno=338571
3061,2018-05-25,삼성바이오로직스감리위2차회의대심제로진행중,http://news.sbs.co.kr/news/endPage.do?news_id=N1004773477&plink=ORI&cooper=NAVER
3062,2018-05-25,굳게입다문김태한삼성바이오로직스대표감리위출석,http://news.mt.co.kr/mtview.php?no=2018052511075512053
3063,2018-05-25,삼성바이오로직스작년에처음법인세18억6500만원냈다,http://www.intn.co.kr/news/articleView.html?idxno=2000367
3064,2018-05-25,삼성바이오로직스운명의날주가는강세,http://www.nbntv.co.kr/news/articleView.html?idxno=104130
3065,2018-05-25,삼성바이오로직스감리위2차회의대심제로진행중,http://news.sbs.co.kr/news/endPage.do?news_id=N1004773525&plink=ORI&cooper=NAVER
3066,2018-05-25,삼성바이오로직스분식회계규탄집회,http://www.newsis.com/view/?id=NISI20180525_0014113222
3067,2018-05-25,삼바삼성바이오로직스분식회계규탄집회,http://www.newsis.com/view/?id=NISI20180525_0014113223
3068,2018-05-25,삼성바이오로직스분식회계규탄집회,http://www.newsis.com/view/?id=NISI20180525_0014113226
3069,2018-05-25,삼성바이오로직스분식회계규탄집회,http://www.newsis.com/view/?id=NISI20180525_0014113224
3070,2018-05-25,삼성바이오로직스분식회계규탄집회,http://www.newsis.com/view/?id=NISI20180525_0014113225
3071,2018-05-25,삼성바이오로직스2차감리위개시대심제로진행,http://biz.newdaily.co.kr/news/article.html?no=10161626
3072,2018-05-25,삼성바이오로직스분식회계심의2차감리위열려,http://www.sisajournal-e.com/biz/article/184362
3073,2018-05-25,삼성바이오로직스분식회계의혹규탄집회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525112200013&did=1196m
3074,2018-05-25,삼성바이오로직스분식회계의혹규탄집회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525112100013&did=1196m
3075,2018-05-25,삼성바이오로직스분식회계의혹규탄,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525112400013&did=1196m
3076,2018-05-25,삼성바이오로직스분식회계의혹규탄집회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525112300013&did=1196m
3077,2018-05-25,삼성바이오로직스분식회계의혹규탄,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180525112600013&did=1196m
3078,2018-05-25,아주종목분석삼성바이오로직스2차감리위개최에도강세,http://www.ajunews.com/view/20180525135935482
3079,2018-05-25,삼성바이오로직스이번엔대면감리위주가는고공행진,http://www.g-enews.com/ko-kr/news/article/news_all/201805251358212801c16aa2f016_1/article.html
3080,2018-05-25,삼성바이오로직스2차감리위1차때코스피하루저녁에5조이상증발해,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065591570398761
3081,2018-05-25,삼성바이오로직스2차감리위1차때하루증발액5조이상돼,http://www.youngnong.co.kr/news/articleView.html?idxno=10673
3082,2018-05-25,김태한삼성바이오로직스대표감리위앞두고아무런대답없어지난1차때와다른모습,http://www.topstarnews.net/news/articleView.html?idxno=417848
3083,2018-05-25,김태한감리위에서삼성바이오로직스회계놓고금감원과공방,http://www.businesspost.co.kr/BP?command=article_view&num=83524
3084,2018-05-25,디스패치문문기사에삼성바이오로직스언급음모론사전차단,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0500&key=20180525.99099011906
3085,2018-05-25,삼성바이오로직스2차감리위열려금융위이달안에결론,http://news.bbsi.co.kr/news/articleView.html?idxno=881530
3086,2018-05-25,금융위삼성바이오로직스2차감리위오후7시종료예정,http://news.hankyung.com/article/2018052535336
3087,2018-05-25,관점뉴스삼성바이오로직스와대결중인금감원윤석헌원장위법논란에곤혹,http://www.news2day.co.kr/104580
3088,2018-05-25,최저임금에상여금과복리후생비포함삼성바이오로직스2차심의결론주목,http://news.bbsi.co.kr/news/articleView.html?idxno=881548
3089,2018-05-25,셀트리온삼성바이오로직스주가올라남북경협주대안으로부각,http://www.businesspost.co.kr/BP?command=article_view&num=83564
3090,2018-05-25,삼성바이오로직스금감원날선공방결국3차회의로,http://www.edaily.co.kr/news/newspath.asp?newsid=04090166619212528
3091,2018-05-25,삼성바이오로직스분식회계다룰2차회의종료결론은3차회의후,http://news.heraldcorp.com/view.php?ud=20180525000912
3092,2018-05-25,삼성바이오로직스감리위31일3차회의개최감리위원만참석,http://news.hankyung.com/article/2018052541816
3093,2018-05-25,삼성바이오로직스감리위3차간다,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180525194614
3094,2018-05-25,감리위삼성바이오로직스분식회계결론못내31일정례회의통해결론낼듯,http://www.viva100.com/main/view.php?key=20180525010008847
3095,2018-05-25,감리위삼성바이오로직스분식회계논란31일결론내기로,http://www.businesspost.co.kr/BP?command=article_view&num=83591
3096,2018-05-25,삼성바이오로직스3자대심에도결론못내31일3차감리위,http://www.ebn.co.kr/news/view/942799
3097,2018-05-25,김태한삼성바이오로직스대표금융당국에정중히사과,http://www.mediapen.com/news/view/357350
3098,2018-05-25,삼성바이오로직스감리위또결론못내31일결론날듯,http://imnews.imbc.com/news/2018/econo/article/4619681_22671.html
3099,2018-05-25,삼성바이오로직스회계위반3차전공방이어져이달말막판결론,http://www.topstarnews.net/news/articleView.html?idxno=418113
3100,2018-05-26,금감원삼성바이오로직스재판형식뜨거운설전,http://www.ytn.co.kr/_ln/0102_201805260024426774
3101,2018-05-26,3상통과대박주장하는삼성바이오로직스사실일까,http://www.insightkorea.co.kr//news/articleView.html?idxno=25291
3102,2018-05-26,삼성바이오로직스분식회계의혹31일감리위서결론,http://www.econovill.com/news/articleView.html?idxno=338634
3103,2018-05-27,마라톤공방에도결론못낸삼성바이오로직스심의31일정례회의서마침표,http://www.ekn.kr/news/article.html?no=364356
3104,2018-05-27,삼성바이오로직스회계위반여부31일1차결론내달7일증선위로,http://www.etnews.com/20180527000112
3105,2018-05-27,삼성바이오로직스감리위31일결론,http://www.fnnews.com/news/201805271738074157
3106,2018-05-27,삼성바이오로직스회계처리논란31일감리위원회서결론나올듯,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=752801
3107,2018-05-28,특징주삼성바이오로직스분식회계혐의최종결정임박외인은매수vs주가는주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201805280904365479c642673384_1/article.html
3108,2018-05-28,삼성바이오로직스2차감리위종료31일3차감리위,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003216311
3109,2018-05-28,특징주셀트리온삼성바이오로직스동반하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=237536
3110,2018-05-28,이데일리N삼성바이오로직스분식회계의혹31일감리위에서결론外,http://www.edaily.co.kr/news/newspath.asp?newsid=01984406619213512
3111,2018-05-28,삼성바이오로직스분식회계31일3차감리위서결론,http://www.intn.co.kr/news/articleView.html?idxno=2000428
3112,2018-05-28,경협주의날무더기상한가vsIT셀트리온삼성바이오로직스하락,http://www.choicenews.co.kr/news/articleView.html?idxno=41773
3113,2018-05-28,셀트리온삼성바이오로직스주가하락남북경협주에매수몰린탓,http://www.businesspost.co.kr/BP?command=article_view&num=83783
3114,2018-05-29,삼성바이오로직스목표가7↓53만원제시유진證,http://www.newspim.com/news/view/20180529000095
3115,2018-05-29,퀵리포트삼성바이오로직스매수유지목표가7↓53만원유진證,http://www.itooza.com/common/iview.php?no=2018052908470029304
3116,2018-05-29,삼성바이오로직스주한미얀마라트비아대사등본사방문,http://view.asiae.co.kr/news/view.htm?idxno=2018052908462314836
3117,2018-05-29,글로벌VIP잇따라삼성바이오로직스방문,http://www.newsis.com/view/?id=NISX20180529_0000321027&cID=13001&pID=13000
3118,2018-05-29,특징주삼성바이오로직스반갑다외국인주가기지개,http://www.g-enews.com/ko-kr/news/article/news_all/201805290914155348c642673384_1/article.html
3119,2018-05-29,삼성바이오로직스전일대비약3상승한441500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805290108&t=NN
3120,2018-05-29,14개국주한대사삼성바이오로직스방문,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180529091023
3121,2018-05-29,주한미얀마대사등삼성바이오로직스방문,http://www.newspim.com/news/view/20180529000126
3122,2018-05-29,14개국주한대사보좌관삼성바이오로직스본사방문,http://www.enewstoday.co.kr/news/articleView.html?idxno=1194564
3123,2018-05-29,14개국글로벌VIP삼성바이오로직스본사방문,http://www.dailian.co.kr/news/view/716055/?sc=naver
3124,2018-05-29,삼성바이오로직스주한미얀마라트비아대사등본사방문,http://www.etoday.co.kr/news/section/newsview.php?idxno=1627122
3125,2018-05-29,삼성바이오로직스14개국주한대사등VIP21명이28일본사방문,http://weekly.cnbnews.com/news/article.html?no=124677
3126,2018-05-29,삼성바이오로직스해외VIP필수방문코스부상,http://news.mt.co.kr/mtview.php?no=2018052909471443636
3127,2018-05-29,삼성바이오로직스글로벌VIP랜드마크눈도장,http://daily.hankooki.com/lpage/life/201805/dh20180529095738138950.htm
3128,2018-05-29,삼성바이오로직스김태한사장송도가글로벌최고바이오클러스터로자리잡을것”,http://www.fnnews.com/news/201805290956167619
3129,2018-05-29,삼성바이오로직스글로벌VIP잇따라방문,http://www.newsworks.co.kr/news/articleView.html?idxno=189884
3130,2018-05-29,글로벌VIP잇따라삼성바이오로직스방문,http://www.sporbiz.co.kr/news/articleView.html?idxno=238121
3131,2018-05-29,삼성바이오로직스송도본사는글로벌VIP의단골방문코스,http://www.ebn.co.kr/news/view/943082
3132,2018-05-29,삼성바이오로직스주한외교사절단방문,http://www.dailian.co.kr/news/view/716076/?sc=naver
3133,2018-05-29,글로벌VIP들삼성바이오로직스본사방문필수코스로자리잡아,http://www.viva100.com/main/view.php?key=20180529010009814
3134,2018-05-29,시민단체이재용고발삼성바이오로직스기업가치뻥튀기,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180529048600004&did=1195m
3135,2018-05-29,뉴스투데이E삼성바이오로직스글로벌VIP필수방문코스되다,http://www.news2day.co.kr/104702
3136,2018-05-29,시민단체삼성바이오로직스기업가치뻥튀기”이재용부회장고발,http://news.kbs.co.kr/news/view.do?ncd=3656420&ref=A
3137,2018-05-29,인천송도삼성바이오로직스시설글로벌VIP들필수방문코스로부상,http://www.m-i.kr/news/articleView.html?idxno=419137
3138,2018-05-29,삼성바이오로직스는글로벌VIP필수코스,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1056395
3139,2018-05-29,글로벌VIP들의필수방문코스된삼성바이오로직스,http://sports.khan.co.kr/news/sk_index.html?art_id=201805291354003&sec_id=561801&pt=nv
3140,2018-05-29,삼성바이오로직스의역공분식회계논란새국면,http://ilyo.co.kr/?ac=article_view&entry_id=298308
3141,2018-05-29,김태한삼성바이오로직스방문한한국주재대사들에게사업소개,http://www.businesspost.co.kr/BP?command=article_view&num=83831
3142,2018-05-29,재벌개혁코드맞추기인가비정상화의정상화인가금융당국삼성생명삼성바이오로직스잇단옥죄기,http://news.mk.co.kr/newsRead.php?year=2018&no=340075
3143,2018-05-29,미얀마라트비아등14개국주한대사삼성바이오로직스견학,http://news.mk.co.kr/newsRead.php?year=2018&no=340093
3144,2018-05-29,시민단체삼성바이오로직스상장은사기이재용등고발,http://news.mt.co.kr/mtview.php?no=2018052914588219099
3145,2018-05-29,시민단체삼성바이오로직스상장은사기26명고발,http://www.newsis.com/view/?id=NISX20180529_0000321525&cID=10201&pID=10200
3146,2018-05-29,삼성바이오로직스상장은사기”투기자본감시센터검찰고발,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018052915530202470&LinkID=632&objId=A2018052915530202470&portalCode=naver
3147,2018-05-29,위기의삼성바이오로직스역주행이유는,http://www.kormedi.com/news/news/drug_dist/1227481_2906.html
3148,2018-05-29,시민단체삼성바이오로직스상장은사기삼성경영진고발,http://www.etoday.co.kr/news/section/newsview.php?idxno=1627379
3149,2018-05-29,14개국주한대사보좌관삼성바이오로직스방문,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018052911014162304
3150,2018-05-29,삼성바이오로직스31일운명의날감리위결론은,http://www.viva100.com/main/view.php?key=20180529010009891
3151,2018-05-29,시민단체삼성바이오로직스상장사기이재용삼성전자부회장고발,http://www.ytn.co.kr/_ln/0103_201805291707187833
3152,2018-05-29,셀트리온3총사주가소폭내리고삼성바이오로직스는약간올라,http://www.businesspost.co.kr/BP?command=article_view&num=83906
3153,2018-05-29,투기자본감시센터삼성바이오로직스회계놓고삼성경영진고발,http://www.businesspost.co.kr/BP?command=article_view&num=83893
3154,2018-05-29,삼성바이오로직스글로벌VIP필수방문코스,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1480680
3155,2018-05-29,삼성바이오로직스글로벌VIP러시,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=753195
3156,2018-05-29,글로벌VIP삼성바이오로직스벤치마킹,http://www.kyeongin.com/main/view.php?key=20180529010011184
3157,2018-05-29,삼성바이오로직스글로벌VIP들의필수방문코스,http://www.joongboo.com/?mod=news&act=articleView&idxno=1255284
3158,2018-05-30,요즘글로벌VIP필수방문코스는삼성바이오로직스,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=812663
3159,2018-05-30,삼성바이오로직스美바이오USA서CDO사업수주나선다,http://news1.kr/articles/?3330476
3160,2018-05-30,특징주삼성바이오로직스분식회계관련3차감리위초읽기외인순매도우위에주가는주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201805300911044383c642673384_1/article.html
3161,2018-05-30,특징주셀트리온삼성바이오로직스동반하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=238594
3162,2018-05-30,삼성바이오로직스美바이오USA서CDO사업수주나설예정,http://www.nbntv.co.kr/news/articleView.html?idxno=104248
3163,2018-05-30,삼성바이오로직스해외VIP필수방문코스로자리매김,http://www.metroseoul.co.kr/news/newsview?newscd=2018052900135
3164,2018-05-30,삼성바이오로직스3차감리위31일진행마지막심의,http://www.mdtoday.co.kr/mdtoday/index.html?no=322494
3165,2018-05-30,삼성바이오로직스운명의31일증선위는7일,http://www.metroseoul.co.kr/news/newsview?newscd=2018053000148
3166,2018-05-30,내일의경제일정금융위삼성바이오로직스3차감리위원회진행,http://www.asiatime.co.kr/news/articleView.html?idxno=181866
3167,2018-05-30,삼성바이오로직스분식회계삼성생명전자지분매각빅딜설현실로,http://www.sporbiz.co.kr/news/articleView.html?idxno=238910
3168,2018-05-30,삼성바이오로직스주가감리위앞두고하락셀트리온주가는선방,http://www.businesspost.co.kr/BP?command=article_view&num=84107
3169,2018-05-31,삼성바이오로직스회계논란3차감리위서종식될까,http://www.edaily.co.kr/news/newspath.asp?newsid=01210326619214496
3170,2018-05-31,삼성바이오로직스감리위오늘마침표감리위원간집중토론열린다,http://www.kukinews.com/news/article.html?no=553212
3171,2018-05-31,삼성바이오로직스오늘마지막감리위열려,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201805310600011&code=920100
3172,2018-05-31,삼성바이오로직스감리위오늘3차회의결론도출시도,http://news.hankyung.com/article/2018053127017
3173,2018-05-31,삼성바이오로직스감리위3차회의연다,http://www.ajunews.com/view/20180531072033577
3174,2018-05-31,오늘의증시5월31일삼성바이오로직스3차감리위고려개발유상증자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1627908
3175,2018-05-31,뉴스핌시론삼성바이오로직스감리에정치적판단안된다,http://www.newspim.com/news/view/20180531000067
3176,2018-05-31,삼성바이오로직스감리위원회3차회의,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10283083
3177,2018-05-31,삼성바이오로직스오늘3차회의결론나올까,http://www.cstimes.com/?mod=news&act=articleView&idxno=277015
3178,2018-05-31,삼성바이오로직스감리위3차회의개최최종결론도출전망,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018053108542800529&LinkID=632&objId=A2018053108542800529&portalCode=naver
3179,2018-05-31,특징주삼성바이오로직스반갑다외국인분식회계관련감리위3차회의일에외인은사자,http://www.g-enews.com/ko-kr/news/article/news_all/201805310913388193c642673384_1/article.html
3180,2018-05-31,제약톡톡삼성바이오로직스분식회계감리위오늘결론내린다,http://news.heraldcorp.com/view.php?ud=20180531000163
3181,2018-05-31,삼성바이오로직스최종감리위DDAY진술無진행,http://www.inews24.com/php/news_view.php?g_serial=1097830&g_menu=022300&rrf=nv
3182,2018-05-31,특징주삼성바이오로직스3차감리위앞두고상승세,http://www.viva100.com/main/view.php?key=20180531010010676
3183,2018-05-31,삼성바이오로직스전일대비약3상승한439000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805310199&t=NN
3184,2018-05-31,특징주삼성바이오로직스3상승외인매수로전환,http://view.asiae.co.kr/news/view.htm?idxno=2018053110533368548
3185,2018-05-31,감리위삼성바이오로직스분식회계여부논의,http://news.kbs.co.kr/news/view.do?ncd=3657703&ref=A
3186,2018-05-31,삼성바이오로직스분식회계혐의오늘결론난다,http://www.wolyo.co.kr/news/articleView.html?idxno=61877
3187,2018-05-31,삼성바이오로직스시총한달새4조원추락,http://www.mdtoday.co.kr/mdtoday/index.html?no=322602
3188,2018-05-31,삼바삼성바이오로직스감리위마지막회의표결로결론,http://www.naeil.com/news_view/?id_art=277431
3189,2018-05-31,삼성바이오로직스분식회계어떤결론나올까,http://www.smedaily.co.kr/news/articleView.html?idxno=76254
3190,2018-05-31,분식회계논란삼성바이오로직스2상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=322615
3191,2018-05-31,삼성바이오로직스감리위3차회의최종결론에쏠리는눈,http://www.betanews.net:8080/article/860647.html
3192,2018-05-31,삼성바이오로직스김태한사장송도글로벌최고바이오클러스터로자리잡을수있도록최선을다할것,http://www.segye.com/content/html/2018/05/31/20180531003845.html?OutUrl=naver
3193,2018-05-31,삼성바이오로직스논란감리위마침표찍나오늘3차회의,http://www.metroseoul.co.kr/news/newsview?newscd=2018053100081
3194,2018-05-31,삼성바이오로직스분식회계감리위오늘결론내린다,http://news1.kr/photos/view/?3136769
3195,2018-05-31,감리위31일오늘삼성바이오로직스분식회계회의차분한토론이있을것,http://www.topstarnews.net/news/articleView.html?idxno=421260
3196,2018-05-31,특징주삼성바이오로직스3차감리위막오른가운데상승세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1628139
3197,2018-05-31,삼성바이오로직스논란감리위마침표찍나,http://news1.kr/photos/view/?3136880
3198,2018-05-31,삼성바이오로직스감리위참석하는김학수위원장,http://news1.kr/photos/view/?3136879
3199,2018-05-31,삼성바이오로직스감리위마침표찍을정례회의시작,http://www.kukinews.com/news/article.html?no=553471
3200,2018-05-31,삼성바이오로직스3차감리위원회참석하는김학수위원장,http://www.newsis.com/view/?id=NISI20180531_0014131071
3201,2018-05-31,삼성바이오로직스3차감리위원회참석하는김학수위원장,http://www.newsis.com/view/?id=NISI20180531_0014131072
3202,2018-05-31,삼성바이오로직스3차감리위원회참석하는김학수위원장,http://www.newsis.com/view/?id=NISI20180531_0014131068
3203,2018-05-31,삼성바이오로직스3차감리위원회참석하는김학수위원장,http://www.newsis.com/view/?id=NISI20180531_0014131067
3204,2018-05-31,사진삼성바이오로직스분식회계오늘결론날까,http://www.newspim.com/news/view/20180531000386
3205,2018-05-31,삼성바이오로직스감리위3차회의서결론낸다7일증선위대심제전망,http://news.hankyung.com/article/2018053153956
3206,2018-05-31,삼성바이오로직스분식회계가릴3차감리위열려내달7일증선위앞둬결론낼듯,http://www.segye.com/content/html/2018/05/31/20180531004767.html?OutUrl=naver
3207,2018-05-31,삼성바이오로직스의운명은,http://news.kmib.co.kr/article/view.asp?arcid=0012402221&code=61141111&cp=nv
3208,2018-05-31,삼성바이오로직스3차감리위원회회의개최취재진접촉엄격히통제,http://www.topstarnews.net/news/articleView.html?idxno=421315
3209,2018-05-31,삼성바이오로직스분식회계판정은주식소폭상승흐름이라면,http://www.youngnong.co.kr/news/articleView.html?idxno=10963
3210,2018-05-31,삼성바이오로직스3차감리위시작결론낼듯,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10283191
3211,2018-05-31,삼성바이오로직스분식회계주식흐름으로예상해본결론은,http://viewers.heraldcorp.com/news/articleView.html?idxno=14434
3212,2018-05-31,감리위삼성바이오로직스분식회계혐의오늘마무리,http://news.kbs.co.kr/news/view.do?ncd=3657912&ref=A
3213,2018-05-31,삼성바이오로직스분식회계감리위오늘결론도출내달7일증선위상정,http://www.kyeongin.com/main/view.php?key=20180531010012319
3214,2018-05-31,금융위삼성바이오로직스감리위결과공개불가,http://www.sporbiz.co.kr/news/articleView.html?idxno=239427
3215,2018-05-31,삼성바이오로직스감리위오늘결론낼듯,http://imnews.imbc.com/news/2018/econo/article/4627774_22671.html
3216,2018-05-31,분식회계논란삼성바이오로직스3차감리위서결판,http://www.kpinews.co.kr/news/articleView.html?idxno=75069
3217,2018-05-31,삼성바이오로직스주가상승셀트리온3총사는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=84251
3218,2018-05-31,이정미정의당대표삼성바이오로직스방문해송도악취문제협의,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1481802
3219,2018-05-31,삼성바이오로직스분식회계여부증선위판가름,http://www.medicaltimes.com/News/1118974
3220,2018-05-31,삼성바이오로직스공은증선위로징계수위는,http://www.fnnews.com/news/201805311909055960
3221,2018-05-31,삼성바이오로직스징계수위는,http://www.fnnews.com/news/201805312132444327
3222,2018-05-31,삼성바이오로직스감리위3차회의종료자정이후예상1일추가공지,http://news.hankyung.com/article/2018053171356
3223,2018-05-31,삼성바이오로직스3차감리위내일끝난다,http://www.sporbiz.co.kr/news/articleView.html?idxno=239498
3224,2018-05-31,마감3차감리위삼성바이오로직스강세셀트리온은하락,http://www.sporbiz.co.kr/news/articleView.html?idxno=239505
3225,2018-06-01,시민단체삼성바이오로직스분식회계의혹관련해이재용최지성김태한고발,http://www.topstarnews.net/news/articleView.html?idxno=421650
3226,2018-06-01,삼성바이오로직스감리위자정넘겨마무리,http://news.kbs.co.kr/news/view.do?ncd=3658195&ref=A
3227,2018-06-01,삼성바이오로직스3차감리위증선위로공넘겨어떤징계,http://www.econovill.com/news/articleView.html?idxno=338993
3228,2018-06-01,삼성바이오로직스둘러싼34시간마라톤회의감리위다수의견놓고증선위서최종결론,http://www.news2day.co.kr/104918
3229,2018-06-01,삼성바이오로직스감리위마무리절차징계는7일증선위서논의,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3547265
3230,2018-06-01,삼성바이오로직스감리위종결7일증선위상정,http://www.ebn.co.kr/news/view/943587
3231,2018-06-01,삼성바이오로직스감리위심의종료증선위에전달,http://news.hankyung.com/article/2018060177886
3232,2018-06-01,특징주삼성바이오로직스3차감리위종료외인매수주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201806010905029882c642673384_1/article.html
3233,2018-06-01,삼성바이오로직스감리위심의끝이제공은증선위로,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10283290
3234,2018-06-01,특징주3차감리위마친삼성바이오로직스이틀째상승,http://news.mt.co.kr/mtview.php?no=2018060109092071026
3235,2018-06-01,삼성바이오로직스감리위31일자정넘겨마무리,http://www.sporbiz.co.kr/news/articleView.html?idxno=239579
3236,2018-06-01,삼성바이오로직스감리위심의끝오는7일증선위개최,http://www.mediapen.com/news/view/358853
3237,2018-06-01,삼성바이오로직스분식회계논란장기전전망주가2↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=322710
3238,2018-06-01,삼성바이오로직스전일대비약3상승한449500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806010107&t=NN
3239,2018-06-01,특징주3차감리위마친삼성바이오로직스강세,http://www.ebn.co.kr/news/view/943606
3240,2018-06-01,특징주감리위끝난삼성바이오로직스이틀째상승,http://www.newsis.com/view/?id=NISX20180601_0000324652&cID=10401&pID=10400
3241,2018-06-01,특징주삼성바이오로직스분식회계의혹감리위종료강세,http://www.fnnews.com/news/201806010910094434
3242,2018-06-01,특징주감리위종료삼성바이오로직스강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180601048900008&did=1195m
3243,2018-06-01,HotLine삼성바이오로직스감리위종료2거래일연속상승,http://news.mk.co.kr/newsRead.php?year=2018&no=347979
3244,2018-06-01,한경로보뉴스삼성바이오로직스5이상상승주가상승흐름단기이평선정배열중기이평선역배열,http://news.hankyung.com/article/201806018210L
3245,2018-06-01,유삼성바이오로직스전일대비747상승일일회전율은024기록,http://www.sedaily.com/NewsView/1S0N0PE8U7
3246,2018-06-01,특징주회복세보이는삼성바이오로직스7넘게급등,http://www.ekn.kr/news/article.html?no=365474
3247,2018-06-01,특징주감리위끝난삼성바이오로직스이틀째상승,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018060109284225059
3248,2018-06-01,특징주삼성바이오로직스감리위심의종료에5대상승,http://www.newstomato.com/ReadNews.aspx?no=827562
3249,2018-06-01,특징주삼성바이오로직스분식회계무혐의주가급등세,http://www.sporbiz.co.kr/news/articleView.html?idxno=239596
3250,2018-06-01,특징주삼성바이오로직스감리위종료에강세,http://www.viva100.com/main/view.php?key=20180601010000065
3251,2018-06-01,특징주삼성바이오로직스3차감리위종료에강세,http://www.cstimes.com/?mod=news&act=articleView&idxno=277155
3252,2018-06-01,특징주삼성바이오로직스3차감리위종료소식에급등세,http://www.newsprime.co.kr/news/article.html?no=418326
3253,2018-06-01,특징주3차감리위종료삼성바이오로직스이틀째강세,http://www.seoulfn.com/news/articleView.html?idxno=307809
3254,2018-06-01,이데일리N삼성바이오로직스감리위진통결론도출안간힘外,http://www.edaily.co.kr/news/newspath.asp?newsid=02164806619237456
3255,2018-06-01,특징주셀트리온삼성바이오로직스에수혜강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=239603
3256,2018-06-01,특징주삼성바이오로직스감리위종료에이틀째오름세,http://moneys.mt.co.kr/news/mwView.php?no=2018060109578061684
3257,2018-06-01,보도참고삼성바이오로직스건감리위심의종료심의결과는증선위보고예정,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156272843
3258,2018-06-01,삼성바이오로직스3차감리위종료7일증선위보고키로,http://www.wolyo.co.kr/news/articleView.html?idxno=61962
3259,2018-06-01,삼성바이오로직스감리위종료증선위에쟁점별다수소수의견전달,http://www.hani.co.kr/arti/economy/finance/847271.html
3260,2018-06-01,이정미의원송도악취문제해결위해삼성바이오로직스방문,http://www.kukinews.com/news/article.html?no=553751
3261,2018-06-01,삼성바이오로직스증선위도대심제로진행고의분식회계유지될까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1628453
3262,2018-06-01,삼성바이오로직스바이오USA서CDO사업수주적극나서,http://www.mdtoday.co.kr/mdtoday/index.html?no=322646
3263,2018-06-01,삼성바이오로직스감리위원회종료7일증선위에의견전달,http://www.ekn.kr/news/article.html?no=365517
3264,2018-06-01,국민연금삼성바이오로직스제재수위촉각,http://view.asiae.co.kr/news/view.htm?idxno=2018060111134786101
3265,2018-06-01,분식회계논란삼성바이오로직스감리위심의종료어떤결과나올까,http://www.newsrep.co.kr/news/articleView.html?idxno=51375
3266,2018-06-01,특징주감리위종료삼성바이오로직스주가강세,http://www.mediapen.com/news/view/358918
3267,2018-06-01,삼성바이오로직스감리위종료7일증선위보고,http://www.dailypharm.com/News/240418
3268,2018-06-01,삼바삼성바이오로직스감리위결정증선위서뒤집힐까,http://news.heraldcorp.com/view.php?ud=20180601000346
3269,2018-06-01,삼성바이오로직스감리위심의종료7일증선위보고,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1481984
3270,2018-06-01,감리위삼성바이오로직스분식회계심의종료,http://www.kbanker.co.kr/news/articleView.html?idxno=73486
3271,2018-06-01,감리위삼성바이오로직스심의종료에주가꿈틀,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1056539
3272,2018-06-01,삼성바이오로직스감리위심의종료에주가↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=322737
3273,2018-06-01,삼성바이오로직스감리위끝내주가이틀째오름세보이는中,http://www.topstarnews.net/news/articleView.html?idxno=421991
3274,2018-06-01,삼성바이오로직스감리위종료증선위에결과전달,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180601.99099000322
3275,2018-06-01,삼성바이오로직스감리위심의결과증선위에서바뀔까,http://www.mdtoday.co.kr/mdtoday/index.html?no=322762
3276,2018-06-01,전국국공립대학교총장협의회방문단삼성바이오로직스방문,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180601142900013&did=1196m
3277,2018-06-01,바이오의약품설명하는윤광훈삼성바이오로직스부사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180601142700013&did=1196m
3278,2018-06-01,감리위삼성바이오로직스분식회계논란증선위에공넘겨,http://www.businesspost.co.kr/BP?command=article_view&num=84347
3279,2018-06-01,삼성바이오로직스감리위종료위원간의견차있었다,http://biz.newdaily.co.kr/site/data/html/2018/06/01/2018060100068.html
3280,2018-06-01,外人매수속삼성전자삼성바이오로직스상승vs블록딜후삼성생명연일하락,http://www.choicenews.co.kr/news/articleView.html?idxno=41887
3281,2018-06-01,삼성바이오로직스감리위자정넘어종료증선위에보고예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=322773
3282,2018-06-01,삼성바이오로직스감리위끝난이후2일연속강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=322778
3283,2018-06-01,ET투자뉴스삼성바이오로직스207940수주공급계약유럽소재제약사,http://www.etnews.com/20180601000306
3284,2018-06-01,공시삼성바이오로직스100억원규모판매공급계약체결,http://www.newsway.co.kr/view.php?tp=1&ud=2018060117195781961
3285,2018-06-01,삼성바이오로직스유럽제약사와100억원의약품위탁생산계약,http://biz.chosun.com/site/data/html_dir/2018/06/01/2018060102397.html
3286,2018-06-01,삼성바이오로직스유럽제약사와100억규모의약품위탁생산계약,http://www.newsis.com/view/?id=NISX20180601_0000325340&cID=10401&pID=10400
3287,2018-06-01,삼성바이오로직스유럽제약사와100억규모의약품위탁생산계약,http://www.fnnews.com/news/201806011724323491
3288,2018-06-01,e2BOT삼성바이오로직스100억규모의의약품위탁생산계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1628677
3289,2018-06-01,삼성바이오로직스유럽제약사와100억원규모위탁생산계약,http://news.mt.co.kr/mtview.php?no=2018060117265926186
3290,2018-06-01,한경로보뉴스삼성바이오로직스수주공시의약품위탁생산계약1002억원매출액대비216,http://news.hankyung.com/article/201806011002L
3291,2018-06-01,삼성바이오로직스100억원규모의약품위탁생산계약체결,http://www.sedaily.com/NewsView/1S0N2KSDM3
3292,2018-06-01,삼성바이오로직스유럽제약사와100억원위탁생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180601159400008&did=1195m
3293,2018-06-01,삼성바이오로직스유럽제약사와100억원규모계약체결,http://view.asiae.co.kr/news/view.htm?idxno=2018060117402498383
3294,2018-06-01,삼성바이오로직스유럽제약사와100억원위탁생산계약체결,http://www.asiatoday.co.kr/view.php?key=20180601010000453
3295,2018-06-01,삼성바이오로직스3차감리위종료6월중순결과나올듯,http://it.chosun.com/site/data/html_dir/2018/06/01/2018060102497.html
3296,2018-06-01,삼성바이오로직스100억규모의약품위탁생산계약,http://www.newsworks.co.kr/news/articleView.html?idxno=191000
3297,2018-06-01,삼성바이오로직스셀트리온주가동반상승투자심리회복,http://www.businesspost.co.kr/BP?command=article_view&num=84388
3298,2018-06-01,특징주감리위종료삼성바이오로직스강세종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180601048951008&did=1195m
3299,2018-06-01,특징주삼성바이오로직스이틀연속상승세감리위종료,http://www.kyeongin.com/main/view.php?key=20180601010000195
3300,2018-06-01,SR공정운영삼성바이오로직스감리위심의종료다수소수의견전달,http://www.srtimes.kr/news/articleView.html?idxno=20177
3301,2018-06-01,삼성바이오로직스감리위종료7일증선위에결과보고,http://www.obsnews.co.kr/news/articleView.html?idxno=1099005
3302,2018-06-01,단독감리위원회다수의견삼성바이오로직스회계분식,http://news.sbs.co.kr/news/endPage.do?news_id=N1004785171&plink=ORI&cooper=NAVER
3303,2018-06-02,삼성바이오로직스분식회계의혹감리위원회심의종료,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00004&news_seq_no=3548385
3304,2018-06-02,삼성바이오로직스유럽제약사와100억규모의약품위탁생산계약매출액의216규모,http://www.econonews.co.kr/news/articleView.html?idxno=26231
3305,2018-06-03,주간추천종목KB증권영원무역농심삼성바이오로직스,http://www.fntimes.com/html/view.php?ud=201806030652038531f09e13944d_18
3306,2018-06-03,삼성바이오로직스분식회계다수의견,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=753935
3307,2018-06-04,KB증권영원무역농심삼성바이오로직스,http://www.seoulfn.com/news/articleView.html?idxno=310133
3308,2018-06-04,삼성바이오로직스유럽제약사와100억규모의약품위탁생산계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=322840
3309,2018-06-04,특징주삼성바이오로직스분식회계다수의결가능성에3약세,http://news.mt.co.kr/mtview.php?no=2018060409080306527
3310,2018-06-04,특징주삼성바이오로직스분식회계다수의견하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=240502
3311,2018-06-04,특징주삼성바이오로직스증선위불확실성에도유럽제약사와공급계약외인매수주가반전주목,http://www.g-enews.com/ko-kr/news/article/news_all/201806040914561281c642673384_1/article.html
3312,2018-06-04,특징주삼성바이오로직스분식회계다수의견에하락세,http://www.seoulfn.com/news/articleView.html?idxno=310149
3313,2018-06-04,특징주증선위앞둔삼성바이오로직스4대약세,http://www.newsis.com/view/?id=NISX20180604_0000326460&cID=10401&pID=10400
3314,2018-06-04,장마감후공시삼성바이오로직스유럽제약사와위탁생산계약체결,http://www.newstomato.com/ReadNews.aspx?no=827864
3315,2018-06-04,삼성바이오로직스분식회계최종결론은또다시하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=322863
3316,2018-06-04,삼성바이오로직스전일대비약6하락한424500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806040164&t=NN
3317,2018-06-04,삼성바이오로직스분식회계다수의결가능성약세,http://www.nbntv.co.kr/news/articleView.html?idxno=104381
3318,2018-06-04,특징주삼성바이오로직스분식회계다수의견에급락,http://www.ebn.co.kr/news/view/943869
3319,2018-06-04,삼성바이오로직스감리위원회다수의견분식회계보도영향급락세,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180604.99099001259
3320,2018-06-04,ISSUEINSIDE삼성바이오로직스3차감리위마무리고의적분식증거안나와공은증선위로,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=353521
3321,2018-06-04,삼성바이오로직스사흘만에하락세전거래일보다410내린43만3000원에거래,http://www.topstarnews.net/news/articleView.html?idxno=423035
3322,2018-06-04,삼성바이오로직스분식회계의혹결과누출에금융당국전전긍긍,http://www.kukinews.com/news/article.html?no=554312
3323,2018-06-04,삼성바이오로직스10하락전일보다45500원내린406000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806040327&t=NN
3324,2018-06-04,최종구삼성바이오로직스회계의혹삼성경영권승계관련성있는지논의발언새삼화제,http://www.topstarnews.net/news/articleView.html?idxno=423071
3325,2018-06-04,삼성바이오로직스8하락감리위끝난지사흘만에하락전환,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3549668
3326,2018-06-04,특징주삼성바이오로직스증선위불확실성에낙폭확대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806040272&t=NN
3327,2018-06-04,삼성바이오로직스보도영향으로낙폭커,http://www.ggilbo.com/news/articleView.html?idxno=514540
3328,2018-06-04,증선위불확실성삼성바이오로직스급락바이오주하락,http://news.hankyung.com/article/2018060475786
3329,2018-06-04,삼성바이오로직스32500원72내린419000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806040438&t=NN
3330,2018-06-04,삼성바이오로직스주가돌연추락감리위에서무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=41934
3331,2018-06-04,종합증선위앞둔삼성바이오로직스7대급락,http://www.newsis.com/view/?id=NISX20180604_0000327067&cID=10401&pID=10400
3332,2018-06-04,삼성바이오로직스4일3만2천500원급락3차감리위마무리되며증선위발표임박,http://news.imaeil.com/Finance/2018060416492491915
3333,2018-06-04,삼성바이오로직스감리위서금감원의도적분식회계프레임일단좌초,http://www.news2day.co.kr/105051
3334,2018-06-04,코스피기관순매도삼성바이오로직스삼성물산SK하이닉스,http://www.newsway.co.kr/view.php?tp=1&ud=2018060417263432916
3335,2018-06-04,삼성바이오로직스중징계가능성에주가급락셀트리온동반하락,http://www.businesspost.co.kr/BP?command=article_view&num=84607
3336,2018-06-04,삼성바이오로직스감리위서승리분식회계논란벗어나나,http://www.sporbiz.co.kr/news/articleView.html?idxno=240822
3337,2018-06-05,tbs김어준의뉴스공장삼성바이오로직스감리위원회결과공개논란증폭이유는,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10283852
3338,2018-06-05,삼성바이오로직스11000원263오른430000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806050076&t=NN
3339,2018-06-05,삼성바이오로직스전일대비약4상승한436500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806050085&t=NN
3340,2018-06-05,특징주삼성바이오로직스급락후하루만에3반등,http://news.mt.co.kr/mtview.php?no=2018060509061851505
3341,2018-06-05,특징주삼성바이오로직스증선위반전기대주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201806050905343989c642673384_1/article.html
3342,2018-06-05,특징주삼성바이오로직스전일급락딛고반등,http://www.sporbiz.co.kr/news/articleView.html?idxno=240992
3343,2018-06-05,특징주삼성바이오로직스장초반3대상승,http://www.ekn.kr/news/article.html?no=366137
3344,2018-06-05,특징주바이오주반등삼성바이오로직스3↑,http://news.hankyung.com/article/2018060500296
3345,2018-06-05,삼성바이오로직스셀트리온바이오USA에서CDMO사업확대,http://www.sedaily.com/NewsView/1S0OVLZ493
3346,2018-06-05,2018바이오USA삼성바이오로직스바이오USA서글로벌경쟁력알려,http://www.fnnews.com/news/201806050821408868
3347,2018-06-05,특징주삼성바이오로직스반등증선위앞두고주가갈팡질팡,http://www.newsis.com/view/?id=NISX20180605_0000327682&cID=10401&pID=10400
3348,2018-06-05,특징주삼성바이오로직스급락후하루만에3반등,http://www.cstimes.com/?mod=news&act=articleView&idxno=277420
3349,2018-06-05,롤러코스터삼성바이오로직스급락하루만에4반등,http://news.heraldcorp.com/view.php?ud=20180605000167
3350,2018-06-05,특징주삼성바이오로직스급락하루만에반등,http://www.ebn.co.kr/news/view/944029
3351,2018-06-05,ET투자뉴스삼성바이오로직스_돋보이는상승세현재251,http://www.etnews.com/20180605000039
3352,2018-06-05,삼성바이오로직스바이오USA서약110건미팅진행,http://www.medigatenews.com/news/3127616663
3353,2018-06-05,삼성바이오로직스바이오USA서110건미팅진행,http://www.dailypharm.com/News/240511
3354,2018-06-05,삼성바이오로직스세계최대바이오전시회참가,http://www.newsworks.co.kr/news/articleView.html?idxno=191435
3355,2018-06-05,삼성바이오로직스세계최대바이오박람회바이오USA8년째단독부스설치,http://www.edaily.co.kr/news/newspath.asp?newsid=02292726619238768
3356,2018-06-05,삼성바이오로직스급락후하루만에3반등,http://www.nbntv.co.kr/news/articleView.html?idxno=104412
3357,2018-06-05,특징주삼성바이오로직스하루만에반등외인기관쌍끌이매수에2상승,http://view.asiae.co.kr/news/view.htm?idxno=2018060510180487347
3358,2018-06-05,삼성바이오로직스바이오USA서의약품개발제조수주나선다,http://www.newsis.com/view/?id=NISX20180605_0000327762&cID=13001&pID=13000
3359,2018-06-05,삼성바이오로직스2018BIO인터내셔널컨벤션참가,http://www.ebn.co.kr/news/view/944049
3360,2018-06-05,삼성바이오로직스2018바이오인터내셔널컨벤션참가,http://www.sisaon.co.kr/news/articleView.html?idxno=73788
3361,2018-06-05,미니인터뷰삼성바이오로직스분식회계감리위원회결과공개논란증폭된이유는,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10283900
3362,2018-06-05,삼성바이오로직스최고바이오컨퍼런스참석,http://www.whosaeng.com/sub_read.html?uid=101867§ion=sc5
3363,2018-06-05,삼성바이오로직스세계최대바이오전시회참가,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180605103600
3364,2018-06-05,삼성바이오로직스2018BIO인터내셔널컨벤션참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1197315
3365,2018-06-05,삼성바이오로직스바이오USA서적극수주셀트리온도CDMO사업개시,http://www.sporbiz.co.kr/news/articleView.html?idxno=241041
3366,2018-06-05,삼성바이오로직스바이오USA서약110건미팅진행CDO사업강조,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018060510485026459
3367,2018-06-05,삼성바이오로직스8년연속바이오USA참가,http://www.kpinews.co.kr/news/articleView.html?idxno=75342
3368,2018-06-05,삼성바이오로직스바이오USA서CDMO경쟁력과시,http://news.mt.co.kr/mtview.php?no=2018060511102984628
3369,2018-06-05,뉴스투데이E삼성바이오로직스2018BIO인터내셔널컨벤션가다8년연속단독부스마련,http://www.news2day.co.kr/105096
3370,2018-06-05,삼성바이오로직스시장교란행위에증선위서뒤집힐까기사라니,http://www.gobalnews.com/news/articleView.html?idxno=25212
3371,2018-06-05,CDO수주나선삼성바이오로직스바이오USA서110건줄미팅,http://news1.kr/articles/?3336626
3372,2018-06-05,바이오주상승삼성바이오로직스급락후하루만에반등,https://cnbc.sbs.co.kr/article_hub/10000904054?division=NAVER
3373,2018-06-05,삼성바이오로직스바이오USA서잠재거래처발굴주력,http://news.mk.co.kr/newsRead.php?year=2018&no=356384
3374,2018-06-05,한국경제TV증시라인삼성바이오로직스분식회계vs기업회계준수,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806050377&t=NNv
3375,2018-06-05,삼성바이오로직스세계최대바이오박람회단독부스참가,http://www.m-i.kr/news/articleView.html?idxno=421542
3376,2018-06-05,삼성바이오로직스세계1위바이오클러스터도시를가다,http://www.ekn.kr/news/article.html?no=366249
3377,2018-06-05,삼성바이오로직스2018BIO인터내셔널컨벤션참가,http://www.metroseoul.co.kr/news/newsview?newscd=2018060500065
3378,2018-06-05,삼성바이오로직스BIO국제컨벤션서110건미팅,http://medipana.com/news/news_viewer.asp?NewsNum=220987&MainKind=A&NewsKind=5&vCount=12&vKind=1
3379,2018-06-05,최종구삼성바이오로직스분식회계증선위서충분한논의거칠것,http://news.hankyung.com/article/2018060524046
3380,2018-06-05,증시외국인매도현대로템급락vs삼성바이오로직스셀트리온반등,http://www.choicenews.co.kr/news/articleView.html?idxno=41971
3381,2018-06-05,삼성바이오로직스분식회계결국증선위로35시간마라톤회의도수포,http://www.iminju.net/news/articleView.html?idxno=35992
3382,2018-06-05,삼성바이오로직스바이오USA단독부스참가잠재고객발굴,http://www.dailian.co.kr/news/view/717846/?sc=naver
3383,2018-06-05,글로벌공략삼성바이오로직스바이오약생산력위풍당당홍보,http://www.ajunews.com/view/20180605170920628
3384,2018-06-05,최종구증권선물위에서삼성바이오로직스회계논란충분히논의,http://www.businesspost.co.kr/BP?command=article_view&num=84731
3385,2018-06-05,삼성바이오로직스8년째바이오USA참가혁신적경쟁력전파,http://www.fnnews.com/news/201806051723580913
3386,2018-06-05,삼성바이오로직스셀트리온주가올라미국바이오행사참가효과,http://www.businesspost.co.kr/BP?command=article_view&num=84750
3387,2018-06-05,최종구삼성바이오로직스증선위회의여러번이뤄질것,http://www.ekn.kr/news/article.html?no=366338
3388,2018-06-05,삼성바이오로직스미국에서열리는BIO인터내셔널컨벤션참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=323062
3389,2018-06-05,최종구삼성바이오로직스감리여러번논의필요,http://www.econovill.com/news/articleView.html?idxno=339274
3390,2018-06-05,삼성바이오로직스바이오USA서약110건미팅진행CDO사업강조,http://daily.hankooki.com/lpage/economy/201806/dh20180605213441138080.htm
3391,2018-06-06,삼성바이오로직스의약품생산력세계최고맡겨보시죠,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=813701
3392,2018-06-06,간추린뉴스삼성바이오로직스美BIO국제컨벤션참가外,http://news.donga.com/3/all/20180605/90421486/1
3393,2018-06-06,삼성바이오로직스제재증선위민간위원3명이결정할듯,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10284044
3394,2018-06-06,바이오USA참가한삼성바이오로직스와셀트리온,http://news1.kr/photos/view/?3145774
3395,2018-06-06,삼성바이오로직스BTIT경쟁력제고글로벌CDMO기업레벨업,http://www.viva100.com/main/view.php?key=20180606010001544
3396,2018-06-06,내일삼성바이오로직스관련증선위개최민간위원주도,http://news.sbs.co.kr/news/endPage.do?news_id=N1004790571&plink=ORI&cooper=NAVER
3397,2018-06-06,2018바이오USA삼성바이오로직스부스,http://news1.kr/photos/view/?3145963
3398,2018-06-06,삼성바이오로직스미국2018BIO인터내셔널컨벤션참가,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1483821
3399,2018-06-06,삼성바이오로직스내일증선위첫회의논쟁지속될듯,http://www.sporbiz.co.kr/news/articleView.html?idxno=241610
3400,2018-06-07,운명의날삼성바이오로직스분식회계갈림길거래정지상장폐지가능성은,http://www.g-enews.com/ko-kr/news/article/news_all/201806051732077919c642673384_1/article.html
3401,2018-06-07,삼성바이오로직스분식회계증선위개최회계처리와산업영향이양대변수,http://www.news2day.co.kr/105093
3402,2018-06-07,삼성바이오로직스제재수위결정증선위7일열려쟁점은,http://www.edaily.co.kr/news/newspath.asp?newsid=01400566619239424
3403,2018-06-07,증권선물위삼성바이오로직스분식회계논란가릴첫회의열어,http://www.businesspost.co.kr/BP?command=article_view&num=84821
3404,2018-06-07,오늘의경제일정증선위삼성바이오로직스제재수위결정,http://www.asiatime.co.kr/news/articleView.html?idxno=182684
3405,2018-06-07,오늘삼성바이오로직스증선위분식회계여부이르면7월결론,https://cnbc.sbs.co.kr/article_hub/10000904162?division=NAVER
3406,2018-06-07,특징주삼성바이오로직스증선위결정촉각외인은매도공세,http://www.g-enews.com/ko-kr/news/article/news_all/201806070907438663c16aa2f016_1/article.html
3407,2018-06-07,특징주증선위DDAY삼성바이오로직스하락세,http://www.newsis.com/view/?id=NISX20180607_0000329261&cID=10401&pID=10400
3408,2018-06-07,특징주증선위개최삼성바이오로직스하락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180607038100008&did=1195m
3409,2018-06-07,삼성바이오로직스분식회계심의증선위7일첫회의,http://www.kukinews.com/news/article.html?no=555057
3410,2018-06-07,증선위예정삼성바이오로직스장초반약세,http://www.sedaily.com/NewsView/1S0PS3UVAL
3411,2018-06-07,오늘증선위첫회의삼성바이오로직스운명은,https://cnbc.sbs.co.kr/article_hub/10000904179?division=NAVER
3412,2018-06-07,특징주삼성바이오로직스증선위당일주가주춤,http://www.newsprime.co.kr/news/article.html?no=418871
3413,2018-06-07,현장연결삼성바이오로직스제재증선위에쏠린눈누구손들어줄까,https://cnbc.sbs.co.kr/article_hub/10000904188?division=NAVER
3414,2018-06-07,특징주삼성바이오로직스증선위첫날1약세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018060709355771020
3415,2018-06-07,삼성바이오로직스제재여부결정증선위첫회의,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10284213
3416,2018-06-07,바이오USA삼성바이오로직스3년뒤CDO도글로벌1위목표,http://news1.kr/articles/?3337977
3417,2018-06-07,바이오USA삼성바이오로직스3년내CDO사업글로벌넘버원될것,http://view.asiae.co.kr/news/view.htm?idxno=2018060705411218065
3418,2018-06-07,2018바이오USA삼성바이오로직스CDO첫미국수주3년내글로벌1위,http://www.newspim.com/news/view/20180607000148
3419,2018-06-07,2018바이오USA삼성바이오로직스고객맞춤형CDO로5년내시장1위차지할것,http://www.fnnews.com/news/201806070501425617
3420,2018-06-07,김용범증선위원장삼성바이오로직스와회계법인에소명기회최대한보장,http://view.asiae.co.kr/news/view.htm?idxno=2018060710060727426
3421,2018-06-07,증선위원장삼성바이오로직스문제공정하게처리정보보안당부,http://www.mediapen.com/news/view/360165
3422,2018-06-07,김용범삼성바이오로직스분식회계공정하게판단소명기회최대보장,http://news.hankyung.com/article/2018060763456
3423,2018-06-07,증선위분식회계의혹삼성바이오로직스첫회의,http://www.polinews.co.kr/news/article.html?no=357894
3424,2018-06-07,특징주증선위개최삼성바이오로직스상승전환,http://www.mediapen.com/news/view/360168
3425,2018-06-07,보도참고삼성바이오로직스감리결과조치안심의前증선위원장모두발언,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156273692
3426,2018-06-07,특징주운명의날삼성바이오로직스등락거듭,http://moneys.mt.co.kr/news/mwView.php?no=2018060710148093169
3427,2018-06-07,포토삼성바이오로직스증선위첫개최,http://view.asiae.co.kr/news/view.htm?idxno=2018060710184270977
3428,2018-06-07,포토삼성바이오로직스증선위주재하는김용범금융위부위원장,http://view.asiae.co.kr/news/view.htm?idxno=2018060710183865536
3429,2018-06-07,포토삼성바이오로직스증선위첫개최,http://view.asiae.co.kr/news/view.htm?idxno=2018060710182362835
3430,2018-06-07,포토삼성바이오로직스분식회계여부가릴증선위시작,http://view.asiae.co.kr/news/view.htm?idxno=2018060710195297642
3431,2018-06-07,포토삼성바이오로직스증선위주재하는김용범,http://view.asiae.co.kr/news/view.htm?idxno=2018060710191183409
3432,2018-06-07,포토삼성바이오로직스분식회계여부가릴증선위,http://view.asiae.co.kr/news/view.htm?idxno=2018060710194794490
3433,2018-06-07,김용범삼성바이오로직스분식회계심의공정하게판단할것”,http://moneys.mt.co.kr/news/mwView.php?no=2018060710258065127
3434,2018-06-07,삼성바이오로직스분식회계논란결과는,http://news1.kr/photos/view/?3147188
3435,2018-06-07,김용범삼성바이오로직스분식회계선입견없이판단할것,http://news1.kr/photos/view/?3147193
3436,2018-06-07,김용범삼성바이오로직스분식회계여부공정하게판단,http://news.heraldcorp.com/view.php?ud=20180607000256
3437,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.newsis.com/view/?id=NISI20180607_0014151348
3438,2018-06-07,삼성바이오로직스1차증선위참석하는김용범부위원장,http://www.newsis.com/view/?id=NISI20180607_0014151342
3439,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.newsis.com/view/?id=NISI20180607_0014151349
3440,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.newsis.com/view/?id=NISI20180607_0014151343
3441,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.newsis.com/view/?id=NISI20180607_0014151348
3442,2018-06-07,삼성바이오로직스1차증선위참석하는김용범부위원장,http://www.newsis.com/view/?id=NISI20180607_0014151342
3443,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.newsis.com/view/?id=NISI20180607_0014151345
3444,2018-06-07,NW포토증권선물위원회오늘삼성바이오로직스분식회계여부논의착수,http://www.newsway.co.kr/view.php?tp=1&ud=2018060710330034821
3445,2018-06-07,김용범삼성바이오로직스분식회계여부공정하게판단,http://news1.kr/photos/view/?3147222
3446,2018-06-07,삼성바이오로직스분식회계논란해법은,http://news1.kr/photos/view/?3147211
3447,2018-06-07,NW포토삼성바이오로직스회계논란2라운드,http://www.newsway.co.kr/view.php?tp=1&ud=2018060710342792384
3448,2018-06-07,사진삼성바이오로직스1차증선위원회,http://news.mt.co.kr/mtview.php?no=2018060710362922902
3449,2018-06-07,삼성바이오로직스1차증선위참석하는김용범금융위부위원장,http://news1.kr/photos/view/?3147197
3450,2018-06-07,NW포토증선위삼성바이오로직스회계처리첫회의,http://www.newsway.co.kr/view.php?tp=1&ud=2018060710355194836
3451,2018-06-07,사진삼성바이오로직스1차증선위,http://news.mt.co.kr/mtview.php?no=2018060710370332351
3452,2018-06-07,삼성바이오로직스1차증선위주재하는김용범부위원장,http://news1.kr/photos/view/?3147243
3453,2018-06-07,NW포토증선위삼성바이오로직스분식회계혐의회의,http://www.newsway.co.kr/view.php?tp=1&ud=2018060710383839001
3454,2018-06-07,삼성바이오로직스제1차증선위주재하는김용범금융위부위원장,http://news1.kr/photos/view/?3147254
3455,2018-06-07,삼성바이오로직스증선위첫회의시작공정하게,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10284234
3456,2018-06-07,김용범삼성바이오로직스논란공정하게판단하겠다,http://news1.kr/photos/view/?3147248
3457,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.nocutnews.co.kr/news/4981339
3458,2018-06-07,삼성바이오로직스1차증권선물위원회,http://www.nocutnews.co.kr/news/4981340
3459,2018-06-07,삼성바이오로직스1차증선위원회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607059800013&did=1196m
3460,2018-06-07,삼성바이오로직스증선위참석한조성욱교수,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607060900013&did=1196m
3461,2018-06-07,포토삼성바이오로직스1차증권선물위원회주재하는김용범,http://view.asiae.co.kr/news/view.htm?idxno=2018060710443892044
3462,2018-06-07,포토삼성바이오로직스1차증권선물위원회,http://view.asiae.co.kr/news/view.htm?idxno=2018060710444796191
3463,2018-06-07,사진증선위분식회계삼성바이오로직스첫회의,http://www.newspim.com/news/view/20180607000187
3464,2018-06-07,삼성바이오로직스분식회계여부는,http://www.newsis.com/view/?id=NISI20180607_0014151458
3465,2018-06-07,포토삼성바이오로직스운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018060710453217390
3466,2018-06-07,포토삼성바이오로직스운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018060710452712824
3467,2018-06-07,삼성바이오로직스증선위참석한조성국박재환교수,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607061000013&did=1196m
3468,2018-06-07,포토분식회계논란삼성바이오로직스운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018060710454424393
3469,2018-06-07,포토분식회계혐의삼성바이오로직스운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018060710452105206
3470,2018-06-07,삼성바이오로직스분식회계여부는,http://www.newsis.com/view/?id=NISI20180607_0014151474
3471,2018-06-07,증권선물위삼성바이오로직스분식회계혐의논의,http://www.newsis.com/view/?id=NISI20180607_0014151468
3472,2018-06-07,삼성바이오로직스분식회계혐의논의,http://www.newsis.com/view/?id=NISI20180607_0014151471
3473,2018-06-07,삼성바이오로직스분식회계혐의논의,http://www.newsis.com/view/?id=NISI20180607_0014151470
3474,2018-06-07,삼성바이오로직스분식회계혐의논의,http://www.newsis.com/view/?id=NISI20180607_0014151472
3475,2018-06-07,삼성바이오로직스분식회계여부논의,http://www.newsis.com/view/?id=NISI20180607_0014151478
3476,2018-06-07,삼성바이오로직스분식회계여부는,http://www.newsis.com/view/?id=NISI20180607_0014151477
3477,2018-06-07,포토삼성바이오로직스분식회계여부가릴증선위,http://view.asiae.co.kr/news/view.htm?idxno=2018060710502173206
3478,2018-06-07,포토삼성바이오로직스분식회계여부가릴증선위,http://view.asiae.co.kr/news/view.htm?idxno=2018060710501570142
3479,2018-06-07,포토삼성바이오로직스분식회계여부가릴증권선물위원회,http://view.asiae.co.kr/news/view.htm?idxno=2018060710504180740
3480,2018-06-07,삼성바이오로직스분식회계회의참석한금융당국관계자들,http://www.newsis.com/view/?id=NISI20180607_0014151517
3481,2018-06-07,삼성바이오로직스1차증선위원회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607065200013&did=1196m
3482,2018-06-07,삼성바이오로직스1차증선위원회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607065400013&did=1196m
3483,2018-06-07,포토증선위삼성바이오로직스분식회계혐의는,http://www.edaily.co.kr/news/newspath.asp?newsid=02581366619239424
3484,2018-06-07,포토증권선물위원회삼성바이오로직스분식회계혐의는,http://www.edaily.co.kr/news/newspath.asp?newsid=02578086619239424
3485,2018-06-07,포토증선위삼성바이오로직스분식회계판단은,http://www.edaily.co.kr/news/newspath.asp?newsid=02594486619239424
3486,2018-06-07,포토증권선물위원회삼성바이오로직스분식회계의혹은,http://www.edaily.co.kr/news/newspath.asp?newsid=02587926619239424
3487,2018-06-07,포토증선위삼성바이오로직스분식회계의혹은,http://www.edaily.co.kr/news/newspath.asp?newsid=02584646619239424
3488,2018-06-07,포토증권선물위원회삼성바이오로직스분식회계판단은,http://www.edaily.co.kr/news/newspath.asp?newsid=02591206619239424
3489,2018-06-07,포토증선위삼성바이오로직스분식회계여부는,http://www.edaily.co.kr/news/newspath.asp?newsid=02597766619239424
3490,2018-06-07,포토증권선물위원회삼성바이오로직스분식회계여부는,http://www.edaily.co.kr/news/newspath.asp?newsid=02601046619239424
3491,2018-06-07,포토삼성바이오로직스분식회계증선위민간위원들의판단은,http://www.edaily.co.kr/news/newspath.asp?newsid=02699446619239424
3492,2018-06-07,포토삼성바이오로직스분식회계증선위위원들의판단은,http://www.edaily.co.kr/news/newspath.asp?newsid=02702726619239424
3493,2018-06-07,포토삼성바이오로직스분식회계위원들의판단은,http://www.edaily.co.kr/news/newspath.asp?newsid=02709286619239424
3494,2018-06-07,분식회계혐의삼성바이오로직스운명은,http://news.kmib.co.kr/article/view.asp?arcid=0012420083&code=61141111&cp=nv
3495,2018-06-07,머니S포토삼성바이오로직스관련금융위증선위개최,http://moneys.mt.co.kr/news/mwView.php?no=2018060710408087330
3496,2018-06-07,머니S포토삼성바이오로직스관련금융위증선위주목,http://moneys.mt.co.kr/news/mwView.php?no=2018060710428086652
3497,2018-06-07,증권선물위김용범삼성바이오로직스회계논란공정히가린다”,http://www.businesspost.co.kr/BP?command=article_view&num=84844
3498,2018-06-07,특징주종합증선위DDAY삼성바이오로직스주가엎치락뒤치락,http://www.newsis.com/view/?id=NISX20180607_0000329514&cID=10401&pID=10400
3499,2018-06-07,현장연결삼성바이오로직스증선위개최선입견없이판단”,https://cnbc.sbs.co.kr/article_hub/10000904215?division=NAVER
3500,2018-06-07,김용범금융위부위원장삼성바이오로직스관련의혹회사와회계법인에게소명기회최대한보장,http://www.asiatoday.co.kr/view.php?key=20180607010002869
3501,2018-06-07,삼성바이오로직스증선위첫회의시작증선위원장민간위원판단존중절대보안유지”,http://www.foodtvnews.com/news/article.html?no=7923
3502,2018-06-07,증권선물위원회삼성바이오로직스회계처리적절논란소명기회최대한보장,http://www.newsrep.co.kr/news/articleView.html?idxno=51587
3503,2018-06-07,증선위개최삼성바이오로직스하락세,https://cnbc.sbs.co.kr/article_hub/10000904224?division=NAVER
3504,2018-06-07,포토삼성바이오로직스분식회계혐의판단하는증권선물위원회,http://www.metroseoul.co.kr/news/newsview?newscd=2018060700081
3505,2018-06-07,삼성바이오로직스의약품위탁개발첫수주,http://news.mk.co.kr/newsRead.php?year=2018&no=360438
3506,2018-06-07,포토김태한삼성바이오로직스대표증선위출석,http://view.asiae.co.kr/news/view.htm?idxno=2018060712512172651
3507,2018-06-07,포토취재진질문받는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060712534382861
3508,2018-06-07,포토김태한삼성바이오로직스사장미소띈얼굴로출석,http://view.asiae.co.kr/news/view.htm?idxno=2018060712541985108
3509,2018-06-07,사진첫증선위출석한김태한삼성바이오로직스대표,http://www.newspim.com/news/view/20180607000241
3510,2018-06-07,포토분식회계논란질문에답변하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060712562398192
3511,2018-06-07,포토질문에답변하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060712574701203
3512,2018-06-07,증선위참석하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607112300013&did=1196m
3513,2018-06-07,증선위참석하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607112200013&did=1196m
3514,2018-06-07,포토김태한삼성바이오로직스대표향한질문세례,http://view.asiae.co.kr/news/view.htm?idxno=2018060713004709049
3515,2018-06-07,포토김태한삼성바이오로직스대표향한질문세례,http://view.asiae.co.kr/news/view.htm?idxno=2018060713003906764
3516,2018-06-07,포토김태한삼성바이오로직스대표에쏟아지는질문,http://view.asiae.co.kr/news/view.htm?idxno=2018060713011218222
3517,2018-06-07,포토김태한삼성바이오로직스대표에쏟아지는질문,http://view.asiae.co.kr/news/view.htm?idxno=2018060713010714043
3518,2018-06-07,증선위참석하는김태한삼성바이오로직스대표,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607112700013&did=1196m
3519,2018-06-07,삼성바이오로직스증선위좁은문통과,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607113600013&did=1196m
3520,2018-06-07,삼성바이오로직스증선위좁은문통과,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607113500013&did=1196m
3521,2018-06-07,포토김태한삼성바이오로직스대표희미한미소,http://view.asiae.co.kr/news/view.htm?idxno=2018060713055139746
3522,2018-06-07,포토정부서울청사찾은김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060713050933926
3523,2018-06-07,포토증권선물위원회향하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060713053236008
3524,2018-06-07,증선위출석하는삼성바이오로직스관계자,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607114100013&did=1196m
3525,2018-06-07,이데일리N증선위삼성바이오로직스분식회계첫논의外,http://www.edaily.co.kr/news/newspath.asp?newsid=03106166619239424
3526,2018-06-07,포토취재진질문답하는김태한삼성바이오로직스사장,http://www.edaily.co.kr/news/newspath.asp?newsid=03112726619239424
3527,2018-06-07,포토미소보이는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060713125178544
3528,2018-06-07,포토몸수색받는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060713120267745
3529,2018-06-07,포토삼성바이오로직스향한질문,http://view.asiae.co.kr/news/view.htm?idxno=2018060713121770807
3530,2018-06-07,포토정부서울청사찾은김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060713123675006
3531,2018-06-07,포토증권선물위원회출석하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018060713132187274
3532,2018-06-07,포토오늘삼성바이오로직스증선위원회첫회의,http://www.sisaon.co.kr/news/articleView.html?idxno=73873
3533,2018-06-07,포토김태한삼성바이오로직스대표여유로운미소,http://view.asiae.co.kr/news/view.htm?idxno=2018060713163503248
3534,2018-06-07,질문받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607116600013&did=1196m
3535,2018-06-07,질문받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607116700013&did=1196m
3536,2018-06-07,질문받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607116800013&did=1196m
3537,2018-06-07,증선위향하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607117200013&did=1196m
3538,2018-06-07,증선위향하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180607117300013&did=1196m
3539,2018-06-07,사진삼성바이오로직스분식회계심의증선위첫회의,http://www.newspim.com/news/view/20180607000253
3540,2018-06-07,김태한삼성바이오로직스사장진실하고성실하게소명하겠다,http://www.asiatoday.co.kr/view.php?key=20180607010003004
3541,2018-06-07,김태한삼성바이오로직스사장빠른정상화위해적극소명하겠다,http://news.hankyung.com/article/2018060779086
3542,2018-06-07,서울포토삼성바이오로직스증선위서발언하는김용범금융위부위원장,http://www.seoul.co.kr/news/newsView.php?id=20180607500070&wlog_tag3=naver
3543,2018-06-07,서울포토삼성바이오로직스증선위대화나누는금융당국관계자들,http://www.seoul.co.kr/news/newsView.php?id=20180607500073&wlog_tag3=naver
3544,2018-06-07,삼성바이오로직스분식회계첫증선위김용범선입견없이판단,http://www.ekn.kr/news/article.html?no=366600
3545,2018-06-07,삼성바이오로직스증권선물위원회,http://www.fnnews.com/news/201806071442163524
3546,2018-06-07,김용범증권선물위원장삼성바이오로직스어떤선입견도없이공정하게이뤄질것,http://www.m-i.kr/news/articleView.html?idxno=422238
3547,2018-06-07,김용범삼성바이오로직스안건민간위원판단존중”,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180607.99099003015
3548,2018-06-07,삼성바이오로직스증선위개막바이오젠에쏠린눈,http://www.ebn.co.kr/news/view/944296
3549,2018-06-07,삼성바이오로직스분식회계공정하게심의,http://www.dailymedi.com/detail.php?number=831311&thread=22r05
3550,2018-06-07,특징주증선위개최삼성바이오로직스소폭하락종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180607038151008&did=1195m
3551,2018-06-07,6월7일목요일특징주삼성바이오로직스,http://www.leaders.kr/news/articleView.html?idxno=67631
3552,2018-06-07,증선위개최삼성바이오로직스약보합마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=323210
3553,2018-06-07,증선위회의첫날삼성바이오로직스약보합마감,http://www.choicenews.co.kr/news/articleView.html?idxno=42020
3554,2018-06-07,특징주증선위회의삼성삼성바이오로직스하락마감,http://www.kpinews.co.kr/news/articleView.html?idxno=75501
3555,2018-06-07,아주종목분석증선위개최삼성바이오로직스소폭하락,http://www.ajunews.com/view/20180607162908704
3556,2018-06-07,삼성바이오로직스운명좌우할증권선물위민간위원3인은누구,http://www.businesspost.co.kr/BP?command=article_view&num=84894
3557,2018-06-07,분식회계논란삼성바이오로직스공은증선위로,http://www.kpinews.co.kr/news/articleView.html?idxno=75493
3558,2018-06-07,삼성바이오로직스의약품위탁개발첫번째수주,http://www.nbntv.co.kr/news/articleView.html?idxno=104456
3559,2018-06-07,삼성바이오로직스증선위김용범공정하게판단할것,http://www.nbntv.co.kr/news/articleView.html?idxno=104459
3560,2018-06-07,삼성바이오로직스5년내CDO시장세계1위할것,http://www.fnnews.com/news/201806071700294598
3561,2018-06-07,삼성바이오로직스증권선물위민간위원어떻게설득할까,http://www.businesspost.co.kr/BP?command=article_view&num=84916
3562,2018-06-07,삼성바이오로직스분식회계증선위첫회의돌입,http://www.wsobi.com/news/articleView.html?idxno=61354
3563,2018-06-07,삼성바이오로직스1차증선위참석후청사나서는김태한대표,http://news1.kr/photos/view/?3148691
3564,2018-06-07,함박웃음지으며증선위마친김태한삼성바이오로직스대표,http://news1.kr/photos/view/?3148686
3565,2018-06-07,삼성바이오로직스첫증선위김태한사장적극소명할것,http://www.wolyo.co.kr/news/articleView.html?idxno=62253
3566,2018-06-07,김태한삼성바이오로직스대표할말없습니다,http://news1.kr/photos/view/?3148693
3567,2018-06-07,김태한삼성바이오로직스대표할말없습니다,http://news1.kr/photos/view/?3148706
3568,2018-06-07,삼성바이오로직스1차증선위참석후청사나서는김태한대표,http://news1.kr/photos/view/?3148702
3569,2018-06-07,김용범삼성바이오로직스의혹공정한방식으로일반에공개,http://www.fnnews.com/news/201806071718288910
3570,2018-06-07,영상증선위대심제마친김태한삼성바이오로직스사장묵묵부답,http://www.newspim.com/news/view/20180607000409
3571,2018-06-07,삼성바이오로직스첫증선위열려민간위원판단존중”,https://cnbc.sbs.co.kr/article_hub/10000904275?division=NAVER
3572,2018-06-07,삼성바이오로직스분식논란2라운드개막,http://news20.busan.com/controller/newsController.jsp?newsId=20180607000203
3573,2018-06-07,셀트리온3총사주가모두올라삼성바이오로직스는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=84938
3574,2018-06-07,삼성바이오로직스분식회계공방증선위첫회의,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1484402
3575,2018-06-07,삼성바이오로직스분식회계의혹20일2차증선위서계속논의,http://www.asiatoday.co.kr/view.php?key=20180607010003367
3576,2018-06-07,삼성바이오로직스증선위20일2차회의도대심제로진행,http://news.hankyung.com/article/2018060701206
3577,2018-06-07,삼성바이오로직스증선위결론못내20일2차회의,http://www.ebn.co.kr/news/view/944363
3578,2018-06-07,삼성바이오로직스증선위20일2차회의대심제로진행,http://www.ajunews.com/view/20180607222225802
3579,2018-06-07,삼성바이오로직스증선위첫회의,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=754718
3580,2018-06-07,증선위삼성바이오로직스2차회의이달20일대심제진행한다,http://www.mediapen.com/news/view/360366
3581,2018-06-07,금융위증권선물위원회첫회의심의절차착수공울린분식회계판단공방전삼성바이오로직스혐의벗을까,http://www.kyeongin.com/main/view.php?key=20180607010002427
3582,2018-06-08,삼성바이오로직스증선위첫회의결론못내20일2차회의,http://www.ekn.kr/news/article.html?no=366733
3583,2018-06-08,삼성바이오로직스첫증선위결론못내20일2차증선위개최,https://cnbc.sbs.co.kr/article_hub/10000904319?division=NAVER
3584,2018-06-08,삼성바이오로직스분식회계결론못내20일2차회의,http://www.cstimes.com/?mod=news&act=articleView&idxno=277663
3585,2018-06-08,삼성바이오로직스첫증선위결론못내20일2차회의,http://medipana.com/news/news_viewer.asp?NewsNum=221084&MainKind=A&NewsKind=5&vCount=12&vKind=1
3586,2018-06-08,특징주삼성바이오로직스분식회계진통에도강세외인은러브콜,http://www.g-enews.com/ko-kr/news/article/news_all/201806080907161352c16aa2f016_1/article.html
3587,2018-06-08,특징주삼성바이오로직스1차증선위마쳐강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=242272
3588,2018-06-08,장용혁의마켓시그널삼성바이오로직스셀트리온숏커버링타이밍,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018060808241260321
3589,2018-06-08,삼성바이오로직스의약품위탁개발3건수주,http://www.edaily.co.kr/news/newspath.asp?newsid=01866326619239752
3590,2018-06-08,1차증선위끝난삼성바이오로직스소폭강세,http://www.sedaily.com/NewsView/1S0Q8INUGO
3591,2018-06-08,삼성바이오로직스회계논란새국면바이오젠행보촉각,http://moneys.mt.co.kr/news/mwView.php?no=2018060805518018015
3592,2018-06-08,오운암의속살속살제2제3의셀트리온과삼성바이오로직스나와야,http://www.news2day.co.kr/105241
3593,2018-06-08,삼성바이오로직스분식회계의혹2라운드도장기화예상,http://www.asiatoday.co.kr/view.php?key=20180608010003484
3594,2018-06-08,삼성바이오로직스주가롤러코스터변동성전망은,https://cnbc.sbs.co.kr/article_hub/10000904391?division=NAVER
3595,2018-06-08,증선위끝난삼성바이오로직스소폭강세코스피코스닥모두약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=323321
3596,2018-06-08,삼성바이오로직스분식회계결론도출진통20일2차대심열린다,http://www.wolyo.co.kr/news/articleView.html?idxno=62302
3597,2018-06-08,13시간공방에도삼성바이오로직스분식회계논란여전,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002443234&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
3598,2018-06-08,삼성바이오로직스분식회계가릴증권선물위장기화가능성,http://www.businesspost.co.kr/BP?command=article_view&num=85016
3599,2018-06-08,삼성바이오로직스주가소폭올라셀트리온3총사는떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=85077
3600,2018-06-10,증선위삼성바이오로직스의혹에12일임시회의,http://news.mt.co.kr/mtview.php?no=2018061009044330946
3601,2018-06-10,삼성바이오로직스증선위12일임시회의개최금감원만출석,http://news.hankyung.com/article/2018061063486
3602,2018-06-10,삼성바이오로직스2차증선위12일임시회개최금감원만출석,http://news.einfomax.co.kr/news/articleView.html?idxno=3452687
3603,2018-06-10,증선위12일삼성바이오로직스의혹검토임시회의개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018061009402528081
3604,2018-06-10,삼성바이오로직스증선위12일임시회의심도있는논의필요,http://www.sportsseoul.com/news/read/645054
3605,2018-06-10,삼성바이오로직스증선위12일임시회의금감원만출석,http://www.asiatoday.co.kr/view.php?key=20180610010004113
3606,2018-06-10,증선위삼성바이오로직스분식회계혐의12일임시회의개최,http://www.polinews.co.kr/news/article.html?no=358152
3607,2018-06-10,증선위12일삼성바이오로직스심의임시회개최,http://www.seoulfn.com/news/articleView.html?idxno=310709
3608,2018-06-10,삼성바이오로직스증선위12일임시회의개최,http://www.ezyeconomy.com/news/articleView.html?idxno=83693
3609,2018-06-10,증선위삼성바이오로직스의혹관련임시회의12일개최충분한논의필요,http://www.econonews.co.kr/news/articleView.html?idxno=26662
3610,2018-06-10,삼성바이오로직스증선위오는12일임시회개최,http://www.kukinews.com/news/article.html?no=555848
3611,2018-06-10,증선위12일삼성바이오로직스분식논의임시회의연다,http://www.hani.co.kr/arti/economy/finance/848410.html
3612,2018-06-10,증권선물위삼성바이오로직스회계논란다룰임시회의열기로,http://www.businesspost.co.kr/BP?command=article_view&num=85134
3613,2018-06-10,증선위삼성바이오로직스분식논의임시회의개최,http://www.econovill.com/news/articleView.html?idxno=339514
3614,2018-06-10,증선위12일삼성바이오로직스분식회계의혹임시회의개최,http://sports.khan.co.kr/news/sk_index.html?art_id=201806101510003&sec_id=564001&pt=nv
3615,2018-06-10,삼성바이오로직스증선위12일임시회개최금감원만출석,http://www.sporbiz.co.kr/news/articleView.html?idxno=243081
3616,2018-06-10,증권선물위돌연임시회의삼성바이오로직스유리할까불리할까,http://www.businesspost.co.kr/BP?command=article_view&num=85144
3617,2018-06-10,삼성바이오로직스분식회계심의임시위열린다,http://www.joongboo.com/?mod=news&act=articleView&idxno=1258076
3618,2018-06-11,삼성바이오로직스증선위오늘임시회의개최,http://www.obsnews.co.kr/news/articleView.html?idxno=1100203
3619,2018-06-11,삼성바이오로직스임시위12일개최왜,http://news.heraldcorp.com/view.php?ud=20180611000079
3620,2018-06-11,특징주삼성바이오로직스증선위임시회의앞두고하락,http://www.viva100.com/main/view.php?key=20180611010002906
3621,2018-06-11,증권선물위12일비공개임시회의삼성바이오로직스분식회계여부심의,http://news.heraldcorp.com/view.php?ud=20180611000468
3622,2018-06-11,코스피↑코스닥↓셀트리온3대장삼성바이오로직스신라젠공동약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=323451
3623,2018-06-11,정리Time삼성바이오로직스분식회계논란정리,http://www.sisafocus.co.kr/news/articleView.html?idxno=186972
3624,2018-06-11,코스피상승마감셀트리온삼성바이오로직스신라젠약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=323493
3625,2018-06-11,내일의경제일정증선위삼성바이오로직스관련임시회개최,http://www.asiatime.co.kr/news/articleView.html?idxno=183176
3626,2018-06-11,셀트리온과삼성바이오로직스주가모두소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=85250
3627,2018-06-12,특징주삼성바이오로직스금융위깜짝임시회의에외인매수우위강세,http://www.g-enews.com/ko-kr/news/article/news_all/201806120907572427c16aa2f016_1/article.html
3628,2018-06-12,삼성바이오로직스임시증선위소식에상승,http://www.sedaily.com/NewsView/1S0S35Q3U0
3629,2018-06-12,특징주삼성바이오로직스임시증선위앞두고오름세,http://www.sporbiz.co.kr/news/articleView.html?idxno=243838
3630,2018-06-12,삼성바이오로직스임시증선위소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=323551
3631,2018-06-12,삼성바이오로직스증선위임시회의금감원만부른이유,http://www.news2day.co.kr/105393
3632,2018-06-12,삼성전자가삼성물산보유의삼성바이오로직스지분살수도,http://www.businesspost.co.kr/BP?command=article_view&num=85321
3633,2018-06-12,특징주증선위임시회의삼성바이오로직스2대상승,http://www.asiatime.co.kr/news/articleView.html?idxno=183359
3634,2018-06-12,삼성바이오로직스증선위임시회의감리근거설명,http://www.ebn.co.kr/news/view/944887
3635,2018-06-12,증권선물위삼성바이오로직스회계심의에공정성시비나올수도,http://www.businesspost.co.kr/BP?command=article_view&num=85393
3636,2018-06-12,삼성바이오로직스셀트리온주가올라외국인과기관모두매수,http://www.businesspost.co.kr/BP?command=article_view&num=85415
3637,2018-06-13,증선위삼성바이오로직스2015년이전회계도살핀다,http://news.mt.co.kr/mtview.php?no=2018061310360100376
3638,2018-06-13,삼성바이오로직스증선위2015년이전회계도따져본다,http://news.hankyung.com/article/2018061398866
3639,2018-06-13,금융위삼성바이오로직스2015년이전회계적정성검토,http://biz.newdaily.co.kr/site/data/html/2018/06/13/2018061300019.html
3640,2018-06-13,증선위삼성바이오로직스2015년이전회계적정성도검토,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018061312091696676
3641,2018-06-13,삼성바이오로직스2015년이전회계변수로,http://www.sedaily.com/NewsView/1S0SJN4SOI
3642,2018-06-13,금융위삼성바이오로직스2015년이전회계도본다,http://www.kpinews.co.kr/news/articleView.html?idxno=75880
3643,2018-06-13,증선위삼성바이오로직스2015년이전회계도검토,http://www.sisajournal-e.com/biz/article/185180
3644,2018-06-13,증선위삼성바이오로직스2015년이전회계처리도적정성검토,http://www.mediapen.com/news/view/361656
3645,2018-06-13,증선위삼성바이오로직스2015년이전회계처리도살핀다,http://www.edaily.co.kr/news/newspath.asp?newsid=01787606619241392
3646,2018-06-13,삼성바이오로직스회계처리논란금감원이놓친부분은,http://www.segye.com/content/html/2018/06/13/20180613000830.html?OutUrl=naver
3647,2018-06-13,증선위삼성바이오로직스2015년이전회계처리적정성검토,http://sports.chosun.com/news/ntype.htm?id=201806140100106340008163&servicedate=20180613
3648,2018-06-13,증선위삼성바이오로직스2015년이전회계적정성검토,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1486155
3649,2018-06-13,증선위삼성바이오로직스2015년이전회계처리적정성도검토,http://www.seoulfn.com/news/articleView.html?idxno=310985
3650,2018-06-13,증선위삼성바이오로직스2015년이전회계도살펴본다,http://www.segyefn.com/newsView/20180613000854?OutUrl=naver
3651,2018-06-13,증선위삼성바이오로직스2015년이전회계처리적정성도검토,http://www.ceoscoredaily.com/news/article.html?no=42222
3652,2018-06-13,증권선물위는왜삼성바이오로직스이전회계처리도살펴볼까,http://www.businesspost.co.kr/BP?command=article_view&num=85482
3653,2018-06-13,삼성바이오로직스2015년이전회계처리적정성도검토,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10285358
3654,2018-06-14,증선위삼성바이오로직스과거회계기준일관성이핵심쟁점,http://www.asiatoday.co.kr/view.php?key=20180613010006038
3655,2018-06-14,삼성바이오로직스2015년이전자료도들여다본다”,http://news.heraldcorp.com/view.php?ud=20180614000039
3656,2018-06-14,보도참고삼성바이오로직스건관련증권선물위원회논의경과,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156274709
3657,2018-06-14,증선위삼성바이오로직스2015년이전회계처리살핀다,http://www.polinews.co.kr/news/article.html?no=358480
3658,2018-06-14,삼성바이오로직스2015년이전회계처리도검사,http://www.newsrep.co.kr/news/articleView.html?idxno=52062
3659,2018-06-14,삼성바이오로직스분식회계논란과실판단가능성열렸다,http://www.sisajournal-e.com/biz/article/185223
3660,2018-06-14,삼성바이오로직스주가돌연추락무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=42194
3661,2018-06-14,삼성바이오로직스회계논란놓고증권선물위징계수위낮아지나,http://www.businesspost.co.kr/BP?command=article_view&num=85597
3662,2018-06-14,셀트리온주가올라시총3위로삼성바이오로직스주가는급락,http://www.businesspost.co.kr/BP?command=article_view&num=85637
3663,2018-06-15,증선위삼성바이오로직스2015년이전회계처리검토,http://www.kbanker.co.kr/news/articleView.html?idxno=73718
3664,2018-06-15,삼성바이오로직스논란에기업공개시장썰렁하반기는대어많아,http://www.businesspost.co.kr/BP?command=article_view&num=85742
3665,2018-06-15,셀트리온주가외국인매수세에급등삼성바이오로직스는제자리,http://www.businesspost.co.kr/BP?command=article_view&num=85776
3666,2018-06-17,삼성바이오로직스에피스설립부터관계사냐종속사냐논란재점화,http://www.mdtoday.co.kr/mdtoday/index.html?no=323756
3667,2018-06-18,올증시사상최고가경신종목은삼성바이오로직스등313개,http://www.newsis.com/view/?id=NISX20180617_0000338086&cID=10401&pID=10400
3668,2018-06-18,삼성바이오로직스등313개종목올해사상최고가,http://www.newstomato.com/ReadNews.aspx?no=830115
3669,2018-06-18,올들어삼성바이오로직스등313종목사상최고가경신,http://www.ekn.kr/news/article.html?no=368491
3670,2018-06-18,삼성바이오로직스∙KB금융∙LG생활건강최고가경신,http://www.fntimes.com/html/view.php?ud=2018061808312986181d6f57e61a_18
3671,2018-06-18,삼성바이오로직스KB금융등올들어사상최고가경신,http://www.dt.co.kr/contents.html?article_no=2018061702109958033001&ref=naver
3672,2018-06-18,삼성바이오로직스셀트리온등313곳주가올해사상최고가경신,http://www.businesspost.co.kr/BP?command=article_view&num=85869
3673,2018-06-18,금융위삼성바이오로직스이례적보도자료檢수사회피꼼수,http://www.gobalnews.com/news/articleView.html?idxno=25301
3674,2018-06-18,올해삼성바이오로직스등313종목사상최고가,http://www.newsprime.co.kr/news/article.html?no=419868
3675,2018-06-18,김경률삼성바이오로직스의도검찰로가지않는것,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10286105
3676,2018-06-18,셀트리온주가외국인매수세에상승삼성바이오로직스는하락,http://www.businesspost.co.kr/BP?command=article_view&num=85968
3677,2018-06-18,돋보기삼성바이오로직스와분식회계,http://news20.busan.com/controller/newsController.jsp?newsId=20180618000205
3678,2018-06-19,특징주삼성바이오로직스증선위2차하루앞두고3↓40만원대내줘,http://www.edaily.co.kr/news/newspath.asp?newsid=02010646619243360
3679,2018-06-19,삼성바이오로직스전일대비약5하락한387000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806190186&t=NN
3680,2018-06-19,특징주삼성바이오로직스2차증선위앞두고4대하락40만원선붕괴,http://www.etoday.co.kr/news/section/newsview.php?idxno=1632911
3681,2018-06-19,회계논란삼성바이오로직스상반기실적은순항,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180619103745
3682,2018-06-19,삼성바이오로직스고의성여부판단할2차회의앞두고주가흔들,http://www.g-enews.com/ko-kr/news/article/news_all/201806191118442147c16aa2f016_1/article.html
3683,2018-06-19,삼성바이오로직스내일2차증선위고의적회계처리여부파악,http://www.cstimes.com/?mod=news&act=articleView&idxno=278547
3684,2018-06-19,특징주삼성바이오로직스증선위심의앞두고급락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180619127800008&did=1195m
3685,2018-06-19,특징주삼성바이오로직스증선위3차심의앞두고급락,http://www.mediapen.com/news/view/363050
3686,2018-06-19,삼성바이오로직스증선위하루앞두고끝내급락마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=324149
3687,2018-06-19,外人투매속코스피연중최저셀트리온삼성바이오로직스추락,http://www.choicenews.co.kr/news/articleView.html?idxno=42306
3688,2018-06-19,내일의경제일정증선위삼성바이오로직스2차정례회의,http://www.asiatime.co.kr/news/articleView.html?idxno=184356
3689,2018-06-19,셀트리온주가외국인매도에맥못춰삼성바이오로직스도급락,http://www.businesspost.co.kr/BP?command=article_view&num=86104
3690,2018-06-20,오늘의증시삼성바이오로직스증선위데코앤이제3자배정유증6월20일,http://www.etoday.co.kr/news/section/newsview.php?idxno=1633154
3691,2018-06-20,삼성바이오로직스전일대비약4상승한396000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806200080&t=NN
3692,2018-06-20,특징주삼성바이오로직스3차증선위맞아5반등,http://news.mt.co.kr/mtview.php?no=2018062009061926482
3693,2018-06-20,한경로보뉴스삼성바이오로직스5이상상승외국계매수창구상위에등장모건스메릴린치등,http://news.hankyung.com/article/201806203327L
3694,2018-06-20,삼성바이오로직스증선위3차회의앞두고5급등,http://www.sedaily.com/NewsView/1S0VQN0CTR
3695,2018-06-20,특징주삼성바이오로직스증선위회의앞두고상승바이오주강세,http://news.hankyung.com/article/2018062033156
3696,2018-06-20,특징주삼성바이오로직스증선위3차앞두고4대강세,http://www.seoulfn.com/news/articleView.html?idxno=312067
3697,2018-06-20,특징주삼성바이오로직스2차증선위정례회의앞두고5반등,http://www.g-enews.com/ko-kr/news/article/news_all/201806200914066001c16aa2f016_1/article.html
3698,2018-06-20,특징주삼성바이오로직스증선위앞두고강세,http://www.newstomato.com/ReadNews.aspx?no=830845
3699,2018-06-20,특징주삼성바이오로직스3차증선위당일강세,http://www.newsprime.co.kr/news/article.html?no=420117
3700,2018-06-20,특징주삼성바이오로직스증선위2차회의앞두고강세,http://www.ekn.kr/news/article.html?no=369084
3701,2018-06-20,특징주증선위세번째심의삼성바이오로직스강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180620037700008&did=1195m
3702,2018-06-20,특징주삼성바이오로직스3차증선위앞두고반등,http://www.viva100.com/main/view.php?key=20180620010006223
3703,2018-06-20,특징주삼성바이오로직스증선위2차심의앞두고강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806200099&t=NN
3704,2018-06-20,특징주삼성바이오로직스증선위3차회의앞두고급등40만원선회복,http://www.etoday.co.kr/news/section/newsview.php?idxno=1633192
3705,2018-06-20,특징주증선위앞둔삼성바이오로직스강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01882726619243688
3706,2018-06-20,HotLine삼성바이오로직스증선위3차회의앞두고강세,http://news.mk.co.kr/newsRead.php?year=2018&no=387992
3707,2018-06-20,삼성바이오로직스3차증선위관건은과거회계처리,http://www.edaily.co.kr/news/newspath.asp?newsid=01889286619243688
3708,2018-06-20,3차증선위앞둔삼성바이오로직스4상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=324248
3709,2018-06-20,아주종목분석삼성바이오로직스증선위회의앞두고4대상승,http://www.ajunews.com/view/20180620093950395
3710,2018-06-20,삼성바이오로직스증선위3차회의회계처리고의성판단,http://www.sisajournal-e.com/biz/article/185447
3711,2018-06-20,특징주삼성바이오로직스증선위3차회의앞두고상승,http://www.inews24.com/php/news_view.php?g_serial=1102526&g_menu=022300&rrf=nv
3712,2018-06-20,특징주삼성바이오로직스6급등전환급락마감후반등성공,http://www.econonews.co.kr/news/articleView.html?idxno=27291
3713,2018-06-20,특징주삼성바이오로직스증선위2차정례회의에상승,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018062010144101042&LinkID=632&objId=A2018062010144101042&portalCode=naver
3714,2018-06-20,9부능선삼성바이오로직스분식논란20일증선위서공방마무리,http://www.metroseoul.co.kr/news/newsview?newscd=2018061900153
3715,2018-06-20,삼성바이오로직스제2차증선위,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620066500013&did=1196m
3716,2018-06-20,삼성바이오로직스제2차증선위,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620067500013&did=1196m
3717,2018-06-20,삼성바이오로직스제2차증선위,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620067600013&did=1196m
3718,2018-06-20,삼성바이오로직스증선위3차회의2015년이전회계검토,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10286470
3719,2018-06-20,유삼성바이오로직스전일대비709상승일일회전율은021기록,http://www.sedaily.com/NewsView/1S0VR23AOA
3720,2018-06-20,증선위삼성바이오로직스분식회계관건은2012년2015년회계처리,http://news.heraldcorp.com/view.php?ud=20180620000360
3721,2018-06-20,오늘증선위세번째심의삼성바이오로직스강세,https://cnbc.sbs.co.kr/article_hub/10000905655?division=NAVER
3722,2018-06-20,질문받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620108100013&did=1196m
3723,2018-06-20,질문받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620108200013&did=1196m
3724,2018-06-20,검색받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620110300013&did=1196m
3725,2018-06-20,검색받는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620110200013&did=1196m
3726,2018-06-20,2차증선위참석하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180620111300013&did=1196m
3727,2018-06-20,취재진질문에답하는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195740
3728,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195732
3729,2018-06-20,웃음짓는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195735
3730,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195730
3731,2018-06-20,취재진질문에답하는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195738
3732,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195733
3733,2018-06-20,취재진질문에답하는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195736
3734,2018-06-20,취재진질문에답하는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195739
3735,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195734
3736,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195729
3737,2018-06-20,취재진질문에답하는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195737
3738,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195728
3739,2018-06-20,삼성바이오로직스2차증선위참석하는김태한대표이사,http://www.newsis.com/view/?id=NISI20180620_0014195731
3740,2018-06-20,특징주삼성바이오로직스3차증선위심의에도강세,http://moneys.mt.co.kr/news/mwView.php?no=2018062013088099816
3741,2018-06-20,질문에답하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3169884
3742,2018-06-20,증선위출석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3169868
3743,2018-06-20,미소짓는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3169882
3744,2018-06-20,특징주증선위세번째심의삼성바이오로직스강세,http://www.kyeongin.com/main/view.php?key=20180620010007609
3745,2018-06-20,삼성바이오로직스상폐위기에주가상승세무엇때문에,http://www.gnmaeil.com/news/articleView.html?idxno=374995
3746,2018-06-20,삼성바이오로직스회계처리고의인가과실인가핵심은과거회계처리,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180620.99099009729
3747,2018-06-20,특징주삼성바이오로직스증권위2차회의에10↑,http://view.asiae.co.kr/news/view.htm?idxno=2018062014215558195
3748,2018-06-20,삼성바이오로직스주가10↑증선위영향은,http://www.econovill.com/news/articleView.html?idxno=340072
3749,2018-06-20,삼성물산부터삼성바이오로직스까지삼성지배구조개편시나리오는,http://www.topstarnews.net/news/articleView.html?idxno=431937
3750,2018-06-20,특징주증선위세번째심의삼성바이오로직스급등종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180620037751008&did=1195m
3751,2018-06-20,삼성바이오로직스로직스3차증선위진행관건은과거회계처리,http://www.segye.com/content/html/2018/06/20/20180620001546.html?OutUrl=naver
3752,2018-06-20,삼성바이오로직스증선위정례회의결과앞두고급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=324312
3753,2018-06-20,특징주종합3차증선위당일10급등한삼성바이오로직스,http://www.newsis.com/view/?id=NISX20180620_0000341681&cID=10401&pID=10400
3754,2018-06-20,김태한증권선물위출석해삼성바이오로직스회계진실히소명,http://www.businesspost.co.kr/BP?command=article_view&num=86196
3755,2018-06-20,外人매수속코스피반등삼성바이오로직스셀트리온활짝,http://www.choicenews.co.kr/news/articleView.html?idxno=42338
3756,2018-06-20,삼성바이오로직스내달4일분식회계최종결론고의vs실수,http://www.viva100.com/main/view.php?key=20180620010006451
3757,2018-06-20,삼성바이오로직스분식회계혐의3차심의고의성여부관건,https://cnbc.sbs.co.kr/article_hub/10000905688?division=NAVER
3758,2018-06-20,회계논란삼성바이오로직스불안한주가흐름시총10조증발,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062016144118601
3759,2018-06-20,아주종목분석세번째증선위삼성바이오로직스10급등,http://www.ajunews.com/view/20180620175324830
3760,2018-06-20,삼성바이오로직스고의분식보다과실에무게,http://news.hankyung.com/article/2018062066231
3761,2018-06-20,삼성바이오로직스2015년전회계처리쟁점,http://www.ebn.co.kr/news/view/945771
3762,2018-06-20,삼성바이오로직스셀트리온주가강세기관과외국인모두매수,http://www.businesspost.co.kr/BP?command=article_view&num=86245
3763,2018-06-20,삼성바이오로직스내달4일분식회계최종결론고의성여부관건,http://www.m-i.kr/news/articleView.html?idxno=426033
3764,2018-06-21,제약톡톡삼성바이오로직스운명가를제2라운드결과는,http://news.heraldcorp.com/view.php?ud=20180621000069
3765,2018-06-21,특징주삼성바이오로직스증선위2차회의종료주가는약세,http://www.g-enews.com/ko-kr/news/article/news_all/201806210906143025c16aa2f016_1/article.html
3766,2018-06-21,삼성바이오로직스캐나다연방보건부서제1공장생산제품인증획득,http://news.mk.co.kr/newsRead.php?year=2018&no=391093
3767,2018-06-21,삼성바이오로직스캐나다연방보건부첫제조승인획득,http://view.asiae.co.kr/news/view.htm?idxno=2018062109313569961
3768,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.dailian.co.kr/news/view/720935/?sc=naver
3769,2018-06-21,삼성바이오로직스캐나다서1공장생산제품제조승인추가획득,http://www.fnnews.com/news/201806210929137273
3770,2018-06-21,삼성바이오로직스2일연속상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=324371
3771,2018-06-21,삼성바이오로직스캐나다向바이오의약품제조승인획득,http://biz.chosun.com/site/data/html_dir/2018/06/21/2018062101021.html
3772,2018-06-21,삼성바이오로직스1공장캐나다제조승인,http://www.dailypharm.com/News/240994
3773,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.newsis.com/view/?id=NISX20180621_0000342245&cID=13001&pID=13000
3774,2018-06-21,삼성전자삼성바이오로직스호재성이슈로상승출발,http://www.insightkorea.co.kr//news/articleView.html?idxno=25936
3775,2018-06-21,삼성바이오로직스캐나다서1공장제조승인첫획득,http://www.asiatoday.co.kr/view.php?key=20180621010010664
3776,2018-06-21,삼성바이오로직스캐나다보건당국제조승인획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01990966619244016
3777,2018-06-21,삼성바이오로직스캐나다연방보건부제조승인획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1633627
3778,2018-06-21,삼성바이오로직스캐나다공장제조승인획득,http://medipana.com/news/news_viewer.asp?NewsNum=221644&MainKind=A&NewsKind=5&vCount=12&vKind=1
3779,2018-06-21,삼성바이오로직스캐나다제조승인획득,http://www.newspim.com/news/view/20180621000116
3780,2018-06-21,삼성바이오로직스증선위금융감독원에조치안보완요구,http://news.hankyung.com/article/2018062184066
3781,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.mediapen.com/news/view/363480
3782,2018-06-21,삼성바이오로직스캐나다시장진출한다,http://news.heraldcorp.com/view.php?ud=20180621000203
3783,2018-06-21,삼성바이오로직스1공장제품캐나다판매길열려,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180621050300017&did=1195m
3784,2018-06-21,삼성바이오로직스캐나다연방보건부서1공장생산제품제조승인추가획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1202851
3785,2018-06-21,증선위삼성바이오로직스감리조치안보완요청,http://www.ebn.co.kr/news/view/945839
3786,2018-06-21,삼성바이오로직스캐나다에서제조승인획득,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180621100338
3787,2018-06-21,삼성바이오로직스분식회계최종결정7월중순으로연기,http://www.seoulfn.com/news/articleView.html?idxno=312222
3788,2018-06-21,보도참고삼성바이오로직스건관련증선위심의경과3차회의후,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156276163
3789,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=324388
3790,2018-06-21,증선위삼성바이오로직스관련금감원에보완요구,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10286656
3791,2018-06-21,아파야챙길래동아쏘시오그룹삼성바이오로직스대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/201806211024029478e6a49afa8d_1/article.html
3792,2018-06-21,삼성바이오로직스캐나다첫제조승인획득,http://news.hankyung.com/article/201806218506f
3793,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득관련시장진출발판마련,http://www.segye.com/content/html/2018/06/21/20180621001466.html?OutUrl=naver
3794,2018-06-21,특징주분식회계결론다음달로삼성바이오로직스주가관망세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062110302890515
3795,2018-06-21,증선위금감원에삼성바이오로직스감리조치안보완요청,http://news.sbs.co.kr/news/endPage.do?news_id=N1004812303&plink=ORI&cooper=NAVER
3796,2018-06-21,삼성바이오로직스캐나다연방보건부제조승인획득,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018062110374701174&LinkID=632&objId=A2018062110374701174&portalCode=naver
3797,2018-06-21,삼성바이오로직스생산제품첫캐나다보건부GMP인증,http://news1.kr/articles/?3351155
3798,2018-06-21,삼성바이오로직스캐나다진출가시화첫제조승인획득,http://www.biospectator.com/view/news_view.php?varAtcId=5694
3799,2018-06-21,증권선물위원회금감원삼성바이오로직스기존조치안구체화해보완하라,http://www.newsrep.co.kr/news/articleView.html?idxno=52681
3800,2018-06-21,삼성바이오로직스회계논란결말일러야7월중순,http://www.edaily.co.kr/news/newspath.asp?newsid=02351766619244016
3801,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득글로벌시장공략박차,http://www.viva100.com/main/view.php?key=20180621010006757
3802,2018-06-21,삼성바이오로직스캐나다진출파란불,http://www.sedaily.com/NewsView/1S0W87QIGC
3803,2018-06-21,뉴스투데이E삼성바이오로직스캐나다시장진출발판마련헬스캐나다첫제조승인획득,http://www.news2day.co.kr/105877
3804,2018-06-21,삼성바이오로직스캐나다서1공장제조승인획득,http://www.kpinews.co.kr/news/articleView.html?idxno=76475
3805,2018-06-21,증선위금감원에삼성바이오로직스감리조치안보완요청,http://www.ekn.kr/news/article.html?no=369391
3806,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.newsworks.co.kr/news/articleView.html?idxno=195071
3807,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://news.mt.co.kr/mtview.php?no=2018062110590873158
3808,2018-06-21,늦어지는삼성바이오로직스회계결론지쳐가는바이오업계,http://www.edaily.co.kr/news/newspath.asp?newsid=02542006619244016
3809,2018-06-21,삼성바이오로직스캐나다서첫제조승인,http://news.mk.co.kr/newsRead.php?year=2018&no=391700
3810,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득발표,http://www.m-i.kr/news/articleView.html?idxno=426151
3811,2018-06-21,삼성바이오로직스1공장캐나다로부터첫제조승인획득,http://www.ceoscoredaily.com/news/article.html?no=42554
3812,2018-06-21,삼성바이오로직스캐나다연방보건부서첫제조승인획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062112574989107
3813,2018-06-21,삼성증권배당오류사고제제심21일열려삼성바이오로직스증선위결과는,http://www.topstarnews.net/news/articleView.html?idxno=432577
3814,2018-06-21,증선위삼성바이오로직스회계감리원조치안보완해야,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1488799
3815,2018-06-21,삼성바이오로직스바이오의약품제조놓고캐나다승인도받아,http://www.businesspost.co.kr/BP?command=article_view&num=86304
3816,2018-06-21,증권선물위삼성바이오로직스감리조치안보완금감원에요청,http://www.mediapen.com/news/view/363567
3817,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.asiatoday.co.kr/view.php?key=20180621010010988
3818,2018-06-21,삼성바이오로직스헬스캐나다제조승인획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018062100019
3819,2018-06-21,삼성바이오로직스캐나다제조승인획득,http://www.kormedi.com/news/news/drug_dist/1227872_2906.html
3820,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인,http://www.viva100.com/main/view.php?key=20180621010006970
3821,2018-06-21,삼성바이오로직스캐나다연방보건부첫제조승인획득,http://www.dt.co.kr/contents.html?article_no=2018062102109960102001&ref=naver
3822,2018-06-21,증선위삼성바이오로직스감리조치안보완요청내달중순께최종결정,http://www.foodtvnews.com/news/article.html?no=8549
3823,2018-06-21,증권선물위삼성바이오로직스회계과실로방향잡아가나,http://www.businesspost.co.kr/BP?command=article_view&num=86316
3824,2018-06-21,삼성바이오로직스분식회계의혹다음달중순최종결론,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002447457&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
3825,2018-06-21,삼성바이오로직스캐나다연방보건부헬스캐나다첫제조승인획득,http://www.ekn.kr/news/article.html?no=369513
3826,2018-06-21,최중경공인회계사회장삼성바이오로직스회계문제전문가판단이중요,http://biz.newdaily.co.kr/site/data/html/2018/06/21/2018062100122.html
3827,2018-06-21,코스피코스닥동반↓셀트리온3대장삼성바이오로직스신라젠도공동↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=324457
3828,2018-06-21,박용진금융위는삼성바이오로직스의혹제대로규명해야,http://www.choicenews.co.kr/news/articleView.html?idxno=42370
3829,2018-06-21,삼성바이오로직스감리안과거회계처리추가해달라,http://www.fnnews.com/news/201806211724333899
3830,2018-06-21,삼성바이오로직스1공장캐나다의약품제조승인획득,http://www.seoulfn.com/news/articleView.html?idxno=312285
3831,2018-06-21,삼성바이오로직스캐나다연방보건부제조승인,http://www.dt.co.kr/contents.html?article_no=2018062202101322814001&ref=naver
3832,2018-06-21,삼성바이오로직스중과실징계받아최악의상황벗어나나,http://www.businesspost.co.kr/BP?command=article_view&num=86352
3833,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1489081
3834,2018-06-21,증선위삼성바이오로직스회계감리조치안보완요청,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1489028
3835,2018-06-21,셀트리온3총사와삼성바이오로직스주가모두떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=86393
3836,2018-06-21,삼성바이오로직스캐나다정부제조승인획득,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=756677
3837,2018-06-21,삼성바이오로직스캐나다시장열었다,http://www.kyeongin.com/main/view.php?key=20180621010008221
3838,2018-06-21,삼성바이오로직스헬스캐나다첫제조승인획득,http://www.joongboo.com/?mod=news&act=articleView&idxno=1261282
3839,2018-06-22,발빠른삼성바이오로직스캐나다서도제조승인획득,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=815753
3840,2018-06-22,삼성바이오로직스2014년이전회계가쟁점,http://news.kbs.co.kr/news/view.do?ncd=3668039&ref=A
3841,2018-06-22,삼성바이오로직스회계논란금융위증선위결정지연될것”,http://www.econovill.com/news/articleView.html?idxno=340177
3842,2018-06-22,뉴투분석둘다냐둘중하나냐삼성증권중징계결정이삼성바이오로직스에미칠영향촉각,http://www.news2day.co.kr/105943
3843,2018-06-22,특징주삼성바이오로직스증선위감독원조치안보완요청주가에호재,http://www.g-enews.com/ko-kr/news/article/news_all/201806220919387101c642673384_1/article.html
3844,2018-06-22,증선위삼성바이오로직스2015년이전회계도심의필요,http://www.siminilbo.co.kr/news/articleView.html?idxno=569217
3845,2018-06-22,삼성바이오로직스전일대비약4상승한430000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806220145&t=NN
3846,2018-06-22,특징주증선위금감원에자료보완요청삼성바이오로직스3↑,http://view.asiae.co.kr/news/view.htm?idxno=2018062210354053366
3847,2018-06-22,한경로보뉴스삼성바이오로직스5이상상승주가20일이평선상회단기중기이평선역배열,http://news.hankyung.com/article/201806223901L
3848,2018-06-22,유삼성바이오로직스전일대비723상승일일회전율은033기록,http://www.sedaily.com/NewsView/1S0WNVUZA5
3849,2018-06-22,삼성바이오로직스2014년이전회계가쟁점,http://news.kbs.co.kr/news/view.do?ncd=3668243&ref=A
3850,2018-06-22,코스피연중최저기록후반등코스닥도혼조세삼성바이오로직스강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=324550
3851,2018-06-22,최종구삼성바이오로직스분식회계결론7월에낸다,http://www.businesspost.co.kr/BP?command=article_view&num=86444
3852,2018-06-22,삼성바이오로직스분식회계7월결론,http://www.kpinews.co.kr/news/articleView.html?idxno=76582
3853,2018-06-22,최종구금융위원장삼성바이오로직스문제내달중결론날것,http://www.mediapen.com/news/view/363837
3854,2018-06-22,분석삼성바이오로직스조치보완요구커지는공정성논란,http://www.inews24.com/php/news_view.php?g_serial=1103365&g_menu=022300&rrf=nv
3855,2018-06-22,삼성바이오로직스주가급등해시총순위뛰어셀트리온도올라,http://www.businesspost.co.kr/BP?command=article_view&num=86504
3856,2018-06-22,코스피혼조속연중최저기록후반등코스닥소폭상승삼성바이오로직스↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=324596
3857,2018-06-25,특징주삼성바이오로직스증선위보완자료요청주가약세,http://www.g-enews.com/ko-kr/news/article/news_all/201806250915135580c16aa2f016_1/article.html
3858,2018-06-25,특징주삼성바이오로직스금감원에자료보완요청소식에주가↓,http://www.newsprime.co.kr/news/article.html?no=420509
3859,2018-06-25,외국인또매도25일초반SK하이닉스삼성바이오로직스등하락,http://www.choicenews.co.kr/news/articleView.html?idxno=42425
3860,2018-06-25,삼성바이오로직스금융개혁시금석될수있다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219493
3861,2018-06-25,삼성바이오로직스전일대비약4하락한419000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806250285&t=NN
3862,2018-06-25,최명성의바닥탈출심리적바닥은확인했다삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062513324118044
3863,2018-06-25,삼성바이오로직스17000원389내린420500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806250467&t=NN
3864,2018-06-25,外人매도에도코스피찔끔올라SK하이닉스삼성바이오로직스급락,http://www.choicenews.co.kr/news/articleView.html?idxno=42440
3865,2018-06-25,심상정금융위는삼성바이오로직스회계논란을검찰에넘겨야,http://www.businesspost.co.kr/BP?command=article_view&num=86680
3866,2018-06-25,셀트리온주가제자리삼성바이오로직스는매도공세에하락,http://www.businesspost.co.kr/BP?command=article_view&num=86716
3867,2018-06-26,삼성바이오로직스전일대비약3하락한407500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806260100&t=NN
3868,2018-06-26,외국인셀트리온주식사들이고삼성바이오로직스는팔고,http://www.businesspost.co.kr/BP?command=article_view&num=86845
3869,2018-06-27,삼성바이오로직스바이오파마엑스포서일본CDMO사업확장나선다,http://www.asiatoday.co.kr/view.php?key=20180627010013903
3870,2018-06-27,뉴스투데이L삼성바이오로직스아시아바이오최대전시BioPharmaExpo2년째참가,http://www.news2day.co.kr/106202
3871,2018-06-27,삼성바이오로직스日바이오제약최대전시회참가,http://biz.chosun.com/site/data/html_dir/2018/06/27/2018062700834.html
3872,2018-06-27,삼성바이오로직스日바이오전시회바이오텍재팬참가,http://www.edaily.co.kr/news/newspath.asp?newsid=01866326619245984
3873,2018-06-27,삼성바이오로직스일본바이오파마엑스포2018참가,http://www.ebn.co.kr/news/view/946464
3874,2018-06-27,삼성바이오로직스日바이오파마엑스포서CDO사업확장나서,http://www.newsis.com/view/?id=NISX20180627_0000347335&cID=13001&pID=13000
3875,2018-06-27,삼성바이오로직스일본바이오파마엑스포2년연속참가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062708413244167
3876,2018-06-27,삼성바이오로직스지아이이노베이션CDO계약,http://www.biospectator.com/view/news_view.php?varAtcId=5720
3877,2018-06-27,삼성바이오로직스일본바이오파마엑스포2년연속참가,http://www.dailian.co.kr/news/view/722173/?sc=naver
3878,2018-06-27,삼성바이오로직스日바이오파마엑스포참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1204998
3879,2018-06-27,삼성바이오로직스日바이오엑스포참가,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180627095739
3880,2018-06-27,아파야챙길래대웅제약삼성바이오로직스보령바이오파마,http://www.g-enews.com/ko-kr/news/article/news_all/201806271009197475e6a49afa8d_1/article.html
3881,2018-06-27,특징주삼성바이오로직스일본바이오제약박람회참가소식에반등,http://moneys.mt.co.kr/news/mwView.php?no=2018062710128074837
3882,2018-06-27,삼성바이오로직스일본바이오파마엑스포에참가,http://www.newsworks.co.kr/news/articleView.html?idxno=196409
3883,2018-06-27,삼성바이오로직스日바이오파마엑스포참가CDO고객발굴,http://view.asiae.co.kr/news/view.htm?idxno=2018062710371710001
3884,2018-06-27,박용진금융위삼성바이오로직스봐주기하나국정조사예고,http://www.topstarnews.net/news/articleView.html?idxno=435538
3885,2018-06-27,삼성바이오로직스일본BioPharmaExpo2년연속참가알려,http://www.m-i.kr/news/articleView.html?idxno=428010
3886,2018-06-27,삼성바이오로직스일본바이오엑스포서글로벌경쟁력과시,http://news.mk.co.kr/newsRead.php?year=2018&no=404585
3887,2018-06-27,삼성바이오로직스日바이오파마엑스포2년연속참가,http://daily.hankooki.com/lpage/life/201806/dh20180627111032138950.htm
3888,2018-06-27,삼성바이오로직스日바이오파마엑스포서홍보전,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1057405
3889,2018-06-27,코스피코스닥동반↑셀트리온3대장삼성바이오로직스공동상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=324960
3890,2018-06-27,삼성바이오로직스일본바이오파마엑스포참가소식에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=324962
3891,2018-06-27,삼성바이오로직스바이오파마엑스포2018참가,http://www.metroseoul.co.kr/news/newsview?newscd=2018062700109
3892,2018-06-27,CDO고객발굴나선삼성바이오로직스,http://www.dt.co.kr/contents.html?article_no=2018062702109931102001&ref=naver
3893,2018-06-27,삼성바이오로직스일본바이오제약행사에서수출선확보추진,http://www.businesspost.co.kr/BP?command=article_view&num=86933
3894,2018-06-27,삼성바이오로직스일본바이오제약전시회참가CDO고객발굴,http://www.sedaily.com/NewsView/1S0Z0494VX
3895,2018-06-27,삼성바이오로직스日바이오파마엑스포참가,http://www.ciobiz.co.kr/news/article.html?id=20180627120034
3896,2018-06-27,삼성바이오로직스일본바이오파마엑스포2년연속참가,http://www.fnnews.com/news/201806271555538053
3897,2018-06-27,삼성바이오로직스日최대바이오전시회2년연속참가,http://www.viva100.com/main/view.php?key=20180627010008630
3898,2018-06-27,코스피코스닥↓삼성바이오로직스바이오파마엑스포참가소식에반등성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=324999
3899,2018-06-27,셀트리온주가4거래일째상승삼성바이오로직스도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=87018
3900,2018-06-27,삼성바이오로직스일본BioPharmaExpo참가,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1491071
3901,2018-06-27,삼성바이오로직스日잠재고객발굴잰걸음,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=757527
3902,2018-06-27,삼성바이오로직스亞생산허브로일본제약전시회단독부스마케팅,http://www.kyeongin.com/main/view.php?key=20180627010010537
3903,2018-06-28,삼성바이오로직스일본바이오파마엑스포2년연속참가,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=816487
3904,2018-06-28,삼성바이오로직스日BioPharmaExpo2년연속참가亞바이오의약품생산허브성장기여,http://www.segye.com/content/html/2018/06/27/20180627003725.html?OutUrl=naver
3905,2018-06-28,삼성바이오로직스태풍의눈속으로증권가쓰나미예고,http://www.g-enews.com/ko-kr/news/article/news_all/201806271717541716c642673384_1/article.html
3906,2018-06-28,삼성바이오로직스日바이오파마엑스포참가,http://www.betanews.net:8080/article/873511.html
3907,2018-06-28,삼성바이오로직스세계2위日의약품시장공략,http://www.kormedi.com/news/news/drug_dist/1227969_2906.html
3908,2018-06-28,삼성바이오로직스일본바이오파마엑스포2년연속참가,http://www.asiatoday.co.kr/view.php?key=20180628010015071
3909,2018-06-28,삼성바이오로직스증선위심의임박제재수위는,http://www.wolyo.co.kr/news/articleView.html?idxno=63634
3910,2018-06-28,셀트리온3총사주가하락삼성바이오로직스주가도떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=87146
3911,2018-06-29,단독바이오젠삼성바이오로직스콜옵션행사7억달러지불,http://news1.kr/articles/?3358354
3912,2018-06-29,삼성바이오로직스지아이이노베이션과CDO계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=325160
3913,2018-06-29,삼성바이오로직스삼성바이오에피스주식922만여주바이오젠에양도결정,http://view.asiae.co.kr/news/view.htm?idxno=2018062907110581429
3914,2018-06-29,삼성바이오로직스바이오에피스주식922만여주바이오젠에양도결정,http://www.ekn.kr/news/article.html?no=370998
3915,2018-06-29,삼성바이오로직스바이오젠콜옵션행사로7486억유입2보,http://www.edaily.co.kr/news/newspath.asp?newsid=01413686619246640
3916,2018-06-29,삼성바이오로직스바이오젠콜옵션행사에피스공동경영상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01433366619246640
3917,2018-06-29,바이오젠콜옵션행사삼성바이오로직스분식회계의혹벗어나나,http://www.ajunews.com/view/20180629081740360
3918,2018-06-29,삼성바이오로직스바이오젠콜옵션행사”922만주양도,http://www.sisajournal-e.com/biz/article/185850
3919,2018-06-29,삼성바이오로직스바이오젠콜옵션행사증선위힘실린다종합,http://view.asiae.co.kr/news/view.htm?idxno=2018062908330698083
3920,2018-06-29,삼성바이오로직스바이오젠삼성바이오에피스콜옵션행사”,http://www.fntimes.com/html/view.php?ud=201806290840463173f09e13944d_18
3921,2018-06-29,바이오젠콜옵션행사삼성바이오로직스회계논란새국면종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01633446619246640
3922,2018-06-29,공시삼성바이오로직스바이오젠삼성바이오에피스콜옵션행사,http://www.viva100.com/main/view.php?key=20180629010009497
3923,2018-06-29,삼성바이오로직스전일대비약5상승한428500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806290090&t=NN
3924,2018-06-29,미국바이오젠삼성바이오로직스에콜옵션행사,http://medipana.com/news/news_viewer.asp?NewsNum=222020&MainKind=A&NewsKind=5&vCount=12&vKind=1
3925,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사강세,http://news.hankyung.com/article/2018062979696
3926,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에3상승,http://news.mt.co.kr/mtview.php?no=2018062909075353410
3927,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에4대급등,http://www.ekn.kr/news/article.html?no=371012
3928,2018-06-29,특징주삼성바이오로직스美바이오젠콜옵션행사소식에상승,http://biz.chosun.com/site/data/html_dir/2018/06/29/2018062900837.html
3929,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180629037400008&did=1195m
3930,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에강세,http://www.fnnews.com/news/201806290907524711
3931,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에강세,http://www.fnnews.com/news/201806290907524711
3932,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사회계논란종식기대에주가강세,http://www.g-enews.com/ko-kr/news/article/news_all/201806290909124804c16aa2f016_1/article.html
3933,2018-06-29,삼성바이오로직스美바이오젠콜옵션행사소식에강세,http://www.sedaily.com/NewsView/1S0ZVDKED9
3934,2018-06-29,HotLine삼성바이오로직스바이오젠콜옵션행사소식에강세,http://news.mk.co.kr/newsRead.php?year=2018&no=409933
3935,2018-06-29,특징주美바이오젠콜옵션행사에삼성바이오로직스4↑,http://www.newsis.com/view/?id=NISX20180629_0000349801&cID=10401&pID=10400
3936,2018-06-29,삼성바이오로직스바이오젠삼바에피스콜옵션소식에장초반강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=325199
3937,2018-06-29,삼성바이오로직스바이오젠콜옵션행사소식에주가↑,http://www.newsprime.co.kr/news/article.html?no=421133
3938,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에강세,http://www.fntimes.com/html/view.php?ud=20180629092010526f09e13944d_18
3939,2018-06-29,특징주삼성바이오로직스美바이오젠콜옵션행사에강세,http://www.ebn.co.kr/news/view/946783
3940,2018-06-29,삼성바이오로직스바이오젠콜옵션행사이후주가강세,http://news1.kr/articles/?3358447
3941,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션소식에강세,http://www.foodtvnews.com/news/article.html?no=8854
3942,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806290123&t=NN
3943,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사에상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1636350
3944,2018-06-29,삼성바이오로직스바이오젠콜옵션행사소식에강세,http://news.heraldcorp.com/view.php?ud=20180629000121
3945,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사소식에강세,http://www.seoulfn.com/news/articleView.html?idxno=312964
3946,2018-06-29,삼성바이오로직스美바이오젠콜옵션행사,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018062909333800746&LinkID=632&objId=A2018062909333800746&portalCode=naver
3947,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사상승,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018062909424100790&LinkID=632&objId=A2018062909424100790&portalCode=naver
3948,2018-06-29,美바이오젠콜옵션행사공시삼성바이오로직스주가4상승,http://www.topstarnews.net/news/articleView.html?idxno=436850
3949,2018-06-29,특징주삼성바이오로직스美바이오젠콜옵션행사에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=250145
3950,2018-06-29,특징주삼성바이오로직스주가상승바이오젠콜옵션행사,http://www.mediapen.com/news/view/365381
3951,2018-06-29,바이오젠콜옵션행사삼성바이오로직스분식회계심의영향은,http://www.polinews.co.kr/news/article.html?no=359993
3952,2018-06-29,바이오젠에피스콜옵션행사삼성바이오로직스운명은,http://news.hankyung.com/article/2018062986266
3953,2018-06-29,바이오젠삼성바이오에피스에콜옵션행사삼성바이오로직스분식회계심의새국면맞을까,http://www.topdaily.kr/news/articleView.html?idxno=52460
3954,2018-06-29,삼성바이오로직스바이오젠콜옵션행사922만주양도,http://www.sisaweek.com/news/articleView.html?idxno=110156
3955,2018-06-29,바이오젠삼성바이오에피스콜옵션행사지분499삼성바이오로직스증선위심의영향은,http://www.kyeongin.com/main/view.php?key=20180629001151249
3956,2018-06-29,삼성바이오로직스논란새국면美바이오젠콜옵션행사,http://www.kpinews.co.kr/news/articleView.html?idxno=77080
3957,2018-06-29,바이오젠콜옵션삼성바이오로직스분식회계새국면,http://www.dailymedi.com/detail.php?number=832008&thread=22r05
3958,2018-06-29,공시삼성바이오로직스자회사삼성바이오에피스에바이오젠콜옵션행사,http://www.g-enews.com/ko-kr/news/article/news_all/201806291337476786c642673384_1/article.html
3959,2018-06-29,삼성바이오로직스바이오젠삼성바이오에피스콜옵션행사”,http://www.edaily.co.kr/news/newspath.asp?newsid=02699446619246640
3960,2018-06-29,최종구삼성바이오로직스삼성증권문제에너무많은에너지쓰고있어발언눈길,http://www.topstarnews.net/news/articleView.html?idxno=437073
3961,2018-06-29,삼성바이오로직스바이오젠삼성바이오에피스콜옵션행사,http://www.newstomato.com/ReadNews.aspx?no=832861
3962,2018-06-29,삼성바이오로직스전일대비196올라장마감바이오젠콜옵션행사덕,http://www.topdaily.kr/news/articleView.html?idxno=52490
3963,2018-06-29,바이오젠콜옵션행사로지분499확보삼성바이오로직스와공동경영,http://www.ekn.kr/news/article.html?no=371160
3964,2018-06-29,금융위바이오젠콜옵션행사삼성바이오로직스수위변수는있지만중징계피하긴어려울듯,http://www.ltn.kr/news/articleView.html?idxno=10434
3965,2018-06-29,셀트리온3총사와삼성바이오로직스주가동반상승,http://www.businesspost.co.kr/BP?command=article_view&num=87288
3966,2018-06-29,삼성바이오로직스미국바이오젠이바이오에피스콜옵션행사,http://www.businesspost.co.kr/BP?command=article_view&num=87261
3967,2018-06-29,특징주삼성바이오로직스바이오젠콜옵션행사전일대비196상승,http://www.asiatime.co.kr/news/articleView.html?idxno=186012
3968,2018-06-29,바이오젠의삼성바이오로직스콜옵션행사금감원의악몽될까,http://www.news2day.co.kr/106433
3969,2018-06-29,삼성바이오로직스회계논란에바이오젠콜옵션행사가영향끼칠까,http://www.businesspost.co.kr/BP?command=article_view&num=87274
3970,2018-07-01,삼성바이오로직스로인한금융감독원과증권선물위의갈등생기나,http://www.ftoday.co.kr/news/articleView.html?idxno=100766
3971,2018-07-02,더벨삼성바이오로직스콜옵션확정판세영향은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201806290100046130002823
3972,2018-07-02,셀트리온주가약세장에서선방삼성바이오로직스는소폭내려,http://www.businesspost.co.kr/BP?command=article_view&num=87496
3973,2018-07-03,특징주삼성바이오로직스3차증선위임박수정조치안변수주가는탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201807030909055102c642673384_1/article.html
3974,2018-07-03,삼성바이오로직스전일대비약3상승한429000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807030202&t=NN
3975,2018-07-03,콕짚는그래픽경제바이오젠콜옵션전략과삼성바이오로직스회계논란에대한엉뚱한생각,http://www.g-enews.com/ko-kr/news/article/news_all/201807031240428746e5acafd9db_1/article.html
3976,2018-07-03,분식회계의혹삼성바이오로직스코스피약세속강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=325575
3977,2018-07-03,삼성바이오로직스14500원35오른429000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807030538&t=NN
3978,2018-07-03,삼성바이오로직스증선위내일대심제진행수정안심의여부주목,http://news.sbs.co.kr/news/endPage.do?news_id=N1004830719&plink=ORI&cooper=NAVER
3979,2018-07-03,삼성바이오로직스주가뛰어시총순위올라셀트리온3총사는하락,http://www.businesspost.co.kr/BP?command=article_view&num=87643
3980,2018-07-03,내일의경제일정증선위삼성바이오로직스분식회계조치안논의,http://www.asiatime.co.kr/news/articleView.html?idxno=186577
3981,2018-07-03,이데일리내일의경제일정증선위삼성바이오로직스회계부정논의,http://www.edaily.co.kr/news/newspath.asp?newsid=03906486619270912
3982,2018-07-04,이데일리오늘의경제일정증선위삼성바이오로직스회계부정논의,http://www.edaily.co.kr/news/newspath.asp?newsid=01279206619271240
3983,2018-07-04,삼성바이오로직스회계처리위반여부최종결론늦어질듯4차증선위앞두고주가회복,http://www.news2day.co.kr/106605
3984,2018-07-04,2018년7월4일오늘의주요일정경제산업기재부제2차혁신성장관계장관회의금융위증선위정례회의삼성바이오로직스회계부정논의外,http://www.mediapen.com/news/view/366526
3985,2018-07-04,삼성바이오로직스500원012내린428500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807040085&t=NN
3986,2018-07-04,특징주삼성바이오로직스증선위개최수정안심의여부촉각주가는꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201807040919515567c642673384_1/article.html
3987,2018-07-04,삼성바이오로직스증선위벌써네번째일단은대심제,http://www.inews24.com/php/news_view.php?g_serial=1106356&g_menu=022300&rrf=nv
3988,2018-07-04,특징주삼성바이오로직스증선위네번째심의일약세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180704042300008&did=1195m
3989,2018-07-04,증선위삼성증권유령주식배당사고삼성바이오로직스분신회계논의,http://news1.kr/photos/view/?3190751
3990,2018-07-04,증선위삼성증권유령주식배당사고삼성바이오로직스분신회계논의,http://news1.kr/photos/view/?3190758
3991,2018-07-04,삼성바이오로직스오늘증선위4차정례회의약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=325674
3992,2018-07-04,증선위삼성바이오로직스4차회의수정안도논의,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10288743
3993,2018-07-04,끝까지판다삼성바이오로직스가치7조원부풀렸다수상한에버랜드땅값감사결과전격공개풀영상,http://news.sbs.co.kr/news/endPage.do?news_id=N1004831811&plink=ORI&cooper=NAVER
3994,2018-07-04,증선위삼성바이오로직스분식회계논란4차회의추가조치안쟁점,http://www.polinews.co.kr/news/article.html?no=360486
3995,2018-07-04,4차분식회계심의삼성바이오로직스사태이달중결론날까,http://www.wolyo.co.kr/news/articleView.html?idxno=63896
3996,2018-07-04,코스피↓코스닥↑셀트리온3대장삼성바이오로직스동반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=325716
3997,2018-07-04,삼성바이오로직스분식회계오늘심의대심제로진행,http://news.sbs.co.kr/news/endPage.do?news_id=N1004832106&plink=ORI&cooper=NAVER
3998,2018-07-04,증선위삼성증권유령주식배당사고삼성바이오로직스분신회계논의,http://www.fntoday.co.kr/news/articleView.html?idxno=165087
3999,2018-07-04,증권선물위삼성증권배당사고와삼성바이오로직스회계논란논의,http://www.businesspost.co.kr/BP?command=article_view&num=87725
4000,2018-07-04,포토미소머금은김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018070414204208038
4001,2018-07-04,포토활짝웃는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018070414210413736
4002,2018-07-04,포토입꾹다문삼성바이오로직스,http://view.asiae.co.kr/news/view.htm?idxno=2018070414233231282
4003,2018-07-04,증권선물위출석하는삼성바이오로직스,http://news1.kr/photos/view/?3191548
4004,2018-07-04,증권선물위원회출석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3191551
4005,2018-07-04,김태한삼성바이오로직스사장증권선물위출석,http://news1.kr/photos/view/?3191550
4006,2018-07-04,포토굳은표정의김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018070414265162592
4007,2018-07-04,포토김태한삼성바이오로직스사장증권선물위원회출석,http://view.asiae.co.kr/news/view.htm?idxno=2018070414270968499
4008,2018-07-04,증권선물위출석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3191549
4009,2018-07-04,취재진질문받는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3191554
4010,2018-07-04,질문받는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3191553
4011,2018-07-04,질문받는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3191560
4012,2018-07-04,김태한삼성바이오로직스사장증권선물위출석,http://news1.kr/photos/view/?3191559
4013,2018-07-04,금융위증권선물위출석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3191557
4014,2018-07-04,김태한삼성바이오로직스사장금융위증권선물위출석,http://news1.kr/photos/view/?3191569
4015,2018-07-04,포토짐챙기는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018070414353638580
4016,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704121500013&did=1196m
4017,2018-07-04,포토증선위향하는김태한삼성바이오로직스사장,http://view.asiae.co.kr/news/view.htm?idxno=2018070414361750418
4018,2018-07-04,증선위참석하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704122200013&did=1196m
4019,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704121900013&did=1196m
4020,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704121800013&did=1196m
4021,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704122600013&did=1196m
4022,2018-07-04,증선위참석하는김태한삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704123200013&did=1196m
4023,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704126900013&did=1196m
4024,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704126500013&did=1196m
4025,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704126400013&did=1196m
4026,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704126300013&did=1196m
4027,2018-07-04,증선위참석하는삼성바이오로직스사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180704127400013&did=1196m
4028,2018-07-04,삼성바이오로직스7500원175내린421500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807040482&t=NN
4029,2018-07-04,특징주삼성바이오로직스증선위네번째심의일하락종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180704042351008&did=1195m
4030,2018-07-04,삼성바이오로직스분식회계논란관련네번째심의일하락,http://www.mdtoday.co.kr/mdtoday/index.html?no=325755
4031,2018-07-04,증선위오후에는삼성바이오로직스문제만논의감리조치수정안심의병행,http://www.mediapen.com/news/view/366692
4032,2018-07-04,코스피↓코스닥↑셀트리온3대장삼성바이오로직스공동↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=325763
4033,2018-07-04,국민연금의삼성바이오로직스가치조작회계징계에영향줄까,http://www.businesspost.co.kr/BP?command=article_view&num=87770
4034,2018-07-04,강문순의이슈들여다보기삼성바이오로직스분식논란제재시나리오는고의냐과실이냐삼성금감원누가이기든파장클듯,http://www.fnnews.com/news/201807041713368208
4035,2018-07-04,증선위삼성바이오로직스새조치안병행심의,http://www.ebn.co.kr/news/view/947427
4036,2018-07-04,셀트리온주가매도세에하락삼성바이오로직스도힘못써,http://www.businesspost.co.kr/BP?command=article_view&num=87800
4037,2018-07-04,삼성바이오로직스증선위18일정례회의서논의계속할것,http://news.hankyung.com/article/2018070478106
4038,2018-07-04,증선위분식회계의혹삼성바이오로직스다음정례회의서재논의,http://www.asiatime.co.kr/news/articleView.html?idxno=186839
4039,2018-07-04,삼성바이오로직스4차증선위종료18일5차회의,http://news.einfomax.co.kr/news/articleView.html?idxno=3456602
4040,2018-07-04,경제전망대삼성바이오로직스송도11공구10만평이나필요한가,http://www.kyeongin.com/main/view.php?key=20180704010001440
4041,2018-07-05,삼성바이오로직스분식회계의혹금감원추가조치안제출로심의장기화,http://www.asiatoday.co.kr/view.php?key=20180704010002729
4042,2018-07-05,tbs김어준의뉴스공장삼성바이오로직스분식회계금융위결론주시,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0500&key=20180705.99099002129
4043,2018-07-05,퀵리포트삼성바이오로직스매수유지목표가53만원유지유진證,http://www.itooza.com/common/iview.php?no=2018070508463018699
4044,2018-07-05,삼성바이오로직스목표가53만원유지전일종가42만1500원유진證,http://www.newspim.com/news/view/20180705000093
4045,2018-07-05,삼성바이오로직스증선위이달중마무리예상유진증권,http://www.sedaily.com/NewsView/1S1YSILHUQ
4046,2018-07-05,삼성바이오로직스421500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807050070&t=NN
4047,2018-07-05,제약톡톡삼성바이오로직스분식회계처리논란증선위5차회의까지간다,http://news.heraldcorp.com/view.php?ud=20180705000077
4048,2018-07-05,ET투자뉴스삼성바이오로직스예상수준의2분기BUY유지유진투자증권,http://www.etnews.com/20180705000053
4049,2018-07-05,당국제재막바지삼성바이오로직스삼성증권주가는희비불확실성해소관건,http://www.g-enews.com/ko-kr/news/article/news_all/201807051123316833c16aa2f016_1/article.html
4050,2018-07-05,삼성바이오로직스분식회계공방이달종지부찍나,http://www.asiatime.co.kr/news/articleView.html?idxno=186936
4051,2018-07-05,카드뉴스김어준생각삼성바이오로직스빠져나갈까금융위의선택주시,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10288984
4052,2018-07-05,삼성바이오로직스분식회계논란,http://www.newsmaker.or.kr/news/articleView.html?idxno=61889
4053,2018-07-05,삼성바이오로직스8500원202내린413000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807050559&t=NN
4054,2018-07-05,삼성바이오로직스내년3공장가동효과본격화예상,http://www.newsworks.co.kr/news/articleView.html?idxno=198546
4055,2018-07-05,셀트리온3총사와삼성바이오로직스주가동반하락,http://www.businesspost.co.kr/BP?command=article_view&num=87923
4056,2018-07-06,증선위삼성바이오로직스분식회계논란18일재논의,http://www.mdtoday.co.kr/mdtoday/index.html?no=325898
4057,2018-07-06,국민연금이삼성바이오로직스가치조작증선위에영향주나,http://www.econovill.com/news/articleView.html?idxno=341053
4058,2018-07-06,삼성바이오로직스500원012오른413500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807060079&t=NN
4059,2018-07-06,주간한국삼성바이오로직스불리한쟁점에빠져나갈구멍은,http://daily.hankooki.com/lpage/economy/201807/dh20180706093744138060.htm
4060,2018-07-06,증선위18일삼성바이오로직스회계부정의혹결론,http://news.hankyung.com/article/2018070641237
4061,2018-07-06,증선위18일삼성바이오로직스분식회계결론낼듯,http://www.ekn.kr/news/article.html?no=372633
4062,2018-07-06,증선위18일정례회의서삼성바이오로직스분식회계논란종지부,http://daily.hankooki.com/lpage/economy/201807/dh20180706142629138100.htm
4063,2018-07-06,삼성바이오로직스3000원073내린410000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807060495&t=NN
4064,2018-07-06,증선위삼성바이오로직스회계부정의혹18일결론,http://it.chosun.com/site/data/html_dir/2018/07/06/2018070602429.html
4065,2018-07-06,삼성바이오로직스금감원초강수로회계징계낮추기흔들,http://www.businesspost.co.kr/BP?command=article_view&num=88055
4066,2018-07-06,삼성바이오로직스주가약세셀트리온3총사주가는올라,http://www.businesspost.co.kr/BP?command=article_view&num=88084
4067,2018-07-06,증권선물위삼성바이오로직스회계처리징계놓고고민깊어졌다,http://www.businesspost.co.kr/BP?command=article_view&num=88086
4068,2018-07-08,금융당국삼성바이오로직스회계부정이달안에결론목표,http://www.nocutnews.co.kr/news/4996798
4069,2018-07-09,삼성바이오로직스전일대비약3상승한424000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807090102&t=NN
4070,2018-07-09,한경로보뉴스삼성바이오로직스5이상상승예상수준의2분기7월증선위마무리가능성유진투자증권BUY유지,http://news.hankyung.com/article/201807090136L
4071,2018-07-09,특징주삼성바이오로직스나흘만에상승6↑,http://view.asiae.co.kr/news/view.htm?idxno=2018070909284076022
4072,2018-07-09,특징주삼성바이오로직스4일만에급반등외인사자,http://www.ebn.co.kr/news/view/947827
4073,2018-07-09,특징주삼성바이오로직스바이오젠치매신약임상성공에상승,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018070909533700897&LinkID=632&objId=A2018070909533700897&portalCode=naver
4074,2018-07-09,삼성바이오로직스금감원금융위엇갈린해석에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326076
4075,2018-07-09,윤석헌삼성바이오로직스감리조치안수정원안고수,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10289518
4076,2018-07-09,증선위보완거부윤석헌삼성바이오로직스사태원안고수가우리입장,http://www.topstarnews.net/news/articleView.html?idxno=442453
4077,2018-07-09,코스피기관순매수삼성전자SK하이닉스삼성바이오로직스,http://www.newsway.co.kr/view.php?tp=1&ud=2018070916132867134
4078,2018-07-09,삼성바이오로직스주가징계완화기대에급등셀트리온은하락,http://www.businesspost.co.kr/BP?command=article_view&num=88283
4079,2018-07-09,윤석헌금감원은삼성바이오로직스징계의원안고수,http://www.businesspost.co.kr/BP?command=article_view&num=88252
4080,2018-07-10,윤석헌금감원장삼성바이오로직스사태강공드라이브시사,http://www.topstarnews.net/news/articleView.html?idxno=442905
4081,2018-07-10,ET투자뉴스삼성바이오로직스_대형주의상승흐름에소외되면서현재211,http://www.etnews.com/20180710000027
4082,2018-07-10,특징주삼성바이오로직스증선위임시회의임박주가는주춤,http://www.g-enews.com/ko-kr/news/article/news_all/20180710091510520c642673384_1/article.html
4083,2018-07-10,CLSA삼성바이오로직스긍정론에주의해야,http://www.choicenews.co.kr/news/articleView.html?idxno=42804
4084,2018-07-10,삼성바이오로직스10000원234내린417000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807100506&t=NN
4085,2018-07-10,셀트리온3총사주가소폭하락삼성바이오로직스주가도떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=88457
4086,2018-07-10,삼성바이오로직스회계징계수위결정못하고논의장기화될수도,http://www.businesspost.co.kr/BP?command=article_view&num=88481
4087,2018-07-11,윤석헌금감원장삼성바이오로직스사태부터근로자추천이사제까지금융위와입장차,http://www.topstarnews.net/news/articleView.html?idxno=443661
4088,2018-07-11,삼성바이오로직스2500원06내린414500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807110078&t=NN
4089,2018-07-11,특징주삼성바이오로직스증선위임시회의D1외인팔자에도주가꿋꿋,http://www.g-enews.com/ko-kr/news/article/news_all/201807110912357386c642673384_1/article.html
4090,2018-07-11,셀트리온3총사주가모두내려삼성바이오로직스주가도약세,http://www.businesspost.co.kr/BP?command=article_view&num=88634
4091,2018-07-12,금감원제2의삼성바이오로직스사태방지나서분식회계근절,http://www.topstarnews.net/news/articleView.html?idxno=444366
4092,2018-07-12,삼성바이오로직스증선위12일임시회의개최,http://biz.chosun.com/site/data/html_dir/2018/07/12/2018071200600.html
4093,2018-07-12,삼성바이오로직스증선위12일오후임시회의개최,http://news.hankyung.com/article/2018071230136
4094,2018-07-12,오늘의경제일정증선위삼성바이오로직스임시회처리방향등논의,http://www.asiatime.co.kr/news/articleView.html?idxno=187934
4095,2018-07-12,삼성바이오로직스증선위12일오후임시회의개최,http://www.asiatime.co.kr/news/articleView.html?idxno=187936
4096,2018-07-12,금융위12일삼성바이오로직스임시증선위개최,http://biz.newdaily.co.kr/site/data/html/2018/07/12/2018071200007.html
4097,2018-07-12,증선위오늘1시반삼성바이오로직스임시회의,http://www.newspim.com/news/view/20180712000127
4098,2018-07-12,증선위12일삼성바이오로직스임시회의개최,http://www.newstomato.com/ReadNews.aspx?no=835242
4099,2018-07-12,삼성바이오로직스1000원024오른416000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807120063&t=NN
4100,2018-07-12,증선위오늘삼성바이오로직스임시회의개최,http://www.ebn.co.kr/news/view/948229
4101,2018-07-12,특징주삼성바이오로직스증선위임시회의개최감독원원안고수외인사자에주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201807120906453879c642673384_1/article.html
4102,2018-07-12,특징주증선위임시회의열리는날삼성바이오로직스반등,http://www.newsis.com/view/?id=NISX20180712_0000361582&cID=10401&pID=10400
4103,2018-07-12,삼성바이오로직스반등3거래일만에상승증선위분식간련5번째비공개회의,http://www.econonews.co.kr/news/articleView.html?idxno=29047
4104,2018-07-12,삼성바이오로직스분식회계증선위오늘임시회의,http://news.sbs.co.kr/news/endPage.do?news_id=N1004843898&plink=ORI&cooper=NAVER
4105,2018-07-12,특징주삼성바이오로직스증선위임시회의개최3거래일만에반등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1640713
4106,2018-07-12,삼성바이오로직스증선위임시회의앞두고3거래일만에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326477
4107,2018-07-12,증선위오늘오후임시회의개최삼성바이오로직스감리조치안심의,http://www.mediapen.com/news/view/368514
4108,2018-07-12,윤석헌금감원장삼성바이오로직스증선위참고자료제출할것,http://news.einfomax.co.kr/news/articleView.html?idxno=3457697
4109,2018-07-12,삼성바이오로직스분식회계증선위오늘5번째심의비공개로진행,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3581755
4110,2018-07-12,윤석헌삼성바이오로직스증선위에참고자료제출,http://www.inews24.com/php/news_view.php?g_serial=1108531&g_menu=022300&rrf=nv
4111,2018-07-12,증선위오늘12일삼성바이오로직스관련임시회의,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10290086
4112,2018-07-12,증권선물위삼성바이오로직스회계놓고금감원의견들어,http://www.businesspost.co.kr/BP?command=article_view&num=88682
4113,2018-07-12,증선위12일오후삼성바이오로직스분식회계임시회개최,http://www.seoulfn.com/news/articleView.html?idxno=314109
4114,2018-07-12,특징주삼성바이오로직스증선위결과발표앞두고2상승,http://view.asiae.co.kr/news/view.htm?idxno=2018071214383941683
4115,2018-07-12,삼성바이오로직스증선위긴급결과브리핑앞두고상승세,http://www.sedaily.com/NewsView/1S2219LZOS
4116,2018-07-12,한경로보뉴스삼성바이오로직스5이상상승예상수준의2분기7월증선위마무리가능성유진투자증권BUY유지,http://news.hankyung.com/article/201807125134L
4117,2018-07-12,특징주삼성바이오로직스증선위발표앞두고강세,http://news.mt.co.kr/mtview.php?no=2018071214461094556
4118,2018-07-12,특징주삼성바이오로직스강세증선위긴급브리핑,http://news.hankyung.com/article/2018071251716
4119,2018-07-12,삼성바이오로직스증선위오늘오후4시결과발표,http://news.hankyung.com/article/2018071251926
4120,2018-07-12,삼성바이오로직스증선위긴급발표앞두고강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326509
4121,2018-07-12,바이오주줄줄이강세증선위삼성바이오로직스긴급브리핑,http://news.hankyung.com/article/2018071252976
4122,2018-07-12,삼성바이오로직스증선위긴급브리핑앞두고3넘게상승,http://biz.newdaily.co.kr/site/data/html/2018/07/12/2018071200144.html
4123,2018-07-12,금융위오후4시삼성바이오로직스심의브리핑,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000110
4124,2018-07-12,특징주종합증선위일부결론발표삼성바이오로직스상승,http://www.newsis.com/view/?id=NISX20180712_0000362210&cID=10401&pID=10400
4125,2018-07-12,특징주삼성바이오로직스증선위기자브리핑앞두고상승,http://www.kyeongin.com/main/view.php?key=20180712010004445
4126,2018-07-12,특징주삼성바이오로직스증선위긴급브리핑소식에3상승,http://www.edaily.co.kr/news/newspath.asp?newsid=03827766619273864
4127,2018-07-12,증선위삼성바이오로직스회계위반인정검찰고발,http://news.mt.co.kr/mtview.php?no=2018071214272179011
4128,2018-07-12,증선위삼성바이오로직스담당임원해임권고감사인지정및검찰고발등조치의결,http://view.asiae.co.kr/news/view.htm?idxno=2018071216000428224
4129,2018-07-12,증선위삼성바이오로직스담당임원해임권고감사인지정및검찰고발등조치의결,http://view.asiae.co.kr/news/view.htm?idxno=2018071215581204078
4130,2018-07-12,속보증선위삼성바이오로직스담당임원해임권고감사인지정검찰고발,http://www.kukinews.com/news/article.html?no=566239
4131,2018-07-12,삼성바이오로직스결국금감원이꼬리내렸나,http://www.asiatime.co.kr/news/articleView.html?idxno=188089
4132,2018-07-12,증선위삼성바이오로직스회계부정심의결과발표,http://www.ytn.co.kr/_pn/0301_201807121601360818
4133,2018-07-12,현장영상증선위삼성바이오로직스분식회계결론,http://www.ytn.co.kr/_ln/0102_201807121603518906
4134,2018-07-12,증선위삼성바이오로직스에임원해임권고검찰고발조치의결,http://news.hankyung.com/article/2018071254786
4135,2018-07-12,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712176400013&did=1196m
4136,2018-07-12,삼성바이오로직스회계부정심의결과발표,http://news1.kr/photos/view/?3204096
4137,2018-07-12,1보증선위삼성바이오로직스담당임원해임권고검찰고발,http://www.newspim.com/news/view/20180712000447
4138,2018-07-12,삼성바이오로직스주가증선위발표앞두고상승마감전일대비337▲,http://www.joongboo.com/?mod=news&act=articleView&idxno=1267327
4139,2018-07-12,증선위삼성바이오로직스고의공시누락지배력변경은판단보류,http://news.sbs.co.kr/news/endPage.do?news_id=N1004844838&plink=ORI&cooper=NAVER
4140,2018-07-12,속보증선위삼성바이오로직스공시누락고의판단,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000129
4141,2018-07-12,속보증선위삼성바이오로직스회계기준위반검찰고발,http://www.ekn.kr/news/article.html?no=373840
4142,2018-07-12,삼성바이오로직스담당임원해고검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712178600013&did=1196m
4143,2018-07-12,증선위삼성바이오로직스분식회계결론1보,http://www.newsworks.co.kr/news/articleView.html?idxno=200158
4144,2018-07-12,증선위삼성바이오로직스조사결과발표,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712178300013&did=1196m
4145,2018-07-12,속보증선위삼성바이오로직스고의공시누락인정,http://www.kukinews.com/news/article.html?no=566248
4146,2018-07-12,삼성바이오로직스회계처리기준위반검찰고발,http://news1.kr/photos/view/?3204107
4147,2018-07-12,증선위삼성바이오로직스공시누락고의판단검찰고발조치,http://news.hankyung.com/article/2018071256266
4148,2018-07-12,삼성바이오로직스담당임원해임권고검찰고발등의결,http://www.ebn.co.kr/news/view/948332
4149,2018-07-12,삼성바이오로직스회계위반인정검찰고발,http://news1.kr/photos/view/?3204109
4150,2018-07-12,전문삼성바이오로직스증권선물위원회의결내용,http://view.asiae.co.kr/news/view.htm?idxno=2018071216083892411
4151,2018-07-12,증선위삼성바이오로직스조사결과브리핑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712177800013&did=1196m
4152,2018-07-12,증선위삼성바이오로직스에임원해임권고검찰고발조치의결1보,http://www.fnnews.com/news/201807121606380455
4153,2018-07-12,증선위삼성바이오로직스회계위반인정검찰고발2보,http://www.fnnews.com/news/201807121607514539
4154,2018-07-12,김용범증선위원장삼성바이오로직스회계기준위반고의공시누락,http://view.asiae.co.kr/news/view.htm?idxno=2018071216102617588
4155,2018-07-12,증선위삼성바이오로직스분식회계결론,http://www.mediapen.com/news/view/368669
4156,2018-07-12,속보증선위삼성바이오로직스공시누락고의판단,http://www.viva100.com/main/view.php?key=20180712010004700
4157,2018-07-12,속보증선위삼성바이오로직스임원해임감사인지정검찰고발의결,http://www.viva100.com/main/view.php?key=20180712010004702
4158,2018-07-12,증선위삼성바이오로직스관련긴급브리핑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712183100013&did=1196m
4159,2018-07-12,증선위삼성바이오로직스담당임원해고검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712178800013&did=1196m
4160,2018-07-12,삼성바이오로직스제재수위발표,http://news1.kr/photos/view/?3204112
4161,2018-07-12,속보증선위삼성바이오로직스공시누락고의판단,http://www.kyeongin.com/main/view.php?key=20180712010004451
4162,2018-07-12,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712182700013&did=1196m
4163,2018-07-12,삼성바이오로직스담당임원해고검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712175500013&did=1196m
4164,2018-07-12,옵션만기일코스피웃었다셀트리온삼성바이오로직스껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=42900
4165,2018-07-12,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712183500013&did=1196m
4166,2018-07-12,증선위삼성바이오로직스담당임원해고검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712183600013&did=1196m
4167,2018-07-12,증권선물위원회삼성바이오로직스분식회계고의판단,http://www.kyeongin.com/main/view.php?key=20180712010004461
4168,2018-07-12,증선위삼성바이오로직스고의공시누락회계처리는추가감리상보,http://www.fnnews.com/news/201807121620154376
4169,2018-07-12,삼성바이오로직스일부고의분식결론법적공방이어질까,http://www.seoulwire.com/news/articleView.html?idxno=18533
4170,2018-07-12,증권선물위원회삼성바이오로직스분식회계고의판단,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807120489&t=NN
4171,2018-07-12,증선위삼성바이오로직스분식회계고의판단검찰고발등제재의결,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000138
4172,2018-07-12,포토삼성바이오로직스관련증권선물위원회긴급브리핑,http://view.asiae.co.kr/news/view.htm?idxno=2018071216273146020
4173,2018-07-12,김용범부위원장삼성바이오로직스제제수위발표,http://news1.kr/photos/view/?3204171
4174,2018-07-12,증선위삼성바이오로직스고의공시누락,http://view.asiae.co.kr/news/view.htm?idxno=2018071216281758359
4175,2018-07-12,삼성바이오로직스분식회계고의판단시간외하한가,http://news.mt.co.kr/mtview.php?no=2018071216265321838
4176,2018-07-12,증선위삼성바이오로직스일부고의분식결론,http://news1.kr/photos/view/?3204170
4177,2018-07-12,증선위삼성바이오로직스분식회계고의판단검찰고발,http://www.sedaily.com/NewsView/1S221GGPZ5
4178,2018-07-12,포토삼성바이오로직스의운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018071216292164555
4179,2018-07-12,특징주삼성바이오로직스증선위긴급브리핑소식에3대상승,http://www.seoulfn.com/news/articleView.html?idxno=314157
4180,2018-07-12,증선위삼성바이오로직스검찰고발회계위반인정,http://medipana.com/news/news_viewer.asp?NewsNum=222639&MainKind=A&NewsKind=5&vCount=12&vKind=1
4181,2018-07-12,증선위삼성바이오로직스검찰고발,http://www.newstomato.com/ReadNews.aspx?no=835415
4182,2018-07-12,삼성바이오로직스고의로회계기준위반했다”증선위검찰에고발,http://news.heraldcorp.com/view.php?ud=20180712000737
4183,2018-07-12,포토삼성바이오로직스의운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018071216311771427
4184,2018-07-12,증선위삼성바이오로직스공시고의누락검찰고발의결속보,http://www.dt.co.kr/contents.html?article_no=2018071202109958614001&ref=naver
4185,2018-07-12,금융위삼성바이오로직스회계위반,http://news1.kr/photos/view/?3204181
4186,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283325
4187,2018-07-12,김용범부위원장삼성바이오로직스일부고의분식결론,http://news1.kr/photos/view/?3204186
4188,2018-07-12,증선위삼성바이오로직스회계위반검찰고발,http://news1.kr/photos/view/?3204180
4189,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283324
4190,2018-07-12,삼성바이오로직스상승마감명백한회계기준을중대하게위반검찰고발,http://www.econonews.co.kr/news/articleView.html?idxno=29118
4191,2018-07-12,삼성바이오로직스분식회계여부발표하는김용범부위원장,http://news1.kr/photos/view/?3204187
4192,2018-07-12,사진김용범증권선물위원장삼성바이오로직스감리결과발표,http://www.newspim.com/news/view/20180712000487
4193,2018-07-12,증선위삼성바이오로직스회계위반결론검찰고발,http://www.fntimes.com/html/view.php?ud=20180712162834430179ad43907_18
4194,2018-07-12,증선위삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712191800013&did=1196m
4195,2018-07-12,증선위삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712191900013&did=1196m
4196,2018-07-12,증선위삼성바이오로직스회계기준위반결론검찰고발,http://www.ekn.kr/news/article.html?no=373866
4197,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283357
4198,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283354
4199,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283359
4200,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283356
4201,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283358
4202,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283355
4203,2018-07-12,증선위삼성바이오로직스회계부정고의판단검찰고발조치,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201807121634456290179
4204,2018-07-12,증선위삼성바이오로직스공시누락고의회계기준변경판단유보,http://news.hankyung.com/article/2018071257746
4205,2018-07-12,증권선물위원회삼성바이오로직스분식회계고의로판단담당임원해임권고,http://www.inews24.com/php/news_view.php?g_serial=1108692&g_menu=050300&rrf=nv
4206,2018-07-12,삼성바이오로직스발표향하는김용범부위원장,http://news1.kr/photos/view/?3204220
4207,2018-07-12,삼성바이오로직스증선위발표에시간외거래하한가,http://news.hankyung.com/article/2018071257946
4208,2018-07-12,증선위삼성바이오로직스담당임원해고검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712192700013&did=1196m
4209,2018-07-12,김용범부위원장삼성바이오로직스조사발표위해,http://news1.kr/photos/view/?3204223
4210,2018-07-12,삼성바이오로직스분식회계여부발표,http://news1.kr/photos/view/?3204230
4211,2018-07-12,특징주고의공시누락삼성바이오로직스시간외하한가,http://view.asiae.co.kr/news/view.htm?idxno=2018071216411247365
4212,2018-07-12,증선위삼성바이오로직스분식회계고의결론검찰고발,http://www.cstimes.com/?mod=news&act=articleView&idxno=280509
4213,2018-07-12,삼성바이오로직스증선위일부회계위반인정검찰고발,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180712.99099006062
4214,2018-07-12,삼성바이오로직스분식회계여부발표마친김용범부위원장,http://news1.kr/photos/view/?3204225
4215,2018-07-12,증선위삼성바이오로직스공시고의누락검찰고발자회사변경은추가감리,http://www.joongboo.com/?mod=news&act=articleView&idxno=1267339
4216,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283376
4217,2018-07-12,증선위삼성바이오로직스분식회계고의판단,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3582247
4218,2018-07-12,삼성바이오로직스회계위반결론증시정상거래,http://news1.kr/articles/?3370530
4219,2018-07-12,거래소삼성바이오로직스13일오전까지매매거래중지,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201807121642001&code=920100
4220,2018-07-12,삼성바이오로직스고의공시누락증권선물위원회검찰고발시상장폐지심사대상가능성,http://news.imaeil.com/Economy/2018071216424934051
4221,2018-07-12,삼성바이오로직스매매거래정지,http://www.sedaily.com/NewsView/1S22189QIL
4222,2018-07-12,증선위삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712193300013&did=1196m
4223,2018-07-12,증선위삼성바이오로직스분식회계고의판단검찰고발의결,http://www.ezyeconomy.com/news/articleView.html?idxno=84347
4224,2018-07-12,삼성바이오로직스회계처리고의결론,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712194100013&did=1196m
4225,2018-07-12,삼성바이오로직스회계위반결론검찰고발예정,http://www.medicaltimes.com/News/1119887
4226,2018-07-12,금융위증선위삼성바이오로직스회계위반결정,http://news1.kr/photos/view/?3204188
4227,2018-07-12,증선위삼성바이오로직스회계위반인정,http://news1.kr/photos/view/?3204190
4228,2018-07-12,삼성바이오로직스회계처리고의결론,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712194200013&did=1196m
4229,2018-07-12,답변하는김용범부위원장삼성바이오로직스회계위반결정은,http://news1.kr/photos/view/?3204199
4230,2018-07-12,증선위삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712195600013&did=1196m
4231,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283390
4232,2018-07-12,사진김용범증권선물위원장삼성바이오로직스회계기준위반,http://www.newspim.com/news/view/20180712000501
4233,2018-07-12,거래소삼성바이오로직스매매거래정지,http://news.mt.co.kr/mtview.php?no=2018071216432119017
4234,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283393
4235,2018-07-12,증선위삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712195600013&did=1196m
4236,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://www.newsis.com/view/?id=NISI20180712_0014283391
4237,2018-07-12,금융당국삼성바이오로직스고의공시누락,http://www.kormedi.com/news/news/drug_dist/1228212_2906.html
4238,2018-07-12,증선위삼성바이오로직스고의분식결론,http://sports.khan.co.kr/news/sk_index.html?art_id=201807121647013&sec_id=561801&pt=nv
4239,2018-07-12,증선위삼성바이오로직스고의분식결론,http://www.newscj.com/news/articleView.html?idxno=537145
4240,2018-07-12,고의공시누락삼성바이오로직스는어떤기업,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000148
4241,2018-07-12,삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712197800013&did=1196m
4242,2018-07-12,삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712197300013&did=1196m
4243,2018-07-12,삼성바이오로직스고의공시누락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712197200013&did=1196m
4244,2018-07-12,삼성바이오로직스회계기준위반,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712198300013&did=1196m
4245,2018-07-12,삼성바이오로직스제재수위발표하는김용범부위원장,http://news1.kr/photos/view/?3204276
4246,2018-07-12,거래소삼성바이오로직스13일오전9시까지시간외거래매매정지속보,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071216470731983
4247,2018-07-12,삼성바이오로직스증선위발쇼크고의로회계기준위반거래정지등후폭풍,http://www.g-enews.com/ko-kr/news/article/news_all/201807121628293223c642673384_1/article.html
4248,2018-07-12,사진삼성바이오로직스감리결과발표앞둔김용범증권선물위원장,http://www.newspim.com/news/view/20180712000507
4249,2018-07-12,김용범부위원장삼성바이오로직스분식회계여부발표,http://news1.kr/photos/view/?3204275
4250,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://news1.kr/photos/view/?3204280
4251,2018-07-12,증선위삼성바이오로직스회계위반맞다,http://news1.kr/photos/view/?3204277
4252,2018-07-12,거래소삼성바이오로직스매매거래정지13일9시까지,http://news.hankyung.com/article/2018071258626
4253,2018-07-12,삼성바이오로직스회계기준위반,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712198800013&did=1196m
4254,2018-07-12,사진증권선물위원회삼성바이오로직스고의분식결론,http://www.newspim.com/news/view/20180712000509
4255,2018-07-12,증선위삼성바이오로직스고의로공시누락檢고발지배력부당변경은판단유보,http://www.segye.com/content/html/2018/07/12/20180712005174.html?OutUrl=naver
4256,2018-07-12,거래소삼성바이오로직스거래정지상장폐지실질심사대상아냐,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807120507&t=NN
4257,2018-07-12,증선위삼성바이오로직스고의분식결론상장실질심사다시받을수도,http://www.polinews.co.kr/news/article.html?no=361352
4258,2018-07-12,공시삼성바이오로직스13일오전9시까지장외매매거래정지,http://www.metroseoul.co.kr/news/newsview?newscd=2018071200147
4259,2018-07-12,공시삼성바이오로직스13일오전9시까지매매거래정지,http://www.fnnews.com/news/201807121653494574
4260,2018-07-12,삼성바이오로직스보도자료받는취재진들,http://news1.kr/photos/view/?3204293
4261,2018-07-12,사진증선위삼성바이오로직스고의공시누락결론,http://news.mt.co.kr/mtview.php?no=2018071216551076310
4262,2018-07-12,거래소삼성바이오로직스매매거래정지,http://www.newsis.com/view/?id=NISX20180712_0000362331&cID=10401&pID=10400
4263,2018-07-12,사진삼성바이오로직스관련브리핑하는김용범부위원장,http://news.mt.co.kr/mtview.php?no=2018071216564690642
4264,2018-07-12,거래소삼성바이오로직스매매거래정지,http://www.newspim.com/news/view/20180712000512
4265,2018-07-12,사진증선위삼성바이오로직스회계기준위반,http://news.mt.co.kr/mtview.php?no=2018071216574123084
4266,2018-07-12,증선위삼성바이오로직스고의적분식회계결론상장폐지,http://www.econovill.com/news/articleView.html?idxno=341506
4267,2018-07-12,거래소삼성바이오로직스에13일오전9시까지매매거래정지,http://www.g-enews.com/ko-kr/news/article/news_all/201807121656452681c642673384_1/article.html
4268,2018-07-12,포토증선위삼성바이오로직스분식회계고의판단,http://view.asiae.co.kr/news/view.htm?idxno=2018071216594358634
4269,2018-07-12,포토증선위삼성바이오로직스분식회계고의판단,http://view.asiae.co.kr/news/view.htm?idxno=2018071216593555369
4270,2018-07-12,포토증선위삼성바이오로직스분식회계고의판단,http://view.asiae.co.kr/news/view.htm?idxno=2018071217000764103
4271,2018-07-12,포토삼성바이오로직스의운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018071217003077124
4272,2018-07-12,삼성바이오로직스명백한회계기준중대위반,http://www.choicenews.co.kr/news/articleView.html?idxno=42903
4273,2018-07-12,포토삼성바이오로직스의운명은,http://view.asiae.co.kr/news/view.htm?idxno=2018071217002570141
4274,2018-07-12,포토삼성바이오로직스관련증권선물위원회긴급브리핑,http://view.asiae.co.kr/news/view.htm?idxno=2018071217000261168
4275,2018-07-12,포토증선위삼성바이오로직스분식회계고의판단,http://view.asiae.co.kr/news/view.htm?idxno=2018071217000764103
4276,2018-07-12,사진삼성바이오로직스고의분식결론나서는김용범증권선물위원장,http://www.newspim.com/news/view/20180712000516
4277,2018-07-12,사진증선위삼성바이오로직스검찰에고발,http://news.mt.co.kr/mtview.php?no=2018071217004912627
4278,2018-07-12,증선위삼성바이오로직스공시고의누락검찰고발키로,http://www.seoulfn.com/news/articleView.html?idxno=314162
4279,2018-07-12,무역전쟁우려완화코스피2285마감삼성바이오로직스셀트리온상승,http://www.asiatime.co.kr/news/articleView.html?idxno=188110
4280,2018-07-12,포토증선위삼성바이오로직스회계기준위반결론검찰고발,http://view.asiae.co.kr/news/view.htm?idxno=2018071217022695899
4281,2018-07-12,증선위삼성바이오로직스회계부정고의판단검찰고발,http://www.etoday.co.kr/news/section/newsview.php?idxno=1640991
4282,2018-07-12,윤부근부회장삼성바이오로직스관련소식받나,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712201300013&did=1196m
4283,2018-07-12,삼성바이오로직스회계기준위반,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712202100013&did=1196m
4284,2018-07-12,삼성바이오로직스고의분식회계공시누락증선위바이오젠삼성바이오에피스콜옵션은예고된것,http://www.ltn.kr/news/articleView.html?idxno=10580
4285,2018-07-12,공시삼성바이오로직스내일개장까지거래정지,http://www.newsway.co.kr/news/view?tp=1&ud=2018071217050058649
4286,2018-07-12,삼성바이오로직스고의로공시누락콜옵션등위반가능성인식하고도누락,http://www.econonews.co.kr/news/articleView.html?idxno=29122
4287,2018-07-12,삼성바이오로직스어떤회사현재홈페이지에관련해명글없어,http://news.imaeil.com/Economy/2018071217055930529
4288,2018-07-12,거래소삼성바이오로직스13일오전9시까지거래정지,http://www.viva100.com/main/view.php?key=20180712010004744
4289,2018-07-12,증선위삼성바이오로직스고의분식판단검찰고발,http://news.kbs.co.kr/news/view.do?ncd=4008268&ref=A
4290,2018-07-12,삼성바이오로직스주가시간외거래하한가로추락내일개장까지거래정지,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000166
4291,2018-07-12,현장스케치증선위삼성바이오로직스공시고의누락결론,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=526596
4292,2018-07-12,금융위삼성바이오로직스공시누락결론,http://www.dailymedi.com/detail.php?number=832474&thread=22r05
4293,2018-07-12,삼성바이오로직스행정소송등법적대응불사강공,http://www.edaily.co.kr/news/newspath.asp?newsid=04145926619273864
4294,2018-07-12,증선위삼성바이오로직스공시누락고의회계처리는추가감리,http://news.hankyung.com/article/2018071256996
4295,2018-07-12,증선위삼성바이오로직스콜옵션공시누락만고의성인정나머지는금감원에재감리,http://www.kyeongin.com/main/view.php?key=20180712010004507
4296,2018-07-12,삼성바이오로직스증선위회계처리기준위반결정에유감표명,http://www.fnnews.com/news/201807121712510851
4297,2018-07-12,삼성바이오로직스증선위결정유감행정소송등법적구제강구,http://biz.chosun.com/site/data/html_dir/2018/07/12/2018071202593.html
4298,2018-07-12,삼성바이오로직스고의공시누락,http://imnews.imbc.com/replay/2018/nw1700/article/4693907_23836.html
4299,2018-07-12,삼성바이오로직스내일개장까지거래정지,http://www.fntimes.com/html/view.php?ud=201807121714272065f09e13944d_18
4300,2018-07-12,삼성바이오로직스회계위반맞다증선위인정및검찰고발,http://www.sisafocus.co.kr/news/articleView.html?idxno=188495
4301,2018-07-12,삼성바이오로직스증선위결론유감행정소송강구,http://www.newspim.com/news/view/20180712000526
4302,2018-07-12,삼성바이오로직스고의회계위반검찰고발,http://www.dailypharm.com/News/241740
4303,2018-07-12,증선위삼성바이오로직스분식회계고의로판단,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=92577
4304,2018-07-12,삼성바이오로직스상장폐지아냐13일정상거래,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071217144194535
4305,2018-07-12,삼성바이오로직스시간외거거래하한가추락내일개장까지거래정지,http://www.ceoscoredaily.com/news/article.html?no=43402
4306,2018-07-12,삼성바이오로직스국제회계기준에따라적법하게이행행정소송강구,http://www.newsis.com/view/?id=NISX20180712_0000362289&cID=13001&pID=13000
4307,2018-07-12,제약바이오업계삼성바이오로직스이슈업계발목우려상보,http://www.edaily.co.kr/news/newspath.asp?newsid=04224646619273864
4308,2018-07-12,삼성바이오로직스금융위상대행정소송강구,http://news.mt.co.kr/mtview.php?no=2018071217142769271
4309,2018-07-12,삼성바이오로직스시간외거래하한가추락내일개장까지거래정지,http://www.seoulfn.com/news/articleView.html?idxno=314168
4310,2018-07-12,삼성바이오로직스증선위결과발표에유감행정소송등법적구제수단강구,http://www.sisafocus.co.kr/news/articleView.html?idxno=188499
4311,2018-07-12,다시미뤄진삼성바이오로직스분식회계최종결말,http://www.sisajournal-e.com/biz/article/186451
4312,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://news.kmib.co.kr/article/view.asp?arcid=0012518260&code=61141111&cp=nv
4313,2018-07-12,삼성바이오로직스회계투명성높이고내부감시장치강화,http://view.asiae.co.kr/news/view.htm?idxno=2018071217174145039
4314,2018-07-12,삼성바이오로직스회계기준위반,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712211300013&did=1196m
4315,2018-07-12,증선위삼성바이오로직스고의공시누락검찰고발,http://www.biospectator.com/view/news_view.php?varAtcId=5813
4316,2018-07-12,삼성바이오로직스회계기준위반결론13일까지매매거래정지종합,http://www.ekn.kr/news/article.html?no=373881
4317,2018-07-12,삼성바이오로직스회계기준위반,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180712211200013&did=1196m
4318,2018-07-12,삼성바이오로직스증선위결정유감행정소송제기”,http://www.sedaily.com/NewsView/1S221N3CAH
4319,2018-07-12,특징주삼성바이오로직스회계부정고의판단에가격제한폭까지하락거래정지,http://www.news2day.co.kr/107134
4320,2018-07-12,삼성바이오로직스증선위에유감표명행정소송불사,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807120516&t=NN
4321,2018-07-12,삼성바이오로직스시간외거래하한가추락13일개장까지거래정지,http://news.kbs.co.kr/news/view.do?ncd=4008297&ref=A
4322,2018-07-12,금융위삼성바이오로직스상장폐지검토없다”,http://www.kukinews.com/news/article.html?no=566307
4323,2018-07-12,삼성바이오로직스증선위의분식회계공시위반결과에행정소송등대응,http://www.kukinews.com/news/article.html?no=566303
4324,2018-07-12,삼성바이오로직스홈페이지입장문공지행정소송등법적구제수단강구할예정,http://news.imaeil.com/Economy/2018071217301265846
4325,2018-07-12,삼성바이오로직스고의공시누락,http://imnews.imbc.com/news/2018/econo/article/4693782_22671.html
4326,2018-07-12,삼성바이오로직스증선위결정에유감행정소송예정,http://www.viva100.com/main/view.php?key=20180712010004768
4327,2018-07-12,증선위삼성바이오로직스고의공시누락검찰고발,http://news.sbs.co.kr/news/endPage.do?news_id=N1004844935&plink=ORI&cooper=NAVER
4328,2018-07-12,삼성바이오로직스증선위결정유감행정소송강구,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071217275759837
4329,2018-07-12,거래소13일오전9시까지삼성바이오로직스매매거래정지,http://news.mk.co.kr/newsRead.php?year=2018&no=440677
4330,2018-07-12,삼성바이오로직스분식회계판정에행정소송등강구할것,http://news.mk.co.kr/newsRead.php?year=2018&no=440682
4331,2018-07-12,삼성바이오로직스매우유감행정소송등구제수단강구,http://www.dailian.co.kr/news/view/725456/?sc=naver
4332,2018-07-12,핵심쟁점판단미룬증선위분식불씨남긴삼성바이오로직스,http://news.mt.co.kr/mtview.php?no=2018071217024895570
4333,2018-07-12,종합거래소삼성바이오로직스매매거래정지상폐심사대상아냐,http://www.newsis.com/view/?id=NISX20180712_0000362361&cID=10401&pID=10400
4334,2018-07-12,증선위삼성바이오로직스공시누락고의판단검찰고발예정,http://www.tfnews.co.kr/news/article.html?no=50129
4335,2018-07-12,증선위삼성바이오로직스회계위반검찰고발”,https://cnbc.sbs.co.kr/article_hub/10000908269?division=NAVER
4336,2018-07-12,삼성바이오로직스행정소송등법적대응불사”,http://www.newsway.co.kr/news/view?tp=1&ud=2018071217365774232
4337,2018-07-12,증선위삼성바이오로직스회계변경부분판단보류,http://www.kpinews.co.kr/news/articleView.html?idxno=77846
4338,2018-07-12,삼성바이오로직스증선위결정유감행정소송진행”,http://news.kbs.co.kr/news/view.do?ncd=4008302&ref=A
4339,2018-07-12,삼성바이오로직스자사고의공시누락증선위에행정소송회계처리적법하게이행했다,http://www.starseoultv.com/news/articleView.html?idxno=501349
4340,2018-07-12,증선위삼성바이오로직스고의로회계기준위반”검찰고발,http://www.m-economynews.com/news/article.html?no=22761
4341,2018-07-12,삼성바이오로직스증선위결정유감행정소송강구,http://biz.newdaily.co.kr/site/data/html/2018/07/12/2018071200203.html
4342,2018-07-12,삼성바이오로직스증선위발표매우유감스럽다,http://www.ebn.co.kr/news/view/948353
4343,2018-07-12,삼성바이오로직스고의공시누락발표유감행정소송강구,http://www.etnews.com/20180712000374
4344,2018-07-12,삼성바이오로직스왜거래정지인식하고도고의누락명백한위반,http://www.inews24.com/php/news_view.php?g_serial=1108719&g_menu=050300&rrf=nv
4345,2018-07-12,삼성바이오로직스검찰고발에도주식은정상거래,http://moneys.mt.co.kr/news/mwView.php?no=2018071217358085068
4346,2018-07-12,삼성바이오로직스증선위결정유감행정소송강구,http://www.wolyo.co.kr/news/articleView.html?idxno=64348
4347,2018-07-12,삼성바이오로직스증선위결과유감행정소송대응”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1641013
4348,2018-07-12,박용진삼성바이오로직스콜옵션공시누락배후밝혀져야”,http://www.fntimes.com/html/view.php?ud=201807121746376307f09e13944d_18
4349,2018-07-12,삼성바이오로직스증선위결정유감행정소송등법적수단강구,http://news.hankyung.com/article/2018071262756
4350,2018-07-12,증선위삼성바이오로직스檢고발박용진절반의승리”,http://www.mhj21.com/sub_read.html?uid=115151§ion=sc118
4351,2018-07-12,삼성바이오로직스거래정지상장폐지되나,http://www.namdonews.com/news/articleView.html?idxno=482029
4352,2018-07-12,삼성바이오로직스증선위결론유감행정소송불사하겠다,http://daily.hankooki.com/lpage/economy/201807/dh20180712174550138060.htm
4353,2018-07-12,한국거래소삼성바이오로직스상장폐지심사대상아냐,http://news.einfomax.co.kr/news/articleView.html?idxno=3457852
4354,2018-07-12,일지삼성바이오로직스분식회계논란,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180712161200008&did=1195m
4355,2018-07-12,삼성바이오로직스모든회계처리적법하게이행법적구제수단강구할것,http://www.segye.com/content/html/2018/07/12/20180712006096.html?OutUrl=naver
4356,2018-07-12,증권위삼성바이오로직스고의로공시누락했다판단,http://www.medigatenews.com/news/4057485966
4357,2018-07-12,증선위삼성바이오로직스공시누락부분고의판단,http://www.kyeongin.com/main/view.php?key=20180712010004536
4358,2018-07-12,삼성바이오로직스법적구제수단강구할것,http://www.m-i.kr/news/articleView.html?idxno=433321
4359,2018-07-12,삼성바이오로직스회계부정고의증선위결정유감법적구제수단강구,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000182
4360,2018-07-12,회계기준위반삼성바이오로직스주가향방은,http://www.ebn.co.kr/news/view/948343
4361,2018-07-12,삼성바이오로직스매매거래정지13일오전9시해제,http://www.ekn.kr/news/article.html?no=373887
4362,2018-07-12,삼성바이오로직스증선위결정유감행정소송등강구강력반발,http://www.ezyeconomy.com/news/articleView.html?idxno=84348
4363,2018-07-12,삼성바이오로직스충격오래가지않을것단기투심은부정적,http://view.asiae.co.kr/news/view.htm?idxno=2018071218045477912
4364,2018-07-12,삼성바이오로직스증선위발표유감회계처리적법입증할것”,http://www.ajunews.com/view/20180712175611892
4365,2018-07-12,삼성바이오로직스고의회계위반인정제약바이오주영향은,http://www.ebn.co.kr/news/view/948351
4366,2018-07-12,삼성바이오로직스고의로공시누락의미는,http://www.pressian.com/news/article.html?no=203571&utm_source=naver&utm_medium=search
4367,2018-07-12,삼성바이오로직스증선위결정유감행정소송등법적구제수단강구”,http://it.chosun.com/site/data/html_dir/2018/07/12/2018071202777.html
4368,2018-07-12,코스피코스닥미중무역전쟁우려에도상승거래정지삼성바이오로직스시간외하한가,http://www.kyeongin.com/main/view.php?key=20180712010004553
4369,2018-07-12,증선위삼성바이오로직스회계처리위반결론,http://www.wolyo.co.kr/news/articleView.html?idxno=64342
4370,2018-07-12,삼성바이오로직스증선위고의공시누락결정에행정소송강구,http://www.kyeongin.com/main/view.php?key=20180712010004554
4371,2018-07-12,삼성바이오로직스상장폐지거래소심사대상아니야하지만,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180712.99099006154
4372,2018-07-12,증권선물위삼성바이오로직스공시누락고발분식판단은유보”,http://www.businesspost.co.kr/BP?command=article_view&num=88772
4373,2018-07-12,거래소삼성바이오로직스매매거래정지상폐심사대상은아냐,http://www.ajunews.com/view/20180712181340903
4374,2018-07-12,증선위삼성바이오로직스고의분식판단검찰고발,http://news.kbs.co.kr/news/view.do?ncd=4008315&ref=A
4375,2018-07-12,일문일답김용범삼성바이오로직스지배권변동은새로운안건으로봐야,http://www.seoulfn.com/news/articleView.html?idxno=314180
4376,2018-07-12,김태한삼성바이오로직스최대위기어떻게돌파하나,http://www.businesspost.co.kr/BP?command=article_view&num=88787
4377,2018-07-12,증선위삼성바이오로직스공시누락고의로판단,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1496729
4378,2018-07-12,박용진의원삼성바이오로직스분식회계결과발표절반의승리,http://view.asiae.co.kr/news/view.htm?idxno=2018071218385347962
4379,2018-07-12,증선위삼성바이오로직스고의분식판단삼바행정소송검토등강력반발,http://www.news2day.co.kr/107143
4380,2018-07-12,삼성바이오로직스중대회계위반”검찰고발,http://news.kmib.co.kr/article/view.asp?arcid=0923979972&code=11151100&cp=nv
4381,2018-07-12,한국거래소삼성바이오로직스시간외거래정지13일오전9시재개예정,http://www.newstomato.com/ReadNews.aspx?no=835506
4382,2018-07-12,삼성바이오로직스강력반발행정소송등통해결백입증”,http://news.kmib.co.kr/article/view.asp?arcid=0923979968&code=11131900&cp=nv
4383,2018-07-12,삼성바이오로직스주가시간외거래에서하한가셀트리온은올라,http://www.businesspost.co.kr/BP?command=article_view&num=88808
4384,2018-07-12,삼성바이오로직스증선위발표반발행정소송등법적구제수단강구할것,http://www.joongboo.com/?mod=news&act=articleView&idxno=1267497
4385,2018-07-12,박용진삼성바이오로직스분식회계판정절반의승리,http://www.inews24.com/php/news_view.php?g_serial=1108727&g_menu=022300&rrf=nv
4386,2018-07-12,삼성바이오로직스증선위발표유감법적구제수단강구,http://www.nocutnews.co.kr/news/4999852
4387,2018-07-12,거래소삼성바이오로직스상장폐지심사대상아냐사측행정소송강구,http://www.ekn.kr/news/article.html?no=373900
4388,2018-07-12,삼성바이오로직스증선위의결불복행정소송강구,http://www.fntimes.com/html/view.php?ud=201807121904059370f09e13944d_18
4389,2018-07-12,삼성바이오로직스증선위발표유감행정소송할것,http://www.ytn.co.kr/_ln/0102_201807121911081335
4390,2018-07-12,삼성바이오로직스시간외거래에서하한가기록13일오전9시까지매매거래정지,http://www.joongboo.com/?mod=news&act=articleView&idxno=1267522
4391,2018-07-12,증선위가삼성바이오로직스분식회계여부에대해복잡한판단을내렸다,https://www.huffingtonpost.kr/entry/story_kr_5b4717f4e4b022fdcc563c65?utm_id=naver
4392,2018-07-12,삼성바이오로직스매우유감법적구제수단강구,http://www.inews24.com/php/news_view.php?g_serial=1108732&g_menu=022620&rrf=nv
4393,2018-07-12,증선위삼성바이오로직스고의누락회계기준위반”,http://news.kbs.co.kr/news/view.do?ncd=4008339&ref=A
4394,2018-07-12,사설고의로드러난삼성바이오로직스회계부정,http://www.hani.co.kr/arti/opinion/editorial/853086.html
4395,2018-07-12,﻿금융위원회증권선물위원회vs삼성바이오로직스분식회계누락법적다툼예고,http://medicalworldnews.co.kr/news/view.php?idx=1510926499
4396,2018-07-12,삼성바이오로직스고의공시누락결론,http://news.bizwatch.co.kr/article/finance/2018/07/12/0022/naver
4397,2018-07-12,증선위삼성바이오로직스고의공시누락결론,http://news20.busan.com/controller/newsController.jsp?newsId=20180712000282
4398,2018-07-12,그래픽삼성바이오로직스회계처리기준위반주요일지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=GYH20180712001300044&did=1363m
4399,2018-07-12,김용범삼성바이오로직스공시누락과삼성승계연관판단어려워,http://www.businesspost.co.kr/BP?command=article_view&num=88788
4400,2018-07-12,삼성바이오로직스증권선물위결정에행정소송등법적대응,http://www.businesspost.co.kr/BP?command=article_view&num=88791
4401,2018-07-12,핫이슈2010년이건희회장의경고발언으로설립된기업삼성바이오로직스비합법고의성vs처리적절성논란확산,http://www.newsfarm.co.kr/news/articleView.html?idxno=27585
4402,2018-07-12,삼성바이오로직스유감표명법적구제수단강구할것,http://www.metroseoul.co.kr/news/newsview?newscd=2018071200169
4403,2018-07-12,삼성바이오로직스회계처리기준위반주요일지,http://www.ggilbo.com/news/articleView.html?idxno=526051
4404,2018-07-12,증선위삼성바이오로직스회계위반이라판단감사지정및검찰고발의결,http://news.hankyung.com/article/201807126704I
4405,2018-07-12,삼성바이오로직스13일주권매매거래재개,http://www.newspim.com/news/view/20180712000591
4406,2018-07-12,삼성바이오로직스신뢰타격우려기업윤리에흠집,http://www.ekn.kr/news/article.html?no=373902
4407,2018-07-12,금감원삼성바이오로직스분식회계공을다시넘겨받았다,http://www.businesspost.co.kr/BP?command=article_view&num=88815
4408,2018-07-12,삼성바이오로직스증선위조치상장폐지대상아니다”13일거래정지풀리나,http://www.econovill.com/news/articleView.html?idxno=341532
4409,2018-07-12,삼성바이오로직스고의분식이재용승계흔들,http://www.obsnews.co.kr/news/articleView.html?idxno=1105161
4410,2018-07-12,박용진증선위삼성바이오로직스사태금감원에게미뤘다”,http://www.newsway.co.kr/news/view?tp=1&ud=2018071221322896912
4411,2018-07-12,삼성바이오로직스증선위상장적격성실질심사사유는해당하지않아,http://www.econonews.co.kr/news/articleView.html?idxno=29128
4412,2018-07-12,삼성바이오로직스행정소송강구모든회계적법하게처리적정성소명했는데매우유감,http://www.econonews.co.kr/news/articleView.html?idxno=29136
4413,2018-07-12,삼성바이오로직스고의로공시누락증선위담당임원해임권고검찰고발등제재내리기로,http://www.topdaily.kr/news/articleView.html?idxno=53093
4414,2018-07-12,삼성바이오로직스고의로공시누락최종판정,http://www.joongboo.com/?mod=news&act=articleView&idxno=1267493
4415,2018-07-12,삼성바이오로직스증선위판정에갑을론박왜,http://www.betanews.net:8080/article/880565.html
4416,2018-07-12,증선위가내놓은삼성바이오로직스판정에떠들썩한이유는,http://www.gnmaeil.com/news/articleView.html?idxno=377051
4417,2018-07-12,증선위삼성바이오로직스공시누락에성급한검찰고발분식회계여부는결정보류,http://www.techholic.co.kr/news/articleView.html?idxno=176937
4418,2018-07-12,삼성바이오로직스어떤기업이길래증선위조치에떠들썩삼성미래동력상장폐지할뻔,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180712.99099006197
4419,2018-07-13,증권선물위원회삼성바이오로직스고의분식회계판단,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180713.22015006128
4420,2018-07-13,오늘삼성바이오로직스유례없는폭락기록하나차후상폐심사가능성있어,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180713.99099006160
4421,2018-07-13,삼성바이오로직스어떤기업상장폐지위기넘기삼성미래동력,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180713.99099006206
4422,2018-07-13,삼성바이오로직스분식회계고의판정,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=818547
4423,2018-07-13,증선위삼성바이오로직스관계사판단유보왜,http://www.medicaltimes.com/News/1119895
4424,2018-07-13,화제의IT키워드신형아반떼안드로이드오토라크니삼성바이오로직스,http://it.chosun.com/site/data/html_dir/2018/07/12/2018071203672.html
4425,2018-07-13,브랜드믿고거액투자했는데멘붕상태삼성바이오로직스투자자들허탈그리고분노,http://www.g-enews.com/ko-kr/news/article/news_all/201807130618515044e4869c120_1/article.html
4426,2018-07-13,김어준의뉴스공장김경율증선위삼성바이오로직스고의분식회계결론향후진행방향은,http://www.mediapen.com/news/view/368747
4427,2018-07-13,천지일보이슈종합삼성바이오고용쇼크노량진시장갈등삼성바이오로직스문고리3인방,http://www.newscj.com/news/articleView.html?idxno=537222
4428,2018-07-13,tbs김어준의뉴스공장증선위삼성바이오로직스징계은행강도에주차위반딱지만뗀것,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0500&key=20180713.99099006233
4429,2018-07-13,삼성바이오로직스불확실성상존최악가지는않을것,http://news.hankyung.com/article/2018071371406
4430,2018-07-13,삼성바이오로직스증선위결론장중거래실질영향없어대신,http://news.mt.co.kr/mtview.php?no=2018071307442035187
4431,2018-07-13,삼성바이오로직스상장폐지가능성낮다”한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1641133
4432,2018-07-13,삼성바이오로직스회계위반했다는증선위에유감행정소송,http://www.meconomynews.com/news/articleView.html?idxno=15727
4433,2018-07-13,삼성바이오로직스개별종목접근제약바이오불확실성해소하나,http://news.hankyung.com/article/2018071371666
4434,2018-07-13,삼성바이오로직스의파장어디까지갈까,http://news.mt.co.kr/mtview.php?no=2018071308132461916
4435,2018-07-13,제약바이오주저점매수기회삼성바이오로직스는개별이슈”,http://www.fntimes.com/html/view.php?ud=201807130818045386f09e13944d_18
4436,2018-07-13,바이오주삼성바이오로직스발불확실성일단락하나금투,http://www.newstomato.com/ReadNews.aspx?no=835520
4437,2018-07-13,클릭e종목삼성바이오로직스상장폐지가능성제한적,http://view.asiae.co.kr/news/view.htm?idxno=2018071308233093750
4438,2018-07-13,삼성바이오로직스상폐가능성낮아업계불확실성해소”종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01482566619274192
4439,2018-07-13,삼성바이오로직스상폐가능성낮아업계불확실성해소”종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01482566619274192
4440,2018-07-13,삼성바이오로직스거래정지증선위에유감행정소송간다,http://www.namdonews.com/news/articleView.html?idxno=482153
4441,2018-07-13,삼성바이오로직스상장폐지가능성은제한적”한국투자증권,http://www.fntimes.com/html/view.php?ud=201807130829451760f09e13944d_18
4442,2018-07-13,주요공시삼성바이오로직스회계처리기준위반으로검찰고발등조치,http://www.cstimes.com/?mod=news&act=articleView&idxno=280549
4443,2018-07-13,삼성바이오로직스공시기준위반은상장폐지와무관,http://www.businesspost.co.kr/BP?command=article_view&num=88831
4444,2018-07-13,아주종목분석한국투자삼성바이오로직스상장폐지가능성낮아,http://www.ajunews.com/view/20180713082300991
4445,2018-07-13,삼성바이오로직스불확실성상존하나상폐되진않을것한국證,http://www.ebn.co.kr/news/view/948378
4446,2018-07-13,삼성물산삼성바이오로직스이슈영향한정적”KB증권,http://www.fntimes.com/html/view.php?ud=20180713084235583f09e13944d_18
4447,2018-07-13,제약바이오주저가매수할때삼성바이오로직스사태일단락,http://www.businesspost.co.kr/BP?command=article_view&num=88836
4448,2018-07-13,삼성바이오로직스불확실성여전하지만상장폐지가능성낮다”,http://www.cstimes.com/?mod=news&act=articleView&idxno=280553
4449,2018-07-13,HotLine삼성바이오로직스상폐가능성매우낮아,http://news.mk.co.kr/newsRead.php?year=2018&no=441622
4450,2018-07-13,증선위삼성바이오로직스공시위반만판단삼바놓고금융위금감원힘겨루기에투자자만울상,http://news.heraldcorp.com/view.php?ud=20180713000052
4451,2018-07-13,오늘의종목삼성바이오로직스단기간바이오위축장기지속없다,http://www.sedaily.com/NewsView/1S22HI3O3P
4452,2018-07-13,한국거래소삼성바이오로직스13일매매거래재개”,http://www.newsway.co.kr/news/view?tp=1&ud=2018071308542721671
4453,2018-07-13,삼성바이오로직스24000원559내린405000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807130065&t=NN
4454,2018-07-13,삼성물산삼성바이오로직스우려는과도KB증권,http://www.ebn.co.kr/news/view/948383
4455,2018-07-13,한국투자증권삼성바이오로직스불확실성상존하나최악은아냐”,http://www.newsway.co.kr/news/view?tp=1&ud=2018071308592876402
4456,2018-07-13,특징주삼성바이오로직스증선위고의성인정에하락,http://news.mt.co.kr/mtview.php?no=2018071308590393973
4457,2018-07-13,삼성바이오로직스공시누락중징계분식회계판단은보류,https://cnbc.sbs.co.kr/article_hub/10000908324?division=NAVER
4458,2018-07-13,삼성바이오로직스반쪽결론옐로카드받은삼바레드카드까지가나안가나,http://news.heraldcorp.com/view.php?ud=20180713000065
4459,2018-07-13,삼성바이오로직스콜옵션공시누락상폐와무관대신證,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071309020231196
4460,2018-07-13,특징주삼성바이오로직스회계처리기준위반vs상장폐지가능성희박외인매수에도주가흔들,http://www.g-enews.com/ko-kr/news/article/news_all/20180713090344899c642673384_1/article.html
4461,2018-07-13,속보삼성바이오로직스559하락출발,http://www.sedaily.com/NewsView/1S22H8Z7PP
4462,2018-07-13,증선위삼성바이오로직스공시누락인정분식회계유보,http://news.kbs.co.kr/news/view.do?ncd=4008580&ref=A
4463,2018-07-13,특징주삼성바이오로직스장초반부터매도세쏟아지며4대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=29143
4464,2018-07-13,특징주삼성바이오로직스회계기준위반소식에4대급락,http://www.fntimes.com/html/view.php?ud=201807130904326824f09e13944d_18
4465,2018-07-13,특징주삼성바이오로직스하락고의적공시누락판단,http://news.hankyung.com/article/2018071374366
4466,2018-07-13,삼성바이오로직스상장폐지가능성제한적한국투자증권,http://www.dt.co.kr/contents.html?article_no=2018071302109932048002&ref=naver
4467,2018-07-13,회계처리변경고의누락삼성바이오로직스장초반하락세,http://www.sedaily.com/NewsView/1S22HQE771
4468,2018-07-13,특징주삼성바이오로직스급락세상폐가능성낮아,http://www.asiatime.co.kr/news/articleView.html?idxno=188184
4469,2018-07-13,특징주삼성바이오로직스증선위콜옵션공시누락결론에약세,http://www.ekn.kr/news/article.html?no=373929
4470,2018-07-13,삼성바이오로직스공시누락고의성인정한증선위에행정소송건다 ,http://www.topdaily.kr/news/articleView.html?idxno=53123
4471,2018-07-13,한투증권삼성바이오로직스상장폐지가능성제한적,http://www.sedaily.com/NewsView/1S22GP5F95
4472,2018-07-13,특징주고의공시누락삼성바이오로직스5대하락,http://www.newsis.com/view/?id=NISX20180713_0000362745&cID=10401&pID=10400
4473,2018-07-13,ET투자뉴스삼성바이오로직스_상대적인하락폭더욱커현재606,http://www.etnews.com/20180713000019
4474,2018-07-13,하나금융투자삼성바이오로직스이슈제약바이오섹터불확실성해소”,http://www.newsway.co.kr/news/view?tp=1&ud=2018071309123552979
4475,2018-07-13,특징주삼성바이오로직스증선위징계에약세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180713034200008&did=1195m
4476,2018-07-13,특징주삼성바이오로직스검찰고발등증선위조치에6하락,http://view.asiae.co.kr/news/view.htm?idxno=2018071309141681967
4477,2018-07-13,특징주′회계기준위반처분′삼성바이오로직스6대하락출발,http://www.newspim.com/news/view/20180713000124
4478,2018-07-13,특징주삼성바이오로직스공시고의누락결정에급락,http://www.newstomato.com/ReadNews.aspx?no=835537
4479,2018-07-13,삼성바이오로직스약세상장폐지우려불식에하락폭은제한,http://news.einfomax.co.kr/news/articleView.html?idxno=3457948
4480,2018-07-13,특징주삼성바이오로직스회계기준위반결론에5이상급락,http://www.inews24.com/php/news_view.php?g_serial=1108812&g_menu=022300&rrf=nv
4481,2018-07-13,특징주삼성바이오로직스증선위공시누락고의성인정소식에하락세,http://www.dt.co.kr/contents.html?article_no=2018071302109932048004&ref=naver
4482,2018-07-13,특징주삼성바이오로직스공시고의누락판단에하락,http://www.ebn.co.kr/news/view/948385
4483,2018-07-13,증선위삼성바이오로직스공시위반만판단삼성바이오콜옵션공시누락”금융위는왜고의로본걸까,http://news.heraldcorp.com/view.php?ud=20180713000100
4484,2018-07-13,삼성바이오로직스고의회계위반외신들도관심,http://www.dailypharm.com/News/241760
4485,2018-07-13,한국거래소삼성바이오로직스상장폐지심사대상아니다,http://www.mdtoday.co.kr/mdtoday/index.html?no=326587
4486,2018-07-13,특징주삼성물산삼성바이오로직스불똥우려에주가낙폭확대,http://www.g-enews.com/ko-kr/news/article/news_all/201807130916017730c16aa2f016_1/article.html
4487,2018-07-13,고의공시누락삼성바이오로직스13일장초반급락향방은,http://www.choicenews.co.kr/news/articleView.html?idxno=42914
4488,2018-07-13,삼성바이오로직스회계위반제재에주가3대하락,http://news1.kr/articles/?3370999
4489,2018-07-13,특징주삼성바이오로직스증선위고의공시누락결정↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807130100&t=NN
4490,2018-07-13,특징주삼성바이오로직스급락회계기준위반영향,http://www.fetv.co.kr/news/article.html?no=9464
4491,2018-07-13,특징주바이오업계삼성바이오로직스충격벗어나오름세반전,http://www.news2day.co.kr/107158
4492,2018-07-13,특징주고의공시누락삼성바이오로직스주가급락개미투자자냉가슴,http://www.kukinews.com/news/article.html?no=566447
4493,2018-07-13,특징주셀트리온삼성바이오로직스여파하락세,http://www.asiatime.co.kr/news/articleView.html?idxno=188200
4494,2018-07-13,특징주삼성바이오로직스증선위고의성판단에하락세,http://www.seoulfn.com/news/articleView.html?idxno=314195
4495,2018-07-13,특징주고의공시누락삼성바이오로직스장초반약세,http://www.mediapen.com/news/view/368784
4496,2018-07-13,고의공시누락삼성바이오로직스주가하락세,http://imnews.imbc.com/news/2018/econo/article/4694744_22671.html
4497,2018-07-13,삼성바이오로직스약세출발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180713028600013&did=1196m
4498,2018-07-13,증선위삼성바이오로직스공시위반만판단최악모면한삼성바이오분식논란향방은,http://news.heraldcorp.com/view.php?ud=20180713000150
4499,2018-07-13,금감원증선위삼성바이오로직스재감리요청에대응방안모색,http://www.kyeongin.com/main/view.php?key=20180713010004683
4500,2018-07-13,HotLine삼성바이오로직스고의공시누락결정에급락,http://news.mk.co.kr/newsRead.php?year=2018&no=441936
4501,2018-07-13,증선위삼성바이오로직스공시누락인정분식회계유보,http://news.kbs.co.kr/news/view.do?ncd=4008613&ref=A
4502,2018-07-13,특징주삼성물산삼성바이오로직스여파약세,http://www.fntimes.com/html/view.php?ud=201807131003402117f09e13944d_18
4503,2018-07-13,증선위삼성바이오로직스분식회계혐의재감리요청금감원당혹,http://news.hankyung.com/article/2018071378177
4504,2018-07-13,삼성바이오로직스의13일의금요일폭락장열리나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180713.99099006311
4505,2018-07-13,금감원삼성바이오로직스재감리관련입장오늘공개,http://www.ytn.co.kr/_ln/0102_201807131012089074
4506,2018-07-13,금감원삼성바이오로직스재감리관련입장오늘공개,http://www.ytn.co.kr/_ln/0102_201807131012089074
4507,2018-07-13,삼성바이오로직스증선위회계기준위반결정에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326596
4508,2018-07-13,특징주삼성바이오로직스고의공시누락6하락,http://www.dailian.co.kr/news/view/725603/?sc=naver
4509,2018-07-13,특징주삼성바이오로직스증선위공시고의누락결정에약세,http://www.sporbiz.co.kr/news/articleView.html?idxno=254086
4510,2018-07-13,검찰고발등증선위중징계삼성바이오로직스6하락,http://www.econovill.com/news/articleView.html?idxno=341547
4511,2018-07-13,특징주삼성바이오로직스고의공시누락결정에하락,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018071310140100910&LinkID=632&objId=A2018071310140100910&portalCode=naver
4512,2018-07-13,삼성바이오로직스하락세로출발업계영향제한적,http://www.kormedi.com/news/news/drug_dist/1228226_2906.html
4513,2018-07-13,특징주삼성바이오로직스증선위´고의누락´결론에하락,http://www.sisaon.co.kr/news/articleView.html?idxno=75221
4514,2018-07-13,삼성바이오로직스논란은지속상폐는면할것,http://www.whitepaper.co.kr/news/articleView.html?idxno=102735
4515,2018-07-13,다시금감원에넘어간삼성바이오로직스증선위첫재감리요청,http://www.whitepaper.co.kr/news/articleView.html?idxno=102738
4516,2018-07-13,삼성바이오로직스회계위반결론에도바이오株상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326598
4517,2018-07-13,고의공시누락삼성바이오로직스6급락,http://daily.hankooki.com/lpage/economy/201807/dh20180713103642138110.htm
4518,2018-07-13,삼성바이오로직스상장폐지일단락예상된결과토러스,http://www.breaknews.com/sub_read.html?uid=589664§ion=sc3
4519,2018-07-13,고의공시누락결정에삼성바이오로직스주식급락,http://www.mhj21.com/sub_read.html?uid=115158§ion=sc243
4520,2018-07-13,삼성바이오로직스분식회계판정상식의승리미뤄진정의실현절반의승리,http://www.econonews.co.kr/news/articleView.html?idxno=29177
4521,2018-07-13,삼성바이오로직스주가하락다른바이오주는상승세,http://news.hankyung.com/article/2018071380166
4522,2018-07-13,삼성바이오로직스증선위제재결정에5하락증시불확실성지속,http://view.asiae.co.kr/news/view.htm?idxno=2018071311173394003
4523,2018-07-13,브리핑최석대변인증선위삼성바이오로직스반쪽결론아시아나항공박삼구회장맞춤이벤트행사승무원에강요관련,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=426&aid=0000006595
4524,2018-07-13,삼성바이오로직스증선위등결과발표납득위해소명,http://www.newsfreezone.co.kr/news/articleView.html?idxno=70176
4525,2018-07-13,뉴스후삼성바이오로직스분식회계판단유보어떻게해석해야하나,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071310350115301
4526,2018-07-13,금감원삼성바이오로직스관련금융위결정존중,http://www.newstomato.com/ReadNews.aspx?no=835571
4527,2018-07-13,부자들은경제신문을읽는다삼성바이오로직스의파장어디까지갈까外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071311345121430
4528,2018-07-13,코스피코스닥동반↑증선위로부터제재받은삼성바이오로직스↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=326612
4529,2018-07-13,금융위금감원갈등심화삼성바이오로직스분식회계여부결론보류,http://www.news2day.co.kr/107177
4530,2018-07-13,증선위반쪽결정삼성바이오로직스핵심쟁점은결론유보”,http://news.kbs.co.kr/news/view.do?ncd=4008703&ref=A
4531,2018-07-13,The이슈공시누락고의판단삼성바이오로직스미래는,http://www.newstomato.com/ReadNews.aspx?no=835561
4532,2018-07-13,투데이뉴스콕증선위삼성바이오로직스고의공시누락판단,http://www.newstomato.com/ReadNews.aspx?no=835560
4533,2018-07-13,돈잘버는증권맨에게듣는다삼성바이오로직스업황파장지속vs불확실성제거,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071311345151069
4534,2018-07-13,금감원삼성바이오로직스공시누락고의결정존중,http://www.kyeongin.com/main/view.php?key=20180713010004724
4535,2018-07-13,대신증권삼성바이오로직스콜옵션공시누락상장폐지와무관”이유는,http://www.cnbnews.com/news/article.html?no=379540
4536,2018-07-13,삼성바이오로직스하락세보여증선위징계영향,http://www.topstarnews.net/news/articleView.html?idxno=445427
4537,2018-07-13,금감원증선위의삼성바이오로직스감리결과존중”,http://news.kmib.co.kr/article/view.asp?arcid=0012520606&code=61141111&cp=nv
4538,2018-07-13,코스피외인기관사자에2300선순항삼성바이오로직스하락,http://news.hankyung.com/article/2018071387596
4539,2018-07-13,금감원증선위삼성바이오로직스재감리요구수용키로,http://news.mk.co.kr/newsRead.php?year=2018&no=442640
4540,2018-07-13,분석삼성바이오로직스결과에잠잠한바이오주,http://www.inews24.com/php/news_view.php?g_serial=1108924&g_menu=022300&rrf=nv
4541,2018-07-13,삼성바이오로직스주가약세지속6안팎하락,http://news1.kr/articles/?3371326
4542,2018-07-13,금융위삼성바이오로직스공시고의누락,http://www.monews.co.kr/news/articleView.html?idxno=116858
4543,2018-07-13,삼성바이오로직스금감원과검찰상대로길고고단한다툼,http://www.businesspost.co.kr/BP?command=article_view&num=88893
4544,2018-07-13,금감원증선위의삼성바이오로직스재감리요구수용증선위의삼성바이오로직스중징계로주가6하락,http://www.topstarnews.net/news/articleView.html?idxno=445468
4545,2018-07-13,삼성물산주가에삼성바이오로직스회계논란의영향은제한적,http://www.businesspost.co.kr/BP?command=article_view&num=88896
4546,2018-07-13,삼바춤을추고있는그대”삼성바이오로직스분식회계논란꼬리내린금감원,http://ilyo.co.kr/?ac=article_view&entry_id=303546
4547,2018-07-13,금감원증선위삼성바이오로직스재감리요구수용,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3583156
4548,2018-07-13,삼성바이오로직스27000원629내린402000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807130448&t=NN
4549,2018-07-13,인베스트조선장기전된삼성바이오로직스사태패자만남았다,http://www.investchosun.com/?p=3228242
4550,2018-07-13,참여연대증선위가면죄부”삼성바이오로직스내주검찰고발,http://www.hankookilbo.com/v/83dd0accdde94327b58ec2df38a42336
4551,2018-07-13,삼성바이오로직스자회사부풀리기증선위금감원충돌,http://www.seoulfn.com/news/articleView.html?idxno=314243
4552,2018-07-13,코스피이틀째상승해2310선회복삼성바이오로직스하락,http://news.hankyung.com/article/2018071393756
4553,2018-07-13,특징주삼성바이오로직스증선위징계에약세종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180713034251008&did=1195m
4554,2018-07-13,특징주삼성바이오로직스증선위징계에약세,http://www.kyeongin.com/main/view.php?key=20180713010004764
4555,2018-07-13,이데일리N금감원삼성바이오로직스재감리입장오늘중표명外,http://www.edaily.co.kr/news/newspath.asp?newsid=03460406619274192
4556,2018-07-13,금감원삼성바이오로직스회계더조사하겠다”,http://www.econovill.com/news/articleView.html?idxno=341581
4557,2018-07-13,금감원삼성바이오로직스재감리가닥잡았지만우왕좌왕,http://www.businesspost.co.kr/BP?command=article_view&num=88904
4558,2018-07-13,삼성바이오로직스핵심쟁점고의적 회계분식여부피해간증선위결론삼바는회계처리적법주장,http://www.topstarnews.net/news/articleView.html?idxno=445497
4559,2018-07-13,美훈풍한국증시활짝SK하이닉스삼성전기껑충vs삼성바이오로직스추락,http://www.choicenews.co.kr/news/articleView.html?idxno=42933
4560,2018-07-13,삼성바이오로직스증선위회계기준위반결정에약세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=326639
4561,2018-07-13,삼성바이오로직스6대하락마감고의공시누락여파이어져,http://www.econonews.co.kr/news/articleView.html?idxno=29213
4562,2018-07-13,금융감독원증선위삼성바이오로직스재감리결정수용하기로,http://www.mediapen.com/news/view/368941
4563,2018-07-13,특징주삼성바이오로직스6대하락증선위징계여파,http://moneys.mt.co.kr/news/mwView.php?no=2018071316248065240
4564,2018-07-13,삼성바이오로직스공시고의누락의결에6대하락,http://www.ebn.co.kr/news/view/948469
4565,2018-07-13,6넘게하락한삼성바이오로직스,http://news1.kr/photos/view/?3206245
4566,2018-07-13,삼성바이오로직스큰폭으로하락,http://news1.kr/photos/view/?3206247
4567,2018-07-13,큰폭으로하락한삼성바이오로직스,http://news1.kr/photos/view/?3206248
4568,2018-07-13,하락면치못한삼성바이오로직스,http://news1.kr/photos/view/?3206246
4569,2018-07-13,금감원증선위삼성바이오로직스재감리요구존중,http://www.m-i.kr/news/articleView.html?idxno=433572
4570,2018-07-13,논란의삼성바이오로직스상장폐지가능성은,http://news.mt.co.kr/mtview.php?no=2018071314173973325
4571,2018-07-13,금감원삼성바이오로직스재감리증선위요구수용키로,http://www.joseilbo.com/news/news_read.php?uid=357060&class=53&grp=
4572,2018-07-13,증선위삼성바이오로직스검찰에고발키로,http://www.wsobi.com/news/articleView.html?idxno=62576
4573,2018-07-13,삼성바이오로직스하락세,http://news1.kr/photos/view/?3206283
4574,2018-07-13,삼성바이오로직스일부고의분식판단에흔들리는전망,http://www.sisajournal-e.com/biz/article/186506
4575,2018-07-13,삼성바이오로직스이주식을어이할꼬,http://www.finomy.com/news/articleView.html?idxno=56262
4576,2018-07-13,금감원삼성바이오로직스재감리하겠다,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10290409
4577,2018-07-13,아주종목분석삼성바이오로직스증선위결정에약세마감,http://www.ajunews.com/view/20180713170933347
4578,2018-07-13,삼성바이오로직스주가급락해시총순위하락셀트리온은제자리,http://www.businesspost.co.kr/BP?command=article_view&num=88933
4579,2018-07-13,삼성바이오로직스대우조선해양등이타산지석증권사최악은피할것”,http://www.g-enews.com/ko-kr/news/article/news_all/201807131710237178c642673384_1/article.html
4580,2018-07-13,금감원삼성바이오로직스재감리요청수용,http://www.seoulfn.com/news/articleView.html?idxno=314272
4581,2018-07-13,증선위의결에법적대응선언한삼성바이오로직스분식회계파장어디까지,http://www.sisaon.co.kr/news/articleView.html?idxno=75253
4582,2018-07-13,바이오주삼성바이오로직스디커플링시작,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018071316241174643
4583,2018-07-13,분석사상초유재감리핵심빠진삼성바이오로직스결론,http://www.inews24.com/php/news_view.php?g_serial=1109043&g_menu=022300&rrf=nv
4584,2018-07-13,삼성바이오로직스불똥튈까전전긍긍제약바이오업계,http://www.sporbiz.co.kr/news/articleView.html?idxno=254186
4585,2018-07-13,삼성바이오로직스상장폐지가능성은,http://www.nbntv.co.kr/news/articleView.html?idxno=106748
4586,2018-07-13,삼성바이오로직스약세로마감섹터불확실성일단락됐다,http://www.ggilbo.com/news/articleView.html?idxno=526155
4587,2018-07-13,증권선물위는삼성바이오로직스공시누락을왜고의로봤나,http://www.businesspost.co.kr/BP?command=article_view&num=88949
4588,2018-07-13,삼성바이오로직스가치일주일새48조가116조로,http://imnews.imbc.com/replay/2018/nwdesk/article/4695791_22663.html
4589,2018-07-13,장기전돌입삼성바이오로직스사태주가향방은,http://www.newsprime.co.kr/news/article.html?no=422768
4590,2018-07-14,위기모면삼성바이오로직스불확실성완전해소되나,http://www.wolyo.co.kr/news/articleView.html?idxno=64407
4591,2018-07-14,삼성바이오로직스다시감리핵심외면한반쪽결론,http://news.sbs.co.kr/news/endPage.do?news_id=N1004847058&plink=ORI&cooper=NAVER
4592,2018-07-14,뉴스해설삼성바이오로직스사태장기화누가책임지나,http://news.kbs.co.kr/news/view.do?ncd=4009102&ref=A
4593,2018-07-14,삼성바이오로직스이슈장기화제약바이오주영향은,http://www.choicenews.co.kr/news/articleView.html?idxno=42937
4594,2018-07-14,박용진삼성바이오로직스판정절반의승리금감원엔태산같은부담감”,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10290461
4595,2018-07-14,심상정금감원삼성바이오로직스직접검찰고발해야,http://www.newsis.com/view/?id=NISX20180714_0000363661&cID=10301&pID=10300
4596,2018-07-14,반쪽결론삼성바이오로직스재감리수용논란,http://moneys.mt.co.kr/news/mwView.php?no=2018071410318070411
4597,2018-07-14,심상정금감원삼성바이오로직스직접검찰고발해야,http://news.mt.co.kr/mtview.php?no=2018071410587697195
4598,2018-07-14,상장폐지심사피한삼성바이오로직스최악상황은면했지만,http://www.kidd.co.kr/news/203683
4599,2018-07-14,정의당심상정금감원삼성바이오로직스직접검찰고발해야”,http://sports.khan.co.kr/news/sk_index.html?art_id=201807141237003&sec_id=564001&pt=nv
4600,2018-07-14,심상정금감원삼성바이오로직스재감리아닌검찰고발해야,http://www.ntoday.co.kr/news/articleView.html?idxno=62461
4601,2018-07-14,천지일보주간핫이슈10최저임금8350원소상공인반발전국폭염특보문재인신남방정책김정은친서공개북미협상삼성바이오로직스,http://www.newscj.com/news/articleView.html?idxno=537568
4602,2018-07-15,증선위조치에삼성바이오로직스주가휘청한국투자증권의삼바관련보고서정말문제없나,http://www.choicenews.co.kr/news/articleView.html?idxno=42947
4603,2018-07-15,주간주요공시삼성바이오로직스고의공시누락검찰고발조치,http://www.cstimes.com/?mod=news&act=articleView&idxno=280571
4604,2018-07-16,삼성물산삼성바이오로직스불확실성감안해도과매도구간교보증권,http://www.fntimes.com/html/view.php?ud=201807160748231702f09e13944d_18
4605,2018-07-16,OBS전격인터뷰삼성바이오로직스증선위제재결정과제는,http://www.obsnews.co.kr/news/articleView.html?idxno=1105535
4606,2018-07-16,NH투자증권효성삼성바이오로직스등KOSPI200편입이벤트주목,http://www.g-enews.com/ko-kr/news/article/news_all/201807160850207404c16aa2f016_1/article.html
4607,2018-07-16,삼성바이오로직스6500원162오른408500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807160082&t=NN
4608,2018-07-16,삼성물산현주가는과매도삼성바이오로직스감안해도저평가,http://www.businesspost.co.kr/BP?command=article_view&num=89035
4609,2018-07-16,특징주삼성바이오로직스증선위쇼크서벗어나나외인공방vs주가는꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201807160903491457c642673384_1/article.html
4610,2018-07-16,특징주삼성바이오로직스급락딛고반등세,http://www.asiatime.co.kr/news/articleView.html?idxno=188457
4611,2018-07-16,삼성바이오로직스하루만에반등세돌아서,http://www.sedaily.com/NewsView/1S23UZ9B16
4612,2018-07-16,특징주삼성바이오로직스증선위제재후반등,http://www.ebn.co.kr/news/view/948574
4613,2018-07-16,특징주삼성바이오로직스증선위제재후2거래일만에반등세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1641781
4614,2018-07-16,특징주삼성바이오로직스주가장초반상승,http://www.mediapen.com/news/view/369319
4615,2018-07-16,특징주삼성바이오로직스하루만에회복세,http://www.fntimes.com/html/view.php?ud=201807160954075217f09e13944d_18
4616,2018-07-16,ISSUEINSIDE삼성바이오로직스공시누락고의결론분식회계판단또미뤄바이오투자찬물,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=446383
4617,2018-07-16,특징주삼성바이오로직스증선위제재결정후2거래일만에반등세,http://www.dt.co.kr/contents.html?article_no=2018071602109932048009&ref=naver
4618,2018-07-16,삼성바이오로직스전일대비약3상승한415000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807160241&t=NN
4619,2018-07-16,특징주삼성바이오로직스하루만에반등3↑,http://view.asiae.co.kr/news/view.htm?idxno=2018071610452659297
4620,2018-07-16,삼성바이오로직스제재이후반등세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326720
4621,2018-07-16,코스피반등조짐속혼조세삼성바이오로직스상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326732
4622,2018-07-16,정지원한국거래소이사장북한자본시장설립추진대비중삼성바이오로직스상장폐지논란규정대로할것”,http://www.g-enews.com/ko-kr/news/article/news_all/201807161442036286c642673384_1/article.html
4623,2018-07-16,폴리텍바이오캠퍼스2018삼성바이오로직스산학인턴교육입교,http://www.asiatoday.co.kr/view.php?key=20180716010009157
4624,2018-07-16,정지원거래소이사장삼성바이오로직스추가조사결과따라상폐심사도”,http://www.fntimes.com/html/view.php?ud=2018071615481237641d6f57e61a_18
4625,2018-07-16,코스피하락IT혼조vs셀트리온삼성바이오로직스올라,http://www.choicenews.co.kr/news/articleView.html?idxno=42978
4626,2018-07-16,삼성바이오로직스시민단체와정치권의검찰수사압박커져곤경,http://www.businesspost.co.kr/BP?command=article_view&num=89105
4627,2018-07-16,아주종목분석삼성바이오로직스2가까이상승마감,http://www.ajunews.com/view/20180716163353390
4628,2018-07-16,삼성바이오로직스셀트리온주가동반상승외국인두주식매수,http://www.businesspost.co.kr/BP?command=article_view&num=89139
4629,2018-07-16,정지원삼성바이오로직스회계기준위반나오면상장폐지심사”,http://www.businesspost.co.kr/BP?command=article_view&num=89166
4630,2018-07-16,코스피반등조짐에도하락마감삼성바이오로직스상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326808
4631,2018-07-17,삼성바이오로직스불확실성지속상장폐지가능성은낮아,http://www.mdtoday.co.kr/mdtoday/index.html?no=326763
4632,2018-07-17,특징주삼성바이오로직스이틀째오름세상폐가능성희박,http://www.asiatime.co.kr/news/articleView.html?idxno=188723
4633,2018-07-17,특징주삼성바이오로직스금융당국제재후이틀째강세,http://www.newstomato.com/ReadNews.aspx?no=836111
4634,2018-07-17,삼성바이오로직스금감원상대로손해배상소송추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=326775
4635,2018-07-17,코스피코스닥동반↓삼성바이오로직스연속2일상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326869
4636,2018-07-17,공시삼성바이오로직스23일상반기결산실적공시,http://www.newsway.co.kr/news/view?tp=1&ud=2018071715502685570
4637,2018-07-17,코스피코스닥동반↓삼성바이오로직스2일연속상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=326918
4638,2018-07-17,셀트리온삼성바이오로직스주가올라기관과외국인동반매수,http://www.businesspost.co.kr/BP?command=article_view&num=89301
4639,2018-07-17,한국폴리텍대학바이오캠퍼스삼성바이오로직스산학인턴교육입교,http://www.daejonilbo.com/news/newsitem.asp?pk_no=1326193
4640,2018-07-18,심상정금감원이삼성바이오로직스직접검찰고발해야증선위비판,http://www.topstarnews.net/news/articleView.html?idxno=447824
4641,2018-07-18,특징주삼성바이오로직스상장폐지가능성희박진단사흘째오름세,http://www.g-enews.com/ko-kr/news/article/news_all/201807180906584516c16aa2f016_1/article.html
4642,2018-07-18,참여연대삼성바이오로직스및삼정안진회계법인검찰고발,http://biz.chosun.com/site/data/html_dir/2018/07/18/2018071801498.html
4643,2018-07-18,불씨남긴삼성바이오로직스감리공은다시금감원으로,http://www.metroseoul.co.kr/news/newsview?newscd=2018071800173
4644,2018-07-18,삼성바이오로직스주가올라시총순위뛰어셀트리온은떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=89454
4645,2018-07-19,채이배국민연금의이재용경영권승계관여여부수사해야삼성바이오로직스,http://www.topstarnews.net/news/articleView.html?idxno=448737
4646,2018-07-19,특징주삼성바이오로직스외국인러브콜봇물주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201807190923245040c642673384_1/article.html
4647,2018-07-19,비바시스템즈삼성바이오로직스에자사문서관리솔루션시스템도입,http://www.mdtoday.co.kr/mdtoday/index.html?no=327120
4648,2018-07-19,삼성바이오로직스전세계파트너와CDMO문서관리일원화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220342
4649,2018-07-19,시민단체삼성바이오로직스회계부정검찰고발,http://www.ytn.co.kr/_ln/0103_201807191119409398
4650,2018-07-19,비바삼성바이오로직스에문서관리솔루션제공,http://medipana.com/news/news_viewer.asp?NewsNum=222923&MainKind=A&NewsKind=5&vCount=12&vKind=1
4651,2018-07-19,참여연대회계부정혐의삼성바이오로직스검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180719069300004&did=1195m
4652,2018-07-19,참여연대삼성바이오로직스검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180719081500013&did=1196m
4653,2018-07-19,참여연대삼성바이오로직스검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180719082400013&did=1196m
4654,2018-07-19,참여연대삼성바이오로직스검찰고발,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180719083800013&did=1196m
4655,2018-07-19,참여연대삼성바이오로직스회계법인대표분식회계혐의로검찰고발,http://news.mk.co.kr/newsRead.php?year=2018&no=455051
4656,2018-07-19,참여연대분식회계의혹삼성바이오로직스고발,http://www.newsis.com/view/?id=NISX20180719_0000368356&cID=10201&pID=10200
4657,2018-07-19,참여연대삼성바이오로직스및삼정안진회계법인고발합니다,http://news1.kr/photos/view/?3214545
4658,2018-07-19,참여연대삼성바이오로직스및삼정안진회계법인고발기자회견,http://news1.kr/photos/view/?3214542
4659,2018-07-19,참여연대삼성바이오로직스검찰고발,http://news1.kr/photos/view/?3214564
4660,2018-07-19,삼성바이오로직스분식회계와제일모직삼성물산합병의연관성은,http://news1.kr/photos/view/?3214559
4661,2018-07-19,삼성바이오로직스및삼정안진회계법인회계처리위반으로고발하는참여연대,http://news1.kr/photos/view/?3214556
4662,2018-07-19,삼성바이오로직스및삼정안진회계법인고발장접수하는참여연대,http://news1.kr/photos/view/?3214561
4663,2018-07-19,삼성바이오로직스Veeva글로벌문서관리솔루션도입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058273
4664,2018-07-19,참여연대회계부정삼성바이오로직스검찰고발,http://imnews.imbc.com/news/2018/society/article/4705508_22673.html
4665,2018-07-19,참여연대삼성바이오로직스등분식회계혐의로고발,http://www.newsis.com/view/?id=NISI20180719_0014304885
4666,2018-07-19,참여연대삼성바이오로직스검찰고발,http://www.newsis.com/view/?id=NISI20180719_0014304874
4667,2018-07-19,참여연대삼성바이오로직스등분식회계혐의로고발,http://www.newsis.com/view/?id=NISI20180719_0014304883
4668,2018-07-19,참여연대삼성바이오로직스검찰고발,http://www.newsis.com/view/?id=NISI20180719_0014304872
4669,2018-07-19,참여연대분식회계혐의관련삼성바이오로직스고발,http://www.newsis.com/view/?id=NISI20180719_0014304881
4670,2018-07-19,삼성바이오로직스비바시스템즈문서관리솔루션도입,http://www.medicaltimes.com/News/1120004
4671,2018-07-19,참여연대분식회계혐의삼성바이오로직스검찰고발,http://www.ebn.co.kr/news/view/949067
4672,2018-07-19,참여연대분식회계의혹삼성바이오로직스검찰고발,http://www.ezyeconomy.com/news/articleView.html?idxno=84459
4673,2018-07-19,참여연대삼성바이오로직스고발왜,http://www.updownnews.co.kr/news/articleView.html?idxno=94028
4674,2018-07-19,참여연대회계부정혐의삼성바이오로직스서울중앙지검에고발,https://www.lawtimes.co.kr/Legal-News/Legal-News-View?serial=144971
4675,2018-07-19,비바시스템즈삼성바이오로직스에문서관리솔루션제공,http://www.hellot.net/new_hellot/magazine/magazine_read.html?code=202&sub=004&idx=41877
4676,2018-07-19,참여연대분식회계혐의삼성바이오로직스고발,http://www.smedaily.co.kr/news/articleView.html?idxno=77211
4677,2018-07-19,삼성바이오로직스9000원217오른423500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807190476&t=NN
4678,2018-07-19,삼성바이오로직스는정말특혜를받았나,http://view.asiae.co.kr/news/view.htm?idxno=2018071915385744494
4679,2018-07-19,참여연대회계부정혐의삼성바이오로직스회계법인검찰고발,http://www.etoday.co.kr/news/section/newsview.php?idxno=1643408
4680,2018-07-19,참여연대삼성바이오로직스회계부정혐의로검찰고발,http://www.sedaily.com/NewsView/1S259S8FOO
4681,2018-07-19,코스피연일하락LG디스플레이삼성SDI삼성바이오로직스는껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=43086
4682,2018-07-19,참여연대외감법자본시장법위반삼성바이오로직스등검찰고발,http://www.asiatime.co.kr/news/articleView.html?idxno=189393
4683,2018-07-19,참여연대회계부정혐의삼성바이오로직스검찰고발,http://news.hankyung.com/article/2018071990196
4684,2018-07-19,참여연대분식회계혐의삼성바이오로직스檢고발,http://news1.kr/articles/?3376685
4685,2018-07-19,코스피외국인순매수삼성바이오로직스삼성전자SK하이닉스,http://www.newsway.co.kr/news/view?tp=1&ud=2018071917401695647
4686,2018-07-19,삼성바이오로직스주가외국인매수에올라셀트리온은소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=89633
4687,2018-07-19,삼성바이오로직스분식회계와제일모직삼성물산합병의연관성은,http://www.fntoday.co.kr/news/articleView.html?idxno=166089
4688,2018-07-19,참여연대분식회계의혹삼성바이오로직스검찰고발,http://www.inews24.com/php/news_view.php?g_serial=1110564&g_menu=022300&rrf=nv
4689,2018-07-19,참여연대회계부정혐의삼성바이오로직스검찰고발,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1499516
4690,2018-07-19,참여연대회계부정혐의삼성바이오로직스회계법인대표등검찰고발,http://www.ltn.kr/news/articleView.html?idxno=10670
4691,2018-07-20,삼성바이오로직스VeevaVaultQualityDocs도입문서관리일원화,http://medicalworldnews.co.kr/news/view.php?idx=1510926616
4692,2018-07-20,참여연대삼성바이오로직스검찰고발콜옵션공시누락합병위한사전작업,http://www.topstarnews.net/news/articleView.html?idxno=449518
4693,2018-07-20,퀵리포트삼성바이오로직스매수유지목표가66만원유지SK證,http://www.itooza.com/common/iview.php?no=2018072007385211254
4694,2018-07-20,삼성바이오로직스목표가66만원유지전일종가42만3500원SK證,http://www.newspim.com/news/view/20180720000058
4695,2018-07-20,삼성바이오로직스바이오젠콜옵션증선위결론에불확실성해소SK증권,http://news.mt.co.kr/mtview.php?no=2018072007391902810
4696,2018-07-20,삼성바이오로직스점진적인불확실성회복SK증권,http://www.fnnews.com/news/201807200746526410
4697,2018-07-20,삼성바이오로직스바이오젠회계처리점진적불확실성해소SK證,http://www.ebn.co.kr/news/view/949155
4698,2018-07-20,삼성바이오로직스점진적불확실성회복에주목SK,http://www.cstimes.com/?mod=news&act=articleView&idxno=281154
4699,2018-07-20,삼성바이오로직스점진적으로불확실성회복,http://www.ekn.kr/news/article.html?no=375495
4700,2018-07-20,삼성바이오로직스3000원071오른426500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807200066&t=NN
4701,2018-07-20,특징주삼성바이오로직스증선위발표후5거래일연속↑,http://www.newsis.com/view/?id=NISX20180720_0000369239&cID=10401&pID=10400
4702,2018-07-20,삼성바이오로직스VeevaVaultQualityDocs도입,http://www.bokuennews.com/news/article.html?no=162692
4703,2018-07-20,특징주삼성바이오로직스회계불확실성완화에닷새째상승세,http://www.g-enews.com/ko-kr/news/article/news_all/201807200923118494c16aa2f016_1/article.html
4704,2018-07-20,ET투자뉴스삼성바이오로직스점진적인불확실성매수유지SK증권,http://www.etnews.com/20180720000029
4705,2018-07-20,삼성바이오로직스주식사도된다회계논란불확실성줄어들어,http://www.businesspost.co.kr/BP?command=article_view&num=89699
4706,2018-07-20,특징주삼성바이오로직스증권위발표이후5거래일연속오름세,http://www.dt.co.kr/contents.html?article_no=2018072002109932048005&ref=naver
4707,2018-07-20,삼성바이오로직스불확실성걷히면서5거래일연속상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=327278
4708,2018-07-20,삼성바이오로직스파이프라인앞세워불확실성돌파하나,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058342
4709,2018-07-20,참여연대삼성바이오로직스회계법인검찰고발왜,http://www.sisaweek.com/news/articleView.html?idxno=111098
4710,2018-07-20,삼성바이오로직스1000원024오른424500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807200408&t=NN
4711,2018-07-20,삼성바이오로직스분식회계일단락제약바이오투심은냉랭,http://www.mdtoday.co.kr/mdtoday/index.html?no=327346
4712,2018-07-20,비바삼성바이오로직스에문서관리솔루션제공,http://www.bosa.co.kr/news/articleView.html?idxno=2087102
4713,2018-07-20,삼성바이오로직스주가외국인매수에올라셀트리온은내려,http://www.businesspost.co.kr/BP?command=article_view&num=89779
4714,2018-07-21,코스피코스닥삼성바이오로직스부터신라젠까지20일흐름은어떠했나,http://www.topstarnews.net/news/articleView.html?idxno=450250
4715,2018-07-21,삼성바이오로직스논란여전히궁금한점들,http://ilyo.co.kr/?ac=article_view&entry_id=304074
4716,2018-07-21,참여연대회계부정혐의삼성바이오로직스대표등검찰고발,http://www.fnnews.com/news/201807211231480476
4717,2018-07-21,삼성바이오로직스비바문서관리솔루션도입으로문서관리일원화,http://www.industrynews.co.kr/news/articleView.html?idxno=25310
4718,2018-07-22,삼성바이오로직스분식회계검찰수사요구하는움직임에촉각,http://www.businesspost.co.kr/BP?command=article_view&num=89858
4719,2018-07-22,스트레이트김경율삼성바이오로직스관련해김용범발언비판피의자중심결정,http://www.topstarnews.net/news/articleView.html?idxno=450866
4720,2018-07-23,오늘의증시현대중공업삼성바이오로직스실적발표7월23일,http://www.etoday.co.kr/news/section/newsview.php?idxno=1644147
4721,2018-07-23,삼성바이오로직스4500원106오른429000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807230075&t=NN
4722,2018-07-23,특징주삼성바이오로직스2분기실적공시앞두고외인러브콜,http://www.g-enews.com/ko-kr/news/article/news_all/201807230922258246c16aa2f016_1/article.html
4723,2018-07-23,스트레이트삼성바이오로직스사태로바라본삼성과금융위원회의관계,http://www.mediapen.com/news/view/370979
4724,2018-07-23,삼성바이오로직스10000원236내린414500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807230560&t=NN
4725,2018-07-23,잠정실적삼성바이오로직스올해2Q영업익237억흑자전환,http://www.itooza.com/common/iview.php?no=2018072315580519546
4726,2018-07-23,삼성바이오로직스2Q영업익237억흑자전환성공1보,http://news1.kr/articles/?3379392
4727,2018-07-23,삼성바이오로직스올해2Q영업익237억흑자전환,http://www.newspim.com/news/view/20180723000451
4728,2018-07-23,삼성바이오로직스2분기매출1254억원영업이익237억원,http://www.newsworks.co.kr/news/articleView.html?idxno=202560
4729,2018-07-23,삼성바이오로직스2분기매출1254억원영업이익237억원기록,http://www.fnnews.com/news/201807231601284994
4730,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180723122800008&did=1195m
4731,2018-07-23,삼성바이오로직스2분기매출1254억원영업이익237억원,http://www.newsworks.co.kr/news/articleView.html?idxno=202560
4732,2018-07-23,삼성바이오로직스올2Q영업이익237억전년比흑자전환,http://news.mt.co.kr/mtview.php?no=2018072316031623258
4733,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://www.newsis.com/view/?id=NISX20180723_0000371498&cID=10401&pID=10400
4734,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://www.fnnews.com/news/201807231605543963
4735,2018-07-23,삼성바이오로직스2Q영업익237억흑자전환,http://news.einfomax.co.kr/news/articleView.html?idxno=3459374
4736,2018-07-23,1보삼성바이오로직스2Q영업익237억흑자전환,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180723160513
4737,2018-07-23,공시삼성바이오로직스2Q영업익237억전년比흑자전환,http://www.newsway.co.kr/news/view?tp=1&ud=2018072316094943265
4738,2018-07-23,삼성바이오로직스2Q영업이익237억흑자전환,http://www.mdtoday.co.kr/mdtoday/index.html?no=327452
4739,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.asiatoday.co.kr/view.php?key=20180723010013021
4740,2018-07-23,삼성바이오로직스2Q영업이익237억원전분기대비137↑,http://www.enewstoday.co.kr/news/articleView.html?idxno=1214773
4741,2018-07-23,삼성바이오로직스2분기매출1254억영업익237억,http://medipana.com/news/news_viewer.asp?NewsNum=223080&MainKind=A&NewsKind=5&vCount=12&vKind=1
4742,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환전분기대비137↑,http://www.segye.com/content/html/2018/07/23/20180723004542.html?OutUrl=naver
4743,2018-07-23,삼성바이오로직스2분기영업이익237억원전년동기대비379↑,http://news.mk.co.kr/newsRead.php?year=2018&no=462846
4744,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환성공,http://www.viva100.com/main/view.php?key=20180723010008475
4745,2018-07-23,삼성바이오로직스2분기영업익237억원전년비379↑,http://biz.chosun.com/site/data/html_dir/2018/07/23/2018072302118.html
4746,2018-07-23,삼성바이오로직스2분기영업익237억원CMO수주가능성더높아져,http://www.dt.co.kr/contents.html?article_no=2018072302109932047001&ref=naver
4747,2018-07-23,삼성바이오로직스2분기영업이익237억원흑자전환,http://www.ceoscoredaily.com/news/article.html?no=43743
4748,2018-07-23,삼성바이오로직스2공장가동효과2Q영업익237억,http://www.biospectator.com/view/news_view.php?varAtcId=5868
4749,2018-07-23,삼성바이오로직스2분기영업익237억전분기比137↑,http://www.newsis.com/view/?id=NISX20180723_0000371510&cID=13001&pID=13000
4750,2018-07-23,공시삼성바이오로직스2분기영업익237억원전년比흑자전환,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018072316263302730&LinkID=632&objId=A2018072316263302730&portalCode=naver
4751,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.dailian.co.kr/news/view/727789/?sc=naver
4752,2018-07-23,삼성바이오로직스2Q매출1254억전년比98껑충상보,http://news1.kr/articles/?3379427
4753,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://view.asiae.co.kr/news/view.htm?idxno=2018072316312326338
4754,2018-07-23,삼성바이오로직스2분기영업이익237억흑자전환,http://www.polinews.co.kr/news/article.html?no=362480
4755,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://news.heraldcorp.com/view.php?ud=20180723000754
4756,2018-07-23,삼성바이오로직스2분기영업익237억전년비흑자전환,http://www.newspim.com/news/view/20180723000467
4757,2018-07-23,삼성바이오로직스2분기영업익237억2공장가동률증가영향,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807230586&t=NN
4758,2018-07-23,삼성바이오로직스2공장가동률상승에2Q영업익전년比378↑,http://view.asiae.co.kr/news/view.htm?idxno=2018072316365052901
4759,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018072316303080278
4760,2018-07-23,공시삼성바이오로직스2분기영업이익237억원전년대비흑자전환,http://www.g-enews.com/ko-kr/news/article/news_all/201807231634291555c642673384_1/article.html
4761,2018-07-23,삼성바이오로직스2분기영업익237억전년比흑자전환,http://www.ajunews.com/view/20180723163636186
4762,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.dt.co.kr/contents.html?article_no=2018072302109931102002&ref=naver
4763,2018-07-23,삼성바이오로직스2분기영업익237억원전년대비흑자전환,http://www.choicenews.co.kr/news/articleView.html?idxno=43172
4764,2018-07-23,삼성바이오로직스2분기매출1254억전년比984↑,http://daily.hankooki.com/lpage/economy/201807/dh20180723164954138060.htm
4765,2018-07-23,삼성바이오로직스2분기영업이익237억원흑자전환,http://www.newsprime.co.kr/news/article.html?no=423818
4766,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=04182006619277472
4767,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180723122851008&did=1195m
4768,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://news.kbs.co.kr/news/view.do?ncd=4013387&ref=A
4769,2018-07-23,삼성바이오로직스2분기영업이익237억흑자전환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1644549
4770,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.mediapen.com/news/view/371104
4771,2018-07-23,삼성바이오로직스2Q2공장가동으로전분기比영업이익137↑,http://www.news2day.co.kr/107646
4772,2018-07-23,셀트리온3총사주가급락삼성바이오로직스도약세,http://www.businesspost.co.kr/BP?command=article_view&num=89989
4773,2018-07-23,삼성바이오로직스2분기영업익237억흑자전환,http://www.metroseoul.co.kr/news/newsview?newscd=2018072300180
4774,2018-07-23,삼성바이오로직스2분기흑자전환에성공,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180723170458
4775,2018-07-23,삼성바이오로직스올2분기매출1254억원영업이익237억원기록,http://www.ekn.kr/news/article.html?no=376153
4776,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.sisajournal-e.com/biz/article/186904
4777,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://biz.newdaily.co.kr/site/data/html/2018/07/23/2018072300160.html
4778,2018-07-23,삼성바이오로직스2분기매출1254억영업이익237억,http://www.medigatenews.com/news/1936173731
4779,2018-07-23,삼성바이오로직스2분기영업익237억원전년동기대비378증가,http://www.etnews.com/20180723000439
4780,2018-07-23,삼성바이오로직스분식회계논란에도2Q호실적기록연내성장가능성↑​​​​​​​,http://www.wolyo.co.kr/news/articleView.html?idxno=64898
4781,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.asiatime.co.kr/news/articleView.html?idxno=189971
4782,2018-07-23,삼성바이오로직스2Q영업익237억흑자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=04542806619277472
4783,2018-07-23,삼성바이오로직스2분기매출소폭줄었지만영업이익급증,http://www.businesspost.co.kr/BP?command=article_view&num=90000
4784,2018-07-23,티브로드인천삼성바이오로직스영업이익137증가,http://ch1.tbroad.com/content/view?parent_no=24&content_no=58&p_no=61557
4785,2018-07-23,삼성바이오로직스2분기영업이익237억원흑자전환,http://news20.busan.com/controller/newsController.jsp?newsId=20180723000248
4786,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.seoulfn.com/news/articleView.html?idxno=314980
4787,2018-07-23,삼성바이오로직스2분기영업익237억원흑자전환,http://www.fetv.co.kr/news/article.html?no=9956
4788,2018-07-23,삼성바이오로직스흑자전환2분기영업이익237억공장가동률증가,http://www.econonews.co.kr/news/articleView.html?idxno=30068
4789,2018-07-23,삼성바이오로직스2분기매출1254억영업이익237억,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1500742
4790,2018-07-24,삼성바이오로직스흑자전환2분기영업익237억원,http://sports.khan.co.kr/news/sk_index.html?art_id=201807240000053&sec_id=564001&pt=nv
4791,2018-07-24,순항이어가는삼성바이오로직스2분기영업익237억원기록,http://www.asiatoday.co.kr/view.php?key=20180723010013023
4792,2018-07-24,스트레이트삼성바이오로직스사태와금융위집중조명,http://www.topstarnews.net/news/articleView.html?idxno=451337
4793,2018-07-24,삼성바이오로직스가동률증가로2분기호실적유진,http://news.hankyung.com/article/2018072410126
4794,2018-07-24,삼성바이오로직스2분기영업익흑전기대이상실적유안타증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1644616
4795,2018-07-24,삼성바이오로직스목표가61만원유지전일종가41만4500원한투證,http://www.newspim.com/news/view/20180724000042
4796,2018-07-24,삼성바이오로직스목표가51만원유지전일종가41만4500원유안타證,http://www.newspim.com/news/view/20180724000048
4797,2018-07-24,퀵리포트삼성바이오로직스매수유지목표가51만원유지유안타證,http://www.itooza.com/common/iview.php?no=2018072407343487609
4798,2018-07-24,퀵리포트삼성바이오로직스매수유지목표가61만원유지한투證,http://www.itooza.com/common/iview.php?no=2018072407340758896
4799,2018-07-24,삼성바이오로직스목표가53만원유지전일종가41만4500원유진證,http://www.newspim.com/news/view/20180724000068
4800,2018-07-24,퀵리포트삼성바이오로직스매수유지목표가53만원유지유진證,http://www.itooza.com/common/iview.php?no=2018072407374096945
4801,2018-07-24,I리포트삼성바이오로직스2분기영업익추정치상회–유안타證,http://www.inews24.com/php/news_view.php?g_serial=1111474&g_menu=022300&rrf=nv
4802,2018-07-24,퀵리포트삼성바이오로직스매수유지목표가9↓59만원현대차證,http://www.itooza.com/common/iview.php?no=2018072407583223363
4803,2018-07-24,삼성바이오로직스목표가9↓59만원제시현대차證,http://www.newspim.com/news/view/20180724000092
4804,2018-07-24,삼성바이오로직스펀데멘탈과리스크모두확인해야유안타증권,http://news.mt.co.kr/mtview.php?no=2018072407570443713
4805,2018-07-24,한투증권삼성바이오로직스2분기실적기대이상,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180724021400008&did=1195m
4806,2018-07-24,삼성바이오로직스당분간주가변동지속될듯–유안타증권,http://www.fntimes.com/html/view.php?ud=2018072408095144761d6f57e61a_18
4807,2018-07-24,2분기호실적에한숨돌린삼성바이오로직스주가는안갯속,http://news.hankyung.com/article/2018072411326
4808,2018-07-24,퀵리포트삼성바이오로직스중립유지목표가미제시IBK證,http://www.itooza.com/common/iview.php?no=2018072408205315616
4809,2018-07-24,삼성바이오로직스올2분기매출1254억영업이익237억흑자발표,http://www.m-i.kr/news/articleView.html?idxno=436739
4810,2018-07-24,삼성바이오로직스2분기양호한성장기록현대차,http://www.cstimes.com/?mod=news&act=articleView&idxno=281421
4811,2018-07-24,삼성바이오로직스바이오시밀러경쟁심화에목표가↓현대차,http://www.sedaily.com/NewsView/1S27IGO8L6
4812,2018-07-24,삼성바이오로직스2분기깜짝실적주가긍정적한국투자증권,http://www.dt.co.kr/contents.html?article_no=2018072402109932048002&ref=naver
4813,2018-07-24,삼성바이오로직스목표주가하향경쟁심화로시장점유율떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=90043
4814,2018-07-24,삼성바이오로직스영업이익↑2분기237억,http://www.kormedi.com/news/news/drug_dist/1228398_2906.html
4815,2018-07-24,삼성바이오로직스2Q실적기대치크게상회한국투자證,http://www.seoulfn.com/news/articleView.html?idxno=315005
4816,2018-07-24,HotLine삼성바이오로직스시장기대뛰어넘은2분기실적,http://news.mk.co.kr/newsRead.php?year=2018&no=463806
4817,2018-07-24,IBK투자증권삼성바이오로직스어닝서프라이즈에도회계감리불확실성부담,http://www.g-enews.com/ko-kr/news/article/news_all/201807240831239637c16aa2f016_1/article.html
4818,2018-07-24,유안타증권삼성바이오로직스펀더멘털과리스크를모두확인해야”,http://www.newsway.co.kr/news/view?tp=1&ud=2018072408525397160
4819,2018-07-24,삼성바이오로직스3Q실적저점예상유진,http://www.ebn.co.kr/news/view/949502
4820,2018-07-24,특징주삼성바이오로직스기대치넘는2Q실적에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=01974566619277800
4821,2018-07-24,IBK證삼성바이오로직스2분기실적과중장기사업전망모두양호회계감리이슈가관건”,http://www.lawissue.co.kr/view.php?ud=2018072408581593039817d053b9_12
4822,2018-07-24,특징주삼성바이오로직스2분기깜짝실적에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180724034500008&did=1195m
4823,2018-07-24,특징주삼성바이오로직스2분기어닝서프라이즈에외인사자화답주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201807240916002493c642673384_1/article.html
4824,2018-07-24,특징주삼성바이오로직스2분기호실적에상승,http://news.hankyung.com/article/2018072414806
4825,2018-07-24,특징주삼성바이오로직스2Q기대치상회실적에강세,http://www.seoulfn.com/news/articleView.html?idxno=315021
4826,2018-07-24,삼성바이오로직스2분기흑자전환2분기영업익237억원,http://www.sporbiz.co.kr/news/articleView.html?idxno=256823
4827,2018-07-24,특징주2Q어닝서프라이즈삼성바이오로직스강세,http://www.newsis.com/view/?id=NISX20180724_0000372082&cID=10401&pID=10400
4828,2018-07-24,특징주삼성바이오로직스2분기실적개선에상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807240123&t=NN
4829,2018-07-24,특징주삼성바이오로직스2분기깜짝실적에상승세,http://www.dt.co.kr/contents.html?article_no=2018072402109932048009&ref=naver
4830,2018-07-24,ET투자뉴스삼성바이오로직스양호한성장기록BUY현대차투자증권,http://www.etnews.com/20180724000035
4831,2018-07-24,특징주삼성바이오로직스펀더멘털과리스크를고루살펴야할때,http://www.sisaon.co.kr/news/articleView.html?idxno=75565
4832,2018-07-24,ET투자뉴스삼성바이오로직스다시한번효율성BUY신규유진투자증권,http://www.etnews.com/20180724000092
4833,2018-07-24,ET투자뉴스삼성바이오로직스펀더멘털과리스크를BUYM유안타증권,http://www.etnews.com/20180724000095
4834,2018-07-24,삼성바이오로직스2분기실적에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=327545
4835,2018-07-24,ET투자뉴스삼성바이오로직스한시름놓게한2매수유지한국투자증권,http://www.etnews.com/20180724000107
4836,2018-07-24,삼성바이오로직스2분기영업익237억전분기대비137↑,http://www.sisaweek.com/news/articleView.html?idxno=111237
4837,2018-07-24,삼성바이오로직스2분기호실적펀더멘탈에집중해야한투증권,http://www.ekn.kr/news/article.html?no=376220
4838,2018-07-24,퀵리포트삼성바이오로직스매수유지목표가49만원유지대신證,http://www.itooza.com/common/iview.php?no=2018072411163012114
4839,2018-07-24,삼성바이오로직스목표가49만원유지전일종가41만4500원대신證,http://www.newspim.com/news/view/20180724000269
4840,2018-07-24,특징주삼성바이오로직스2분기실적개선소식에상승세,http://biz.chosun.com/site/data/html_dir/2018/07/24/2018072400942.html
4841,2018-07-24,삼성바이오로직스시장기대치크게상회한실적,http://www.nspna.com/news/?mode=view&newsid=295775
4842,2018-07-24,삼성바이오로직스삼성바이오에피스지분법손실여전CLSA,http://www.choicenews.co.kr/news/articleView.html?idxno=43194
4843,2018-07-24,삼성바이오로직스2분기영업익흑자전환성공올해인증기관승인건수16건예상,http://www.techholic.co.kr/news/articleView.html?idxno=177129
4844,2018-07-24,코스피코스닥동반↑셀트리온3대장삼성바이오로직스공동↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=327563
4845,2018-07-24,삼성바이오로직스강세2분기흑자전환어닝서프라이즈,http://www.econonews.co.kr/news/articleView.html?idxno=30145
4846,2018-07-24,삼성바이오로직스회계논란속에도영업이익증가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058464
4847,2018-07-24,삼성바이오로직스2분기매출액1254억원영업이익237억원전망,http://www.newsworks.co.kr/news/articleView.html?idxno=202769
4848,2018-07-24,삼성바이오로직스2분기실적은기대이상하반기실적은낙관못해,http://www.businesspost.co.kr/BP?command=article_view&num=90099
4849,2018-07-24,삼성바이오로직스2공장가동률증가및상업생산집중으로어닝서프라이즈,http://www.newsworks.co.kr/news/articleView.html?idxno=202911
4850,2018-07-24,삼성바이오로직스수익성높은2공장의가동률상승으로영업이익은시장기대치상회,http://www.newsworks.co.kr/news/articleView.html?idxno=202915
4851,2018-07-24,셀트리온삼성바이오로직스주가동반하락기관매물쏟아져,http://www.businesspost.co.kr/BP?command=article_view&num=90178
4852,2018-07-24,삼성바이오로직스흑자전환올2분기영업익237억달성,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=761478
4853,2018-07-25,삼성바이오로직스2분기영업이익깜짝,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=819965
4854,2018-07-25,윤석헌25일국회정무위참석야당삼성바이오로직스사태벼르고있어,http://www.topstarnews.net/news/articleView.html?idxno=452514
4855,2018-07-25,삼성바이오로직스미국유럽일본완제품제조승인,http://www.dailypharm.com/News/242175
4856,2018-07-25,삼성바이오로직스美FDA완제의약품제조승인첫획득,http://view.asiae.co.kr/news/view.htm?idxno=2018072509074244797
4857,2018-07-25,특징주삼성바이오로직스자회사유럽시장확대기대만발주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201807250906375399c642673384_1/article.html
4858,2018-07-25,삼성바이오로직스첫FDA완제의약품제조승인획득,http://news.hankyung.com/article/2018072560606
4859,2018-07-25,삼성바이오로직스미국FDA완제의약품제조승인획득,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180725033200017&did=1195m
4860,2018-07-25,삼성바이오로직스FDA로부터완제의약품첫제조승인,http://news1.kr/articles/?3381094
4861,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.asiatoday.co.kr/view.php?key=20180725010014103
4862,2018-07-25,삼성바이오로직스미국FDA완제의약품제조승인첫획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807250103&t=NN
4863,2018-07-25,삼성바이오로직스美FDA첫완제의약품제조승인획득,http://www.dailian.co.kr/news/view/728233/?sc=naver
4864,2018-07-25,삼성바이오로직스미국FDA첫완제의약품제조승인획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018072509150590722
4865,2018-07-25,삼성바이오로직스美FDA첫완제의약품제조승인획득,http://www.inews24.com/php/news_view.php?g_serial=1111855&g_menu=022620&rrf=nv
4866,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.newsway.co.kr/news/view?tp=1&ud=2018072509280471631
4867,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018072500005
4868,2018-07-25,삼성바이오로직스美FDA서완제의약품제조승인획득,http://news.mk.co.kr/newsRead.php?year=2018&no=466889
4869,2018-07-25,삼성바이오로직스美FDA로부터완제의약품제조승인획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1215389
4870,2018-07-25,삼성바이오로직스첫FDA제조승인美진출본격화상보,http://www.edaily.co.kr/news/newspath.asp?newsid=02332086619278128
4871,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://news.heraldcorp.com/view.php?ud=20180725000157
4872,2018-07-25,삼성바이오로직스美FDA서첫완제의약품제조승인,http://biz.chosun.com/site/data/html_dir/2018/07/25/2018072500818.html
4873,2018-07-25,삼성바이오로직스미국FDA첫완제의약품제조승인획득,http://www.fetv.co.kr/news/article.html?no=10033
4874,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.ceoscoredaily.com/news/article.html?no=43850
4875,2018-07-25,ET투자뉴스삼성바이오로직스무난한실적달성BUY대신증권,http://www.etnews.com/20180725000049
4876,2018-07-25,삼성바이오로직스美FDA완제의약품제조승인첫획득,http://www.newspim.com/news/view/20180725000215
4877,2018-07-25,삼성바이오로직스미FDA첫완제의약품제조승인획득,http://www.newsis.com/view/?id=NISX20180725_0000373293&cID=13001&pID=13000
4878,2018-07-25,삼성바이오로직스실적순항길2분기영업익237억원,http://www.econovill.com/news/articleView.html?idxno=342376
4879,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.medigatenews.com/news/3194326504
4880,2018-07-25,삼성바이오로직스미국FDA완제의약품첫승인,http://www.sedaily.com/NewsView/1S2804ADZL
4881,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득발표,http://www.m-i.kr/news/articleView.html?idxno=437289
4882,2018-07-25,삼성바이오로직스미국FDA완제의약품제조승인획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1645189
4883,2018-07-25,삼성바이오로직스FDA완제약제조승인획득,http://medipana.com/news/news_viewer.asp?NewsNum=223160&MainKind=A&NewsKind=5&vCount=12&vKind=1
4884,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://news.hankyung.com/article/201807256457f
4885,2018-07-25,삼성바이오로직스미FDA첫완제의약품제조승인획득,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018072510312801158&LinkID=632&objId=A2018072510312801158&portalCode=naver
4886,2018-07-25,삼성바이오로직스미FDA완제의약품제조승인받아,http://www.newsworks.co.kr/news/articleView.html?idxno=202985
4887,2018-07-25,삼성바이오로직스미FDA완제의약품제조승인획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=327676
4888,2018-07-25,삼성바이오로직스美FDA완제의약품제조승인획득미국공급가시화,http://daily.hankooki.com/lpage/life/201807/dh20180725104742138950.htm
4889,2018-07-25,최종구삼성바이오로직스금감원새로운조치안심의의결,http://www.asiatime.co.kr/news/articleView.html?idxno=190289
4890,2018-07-25,삼성바이오로직스첫FDA제조승인美공략가속도종합,http://www.edaily.co.kr/news/newspath.asp?newsid=03043846619278128
4891,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.nocutnews.co.kr/news/5005930
4892,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://news.mt.co.kr/mtview.php?no=2018072510261166956
4893,2018-07-25,삼성바이오로직스미국FDA로부터첫완제의약품제조승인획득,http://www.econonews.co.kr/news/articleView.html?idxno=30257
4894,2018-07-25,삼성바이오로직스미국식품의약국의완제의약품제조승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=90253
4895,2018-07-25,삼성바이오로직스논란딛고올해도성장할것,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058528
4896,2018-07-25,삼성바이오로직스미국완제의약품제조승인획득,http://www.seoulfn.com/news/articleView.html?idxno=315151
4897,2018-07-25,삼성바이오로직스FDA서첫완제의약품제조승인획득고객편의성高高,http://www.segye.com/content/html/2018/07/25/20180725003254.html?OutUrl=naver
4898,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.fnnews.com/news/201807251331202145
4899,2018-07-25,삼성바이오로직스미국FDA첫완제의약품제조승인획득,http://www.sisaon.co.kr/news/articleView.html?idxno=75648
4900,2018-07-25,삼성바이오로직스美FDA서첫완제의약품제조승인획득,http://www.viva100.com/main/view.php?key=20180725010009415
4901,2018-07-25,삼성바이오로직스2분기실적반등성공2공장가동률상승으로전분기대비영업이익137↑,http://sports.khan.co.kr/news/sk_index.html?art_id=201807251456003&sec_id=561801&pt=nv
4902,2018-07-25,삼성바이오로직스美FDA첫완제의약품제조승인획득,http://biz.newdaily.co.kr/site/data/html/2018/07/25/2018072500024.html
4903,2018-07-25,특징주삼성바이오로직스FDA완제의약품제조승인획득에도5대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=30270
4904,2018-07-25,삼성바이오로직스FDA완제품제조승인,http://news.mk.co.kr/newsRead.php?year=2018&no=468009
4905,2018-07-25,삼성바이오로직스미FDA완제약제조승인첫획득,http://www.ajunews.com/view/20180725151507509
4906,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.etnews.com/20180725000356
4907,2018-07-25,코스피외국인순매도셀트리온삼성전자삼성바이오로직스,http://www.newsway.co.kr/news/view?tp=1&ud=2018072516174632142
4908,2018-07-25,검찰삼성바이오로직스회계의혹고발특수부배당,http://www.newsis.com/view/?id=NISX20180725_0000373858&cID=10201&pID=10200
4909,2018-07-25,外人바이오주투매셀트리온삼성바이오로직스급락,http://www.choicenews.co.kr/news/articleView.html?idxno=43241
4910,2018-07-25,윤석헌금감원장삼성바이오로직스재감리신속히마무리할것,http://www.mediapen.com/news/view/371698
4911,2018-07-25,뉴스투데이E삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.news2day.co.kr/107813
4912,2018-07-25,삼성바이오로직스FDA완제의약품제조승인,http://www.kpinews.co.kr/news/articleView.html?idxno=78275
4913,2018-07-25,셀트리온과삼성바이오로직스주가급락외국인매도에맥못춰,http://www.businesspost.co.kr/BP?command=article_view&num=90335
4914,2018-07-25,삼성바이오로직스미국FDA완제의약품제조승인획득,http://www.hankookilbo.com/v/87e9d9ae46004e8d9eb33a2b6abe7971
4915,2018-07-25,삼성바이오로직스유럽일본이어미국서도완제품제조승인,http://www.sisaweek.com/news/articleView.html?idxno=111311
4916,2018-07-25,윤석헌금감원장삼성바이오로직스재감리연내마무리,http://www.ekn.kr/news/article.html?no=376708
4917,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1501776
4918,2018-07-25,윤석헌삼성바이오로직스공시누락이삼성물산합병에영향,http://www.businesspost.co.kr/BP?command=article_view&num=90379
4919,2018-07-25,삼성바이오로직스FDA첫완제의약품제조승인,http://www.kgnews.co.kr/news/articleView.html?idxno=522292
4920,2018-07-26,삼성바이오로직스FDA완제의약품제조승인획득,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=820209
4921,2018-07-26,삼성바이오로직스미FDA완제의약품제조승인획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220580
4922,2018-07-26,윤석헌금감원장삼성바이오로직스분식회계관련해검찰에서규명할것,http://www.topstarnews.net/news/articleView.html?idxno=453230
4923,2018-07-26,삼성물산삼성전자삼성바이오로직스등계열사영향목표가↓미래에셋대우,http://www.fntimes.com/html/view.php?ud=201807260811166907f09e13944d_18
4924,2018-07-26,삼성바이오로직스전일대비약5하락한369000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807260106&t=NN
4925,2018-07-26,특징주삼성바이오로직스바이오업종투지심리위축에↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02545286619278456
4926,2018-07-26,삼성바이오로직스하락세코스닥코스피지수는,http://www.ggilbo.com/news/articleView.html?idxno=530379
4927,2018-07-26,삼성바이오로직스팔자외국계집중포화투자심리위축추락거듭,http://www.g-enews.com/ko-kr/news/article/news_all/201807260942164294e4869c120_1/article.html
4928,2018-07-26,특징주삼성바이오로직스4거래일연속하락세에5대낙폭까지장초반부터매도세,http://www.econonews.co.kr/news/articleView.html?idxno=30312
4929,2018-07-26,특징주삼성바이오로직스연일하락세579,http://www.kyeongin.com/main/view.php?key=20180726000944071
4930,2018-07-26,특징주삼성바이오로직스금감원장새감리안마련방침에급락,http://www.asiatime.co.kr/news/articleView.html?idxno=190496
4931,2018-07-26,삼성바이오로직스주가뚝뚝떨어져3달전최고가60만원의반토막,http://news.imaeil.com/Finance/2018072609505567805
4932,2018-07-26,삼성바이오로직스미FDA완제승인에도주가하락왜,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180726.99099012706
4933,2018-07-26,삼성바이오로직스비온뒤땅굳는다미FDA완제의약품생산승인획득,http://www.econovill.com/news/articleView.html?idxno=342464
4934,2018-07-26,삼성바이오로직스외국인팔자세에나흘째약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=327790
4935,2018-07-26,삼성바이오로직스새감리조치안가급적올해마련,http://news.sbs.co.kr/news/endPage.do?news_id=N1004864253&plink=ORI&cooper=NAVER
4936,2018-07-26,삼성바이오로직스회계부정문제환기되자하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=327814
4937,2018-07-26,셀트리온삼성바이오로직스등바이오주맥못추는이유는,http://www.fntimes.com/html/view.php?ud=201807261549431870f09e13944d_18
4938,2018-07-26,코스피외국인순매도삼성바이오로직스GS건설한국금융지주,http://www.newsway.co.kr/news/view?tp=1&ud=2018072616521472514
4939,2018-07-26,검찰로가는삼성바이오로직스회계논란삼성물산합병도팔까,http://www.businesspost.co.kr/BP?command=article_view&num=90490
4940,2018-07-26,삼성바이오로직스주가회계리스크로급락셀트리온은반등,http://www.businesspost.co.kr/BP?command=article_view&num=90540
4941,2018-07-26,삼성바이오로직스와바이오젠합작관계누가유리한가,http://www.edaily.co.kr/news/newspath.asp?newsid=05159446619278456
4942,2018-07-26,삼성바이오로직스FDA로부터첫완제의약품에대한제조승인획득,http://www.joongboo.com/?mod=news&act=articleView&idxno=1270918
4943,2018-07-27,삼성바이오로직스美FDA완제승인에도주가폭락분식회계업보크다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180727.99099013041
4944,2018-07-27,삼성바이오로직스분식회계부터중국가짜백신까지바이오제약주곤두박질,http://www.topstarnews.net/news/articleView.html?idxno=453975
4945,2018-07-27,셀트리온주가소폭올라삼성바이오로직스는제자리걸음,http://www.businesspost.co.kr/BP?command=article_view&num=90690
4946,2018-07-29,stock톡다시안갯속에휩싸인삼성바이오로직스주가,http://www.newsway.co.kr/news/view?tp=1&ud=2018072714593494597
4947,2018-07-29,주간한국삼성바이오로직스회계부정檢수사잡음에난항예고,http://daily.hankooki.com/lpage/economy/201807/dh20180729070054138060.htm
4948,2018-07-30,검찰삼성바이오로직스분식회계의혹고발건특수부에배당,http://www.mdtoday.co.kr/mdtoday/index.html?no=327819
4949,2018-07-30,삼성바이오로직스부터신라젠셀트리온까지KRX헬스케어지수6주연속하락,http://www.topstarnews.net/news/articleView.html?idxno=455336
4950,2018-07-30,삼성바이오로직스재감리놓고딜레마빠진금감원,http://www.asiatime.co.kr/news/articleView.html?idxno=191043
4951,2018-07-30,삼성바이오로직스주가소폭하락셀트리온은약간올라,http://www.businesspost.co.kr/BP?command=article_view&num=90906
4952,2018-07-31,어제증시코스피기관매도세에눌려약보합세삼성바이오로직스부터SK하이닉스까지,http://www.topstarnews.net/news/articleView.html?idxno=455952
4953,2018-07-31,삼성바이오로직스회계논란에서보는약정사항주석의중요성,http://premium.mk.co.kr/view.php?no=23040
4954,2018-07-31,셀트리온3총사호재에주가급등삼성바이오로직스는소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=91061
4955,2018-08-01,삼성바이오로직스2분기매출1254억원영업이익237억원,http://www.kukinews.com/news/article.html?no=572316
4956,2018-08-01,삼성바이오로직스공시누락서울중앙지검특수2부가수사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180801118500004&did=1195m
4957,2018-08-01,삼성바이오로직스공시누락서울중앙지검특수2부가수사,http://news.sbs.co.kr/news/endPage.do?news_id=N1004872704&plink=ORI&cooper=NAVER
4958,2018-08-01,삼성바이오로직스공시누락서울중앙지검특수2부가수사하기로,http://news.kbs.co.kr/news/view.do?ncd=4018068&ref=A
4959,2018-08-01,무역분쟁완화한국증시활짝IT혼조셀트리온삼성바이오로직스껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=43454
4960,2018-08-01,삼성바이오로직스공시누락사건서울중앙지검특수2부에배당,http://www.fnnews.com/news/201808011614323824
4961,2018-08-01,삼성바이오로직스공시누락사건서울중앙지검특수2부에배당,http://www.seoulwire.com/news/articleView.html?idxno=21228
4962,2018-08-01,삼성바이오로직스공시누락사건서울중앙지검특수2부배당,http://www.asiatoday.co.kr/view.php?key=20180801010000570
4963,2018-08-01,셀트리온3총사주가강세삼성바이오로직스도동반상승,http://www.businesspost.co.kr/BP?command=article_view&num=91209
4964,2018-08-01,삼성바이오로직스공시누락서울중앙지검특수2부가수사,http://www.etnews.com/20180801000493
4965,2018-08-01,삼성바이오로직스공시누락서울중앙지검특수2부가수사,https://cnbc.sbs.co.kr/article_hub/10000910438?division=NAVER
4966,2018-08-01,美FDA정책에삼성바이오로직스셀트리온시장확대하나,http://www.econovill.com/news/articleView.html?idxno=342935
4967,2018-08-01,검찰삼성바이오로직스공시누락수사착수,http://www.newstomato.com/ReadNews.aspx?no=839330
4968,2018-08-01,삼성바이오로직스공시누락서울중앙지검특수2부가수사,http://imnews.imbc.com/news/2018/society/article/4730882_22673.html
4969,2018-08-01,검찰삼성바이오로직스공시누락사건배당수사착수,http://www.yonhapnewstv.co.kr/MYH20180801023300038/?did=1825m
4970,2018-08-02,삼성바이오로직스분식회계이슈부터네이처셀대표구속까지바이오업계침체,http://www.topstarnews.net/news/articleView.html?idxno=457061
4971,2018-08-02,셀트리온주가외국인매수에올라삼성바이오로직스는떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=91352
4972,2018-08-03,오늘의매일경제TV삼성바이오로직스분식회계논란진실은,http://news.mk.co.kr/newsRead.php?year=2018&no=487112
4973,2018-08-03,삼성바이오로직스고의공시누락근거제시못한증선위,http://www.mdtoday.co.kr/mdtoday/index.html?no=328555
4974,2018-08-03,어제증시삼성바이오로직스하락셀트리온신라젠상승미중무역분정우려의결과는,http://www.topstarnews.net/news/articleView.html?idxno=457704
4975,2018-08-03,삼성바이오로직스전일대비약5상승한396500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808030067&t=NN
4976,2018-08-03,특징주삼성바이오로직스장초반부터6대급등40만원돌파,http://www.econonews.co.kr/news/articleView.html?idxno=31156
4977,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에상승,http://news.mt.co.kr/mtview.php?no=2018080309033746957
4978,2018-08-03,한경로보뉴스삼성바이오로직스5이상상승매출원가율감소IBK투자증권중립유지,http://news.hankyung.com/article/201808037013L
4979,2018-08-03,특징주삼성바이오로직스증선위발호재주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201808030904389082c642673384_1/article.html
4980,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=01800726619303712
4981,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도영향상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1648789
4982,2018-08-03,삼성바이오로직스반발매수로급반등장중40만원회복,http://news.einfomax.co.kr/news/articleView.html?idxno=3461432
4983,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에강세,http://www.newsprime.co.kr/news/article.html?no=425146
4984,2018-08-03,특징주삼성바이오로직스금감원재감리포기강세,http://www.asiatime.co.kr/news/articleView.html?idxno=191890
4985,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에상승,http://www.cstimes.com/?mod=news&act=articleView&idxno=282408
4986,2018-08-03,특징주삼성바이오로직스급등세40만원대호가,http://www.kyeongin.com/main/view.php?key=20180803010000824
4987,2018-08-03,특징주삼성바이오로직스금감원재감리포기소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2018080309218028011
4988,2018-08-03,삼성바이오로직스금감원재감리사실상포기상승세,http://www.ggilbo.com/news/articleView.html?idxno=532782
4989,2018-08-03,금감원삼성바이오로직스재감리포기사실무근,http://www.asiatime.co.kr/news/articleView.html?idxno=191894
4990,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에오름세,http://www.seoulfn.com/news/articleView.html?idxno=315993
4991,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에급등,http://www.ebn.co.kr/news/view/950810
4992,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에강세,http://www.fntimes.com/html/view.php?ud=201808030934391457f09e13944d_18
4993,2018-08-03,유삼성바이오로직스전일대비701상승일일회전율은023기록,http://www.sedaily.com/NewsView/1S37TI6OKZ
4994,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에상승,http://www.fetv.co.kr/news/article.html?no=10462
4995,2018-08-03,특징주삼성바이오로직스금감원재감리포기소식에6대↑,http://www.dt.co.kr/contents.html?article_no=2018080302100932059006&ref=naver
4996,2018-08-03,삼성바이오로직스금감원재감리포기설에강세2Q실적도호조,http://www.whitepaper.co.kr/news/articleView.html?idxno=105888
4997,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에급등40만원선회복,http://view.asiae.co.kr/news/view.htm?idxno=2018080309451373751
4998,2018-08-03,삼성바이오로직스비합법고의성vs처리적절성2010년이건희회장의경고발언으로설립된기업이다관심급부상,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=94275
4999,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에상승,http://www.dailian.co.kr/news/view/730329/?sc=naver
5000,2018-08-03,특징주삼성바이오로직스장초반강세금감원재감리포기보도영향,http://www.mediapen.com/news/view/373553
5001,2018-08-03,주목2010년이건희회장의경고발언으로설립된기업삼성바이오로직스비합법고의성vs처리적절성논란재확산,http://www.kbsm.net/default/index_view_page.php?idx=213909&part_idx=318
5002,2018-08-03,금감원삼성바이오로직스재감리포기보도사실무근”,http://www.fntimes.com/html/view.php?ud=201808031007292985f09e13944d_18
5003,2018-08-03,금감원삼성바이오로직스재감리포기보도사실아냐,http://news.hankyung.com/article/2018080375936
5004,2018-08-03,삼성바이오로직스재감리포기보도에약세금감원사실무근반박,http://www.seoulwire.com/news/articleView.html?idxno=21489
5005,2018-08-03,금감원삼성바이오로직스재감리포기보도사실무근”,http://www.viva100.com/main/view.php?key=20180803010000939
5006,2018-08-03,금감원삼성바이오로직스재감리포기보도사실아니다,http://www.insightkorea.co.kr//news/articleView.html?idxno=28413
5007,2018-08-03,금감원삼성바이오로직스재감리포기전혀사실아냐”,http://news.kmib.co.kr/article/view.asp?arcid=0012574537&code=61141111&cp=nv
5008,2018-08-03,금감원삼성바이오로직스재감리중단보도사실과달라,http://www.nspna.com/news/?mode=view&newsid=297762
5009,2018-08-03,검찰수사본격화삼성바이오로직스널뛰는주가,http://www.dailymedi.com/detail.php?number=833232&thread=22r05
5010,2018-08-03,금감원삼성바이오로직스재감리포기전혀사실과다르다”,http://www.sporbiz.co.kr/news/articleView.html?idxno=259853
5011,2018-08-03,특징주삼성바이오로직스금감원재감리포기보도에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=259868
5012,2018-08-03,금감원삼성바이오로직스재감리포기사실아냐,http://moneys.mt.co.kr/news/mwView.php?no=2018080314368089212
5013,2018-08-03,금감원삼성바이오로직스재감리포기사실무근,http://www.seoulfn.com/news/articleView.html?idxno=316065
5014,2018-08-03,삼성바이오로직스주가강세셀트리온3총사는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=91519
5015,2018-08-03,금감원삼성바이오로직스재감리포기보도는사실무근,http://www.businesspost.co.kr/BP?command=article_view&num=91522
5016,2018-08-06,특징주삼성바이오로직스반갑다외국인주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201808060909317209c642673384_1/article.html
5017,2018-08-06,삼성바이오로직스반등에무게분식회계논란새국면,http://www.kpinews.co.kr/news/articleView.html?idxno=78710
5018,2018-08-06,코스피코스닥동반↑삼성바이오로직스신라젠도↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=328729
5019,2018-08-06,금감원삼성바이오로직스재감리중단보도사실아니야,http://www.topstarnews.net/news/articleView.html?idxno=459307
5020,2018-08-06,삼성바이오로직스김동연효과에주가올라셀트리온3총사하락,http://www.businesspost.co.kr/BP?command=article_view&num=91697
5021,2018-08-07,어제증시코스피228650코스닥78141삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=459711
5022,2018-08-07,특징주삼성바이오로직스삼성의제2반도체의지에강세,http://news.mt.co.kr/mtview.php?no=2018080709114132517
5023,2018-08-07,코스피강보합출발삼성바이오로직스3대강세,http://news.mt.co.kr/mtview.php?no=2018080708544163687
5024,2018-08-07,특징주삼성바이오로직스이재용바이오규제완화요청에상승,http://www.etoday.co.kr/news/section/newsview.php?idxno=1649846
5025,2018-08-07,특징주삼성바이오로직스바이오규제완화기대고조주가탄력,http://www.g-enews.com/ko-kr/news/article/news_all/201808070918185229c642673384_1/article.html
5026,2018-08-07,특징주삼성바이오로직스김동연에규제완화요청에강세,http://www.asiatime.co.kr/news/articleView.html?idxno=192429
5027,2018-08-07,특징주삼성바이오로직스강세삼성바이오규제완화건의,http://news.hankyung.com/article/2018080772406
5028,2018-08-07,특징주삼성바이오로직스바이오사업투자확대기대감에강세,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018080709215000579&LinkID=632&objId=A2018080709215000579&portalCode=naver
5029,2018-08-07,삼성바이오로직스바이오규제완화소식에상승,http://www.sedaily.com/NewsView/1S39NFCQY7
5030,2018-08-07,특징주삼성바이오로직스이재용부회장규제완화요청에상승,http://www.newsis.com/view/?id=NISX20180807_0000384283&cID=10401&pID=10400
5031,2018-08-07,특징주삼성바이오로직스이재용규제완화요청에강세,http://www.ebn.co.kr/news/view/951120
5032,2018-08-07,특징주JY제2반도체로키울것삼성바이오로직스↑,http://www.edaily.co.kr/news/newspath.asp?newsid=02053286619305024
5033,2018-08-07,관심주삼성바이오로직스규제완화기대감에상승SK하이닉스하루만에반등,http://www.insightkorea.co.kr//news/articleView.html?idxno=28680
5034,2018-08-07,HotLine삼성바이오로직스바이오규제완화기대감에강세,http://news.mk.co.kr/newsRead.php?year=2018&no=493836
5035,2018-08-07,이재용바이오규제완화요청삼성바이오로직스7일오전강세,http://www.choicenews.co.kr/news/articleView.html?idxno=43572
5036,2018-08-07,특징주삼성바이오로직스삼성규제완화요청소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2018080709598070085
5037,2018-08-07,특징주삼성바이오로직스이재용부회장바이오규제완화요청에강세,http://www.fnnews.com/news/201808070957252671
5038,2018-08-07,특징주삼성바이오로직스규제완화기대감에강세,http://view.asiae.co.kr/news/view.htm?idxno=2018080710375664092
5039,2018-08-07,특징주삼성바이오로직스이재용부회장규제완화요청에49↑,http://www.fntimes.com/html/view.php?ud=201808071039397974f09e13944d_18
5040,2018-08-07,한경로보뉴스삼성바이오로직스5이상상승매출원가율감소IBK투자증권중립유지,http://news.hankyung.com/article/201808077784L
5041,2018-08-07,특징주삼성바이오로직스규제완화기대감에↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808070175&t=NN
5042,2018-08-07,삼성바이오로직스전일대비약6상승한423500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808070178&t=NN
5043,2018-08-07,삼성바이오로직스6대상승으로42만3000원기록이유는규제완화기대감,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180807.99099003000
5044,2018-08-07,허리숙인이재용이삼성바이오로직스를살린다주가반등7일오전42만1천500원,http://news.imaeil.com/Finance/2018080711220099098
5045,2018-08-07,삼성바이오로직스6대상승바이오산업이제2의반도체될수있도록과감히투자,http://www.econonews.co.kr/news/articleView.html?idxno=31617
5046,2018-08-07,부자들은경제신문을읽는다삼성바이오로직스삼성의제2반도체피력外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018080711153284141
5047,2018-08-07,장하성나비효과삼성바이오로직스국민연금몰아치나,http://www.asiatime.co.kr/news/articleView.html?idxno=192496
5048,2018-08-07,특징주삼성바이오로직스5대강세규제완화기대,http://biz.chosun.com/site/data/html_dir/2018/08/07/2018080701646.html
5049,2018-08-07,특징주삼성바이오로직스기관매수세에42만원선회복마감,http://view.asiae.co.kr/news/view.htm?idxno=2018080715434799972
5050,2018-08-07,이재용지원사격삼성전자상승삼성바이오로직스급등,http://www.choicenews.co.kr/news/articleView.html?idxno=43591
5051,2018-08-07,아주종목분석삼성바이오로직스규제완화요청에강세,http://www.ajunews.com/view/20180807175502882
5052,2018-08-07,삼성바이오로직스주가급등해시총6위로셀트리온은소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=91842
5053,2018-08-08,바이오산업에불어온규제완화목소리삼성바이오로직스미소,http://www.mdtoday.co.kr/mdtoday/index.html?no=328937
5054,2018-08-08,어제증시코스피230016코스닥78470삼성바이오로직스셀트리온신라젠은,http://www.topstarnews.net/news/articleView.html?idxno=460470
5055,2018-08-08,삼성바이오로직스6000원142오른430000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808080068&t=NN
5056,2018-08-08,특징주삼성바이오로직스삼성그룹바이오규제완화외침주가오름세,http://www.g-enews.com/ko-kr/news/article/news_all/201808080920116891c16aa2f016_1/article.html
5057,2018-08-08,문재인의말言이움직인카카오주가김동연의행동이움직인삼성바이오로직스주가,http://news.imaeil.com/Economy/2018080809433710792
5058,2018-08-08,한경로보뉴스삼성바이오로직스5이상상승주가상승중단기간골든크로스형성,http://news.hankyung.com/article/201808082358L
5059,2018-08-08,특징주삼성바이오로직스오후부터대거매수세몰리며5대상승45만원돌파눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=31785
5060,2018-08-08,특징주삼성바이오로직스삼성성장사업25조투입상승,http://view.asiae.co.kr/news/view.htm?idxno=2018080814054403840
5061,2018-08-08,ET투자뉴스운수장비업종의약품업종강세_현대모비스삼성바이오로직스두드러져,http://www.etnews.com/20180808000211
5062,2018-08-08,특징주삼성바이오로직스삼성4대미래사업선정소식에급등,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018080814124022461
5063,2018-08-08,특징주삼성180조신규투자소식에삼성바이오로직스급등,http://www.newsis.com/view/?id=NISX20180808_0000385737&cID=10401&pID=10400
5064,2018-08-08,바이오는제2의반도체이재용천명에삼성바이오로직스주가훨훨,http://www.dt.co.kr/contents.html?article_no=2018080802109932047003&ref=naver
5065,2018-08-08,삼성바이오로직스25조규모미래산업투자소식에급등세,http://www.mdtoday.co.kr/mdtoday/index.html?no=329012
5066,2018-08-08,삼성경기침체기에180조원통큰투자삼성에스디에스삼성바이오로직스등주가활짝,http://www.g-enews.com/ko-kr/news/article/news_all/2018080814332942004e4869c120_1/article.html
5067,2018-08-08,특징주삼성바이오로직스삼성에스디에스180조투자결정소식에강세,http://news.hankyung.com/article/2018080827106
5068,2018-08-08,삼성180조신규투자삼성바이오로직스도급등,http://star.mt.co.kr/stview.php?no=2018080814415895573
5069,2018-08-08,이재용삼성바이오로직스에집중투자해제2의반도체만들겠다주가껑충,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180808.99099003688
5070,2018-08-08,유삼성바이오로직스전일대비731상승일일회전율은077기록,http://www.sedaily.com/NewsView/1S3A53IY3C
5071,2018-08-08,삼성바이오로직스삼성성장사업투자소식에급등,http://news20.busan.com/controller/newsController.jsp?newsId=20180808000106
5072,2018-08-08,삼성투자소식에삼성바이오로직스치솟다평균연봉7600만원신입사원은,http://www.g-enews.com/ko-kr/news/article/news_all/201808081454018254e4869c120_1/article.html
5073,2018-08-08,특징주삼성투자소식에삼성바이오로직스강세,http://www.kyeongin.com/main/view.php?key=20180808001456275
5074,2018-08-08,삼성바이오로직스삼성그룹180조투자발표후주가45만원대돌파,http://www.seoulwire.com/news/articleView.html?idxno=22091
5075,2018-08-08,특징주삼성전기삼성180조투자발표후하락세삼성바이오로직스삼성SDS는급등,http://www.econonews.co.kr/news/articleView.html?idxno=31815
5076,2018-08-08,바이오는제2의반도체이재용천명에삼성바이오로직스주가날았다,http://www.dt.co.kr/contents.html?article_no=2018080802109932047004&ref=naver
5077,2018-08-08,특징주삼성바이오로직스3년간180조원투자방침에급등,http://www.asiatime.co.kr/news/articleView.html?idxno=192762
5078,2018-08-08,삼성바이오로직스대규모투자계획에주가껑충,http://sports.khan.co.kr/news/sk_index.html?art_id=201808081512003&sec_id=564001&pt=nv
5079,2018-08-08,삼성3년간180조투자발표삼성바이오로직스삼성SDS주가에날개달았다,http://www.joongboo.com/?mod=news&act=articleView&idxno=1274241
5080,2018-08-08,삼성바이오로직스30000원708오른454000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808080357&t=NN
5081,2018-08-08,삼성바이오로직스삼성180조원투자소식에7대급등마감종가는45만4000원,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180808.99099003727
5082,2018-08-08,특징주삼성바이오로직스그룹차원대규모신규투자소식에주가급등,http://www.kukinews.com/news/article.html?no=574569
5083,2018-08-08,삼성바이오로직스삼성SDS주가급등이유는,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3603951
5084,2018-08-08,특징주삼성바이오로직스삼성에스디에스나란히강세,http://www.mediapen.com/news/view/374736
5085,2018-08-08,삼성바이오로직스제2반도체육성삼성180조신규투자소식에급등7대상승마감,http://www.econonews.co.kr/news/articleView.html?idxno=31823
5086,2018-08-08,삼성180조신규투자삼성바이오로직스SDS급등,http://www.fnnews.com/news/201808081516346638
5087,2018-08-08,삼성바이오로직스대규모투자계획에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180808169200013&did=1196m
5088,2018-08-08,대규모투자계획에강세보인삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180808169400013&did=1196m
5089,2018-08-08,삼성바이오로직스대규모투자계획에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180808169500013&did=1196m
5090,2018-08-08,대규모투자계획에강세보인삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180808169300013&did=1196m
5091,2018-08-08,특징주삼성바이오로직스SDS대규모투자계획에강세,http://www.kyeongin.com/main/view.php?key=20180808010002399
5092,2018-08-08,삼성180조투자에삼성바이오로직스주가상승,http://www.cnbnews.com/news/article.html?no=381753
5093,2018-08-08,코스피외국인매수세로강보합삼성바이오로직스SDS급등,http://www.seoulwire.com/news/articleView.html?idxno=22108
5094,2018-08-08,삼성투자훈풍삼성바이오로직스삼성SDS아남전자급등,http://www.choicenews.co.kr/news/articleView.html?idxno=43626
5095,2018-08-08,시황코스피외국인사자세에강보합삼성바이오로직스25조투자소식에급등,http://daily.hankooki.com/lpage/economy/201808/dh20180808164644138110.htm
5096,2018-08-08,삼성바이오로직스삼성SDS25조원규모투자계획에급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=329033
5097,2018-08-08,삼성바이오로직스산업규제완화요청에주가급등,http://www.sporbiz.co.kr/news/articleView.html?idxno=261280
5098,2018-08-08,삼성바이오로직스나홀로급등제약바이오주는부진지속,http://moneys.mt.co.kr/news/mwView.php?no=2018080817068089644
5099,2018-08-08,삼성바이오로직스주가180조투자에급등셀트리온도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=92004
5100,2018-08-09,삼성바이오로직스이재용바이오집중투자계획에주가급등,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180809.99099003769
5101,2018-08-09,어제증시8일코스피2301코스닥783삼성바이오로직스셀트리온신라젠은,http://www.topstarnews.net/news/articleView.html?idxno=461157
5102,2018-08-09,한경로보뉴스전일기관거래소에서삼성바이오로직스708대림산업351등순매수,http://news.hankyung.com/article/201808094797L
5103,2018-08-09,삼성바이오로직스3500원077오른457500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808090093&t=NN
5104,2018-08-09,특징주삼성바이오로직스전날급등이어장초반부터강세제2반도체육성,http://www.econonews.co.kr/news/articleView.html?idxno=31894
5105,2018-08-09,ET투자뉴스삼성바이오로직스_지속되는기관매수에관심을가져야현재3085일간올라,http://www.etnews.com/20180809000031
5106,2018-08-09,특징주삼성바이오로직스이재용투자효과에3대상승,http://www.edaily.co.kr/news/newspath.asp?newsid=02177926619305680
5107,2018-08-09,특징주삼성바이오로직스삼성180조규모신규투자주가방긋,http://www.newsprime.co.kr/news/article.html?no=425775
5108,2018-08-09,특징주삼성그룹신규투자삼성바이오로직스삼성에스디에스연일강세,http://view.asiae.co.kr/news/view.htm?idxno=2018080909142593595
5109,2018-08-09,한경로보뉴스삼성바이오로직스5이상상승개장직후거래량큰변동없음전일의22수준,http://news.hankyung.com/article/201808095031L
5110,2018-08-09,한경로보뉴스삼성바이오로직스5이상상승개장직후거래량큰변동없음전일의22수준,http://news.hankyung.com/article/201808095031L
5111,2018-08-09,특징주삼성바이오로직스대규모투자계획에오름세지속,http://www.asiatime.co.kr/news/articleView.html?idxno=192851
5112,2018-08-09,삼성바이오로직스삼성그룹초대형투자에50만원복귀눈앞,http://www.sedaily.com/NewsView/1S3AKC1SGS
5113,2018-08-09,뉴스투데이투자노트삼성바이오로직스4개월만에48만원회복삼성180조원투자발표에바이오주들썩,http://www.news2day.co.kr/108686
5114,2018-08-09,특징주삼성바이오로직스이재용바이오제2의반도체로키운다닷새째상승가도,http://www.g-enews.com/ko-kr/news/article/news_all/201808090918047248c16aa2f016_1/article.html
5115,2018-08-09,특징주삼성바이오로직스바이오규제완화기대에강세,http://www.ebn.co.kr/news/view/951415
5116,2018-08-09,특징주삼성바이오로직스연일상승닷새만에24↑,http://news.hankyung.com/article/2018080950706
5117,2018-08-09,특징주삼성전기전날기관매도딛고2대상승삼성바이오로직스삼성SDS도강세,http://www.econonews.co.kr/news/articleView.html?idxno=31899
5118,2018-08-09,특징주삼성바이오로직스삼성180조대투자에주가강세,http://www.fetv.co.kr/news/article.html?no=10682
5119,2018-08-09,특징주삼성바이오로직스180조투자소식에급등,http://www.newstomato.com/ReadNews.aspx?no=840576
5120,2018-08-09,특징주삼성바이오로직스5거래일연속상승,http://biz.chosun.com/site/data/html_dir/2018/08/09/2018080900852.html
5121,2018-08-09,특징주삼성바이오로직스삼성180조투자계획연일상승세,http://moneys.mt.co.kr/news/mwView.php?no=2018080909498079449
5122,2018-08-09,삼성바이오로직스삼성130조투자소식에이틀째강세,http://www.whitepaper.co.kr/news/articleView.html?idxno=107394
5123,2018-08-09,특징주삼성바이오로직스이재용투자기대감에강세,http://www.fntimes.com/html/view.php?ud=20180809102512626f09e13944d_18
5124,2018-08-09,삼성바이오로직스삼성180조투자발표에상승세,https://cnbc.sbs.co.kr/article_hub/10000911266?division=NAVER
5125,2018-08-09,관심주삼성바이오로직스이틀째급등넷마블신작라인업부재에약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=28820
5126,2018-08-09,삼성180조원투자소식삼성바이오로직스5거래일연속상승전일대비308상승해46만8000원,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180809.99099004222
5127,2018-08-09,삼성바이오로직스대규모투자소식에화색,http://www.smedaily.co.kr/news/articleView.html?idxno=77603
5128,2018-08-09,삼성바이오로직스6000원132오른460000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808090360&t=NN
5129,2018-08-09,삼성바이오로직스수사맡은특수2부의말못할고민,http://news.hankyung.com/article/201808096957A
5130,2018-08-09,삼성바이오로직스주가계속올라셀트리온주가는제자리,http://www.businesspost.co.kr/BP?command=article_view&num=92146
5131,2018-08-10,어제증시9일코스피2303–코스닥789삼성바이오로직스셀트리온신라젠은,http://www.topstarnews.net/news/articleView.html?idxno=461835
5132,2018-08-10,삼성바이오로직스삼성그룹대규모투자등호재에주가껑충,http://www.mdtoday.co.kr/mdtoday/index.html?no=329195
5133,2018-08-10,삼성바이오로직스5500원12내린454500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808100084&t=NN
5134,2018-08-10,특징주삼성180조규모투자여파삼성바이오로직스6일연속상승,http://www.asiatime.co.kr/news/articleView.html?idxno=193087
5135,2018-08-10,특징주삼성바이오로직스삼성180조투자수혜기대엿새째주가날개,http://www.g-enews.com/ko-kr/news/article/news_all/201808100914271063c16aa2f016_1/article.html
5136,2018-08-10,특징주삼성바이오로직스엿새째상승세,http://biz.chosun.com/site/data/html_dir/2018/08/10/2018081001084.html
5137,2018-08-10,삼성바이오로직스6거래일연속상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=329213
5138,2018-08-10,특징주삼성바이오로직스6거래일만에약보합상승멈추고하락세로,http://www.econonews.co.kr/news/articleView.html?idxno=32073
5139,2018-08-10,특징주삼성바이오로직스6거래일만에약보합,http://moneys.mt.co.kr/news/mwView.php?no=2018081010298068735
5140,2018-08-10,삼성바이오로직스4000원087오른464000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808100417&t=NN
5141,2018-08-10,코스피외국인순매수강원랜드GS리테일삼성바이오로직스,http://www.newsway.co.kr/news/view?tp=1&ud=2018081017123511518
5142,2018-08-10,이재용매직주가날아오른삼성바이오로직스,http://news.mt.co.kr/mtview.php?no=2018081017000391181
5143,2018-08-10,관심주삼성전자SK하이닉스셀트리온신라젠하락시총상위종목중삼성바이오로직스만상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=28909
5144,2018-08-10,삼성바이오로직스주가계속올라셀트리온3총사는모두떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=92332
5145,2018-08-12,폴리텍바이오캠퍼스2018삼성바이오로직스산학인턴교육수료,http://www.asiatoday.co.kr/view.php?key=20180812010005417
5146,2018-08-12,연일상승50만원바라보는삼성바이오로직스,http://www.mdtoday.co.kr/mdtoday/index.html?no=329306
5147,2018-08-13,삼성바이오로직스3000원065오른467000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808130078&t=NN
5148,2018-08-13,특징주삼성바이오로직스자회사신약개발기대고조외인사자주가반전주목,http://www.g-enews.com/ko-kr/news/article/news_all/201808130908205209c642673384_1/article.html
5149,2018-08-13,삼성바이오로직스의브레인삼성바이오에피스신약개발돌입,http://www.news2day.co.kr/108912
5150,2018-08-13,급등주테마센터삼성바이오로직스에동결건조기납품오늘의포착종목은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018081313074181130
5151,2018-08-13,ET투자뉴스의약품업종급락세_삼성바이오로직스약세흐름두드러져,http://www.etnews.com/20180813000336
5152,2018-08-13,특징주삼성바이오로직스45만원선깨져7거래일만에하락세,http://www.econonews.co.kr/news/articleView.html?idxno=32374
5153,2018-08-13,삼성바이오로직스18000원388내린446000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808130574&t=NN
5154,2018-08-13,관심주삼성전자셀트리온삼성바이오로직스현대차KB금융신한지주하락SK하이닉스4거래일만에반등,http://www.insightkorea.co.kr//news/articleView.html?idxno=29051
5155,2018-08-13,셀트리온주가골드만삭스충격에급락삼성바이오로직스도하락,http://www.businesspost.co.kr/BP?command=article_view&num=92541
5156,2018-08-14,어제증시골드만삭스보고서에바이오급락삼성바이오로직스셀트리온신라젠은,http://www.topstarnews.net/news/articleView.html?idxno=463780
5157,2018-08-14,삼성바이오로직스500원011내린445500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808140086&t=NN
5158,2018-08-14,특징주삼성바이오로직스골드만삭스발악재서벗어나나주가반등,http://www.g-enews.com/ko-kr/news/article/news_all/201808140920241493c16aa2f016_1/article.html
5159,2018-08-14,특징주삼성바이오로직스하락하루만에다시상승세로45만원회복,http://www.econonews.co.kr/news/articleView.html?idxno=32456
5160,2018-08-14,14일장초반셀트리온삼성바이오로직스반등LG전자급락,http://www.choicenews.co.kr/news/articleView.html?idxno=43758
5161,2018-08-14,삼성바이오로직스10000원224오른456000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808140457&t=NN
5162,2018-08-14,실적속보삼성바이오로직스2Q영업이익237억흑자전환,http://www.itooza.com/common/iview.php?no=2018081416004248445
5163,2018-08-14,삼성바이오로직스2분기개별영업이익237억흑자전환,http://www.newspim.com/news/view/20180814000982
5164,2018-08-14,삼성바이오로직스아시아제약사와1천446억원규모계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180814150700008&did=1195m
5165,2018-08-14,삼성바이오로직스아시아제약사와1446억위탁생산계약,http://www.sedaily.com/NewsView/1S3CWZWXMU
5166,2018-08-14,삼성바이오로직스1446억규모공급계약체결,http://news.mt.co.kr/mtview.php?no=2018081417425274203
5167,2018-08-14,공시삼성바이오로직스아시아제약사와1446억규모위탁생산계약,http://www.newsway.co.kr/news/view?tp=1&ud=2018081417534558220
5168,2018-08-14,삼성바이오로직스아시아제약사와1446억원규모계약,http://www.etnews.com/20180814000531
5169,2018-08-14,삼성바이오로직스아시아제약사와1446억원규모계약,http://www.edaily.co.kr/news/newspath.asp?newsid=05658006619307320
5170,2018-08-14,셀트리온주가골드만삭스충격겨우극복삼성바이오로직스상승,http://www.businesspost.co.kr/BP?command=article_view&num=92689
5171,2018-08-14,롯데그룹CJ그룹삼성바이오로직스참여하는취업콘서트개최,http://www.newsworks.co.kr/news/articleView.html?idxno=207947
5172,2018-08-14,삼성바이오로직스1446억의약품위탁생산계약매출비31,http://www.itooza.com/common/iview.php?no=2018081419135512783
5173,2018-08-14,삼성바이오로직스아시아제약사와1446억의약품위탁생산계약,http://www.businesspost.co.kr/BP?command=article_view&num=92711
5174,2018-08-14,삼성바이오로직스아시아제약사와1446억규모계약체결,http://view.asiae.co.kr/news/view.htm?idxno=2018081419404872991
5175,2018-08-14,삼성바이오로직스아시아기업과1446억규모위탁생산계약,http://news1.kr/articles/?3398836
5176,2018-08-14,삼성바이오로직스아시아제약사와1446억원위탁생산계약체결,http://www.sedaily.com/NewsView/1S3CXGXP1P
5177,2018-08-14,삼성바이오로직스아시아제약사와1446억원규모의약품위탁생산계약체결,http://daily.hankooki.com/lpage/economy/201808/dh20180814214427138080.htm
5178,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10295859
5179,2018-08-15,임원보수김태한삼성바이오로직스대표상반기보수16억7200만원,http://www.newsway.co.kr/news/view?tp=1&ud=2018081503303274222
5180,2018-08-15,삼성바이오로직스올들어5번째의약품위탁생산계약,http://www.newsway.co.kr/news/view?tp=1&ud=2018081505453234130
5181,2018-08-15,금감원삼성바이오로직스재감리착수분식회계입증에주력,http://www.viva100.com/main/view.php?key=20180815010004467
5182,2018-08-15,금융감독원삼성바이오로직스재감리속도낸다,http://www.seoulwire.com/news/articleView.html?idxno=22829
5183,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.fetv.co.kr/news/article.html?no=10905
5184,2018-08-15,삼성바이오로직스1천446억규모의약품위탁생산계약,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20180814222634
5185,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.smedaily.co.kr/news/articleView.html?idxno=77708
5186,2018-08-15,금감원삼성바이오로직스재감리분식회계입증논리개발주력할듯,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201808151120001&code=920301
5187,2018-08-15,금감원삼성바이오로직스재감리착수연내마무리목표,http://www.dailian.co.kr/news/view/732651/?sc=naver
5188,2018-08-15,어제증시코스피2249코스닥758삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=464579
5189,2018-08-15,금감원삼성바이오로직스재감리착수올해증선위의결목표,http://www.asiatime.co.kr/news/articleView.html?idxno=193868
5190,2018-08-15,금감원삼성바이오로직스재감리착수연내마무리목표,http://daily.hankooki.com/lpage/economy/201808/dh20180815124216138110.htm
5191,2018-08-15,금감원삼성바이오로직스재감리착수올해증선위의결까지”,http://www.polinews.co.kr/news/article.html?no=364609
5192,2018-08-15,금감원삼성바이오로직스재감리돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1652958
5193,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.yonhapnewstv.co.kr/MYH20180815005200038/?did=1825m
5194,2018-08-15,금융감독원삼성바이오로직스재감리착수,http://www.segyefn.com/newsView/20180815002228?OutUrl=naver
5195,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.ajunews.com/view/20180815144431605
5196,2018-08-15,금융감독원삼성바이오로직스재감리착수,http://news20.busan.com/controller/newsController.jsp?newsId=20180815000077
5197,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.dt.co.kr/contents.html?article_no=2018081602100558033001&ref=naver
5198,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.newstomato.com/ReadNews.aspx?no=841630
5199,2018-08-15,금감원삼성바이오로직스재감리착수,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1509363
5200,2018-08-15,금감원삼성바이오로직스재감리착수연내마무리목표,http://www.kpinews.co.kr/news/articleView.html?idxno=79417
5201,2018-08-15,금감원삼성바이오로직스재감리연내매듭,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=764625
5202,2018-08-15,금감원삼성바이오로직스재감리착수바이오기업공시강화,http://www.econovill.com/news/articleView.html?idxno=343903
5203,2018-08-16,금감원삼성바이오로직스재감리착수,https://cnbc.sbs.co.kr/article_hub/10000911876?division=NAVER
5204,2018-08-16,삼성바이오로직스1446억규모의약품위탁생산계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=329604
5205,2018-08-16,금감원삼성바이오로직스재감리착수속도낸다,http://www.mdtoday.co.kr/mdtoday/index.html?no=329613
5206,2018-08-16,삼성바이오로직스10000원219내린446000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808160094&t=NN
5207,2018-08-16,특징주삼성바이오로직스분식회계관련재감리착수주가불똥튀나,http://www.g-enews.com/ko-kr/news/article/news_all/201808160908567055c642673384_1/article.html
5208,2018-08-16,특징주삼성바이오로직스약세금감원재감리시작,http://news.hankyung.com/article/2018081656736
5209,2018-08-16,특징주제약바이오주삼성바이오로직스재감리소식에일제히약세,http://moneys.mt.co.kr/news/mwView.php?no=2018081609368090054
5210,2018-08-16,특징주삼성바이오로직스금감원재감리소식에주가주춤,http://www.newsprime.co.kr/news/article.html?no=426474
5211,2018-08-16,특징주삼성바이오로직스장초반부터4대낙폭44만원선깨져,http://www.econonews.co.kr/news/articleView.html?idxno=32716
5212,2018-08-16,특징주삼성바이오로직스금감원재감리착수에3하락,http://view.asiae.co.kr/news/view.htm?idxno=2018081609592872950
5213,2018-08-16,기관외국인매도에30여포인트급락중금감원재감리소식에삼성바이오로직스450↓,http://daily.hankooki.com/lpage/economy/201808/dh20180816102110138110.htm
5214,2018-08-16,제약바이오반기보수1위는삼성바이오로직스김태한사장17억원非임원고액수령자눈길,http://www.kyeongin.com/main/view.php?key=20180816010004847
5215,2018-08-16,오늘증시코스피코스닥장초반하락삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=465019
5216,2018-08-16,삼성바이오로직스16000원351내린440000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808160557&t=NN
5217,2018-08-16,금감원삼성바이오로직스재감리착수,http://www.wsobi.com/news/articleView.html?idxno=63621
5218,2018-08-16,윤석헌금감원장삼성바이오로직스재감리결론달라질수있어”,http://www.fntimes.com/html/view.php?ud=20180816160357889f09e13944d_18
5219,2018-08-16,윤석헌금감원장삼성바이오로직스재감리원안과달라져야”,http://www.mdtoday.co.kr/mdtoday/index.html?no=329705
5220,2018-08-16,김태한삼성바이오로직스사장16억7200만원으로업계보수1위,http://it.chosun.com/site/data/html_dir/2018/08/16/2018081602587.html
5221,2018-08-16,터키쇼크확산삼성전자장중신저가삼성바이오로직스셀트리온하락,http://www.choicenews.co.kr/news/articleView.html?idxno=43827
5222,2018-08-16,윤석헌삼성바이오로직스재감리여러가능성열어놨다,http://www.dailian.co.kr/news/view/732901/?sc=naver
5223,2018-08-16,윤석헌삼성바이오로직스2015년이전회계처리도살펴본다,http://www.businesspost.co.kr/BP?command=article_view&num=92889
5224,2018-08-16,삼성바이오로직스주가금감원재감리에급락셀트리온도떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=92912
5225,2018-08-16,삼성바이오로직스1446억원규모위탁생산계약따내,http://www.techholic.co.kr/news/articleView.html?idxno=177578
5226,2018-08-17,윤석헌금감원장삼성바이오로직스분식회계의혹재감리가능한빨리할것,http://www.topstarnews.net/news/articleView.html?idxno=465586
5227,2018-08-17,CDMO사업속도내는삼성바이오로직스상반기공장가동률매출↑,http://www.asiatoday.co.kr/view.php?key=20180816010008021
5228,2018-08-17,삼성바이오로직스3500원08오른443500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808170071&t=NN
5229,2018-08-17,특징주삼성바이오로직스재감리충격서벗어나나주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201808170902473983c642673384_1/article.html
5230,2018-08-17,한경로보뉴스삼성바이오로직스5이상상승의약품위탁생산계약14461억원매출액대비3112,http://news.hankyung.com/article/201808171510L
5231,2018-08-17,특징주삼성바이오로직스4대상승세로46만원돌파오후들어상승폭커져,http://www.econonews.co.kr/news/articleView.html?idxno=32903
5232,2018-08-17,삼성바이오로직스18000원409오른458000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808170377&t=NN
5233,2018-08-17,관심주셀트리온삼성바이오로직스네이버나노스상승삼성전자SK하이닉스현대모비스하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=29352
5234,2018-08-17,삼성바이오로직스주가계속올라셀트리온3총사주가도상승,http://www.businesspost.co.kr/BP?command=article_view&num=93036
5235,2018-08-17,코스피기관순매수삼성바이오로직스OCI호텔신라,http://www.newsway.co.kr/news/view?tp=1&ud=2018081717400768911
5236,2018-08-20,삼성바이오로직스5000원109오른463000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808200078&t=NN
5237,2018-08-20,삼성바이오로직스2029년까지매출최소3조확보,http://www.dailypharm.com/News/242912
5238,2018-08-20,삼성바이오로직스수주총액3조9000억원규모,http://www.mdtoday.co.kr/mdtoday/index.html?no=329934
5239,2018-08-20,삼성바이오로직스4500원098내린453500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808200389&t=NN
5240,2018-08-20,관심주삼성전자셀트리온삼성바이오로직스신한지주약세SK하이닉스현대차LG화학상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=29524
5241,2018-08-20,코스피↑코스닥↓셀트리온삼성바이오로직스신라젠공동약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=329989
5242,2018-08-20,셀트리온삼성바이오로직스주가하락외국인매도에밀려,http://www.businesspost.co.kr/BP?command=article_view&num=93212
5243,2018-08-21,어제증시코스피소폭상승코스닥하락삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=467734
5244,2018-08-21,삼성바이오로직스4000원088오른457500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808210111&t=NN
5245,2018-08-21,삼성바이오로직스500원011오른454000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808210434&t=NN
5246,2018-08-21,셀트리온주가서정진효과에상승삼성바이오로직스도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=93355
5247,2018-08-22,어제증시코스피2270선회복코스닥소폭상승삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=468492
5248,2018-08-22,삼성바이오로직스3000원066오른457000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808220080&t=NN
5249,2018-08-22,코스피뉴욕증시강세에상승출발삼성전자SK하이닉스셀트리온삼성바이오로직스등오름세,http://www.econonews.co.kr/news/articleView.html?idxno=33436
5250,2018-08-22,관심주삼성전자SK하이닉스현대차나노스상승삼성바이오로직스포스코LG화학신라젠하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=29654
5251,2018-08-22,삼성바이오로직스가치평가증권사리포트에의존”,http://news.kbs.co.kr/news/view.do?ncd=4027943&ref=A
5252,2018-08-22,셀트리온주가제자리걸음삼성바이오로직스는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=93506
5253,2018-08-23,삼성바이오로직스창사이래첫바이오시밀러시생산,http://www.mdtoday.co.kr/mdtoday/index.html?no=330263
5254,2018-08-23,골룸끝까지판다35딜로이트안진과삼정PMG두대형회계법인의황당한삼성바이오로직스가치평가feat홍순탁회계사,https://news.sbs.co.kr/news/endPage.do?news_id=N1004902068&plink=ORI&cooper=NAVER
5255,2018-08-23,관심주SK하이닉스셀트리온네이버KB금융나노스상승세삼성전자삼성바이오로직스CJENM약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=29688
5256,2018-08-23,삼바삼성바이오로직스엉터리기업가치산정논란커져,http://www.naeil.com/news_view/?id_art=286360
5257,2018-08-23,박용진의원증권사리포트짜깁기로삼성바이오로직스가치평가금융위알고도묵인,http://www.choicenews.co.kr/news/articleView.html?idxno=43988
5258,2018-08-23,참여연대삼성바이오로직스가치평가엉터리”,http://moneys.mt.co.kr/news/mwView.php?no=2018082314458065566
5259,2018-08-23,박용진삼성바이오로직스가치평가근거짜깁기한증권사리포트”비판,http://www.nspna.com/news/?mode=view&newsid=301790
5260,2018-08-23,업다운이슈삼바분식회계의혹사건삼성바이오로직스김태한사장어깨가더욱무거워지는까닭은,http://www.updownnews.co.kr/news/articleView.html?idxno=96046
5261,2018-08-23,셀트리온주가외국인매수세에상승삼성바이오로직스는내려,http://www.businesspost.co.kr/BP?command=article_view&num=93657
5262,2018-08-24,DataScore삼성바이오로직스상반기투자줄이고고용늘려,http://www.ceoscoredaily.com/news/article.html?no=44933
5263,2018-08-24,삼성바이오로직스7500원166오른458000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808240305&t=NN
5264,2018-08-24,셀트리온삼성바이오로직스주가올라기관과외국인동반매수,http://www.businesspost.co.kr/BP?command=article_view&num=93786
5265,2018-08-24,묻지도따지지도않고삼성바이오로직스가치가9조원,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002466217&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
5266,2018-08-27,삼성바이오로직스3000원066오른461000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808270077&t=NN
5267,2018-08-27,코스피외국인기관사자에7거래일째↑삼성전자SK하이닉스셀트리온삼성바이오로직스등오름세,http://www.econonews.co.kr/news/articleView.html?idxno=33990
5268,2018-08-27,삼성바이오로직스3500원076내린454500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808270462&t=NN
5269,2018-08-27,딜로이트안진삼성바이오로직스기업가치평가논란으로또위기,http://www.businesspost.co.kr/BP?command=article_view&num=93966
5270,2018-08-27,셀트리온삼성바이오로직스주가동반하락외국인상반된접근,http://www.businesspost.co.kr/BP?command=article_view&num=93987
5271,2018-08-28,어제증시27일코스피코스닥지수상승삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=471939
5272,2018-08-28,김어준의뉴스공장김어준삼성바이오로직스고평가제일모직에부서조차없는바이오부분까지억지로넣어,http://www.topstarnews.net/news/articleView.html?idxno=471930
5273,2018-08-28,삼성바이오로직스2000원044오른456500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808280079&t=NN
5274,2018-08-28,참여연대금융위삼성바이오로직스보고서공개하라,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10298065
5275,2018-08-28,삼성바이오로직스5000원11내린449500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808280354&t=NN
5276,2018-08-28,셀트리온3총사주가하락삼성바이오로직스도약세,http://www.businesspost.co.kr/BP?command=article_view&num=94136
5277,2018-08-29,어제증시29일코스피2300회복코스닥은하락셀트리온신라젠삼성바이오로직스는,http://www.topstarnews.net/news/articleView.html?idxno=472793
5278,2018-08-29,삼성바이오로직스2000원044오른451500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808290083&t=NN
5279,2018-08-29,특징주삼성바이오로직스외국인러브콜주가시동걸리나,http://www.g-enews.com/ko-kr/news/article/news_all/201808290913018916c642673384_1/article.html
5280,2018-08-29,관심주삼성전자SK하이닉스현대차네이버약세셀트리온삼성바이오로직스포스코LG화학강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=30068
5281,2018-08-29,인천연수구시설안전관리공단삼성바이오로직스업무협약체결,http://www.joongdo.co.kr/main/view.php?key=20180829010011651
5282,2018-08-29,삼성바이오로직스500원011오른450000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808290387&t=NN
5283,2018-08-29,셀트리온삼성바이오로직스주가나란히소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=94258
5284,2018-08-29,연수구시설안전관리公삼성바이오로직스업무협약맺고공원녹지유지관리협력,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=766506
5285,2018-08-30,어제증시코스피9일연속상승2310선턱밑셀트리온신라젠삼성바이오로직스는,http://www.topstarnews.net/news/articleView.html?idxno=473538
5286,2018-08-30,삼성바이오로직스2000원044오른452000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808300073&t=NN
5287,2018-08-30,코스피뉴욕증시훈풍에도약보합삼성전자삼성바이오로직스오름세vsSK하이닉스포스코하락세,http://www.econonews.co.kr/news/articleView.html?idxno=34435
5288,2018-08-30,삼성바이오로직스3500원078내린446500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808300373&t=NN
5289,2018-08-30,셀트리온3총사주가모두내려삼성바이오로직스도약세,http://www.businesspost.co.kr/BP?command=article_view&num=94388
5290,2018-08-31,어제증시30일코스피지수상승세마감삼성바이오로직스신라젠셀트리온은,http://www.topstarnews.net/news/articleView.html?idxno=474234
5291,2018-08-31,퀵리포트삼성바이오로직스매수유지목표가61만원유지한투證,http://www.itooza.com/common/iview.php?no=2018083108350619051
5292,2018-08-31,삼성바이오로직스목표가61만원유지전일종가44만6500원한투證,http://www.newspim.com/news/view/20180831000067
5293,2018-08-31,삼성바이오로직스6500원146오른453000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808310072&t=NN
5294,2018-08-31,삼성바이오로직스전일대비약3상승한460000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808310092&t=NN
5295,2018-08-31,특징주삼성바이오로직스하반기모멘텀기대감에상승,http://news.hankyung.com/article/2018083164036
5296,2018-08-31,특징주삼성바이오로직스바이오주펀더멘털개선전망에강세,http://www.g-enews.com/ko-kr/news/article/news_all/201808310914317858c16aa2f016_1/article.html
5297,2018-08-31,특징주삼성바이오로직스투자3공장기대에상승,http://www.inews24.com/php/news_view.php?g_serial=1122010&g_menu=022300&rrf=nv
5298,2018-08-31,특징주삼성바이오로직스3공장수주본격화기대상승,http://www.asiatime.co.kr/news/articleView.html?idxno=196924
5299,2018-08-31,특징주삼성바이오로직스3공장수주기대감에강세,http://www.ekn.kr/news/article.html?no=383512
5300,2018-08-31,한경로보뉴스삼성바이오로직스5이상상승개장직후전일거래량돌파138만주거래중,http://news.hankyung.com/article/201808316595L
5301,2018-08-31,관심주셀트리온삼성바이오로직스네이버신라젠나노스오름세삼성전자SK하이닉스포스코KB금융내림세,http://www.insightkorea.co.kr//news/articleView.html?idxno=30277
5302,2018-08-31,특징주삼성바이오로직스회계부담완화기대감에주가↑,http://www.newsprime.co.kr/news/article.html?no=428256
5303,2018-08-31,삼성바이오로직스하반기주가모멘텀부각에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=331074
5304,2018-08-31,특징주삼성바이오로직스47만원재돌파눈앞장초반부터4대상승,http://www.econonews.co.kr/news/articleView.html?idxno=34537
5305,2018-08-31,ET투자뉴스삼성바이오로직스지금은downsi매수유지한국투자증권,http://www.etnews.com/20180831000047
5306,2018-08-31,삼성바이오로직스16500원37오른463000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808310359&t=NN
5307,2018-08-31,삼성바이오로직스주가상승가능회계논란잦아들고실적좋아져,http://www.businesspost.co.kr/BP?command=article_view&num=94504
5308,2018-08-31,外人매수속삼성바이오로직스동성제약등제약주껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=44211
5309,2018-08-31,삼성바이오로직스주가쌍끌이매수에상승셀트리온도올라,http://www.businesspost.co.kr/BP?command=article_view&num=94568
5310,2018-09-03,삼성바이오로직스5000원108오른468000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809030075&t=NN
5311,2018-09-03,삼성바이오로직스9000원194오른472000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809030373&t=NN
5312,2018-09-03,삼성바이오로직스주가쌍끌이매수에올라셀트리온은하락,http://www.businesspost.co.kr/BP?command=article_view&num=94741
5313,2018-09-04,김어준의뉴스공장박용진의원삼성바이오로직스고평가검찰의신속한수사가필요,http://www.topstarnews.net/news/articleView.html?idxno=476365
5314,2018-09-04,삼성바이오로직스4500원095오른476500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809040068&t=NN
5315,2018-09-04,특징주삼성바이오로직스반갑다외국인주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201809040918253670c642673384_1/article.html
5316,2018-09-04,삼성바이오로직스셀트리온등제약바이오주상승세,http://www.seoulwire.com/news/articleView.html?idxno=25033
5317,2018-09-04,관심주삼성전자포스코네이버CJENM메디톡스약세SK하이닉스셀트리온삼성바이오로직스현대차LG화학강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=30487
5318,2018-09-04,박용진의원예결위의해괴한삼성바이오로직스가치평가금융위는알고도묵인,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=9&seq_800=10299368
5319,2018-09-04,마감삼성바이오로직스기고셀트리온날고삼성SDI52주신고가,http://www.asiatime.co.kr/news/articleView.html?idxno=197732
5320,2018-09-04,셀트리온셀트리온헬스케어주가뛰어삼성바이오로직스는내려,http://www.businesspost.co.kr/BP?command=article_view&num=94886
5321,2018-09-05,1억원이상주문슈퍼개미셀트리온삼성물산삼성바이오로직스샀다,http://www.asiatoday.co.kr/view.php?key=20180904010002077
5322,2018-09-05,특징주삼성바이오로직스외인러브콜주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201809050907534569c642673384_1/article.html
5323,2018-09-05,관심주삼성전자SK하이닉스포스코LG화학네이버약세셀트리온삼성바이오로직스현대차삼성물산강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=30572
5324,2018-09-05,슈퍼개미셀트리온삼성바이오로직스신라젠등바이오株집중매수1억이상주식주문급증,http://www.econonews.co.kr/news/articleView.html?idxno=35108
5325,2018-09-05,코스피코스닥공동↓셀트리온3대장삼성바이오로직스신라젠동반↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=331513
5326,2018-09-05,삼성바이오로직스7000원149내린463000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809050387&t=NN
5327,2018-09-05,코스피코스닥동반↓셀트리온3대장삼성바이오로직스신라젠공동↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=331568
5328,2018-09-05,셀트리온3총사주가모두내려삼성바이오로직스도하락,http://www.businesspost.co.kr/BP?command=article_view&num=95033
5329,2018-09-06,삼성바이오로직스500원011오른463500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809060108&t=NN
5330,2018-09-06,관심주삼성물산삼성바이오로직스SK텔레콤KB금융강세포스코LG화학네이버신한지주약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=30642
5331,2018-09-06,삼성바이오로직스4000원086내린459000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809060446&t=NN
5332,2018-09-06,셀트리온주가쌍끌이매수에올라삼성바이오로직스는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=95187
5333,2018-09-07,삼성바이오로직스459000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809070093&t=NN
5334,2018-09-07,하반기제약바이오일자리①삼성바이오로직스한미약품등113개기업이2956명채용,http://www.news2day.co.kr/110522
5335,2018-09-07,삼성바이오로직스1000원022내린458000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809070426&t=NN
5336,2018-09-07,셀트리온주가쌍끌이매수에올라삼성바이오로직스는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=95310
5337,2018-09-07,관심주삼성전자SK하이닉스삼성바이오로직스현대차포스코하락셀트리온LG화학네이버현대모비스상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=30848
5338,2018-09-08,김어준의다스뵈이다박용진의원삼성바이오로직스고평가논란문제의근본은금융위원회,http://www.topstarnews.net/news/articleView.html?idxno=478299
5339,2018-09-10,삼성바이오로직스3000원066내린455000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809100091&t=NN
5340,2018-09-10,삼성전자SK하이닉스셀트리온삼성바이오로직스신라젠강세포스코LG화학네이버약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=30966
5341,2018-09-10,삼성바이오로직스4500원098오른462500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809100462&t=NN
5342,2018-09-10,셀트리온주가쌍끌이매도에하락삼성바이오로직스는소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=95523
5343,2018-09-11,삼성바이오로직스500원011오른463000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809110083&t=NN
5344,2018-09-11,특징주삼성바이오로직스외국인순매수쇄도주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/2018091109234320c642673384_1/article.html
5345,2018-09-11,삼성바이오로직스4000원086오른466500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809110383&t=NN
5346,2018-09-11,관심주SK하이닉스셀트리온삼성바이오로직스네이버상승삼성전자현대차포스코LG화학하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31109
5347,2018-09-11,셀트리온삼성바이오로직스주가동반상승외국인선택은엇갈려,http://www.businesspost.co.kr/BP?command=article_view&num=95686
5348,2018-09-12,삼성바이오로직스345억의약품위탁생산계약매출비7,http://www.itooza.com/common/iview.php?no=2018091207070716455
5349,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약,http://view.asiae.co.kr/news/view.htm?idxno=2018091207095387803
5350,2018-09-12,삼성바이오로직스345억원규모의약품위탁생산계약체결,http://news.mt.co.kr/mtview.php?no=2018091207171293760
5351,2018-09-12,삼성바이오로직스이뮤노메딕스와346억규모위탁생산계약,http://news1.kr/articles/?3424033
5352,2018-09-12,삼성바이오로직스345억원규모의약품위탁생산계약체결,http://biz.chosun.com/site/data/html_dir/2018/09/12/2018091200433.html
5353,2018-09-12,공시삼성바이오로직스345억원규모의약품위탁생산계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2018091207595134099
5354,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1662598
5355,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약체결,http://news.heraldcorp.com/view.php?ud=20180912000048
5356,2018-09-12,삼성바이오로직스이뮤노메딕스와346억규모위탁생산계약,http://biz.newdaily.co.kr/site/data/html/2018/09/12/2018091200009.html
5357,2018-09-12,한경로보뉴스삼성바이오로직스수주공시의약품위탁생산계약3456억원매출액대비740,http://news.hankyung.com/article/201809125139L
5358,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약,http://www.newsis.com/view/?id=NISX20180912_0000416200&cID=10401&pID=10400
5359,2018-09-12,삼성바이오로직스346억원의약품위탁생산계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180912024400008&did=1195m
5360,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약체결,http://www.newspim.com/news/view/20180912000055
5361,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약,http://www.edaily.co.kr/news/newspath.asp?newsid=01613766619339464
5362,2018-09-12,삼성바이오로직스345억의약품위탁생산계약,http://news.hankyung.com/article/2018091251806
5363,2018-09-12,ET투자뉴스삼성바이오로직스207940수주공급계약Immunomed,http://www.etnews.com/20180912000011
5364,2018-09-12,삼성바이오로직스3500원075오른470000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809120084&t=NN
5365,2018-09-12,삼성바이오로직스ImmunomedicsInc과345억원계약체결,http://news.kmib.co.kr/article/view.asp?arcid=0012676911&code=61141211&cp=nv
5366,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약,http://www.ekn.kr/news/article.html?no=385796
5367,2018-09-12,특징주삼성바이오로직스의약품위탁생산계약체결주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201809120915213758c642673384_1/article.html
5368,2018-09-12,삼성바이오로직스346억원규모의약품위탁생산계약,http://www.dt.co.kr/contents.html?article_no=2018091202109931102002&ref=naver
5369,2018-09-12,특징주삼성바이오로직스美기업과346억규모위탁계약소식에강세,http://www.newsis.com/view/?id=NISX20180912_0000416287&cID=10401&pID=10400
5370,2018-09-12,특징주삼성바이오로직스美제약사와계약체결소식에주가↑,http://www.newsprime.co.kr/news/article.html?no=429654
5371,2018-09-12,삼성바이오로직스이뮤노메딕스와346억규모의약품위탁생산계약매출액의74수준,http://www.econonews.co.kr/news/articleView.html?idxno=35911
5372,2018-09-12,특징주삼성바이오로직스美제약사와계약체결소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2018091209558068376
5373,2018-09-12,삼성바이오로직스345억규모의약품위탁생산계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=332232
5374,2018-09-12,삼성바이오로직스345억규모의약품위탁생산계약,http://biz.chosun.com/site/data/html_dir/2018/09/12/2018091200993.html
5375,2018-09-12,삼성바이오로직스의약품위탁생산계약소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=332233
5376,2018-09-12,삼성바이오로직스美기업과346억원규모의약품위탁생산계약,http://www.newsworks.co.kr/news/articleView.html?idxno=214762
5377,2018-09-12,삼성바이오로직스이뮤노메딕스와346억위탁생산계약,http://daily.hankooki.com/lpage/economy/201809/dh20180912102006138110.htm
5378,2018-09-12,삼성바이오로직스346억규모바이오의약품위탁생산따내,http://www.businesspost.co.kr/BP?command=article_view&num=95759
5379,2018-09-12,삼성바이오로직스345억규모의약품위탁생산계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222091
5380,2018-09-12,삼성바이오로직스345억원규모의약품위탁생산계약체결,http://www.newstomato.com/ReadNews.aspx?no=846468
5381,2018-09-12,삼성바이오로직스美제약사와345억원위탁계약체결,http://www.kormedi.com/news/news/drug_dist/1229219_2906.html
5382,2018-09-12,특징주삼성바이오로직스의약품위탁생산계약소식에장중상승세,http://www.kukinews.com/news/article.html?no=584893
5383,2018-09-12,삼성바이오로직스美바이오기업과위탁생산계약,http://www.kpinews.co.kr/news/articleView.html?idxno=80982
5384,2018-09-12,삼성바이오로직스346억규모의약품위탁생산계약,http://www.wolyo.co.kr/news/articleView.html?idxno=67797
5385,2018-09-12,삼성바이오로직스美제약사와346억원규모의약품위탁생산계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=03316086619339464
5386,2018-09-12,공시의무위반삼성바이오로직스수사어떻게되나,http://ilyo.co.kr/?ac=article_view&entry_id=309422
5387,2018-09-12,삼성바이오로직스1000원021오른467500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809120379&t=NN
5388,2018-09-12,코스피외국인순매수셀트리온LG유플러스삼성바이오로직스,http://www.newsway.co.kr/news/view?tp=1&ud=2018091216405527986
5389,2018-09-12,삼성바이오로직스이뮤노메딕스와CMO계약체결,http://www.techholic.co.kr/news/articleView.html?idxno=178154
5390,2018-09-12,셀트리온3총사주가동반강세삼성바이오로직스도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=95838
5391,2018-09-12,박용진2015년삼성바이오로직스기업가치는왜뻥튀기됐을까,http://www.ytn.co.kr/_ln/0101_201809122229314492
5392,2018-09-12,박용진2015년삼성바이오로직스기업가치는왜뻥튀기됐을까”,http://radio.ytn.co.kr/program/?f=2&id=58045&s_mcd=0263&s_hcd=01
5393,2018-09-13,전일공시삼성바이오로직스346억원의약품위탁생산계약,http://www.smedaily.co.kr/news/articleView.html?idxno=78291
5394,2018-09-13,퀵리포트삼성바이오로직스매수유지목표가22↑60만원삼성證,http://www.itooza.com/common/iview.php?no=2018091308464714664
5395,2018-09-13,삼성바이오로직스목표가22↑60만원제시삼성證,http://www.newspim.com/news/view/20180913000066
5396,2018-09-13,ET투자뉴스삼성바이오로직스우려로가려지지않BUY삼성증권,http://www.etnews.com/20180913000012
5397,2018-09-13,삼성바이오로직스6000원128오른473500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809130094&t=NN
5398,2018-09-13,특징주삼성바이오로직스23공장가동률상승레버리지효과외인팔자에도주가꿋꿋,http://www.g-enews.com/ko-kr/news/article/news_all/20180913092522748c642673384_1/article.html
5399,2018-09-13,셀트리온한미약품삼성바이오로직스등제약바이오주상승세,http://www.seoulwire.com/news/articleView.html?idxno=26300
5400,2018-09-13,코스피미중무역협상재개전망에상승출발삼성전자셀트리온삼성바이오로직스LG화학삼성물산등오름세,http://www.econonews.co.kr/news/articleView.html?idxno=36065
5401,2018-09-13,직업이야기48외국인넘쳐나는삼성바이오로직스내성공조건은영어실력,http://www.news2day.co.kr/110893
5402,2018-09-13,삼성바이오로직스1500원032오른469000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809130383&t=NN
5403,2018-09-13,관심주삼성전자SK하이닉스현대차네이버하락셀트리온삼성바이오로직스포스코LG화학SK텔레콤상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31238
5404,2018-09-13,셀트리온주가쌍끌이매수에상승삼성바이오로직스도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=95991
5405,2018-09-14,삼성바이오로직스500원011오른469500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809140093&t=NN
5406,2018-09-14,관심주삼성전자SK하이닉스현대차포스코LG화학네이버강세셀트리온삼성바이오로직스신라젠CJENM약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31243
5407,2018-09-14,코스피코스닥동반↑셀트리온삼성바이오로직스신라젠도↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=332503
5408,2018-09-14,삼성바이오로직스2000원043오른471000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809140416&t=NN
5409,2018-09-14,삼성바이오로직스주가쌍끌이매수에올라셀트리온3총사하락,http://www.businesspost.co.kr/BP?command=article_view&num=96116
5410,2018-09-17,퀵리포트삼성바이오로직스매수목표가59만원신규제시KTB證,http://www.itooza.com/common/iview.php?no=2018091708303119794
5411,2018-09-17,삼성바이오로직스목표가59만원신규제시전일종가47만1000원KTB證,http://www.newspim.com/news/view/20180917000065
5412,2018-09-17,HotLine삼성바이오로직스3공장가동본격화로CMO실적고성장전망,http://news.mk.co.kr/newsRead.php?year=2018&no=584474
5413,2018-09-17,삼성바이오로직스3000원064오른474000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809170081&t=NN
5414,2018-09-17,ET투자뉴스삼성바이오로직스중장기성장성에주BUYKTB투자증권,http://www.etnews.com/20180917000020
5415,2018-09-17,특징주삼성바이오로직스CMO실적본격화전망에주가↑,http://www.newsprime.co.kr/news/article.html?no=430199
5416,2018-09-17,관심주삼성전자현대차포스코네이버SK텔레콤약세셀트리온삼성바이오로직스SK하이닉스LG화학강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31291
5417,2018-09-17,코스피미국대중관세부과우려에2300선등락셀트리온삼성바이오로직스포스코LG화학등은오름세,http://www.econonews.co.kr/news/articleView.html?idxno=36427
5418,2018-09-17,fnRASSI삼성바이오로직스212오르며거래량증가,http://www.fnnews.com/news/201809171124014460
5419,2018-09-17,삼성바이오로직스3공장가동에따른CMO실적고성장전망,http://www.newsworks.co.kr/news/articleView.html?idxno=216057
5420,2018-09-17,삼성바이오로직스전일대비약3상승한485500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809170412&t=NN
5421,2018-09-17,삼성바이오로직스15000원318오른486000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809170429&t=NN
5422,2018-09-17,셀트리온삼성바이오로직스주가동반급등실적증가기대커져,http://www.businesspost.co.kr/BP?command=article_view&num=96320
5423,2018-09-17,마감제약바이오주투심회복셀트리온삼성바이오로직스상승,http://www.asiatime.co.kr/news/articleView.html?idxno=200493
5424,2018-09-17,관심주삼성전자SK하이닉스현대차포스코네이버하락셀트리온삼성바이오로직스신라젠바이로메드상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31307
5425,2018-09-18,퀵리포트삼성바이오로직스매수유지목표가59만원유지현대차證,http://www.itooza.com/common/iview.php?no=2018091808252212397
5426,2018-09-18,삼성바이오로직스목표가59만원유지전일종가원현대차證,http://www.newspim.com/news/view/20180918000072
5427,2018-09-18,삼성바이오로직스삼성바이오에피스SB5유럽출시임박모멘텀주목–현대차증권,http://www.fntimes.com/html/view.php?ud=2018091808295127811d6f57e61a_18
5428,2018-09-18,현대차증권삼성바이오로직스자회사주력파이프라인임랄디10월유럽출시가능모멘텀양호”,http://www.g-enews.com/ko-kr/news/article/news_all/201809180827356204c642673384_1/article.html
5429,2018-09-18,STOCK삼성바이오로직스양호한모멘텀,http://moneys.mt.co.kr/news/mwView.php?no=2018091808388073866
5430,2018-09-18,삼성바이오로직스3분기영업이익시장추정치하회할것현대차증권,http://www.fnnews.com/news/201809180840529371
5431,2018-09-18,삼성바이오로직스에피스임랄디10월유럽출시전망현대차증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1664877
5432,2018-09-18,I리포트삼성바이오로직스모멘텀은양호현대차證,http://www.inews24.com/php/news_view.php?g_serial=1126656&g_menu=022300&rrf=nv
5433,2018-09-18,삼성바이오로직스3000원064오른474000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809180082&t=NN
5434,2018-09-18,특징주삼성바이오로직스자회사파이프라인기대고조주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201809180908331457c642673384_1/article.html
5435,2018-09-18,현대차증권삼성바이오로직스하반기실적하락에도업황호조로모멘텀유지”,http://www.lawissue.co.kr/view.php?ud=2018091809224987709817d053b9_12
5436,2018-09-18,삼성바이오로직스주가상승가능바이오에피스신약가치재평가,http://www.businesspost.co.kr/BP?command=article_view&num=96371
5437,2018-09-18,삼성바이오로직스2개월만에주가34껑충,http://www.etoday.co.kr/news/section/newsview.php?idxno=1664969
5438,2018-09-18,코스피미중무역분쟁격화애2300선공방SK하이닉스셀트리온삼성바이오로직스등내림세,http://www.econonews.co.kr/news/articleView.html?idxno=36587
5439,2018-09-18,ET투자뉴스삼성바이오로직스하반기실적은쉬어BUY현대차증권,http://www.etnews.com/20180918000131
5440,2018-09-18,삼성바이오로직스3대상승하면서50만원재돌파상승어디까지,http://www.econonews.co.kr/news/articleView.html?idxno=36624
5441,2018-09-18,삼성바이오로직스21000원432오른507000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809180384&t=NN
5442,2018-09-18,삼성바이오로직스올해11월중3공장정상가동,http://www.newsworks.co.kr/news/articleView.html?idxno=216452
5443,2018-09-18,삼성바이오로직스7거래일연속상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=332857
5444,2018-09-18,마감삼성바이오로직스5개월만50만원대안착신라젠상승세지속,http://www.asiatime.co.kr/news/articleView.html?idxno=200809
5445,2018-09-19,삼성바이오로직스5000원099오른512000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809190082&t=NN
5446,2018-09-19,특징주삼성바이오로직스바이오감리종료펀더멘털부각되나주가랠리,http://www.g-enews.com/ko-kr/news/article/news_all/201809190925552922c16aa2f016_1/article.html
5447,2018-09-19,삼성바이오로직스507000원보합권마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809190433&t=NN
5448,2018-09-19,셀트리온주가외국인매수에올라삼성바이오로직스는제자리,http://www.businesspost.co.kr/BP?command=article_view&num=96618
5449,2018-09-20,삼성바이오로직스2000원039오른509000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809200071&t=NN
5450,2018-09-20,삼성바이오로직스전일대비약3상승한523000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809200133&t=NN
5451,2018-09-20,한경로보뉴스삼성바이오로직스5이상상승외국인기관각각4일7일연속순매수,http://news.hankyung.com/article/201809204782L
5452,2018-09-20,관심주삼성전자셀트리온현대차삼성바이오로직스현대차강세SK하이닉스포스코LG화학SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31360
5453,2018-09-20,코스피외국인개인사자에상승출발삼성전자셀트리온현대차삼성바이오로직스현대차등오름세,http://www.econonews.co.kr/news/articleView.html?idxno=36870
5454,2018-09-20,특징주삼성바이오로직스남북경협주로부상강세,http://www.asiatime.co.kr/news/articleView.html?idxno=201242
5455,2018-09-20,제약바이오RD회계처리가이드라인에불확실성털어셀트리온삼성바이오로직스등수혜,http://www.econonews.co.kr/news/articleView.html?idxno=36887
5456,2018-09-20,유삼성바이오로직스전일대비710상승일일회전율은043기록,http://www.sedaily.com/NewsView/1S4PL4MKXP
5457,2018-09-20,특징주삼성바이오로직스오후상승폭확대7↑,http://view.asiae.co.kr/news/view.htm?idxno=2018092013194498602
5458,2018-09-20,삼성바이오로직스7급등하면서54만원재돌파제약바이오회계처리불확실성해소,http://www.econonews.co.kr/news/articleView.html?idxno=36899
5459,2018-09-20,삼성바이오로직스회계처리가이드라인에따른불확실성해소에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=333132
5460,2018-09-20,삼성바이오로직스21000원414오른528000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809200405&t=NN
5461,2018-09-20,삼성바이오로직스주가기관매수에급등셀트리온3총사는급락,http://www.businesspost.co.kr/BP?command=article_view&num=96787
5462,2018-09-21,삼성바이오로직스10000원189오른538000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809210092&t=NN
5463,2018-09-21,삼성바이오로직스장초반강보합기관8거래일연속순매수,http://www.econonews.co.kr/news/articleView.html?idxno=36986
5464,2018-09-21,기업분석삼성바이오로직스이제는회계아닌기업을보자,http://www.ekn.kr/news/article.html?no=387852
5465,2018-09-21,코스피개인기관사자에2330선장중돌파셀트리온삼성바이오로직스현대차LG화학등오름세,http://www.econonews.co.kr/news/articleView.html?idxno=37019
5466,2018-09-21,삼성바이오로직스2000원038오른530000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809210401&t=NN
5467,2018-09-21,코스피기관순매수삼성물산삼성바이오로직스LG화학,http://www.newsway.co.kr/news/view?tp=1&ud=2018092116405249840
5468,2018-09-21,관심주삼성전자셀트리온삼성바이오로직스포스코LG화학상승SK하이닉스네이버신라젠메디톡스하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31394
5469,2018-09-21,셀트리온주가외국인매수에상승삼성바이오로직스도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=96964
5470,2018-09-24,선파마일루메트리유럽허가에삼성바이오로직스수혜가능할까,http://www.mdtoday.co.kr/mdtoday/index.html?no=333292
5471,2018-09-26,셀트리온과삼성바이오로직스는어떤인재를선호할까,http://www.businesspost.co.kr/BP?command=article_view&num=97042
5472,2018-09-26,셀트리온삼성바이오로직스등바이오주대장주악재털고반등모색,http://www.fntimes.com/html/view.php?ud=201809261315354051f09e13944d_18
5473,2018-09-27,연속순매수기관삼성바이오로직스9일째매수,http://www.itooza.com/common/iview.php?no=2018092117100967618
5474,2018-09-27,한경로보뉴스전일기관거래소에서KODEX200TR033삼성바이오로직스038등순매수,http://news.hankyung.com/article/201809279255L
5475,2018-09-27,삼성바이오로직스1000원019오른531000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809270090&t=NN
5476,2018-09-27,김태한삼성바이오로직스대표상반기보수16억원업계톱,http://www.datanews.co.kr/news/article.html?no=101198
5477,2018-09-27,삼성바이오로직스전일대비약3상승한546000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809270115&t=NN
5478,2018-09-27,삼성바이오로직스상승어디까지기관9거래일연속순매수,http://www.econonews.co.kr/news/articleView.html?idxno=37317
5479,2018-09-27,특징주삼성바이오로직스에피스SB5미국진출기대강세,http://www.asiatime.co.kr/news/articleView.html?idxno=201957
5480,2018-09-27,관심주삼성전자셀트리온삼성바이오로직스현대모비스강세SK하이닉스LG화학삼성물산네이버KB금융약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31406
5481,2018-09-27,특징주삼성바이오로직스SB5美심사시작10거래일째오르막,http://www.newsis.com/view/?id=NISX20180927_0000428031&cID=10401&pID=10400
5482,2018-09-27,삼성바이오로직스10거래일연속상승그래프,http://www.mdtoday.co.kr/mdtoday/index.html?no=333412
5483,2018-09-27,코스피미국금리인상에도상승반전삼성전자셀트리온삼성바이오로직스현대모비스등은오름세,http://www.econonews.co.kr/news/articleView.html?idxno=37351
5484,2018-09-27,삼성바이오로직스16000원302오른546000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809270403&t=NN
5485,2018-09-27,공시김태한삼성바이오로직스사장보통주500주증여,http://www.newsway.co.kr/news/view?tp=1&ud=2018092715450770972
5486,2018-09-27,관심주삼성전자삼성바이오로직스현대차포스코LG화학KB금융상승SK하이닉스셀트리온네이버하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31419
5487,2018-09-27,셀트리온주가쌍끌이매도에하락삼성바이오로직스는32올라,http://www.businesspost.co.kr/BP?command=article_view&num=97203
5488,2018-09-28,삼성바이오로직스바이오젠삼성바이오에피스콜옵션계약연기,http://www.ebn.co.kr/news/view/956482
5489,2018-09-28,삼성바이오로직스바이오젠에주식양도내달30일로변경,http://news1.kr/articles/?3436959
5490,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도1개월연장”,http://www.edaily.co.kr/news/newspath.asp?newsid=01567846619344712
5491,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도1개월연장,http://www.ekn.kr/news/article.html?no=388564
5492,2018-09-28,삼성바이오로직스3000원055오른549000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809280075&t=NN
5493,2018-09-28,삼성바이오로직스”바이오젠콜옵션주식양도내달30일로늦춰”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1667801
5494,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도1개월연장,http://www.mdtoday.co.kr/mdtoday/index.html?no=333548
5495,2018-09-28,삼성바이오로직스상승멈추고하락세로기관10거래일연속순매수,http://www.econonews.co.kr/news/articleView.html?idxno=37420
5496,2018-09-28,관심주SK하이닉스셀트리온LG화학네이버KB금융강세삼성전자삼성바이오로직스현대차포스코약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31422
5497,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도1개월지연”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1667820
5498,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도1개월연기,http://www.mediapen.com/news/view/385612
5499,2018-09-28,특징주삼성바이오로직스하락세삼성물산지분매각가능성,http://www.asiatime.co.kr/news/articleView.html?idxno=202209
5500,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도일1개월연장”,http://www.sedaily.com/NewsView/1S4T9M5RP2
5501,2018-09-28,바이오젠삼성바이오로직스콜옵션주식양도연기,http://www.dailymedi.com/detail.php?number=835102&thread=22r05
5502,2018-09-28,삼성바이오로직스바이오젠콜옵션주식양도1개월늦춰,http://news.mk.co.kr/newsRead.php?year=2018&no=606869
5503,2018-09-28,삼성바이오로직스12000원22내린534000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809280384&t=NN
5504,2018-09-28,삼성바이오로직스바이오젠의콜옵션행사예정일한달미뤄져”,http://www.businesspost.co.kr/BP?command=article_view&num=97314
5505,2018-09-28,셀트리온3총사주가모두하락삼성바이오로직스도내려,http://www.businesspost.co.kr/BP?command=article_view&num=97327
5506,2018-09-28,삼성바이오로직스바이오젠콜옵션행사연기,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809280412&t=NN
5507,2018-09-28,EBN오늘28일이슈종합현대차2018코리아세일페스타참가삼성바이오로직스바이오젠삼성바이오에피스콜옵션계약연기코리아세일페스타짐뺀카드사,http://www.ebn.co.kr/news/view/956587
5508,2018-10-01,전일28일주요공시삼성바이오로직스外,http://www.newsway.co.kr/news/view?tp=1&ud=2018100108072681864
5509,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.inews24.com/php/news_view.php?g_serial=1129257&g_menu=022620&rrf=nv
5510,2018-10-01,삼성바이오로직스세계최대규모3공장생산돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=01744966619368656
5511,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2018100108392546324
5512,2018-10-01,삼성바이오로직스세계최대규모3공장생산돌입,http://www.newsis.com/view/?id=NISX20181001_0000430623&cID=13001&pID=13000
5513,2018-10-01,삼성바이오로직스3공장생산돌입단일공장기준세계최대,http://view.asiae.co.kr/news/view.htm?idxno=2018100108571689065
5514,2018-10-01,삼성바이오로직스2000원037오른536000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810010072&t=NN
5515,2018-10-01,삼성바이오로직스3공장cGMP생산돌입,http://medipana.com/news/news_viewer.asp?NewsNum=225865&MainKind=A&NewsKind=5&vCount=12&vKind=1
5516,2018-10-01,삼성바이오로직스세계최대규모3공장제조승인위한생산돌입,http://www.newspim.com/news/view/20181001000087
5517,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://biz.newdaily.co.kr/site/data/html/2018/10/01/2018100100017.html
5518,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.asiatime.co.kr/news/articleView.html?idxno=202528
5519,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1668354
5520,2018-10-01,삼성바이오로직스3공장cGMP검증완료생산돌입,http://www.dailian.co.kr/news/view/742266/?sc=naver
5521,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018100108424841102
5522,2018-10-01,삼성바이오로직스세계최대18만리터바이오의약품3공장생산돌입,http://www.fnnews.com/news/201810010910446860
5523,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.medigatenews.com/news/1346513227
5524,2018-10-01,삼성바이오로직스3공장생산돌입세계최대규모cGMP,http://biz.chosun.com/site/data/html_dir/2018/10/01/2018100100855.html
5525,2018-10-01,삼성바이오로직스3공장cGMP생산돌입2공장보다2개월빨리,http://www.sisafocus.co.kr/news/articleView.html?idxno=192825
5526,2018-10-01,삼성바이오로직스2거래일연속하락기관11거래일연속순매수에도,http://www.econonews.co.kr/news/articleView.html?idxno=37654
5527,2018-10-01,삼성바이오로직스세계최대규모3공장시생산돌입,http://news.heraldcorp.com/view.php?ud=20181001000153
5528,2018-10-01,삼성바이오로직스세계최대18만리터3공장본격가동,http://news1.kr/articles/?3438584
5529,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산개시,http://daily.hankooki.com/lpage/ittech/201810/dh20181001093733145630.htm
5530,2018-10-01,삼성바이오로직스세계최대규모3공장생산들어간다,http://www.sisajournal-e.com/biz/article/189625
5531,2018-10-01,삼성바이오로직스3공장cGMP생산돌입,http://www.sisaon.co.kr/news/articleView.html?idxno=77818
5532,2018-10-01,SK하이닉스셀트리온현대차LG화학네이버강세삼성전자삼성바이오로직스삼성물산약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31444
5533,2018-10-01,삼성바이오로직스3공장cGMP생산돌입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1235392
5534,2018-10-01,삼성바이오로직스3공장시생산돌입年18만ℓ생산거점확보세계최대CMO로우뚝,http://www.sedaily.com/NewsView/1S5QRXD3RU
5535,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.newsworks.co.kr/news/articleView.html?idxno=218602
5536,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입발표,http://www.m-i.kr/news/articleView.html?idxno=456847
5537,2018-10-01,삼성바이오로직스18만리터규모3공장생산돌입,http://www.dailypharm.com/News/244186
5538,2018-10-01,삼성바이오로직스3공장시운전돌입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810010117&t=NN
5539,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.segye.com/content/html/2018/10/01/20181001001095.html?OutUrl=naver
5540,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2018100100046
5541,2018-10-01,삼성바이오로직스3공장생산돌입세계최대규모자체검증완료,http://www.econonews.co.kr/news/articleView.html?idxno=37694
5542,2018-10-01,삼성바이오로직스3공장생산돌입cGMP자체검증완료,http://www.biospectator.com/view/news_view.php?varAtcId=6284
5543,2018-10-01,삼성바이오로직스세계최대규모3공장서cGMP생산시작,http://www.econovill.com/news/articleView.html?idxno=347272
5544,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://news.hankyung.com/article/201810011050f
5545,2018-10-01,삼성바이오로직스3공장cGMP생산돌입,http://www.whosaeng.com/sub_read.html?uid=104731§ion=sc5
5546,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.viva100.com/main/view.php?key=20181001010000079
5547,2018-10-01,삼성바이오로직스세계최대3공장cGMP시생산돌입,http://www.techholic.co.kr/news/articleView.html?idxno=178458
5548,2018-10-01,삼성바이오로직스제3공장자체검증완료시생산돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=333754
5549,2018-10-01,삼성바이오로직스3공장cGMP생산본격돌입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060856
5550,2018-10-01,삼성바이오로직스바이오의약품3공장자체검증완료,http://www.ajunews.com/view/20181001145421881
5551,2018-10-01,삼성바이오로직스4000원075오른538000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810010424&t=NN
5552,2018-10-01,삼성바이오로직스세계최대규모3공장본격가동,http://news.mt.co.kr/mtview.php?no=2018100115214690976
5553,2018-10-01,관심주SK하이닉스삼성바이오로직스LG화학포스코상승삼성전자셀트리온현대차네이버하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31462
5554,2018-10-01,정무위국감MG손보삼성바이오로직스등도마위,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003348809
5555,2018-10-01,셀트리온3총사주가모두하락삼성바이오로직스는소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=97571
5556,2018-10-01,삼성바이오로직스세계최대규모3공장생산돌입,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1524994
5557,2018-10-01,삼성바이오로직스3공장생산시동,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=770725
5558,2018-10-01,삼성바이오로직스세계최대규모3공장cGMP생산돌입,http://www.joongboo.com/news/articleView.html?idxno=1290444
5559,2018-10-02,삼성바이오로직스세계최대3공장생산돌입,http://news.donga.com/3/all/20181001/92219774/1
5560,2018-10-02,퀵리포트삼성바이오로직스매수유지목표가66만원유지SK證,http://www.itooza.com/common/iview.php?no=2018100207363423189
5561,2018-10-02,삼성바이오로직스휴미라바이오시밀러출시임박SK,http://news.hankyung.com/article/2018100240046
5562,2018-10-02,삼성바이오로직스목표가66만원유지전일종가원SK證,http://www.newspim.com/news/view/20181002000063
5563,2018-10-02,아주종목분석삼성바이오로직스휴미라복제품출시호재,http://www.ajunews.com/view/20181002080607254
5564,2018-10-02,삼성바이오로직스3Q실적부진에도임랄디출시기대SK증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1668871
5565,2018-10-02,삼성바이오로직스실적회복기대감회계불확실성이슈해소긍정적,http://www.fntimes.com/html/view.php?ud=201810020846145456f09e13944d_18
5566,2018-10-02,SK증권삼성바이오로직스휴미라바이오시밀러출시주목”,http://www.newsway.co.kr/news/view?tp=1&ud=2018100208504784977
5567,2018-10-02,특징주삼성바이오로직스휴미라바이오시밀러출시임박전망에도약세,http://www.asiatime.co.kr/news/articleView.html?idxno=202804
5568,2018-10-02,삼성바이오로직스상승하루만에약보합53만원선깨지나,http://www.econonews.co.kr/news/articleView.html?idxno=37812
5569,2018-10-02,특징주삼성바이오로직스휴미라바이오시밀러출시임박,http://www.sisaon.co.kr/news/articleView.html?idxno=77881
5570,2018-10-02,관심주삼성전자셀트리온현대차LG화학포스코강세삼성바이오로직스네이버신라젠에이치엘비약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31468
5571,2018-10-02,삼성물산삼성바이오로직스등자회사덕기업가치↑,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060926
5572,2018-10-02,특징주삼성바이오로직스바이오주약세가운데3가까이하락,http://view.asiae.co.kr/news/view.htm?idxno=2018100214280618297
5573,2018-10-02,삼성바이오로직스3분기실적부진전망에하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=333904
5574,2018-10-02,삼성바이오로직스23000원428내린515000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810020376&t=NN
5575,2018-10-02,삼성바이오로직스휴미라바이오시밀러임랄디출시임박,http://www.newsworks.co.kr/news/articleView.html?idxno=300122
5576,2018-10-02,삼성바이오로직스주가쌍끌이매도에하락셀트리온도떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=97693
5577,2018-10-03,삼성바이오로직스삼성바이오에피스동거에기대반우려반,http://www.businesspost.co.kr/BP?command=article_view&num=97737
5578,2018-10-04,삼성바이오로직스4000원078오른519000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810040065&t=NN
5579,2018-10-04,삼성바이오로직스하락하루만에강보합52만원회복눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=37984
5580,2018-10-04,관심주SK하이닉스셀트리온삼성바이오로직스네이버KB금융강세삼성전자현대차포스코LG화학약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31489
5581,2018-10-04,코스피외국인팔자에2300선붕괴SK하이닉스셀트리온삼성바이오로직스삼성물산KB금융등은오름세,http://www.econonews.co.kr/news/articleView.html?idxno=37999
5582,2018-10-04,코스피3645포인트하락한2270대기록삼성바이오로직스KB금융은,http://www.topstarnews.net/news/articleView.html?idxno=493560
5583,2018-10-04,삼성바이오로직스11000원214오른526000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810040452&t=NN
5584,2018-10-04,관심주삼성전자SK하이닉스현대차포스코LG화학하락셀트리온삼성바이오로직스KB금융네이버상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31526
5585,2018-10-04,삼성바이오로직스주가쌍끌이매수에올라셀트리온도반등,http://www.businesspost.co.kr/BP?command=article_view&num=97887
5586,2018-10-05,삼성바이오로직스5000원095내린521000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810050070&t=NN
5587,2018-10-05,관심주삼성전자SK하이닉스셀트리온KB금융LG화학강세삼성바이오로직스현대차포스코네이버신라젠약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31540
5588,2018-10-05,삼성바이오로직스3대낙폭에50만원대로하락상승하루만에,http://www.econonews.co.kr/news/articleView.html?idxno=38170
5589,2018-10-05,삼성바이오로직스18000원342내린508000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810050439&t=NN
5590,2018-10-05,관심주SK하이닉스포스코삼성물산KB금융네이버상승셀트리온삼성바이오로직스LG화학신라젠CJENM하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31561
5591,2018-10-08,삼성바이오로직스2000원039내린506000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810080071&t=NN
5592,2018-10-08,삼성바이오로직스51만원선회복하락딛고강보합,http://www.econonews.co.kr/news/articleView.html?idxno=38362
5593,2018-10-08,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차포스코약세포스코켐텍메니톡스강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31564
5594,2018-10-08,코스피외국인팔자에하락출발SK하이닉스셀트리온삼성바이오로직스현대차삼성물산등내림세,http://www.econonews.co.kr/news/articleView.html?idxno=38392
5595,2018-10-08,삼성바이오로직스1000원02오른509000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810080364&t=NN
5596,2018-10-08,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스상승현대차포스코삼성물산KB금융LG화학하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31573
5597,2018-10-08,셀트리온주가쌍끌이매수에소폭상승삼성바이오로직스도올라,http://www.businesspost.co.kr/BP?command=article_view&num=98228
5598,2018-10-08,코스피외국인팔자에2250선털썩SK하이닉스셀트리온삼성바이오로직스등소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=38460
5599,2018-10-10,biz인사이드삼성바이오로직스위탁생산과위탁개발생산의차이,http://www.econovill.com/news/articleView.html?idxno=347814
5600,2018-10-10,삼성바이오로직스3000원059오른512000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810100077&t=NN
5601,2018-10-10,삼성바이오로직스49만원선마저위태시간지날수록낙폭커져,http://www.econonews.co.kr/news/articleView.html?idxno=38558
5602,2018-10-10,삼성바이오로직스21000원413내린488000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810100661&t=NN
5603,2018-10-10,관심주삼성전자포스코SK텔레콤신라젠CJENM상승SK하이닉스셀트리온삼성바이오로직스현대차KB금융하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31593
5604,2018-10-10,코스피코스닥동반↓셀트리온3대장삼성바이오로직스도같이↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=334703
5605,2018-10-10,삼성바이오로직스주가외국인매도에급락셀트리온도소폭내려,http://www.businesspost.co.kr/BP?command=article_view&num=98418
5606,2018-10-11,삼성바이오로직스직원1인당생산성제약바이오톱10중최하위,http://www.datanews.co.kr/news/article.html?no=101277
5607,2018-10-11,삼성바이오로직스23000원471내린465000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810110053&t=NN
5608,2018-10-11,삼성바이오로직스47만원선마저무너져2거래일연속4대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=38595
5609,2018-10-11,김태한삼성바이오로직스사장4UPs도래바이오의약품수요급증,http://www.newspim.com/news/view/20181011000163
5610,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI컨퍼런스기조강연,http://www.inews24.com/php/news_view.php?g_serial=1131674&g_menu=022620&rrf=nv
5611,2018-10-11,삼성바이오로직스김태한사장2년연속CPhI컨퍼런스기조강연,http://www.newsway.co.kr/news/view?tp=1&ud=2018101109382387732
5612,2018-10-11,김태한삼성바이오로직스사장세계의약품컨퍼런스기조강연사업경쟁력발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1238145
5613,2018-10-11,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차포스코KB금융신라젠CJENM나노스등대부분약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31603
5614,2018-10-11,김태한삼성바이오로직스사장IT바이오융합기술이글로벌신성장동력”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1672308
5615,2018-10-11,삼성바이오로직스김태한사장2년연속CPhI컨퍼런스기조강연,http://www.viva100.com/main/view.php?key=20181011010003419
5616,2018-10-11,삼성바이오로직스김태한사장2년연속CPhI컨퍼런스기조강연,http://www.fnnews.com/news/201810111027384021
5617,2018-10-11,김태한삼성바이오로직스사장ITBT융합기술新성장동력될것,http://www.dt.co.kr/contents.html?article_no=2018101102109931102001&ref=naver
5618,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI컨퍼런스기조강연,http://weekly.cnbnews.com/news/article.html?no=125545
5619,2018-10-11,김태한삼성바이오로직스사장CPhI컨퍼런스서2년연속기조강연,http://www.sisaon.co.kr/news/articleView.html?idxno=78122
5620,2018-10-11,김태한삼성바이오로직스사장의약품컨퍼런스CPhI에서기조강연,http://news.heraldcorp.com/view.php?ud=20181011000444
5621,2018-10-11,김태한삼성바이오로직스사장글로벌의약품전시회CPhI서2년연속기조강연,http://www.sedaily.com/NewsView/1S5VDJWH3L
5622,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI컨퍼런스기조강연,http://news.mk.co.kr/newsRead.php?year=2018&no=632608
5623,2018-10-11,삼성바이오로직스김태한사장2년연속CPhI컨퍼런스기조강연나서,http://www.m-i.kr/news/articleView.html?idxno=459551
5624,2018-10-11,특징주미증시충격에셀트리온삼성바이오로직스신라젠등바이오주큰폭하락,http://www.news2day.co.kr/112288
5625,2018-10-11,김태한삼성바이오로직스사장CPhI컨퍼런스기조강연,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181011111621
5626,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI콘퍼런스기조강연,http://biz.newdaily.co.kr/site/data/html/2018/10/11/2018101100093.html
5627,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI기조강연,http://www.edaily.co.kr/news/newspath.asp?newsid=03529286619371936
5628,2018-10-11,김태한삼성바이오로직스사장4Ups시대도래바이오의약품수요급성장,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018101114483379413
5629,2018-10-11,김태한삼성바이오로직스사장4공장건설은내년하반기에결정,http://news.hankyung.com/article/201810114203i
5630,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI컨퍼런스기조강연,http://www.newsworks.co.kr/news/articleView.html?idxno=301956
5631,2018-10-11,삼성바이오로직스21000원43내린467000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810110736&t=NN
5632,2018-10-11,삼성바이오로직스김태한사장2년연속CPhI컨퍼런스기조강연바이오의약품시장혁신주도,http://www.segye.com/content/html/2018/10/11/20181011003645.html?OutUrl=naver
5633,2018-10-11,삼성바이오로직스자회사에피스머크와체결한바이오시밀러계약해지,http://www.newspim.com/news/view/20181011000588
5634,2018-10-11,삼성바이오로직스김태한사장CPhI2년연속기조강연,http://www.joongboo.com/news/articleView.html?idxno=1293144
5635,2018-10-11,셀트리온삼성바이오로직스주가동반급락외국인매도세강해,http://www.businesspost.co.kr/BP?command=article_view&num=98569
5636,2018-10-11,내일12일의국감백종원출석삼성바이오로직스논란도도마위,http://daily.hankooki.com/lpage/politics/201810/dh20181011181038137470.htm
5637,2018-10-11,김태한삼성바이오로직스사장2년연속CPhI컨퍼런스기조강연,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1528715
5638,2018-10-11,삼성바이오로직스ITBT융합기술시대대비한시장혁신주도내용기조강연,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=772310
5639,2018-10-12,삼성바이오로직스머크와루수두나계약해지단기주가하락요인”,http://www.fntimes.com/html/view.php?ud=201810120144455661f09e13944d_18
5640,2018-10-12,삼성바이오로직스루수두나계약해지단기하락요인NH,http://news.hankyung.com/article/2018101262566
5641,2018-10-12,삼성바이오로직스루수두나계약해지단기하락요인NH,http://www.fnnews.com/news/201810120742356938
5642,2018-10-12,삼성바이오로직스1500원032내린465500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810120085&t=NN
5643,2018-10-12,특징주삼성바이오로직스자회사계약해지리스크에도주가보합세,http://www.g-enews.com/ko-kr/news/article/news_all/201810120905014820c16aa2f016_1/article.html
5644,2018-10-12,삼성바이오로직스46만원선깨져3거래일연속하락세,http://www.econonews.co.kr/news/articleView.html?idxno=38691
5645,2018-10-12,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차포스코SK텔레콤강세KB금융네이버셀트리온헬스케어나노스약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31634
5646,2018-10-12,삼성바이오로직스분식회계금감원국감서집중난타,http://www.straightnews.co.kr/news/articleView.html?idxno=36708
5647,2018-10-12,코스피미국뉴욕증시하락에도상승세SK하이닉스셀트리온삼성바이오로직스포스코삼성물산등오름세,http://www.econonews.co.kr/news/articleView.html?idxno=38726
5648,2018-10-12,김태한삼성바이오로직스사장고령화시대에서CMO산업가능성보다,http://www.news2day.co.kr/112345
5649,2018-10-12,유동수의원삼성바이오로직스재감리조속한마무리및관련회계제도개선방안마련촉구,http://news.heraldcorp.com/view.php?ud=20181012000508
5650,2018-10-12,삼성바이오로직스재감리및관련제도개선방안마련촉구,http://www.sisafocus.co.kr/news/articleView.html?idxno=193623
5651,2018-10-12,2018국감유동수삼성바이오로직스관련회계제도개선방안마련해야”,http://www.fntimes.com/html/view.php?ud=201810121451325716f09e13944d_18
5652,2018-10-12,삼성바이오로직스7500원161오른474500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810120470&t=NN
5653,2018-10-12,2018국감윤석헌금감원장삼성바이오로직스재감리연말까지완료,http://www.fntimes.com/html/view.php?ud=2018101215480433588a55064dd1_18
5654,2018-10-12,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스네이버포스코LG화학신라젠메디톡스상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31644
5655,2018-10-12,금감원장삼성바이오로직스재감리연말까지마무리,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181012141100008&did=1195m
5656,2018-10-12,국감뜨거운감자삼성바이오로직스윤석헌연내에재감리마무리할것,http://www.sporbiz.co.kr/news/articleView.html?idxno=278842
5657,2018-10-12,셀트리온삼성바이오로직스주가약간올라외국인은매도,http://www.businesspost.co.kr/BP?command=article_view&num=98701
5658,2018-10-12,금감원삼성바이오로직스분식회계혐의재감리연말까지마무리,http://www.kyeongin.com/main/view.php?key=20181012010004259
5659,2018-10-12,금감원장삼성바이오로직스재감리연말까지마무리”,http://news.kbs.co.kr/news/view.do?ncd=4049932&ref=A
5660,2018-10-12,2018국감윤석헌삼성바이오로직스재감리연내마무리,http://www.inews24.com/php/news_view.php?g_serial=1132183&g_menu=022300&rrf=nv
5661,2018-10-12,윤석헌금감원장삼성바이오로직스재감리연말내마무리할것,http://www.g-enews.com/ko-kr/news/article/news_all/201810121735409175c16aa2f016_1/article.html
5662,2018-10-12,2018국감윤석헌금감원장삼성바이오로직스재감리연말까지마무리”,http://www.newsway.co.kr/news/view?tp=1&ud=2018101217473225963
5663,2018-10-12,김병욱의원삼정회계법인삼성바이오로직스가치부풀려제일모직합병도와,http://www.choicenews.co.kr/news/articleView.html?idxno=45145
5664,2018-10-12,윤석헌삼성바이오로직스재감리연말까지결과낸다,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181012174537
5665,2018-10-12,재감리앞둔삼성바이오로직스가치평가산정방식두고정치권의견팽팽,http://www.g-enews.com/ko-kr/news/article/news_all/201810121718267121c16aa2f016_1/article.html
5666,2018-10-12,삼성바이오로직스재감리4조5000억주식평가가쟁점,http://www.isisa.net/news/articleView.html?idxno=111889
5667,2018-10-12,윤석헌삼성바이오로직스가치평가때할인율0이해못해,http://www.asiatime.co.kr/news/articleView.html?idxno=204849
5668,2018-10-12,윤석헌삼성바이오로직스분식회계재감리연말까지마무리,http://www.newsprime.co.kr/news/article.html?no=432550
5669,2018-10-12,금감원장삼성바이오로직스재감리연말까지마무리,http://www.dt.co.kr/contents.html?article_no=2018101202100158614003&ref=naver
5670,2018-10-12,윤석헌삼성바이오로직스재감리올해안에마무리한다,http://www.businesspost.co.kr/BP?command=article_view&num=98710
5671,2018-10-12,2018국감윤석헌삼성바이오로직스재감리연말까지마무리,http://www.asiatoday.co.kr/view.php?key=20181012010006707
5672,2018-10-12,금감원장삼성바이오로직스재감리연말까지마무리,http://imnews.imbc.com/news/2018/econo/article/4875183_22671.html
5673,2018-10-12,윤석헌금감원장삼성바이오로직스재감리연말까지마무리,http://daily.hankooki.com/lpage/economy/201810/dh20181012190121138110.htm
5674,2018-10-12,금감원장삼성바이오로직스재감리연말까지마무리”,https://cnbc.sbs.co.kr/article_hub/10000917518?division=NAVER
5675,2018-10-12,윤석헌삼성바이오로직스재감리연말까지마무리,http://www.segyefn.com/newsView/20181012004031?OutUrl=naver
5676,2018-10-14,삼성바이오로직스가치부풀린삼정회계법인에도덕적책임물어야,http://www.nbnnews.co.kr/news/articleView.html?idxno=186549
5677,2018-10-14,삼성바이오로직스평가액시장가치차이12조넘어,http://www.ebn.co.kr/news/view/958032
5678,2018-10-14,EBN오늘14일이슈종합위기의카드사②전업계vs은행계살아남는쪽은文대통령유럽순방길출국삼성바이오로직스평가액시장가치차이12조넘어등,http://www.ebn.co.kr/news/view/958051
5679,2018-10-15,삼성바이오로직스474500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810150074&t=NN
5680,2018-10-15,특징주삼성바이오로직스재감리불씨주가주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201810150913199311c642673384_1/article.html
5681,2018-10-15,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스네이버약세현대차포스코LG화학포스코켐텍나노스강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31654
5682,2018-10-15,삼성바이오로직스9500원2내린465000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810150457&t=NN
5683,2018-10-15,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차네이버하락포스코LG화학KB금융상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31665
5684,2018-10-15,셀트리온주가쌍끌이매도에급락삼성바이오로직스도내려,http://www.businesspost.co.kr/BP?command=article_view&num=98908
5685,2018-10-16,삼성바이오로직스1500원032오른466500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810160069&t=NN
5686,2018-10-16,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학네이버강세포스코CJENM약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31673
5687,2018-10-16,삼성바이오로직스2500원054오른467500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810160419&t=NN
5688,2018-10-16,관심주삼성전자SK하이닉스LG화학네이버셀트리온헬스케어나노스하락셀트리온삼성바이오로직스현대차포스코상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31688
5689,2018-10-16,셀트리온주가외국인매수로소폭올라삼성바이오로직스도강세,http://www.businesspost.co.kr/BP?command=article_view&num=99028
5690,2018-10-17,특징주삼성바이오로직스금감원재감리원안고수에도강세,http://www.asiatime.co.kr/news/articleView.html?idxno=205633
5691,2018-10-17,ET투자뉴스삼성바이오로직스_대형주의상승흐름에소외되면서현재225,http://www.etnews.com/20181017000026
5692,2018-10-17,특징주삼성바이오로직스재감리중징계소식에3대하락,http://view.asiae.co.kr/news/view.htm?idxno=2018101709374287163
5693,2018-10-17,삼성바이오로직스재감리도분식회계,http://imnews.imbc.com/news/2018/politic/article/4882538_22672.html
5694,2018-10-17,특징주삼성바이오로직스중징계전망에5대하락,http://biz.chosun.com/site/data/html_dir/2018/10/17/2018101700766.html
5695,2018-10-17,삼성바이오로직스가파른하락세로44만원선깨져재감리중징계가닥에,http://www.econonews.co.kr/news/articleView.html?idxno=39190
5696,2018-10-17,특징주삼성바이오로직스금감원중징계소식에급락,http://moneys.mt.co.kr/news/mwView.php?no=2018101709568099045
5697,2018-10-17,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차셀트리온헬스케어신라젠CJENM포스코켐텍강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31697
5698,2018-10-17,특징주삼성바이오로직스금감원중징계소식에급락,http://www.asiatoday.co.kr/view.php?key=20181017010009216
5699,2018-10-17,삼성바이오로직스실검은상승세주가는폭락세중징계등불안요소해소연내가능할까,http://news.imaeil.com/Finance/2018101710072223035
5700,2018-10-17,특징주삼성바이오로직스장초반하락중징계가능성↑”,http://www.mediapen.com/news/view/389319
5701,2018-10-17,특징주삼성바이오로직스금감원중징계전망에급락,http://www.fetv.co.kr/news/article.html?no=13901
5702,2018-10-17,삼성바이오로직스금감원회계재감리결과중징계전망에급락세,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181017.99099007337
5703,2018-10-17,삼성바이오로직스금감원중징계전망에5대하락,http://www.seoulwire.com/news/articleView.html?idxno=30115
5704,2018-10-17,삼성바이오로직스재감리중징계소식에64급락,http://news1.kr/articles/?3452461
5705,2018-10-17,삼성바이오로직스재감리도분식회계결론에주가6대하락,http://news20.busan.com/controller/newsController.jsp?newsId=20181017000063
5706,2018-10-17,특징주삼성바이오로직스재감리도중징계전망에6대하락,http://www.newsway.co.kr/news/view?tp=1&ud=2018101710202774050
5707,2018-10-17,금융감독원삼성바이오로직스재감리에서도고의분식회계중징계제재기존결론유지할듯,http://www.joongboo.com/news/articleView.html?idxno=1294624
5708,2018-10-17,특징주삼성바이오로직스금감원중징계소식에6대급락,http://www.viva100.com/main/view.php?key=20181017010005645
5709,2018-10-17,특징주삼성바이오로직스재감리중징계소식에급락,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018101710094483785
5710,2018-10-17,삼성바이오로직스분식회계중징계가능성에주가하락장초반6↓특징주,http://www.kukinews.com/news/article.html?no=594830
5711,2018-10-17,삼성바이오로직스재감리불확실성다시노출회계처리위반및고의성여부또수면위로,http://www.g-enews.com/ko-kr/news/article/news_all/201810171038006425c642673384_1/article.html
5712,2018-10-17,금감원삼성바이오로직스중징계유지하나재감리결과주목,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201810171046001&code=920100
5713,2018-10-17,삼성바이오로직스왜하락8월이후44만원선↓처음분식회계논란,http://www.inews24.com/php/news_view.php?g_serial=1133285&g_menu=050300&rrf=nv
5714,2018-10-17,삼성바이오로직스실검등장에주가눈길갑자기하락세,http://www.topstarnews.net/news/articleView.html?idxno=502363
5715,2018-10-17,금감원삼성바이오로직스재감리마무리단계,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10306337
5716,2018-10-17,코스피상승세지속중징계우려삼성바이오로직스급락,http://news.hankyung.com/article/2018101738046
5717,2018-10-17,특징주삼성바이오로직스중징계소식에하락세,http://news.mt.co.kr/mtview.php?no=2018101711132486654
5718,2018-10-17,금감원재감리도중징계삼성바이오로직스6대급락,http://news.hankyung.com/article/2018101738926
5719,2018-10-17,삼성바이오로직스주가급락금감원중징계가능성고개들어,http://www.businesspost.co.kr/BP?command=article_view&num=99108
5720,2018-10-17,금감원삼성바이오로직스중징계촛불정권예고된답정너,http://www.mediapen.com/news/view/389357
5721,2018-10-17,금감원삼성바이오로직스재감리마무리중징계불가피,http://www.fetv.co.kr/news/article.html?no=13914
5722,2018-10-17,삼성바이오로직스중징계전망에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=335558
5723,2018-10-17,삼성바이오로직스증선위공시누락결론에행정소송제기,http://news1.kr/articles/?3452691
5724,2018-10-17,삼성바이오로직스금융위에행정소송법원서도고의성가린다,http://biz.chosun.com/site/data/html_dir/2018/10/17/2018101701695.html
5725,2018-10-17,삼성바이오로직스증권선물위원회에행정소송제기,http://www.newspim.com/news/view/20181017000380
5726,2018-10-17,삼성바이오로직스증선위고의공시누락판단에행정소송,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181017104200017&did=1195m
5727,2018-10-17,삼성바이오로직스증선위에콜옵션공시고의누락행정소송제기,http://biz.newdaily.co.kr/site/data/html/2018/10/17/2018101700135.html
5728,2018-10-17,금감원삼성바이오로직스분식회계결론유지할듯,http://www.ebn.co.kr/news/view/958512
5729,2018-10-17,삼성바이오로직스공시고의누락관련행정소송,http://news.kbs.co.kr/news/view.do?ncd=4053396&ref=A
5730,2018-10-17,삼성바이오로직스재감리도중징계결론사실이냐,http://www.newsfc.co.kr/news/articleView.html?idxno=33962
5731,2018-10-17,윤석헌삼성바이오로직스재감리서도기존조치안고수시사,http://www.inews24.com/php/news_view.php?g_serial=1133400&g_menu=022300&rrf=nv
5732,2018-10-17,삼성바이오로직스고의공시누락놓고증권선물위에행정소송,http://www.businesspost.co.kr/BP?command=article_view&num=99139
5733,2018-10-17,삼성바이오로직스증선위고의공시누락판단부당행정소송제기,http://www.viva100.com/main/view.php?key=20181017010005885
5734,2018-10-17,삼성바이오로직스증선위고의공시누락불복행정소송제기,http://www.ekn.kr/news/article.html?no=392039
5735,2018-10-17,삼성바이오로직스증선위금감원결정에행정소송제기,http://www.techholic.co.kr/news/articleView.html?idxno=178762
5736,2018-10-17,금감원삼성바이오로직스재감리에도중징계유지가닥,http://www.newsis.com/view/?id=NISX20181017_0000445512&cID=10401&pID=10400
5737,2018-10-17,회계처리정당성입증할것삼성바이오로직스행정소송제기,http://www.newsis.com/view/?id=NISX20181017_0000445513&cID=13001&pID=13000
5738,2018-10-17,삼성바이오로직스17500원374내린450000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810170362&t=NN
5739,2018-10-17,삼성바이오로직스고의공시누락행정소송,http://www.smedaily.co.kr/news/articleView.html?idxno=78931
5740,2018-10-17,금감원과삼성바이오로직스분식회계공방전선전포고직전,http://www.businesspost.co.kr/BP?command=article_view&num=99144
5741,2018-10-17,삼성바이오로직스증선위공시누락위법판단에행정소송,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003365747
5742,2018-10-17,관심주삼성전자SK하이닉스셀트리온현대차포스코LG화학SK텔레콤상승삼성바이오로직스포스코켐텍에이치엘비나노스하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31706
5743,2018-10-17,금감원주가부풀린삼성바이오로직스회계기준중대위반,http://www.isisa.net/news/articleView.html?idxno=111935
5744,2018-10-17,삼성바이오로직스증선위고의공시누락판단에행정소송,http://www.etnews.com/20181017000379
5745,2018-10-17,뉴욕훈풍코스피활짝IT껑충vs삼성바이오로직스대우조선해양급락,http://www.choicenews.co.kr/news/articleView.html?idxno=45264
5746,2018-10-17,삼성바이오로직스재감리도중징계가능성에주가급락,http://www.kpinews.co.kr/news/articleView.html?idxno=82726
5747,2018-10-17,삼성바이오로직스고의공시누락행정소송,http://www.ytn.co.kr/_ln/0102_201810171647047986
5748,2018-10-17,삼성바이오로직스고의공시누락관련행정소송제기,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018101716465649255
5749,2018-10-17,삼성바이오로직스금감원중징계전망에나홀로하락,http://www.newsis.com/view/?id=NISX20181017_0000445771&cID=10401&pID=10400
5750,2018-10-17,삼성바이오로직스분식회계재감리서도중징계예고,https://cnbc.sbs.co.kr/article_hub/10000917960?division=NAVER
5751,2018-10-17,삼성바이오로직스공시누락고의아니다행정소송제기,http://www.econovill.com/news/articleView.html?idxno=348497
5752,2018-10-17,삼성바이오로직스고의공시누락판단증선위에행정소송,http://www.newstomato.com/ReadNews.aspx?no=852214
5753,2018-10-17,분식회계의혹삼성바이오로직스중징계로재감리마무리될듯,http://www.4th.kr/news/articleView.html?idxno=6341
5754,2018-10-17,막바지치닫는금감원삼성바이오로직스의회계논란,http://daily.hankooki.com/lpage/economy/201810/dh20181017182202138110.htm
5755,2018-10-17,삼성바이오로직스회계처리정당증선위에행정소송,http://news.mt.co.kr/mtview.php?no=2018101718270492584
5756,2018-10-17,삼성바이오로직스주가재감리리스크에급락셀트리온은올라,http://www.businesspost.co.kr/BP?command=article_view&num=99196
5757,2018-10-17,삼성바이오로직스증선위고의공시누락판단에행정소송제기,http://www.sporbiz.co.kr/news/articleView.html?idxno=280305
5758,2018-10-17,삼성바이오로직스바이오시밀러임랄디유럽출시전세계매출1위의약품,http://www.asiatime.co.kr/news/articleView.html?idxno=205873
5759,2018-10-17,삼성바이오로직스증선위고의공시누락판단에행정소송,http://news.mk.co.kr/newsRead.php?year=2018&no=648625
5760,2018-10-17,금감원삼성바이오로직스재감리도고의분식회계가닥,http://news.jtbc.joins.com/html/801/NB11711801.html
5761,2018-10-17,삼성바이오로직스증선위고의공시누락판단에행정소송,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810170479&t=NN
5762,2018-10-18,뉴스투데이투자노트삼성바이오로직스재감리회복세바이오관련주에찬물,http://www.news2day.co.kr/112693
5763,2018-10-18,제약톡톡금감원회계기준위반”vs삼성바이오로직스법적대응”,http://news.heraldcorp.com/view.php?ud=20181018000077
5764,2018-10-18,삼성바이오로직스2000원044내린448000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810180084&t=NN
5765,2018-10-18,삼성바이오로직스증선위에행정소송제기,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181018084937
5766,2018-10-18,특징주삼성바이오로직스회계처리위반아니다”행정소송외인매수주가반전주목,http://www.g-enews.com/ko-kr/news/article/news_all/20181018091034665c642673384_1/article.html
5767,2018-10-18,삼성바이오로직스전날하락이어하락여전증선위상대로행정소송제기,http://www.econonews.co.kr/news/articleView.html?idxno=39269
5768,2018-10-18,특징주삼성바이오로직스중징계우려에이틀연속하락,http://www.asiatime.co.kr/news/articleView.html?idxno=205907
5769,2018-10-18,특징주삼성바이오로직스중징계예상에이틀째약세,http://moneys.mt.co.kr/news/mwView.php?no=2018101809238084662
5770,2018-10-18,특징주삼성바이오로직스중징계우려에이틀연속하락,http://www.fetv.co.kr/news/article.html?no=13961
5771,2018-10-18,특징주삼성바이오로직스이틀째약세지속,http://www.seoulfn.com/news/articleView.html?idxno=322362
5772,2018-10-18,특징주삼성바이오로직스중징계우려에약세,http://www.ebn.co.kr/news/view/958590
5773,2018-10-18,특징주삼성바이오로직스2거래일연속약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1675468
5774,2018-10-18,삼성바이오로직스금감원중징계결정유지에2거래일연속하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=335697
5775,2018-10-18,투자자관심주식삼성바이오로직스알파고분석,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810180192&t=NN
5776,2018-10-18,단독삼성바이오로직스방패나선김앤장행정통변호사7인중무장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1675482
5777,2018-10-18,삼성바이오로직스재감리에서도회계처리기준위반삼바분식회계혐의재정리,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10306546
5778,2018-10-18,코스피기관외국인팔자에하락세셀트리온삼성바이오로직스SK텔레콤삼성물산등은오름세,http://www.econonews.co.kr/news/articleView.html?idxno=39328
5779,2018-10-18,삼성바이오로직스6000원133내린444000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810180409&t=NN
5780,2018-10-18,삼성바이오로직스금감원고의분식회계고수에어떻게대응할까,http://www.businesspost.co.kr/BP?command=article_view&num=99288
5781,2018-10-18,삼성바이오로직스주가재감리리스크로또하락셀트리온도내려,http://www.businesspost.co.kr/BP?command=article_view&num=99325
5782,2018-10-19,삼성바이오로직스글로벌경제지포춘지포춘50기업에선정,http://www.fnnews.com/news/201810190812046981
5783,2018-10-19,삼성바이오로직스알파벳아마존등과함께퓨처50기업으로선정,http://news.mk.co.kr/newsRead.php?year=2018&no=651999
5784,2018-10-19,삼성바이오로직스포춘퓨쳐50기업선정,http://www.edaily.co.kr/news/newspath.asp?newsid=01630166619374560
5785,2018-10-19,삼성바이오로직스포춘지퓨처50기업에선정,http://www.newspim.com/news/view/20181019000071
5786,2018-10-19,삼성바이오로직스포춘誌Future50기업선정,http://www.newsway.co.kr/news/view?tp=1&ud=2018101908372831006
5787,2018-10-19,삼성바이오로직스포춘지퓨처50기업선정,http://www.newsworks.co.kr/news/articleView.html?idxno=303840
5788,2018-10-19,삼성바이오로직스포춘미래유망기업에선정,http://news.hankyung.com/article/2018101918186
5789,2018-10-19,삼성바이오로직스포춘선정미래성장50대기업에선정,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181019082708
5790,2018-10-19,삼성바이오로직스포춘Future50기업선정,http://medipana.com/news/news_viewer.asp?NewsNum=226870&MainKind=A&NewsKind=5&vCount=12&vKind=1
5791,2018-10-19,삼성바이오로직스포춘Future50기업선정,http://www.biospectator.com/view/news_view.php?varAtcId=6388
5792,2018-10-19,삼성바이오로직스5000원113내린439000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810190078&t=NN
5793,2018-10-19,삼성바이오로직스포춘지퓨처50기업에선정,http://www.asiatime.co.kr/news/articleView.html?idxno=206152
5794,2018-10-19,삼성바이오로직스아마존알리바바와함께포춘퓨쳐50기업선정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018101908584220103
5795,2018-10-19,삼성바이오로직스미국경제지포춘Future50기업선정,http://www.ajunews.com/view/20181019085951004
5796,2018-10-19,특징주삼성바이오로직스재감리vs행정소송불확실성주가주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201810190917464198c642673384_1/article.html
5797,2018-10-19,삼성바이오로직스전세계50대유망기업선정매출작지만잠재력,http://view.asiae.co.kr/news/view.htm?idxno=2018101909193563510
5798,2018-10-19,삼성바이오로직스포춘Future50기업선정,http://www.whosaeng.com/sub_read.html?uid=105280§ion=sc5
5799,2018-10-19,삼성바이오로직스미국포천지유망기업50에선정,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181019036400017&did=1195m
5800,2018-10-19,삼성바이오로직스포춘誌Future50기업으로선정돼,http://www.m-i.kr/news/articleView.html?idxno=461932
5801,2018-10-19,삼성바이오로직스네이버셀트리온미국포천지세계유망기업50선정주가영향받나,http://news.imaeil.com/Economy/2018101909401992141
5802,2018-10-19,삼성바이오로직스알파벳아마존과포춘글로벌유망50대기업선정돼,http://www.etoday.co.kr/news/section/newsview.php?idxno=1676075
5803,2018-10-19,삼성바이오로직스포춘미래시장선도50대기업선정,http://www.newsis.com/view/?id=NISX20181019_0000447534&cID=13001&pID=13000
5804,2018-10-19,삼성바이오로직스포춘지선정50개유망기업포함,http://biz.chosun.com/site/data/html_dir/2018/10/19/2018101900824.html
5805,2018-10-19,증선위의사록에드러난삼성바이오로직스의민낯,http://www.ohmynews.com/NWS_Web/View/at_pg.aspx?CNTN_CD=A0002480522&CMPT_CD=P0010&utm_source=naver&utm_medium=newsearch&utm_campaign=naver_news
5806,2018-10-19,삼성바이오로직스3거래일연속하락세44만원선밑으로,http://www.econonews.co.kr/news/articleView.html?idxno=39400
5807,2018-10-19,삼성바이오로직스셀트리온네이버포천유망기업50에선정,http://www.sedaily.com/NewsView/1S5Z25G824
5808,2018-10-19,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차포스코KB금융신라젠CJENM포스코켐텍약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31730
5809,2018-10-19,삼성바이오로직스포춘지선정50대유망기업선정,http://daily.hankooki.com/lpage/ittech/201810/dh20181019102949145630.htm
5810,2018-10-19,삼성바이오로직스포춘지Future50기업선정,http://www.ftoday.co.kr/news/articleView.html?idxno=103590
5811,2018-10-19,삼성바이오로직스와셀트리온나란히포춘50에선정,http://www.fnnews.com/news/201810191044552621
5812,2018-10-19,삼성바이오로직스미국포춘유망기업50선정,http://www.seoulfn.com/news/articleView.html?idxno=322504
5813,2018-10-19,삼성바이오로직스포춘지Future50기업선정,http://www.ekn.kr/news/article.html?no=392388
5814,2018-10-19,삼성바이오로직스포춘이꼽은유망기업50에선정,http://www.asiatoday.co.kr/view.php?key=20181019010010705
5815,2018-10-19,삼성바이오로직스미국포천지유망기업50에선정,http://news.mk.co.kr/newsRead.php?year=2018&no=652516
5816,2018-10-19,셀트리온삼성바이오로직스네이버포춘퓨처50선정,http://news1.kr/articles/?3454660
5817,2018-10-19,보도참고삼성바이오로직스의회계처리에대한재감리결과처리절차,http://www.korea.kr/briefing/pressReleaseView.do?newsId=156299480
5818,2018-10-19,삼성바이오로직스포춘50기업선정아마존알리바바와어깨나란히,http://www.mdtoday.co.kr/mdtoday/index.html?no=335947
5819,2018-10-19,삼성바이오로직스분식회계재감리31일증선위상정된다,http://www.inews24.com/php/news_view.php?g_serial=1134001&g_menu=022300&rrf=nv
5820,2018-10-19,포춘지삼성바이오로직스네이버셀트리온유망기업선정,http://www.whitepaper.co.kr/news/articleView.html?idxno=122059
5821,2018-10-19,삼성바이오로직스재감리결과나왔다31일증선위상정,http://www.kukinews.com/news/article.html?no=595731
5822,2018-10-19,삼성바이오로직스구글아마존과포춘지50대유망기업선정,http://www.econovill.com/news/articleView.html?idxno=348634
5823,2018-10-19,삼성바이오로직스글로벌경제지포춘지포춘50기업선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1240685
5824,2018-10-19,증선위삼성바이오로직스회계부정제재빠르면31일결론,http://www.newsway.co.kr/news/view?tp=1&ud=2018101911303086690
5825,2018-10-19,삼성바이오로직스포춘지세계50대유망기업선정,http://www.seoul.co.kr/news/newsView.php?id=20181019500066&wlog_tag3=naver
5826,2018-10-19,증선위31일삼성바이오로직스재감리안건논의,http://biz.chosun.com/site/data/html_dir/2018/10/19/2018101901226.html
5827,2018-10-19,삼성바이오로직스분식회계혐의31일증선위에서재심,http://www.nocutnews.co.kr/news/5047492
5828,2018-10-19,증선위삼성바이오로직스재감리오는31일논의,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10306752
5829,2018-10-19,이데일리N삼성바이오로직스美포천지유망기업50에선정外,http://www.edaily.co.kr/news/newspath.asp?newsid=02774886619374560
5830,2018-10-19,삼성바이오로직스회계부정혐의오는31일증선위재심열린다,http://www.mdtoday.co.kr/mdtoday/index.html?no=335966
5831,2018-10-19,삼성바이오로직스글로벌경제지포춘의Future50기업에선정,http://www.viva100.com/main/view.php?key=20181019010006742
5832,2018-10-19,증선위재감리심의속도삼성바이오로직스행정소송으로맞불,http://www.g-enews.com/ko-kr/news/article/news_all/201810191303054167c642673384_1/article.html
5833,2018-10-19,삼성바이오로직스감리위생략하고증선위상정된다,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1531631
5834,2018-10-19,증선위31일삼성바이오로직스재감리안건심의,http://www.seoulwire.com/news/articleView.html?idxno=30460
5835,2018-10-19,증선위31일삼성바이오로직스재감리안건상정,http://www.seoulfn.com/news/articleView.html?idxno=322523
5836,2018-10-19,삼성바이오로직스포춘퓨처50기업선정,http://www.etnews.com/20181019000158
5837,2018-10-19,증선위31일삼성바이오로직스재감리안건논의,http://www.econovill.com/news/articleView.html?idxno=348660
5838,2018-10-19,삼성바이오로직스분식회계의혹2라운드금융위31일증선위상정,http://www.seoul.co.kr/news/newsView.php?id=20181019500097&wlog_tag3=naver
5839,2018-10-19,금융위오는31일삼성바이오로직스재감리논의,http://moneys.mt.co.kr/news/mwView.php?no=2018101914238011920
5840,2018-10-19,금융위31일증선위삼성바이오로직스분식회계안건상정,http://www.intn.co.kr/news/articleView.html?idxno=2002377
5841,2018-10-19,증선위31일삼성바이오로직스재감리심의,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181019.99099008635
5842,2018-10-19,삼성바이오로직스증선위심의제재수위조만간결론,http://www.segye.com/content/html/2018/10/19/20181019002315.html?OutUrl=naver
5843,2018-10-19,네이버셀트리온삼성바이오로직스포천유망기업50에선정,http://news.hankyung.com/article/2018101937447
5844,2018-10-19,삼성바이오로직스9000원203오른453000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810190414&t=NN
5845,2018-10-19,포춘미래유망기업50네이버6위셀트리온17위삼성바이오로직스47위,http://www.econovill.com/news/articleView.html?idxno=348671
5846,2018-10-19,증선위31일정례회의서삼성바이오로직스재감리안건논의한다,http://www.mediapen.com/news/view/389955
5847,2018-10-19,포춘유망기업50네이버6위셀트리온17위삼성바이오로직스47위선정,http://www.seoulwire.com/news/articleView.html?idxno=30502
5848,2018-10-19,네이버포춘선정유망기업6위셀트리온삼성바이오로직스도순위권,http://www.upinews.kr/news/newsview.php?ncode=1065594628133270
5849,2018-10-19,금융위삼성바이오로직스재감리서두르는데왜,http://www.mediasr.co.kr/news/articleView.html?idxno=49731
5850,2018-10-19,세계미래유망기업톱50네이버6위셀트리온삼성바이오로직스포함페이스북순위는,http://www.greened.kr/news/articleView.html?idxno=79606
5851,2018-10-19,증권위오는31일삼성바이오로직스재감리안건논의치열한공방예상,http://www.topstarnews.net/news/articleView.html?idxno=504718
5852,2018-10-19,증선위31일분식회계의혹삼성바이오로직스재감리안건논의,http://www.choicenews.co.kr/news/articleView.html?idxno=45329
5853,2018-10-19,관심주SK하이닉스셀트리온삼성바이오로직스포스코LG화학SK텔레콤상승삼성전자현대차KB금융나노스하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31741
5854,2018-10-19,셀트리온삼성바이오로직스장초반부진딛고강세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=336028
5855,2018-10-19,삼성바이오로직스분식회계혐의31일증선위에서재심,https://cnbc.sbs.co.kr/article_hub/10000918237?division=NAVER
5856,2018-10-19,삼성바이오로직스재감리안건31일증선위상정감리위생략,http://www.newsprime.co.kr/news/article.html?no=433263
5857,2018-10-19,삼성바이오로직스셀트리온포춘50선정,http://www.fnnews.com/news/201810191719041762
5858,2018-10-19,셀트리온주가쌍끌이매수에급등삼성바이오로직스도올라,http://www.businesspost.co.kr/BP?command=article_view&num=99447
5859,2018-10-19,금융위증권선물위31일열고삼성바이오로직스재감리결과논의,http://www.businesspost.co.kr/BP?command=article_view&num=99441
5860,2018-10-19,네이버포춘선정50대유망기업6위셀트리온삼성바이오로직스순위권,http://www.kyeongin.com/main/view.php?key=20181019010006961
5861,2018-10-19,뉴스8단신증선위31일삼성바이오로직스재감리안건상의,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3663515
5862,2018-10-19,네이버셀트리온삼성바이오로직스포춘50선정,http://www.g-enews.com/ko-kr/news/article/news_all/20181019203154472396aa5dcdf1_1/article.html
5863,2018-10-19,삼성바이오로직스분식회계의혹오는31일증선위상정,http://www.sportsseoul.com/news/read/691015
5864,2018-10-20,코스피기관사자에우상향2150선회복SK하이닉스셀트리온삼성바이오로직스LG화학SK텔레콤등상승전환,http://www.econonews.co.kr/news/articleView.html?idxno=39526
5865,2018-10-20,삼성바이오로직스분식회계논란정치적의심거두고객관적으로판단해야,http://www.techholic.co.kr/news/articleView.html?idxno=178819
5866,2018-10-21,삼성바이오로직스회계논란이재용대법원판결에도영향줄까,http://www.businesspost.co.kr/BP?command=article_view&num=99497
5867,2018-10-21,김태한삼성바이오로직스분식회계논란마무리도책임지나,http://www.businesspost.co.kr/BP?command=article_view&num=99496
5868,2018-10-21,삼성바이오로직스포춘지Future50기업선정,http://www.kgdm.co.kr/news/articleView.html?idxno=611625
5869,2018-10-21,금감원과삼성바이오로직스의회계공방퇴로가안보인다,http://www.businesspost.co.kr/BP?command=article_view&num=99536
5870,2018-10-21,삼성바이오로직스포춘誌Future50기업에선정,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1532137
5871,2018-10-21,삼성바이오로직스포춘지유망기업선정기염,http://www.kgnews.co.kr/news/articleView.html?idxno=529675
5872,2018-10-21,포춘誌선정퓨처50기업삼성바이오로직스,http://www.kyeongin.com/main/view.php?key=20181021010007339
5873,2018-10-21,셀트리온삼성바이오로직스美포천지유망기업눈도장,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=773802
5874,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.newspim.com/news/view/20181022000049
5875,2018-10-22,삼성바이오로직스관세청AEO인증획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01554726619375544
5876,2018-10-22,삼성바이오로직스수출입안전관리우수기업인증,http://www.sedaily.com/NewsView/1S60FJRCL5
5877,2018-10-22,삼성바이오로직스수출입안전관리인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=226974&MainKind=A&NewsKind=5&vCount=12&vKind=1
5878,2018-10-22,삼성바이오로직스AEO인증획득신속통관혜택으로경쟁력↑,http://news.mk.co.kr/newsRead.php?year=2018&no=656547
5879,2018-10-22,삼성바이오로직스5500원121내린447500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810220050&t=NN
5880,2018-10-22,삼성바이오로직스AEO인증수출입경쟁력↑,http://view.asiae.co.kr/news/view.htm?idxno=2018102209064143334
5881,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.m-i.kr/news/articleView.html?idxno=462403
5882,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2018102209104899559
5883,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://news.mt.co.kr/mtview.php?no=2018102209064822752
5884,2018-10-22,특징주삼성바이오로직스3분기실적발표앞두고약세,http://www.g-enews.com/ko-kr/news/article/news_all/201810220914321571c16aa2f016_1/article.html
5885,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.sedaily.com/NewsView/1S60FF6YGZ
5886,2018-10-22,삼성바이오로직스신속통관AEO인증획득,http://www.ebn.co.kr/news/view/958983
5887,2018-10-22,삼성바이오로직스수출입안전관리우수인증획득,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181022035200017&did=1195m
5888,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증,http://www.metroseoul.co.kr/news/newsview?newscd=2018102200024
5889,2018-10-22,삼성바이오로직스수출입안전관리우수업체인증신속통관혜택,http://www.sporbiz.co.kr/news/articleView.html?idxno=281415
5890,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증,http://www.dailian.co.kr/news/view/746497/?sc=naver
5891,2018-10-22,삼성바이오로직스AEO인증획득수출입경쟁력개선,http://www.newsworks.co.kr/news/articleView.html?idxno=304323
5892,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181022090534
5893,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.medigatenews.com/news/2921107335
5894,2018-10-22,삼성바이오로직스AEO인증획득수출입경쟁력개선기대,http://daily.hankooki.com/lpage/ittech/201810/dh20181022094139145630.htm
5895,2018-10-22,삼성바이오로직스수출입안전관리우수인증획득,http://www.newsis.com/view/?id=NISX20181022_0000449216&cID=13001&pID=13000
5896,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.inews24.com/php/news_view.php?g_serial=1134544&g_menu=022620&rrf=nv
5897,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체AEO인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1676765
5898,2018-10-22,인천세관삼성바이오로직스등신규AEO공인인증,http://www.ksg.co.kr/news/main_newsView.jsp?bbsID=news&bbsCategory=KSG&categoryCode=all&backUrl=main_news&pNum=119533
5899,2018-10-22,삼성바이오로직스수출입안전우수업체인증,http://www.asiatoday.co.kr/view.php?key=20181022010011797
5900,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증,http://www.fetv.co.kr/news/article.html?no=14150
5901,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102209530357000
5902,2018-10-22,삼성바이오로직스미중일에서통관우대받는다,http://www.straightnews.co.kr/news/articleView.html?idxno=37329
5903,2018-10-22,코스피기관외국인팔자에하락출발낙폭은좁혀SK하이닉스셀트리온삼성바이오로직스포스코삼성물산등약세,http://www.econonews.co.kr/news/articleView.html?idxno=39670
5904,2018-10-22,삼성바이오로직스무역공급망안정성확보해적극해외수주나선다,http://www.econovill.com/news/articleView.html?idxno=348793
5905,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061498
5906,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://news.hankyung.com/article/201810220818f
5907,2018-10-22,삼성바이오로직스관세청AEO인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1241184
5908,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.ajunews.com/view/20181022134835446
5909,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://biz.newdaily.co.kr/site/data/html/2018/10/22/2018102200019.html
5910,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.segye.com/content/html/2018/10/22/20181022002683.html?OutUrl=naver
5911,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.etnews.com/20181022000339
5912,2018-10-22,국고처신학수종목상담삼성바이오로직스207940,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810200049&t=NNv
5913,2018-10-22,삼성바이오로직스수출입안전관리우수인증,http://www.seoulfn.com/news/articleView.html?idxno=322718
5914,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.ekn.kr/news/article.html?no=392718
5915,2018-10-22,삼성바이오로직스AEO인증글로벌사업경쟁력증대,http://weekly.cnbnews.com/news/article.html?no=125708
5916,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.fnnews.com/news/201810221538188676
5917,2018-10-22,삼성바이오로직스수출입안전관리우수기업으로국제인증받아,http://www.businesspost.co.kr/BP?command=article_view&num=99596
5918,2018-10-22,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스포스코하락현대차LG화학SK텔레콤상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31770
5919,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.dt.co.kr/contents.html?article_no=2018102202109931102005&ref=naver
5920,2018-10-22,뉴투분석삼성바이오로직스회계이슈제2의삼성전자출현막는다,http://www.news2day.co.kr/112948
5921,2018-10-22,삼성바이오로직스주가쌍끌이매도로하락셀트리온도내려,http://www.businesspost.co.kr/BP?command=article_view&num=99649
5922,2018-10-22,50대미래유망기업선정삼성바이오로직스,http://www.dailymedi.com/detail.php?number=836000&thread=22r05
5923,2018-10-22,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1532669
5924,2018-10-22,삼성바이오로직스수출입안전관리우수,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=773996
5925,2018-10-23,삼성바이오로직스분식회계2차공방연내마무리될까,http://www.newsworks.co.kr/news/articleView.html?idxno=304649
5926,2018-10-23,오늘의증시삼성바이오로직스LG생활건강실적발표10월23일,http://www.etoday.co.kr/news/section/newsview.php?idxno=1677304
5927,2018-10-23,삼성바이오로직스7000원157내린440000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810230064&t=NN
5928,2018-10-23,특징주삼성바이오로직스3분기실적발표초읽기외인팔자공세에주가흔들,http://www.g-enews.com/ko-kr/news/article/news_all/201810230915444622c642673384_1/article.html
5929,2018-10-23,삼성바이오로직스전날이어3대낙폭바이오주하락과흐름같이해,http://www.econonews.co.kr/news/articleView.html?idxno=39783
5930,2018-10-23,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스포스코네이버신라젠CJENM포스코켐텍약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31777
5931,2018-10-23,셀트리온삼성바이오로직스등바이오주급락세,http://www.dailymedi.com/detail.php?number=836036&thread=22r05
5932,2018-10-23,코스피기관외국인팔자낙폭키워SK하이닉스셀트리온삼성바이오로직스포스코삼성물산등부진,http://www.econonews.co.kr/news/articleView.html?idxno=39833
5933,2018-10-23,삼성바이오로직스전일대비약8하락한411000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810230331&t=NN
5934,2018-10-23,삼성바이오로직스셀트리온모두6대낙폭으로바이오주급락,http://www.econonews.co.kr/news/articleView.html?idxno=39842
5935,2018-10-23,삼성바이오로직스수출입안전관리우수공인업체인증획득,http://sports.khan.co.kr/news/sk_index.html?art_id=201810231440013&sec_id=561801&pt=nv
5936,2018-10-23,코스피하락세삼성바이오로직스등시총상위종목↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=336386
5937,2018-10-23,삼성바이오로직스제17차세계한상대회홍보관투어참여,http://www.m-i.kr/news/articleView.html?idxno=463142
5938,2018-10-23,삼성바이오로직스29500원66내린417500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810230521&t=NN
5939,2018-10-23,한상대회참가자들삼성바이오로직스방문,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181023169900065&did=1196m
5940,2018-10-23,한상대회참가자들삼성바이오로직스방문,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181023169800065&did=1196m
5941,2018-10-23,삼성바이오로직스올해3Q영업익104억전년비489↓,http://www.newspim.com/news/view/20181023000470
5942,2018-10-23,실적속보삼성바이오로직스별도20183Q영업이익105억원전년비49감소,http://www.fntimes.com/html/view.php?ud=2018102315435980345dfa86c30d_18
5943,2018-10-23,컨센부합삼성바이오로직스올해3Q영업익104억컨센비38↓,http://www.itooza.com/common/iview.php?no=2018102315442818082
5944,2018-10-23,삼성바이오로직스3Q영업익105억원전년比49감소1보,http://news1.kr/articles/?3457881
5945,2018-10-23,삼성바이오로직스3분기영업이익104억전년比489↓,http://news.hankyung.com/article/2018102358896
5946,2018-10-23,삼성바이오로직스3분기영업익105억원49감소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181023129200008&did=1195m
5947,2018-10-23,삼성바이오로직스3Q영업이익105억전년比반토막,http://news.mt.co.kr/mtview.php?no=2018102315462224162
5948,2018-10-23,삼성바이오로직스3분기매출액1011억원영업이익105억원기록,http://www.fnnews.com/news/201810231548003398
5949,2018-10-23,삼성바이오로직스3Q영업이익104억원전년비48감소,http://www.sedaily.com/NewsView/1S60WVML0W
5950,2018-10-23,삼성바이오로직스3Q영업익105억전년比4887↓,http://www.edaily.co.kr/news/newspath.asp?newsid=03870406619375872
5951,2018-10-23,삼성바이오로직스3Q영업익105억전년비489↓,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181023155034
5952,2018-10-23,삼성바이오로직스2018년3분기매출1011억전기대비194감소,http://www.newsway.co.kr/news/view?tp=1&ud=2018102315545613225
5953,2018-10-23,삼성바이오로직스3분기영업이익1047억전년동기比49↓,http://www.nspna.com/news/?mode=view&newsid=313289
5954,2018-10-23,삼성바이오로직스전날보다660빠진41만7500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=556640
5955,2018-10-23,삼성바이오로직스올3분기영업익105억원전년대비557↓,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102315450817498
5956,2018-10-23,삼성바이오로직스매출영업익두자릿수감소,http://medipana.com/news/news_viewer.asp?NewsNum=227105&MainKind=A&NewsKind=5&vCount=12&vKind=1
5957,2018-10-23,삼성바이오로직스3분기매출1011억원영업이익105억원기록,http://www.ekn.kr/news/article.html?no=393102
5958,2018-10-23,삼성바이오로직스3Q영업익105억전년比49↓,http://www.ebn.co.kr/news/view/959225
5959,2018-10-23,삼성바이오로직스3Q영업익105억전분기比557↓,http://view.asiae.co.kr/news/view.htm?idxno=2018102316053124016
5960,2018-10-23,삼성바이오로직스영업익4887↓가동률하락원인상보,http://www.edaily.co.kr/news/newspath.asp?newsid=03991766619375872
5961,2018-10-23,혹독한3분기보낸삼성바이오로직스4분기악재떨칠까,http://www.newstomato.com/ReadNews.aspx?no=853309
5962,2018-10-23,삼성바이오로직스3분기영업익105억원전년동기대비49감소,http://www.ceoscoredaily.com/news/article.html?no=47318
5963,2018-10-23,삼성바이오로직스3분기영업익105억4887↓,http://view.asiae.co.kr/news/view.htm?idxno=2018102316092562337
5964,2018-10-23,삼성바이오로직스3분기영업익105억원전년比488감소,http://biz.chosun.com/site/data/html_dir/2018/10/23/2018102302242.html
5965,2018-10-23,삼성바이오로직스계열사와예적금거래,http://view.asiae.co.kr/news/view.htm?idxno=2018102316104280675
5966,2018-10-23,삼성바이오로직스3분기매출1011억영업이익105억,http://www.fetv.co.kr/news/article.html?no=14257
5967,2018-10-23,공시삼성바이오로직스3분기영업이익105억원전년대비4887감소,http://www.g-enews.com/ko-kr/news/article/news_all/201810231611067761c642673384_1/article.html
5968,2018-10-23,삼성바이오로직스12공장가동률하락에실적곤두박질,http://www.digitaltoday.co.kr/news/articleView.html?idxno=203859
5969,2018-10-23,삼성바이오로직스3Q영업이익105억전년比49↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1677698
5970,2018-10-23,삼성바이오로직스올3분기매출1011억원전분기대비194↓,http://www.sisaon.co.kr/news/articleView.html?idxno=78525
5971,2018-10-23,공시삼성바이오로직스3Q영업익105억원전년比49↓,http://www.newsway.co.kr/news/view?tp=1&ud=2018102316175985137
5972,2018-10-23,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학SK텔레콤포스코신라젠CJENM하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31792
5973,2018-10-23,삼성바이오로직스3분기영업이익105억원전년동기대비49↓,http://news.mk.co.kr/newsRead.php?year=2018&no=661219
5974,2018-10-23,삼성바이오로직스3Q영업이익반토막왜,http://www.inews24.com/php/news_view.php?g_serial=1135046&g_menu=022620&rrf=nv
5975,2018-10-23,삼성바이오로직스3분기영업익105억전년比489↓,http://biz.newdaily.co.kr/site/data/html/2018/10/23/2018102300177.html
5976,2018-10-23,삼성바이오로직스2018년3분기매출1011억영업이익105억,http://www.newsworks.co.kr/news/articleView.html?idxno=305003
5977,2018-10-23,한국증시패닉IT셀트리온삼성바이오로직스직격탄,http://www.choicenews.co.kr/news/articleView.html?idxno=45419
5978,2018-10-23,삼성바이오로직스3분기영업익105억전년比488↓,http://www.newsis.com/view/?id=NISX20181023_0000451207&cID=13001&pID=13000
5979,2018-10-23,삼성바이오로직스2018년3분기매출1011억영업이익105억,http://www.medigatenews.com/news/2119720525
5980,2018-10-23,삼성바이오로직스3분기영업익105억원49감소종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181023129251008&did=1195m
5981,2018-10-23,삼성바이오로직스3분기영업익104억원전년비488↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810230542&t=NN
5982,2018-10-23,삼성바이오로직스3Q영업익105억전년比49↓,http://www.dailian.co.kr/news/view/746993/?sc=naver
5983,2018-10-23,삼성바이오로직스3Q영업익뚝공장가동률하락,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181023163912
5984,2018-10-23,삼성바이오로직스3Q실적뚝생산변경가동률하락탓상보,http://news1.kr/articles/?3457974
5985,2018-10-23,삼성바이오로직스3분기영업익105억원전년比49↓,http://daily.hankooki.com/lpage/ittech/201810/dh20181023164432145630.htm
5986,2018-10-23,삼성바이오로직스3분기매출1011억‥전년비21↓,http://news.hankyung.com/article/201810236147f
5987,2018-10-23,삼성바이오로직스공장가동률낮아져3분기실적대폭뒷걸음질,http://www.businesspost.co.kr/BP?command=article_view&num=99780
5988,2018-10-23,삼성바이오로직스3분기영업익105억원전년비489↓,http://www.cstimes.com/?mod=news&act=articleView&idxno=288141
5989,2018-10-23,삼성바이오로직스3분기연속매출↓생산제품변화,http://www.dailypharm.com/News/245119
5990,2018-10-23,삼성바이오로직스3분기매출영업익감소12공장가동률하락원인,http://www.econovill.com/news/articleView.html?idxno=348925
5991,2018-10-23,삼성바이오로직스3분기영업익105억전년동기대비488↓,http://www.sporbiz.co.kr/news/articleView.html?idxno=281946
5992,2018-10-23,삼성바이오로직스3분기영업익105억전년比488↓,http://www.viva100.com/main/view.php?key=20181023010008218
5993,2018-10-23,삼성바이오로직스2018년도3분기영업이익105억원전년比557↓,http://www.enewstoday.co.kr/news/articleView.html?idxno=1241705
5994,2018-10-23,삼성바이오로직스3분기영업익반토막공장가동률하락,http://www.sisajournal-e.com/biz/article/190561
5995,2018-10-23,삼성바이오로직스3분기영업익반토막공장가동률하락영향”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1677744
5996,2018-10-23,삼성바이오로직스3분기영업익104억488↓,http://www.ajunews.com/view/20181023172813721
5997,2018-10-23,셀트리온주가테마섹충격에급락삼성바이오로직스도대폭밀려,http://www.businesspost.co.kr/BP?command=article_view&num=99797
5998,2018-10-23,삼성바이오로직스3분기영업익105억원,http://www.asiatoday.co.kr/view.php?key=20181023010013181
5999,2018-10-23,삼성바이오로직스3분기매출1011억영업이익105억,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1533128
6000,2018-10-23,삼성바이오로직스3분기영업익반토막전년比49감소,http://www.news2day.co.kr/113082
6001,2018-10-23,삼성바이오로직스3분기영업이익105억원전년동기대비49감소,http://www.polinews.co.kr/news/article.html?no=370509
6002,2018-10-23,삼성바이오로직스세계한상대회홍보관투어참여,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=774223
6003,2018-10-24,퀵리포트삼성바이오로직스매수유지목표가61만원유지한투證,http://www.itooza.com/common/iview.php?no=2018102407325062965
6004,2018-10-24,삼성바이오로직스실적보다증선위가중요한국,http://news.hankyung.com/article/2018102476556
6005,2018-10-24,퀵리포트삼성바이오로직스매수유지목표가59만원유지KTB證,http://www.itooza.com/common/iview.php?no=2018102407503824298
6006,2018-10-24,양재준기자의알투바이오삼성바이오로직스공장에무슨일이이상한매출감소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810230585&t=NN
6007,2018-10-24,I리포트삼성바이오로직스실적보다증선위결과중요–한투證,http://www.inews24.com/php/news_view.php?g_serial=1135163&g_menu=022300&rrf=nv
6008,2018-10-24,삼성바이오로직스목표가61만원유지전일종가41만7500원한투證,http://www.newspim.com/news/view/20181024000040
6009,2018-10-24,삼성바이오로직스목표가59만원유지전일종가41만7500원KTB證,http://www.newspim.com/news/view/20181024000062
6010,2018-10-24,삼성바이오로직스의약품위탁개발까지사업확장,http://www.asiatoday.co.kr/view.php?key=20181024010013253
6011,2018-10-24,한국투자증권삼성바이오로직스실적보다더중요한건증선위”,http://www.newsway.co.kr/news/view?tp=1&ud=2018102408131719729
6012,2018-10-24,삼성바이오로직스주가오른다위탁생산과위탁개발경쟁력지녀,http://www.businesspost.co.kr/BP?command=article_view&num=99852
6013,2018-10-24,삼성바이오로직스3Q실적시장전망치부합NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01630166619376200
6014,2018-10-24,삼성바이오로직스목표가6↓55만원제시현대차證,http://www.newspim.com/news/view/20181024000096
6015,2018-10-24,삼성바이오로직스목표가49만원유지전일종가41만7500원대신證,http://www.newspim.com/news/view/20181024000100
6016,2018-10-24,퀵리포트삼성바이오로직스매수유지목표가6↓55만원현대차證,http://www.itooza.com/common/iview.php?no=2018102408231810761
6017,2018-10-24,퀵리포트삼성바이오로직스매수유지목표가49만원유지대신證,http://www.itooza.com/common/iview.php?no=2018102408243925167
6018,2018-10-24,삼성바이오로직스3Q양호한실적증선위결과주목”한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1677924
6019,2018-10-24,STOCK삼성바이오로직스MSD와계약해지로가치수정목표가↓,http://moneys.mt.co.kr/news/mwView.php?no=2018102408328055791
6020,2018-10-24,한투증권삼성바이오로직스실적보다증선위결과가중요”,http://www.sentv.co.kr/news/view/545458
6021,2018-10-24,대신證삼성바이오로직스CDMO경쟁력강화에주목해야,http://www.newsis.com/view/?id=NISX20181024_0000451635&cID=10401&pID=10400
6022,2018-10-24,HotLine삼성바이오로직스실적악화보다CDO서비스에주목,http://news.mk.co.kr/newsRead.php?year=2018&no=662448
6023,2018-10-24,삼성바이오로직스3분기실적컨센서스부합NH투자證,http://www.seoulfn.com/news/articleView.html?idxno=322901
6024,2018-10-24,삼성바이오로직스4Q1조원현금유입중요한건31일증선위한국투자,http://www.sedaily.com/NewsView/1S61CKXT4P
6025,2018-10-24,삼성바이오로직스3분기영업익105억원증선위논의가더중요,http://www.asiatime.co.kr/news/articleView.html?idxno=207041
6026,2018-10-24,삼성바이오로직스자회사에피스SB9개발중단목표가↓현대차증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1677939
6027,2018-10-24,HotLine삼성바이오로직스CDO서비스로미래고객확보,http://news.mk.co.kr/newsRead.php?year=2018&no=662486
6028,2018-10-24,삼성바이오로직스파이프라인가치축소목표가↓현대차증권,http://www.fntimes.com/html/view.php?ud=2018102408593178871d6f57e61a_18
6029,2018-10-24,삼성바이오로직스3Q영업익105억원전년比49↓,http://www.seoulfn.com/news/articleView.html?idxno=322892
6030,2018-10-24,삼성바이오로직스전날급락딛고강보합42만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=39932
6031,2018-10-24,특징주삼성바이오로직스3분기성적표호재혹은악재주가는꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201810240912344143c642673384_1/article.html
6032,2018-10-24,한투證삼성바이오로직스3분기실적시장기대치충족”투자의견매수,http://news.heraldcorp.com/view.php?ud=20181024000118
6033,2018-10-24,ET투자뉴스삼성바이오로직스실적보다더중요한매수유지한국투자증권,http://www.etnews.com/20181024000038
6034,2018-10-24,삼성바이오로직스2018년3분기매출1011억영업이익105억,http://www.anewsa.com/detail.php?number=1401944&thread=10r03
6035,2018-10-24,한상대회참가자23일오전삼성바이오로직스방문,http://www.anewsa.com/detail.php?number=1401949&thread=01r01
6036,2018-10-24,세계한상대회참가자송도삼성바이오로직스에서사업설명청취,http://www.anewsa.com/detail.php?number=1401950&thread=01r01
6037,2018-10-24,특징주삼성바이오로직스CDMO경쟁력강화주목,http://www.sisaon.co.kr/news/articleView.html?idxno=78546
6038,2018-10-24,삼성바이오로직스3분기성적부진영업이익48↓,http://kormedi.com/?p=1252880
6039,2018-10-24,삼성바이오로직스삼성증권과예적금거래,http://www.mdtoday.co.kr/mdtoday/index.html?no=336476
6040,2018-10-24,삼성바이오로직스잇단악재털고반등할까31일증선위결과주목,http://www.kpinews.co.kr/news/articleView.html?idxno=83074
6041,2018-10-24,관심주셀트리온삼성바이오로직스현대차LG화학포스코신라젠CJENM강세삼성전자SK하이닉스SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31807
6042,2018-10-24,한투證삼성바이오로직스실적기대치충족”,http://news.heraldcorp.com/view.php?ud=20181024000351
6043,2018-10-24,삼성바이오로직스3분기영업이익반토막,http://www.dailymedi.com/detail.php?number=836082&thread=22r05
6044,2018-10-24,삼성바이오로직스3분기실적쇼크향후전망은,http://www.choicenews.co.kr/news/articleView.html?idxno=45441
6045,2018-10-24,삼성바이오로직스공장가동률하락및매출이연으로인한부진한실적,http://www.newsworks.co.kr/news/articleView.html?idxno=305224
6046,2018-10-24,코스피기관사자에상승출발셀트리온삼성바이오로직스현대차LG화학포스코삼성물산등강세,http://www.econonews.co.kr/news/articleView.html?idxno=39962
6047,2018-10-24,ET투자뉴스삼성바이오로직스CDO서비스로미BUYM유안타증권,http://www.etnews.com/20181024000179
6048,2018-10-24,종목삼성바이오로직스CDMO로장기성장예고주가는,http://news.hankyung.com/article/2018102494906
6049,2018-10-24,삼성바이오로직스관세청AEO인증획득,http://www.bokuennews.com/news/article.html?no=166865
6050,2018-10-24,삼성바이오로직스셀트리온모두장초반상승서하락반전14↓,http://www.econonews.co.kr/news/articleView.html?idxno=39975
6051,2018-10-24,ET투자뉴스삼성바이오로직스CMO→CDMBUY현대차증권,http://www.etnews.com/20181024000230
6052,2018-10-24,삼성바이오로직스4분기에는일회성자금유입으로1조원의현금을보유하게될전망,http://www.newsworks.co.kr/news/articleView.html?idxno=305271
6053,2018-10-24,ET투자뉴스삼성바이오로직스CDMO경쟁력강BUY대신증권,http://www.etnews.com/20181024000257
6054,2018-10-24,삼성바이오로직스어려웠던3분기향후전망도만만찮네,http://www.sporbiz.co.kr/news/articleView.html?idxno=282201
6055,2018-10-24,삼성바이오로직스15000원359내린402500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810240444&t=NN
6056,2018-10-24,삼성바이오로직스359하락한40만2500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=557074
6057,2018-10-24,삼성바이오로직스CDMO경쟁력강화에주목해야대신증권,http://www.econonews.co.kr/news/articleView.html?idxno=40018
6058,2018-10-24,관심주현대차LG화학포스코에이치엘비상승삼성전자SK하이닉스셀트리온삼성바이오로직스SK텔레콤하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31826
6059,2018-10-24,삼성바이오로직스3분기매출액1011억원영업이익105억원전망,http://www.newsworks.co.kr/news/articleView.html?idxno=305388
6060,2018-10-24,셀트리온주가테마섹충격에또급락삼성바이오로직스도하락,http://www.businesspost.co.kr/BP?command=article_view&num=99950
6061,2018-10-25,삼성물산주가오른다자회사삼성바이오로직스가실적견인,http://www.businesspost.co.kr/BP?command=article_view&num=99995
6062,2018-10-25,삼성물산내년실적턴어라운드키는삼성바이오로직스”,http://www.fntimes.com/html/view.php?ud=201810250849406934f09e13944d_18
6063,2018-10-25,삼성바이오로직스14000원348내린388500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810250070&t=NN
6064,2018-10-25,삼성바이오로직스4거래일연속하락세39만원선무너져,http://www.econonews.co.kr/news/articleView.html?idxno=40092
6065,2018-10-25,관심주}삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학포스코CJENM신라젠포스코켐텍약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31830
6066,2018-10-25,뉴욕증시재채기코스피도연중최저점출발삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코등약세,http://www.econonews.co.kr/news/articleView.html?idxno=40128
6067,2018-10-25,제넥신하이루킨삼성바이오로직스상업생산합의,http://www.dailypharm.com/News/245221
6068,2018-10-25,삼성바이오로직스셀트리온희비엇갈려셀트리온↑삼성바이오로직스↓,http://www.econonews.co.kr/news/articleView.html?idxno=40153
6069,2018-10-25,삼성바이오로직스11500원286내린391000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810250587&t=NN
6070,2018-10-25,관심주셀트리온LG화학SK텔레콤펄어비스메디톡스상승삼성전자SK하이닉스삼성바이오로직스현대차포스코하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31847
6071,2018-10-25,삼성바이오로직스바이오젠주식양도내달30일로변경,http://news1.kr/articles/?3460207
6072,2018-10-25,셀트리온주가쌍끌이매수에급반등삼성바이오로직스계속내려,http://www.businesspost.co.kr/BP?command=article_view&num=100098
6073,2018-10-25,바이오주외국인선택갈려셀트리온사고삼성바이오로직스팔고,http://www.businesspost.co.kr/BP?command=article_view&num=100111
6074,2018-10-26,삼성바이오로직스5000원128오른396000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810260077&t=NN
6075,2018-10-26,특징주삼성바이오로직스외인이우군주가기지개펴나,http://www.g-enews.com/ko-kr/news/article/news_all/201810260908427028c642673384_1/article.html
6076,2018-10-26,삼성바이오로직스4거래일연속하락세이어약보합장초반상승서하락,http://www.econonews.co.kr/news/articleView.html?idxno=40214
6077,2018-10-26,삼성바이오로직스바이오젠주식양도일연장,http://www.mdtoday.co.kr/mdtoday/index.html?no=336753
6078,2018-10-26,특징주삼성바이오로직스하락바이오젠주식양도연기,http://www.asiatime.co.kr/news/articleView.html?idxno=207617
6079,2018-10-26,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코약세현대차신라젠에이치엘비나노스강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31857
6080,2018-10-26,코스피뉴욕증시상승에도반등힘겨워SK하이닉스셀트리온삼성바이오로직스LG화학포스코등약세,http://www.econonews.co.kr/news/articleView.html?idxno=40249
6081,2018-10-26,삼성바이오로직스셀트리온모두하락세시간지날수록낙폭커져,http://www.econonews.co.kr/news/articleView.html?idxno=40254
6082,2018-10-26,삼성바이오로직스19000원486내린372000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810260576&t=NN
6083,2018-10-26,김병욱관계사로보더라도삼성바이오로직스회계처리부당변경은유효,http://www.mdtoday.co.kr/mdtoday/index.html?no=336812
6084,2018-10-26,코스피코스닥동반↓셀트리온삼성바이오로직스신라젠도공동↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=336829
6085,2018-10-26,관심주셀트리온삼성바이오로직스현대차LG화학SK텔레콤하락SK하이닉스포스코켐텍나노스상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=31880
6086,2018-10-26,삼성바이오로직스바이오젠에피스공동경영또늦어진다,http://www.ajunews.com/view/20181026170051193
6087,2018-10-26,삼성바이오로직스지배력변경없이공정가치평가문제”윤석헌금감원장기존입장재확인,http://www.g-enews.com/ko-kr/news/article/news_all/201810261701472638c642673384_1/article.html
6088,2018-10-26,금감원삼성바이오로직스회계처리재감리결과도분식,http://www.nocutnews.co.kr/news/5051400
6089,2018-10-26,셀트리온삼성바이오로직스주가동반급락외국인매도세에밀려,http://www.businesspost.co.kr/BP?command=article_view&num=100290
6090,2018-10-26,삼성바이오로직스지배력변경없는회계방식변경이문제”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201810261917001&code=920100
6091,2018-10-26,윤석헌금감원장삼성바이오로직스회계처리방식문제있어,http://www.choicenews.co.kr/news/articleView.html?idxno=45522
6092,2018-10-26,윤석헌금감원장삼성바이오로직스2015년회계처리잘못,http://www.techholic.co.kr/news/articleView.html?idxno=178931
6093,2018-10-27,김병욱의원삼성바이오로직스관련재감리조치안질의,http://www.gukjenews.com/news/articleView.html?idxno=1012830
6094,2018-10-28,삼성바이오로직스한달만에30빠져증시패닉재감리발표까지악재줄줄이겹쳐,http://www.econonews.co.kr/news/articleView.html?idxno=40373
6095,2018-10-28,서경스타즈IR삼성바이오로직스3공장생산돌입2년내CMO매출1조,http://www.sedaily.com/NewsView/1S637UB7WD
6096,2018-10-29,Invest삼성바이오로직스사태금감원초강수에당혹스런금융위,http://www.investchosun.com/?p=3231501
6097,2018-10-29,삼성바이오로직스372000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810290074&t=NN
6098,2018-10-29,삼성바이오로직스전일대비약3상승한384000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810290084&t=NN
6099,2018-10-29,특징주삼성바이오로직스3공장모멘텀수면위로외인매수에주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201810290906512534c642673384_1/article.html
6100,2018-10-29,삼성바이오로직스6거래일만에상승세로반등할지주목,http://www.econonews.co.kr/news/articleView.html?idxno=40427
6101,2018-10-29,특징주삼성바이오로직스6일만에오름세,http://www.asiatime.co.kr/news/articleView.html?idxno=208000
6102,2018-10-29,특징주삼성바이오로직스3공장모멘텀주가강세,http://www.fetv.co.kr/news/article.html?no=14541
6103,2018-10-29,관심주삼성전자SK하이닉스포스코현대차신라젠포스코켐텍약세셀트리온삼성바이오로직스LG화학SK텔레콤강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31887
6104,2018-10-29,코스피외국인기관사자에반등셀트리온삼성바이오로직스LG화학SK텔레콤등상승세출발,http://www.econonews.co.kr/news/articleView.html?idxno=40459
6105,2018-10-29,WIKI포커스증선위의삼성바이오로직스회계처리현명한판단이기대되는이유,http://www.wikileaks-kr.org/news/articleView.html?idxno=39295
6106,2018-10-29,삼성바이오로직스셀트리온모두소폭하락상승서하락반전,http://www.econonews.co.kr/news/articleView.html?idxno=40485
6107,2018-10-29,삼성바이오로직스9500원255내린362500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810290595&t=NN
6108,2018-10-29,관심주삼성전자LG화학SK텔레콤CJENM메디톡스상승셀트리온삼성바이오로직스현대차포스코하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31906
6109,2018-10-29,셀트리온삼성바이오로직스주가동반하락외국인매도세강해,http://www.businesspost.co.kr/BP?command=article_view&num=100492
6110,2018-10-30,증선위31일삼성바이오로직스재감리대심제진행,http://www.ebn.co.kr/news/view/959931
6111,2018-10-30,내일삼성바이오로직스분식회계혐의재논의,https://cnbc.sbs.co.kr/article_hub/10000919281?division=NAVER
6112,2018-10-30,삼성바이오로직스362500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810300078&t=NN
6113,2018-10-30,특징주삼성바이오로직스증선위재감리상정임박주가다시불똥튀나,http://www.g-enews.com/ko-kr/news/article/news_all/20181030090500489c642673384_1/article.html
6114,2018-10-30,삼성바이오로직스7거래일만에강보합장초반부터오르락내리락,http://www.econonews.co.kr/news/articleView.html?idxno=40540
6115,2018-10-30,관심주삼성전자SK하이닉스현대차포스코CJENM강세셀트리온삼성바이오로직스LG화학SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31914
6116,2018-10-30,특징주삼성바이오로직스31일증선위앞두고도강세,http://www.asiatime.co.kr/news/articleView.html?idxno=208281
6117,2018-10-30,삼성바이오로직스전일대비약3상승한373500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810300232&t=NN
6118,2018-10-30,증선위분식회계논란삼성바이오로직스31일재감리,http://www.kukinews.com/news/article.html?no=599111
6119,2018-10-30,증선위삼성바이오로직스분식회계재감리,http://www.wsobi.com/news/articleView.html?idxno=66722
6120,2018-10-30,삼성바이오로직스공방2R,http://news.heraldcorp.com/view.php?ud=20181030000378
6121,2018-10-30,한경로보뉴스삼성바이오로직스5이상상승20182Q매출액1254억984영업이익237억흑자전환,http://news.hankyung.com/article/201810300115L
6122,2018-10-30,유삼성바이오로직스전일대비745상승일일회전율은039기록,http://www.sedaily.com/NewsView/1S643UAMU4
6123,2018-10-30,삼성바이오로직스셀트리온모두하락멈추고상승세로특히삼성바이오로직스급등,http://www.econonews.co.kr/news/articleView.html?idxno=40582
6124,2018-10-30,증선위31일삼성바이오로직스재감리이슈다뤄,http://www.intn.co.kr/news/articleView.html?idxno=2002533
6125,2018-10-30,삼성바이오로직스분식회계혐의31일논의재개,http://www.mdtoday.co.kr/mdtoday/index.html?no=337162
6126,2018-10-30,31일삼성바이오로직스분식회계논란2라운드재개,http://www.etnews.com/20181030000325
6127,2018-10-30,삼성바이오로직스10급등전일보다36500원상승한399000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810300563&t=NN
6128,2018-10-30,증선위삼성바이오로직스분식회계혐의재감리,http://sports.khan.co.kr/news/sk_index.html?art_id=201810301547013&sec_id=564001&pt=nv
6129,2018-10-30,삼성바이오로직스분식논란2라운드시작금감원재감리도분식고수,http://www.metroseoul.co.kr/news/newsview?newscd=2018103000182
6130,2018-10-30,증선위31일회의서삼성바이오로직스재감리안건상정,http://www.mediapen.com/news/view/392375
6131,2018-10-30,삼성바이오로직스분식회계공방2라운드증선위31일재감리심의,http://www.g-enews.com/ko-kr/news/article/news_all/201810301606529031c642673384_1/article.html
6132,2018-10-30,삼성바이오로직스증선위앞두고9대급등,http://www.newsis.com/view/?id=NISX20181030_0000458228&cID=10401&pID=10400
6133,2018-10-30,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학현대차상승포스코SK텔레콤CJENM펄어비스하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=31927
6134,2018-10-30,증선위31일삼성바이오로직스재감리안건논의,http://www.fetv.co.kr/news/article.html?no=14663
6135,2018-10-30,삼성바이오로직스금감원더날선분식회계공세어떻게막아낼까,http://www.businesspost.co.kr/BP?command=article_view&num=100621
6136,2018-10-30,내일의경제일정증선위정례회의개최삼성바이오로직스분식회계논의,http://www.asiatime.co.kr/news/articleView.html?idxno=208459
6137,2018-10-30,삼성바이오로직스셀트리온주가동반상승외국인팔고기관사고,http://www.businesspost.co.kr/BP?command=article_view&num=100668
6138,2018-10-30,위기속삼성바이오로직스실적재감리악재딛나,http://www.edaily.co.kr/news/newspath.asp?newsid=04447686619378168
6139,2018-10-31,삼성바이오로직스vs금감원분식회계공방2라운드개시,http://www.newsworks.co.kr/news/articleView.html?idxno=306764
6140,2018-10-31,삼성바이오로직스증선위2R킥오프,http://news1.kr/articles/?3464465
6141,2018-10-31,특징주삼성바이오로직스증선위앞두고약세,http://www.asiatime.co.kr/news/articleView.html?idxno=208517
6142,2018-10-31,특징주삼성바이오로직스증선위재감리안건심의주가는주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201810310909276889c642673384_1/article.html
6143,2018-10-31,특징주삼성바이오로직스증선위앞두고약세,http://www.newsis.com/view/?id=NISX20181031_0000458743&cID=10401&pID=10400
6144,2018-10-31,특징주삼성바이오로직스증선위재감리심의앞두고약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681335
6145,2018-10-31,삼성바이오로직스증선위회의앞두고약세,http://www.sedaily.com/NewsView/1S64KB9IJR
6146,2018-10-31,특징주삼성바이오로직스증선위재감리심의앞두고하락세,http://www.seoulfn.com/news/articleView.html?idxno=323554
6147,2018-10-31,삼성바이오로직스급등하루만에다시하락세로반짝급등이었나,http://www.econonews.co.kr/news/articleView.html?idxno=40687
6148,2018-10-31,특징주삼성바이오로직스증선위심의앞두고하락세,http://www.fetv.co.kr/news/article.html?no=14678
6149,2018-10-31,특징주삼성바이오로직스증선위앞두고주가주춤,http://www.newsprime.co.kr/news/article.html?no=434485
6150,2018-10-31,특징주삼성바이오로직스증선위앞두고약세,http://moneys.mt.co.kr/news/mwView.php?no=2018103109298077281
6151,2018-10-31,특징주삼성바이오로직스증선위재감리앞두고약세,http://www.viva100.com/main/view.php?key=20181031010011145
6152,2018-10-31,특징주삼성바이오로직스증선위심의앞두고약세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018103109293946542
6153,2018-10-31,특징주삼성바이오로직스증선위재감리심의앞두고약세,http://www.dailian.co.kr/news/view/748581/?sc=naver
6154,2018-10-31,특징주삼성바이오로직스증선위심의앞두고약세,http://www.ebn.co.kr/news/view/960136
6155,2018-10-31,관심주삼성전자SK하이닉스나노스강세셀트리온삼성바이오로직스LG화학현대차포스코SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31932
6156,2018-10-31,특징주증선위앞둔삼성바이오로직스40만원회복,http://view.asiae.co.kr/news/view.htm?idxno=2018103110044134369
6157,2018-10-31,최명성의바닥탈출기관매수세로반등삼성바이오로직스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018103109520162788
6158,2018-10-31,제약톡톡삼성바이오로직스분식회계논란장기전갈듯,http://news.heraldcorp.com/view.php?ud=20181031000229
6159,2018-10-31,포토증선위삼성바이오로직스재감리심의,http://view.asiae.co.kr/news/view.htm?idxno=2018103110172181410
6160,2018-10-31,삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031041100013&did=1196m
6161,2018-10-31,포토증선위삼성바이오로직스재감리심의,http://view.asiae.co.kr/news/view.htm?idxno=2018103110173389096
6162,2018-10-31,삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031041900013&did=1196m
6163,2018-10-31,재개된삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031042900013&did=1196m
6164,2018-10-31,금융위원회삼성바이오로직스재감리,http://www.fnnews.com/news/201810311019318462
6165,2018-10-31,재개된삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031042800013&did=1196m
6166,2018-10-31,삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031042700013&did=1196m
6167,2018-10-31,삼성바이오로직스를어찌합니까,http://www.fnnews.com/news/201810311019392642
6168,2018-10-31,삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031042500013&did=1196m
6169,2018-10-31,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031043800013&did=1196m
6170,2018-10-31,시작된삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031044500013&did=1196m
6171,2018-10-31,시작된삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031044400013&did=1196m
6172,2018-10-31,증선위삼성바이오로직스분식회계재감리결과심의,http://news1.kr/photos/view/?3368823
6173,2018-10-31,삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031045900013&did=1196m
6174,2018-10-31,삼성바이오로직스재감리논의,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031045800013&did=1196m
6175,2018-10-31,삼성바이오로직스2라운도오늘증선위재감리심의,http://imnews.imbc.com/news/2018/econo/article/4907681_22671.html
6176,2018-10-31,사진금융위원회삼성바이오로직스분식회계재감리,http://www.newspim.com/news/view/20181031000322
6177,2018-10-31,사진삼성바이오로직스분식회계재감리심의,http://www.newspim.com/news/view/20181031000323
6178,2018-10-31,삼성바이오로직스분식회계의혹재감리,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031051500013&did=1196m
6179,2018-10-31,포토철통보안증선위삼성바이오로직스재감리심의시작,http://www.hani.co.kr/arti/economy/economy_general/868110.html
6180,2018-10-31,코스피상승→하락→반등시도엎치락뒤치락셀트리온삼성바이오로직스LG화학현대차등하락세,http://www.econonews.co.kr/news/articleView.html?idxno=40719
6181,2018-10-31,사진증선위삼성바이오로직스재심의,http://news.mt.co.kr/mtview.php?no=2018103110514187628
6182,2018-10-31,사진증선위삼성바이오로직스재감리심의,http://news.mt.co.kr/mtview.php?no=2018103110543659520
6183,2018-10-31,현장사진삼성전자는17조영업이익호재삼성바이오로직스는분식회계재감리악재희비엇갈릴까,http://news.imaeil.com/Economy/2018103110573459738
6184,2018-10-31,삼성바이오로직스회계위반재감리의날논란무엇,http://www.econovill.com/news/articleView.html?idxno=349454
6185,2018-10-31,삼성바이오로직스분식회계2차공방재감리심의시작,http://news.hankyung.com/article/2018103144037
6186,2018-10-31,삼성바이오로직스금감원분식회계공방2라운드증선위재감리개시,http://www.ekn.kr/news/article.html?no=394682
6187,2018-10-31,증선위삼성바이오로직스재감리심의시작,http://www.fetv.co.kr/news/article.html?no=14697
6188,2018-10-31,증선위오늘31일삼성바이오로직스재감리안건논의,http://www.seoulwire.com/news/articleView.html?idxno=31974
6189,2018-10-31,분식회계논란삼성바이오로직스중징계여부촉각,http://www.kpinews.co.kr/news/articleView.html?idxno=83475
6190,2018-10-31,금융위산하증선위삼성바이오로직스재감리안건심의돌입,http://www.mediapen.com/news/view/392567
6191,2018-10-31,포토증선위삼성바이오로직스분식회계재감리심의시작,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681487
6192,2018-10-31,포토책상에쌓인삼성바이오로직스분식회계의혹재감리심의자료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681483
6193,2018-10-31,포토증선위삼성바이오로직스분식회계재감리심의,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681485
6194,2018-10-31,포토삼성바이오로직스분식회계의혹재감리심의입장하는김용범위원장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681489
6195,2018-10-31,증선위삼성바이오로직스재감리심의시작분식회계공방2차전돌입,http://www.kyeongin.com/main/view.php?key=20181031010011099
6196,2018-10-31,증선위삼성바이오로직스재감리심의,http://www.yonhapnewstv.co.kr/MYH20181031007600038/?did=1825m
6197,2018-10-31,증선위출석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031094900013&did=1196m
6198,2018-10-31,증선위출석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096000013&did=1196m
6199,2018-10-31,검색받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096100013&did=1196m
6200,2018-10-31,검색받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096200013&did=1196m
6201,2018-10-31,삼성바이오로직스분식회계공방2차전시작,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096300013&did=1196m
6202,2018-10-31,삼성바이오로직스김태한대표이사,http://www.fnnews.com/news/201810311308118072
6203,2018-10-31,굳은표정의삼성바이오로직스대표이사,http://www.fnnews.com/news/201810311308332187
6204,2018-10-31,사진금융위원회들어서는김태한삼성바이오로직스사장,http://www.newspim.com/news/view/20181031000445
6205,2018-10-31,취재진질문에답하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3369309
6206,2018-10-31,증선위회의참석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3369304
6207,2018-10-31,질문에답하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3369307
6208,2018-10-31,인사하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096600013&did=1196m
6209,2018-10-31,사진증선위출석하는김태한삼성바이오로직스사장,http://www.newspim.com/news/view/20181031000449
6210,2018-10-31,인사하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096500013&did=1196m
6211,2018-10-31,증선위출석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096900013&did=1196m
6212,2018-10-31,소명나선김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031096800013&did=1196m
6213,2018-10-31,사진검색대통과하는김태한삼성바이오로직스사장,http://www.newspim.com/news/view/20181031000450
6214,2018-10-31,국고처이동근종목상담삼성바이오로직스207940,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810270065&t=NNv
6215,2018-10-31,삼성바이오로직스분식회계의혹공방2R승자는,http://news1.kr/photos/view/?3369312
6216,2018-10-31,질의에답하는김태한삼성바이오로직스사장,http://www.newsis.com/view/?id=NISI20181031_0014606466
6217,2018-10-31,질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031097100013&did=1196m
6218,2018-10-31,질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031097000013&did=1196m
6219,2018-10-31,질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031097100013&did=1196m
6220,2018-10-31,사진김태한삼성바이오로직스사장분식회계공방2차전시작,http://www.newspim.com/news/view/20181031000453
6221,2018-10-31,사진굳은표정의김태한삼성바이오로직스사장,http://www.newspim.com/news/view/20181031000455
6222,2018-10-31,증선위삼성바이오로직스재감리심의자회사삼성바이오에피스가치평가쟁점,http://www.g-enews.com/ko-kr/news/article/news_all/201810311317396502c642673384_1/article.html
6223,2018-10-31,사진인사하는김태한삼성바이오로직스사장,http://www.newspim.com/news/view/20181031000457
6224,2018-10-31,소명나선김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031097400013&did=1196m
6225,2018-10-31,사진취재진앞에선김태한삼성바이오로직스사장,http://www.newspim.com/news/view/20181031000461
6226,2018-10-31,소명나선김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031097500013&did=1196m
6227,2018-10-31,사진김태한삼성바이오로직스사장증선위출석,http://www.newspim.com/news/view/20181031000462
6228,2018-10-31,NW포토증선위향하는김태한삼성바이오로직스대표,http://www.newsway.co.kr/news/view?tp=1&ud=2018103113313845024
6229,2018-10-31,삼성바이오로직스공방2차전개시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181031101900013&did=1196m
6230,2018-10-31,현장사진김태한삼성바이오로직스대표이사31일오후증선위출석분식회계의혹소명,http://news.imaeil.com/Economy/2018103113544523976
6231,2018-10-31,삼성바이오로직스셀트리온상승하루만에하락세특히삼성바이오로직스5대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=40759
6232,2018-10-31,특징주40만원회복했던삼성바이오로직스다시4↓하락,http://view.asiae.co.kr/news/view.htm?idxno=2018103114220943779
6233,2018-10-31,보안검색받는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3369576
6234,2018-10-31,삼성바이오로직스분식회계공방2차전돌입전망은,http://sports.khan.co.kr/news/sk_index.html?art_id=201810311442013&sec_id=564001&pt=nv
6235,2018-10-31,사진증선위향하는김태한삼성바이오로직스사장,http://news.mt.co.kr/mtview.php?no=2018103114441157574
6236,2018-10-31,사진소명나선김태한삼성바이오로직스사장,http://news.mt.co.kr/mtview.php?no=2018103114450020746
6237,2018-10-31,사진인터뷰갖는김태한삼성바이오로직스사장,http://news.mt.co.kr/mtview.php?no=2018103114460481743
6238,2018-10-31,사진증선위참석한김태한삼성바이오로직스사장,http://news.mt.co.kr/mtview.php?no=2018103114475998310
6239,2018-10-31,사진미소짓는김태한삼성바이오로직스사장,http://news.mt.co.kr/mtview.php?no=2018103114492537702
6240,2018-10-31,증선위삼성바이오로직스심의회계논란재공방,http://www.ebn.co.kr/news/view/960188
6241,2018-10-31,증선위삼성바이오로직스분식회계의혹재감리,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003381704
6242,2018-10-31,증선위삼성바이오로직스재감리심의돌입분식회계재점화,http://www.ceoscoredaily.com/news/article.html?no=47676
6243,2018-10-31,금감원삼성바이오로직스분식회계논란2라운드돌입,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201810311516001&code=920100
6244,2018-10-31,삼성바이오로직스재감리결론차기회의로미뤄져속보,http://view.asiae.co.kr/news/view.htm?idxno=2018103116172238676
6245,2018-10-31,증선위삼성바이오로직스분식회계재감리삼바주가264↓,http://www.newsworks.co.kr/news/articleView.html?idxno=307072
6246,2018-10-31,삼성바이오로직스vs금감원외나무다리서다시만나다,http://www.insightkorea.co.kr//news/articleView.html?idxno=31949
6247,2018-10-31,삼성바이오로직스재감리심의다음증선위로,http://www.asiatime.co.kr/news/articleView.html?idxno=208751
6248,2018-10-31,금융위삼성바이오로직스재감리결론못내다음회의로연기,http://www.sporbiz.co.kr/news/articleView.html?idxno=284333
6249,2018-10-31,마감라정찬대표이사보석네이처셀급등증선위심의삼성바이오로직스반락,http://www.asiatime.co.kr/news/articleView.html?idxno=208715
6250,2018-10-31,증선위삼성바이오로직스재감리심의대심제진행,http://www.ajunews.com/view/20181031180705389
6251,2018-10-31,셀트리온3총사와삼성바이오로직스주가쌍끌이매도에동반하락,http://www.businesspost.co.kr/BP?command=article_view&num=100823
6252,2018-10-31,삼성바이오로직스재감리이재용의바이오앞날은,http://www.edaily.co.kr/news/newspath.asp?newsid=04936406619378496
6253,2018-10-31,속보삼성바이오로직스분식회계판단11월14일로연기,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681843
6254,2018-10-31,증선위삼성바이오로직스분식회계판단11월14일로연기,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681844
6255,2018-11-01,삼성바이오로직스회계부정의혹결론못내14일다시논의,http://www.ekn.kr/news/article.html?no=394859
6256,2018-11-01,삼성바이오로직스분식회계인정되면주가는어떻게되나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181101.99099000015
6257,2018-11-01,한경로보뉴스전일외국인거래소에서삼성전기248삼성바이오로직스264등순매도,http://news.hankyung.com/article/201811017792L
6258,2018-11-01,증선위삼성바이오로직스분식회계결론못내14일에재논의,http://www.mediapen.com/news/view/392744
6259,2018-11-01,삼성바이오로직스500원013오른388000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811010073&t=NN
6260,2018-11-01,특징주삼성바이오로직스증선위재감리결론미뤄지자강세,http://www.asiatime.co.kr/news/articleView.html?idxno=208810
6261,2018-11-01,특징주삼성바이오로직스재감리결론연기가호재주가탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201811010912483248c642673384_1/article.html
6262,2018-11-01,삼성바이오로직스회계부정의혹결론못내14일재논의,https://cnbc.sbs.co.kr/article_hub/10000919581?division=NAVER
6263,2018-11-01,특징주삼성바이오로직스증선위재감리연기강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1681946
6264,2018-11-01,삼성바이오로직스장초반상승으로40만원눈앞반등하나,http://www.econonews.co.kr/news/articleView.html?idxno=40828
6265,2018-11-01,특징주삼성바이오로직스증선위재감리결론연기에오름세,http://www.seoulfn.com/news/articleView.html?idxno=323715
6266,2018-11-01,특징주삼성바이오로직스증선위재감리연기에상승세,http://www.fetv.co.kr/news/article.html?no=14768
6267,2018-11-01,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코신라젠포스코켐텍나노스강세SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=31977
6268,2018-11-01,특징주재감리결론미뤄진삼성바이오로직스상승세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110110352017332
6269,2018-11-01,삼성바이오로직스끝나지않는불확실성,http://view.asiae.co.kr/news/view.htm?idxno=2018110110543458750
6270,2018-11-01,삼성바이오로직스분식회계의혹심의연기,http://www.dailymedi.com/detail.php?number=836414&thread=22r05
6271,2018-11-01,고의분식회계스모킹건등장삼성바이오로직스의운명은,http://www.updownnews.co.kr/news/articleView.html?idxno=98562
6272,2018-11-01,코스피뉴욕증시상승에순항삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코등강세,http://www.econonews.co.kr/news/articleView.html?idxno=40853
6273,2018-11-01,삼성바이오로직스전일대비약3상승한399500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811010408&t=NN
6274,2018-11-01,셀트리온오후갑자기매수세로6대급등삼성바이오로직스도상승세,http://www.econonews.co.kr/news/articleView.html?idxno=40860
6275,2018-11-01,증권선물위삼성바이오로직스회계처리결론못내14일재논의,http://www.businesspost.co.kr/BP?command=article_view&num=100890
6276,2018-11-01,르포시운전가동삼성바이오로직스제3신공장가다,http://www.newspim.com/news/view/20181101000556
6277,2018-11-01,삼성바이오로직스2500원065오른390000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811010523&t=NN
6278,2018-11-01,종목탐구삼성바이오로직스신사업진출로악재극복할까,http://biz.newdaily.co.kr/site/data/html/2018/11/01/2018110100181.html
6279,2018-11-01,증선위14일삼성바이오로직스분식회계추가심의주가영향은,http://www.newsworks.co.kr/news/articleView.html?idxno=307466
6280,2018-11-01,삼성바이오로직스금감원과분식회계공방전에서수세몰리나,http://www.businesspost.co.kr/BP?command=article_view&num=100968
6281,2018-11-01,셀트리온주가자사주매입결정에급등삼성바이오로직스도올라,http://www.businesspost.co.kr/BP?command=article_view&num=100996
6282,2018-11-02,삼성바이오로직스3000원077내린387000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811020079&t=NN
6283,2018-11-02,김어준의뉴스공장삼성바이오로직스고의적분식회계문건은결정적인증거증선위가사실상덮어준것,http://www.topstarnews.net/news/articleView.html?idxno=515092
6284,2018-11-02,삼성바이오로직스상승하루만에하락세38만원무너지나,http://www.econonews.co.kr/news/articleView.html?idxno=40923
6285,2018-11-02,코스피미중무역전쟁완화기대감2060대상승SK하이닉스셀트리온삼성바이오로직스LG화학포스코삼성물산등강세,http://www.econonews.co.kr/news/articleView.html?idxno=40952
6286,2018-11-02,코스피코스닥동반↑셀트리온삼성바이오로직스신라젠공동↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=337590
6287,2018-11-02,삼성바이오로직스전일대비약3상승한402000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811020389&t=NN
6288,2018-11-02,삼성바이오로직스고의분식회계결정적단서확보,http://imnews.imbc.com/replay/2018/nw1200/article/4911946_22606.html
6289,2018-11-02,삼성바이오로직스셀트리온모두상승세삼성바이오로직스40만원회복,http://www.econonews.co.kr/news/articleView.html?idxno=40977
6290,2018-11-02,국회정의당논평삼성바이오로직스분식회계철저한검찰수사촉구,http://www.newsfreezone.co.kr/news/articleView.html?idxno=86047
6291,2018-11-02,삼성바이오로직스회계처리변경관련한삼성내부문건추가로유출,http://www.businesspost.co.kr/BP?command=article_view&num=101100
6292,2018-11-02,삼성바이오로직스11500원295오른401500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811020627&t=NN
6293,2018-11-02,코스피코스닥동반↑셀트리온삼성바이오로직스신라젠공동↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=337643
6294,2018-11-02,셀트리온주가개인매수힘입어상승삼성바이오로직스도올라,http://www.businesspost.co.kr/BP?command=article_view&num=101130
6295,2018-11-03,제약바이오한주간이모저모증선위삼성바이오로직스재감리심의본격시작,http://www.edaily.co.kr/news/newspath.asp?newsid=01384166619402112
6296,2018-11-03,코스피미중무역전쟁완화기대감35대급등삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코현대차등상승마감,http://www.econonews.co.kr/news/articleView.html?idxno=41090
6297,2018-11-05,르포청년들이韓바이오산업의미래를삼성바이오로직스가보니,http://www.ekn.kr/news/article.html?no=395544
6298,2018-11-05,삼성바이오로직스4500원112내린397000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811050079&t=NN
6299,2018-11-05,삼성바이오로직스장초반약보합40만원다시깨지나,http://www.econonews.co.kr/news/articleView.html?idxno=41233
6300,2018-11-05,특징주삼성바이오로직스끝나지않은불확실성에하락,http://www.asiatime.co.kr/news/articleView.html?idxno=209442
6301,2018-11-05,관심주삼성전자SK하이닉스포스코현대차메디톡스약세셀트리온삼성바이오로직스LG화학SK텔레콤신라젠에이치엘비강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32031
6302,2018-11-05,코스피외국인기관팔자에낙폭커져셀트리온삼성바이오로직스LG화학SK텔레콤등은강세,http://www.econonews.co.kr/news/articleView.html?idxno=41264
6303,2018-11-05,삼성바이오로직스셀트리온희비엇갈려셀트리온3거래일연속상승,http://www.econonews.co.kr/news/articleView.html?idxno=41289
6304,2018-11-05,삼성바이오로직스2500원062내린399000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811050486&t=NN
6305,2018-11-05,관심주셀트리온SK텔레콤신라젠CJENM에이치엘비상승삼성전자SK하이닉스삼성바이오로직스LG화학포스코현대차하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32043
6306,2018-11-05,셀트리온3총사주가모두올라삼성바이오로직스는소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=101368
6307,2018-11-06,삼성바이오로직스美바이오젠콜옵션종결7595억유입,http://www.edaily.co.kr/news/newspath.asp?newsid=01384166619403096
6308,2018-11-06,삼성바이오로직스바이오젠삼성바이오에피스공동경영,http://www.biospectator.com/view/news_view.php?varAtcId=6513
6309,2018-11-06,삼성바이오로직스내일바이오젠에에피스주식922만주양도완료,http://news.mk.co.kr/newsRead.php?year=2018&no=693461
6310,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도종결,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181106019400017&did=1195m
6311,2018-11-06,삼성바이오로직스7일바이오젠과자산양수도종결,http://news.hankyung.com/article/2018110638716
6312,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결,http://news.mt.co.kr/mtview.php?no=2018110607580828894
6313,2018-11-06,삼성바이오로직스7595억받아美바이오젠자산양수도종결공동경영체제돌입,http://www.betanews.net:8080/article/930526.html
6314,2018-11-06,삼성바이오로직스7일바이오젠과콜옵션주식양도종결,http://news1.kr/articles/?3469310
6315,2018-11-06,삼성바이오로직스7일바이오젠과자산양수도종결공동경영개시,http://www.newsway.co.kr/news/view?tp=1&ud=2018110608035168139
6316,2018-11-06,삼성바이오로직스7일바이오젠에에피스주식922만주양도종결”,http://www.econovill.com/news/articleView.html?idxno=349860
6317,2018-11-06,삼성바이오로직스美바이오젠콜옵션자산양수도종결,http://biz.chosun.com/site/data/html_dir/2018/11/06/2018110600456.html
6318,2018-11-06,종합삼성바이오로직스7일바이오젠과콜옵션자산양수도종결,http://www.newspim.com/news/view/20181106000089
6319,2018-11-06,삼성바이오로직스바이오젠과콜옵션자산양수도종결,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181106081420
6320,2018-11-06,공시삼성바이오로직스바이오젠콜옵션행사로자산양수도종결”,http://www.newsway.co.kr/news/view?tp=1&ud=2018110608243053173
6321,2018-11-06,삼성바이오로직스바이오젠과콜옵션자산양수도종결,http://www.metroseoul.co.kr/news/newsview?newscd=2018110600009
6322,2018-11-06,삼성바이오로직스7일바이오젠사와자산양수도종결,http://www.newsworks.co.kr/news/articleView.html?idxno=308343
6323,2018-11-06,삼성바이오로직스7일바이오젠과콜옵션자산양수도종결,http://biz.newdaily.co.kr/site/data/html/2018/11/06/2018110600007.html
6324,2018-11-06,삼성바이오로직스바이오젠콜옵션절차종결공동경영돌입,http://news.kbs.co.kr/news/view.do?ncd=4067317&ref=A
6325,2018-11-06,삼성바이오로직스바이오젠社와자산양수도종결,http://www.fetv.co.kr/news/article.html?no=14975
6326,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도7일완료,http://www.sedaily.com/NewsView/1S730J9EKF
6327,2018-11-06,삼성바이오로직스7일바이오젠과콜옵션자산양수도종결,http://www.fnnews.com/news/201811060826500652
6328,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결,http://www.inews24.com/php/news_view.php?g_serial=1138082&g_menu=022620&rrf=nv
6329,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도종결,http://www.newsis.com/view/?id=NISX20181106_0000464357&cID=13001&pID=13000
6330,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결공동경영돌입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060067&t=NN
6331,2018-11-06,삼성바이오로직스7일바이오젠과자산양수도종결,http://www.ekn.kr/news/article.html?no=395812
6332,2018-11-06,삼성바이오로직스12000원301오른411000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060069&t=NN
6333,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도종결,http://news.mk.co.kr/newsRead.php?year=2018&no=693625
6334,2018-11-06,삼성바이오로직스전일대비약3상승한411500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060075&t=NN
6335,2018-11-06,삼성바이오로직스바이오젠과콜옵션자산양수도종결,http://www.dailian.co.kr/news/view/749797/?sc=naver
6336,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결예정,http://www.ceoscoredaily.com/news/article.html?no=47854
6337,2018-11-06,삼성바이오로직스바이오젠과에피스공동경영시작한다,http://www.medigatenews.com/news/961701545
6338,2018-11-06,특징주삼성바이오로직스바이오젠서7595억유입기대강세,http://www.asiatime.co.kr/news/articleView.html?idxno=209680
6339,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결약7595억원지급,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110607214134585
6340,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도종결,http://www.dailypharm.com/News/245755
6341,2018-11-06,대장주UPDOWN셀트리온삼성바이오로직스대외적이슈에흔들,http://www.ekn.kr/news/article.html?no=395819
6342,2018-11-06,Invest삼성바이오로직스7일바이오젠에에피스주식922만주양도,http://www.investchosun.com/?p=3231744
6343,2018-11-06,삼성바이오로직스7일바이오젠과콜옵션자산양수도종결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1683791
6344,2018-11-06,삼성바이오로직스약보합딛고상승세40만원회복,http://www.econonews.co.kr/news/articleView.html?idxno=41353
6345,2018-11-06,삼성바이오로직스7일바이오젠社와자산양수도종결,http://www.anewsa.com/detail.php?number=1412942&thread=10r03
6346,2018-11-06,투자자관심주식삼성바이오로직스알파고분석,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060109&t=NN
6347,2018-11-06,삼성바이오로직스7일바이오젠콜옵션대금수취예정”,http://www.kukinews.com/news/article.html?no=601328
6348,2018-11-06,특징주삼성바이오로직스바이오젠콜옵션자산양수도종결외인팔자에도주가강세,http://www.g-enews.com/ko-kr/news/article/news_all/201811060931317011c642673384_1/article.html
6349,2018-11-06,삼성바이오로직스바이오젠자산양수도종결,http://www.viva100.com/main/view.php?key=20181106010001790
6350,2018-11-06,특징주삼성바이오로직스콜옵션절차조기마무리에상승세,http://www.viva100.com/main/view.php?key=20181106010001835
6351,2018-11-06,특징주삼성바이오로직스바이오젠과자산양수도종결에주가↑,http://www.newsprime.co.kr/news/article.html?no=435189
6352,2018-11-06,삼성바이오로직스바이오젠과체결콜옵션자산양수도종결,http://www.asiatoday.co.kr/view.php?key=20181106010002697
6353,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도종결,http://www.seoulfn.com/news/articleView.html?idxno=324151
6354,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결,http://www.wolyo.co.kr/news/articleView.html?idxno=71035
6355,2018-11-06,삼성바이오로직스7일바이오젠社와자산양수도종결,http://www.sisafocus.co.kr/news/articleView.html?idxno=195560
6356,2018-11-06,삼성바이오로직스美바이오젠과에피스공동경영돌입상보,http://www.edaily.co.kr/news/newspath.asp?newsid=02430486619403096
6357,2018-11-06,삼성바이오로직스바이오젠社와자산양수도종결약7595억원지급예정,http://www.m-i.kr/news/articleView.html?idxno=467254
6358,2018-11-06,관심주삼성전자SK하이닉스신라젠CJENM바이로메드메디톡스약세셀트리온삼성바이오로직스LG화학포스코현대차SK텔레콤강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32057
6359,2018-11-06,삼성바이오로직스바이오젠社와자산양수도종결,http://www.bosa.co.kr/news/articleView.html?idxno=2093436
6360,2018-11-06,삼성바이오로직스7일바이오젠과자산양수도종결,http://medipana.com/news/news_viewer.asp?NewsNum=227960&MainKind=A&NewsKind=5&vCount=12&vKind=1
6361,2018-11-06,코스피보합권개인매수에상승셀트리온삼성바이오로직스LG화학포스코현대차SK텔레콤등상승출발,http://www.econonews.co.kr/news/articleView.html?idxno=41406
6362,2018-11-06,삼성바이오로직스7일바이오젠과자산양수도종결성공적합작사례남길것,http://www.segye.com/content/html/2018/11/06/20181106001543.html?OutUrl=naver
6363,2018-11-06,삼성바이오로직스바이오젠바이오에피스공동경영,http://view.asiae.co.kr/news/view.htm?idxno=2018110611241953521
6364,2018-11-06,삼성바이오로직스美바이오젠과에피스공동경영돌입종합,http://www.edaily.co.kr/news/newspath.asp?newsid=02863446619403096
6365,2018-11-06,삼성바이오로직스바이오젠과삼성바이오에피스공동경영전환,http://www.businesspost.co.kr/BP?command=article_view&num=101427
6366,2018-11-06,삼성바이오로직스7일美바이오젠과자산양수도종결7595억원수취,http://daily.hankooki.com/lpage/ittech/201811/dh20181106140147145630.htm
6367,2018-11-06,삼성바이오로직스셀트리온모두소폭하락장내내상승보이다하락반전,http://www.econonews.co.kr/news/articleView.html?idxno=41441
6368,2018-11-06,삼성바이오로직스7일바이오젠과콜옵션자산양수도종결,http://www.wsobi.com/news/articleView.html?idxno=66961
6369,2018-11-06,삼성바이오로직스美바이오젠과자산양수도종결,http://www.etnews.com/20181106000362
6370,2018-11-06,삼성바이오로직스2000원05오른401000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060436&t=NN
6371,2018-11-06,삼성바이오로직스바이오젠에피스공동경영7일부터개시,http://www.ajunews.com/view/20181106152703922
6372,2018-11-06,셀트리온삼성바이오로직스주가모두올라외국인매도이겨내,http://www.businesspost.co.kr/BP?command=article_view&num=101513
6373,2018-11-06,유가증권시장공시롯데푸드두산삼성바이오로직스등,http://news.mk.co.kr/newsRead.php?year=2018&no=695576
6374,2018-11-06,최종구삼성바이오로직스결론연기시간끌기아냐,http://www.inews24.com/php/news_view.php?g_serial=1138287&g_menu=022300&rrf=nv
6375,2018-11-06,삼성바이오로직스바이오젠삼성바이오에피스공동경영,http://sports.khan.co.kr/news/sk_index.html?art_id=201811061749023&sec_id=561801&pt=nv
6376,2018-11-06,삼성바이오로직스美바이오젠과글로벌바이오시장협공재종합,http://www.edaily.co.kr/news/newspath.asp?newsid=04326326619403096
6377,2018-11-06,삼성바이오로직스바이오젠콜옵션자산양수도종결,http://www.kpinews.co.kr/news/articleView.html?idxno=83859
6378,2018-11-06,삼성바이오로직스바이오젠과삼성바이오에피스공동경영돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1684242
6379,2018-11-06,최종구삼성바이오로직스심의는속도보다공정성이더중요,http://www.businesspost.co.kr/BP?command=article_view&num=101519
6380,2018-11-06,삼성바이오로직스바이오젠사와자산양수도종결,http://www.joongboo.com/news/articleView.html?idxno=1300544
6381,2018-11-06,삼성바이오로직스미국바이오젠과자산양수종결,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1538659
6382,2018-11-06,삼성바이오로직스바이오젠과자산양수도종결,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=776461
6383,2018-11-06,삼성바이오로직스바이오젠콜옵션계약자산양수도종결,http://www.kyeongin.com/main/view.php?key=20181106010001817
6384,2018-11-07,박용진삼성바이오로직스고의분식회계정황드러나,http://www.newstomato.com/ReadNews.aspx?no=856392
6385,2018-11-07,삼성바이오로직스기간제근로자제약바이오업계서최다최고,http://www.datanews.co.kr/news/article.html?no=101442
6386,2018-11-07,삼성바이오로직스1500원037내린399500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811070093&t=NN
6387,2018-11-07,특징주삼성바이오로직스미국바이오젠과공동경영전환주가는공방,http://www.g-enews.com/ko-kr/news/article/news_all/201811070921109069c642673384_1/article.html
6388,2018-11-07,박용진오늘삼성바이오로직스내부문건추가공개,http://www.newspim.com/news/view/20181107000183
6389,2018-11-07,관심주삼성전자삼성바이오로직스LG화학현대차포스코켐텍약세SK하이닉스셀트리온포스코SK텔레콤신라젠CJENM강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32079
6390,2018-11-07,NW포토삼성바이오로직스관련질의하는박용진의원,http://www.newsway.co.kr/news/view?tp=1&ud=2018110711183117604
6391,2018-11-07,NW포토삼성바이오로직스질의에답하는최종구금융위원장,http://www.newsway.co.kr/news/view?tp=1&ud=2018110711212164377
6392,2018-11-07,NW포토삼성바이오로직스관련질의하는박용진의원,http://www.newsway.co.kr/news/view?tp=1&ud=2018110711205514557
6393,2018-11-07,올해국감MVP박용진다음타깃은삼성바이오로직스분식회계,http://view.asiae.co.kr/news/view.htm?idxno=2018110711355300413
6394,2018-11-07,삼성바이오로직스분식회계자료,http://www.newsis.com/view/?id=NISI20181107_0014627088
6395,2018-11-07,삼성바이오로직스분식회계자료,http://www.newsis.com/view/?id=NISI20181107_0014627087
6396,2018-11-07,박용진삼성바이오로직스고의분식회계정황포착최종구잘못된건바로잡겠다,http://www.fnnews.com/news/201811071133127632
6397,2018-11-07,삼성바이오로직스문건관련질의하는박용진의원,http://news1.kr/photos/view/?3379800
6398,2018-11-07,삼성바이오로직스문건자료바라보는국무위원들,http://news1.kr/photos/view/?3379803
6399,2018-11-07,M현장박용진삼성바이오로직스관련내부문건공개,http://www.m-economynews.com/news/article.html?no=23826
6400,2018-11-07,박용진삼성바이오로직스가치8조원대고의뻥튀기는사기,http://www.nocutnews.co.kr/news/5057260
6401,2018-11-07,삼성바이오로직스셀트리온보합또는약보합셀트리온24만원선깨져,http://www.econonews.co.kr/news/articleView.html?idxno=41530
6402,2018-11-07,박용진삼성바이오로직스고의분식회계정황,http://news1.kr/articles/?3470831
6403,2018-11-07,최종구금융위원장삼성바이오로직스분식회계의혹삼성물산감리주장일리있다,http://www.g-enews.com/ko-kr/news/article/news_all/201811071406232378c642673384_1/article.html
6404,2018-11-07,삼성바이오로직스내부문건공개하는박용진의원,http://news1.kr/photos/view/?3380165
6405,2018-11-07,박용진의원삼성바이오로직스내부문서공개,http://news1.kr/photos/view/?3380198
6406,2018-11-07,박영선삼성바이오로직스상장특혜의혹도수사요청할생각”,http://view.asiae.co.kr/news/view.htm?idxno=2018110714332517773
6407,2018-11-07,박용진의원삼성바이오로직스내부문건추가공개,http://www.newscj.com/news/articleView.html?idxno=570270
6408,2018-11-07,삼성바이오로직스내부문건공개하는박용진의원,http://www.anewsa.com/detail.php?number=1414618&thread=01r01
6409,2018-11-07,박용진의원손에들린삼성바이오로직스문건,http://news1.kr/photos/view/?3380275
6410,2018-11-07,삼성바이오로직스관련기자회견하는박용진의원,http://news1.kr/photos/view/?3380272
6411,2018-11-07,사진박용진삼성바이오로직스내부문건공개,http://www.newspim.com/news/view/20181107000495
6412,2018-11-07,삼성바이오로직스문서관련답변하는박용진의원,http://news1.kr/photos/view/?3380261
6413,2018-11-07,박용진의원이공개한삼성바이오로직스문서,http://news1.kr/photos/view/?3380262
6414,2018-11-07,박용진의원삼성바이오로직스내부문서공개,http://www.anewsa.com/detail.php?number=1414622&thread=01r01
6415,2018-11-07,박용진의원삼성바이오로직스내부문서공개,http://www.anewsa.com/detail.php?number=1414621&thread=01r01
6416,2018-11-07,삼성바이오로직스의혹관련기자회견하는박용진,http://www.newscj.com/news/articleView.html?idxno=570275
6417,2018-11-07,더불어민주당박용진의원삼성바이오로직스관련기자회견,http://www.nocutnews.co.kr/news/5057367
6418,2018-11-07,박용진삼성바이오로직스관련기자회견,http://www.nocutnews.co.kr/news/5057363
6419,2018-11-07,박용진삼성바이오로직스내부문서공개,http://www.nocutnews.co.kr/news/5057361
6420,2018-11-07,포토박용진의원삼성바이오로직스내부문서공개,http://www.asiatoday.co.kr/view.php?key=20181107010004166
6421,2018-11-07,포토박용진의원삼성바이오로직스분식회계의혹내부문서공개,http://www.asiatoday.co.kr/view.php?key=20181107010004174
6422,2018-11-07,포토삼성바이오로직스내부문서공개하는박용진의원,http://www.asiatoday.co.kr/view.php?key=20181107010004168
6423,2018-11-07,민주당박용진삼성바이오로직스내부문건공개,http://www.nocutnews.co.kr/news/5057372
6424,2018-11-07,삼성바이오로직스분식회계의혹에쏠린관심,http://www.newscj.com/news/articleView.html?idxno=570285
6425,2018-11-07,포토민주당박용진의원삼성바이오로직스내부문서공개,http://www.asiatoday.co.kr/view.php?key=20181107010004176
6426,2018-11-07,포토삼성바이오로직스분식회계의혹기자회견갖는박용진의원,http://www.asiatoday.co.kr/view.php?key=20181107010004178
6427,2018-11-07,포토삼성바이오로직스내부문서든박용진의원,http://www.asiatoday.co.kr/view.php?key=20181107010004183
6428,2018-11-07,포토박용진의원삼성바이오로직스유치원원장만도못한회계처리,http://www.asiatoday.co.kr/view.php?key=20181107010004182
6429,2018-11-07,박용진삼성바이오로직스고의분식회계정황포착,http://www.anewsa.com/detail.php?number=1414651&thread=11r04
6430,2018-11-07,박용진삼성바이오로직스기업가치뻥튀기하려고분식회계,http://moneys.mt.co.kr/news/mwView.php?no=2018110715098085538
6431,2018-11-07,박용진삼성바이오로직스5조원뻥튀기고의분식회계정황”,http://news.chosun.com/site/data/html_dir/2018/11/07/2018110702430.html?utm_source=naver&utm_medium=original&utm_campaign=news
6432,2018-11-07,2011년설립된삼성바이오로직스고의분식회계했나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181107.99099003068
6433,2018-11-07,박용진삼성바이오로직스분식회계사기행위,http://news.heraldcorp.com/view.php?ud=20181107000674
6434,2018-11-07,삼성바이오로직스분식회계정황관련문건공개,http://www.newscj.com/news/articleView.html?idxno=570298
6435,2018-11-07,박용진삼성바이오로직스고의분식회계정황찾았다,http://www.etnews.com/20181107000369
6436,2018-11-07,박용진삼성바이오로직스3조→8조5조뻥튀기분식회계했다,http://www.segye.com/content/html/2018/11/07/20181107002725.html?OutUrl=naver
6437,2018-11-07,박용진의원손에들린삼성바이오로직스내부문건,http://www.newscj.com/news/articleView.html?idxno=570301
6438,2018-11-07,박용진의원비리유치원이어비리삼성바이오로직스고발,http://www.ggilbo.com/news/articleView.html?idxno=561437
6439,2018-11-07,박용진삼성과회계법인이함께삼성바이오로직스가치부풀렸다,http://www.businesspost.co.kr/BP?command=article_view&num=101642
6440,2018-11-07,삼성바이오로직스바이오젠과주식양수도거래종료,http://www.etoday.co.kr/news/section/newsview.php?idxno=1684643
6441,2018-11-07,박용진삼성바이오로직스고의분식회계정황확인삼성물산감리촉구,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3680427
6442,2018-11-07,박용진삼성바이오로직스가치고의로부풀린문건공개금감원감리에착수해야,http://www.fntoday.co.kr/news/articleView.html?idxno=172130
6443,2018-11-07,박용진삼성바이오로직스고의분식회계문건공개,http://www.mhj21.com/sub_read.html?uid=117334§ion=sc243
6444,2018-11-07,박용진삼성바이오로직스고의분식회계또증거나와금감원감리촉구,http://imnews.imbc.com/news/2018/politic/article/4920637_22672.html
6445,2018-11-07,관심주삼성전자SK하이닉스SK텔레콤신라젠메디톡스상승셀트리온삼성바이오로직스LG화학포스코CJENM하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32095
6446,2018-11-07,최종구삼성바이오로직스봐주기없어삼성물산감리공감,http://www.newsworks.co.kr/news/articleView.html?idxno=308976
6447,2018-11-07,포토박용진삼성바이오로직스내부문건폭로,http://www.dailian.co.kr/news/view/750243/?sc=naver
6448,2018-11-07,포토박용진삼성바이오로직스내부문서공개,http://www.dailian.co.kr/news/view/750245/?sc=naver
6449,2018-11-07,박용진삼성바이오로직스고의분식회계의혹등사실로확인”,http://www.sisajournal-e.com/biz/article/191209
6450,2018-11-07,박용진삼성바이오로직스고의분식회계5조뻥튀기정황드러나,http://www.viva100.com/main/view.php?key=20181107010002720
6451,2018-11-07,박용진삼성폭로이재용승계위해삼성물산제일모직합병과정삼성바이오로직스가치뻥튀기,http://www.ltn.kr/news/articleView.html?idxno=20806
6452,2018-11-07,파란창핫뉴스브리핑대체복무기간삼성바이오로직스내부문건상관모욕병사징역형,http://www.ggilbo.com/news/articleView.html?idxno=561545
6453,2018-11-07,박용진삼성바이오로직스고의분식회계정황포착최종구잘못된건바로잡겠다,http://www.fnnews.com/news/201811071749036702
6454,2018-11-07,박용진삼성바이오로직스고의분식회계엄벌해야,http://www.kntimes.co.kr/news/articleView.html?idxno=28450
6455,2018-11-07,박용진삼성바이오로직스고의분식회계정황관련내부문건공개,http://www.ntoday.co.kr/news/articleView.html?idxno=64023
6456,2018-11-07,삼성바이오로직스내부문서실체박용진의원정론관서서면으로배포한이유는,http://www.iminju.net/news/articleView.html?idxno=39885
6457,2018-11-07,셀트리온주가외국인매도에급락삼성바이오로직스도소폭내려,http://www.businesspost.co.kr/BP?command=article_view&num=101690
6458,2018-11-07,영상국감☆박용진삼성저격삼성바이오로직스분식회계내부문건공개,http://facttv.kr/facttvnews/detail.php?number=22669&thread=14r08
6459,2018-11-07,박용진삼성내부문건폭로삼성바이오로직스고의로분식회계,http://www.newsfreezone.co.kr/news/articleView.html?idxno=86767
6460,2018-11-07,박용진의원삼성바이오로직스5억원부풀린분식회계정황,http://www.techholic.co.kr/news/articleView.html?idxno=179101
6461,2018-11-08,오늘주가얼마나폭락할지겁나삼성바이오로직스가치부풀리기일파만파,http://www.g-enews.com/ko-kr/news/article/news_all/2018110806481764064e4869c120_1/article.html
6462,2018-11-08,삼성바이오로직스15000원375내린385000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811080079&t=NN
6463,2018-11-08,삼성바이오로직스셀트리온장초반희비엇갈려삼성바이오로직스4대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=41580
6464,2018-11-08,특징주삼성바이오로직스기업가치뻥튀기주장에주가하락세,http://news.mt.co.kr/mtview.php?no=2018110809061325611
6465,2018-11-08,삼성바이오로직스분식회계의혹에장초반하락,http://www.sedaily.com/NewsView/1S73XQKDDZ
6466,2018-11-08,특징주삼성바이오로직스고의분식회계정황내부문건공개에하락세,http://www.edaily.co.kr/news/newspath.asp?newsid=01984406619403752
6467,2018-11-08,ET투자뉴스삼성바이오로직스_대형주의상승흐름에소외되면서현재263,http://www.etnews.com/20181108000023
6468,2018-11-08,특징주삼성바이오로직스고의분식회계정황박용진의원지적에약세,http://www.asiatime.co.kr/news/articleView.html?idxno=210211
6469,2018-11-08,박용진삼성이재용경영권승계관련새문건있다삼성바이오로직스파장확대,http://www.choicenews.co.kr/news/articleView.html?idxno=45815
6470,2018-11-08,특징주삼성바이오로직스고의분식회계정황내부문건공개에약세,http://www.cstimes.com/?mod=news&act=articleView&idxno=289420
6471,2018-11-08,특징주삼성바이오로직스분식회계정황내부문건공개소식에약세,http://moneys.mt.co.kr/news/mwView.php?no=2018110809228033121
6472,2018-11-08,특징주삼성바이오로직스고의분식회계정황예결위회의여파약세,http://www.fetv.co.kr/news/article.html?no=15150
6473,2018-11-08,특징주내부문건공개여파에삼성바이오로직스약세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181108036600008&did=1195m
6474,2018-11-08,특징주삼성바이오로직스고의분식회계정황문건공개에약세,http://www.newsis.com/view/?id=NISX20181108_0000467026&cID=10401&pID=10400
6475,2018-11-08,특징주삼성바이오로직스고의분식회계문건공개에주가↓,http://www.newsprime.co.kr/news/article.html?no=435516
6476,2018-11-08,특징주삼성바이오로직스분식회계정황내부문건공개에↓,http://www.seoulfn.com/news/articleView.html?idxno=324386
6477,2018-11-08,특징주삼성바이오로직스고의분식회계의혹에하락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1684938
6478,2018-11-08,특징주삼성바이오로직스분식회계정황내부문건공개에하락,http://www.dailian.co.kr/news/view/750340/?sc=naver
6479,2018-11-08,특징주삼성바이오로직스고의분식회계불확실성주가된서리,http://www.g-enews.com/ko-kr/news/article/news_all/201811080943301740c642673384_1/article.html
6480,2018-11-08,특징주삼성바이오로직스고의분식회계주장에약세,http://biz.chosun.com/site/data/html_dir/2018/11/08/2018110800862.html
6481,2018-11-08,특징주삼성바이오로직스내부문건공개에약세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811080172&t=NN
6482,2018-11-08,특징주삼성바이오로직스고의분식회계불확실성주가된서리,http://www.g-enews.com/ko-kr/news/article/news_all/201811080950443635c642673384_1/article.html
6483,2018-11-08,특징주삼성바이오로직스기업가치뻥튀기정황에3대약세,http://www.viva100.com/main/view.php?key=20181108010002895
6484,2018-11-08,특징주삼성바이오로직스고의분식회계정황내부문건소식에하락세,http://www.dt.co.kr/contents.html?article_no=2018110802109932048006&ref=naver
6485,2018-11-08,고의분식회계정황내부문건공개에삼성바이오로직스약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=338125
6486,2018-11-08,삼성바이오로직스내부문건공개여파38만원대로하락,http://www.seoulwire.com/news/articleView.html?idxno=33326
6487,2018-11-08,삼성바이오로직스8조원대로부풀려진가치평가추가증거나왔다,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10310051
6488,2018-11-08,특징주삼성바이오로직스기업가치뻥튀기의혹에하락세,http://www.sporbiz.co.kr/news/articleView.html?idxno=286498
6489,2018-11-08,삼성바이오로직스분식의혹파장삼성물산감리로확대될듯,http://www.naeil.com/news_view/?id_art=294041
6490,2018-11-08,팩트체크삼성바이오로직스고의로5兆뻥튀기자본시장법회계기준벗어난주장일뿐”,http://www.munhwa.com/news/view.html?no=2018110801070203324001
6491,2018-11-08,삼성바이오로직스셀트리온희비계속엇갈려삼성바이오로직스↓셀트리온↑,http://www.econonews.co.kr/news/articleView.html?idxno=41648
6492,2018-11-08,특징주삼성바이오로직스박용진의원내부문건공개여파약세,http://www.newspim.com/news/view/20181108000552
6493,2018-11-08,삼성바이오로직스15500원387내린384500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811080535&t=NN
6494,2018-11-08,특징주내부문건공개여파에삼성바이오로직스약세종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181108036651008&did=1195m
6495,2018-11-08,아주종목분석내부문건공개삼성바이오로직스약4하락,http://www.ajunews.com/view/20181108162855735
6496,2018-11-08,마감삼성바이오로직스박용진의원주장에하락초록뱀스튜디오드래곤쑥,http://www.asiatime.co.kr/news/articleView.html?idxno=210339
6497,2018-11-08,삼성바이오로직스운명의한주주가향방오리무중,http://www.sisajournal-e.com/biz/article/191263
6498,2018-11-08,오늘Who김태한삼성바이오로직스분식회계궁지에더몰리다,http://www.businesspost.co.kr/BP?command=article_view&num=101796
6499,2018-11-08,관심주삼성전자SK하이닉스셀트리온CJENM포스코켐텍상승삼성바이오로직스LG화학포스코현대차SK텔레콤하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32127
6500,2018-11-08,삼성바이오로직스내부문건공개여파에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=338176
6501,2018-11-08,JTBC도침묵한삼성바이오로직스뻥튀기의혹,http://www.gobalnews.com/news/articleView.html?idxno=26343
6502,2018-11-08,셀트리온주가외국인매수덕에올라삼성바이오로직스는급락,http://www.businesspost.co.kr/BP?command=article_view&num=101824
6503,2018-11-08,박용진최종구회계법인의삼성바이오로직스가치평가적정성놓고설전,http://www.choicenews.co.kr/news/articleView.html?idxno=45848
6504,2018-11-08,삼성바이오로직스내부문서공개분식회계의혹재점화이재용부회장에불똥,http://www.greened.kr/news/articleView.html?idxno=82346
6505,2018-11-08,아주종목분석삼성바이오로직스휴미라저가공세내부문건공개에약세,http://www.ajunews.com/view/20181108134906494
6506,2018-11-09,기자수첩분식회계논란삼성바이오로직스나비효과이재용까지전이되나,http://www.kukinews.com/news/article.html?no=602443
6507,2018-11-09,주간한국삼성바이오로직스내부문건박용진의스모킹건인가확대해석인가,http://daily.hankooki.com/lpage/economy/201811/dh20181109070036138060.htm
6508,2018-11-09,김어준의뉴스공장삼성바이오로직스분식회계추가정황바이오젠지분되사와지배력유지,http://www.topstarnews.net/news/articleView.html?idxno=520531
6509,2018-11-09,한경로보뉴스전일기관거래소에서삼성전자011삼성바이오로직스388등순매도,http://news.hankyung.com/article/201811097463L
6510,2018-11-09,삼성바이오로직스2500원065내린382000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811090085&t=NN
6511,2018-11-09,특징주삼성바이오로직스증선위재감리불확실성주가주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201811090907207785c642673384_1/article.html
6512,2018-11-09,삼성바이오로직스셀트리온장초반하락세삼성바이오로직스3거래일연속하락,http://www.econonews.co.kr/news/articleView.html?idxno=41719
6513,2018-11-09,특징주삼성바이오로직스증선위재감리불확실성나흘째약세,http://www.fetv.co.kr/news/article.html?no=15227
6514,2018-11-09,삼성바이오로직스고의회계분식포착소식에나흘째약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=338256
6515,2018-11-09,특징주삼성바이오로직스박의원내부문건공개후2거래일연속약세,http://www.newsis.com/view/?id=NISX20181109_0000468319&cID=10401&pID=10400
6516,2018-11-09,ET투자뉴스삼성바이오로직스_외국인의매수에기관은순매도현재234,http://www.etnews.com/20181109000050
6517,2018-11-09,관심주삼성전자현대차신한지주CJENM224포스코켐텍강세SK하이닉스셀트리온삼성바이오로직스LG화학포스코SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32138
6518,2018-11-09,코스피뉴욕증시혼조에보합권약세SK하이닉스셀트리온삼성바이오로직스LG화학SK텔레콤등하락,http://www.econonews.co.kr/news/articleView.html?idxno=41760
6519,2018-11-09,기자수첩삼성바이오로직스의의도와능력,http://www.sisajournal-e.com/biz/article/191287
6520,2018-11-09,특징주바이오株약세삼성바이오로직스재감리여파,http://www.newspim.com/news/view/20181109000488
6521,2018-11-09,삼성바이오로직스박용진의원내부문건공개후연속약세3대하락,http://www.econonews.co.kr/news/articleView.html?idxno=41780
6522,2018-11-09,퀵리포트삼성바이오로직스매수로상향목표가30↑52만원KB證,http://www.itooza.com/common/iview.php?no=2018110917000015094
6523,2018-11-09,삼성바이오로직스목표가30↑52만원제시KB證,http://www.newspim.com/news/view/20181109000677
6524,2018-11-09,마감삼성바이오로직스여파셀트리온등동반하락초록뱀이틀째상승,http://www.asiatime.co.kr/news/articleView.html?idxno=210551
6525,2018-11-09,셀트리온주가쌍끌이매도에대폭하락삼성바이오로직스도급락,http://www.businesspost.co.kr/BP?command=article_view&num=101991
6526,2018-11-10,코스피뉴욕증시혼조에소폭하락셀트리온삼성바이오로직스포스코LG화학현대차SK텔레콤등내림세,http://www.econonews.co.kr/news/articleView.html?idxno=41832
6527,2018-11-11,증선위삼성바이오로직스분식회계14일최종결론,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10310504
6528,2018-11-11,D3삼성바이오로직스분식회계최종결론난다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1685877
6529,2018-11-11,증선위삼성바이오로직스혐의14일결론,http://www.shinailbo.co.kr/news/articleView.html?idxno=1117631
6530,2018-11-11,오락가락삼성바이오로직스주가위기가기회규모의효과에올라타라,http://www.g-enews.com/ko-kr/news/article/news_all/201811092012376343c642673384_1/article.html
6531,2018-11-12,증선위삼성바이오로직스분식회계14일최종결론낼듯,http://www.asiatime.co.kr/news/articleView.html?idxno=210721
6532,2018-11-12,투자코멘트실시간종목순위0840셀트리온삼성전자삼성바이오로직스,http://www.fntimes.com/html/view.php?ud=2018111208505980125dfa877505_18
6533,2018-11-12,삼성바이오로직스27000원734내린341000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811120064&t=NN
6534,2018-11-12,삼성바이오로직스셀트리온장초반부터대거매도세로급락710↓,http://www.econonews.co.kr/news/articleView.html?idxno=41952
6535,2018-11-12,삼성바이오로직스전일대비약9하락한334500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811120081&t=NN
6536,2018-11-12,특징주삼성바이오로직스분식회계관련최종결론앞두고급락세,http://news.mt.co.kr/mtview.php?no=2018111209080820495
6537,2018-11-12,특징주삼성바이오로직스증선위분식회계결론우려급락,http://www.asiatime.co.kr/news/articleView.html?idxno=210733
6538,2018-11-12,특징주삼성바이오로직스급락분식혐의14일결론,http://news.hankyung.com/article/2018111249806
6539,2018-11-12,ET투자뉴스삼성바이오로직스후보물질을가지고BUY신규KB증권,http://www.etnews.com/20181112000025
6540,2018-11-12,특징주삼성바이오로직스증선위결론앞두고급락세,http://www.newsway.co.kr/news/view?tp=1&ud=2018111209154103454
6541,2018-11-12,특징주삼성바이오로직스증선위최종결론앞두고나흘째하락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1686048
6542,2018-11-12,특징주삼성바이오로직스분식회계최종결론앞두고급락,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111209172156040
6543,2018-11-12,특징주삼성바이오로직스14일증선위분식회계결론앞두고약세,http://www.newspim.com/news/view/20181112000220
6544,2018-11-12,특징주삼성바이오로직스증선위재감리경계감확산에약세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811120114&t=NN
6545,2018-11-12,삼성바이오로직스14일운명의증선위앞두고급락세,http://www.sedaily.com/NewsView/1S75RMHB92
6546,2018-11-12,특징주삼성바이오로직스분식회계최종결론앞두고급락,http://www.dailian.co.kr/news/view/750987/?sc=naver
6547,2018-11-12,특징주삼성바이오로직스증선위분식회계결론우려에하락세,http://www.seoulfn.com/news/articleView.html?idxno=324652
6548,2018-11-12,특징주삼성바이오로직스증선위최종결론소식에급락,http://www.viva100.com/main/view.php?key=20181112010004035
6549,2018-11-12,삼성바이오로직스분식회계증선위결론앞두고9↓,http://view.asiae.co.kr/news/view.htm?idxno=2018111209260223153
6550,2018-11-12,특징주삼성바이오로직스분식혐의결론앞두고주가급락,http://www.fetv.co.kr/news/article.html?no=15346
6551,2018-11-12,특징주삼성바이오로직스증선위분식회계결론임박주가휘청,http://www.g-enews.com/ko-kr/news/article/news_all/201811120928305153c642673384_1/article.html
6552,2018-11-12,특징주삼성바이오로직스증선위최종결론앞두고급락,http://biz.chosun.com/site/data/html_dir/2018/11/12/2018111200851.html
6553,2018-11-12,특징주삼성바이오로직스증선위발표앞두고급락,http://www.ebn.co.kr/news/view/961463
6554,2018-11-12,삼성바이오로직스증선위최종결론앞두고급락,http://www.mdtoday.co.kr/mdtoday/index.html?no=338396
6555,2018-11-12,삼성바이오로직스장초반7대급락중증선위고의분식회계결론전망탓,http://news.imaeil.com/Economy/2018111209364223261
6556,2018-11-12,특징주삼성바이오로직스증선위D2급락,http://www.inews24.com/php/news_view.php?g_serial=1139300&g_menu=022300&rrf=nv
6557,2018-11-12,삼성바이오로직스분식회계혐의최종결론앞두고급락,http://www.kyeongin.com/main/view.php?key=20181112010003465
6558,2018-11-12,삼성바이오로직스증선위최종발표앞두고장중연중최저가급락,http://www.seoulwire.com/news/articleView.html?idxno=33838
6559,2018-11-12,특징주삼성바이오로직스증선위결론앞두고급락,http://moneys.mt.co.kr/news/mwView.php?no=2018111209438036704
6560,2018-11-12,삼성바이오로직스급락세이유는,http://www.ggilbo.com/news/articleView.html?idxno=562643
6561,2018-11-12,삼성바이오로직스목표주가하향삼성바이오에피스가치떨어져,http://www.businesspost.co.kr/BP?command=article_view&num=102109
6562,2018-11-12,삼성바이오로직스전거래일보다910급락33만4500원에거래,http://www.topstarnews.net/news/articleView.html?idxno=522278
6563,2018-11-12,삼성바이오로직스10하락전일보다37000원내린331000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811120163&t=NN
6564,2018-11-12,삼성바이오로직스분식회계의혹14일최종결론앞두고연중최저가,http://daily.hankooki.com/lpage/economy/201811/dh20181112095819138110.htm
6565,2018-11-12,삼성바이오로직스분식회계혐의최종결론부담에급락,http://www.sisajournal-e.com/biz/article/191367
6566,2018-11-12,삼성바이오로직스연일급락세분식회계최종결론목전으로”,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181112.99099004834
6567,2018-11-12,유삼성바이오로직스장중신저가기록324000→323000▼1000,http://www.sedaily.com/NewsView/1S75RN391A
6568,2018-11-12,HotLine삼성바이오로직스분식회계여부결론앞두고급락,http://news.mk.co.kr/newsRead.php?year=2018&no=707619
6569,2018-11-12,삼성바이오로직스상장폐지우려에이재용승계논란까지주가16대급락,http://www.kpinews.co.kr/news/articleView.html?idxno=84077
6570,2018-11-12,삼성바이오로직스분식회계여부14일결론큰파장예상,http://www.topstarnews.net/news/articleView.html?idxno=522372
6571,2018-11-12,삼성바이오로직스장시작1시간반만에시총4조증발,http://view.asiae.co.kr/news/view.htm?idxno=2018111210461628422
6572,2018-11-12,삼성바이오로직스30만원대깨지나증선위발표14일까지계속하락세,http://news.imaeil.com/Economy/2018111210553643015
6573,2018-11-12,관심주삼성전자SK하이닉스셀트리온포스코현대차삼성바이오로직스SK텔레콤신한지주약세LG화학스튜디오드래곤강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32166
6574,2018-11-12,삼성바이오로직스14일증선위발표앞두고급락연중최저가,http://www.betanews.net:8080/article/933411.html
6575,2018-11-12,삼성바이오로직스증선위결정앞두고14대급락,http://news1.kr/articles/?3474429
6576,2018-11-12,코스피2080선삼성바이오로직스증선위발표앞두고급락세,http://www.seoulwire.com/news/articleView.html?idxno=33862
6577,2018-11-12,특징주삼성바이오로직스분식회계최종결론앞두고9대↓,http://www.newsprime.co.kr/news/article.html?no=435866
6578,2018-11-12,셀트리온삼성바이오로직스12일장중급락무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=45910
6579,2018-11-12,특징주증선위분식회계혐의결과발표앞둔삼성바이오로직스주식시장급락,http://www.joongboo.com/news/articleView.html?idxno=1301951
6580,2018-11-12,코스피뉴욕증시하락에급락출발후낙폭줄여SK하이닉스셀트리온포스코현대차삼성바이오로직스등내림세,http://www.econonews.co.kr/news/articleView.html?idxno=41991
6581,2018-11-12,분식회계의혹삼성바이오로직스최종결론앞두고급락30만원선무너질까,http://www.topstarnews.net/news/articleView.html?idxno=522528
6582,2018-11-12,양재준기자의알투바이오코너에몰린금융위삼성바이오로직스해법시나리오는,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811120292&t=NN
6583,2018-11-12,특징주삼성바이오로직스분식회계결론앞두고17대급락,http://news.mt.co.kr/mtview.php?no=2018111213442485338
6584,2018-11-12,삼성바이오로직스상장폐지리스크에주가17폭락,http://www.sisafocus.co.kr/news/articleView.html?idxno=196039
6585,2018-11-12,삼성바이오로직스주가20만원대임박1698305500원,http://news.imaeil.com/Economy/2018111213524086352
6586,2018-11-12,분식혐의논쟁삼성바이오로직스증선위앞두고30만원붕괴우려,http://news.hankyung.com/article/2018111258776
6587,2018-11-12,삼성바이오로직스시총20조깨졌다주가도20만원대,http://news.imaeil.com/Economy/2018111214003830134
6588,2018-11-12,투자자관심주식삼성바이오로직스알파고분석,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811120361&t=NN
6589,2018-11-12,특징주분식회계혐의증선위발표앞둔삼성바이오로직스주가급락,http://www.mediapen.com/news/view/395180
6590,2018-11-12,대장주삼성바이오로직스셀트리온우려바이오주급락,http://news.hankyung.com/article/2018111265446
6591,2018-11-12,특징주삼성바이오로직스증선위분식회계발표앞두고신저가,http://www.finomy.com/news/articleView.html?idxno=60032
6592,2018-11-12,삼성바이오로직스운명의14일앞두고연중최저가경신,http://www.sedaily.com/NewsView/1S75T8FKQ5
6593,2018-11-12,삼성바이오로직스분식회계결론앞두고20급락30만원선붕괴,http://www.fntimes.com/html/view.php?ud=201811121405178669f09e13944d_18
6594,2018-11-12,특징주삼성바이오로직스회계분식결론앞두고30만원붕괴,http://view.asiae.co.kr/news/view.htm?idxno=2018111214192234296
6595,2018-11-12,분식회계혐의삼성바이오로직스증선위최종결론앞두고30만원붕괴,http://www.mdtoday.co.kr/mdtoday/index.html?no=338434
6596,2018-11-12,증선위삼성바이오로직스재감리안건14일결론,http://www.fntimes.com/html/view.php?ud=201811121410209678179ad43907_18
6597,2018-11-12,삼성바이오로직스분식회계14일결정난다고의결론날까,http://www.newsworks.co.kr/news/articleView.html?idxno=310108
6598,2018-11-12,삼성바이오로직스주가2242급락,http://imnews.imbc.com/news/2018/econo/article/4928296_22671.html
6599,2018-11-12,ET투자뉴스삼성바이오로직스파도가잔잔해질때BUY삼성증권,http://www.etnews.com/20181112000349
6600,2018-11-12,분식회계혐의삼성바이오로직스최악의경우상폐대상까지,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181112.99099005034
6601,2018-11-12,삼성바이오로직스시총10위밖으로,http://www.mediasr.co.kr/news/articleView.html?idxno=49979
6602,2018-11-12,삼성바이오로직스증선위최종결론앞두고장중30만원붕괴,http://www.seoulwire.com/news/articleView.html?idxno=33930
6603,2018-11-12,박상기법무삼성바이오로직스구체적특혜단서확인되면수사”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811121507003&sec_id=560901&pt=nv
6604,2018-11-12,이재용부회장경영권승계의묘약삼성바이오로직스분식회계,http://www.mhj21.com/sub_read.html?uid=117440§ion=sc243
6605,2018-11-12,fnRASSI장마감거래소하락종목삼성바이오로직스2242↓,http://www.fnnews.com/news/201811121537267517
6606,2018-11-12,삼성바이오로직스분식회계증선위최종결론앞두고급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1686322
6607,2018-11-12,삼성바이오로직스2242내려14일발표앞둔내일더빠질수도,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181112.99099005082
6608,2018-11-12,삼성바이오로직스5조허공속으로장중28만1천원까지하락시총폭삭,http://www.kyeongin.com/main/view.php?key=20181112010003624
6609,2018-11-12,삼성바이오로직스2242폭락한28만5500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=562889
6610,2018-11-12,삼성바이오로직스36만→28만원대로주가급락,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181112145332
6611,2018-11-12,마감시황삼성바이오로직스셀트리온급락여파반등실패코스피▼027하락마감코스닥2급락,http://www.joongboo.com/news/articleView.html?idxno=1302063
6612,2018-11-12,삼성바이오로직스하루새시총54조증발13위로밀려나,http://www.mdtoday.co.kr/mdtoday/index.html?no=338459
6613,2018-11-12,2016년상장후최대폭하락삼성바이오로직스전일대비2242하락시총5조증발하며4→13위와르르,http://www.joongboo.com/news/articleView.html?idxno=1302064
6614,2018-11-12,삼성바이오로직스주가곤두박질셀트리온도급락,http://www.dailymedi.com/detail.php?number=836814&thread=22r05
6615,2018-11-12,삼성바이오로직스박살시총18조원대주가28만원대내일증시도,http://news.imaeil.com/Economy/2018111216155378662
6616,2018-11-12,증선위삼성바이오로직스분식회계의혹결론임박증권가최악상황은면할듯관측,http://sports.chosun.com/news/ntype.htm?id=201811130100111950008419&servicedate=20181112
6617,2018-11-12,삼성바이오로직스고의분식회계결론나상장폐지위기로몰리나,http://www.businesspost.co.kr/BP?command=article_view&num=102169
6618,2018-11-12,삼성바이오로직스주가뚝뚝상장폐지글쎄일상톡톡플러스,http://www.segye.com/content/html/2018/11/12/20181112003151.html?OutUrl=naver
6619,2018-11-12,코스피코스닥동반하락삼성바이오로직스셀트리온급락여파,http://www.businesspost.co.kr/BP?command=article_view&num=102180
6620,2018-11-12,상폐기로에선바이오대장주삼성바이오로직스시총하루5조증발,http://news.kmib.co.kr/article/view.asp?arcid=0012835043&code=61141211&cp=nv
6621,2018-11-12,코스피208044마감삼성바이오로직스22폭락,http://www.sporbiz.co.kr/news/articleView.html?idxno=287709
6622,2018-11-12,삼성바이오로직스셀트리온하루만에시총9조원증발,http://moneys.mt.co.kr/news/mwView.php?no=2018111216528098869
6623,2018-11-12,박상기삼성바이오로직스상장특혜의혹단서확인되면수사,http://www.businesspost.co.kr/BP?command=article_view&num=102195
6624,2018-11-12,마감셀트리온삼성바이오로직스금란지교동반급락휠라코리아깜짝실적에급등,http://www.asiatime.co.kr/news/articleView.html?idxno=210881
6625,2018-11-12,삼성바이오로직스2242급락바이오株꽁꽁,http://www.ftoday.co.kr/news/articleView.html?idxno=104223
6626,2018-11-12,삼성바이오로직스분식회계결론두고공포심리확산주가22급락,http://www.todaykorea.co.kr/news/view.php?no=257956
6627,2018-11-12,삼성바이오로직스감리심사쇼크삼바IFRS에따라회계처리상장폐지가능성은낮아,http://www.sedaily.com/NewsView/1S75SQ8CA2
6628,2018-11-12,바이오대장주셀트리온삼성바이오로직스폭락에주요바이오종목대거급락,http://www.joongboo.com/news/articleView.html?idxno=1302129
6629,2018-11-12,삼성바이오로직스하루만에시총5조4000억증발4위서13위↓,http://daily.hankooki.com/lpage/economy/201811/dh20181112173208138110.htm
6630,2018-11-12,삼성바이오로직스주가급락시총5조증발셀트리온도급락,http://www.businesspost.co.kr/BP?command=article_view&num=102202
6631,2018-11-12,삼성바이오로직스주가폭락왜,http://www.asiatoday.co.kr/view.php?key=20181112010006986
6632,2018-11-12,삼성바이오로직스셀트리온쇼크에무너진바이오업종,http://news.kmib.co.kr/article/view.asp?arcid=0012835384&code=61141111&cp=nv
6633,2018-11-12,삼성바이오로직스나비효과코스피코스닥동반하락,http://sports.khan.co.kr/news/sk_index.html?art_id=201811122013003&sec_id=564001&pt=nv
6634,2018-11-12,삼성바이오로직스14일결정앞두고급락,https://cnbc.sbs.co.kr/article_hub/10000920891?division=NAVER
6635,2018-11-13,13일삼성바이오로직스주가더떨어지나증선위결론에주목,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181113.99099005121
6636,2018-11-13,삼성바이오로직스분식회계인정될때상장폐지까지,http://www.techholic.co.kr/news/articleView.html?idxno=179170
6637,2018-11-13,뉴욕증시다우지수와르르애플쇼크나스닥지수강타삼성바이오로직스코스피코스닥원달러환율비상,http://www.g-enews.com/ko-kr/news/article/news_all/2018111304400985504a01bf698f_1/article.html
6638,2018-11-13,바이오주좋다고투자했는데쪽박삼성바이오로직스다시삼바춤언제추나,http://www.g-enews.com/ko-kr/news/article/news_all/2018111306254220034e4869c120_1/article.html
6639,2018-11-13,삼성전자삼성바이오로직스주가하락타격미미하나,http://news.hankyung.com/article/2018111388496
6640,2018-11-13,삼성바이오로직스운명의날D1불안한바이오업계,http://www.edaily.co.kr/news/newspath.asp?newsid=01430086619405392
6641,2018-11-13,삼성바이오로직스하루새시가총액5조4천억증발시총4→13위곤두박질,http://www.seoulwire.com/news/articleView.html?idxno=34037
6642,2018-11-13,애플vs삼성바이오로직스뉴욕증시코스피흔드는두거물쇼크어디까지,http://www.g-enews.com/ko-kr/news/article/news_all/20181113074754100004a01bf698f_1/article.html
6643,2018-11-13,뉴스투데이투자노트삼성바이오로직스의운명은정해져있다,http://www.news2day.co.kr/114549
6644,2018-11-13,삼성바이오로직스상장폐지가능성거의없다신한,http://biz.chosun.com/site/data/html_dir/2018/11/13/2018111301123.html
6645,2018-11-13,삼성바이오로직스상장폐지가능성거의없다신한,http://biz.chosun.com/site/data/html_dir/2018/11/13/2018111301123.html
6646,2018-11-13,투자코멘트실시간종목순위0840삼성바이오로직스셀트리온삼성전자,http://www.fntimes.com/html/view.php?ud=201811130850597695dfa8273f1_18
6647,2018-11-13,삼성전자삼성바이오로직스주가급락영향제한적–하나금융투자,http://www.fntimes.com/html/view.php?ud=2018111308494787131d6f57e61a_18
6648,2018-11-13,하나금융투자삼성바이오로직스주가하락삼성전자기업가치에영향미미”,http://www.viva100.com/main/view.php?key=20181113010004536
6649,2018-11-13,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스폭락딛고상승,http://www.econonews.co.kr/news/articleView.html?idxno=42098
6650,2018-11-13,삼성바이오로직스분식회계고의성여부촉각상폐가능성은,http://moneys.mt.co.kr/news/mwView.php?no=2018111309008033542
6651,2018-11-13,특징주삼성바이오로직스장초반소폭반등,http://view.asiae.co.kr/news/view.htm?idxno=2018111309075915567
6652,2018-11-13,특징주삼성바이오로직스증선위앞두고오름세,http://www.sporbiz.co.kr/news/articleView.html?idxno=287863
6653,2018-11-13,특징주삼성바이오로직스전날폭락이후상승세,http://news.mt.co.kr/mtview.php?no=2018111309091588530
6654,2018-11-13,분식회계의혹삼성바이오로직스주가도곤두박질,http://www.mhj21.com/sub_read.html?uid=117458§ion=sc243
6655,2018-11-13,특징주삼성바이오로직스증선위분식회계결정초읽기외인사자에주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201811130904553742c642673384_1/article.html
6656,2018-11-13,ET투자뉴스삼성바이오로직스_돋보이는상승세현재263,http://www.etnews.com/20181113000010
6657,2018-11-13,분식회계의혹삼성바이오로직스주가도곤두박질,http://www.mhj21.com/sub_read.html?uid=117458§ion=sc243
6658,2018-11-13,특징주삼성바이오로직스급락하루만에반등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1686582
6659,2018-11-13,삼바운명D1삼성바이오로직스셀트리온악재제약바이오투자심리개선은언제,http://www.sporbiz.co.kr/news/articleView.html?idxno=287827
6660,2018-11-13,특징주삼성바이오로직스반등세반전증거나올까,http://www.asiatime.co.kr/news/articleView.html?idxno=210951
6661,2018-11-13,한경로보뉴스삼성바이오로직스5이상상승20182Q매출액1254억984영업이익237억흑자전환,http://news.hankyung.com/article/201811139326L
6662,2018-11-13,특징주삼성바이오로직스상승폭확대중최대9↑,http://view.asiae.co.kr/news/view.htm?idxno=2018111309202458097
6663,2018-11-13,삼성바이오로직스전일낙폭과했나장초반급등,http://moneys.mt.co.kr/news/mwView.php?no=2018111309218038194
6664,2018-11-13,삼성바이오로직스장초반소폭반등14일증선위결론주목,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181113.99099005325
6665,2018-11-13,증권업계삼성바이오로직스분식회계혐의결과에촉각상장폐지심사에쏠리는이목,http://www.topstarnews.net/news/articleView.html?idxno=523231
6666,2018-11-13,특징주삼성바이오로직스증선위회의앞두고반등,http://www.fetv.co.kr/news/article.html?no=15409
6667,2018-11-13,특징주삼성바이오로직스급락하루만에반등변동폭확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111309202083307
6668,2018-11-13,특징주삼성바이오로직스급락하루만에반등하락폭만회,http://www.ekn.kr/news/article.html?no=397253
6669,2018-11-13,특징주삼성바이오로직스전날폭락이후상승세,http://www.ebn.co.kr/news/view/961622
6670,2018-11-13,특징주삼성바이오로직스저가매수세에반등,http://www.viva100.com/main/view.php?key=20181113010004571
6671,2018-11-13,유삼성바이오로직스전일대비701상승일일회전율은077기록,http://www.sedaily.com/NewsView/1S767WD9DC
6672,2018-11-13,삼성바이오로직스분식회계의혹발표D1증선위선택은,http://www.sisafocus.co.kr/news/articleView.html?idxno=196086
6673,2018-11-13,특징주삼성바이오로직스저가매수몰려반등,http://www.newsis.com/view/?id=NISX20181113_0000471344&cID=10401&pID=10400
6674,2018-11-13,특징주삼성바이오로직스상장폐지가능성없다증권가분석에강세,http://www.newspim.com/news/view/20181113000191
6675,2018-11-13,삼성바이오로직스반등상장폐지가능성없다,http://news.hankyung.com/article/2018111394676
6676,2018-11-13,특징주삼성바이오로직스하루만에반등8↑,http://www.dt.co.kr/contents.html?article_no=2018111302109932048007&ref=naver
6677,2018-11-13,삼성전자삼성바이오로직스의지분3149를보유중,http://www.newsworks.co.kr/news/articleView.html?idxno=310296
6678,2018-11-13,HotLine삼성바이오로직스운명의날하루앞두고반등,http://news.mk.co.kr/newsRead.php?year=2018&no=710444
6679,2018-11-13,삼성바이오로직스셀트리온등바이오주하루만에반등,http://www.seoulwire.com/news/articleView.html?idxno=34062
6680,2018-11-13,삼성바이오로직스전날폭락떨치고장초반급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=338512
6681,2018-11-13,삼성바이오로직스분식회계혐의결론하루앞두고반등세,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3685403
6682,2018-11-13,삼성바이오로직스단타매수몰렸나12일폭락후13일소폭반등,http://news.imaeil.com/Economy/2018111309491609761
6683,2018-11-13,특징주삼성바이오로직스증선위D1급반등,http://www.inews24.com/php/news_view.php?g_serial=1139507&g_menu=022300&rrf=nv
6684,2018-11-13,분식회계의혹삼성바이오로직스급락하루만에급등세투자자들롤러코스터,http://www.topstarnews.net/news/articleView.html?idxno=523249
6685,2018-11-13,삼성바이오로직스9대반등전날2242↓급락분회복할까,http://www.segye.com/content/html/2018/11/13/20181113000839.html?OutUrl=naver
6686,2018-11-13,운명의날앞둔삼성바이오로직스급락하루만에급반등,http://news20.busan.com/controller/newsController.jsp?newsId=20181113000040
6687,2018-11-13,삼성바이오로직스분식회계여파에도신한금융투자상장폐지가능성없다,http://www.segye.com/content/html/2018/11/13/20181113000762.html?OutUrl=naver
6688,2018-11-13,22폭락→장중9반등삼성바이오로직스주가널뛰기,http://news.kmib.co.kr/article/view.asp?arcid=0012836801&code=61141111&cp=nv
6689,2018-11-13,특징주전날폭락한삼성바이오로직스증선위발표하루앞두고반등세,http://www.joongboo.com/news/articleView.html?idxno=1302348
6690,2018-11-13,삼성바이오로직스분식회계내일결정,https://news.sbs.co.kr/news/endPage.do?news_id=N1005014224&plink=ORI&cooper=NAVER
6691,2018-11-13,삼성바이오로직스전일대비약7상승한304500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811130302&t=NN
6692,2018-11-13,코스피미국증시급락여파2040대삼성바이오로직스는반등,http://www.seoulwire.com/news/articleView.html?idxno=34080
6693,2018-11-13,ET투자뉴스삼성전자삼성바이오로직스의BUY하나금융투자,http://www.etnews.com/20181113000102
6694,2018-11-13,삼성바이오로직스상장폐지피할수있을까투자자들갈팡질팡,http://news.hankyung.com/article/2018111398217
6695,2018-11-13,신한금투삼성바이오로직스상폐가능성없다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811130343&t=NN
6696,2018-11-13,삼성바이오로직스11급등전일보다32500원상승한318000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811130398&t=NN
6697,2018-11-13,분식회계혐의삼성바이오로직스증선위최종결론D1상장폐지가능성낮아,http://www.topstarnews.net/news/articleView.html?idxno=523428
6698,2018-11-13,이슈진단삼성바이오로직스결론D1상장폐지면할수있을까,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003396473
6699,2018-11-13,케이뱅크삼성바이오로직스검찰수사임박박상기법무장관검찰수사언급,http://kpenews.com/Board.aspx?BoardNo=21205
6700,2018-11-13,특징주증선위결과앞둔삼성바이오로직스12반등상승폭확대,http://view.asiae.co.kr/news/view.htm?idxno=2018111314093118824
6701,2018-11-13,뉴투분석참여연대와박용진의원삼성바이오로직스상장폐지원하나,http://www.news2day.co.kr/114590
6702,2018-11-13,삼성바이오로직스분식회계논쟁고의적분식VS회계처리문제없다팽팽증선위결정은,http://www.ekn.kr/news/article.html?no=397335
6703,2018-11-13,삼성바이오로직스주가하락이삼성전자기업가치에줄영향미미,http://www.businesspost.co.kr/BP?command=article_view&num=102315
6704,2018-11-13,삼성바이오로직스셀트리온급락벗어났다특히삼성바이오로직스10대급등,http://www.econonews.co.kr/news/articleView.html?idxno=42152
6705,2018-11-13,삼성바이오로직스분식회계결론나도상장폐지가능성낮아,http://www.businesspost.co.kr/BP?command=article_view&num=102324
6706,2018-11-13,경제오아시스뜨거운감자삼성바이오로직스내일금융위결론,http://imnews.imbc.com/replay/2018/nw1400/article/4930032_24166.html
6707,2018-11-13,삼성바이오로직스분식회계논쟁흔들리는바이오ETF펀드매니저도결과촉각,http://www.ekn.kr/news/article.html?no=397355
6708,2018-11-13,삼성바이오로직스981상승한31만3500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=563339
6709,2018-11-13,”분식회계냐아니냐운명의날앞둔삼성바이오로직스,http://www.fntimes.com/html/view.php?ud=201811131530213961f09e13944d_18
6710,2018-11-13,삼성바이오로직스상장폐지가능성없다증권가관측에9대급등,http://www.kpinews.co.kr/news/articleView.html?idxno=84184
6711,2018-11-13,삼성바이오로직스3분기개별영업이익104억전년비48↓,http://www.newspim.com/news/view/20181113000693
6712,2018-11-13,삼성바이오로직스여의도가살렸다상장존속가능성↑급등세,http://www.m-i.kr/news/articleView.html?idxno=469651
6713,2018-11-13,삼성바이오로직스증선위결론D1상장폐지가능성낮다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111314220068646
6714,2018-11-13,실적속보삼성바이오로직스3Q영업이익104억전년비48↓,http://www.itooza.com/common/iview.php?no=2018111315511516567
6715,2018-11-13,코스피삼성바이오로직스분기보고서201809,http://news.kmib.co.kr/article/view.asp?arcid=0012837827&code=61141211&cp=nv
6716,2018-11-13,삼성바이오로직스운명의D1후폭풍몰아치나,http://www.metroseoul.co.kr/news/newsview?newscd=2018111300184
6717,2018-11-13,분식회계결론앞둔삼성바이오로직스반등투자자긴장은여전,http://www.fntimes.com/html/view.php?ud=201811131554588216f09e13944d_18
6718,2018-11-13,현장에서한아름기자삼성바이오로직스힘빠진제약업계삼바신바람언제다시,http://www.g-enews.com/ko-kr/news/article/news_all/20181113155616538425b4ac5ede_1/article.html
6719,2018-11-13,삼성바이오로직스운명의날D1증선위이후시나리오,http://www.insightkorea.co.kr//news/articleView.html?idxno=32212
6720,2018-11-13,ET투자뉴스삼성바이오로직스3Q어닝서프라이즈영업이익기대치1829↑,http://www.etnews.com/20181113000384
6721,2018-11-13,삼성바이오로직스외인매수에981상승마감,http://www.ekn.kr/news/article.html?no=397394
6722,2018-11-13,삼성바이오로직스3분기영업익105억원49감소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181113139500008&did=1195m
6723,2018-11-13,요동치는삼성바이오로직스무너지는삼성그룹주펀드,http://news.mt.co.kr/mtview.php?no=2018111314513835257
6724,2018-11-13,삼성바이오로직스3분기영업익105억원49↓,http://www.sedaily.com/NewsView/1S769CIYHY
6725,2018-11-13,마켓인사이트삼성바이오로직스로슈CFO출신영입,http://news.hankyung.com/article/201811131790u
6726,2018-11-13,삼성바이오로직스3분기영업익105억원전년비49↓,http://www.mediapen.com/news/view/395535
6727,2018-11-13,삼성바이오로직스3분기영업이익105억원작년동기보다49감소,http://news20.busan.com/controller/newsController.jsp?newsId=20181113000201
6728,2018-11-13,삼성바이오로직스3분기영업익105억원전년비49↓,http://www.cstimes.com/?mod=news&act=articleView&idxno=289835
6729,2018-11-13,오늘Who김태한삼성바이오로직스분식회계결전에뛰어들다,http://www.businesspost.co.kr/BP?command=article_view&num=102336
6730,2018-11-13,관심주삼성전자SK하이닉스셀트리온포스코SK텔레콤하락LG화학현대차삼성바이오로직스메디톡스코오롱티슈진상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=32214
6731,2018-11-13,삼성바이오로직스3Q영업익105억전년比49↓,http://news.mt.co.kr/mtview.php?no=2018111317055201956
6732,2018-11-13,코스피하락속삼성바이오로직스큰폭반등한이유,http://www.news2day.co.kr/114610
6733,2018-11-13,삼성바이오로직스분식회계혐의증선위결론에촉각바이오주넘어증시초미의관심,http://www.econonews.co.kr/news/articleView.html?idxno=42203
6734,2018-11-13,증선위14일삼성바이오로직스운명결정,http://sports.khan.co.kr/news/sk_index.html?art_id=201811131719003&sec_id=564001&pt=nv
6735,2018-11-13,삼성바이오로직스상폐가능성없다,http://www.fnnews.com/news/201811131726391324
6736,2018-11-13,삼성바이오로직스분식회계고의성인정되나이재용승계삼성물산제일모직합병정당성재부상,http://www.4th.kr/news/articleView.html?idxno=6721
6737,2018-11-13,삼성바이오로직스3분기영업익105억원전년比4887↓,http://www.newsis.com/view/?id=NISX20181113_0000472196&cID=10401&pID=10400
6738,2018-11-13,운명의날하루앞둔삼성바이오로직스증선위의결정은,http://daily.hankooki.com/lpage/economy/201811/dh20181113180044138110.htm
6739,2018-11-13,삼성바이오로직스주가외국인매수에급반등셀트리온은하락,http://www.businesspost.co.kr/BP?command=article_view&num=102368
6740,2018-11-13,합병비율은1개월주가기준삼성바이오로직스정치적틀아닌보편적회계기준으로판단해야,http://www.wikileaks-kr.org/news/articleView.html?idxno=40643
6741,2018-11-13,삼성바이오로직스분식회계결론하루앞두고반등,http://www.joongboo.com/news/articleView.html?idxno=1302553
6742,2018-11-13,삼성바이오로직스3분기영업이익105억원매출은1010억6640만원,http://www.econonews.co.kr/news/articleView.html?idxno=42223
6743,2018-11-13,증선위삼성바이오로직스분식회계결론D1바이오株진정언제쯤,http://www.viva100.com/main/view.php?key=20181113010004851
6744,2018-11-14,삼성바이오로직스분식회계결론나면최악엔상장폐지,https://www.ytn.co.kr/_ln/0102_201811140007395811
6745,2018-11-14,14일삼성바이오로직스운명의날증선위어떤결론낼까,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181114.99099005713
6746,2018-11-14,분식회계혐의삼성바이오로직스14일최종결론논란종지부찍을까,http://www.kukinews.com/news/article.html?no=603957
6747,2018-11-14,삼성바이오로직스상장폐지운명의날증시영향력변수,http://www.ajunews.com/view/20181113150342243
6748,2018-11-14,삼성바이오로직스상장폐지운명의날미국뉴욕증시바이오주비상코스피코스닥원달러환율흔들,http://www.g-enews.com/ko-kr/news/article/news_all/2018111404345511314a01bf698f_1/article.html
6749,2018-11-14,삼성바이오로직스운명의날증선위결론은,http://www.newsworks.co.kr/news/articleView.html?idxno=310505
6750,2018-11-14,삼성바이오로직스거래정지주의보우려가현실되면거래재개까지험난,http://www.g-enews.com/ko-kr/news/article/news_all/201811132351012088c642673384_1/article.html
6751,2018-11-14,뉴스투데이투자노트삼성바이오로직스와금감원둘중하나는치명타오전9시증선위개최,http://www.news2day.co.kr/114647
6752,2018-11-14,삼성바이오로직스상장폐지여부촉각,http://www.newstomato.com/ReadNews.aspx?no=857694
6753,2018-11-14,삼성바이오로직스운명의날,http://www.newstomato.com/ReadNews.aspx?no=857696
6754,2018-11-14,뉴욕증시잘나가다막판와르르국제유가71폭락다우지수강타삼성바이오로직스쇼크나스닥바이오흔들,http://www.g-enews.com/ko-kr/news/article/news_all/2018111405335619024a01bf698f_1/article.html
6755,2018-11-14,이슈삼성바이오로직스운명의날고의결론→주식거래정지,http://news.hankyung.com/article/2018111428397
6756,2018-11-14,삼성바이오로직스삼바춤추지못하고주저앉나증선위고의성판단땐최악상폐가능성도,http://www.g-enews.com/ko-kr/news/article/news_all/2018111406254823614e4869c120_1/article.html
6757,2018-11-14,증선위오늘삼성바이오로직스분식혐의결론,http://imnews.imbc.com/replay/2018/nwtoday/article/4930874_22669.html
6758,2018-11-14,모닝브리핑삼성바이오로직스운명의날수능D1예비소집,http://news.hankyung.com/article/2018111428877
6759,2018-11-14,증선위오늘삼성바이오로직스분식혐의결론,http://imnews.imbc.com/replay/2018/nwtoday/article/4930936_22669.html
6760,2018-11-14,삼성바이오로직스운명의날고의분식여부오늘결론,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1197313
6761,2018-11-14,클릭e종목삼성바이오로직스증선위불확실성반영목표가50만원으로하향,http://view.asiae.co.kr/news/view.htm?idxno=2018111407225150343
6762,2018-11-14,코스피코스닥13일주요공시삼성바이오로직스3분기영업익105억원49감소등,http://www.betanews.net:8080/article/934415.html
6763,2018-11-14,삼성바이오로직스분식혐의결전의날떨어지는칼날과저점매수사이”,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181114.99099005837
6764,2018-11-14,삼성바이오로직스증선위결정으로매매거래정지가능성목표가↓SK,http://news.hankyung.com/article/2018111429386
6765,2018-11-14,삼성바이오로직스분식회계혐의고의성발표DDAY영업이익49감소,http://www.topstarnews.net/news/articleView.html?idxno=524218
6766,2018-11-14,내일의경제일정금융위증선위정례회의삼성바이오로직스분식회계의고의성여부최종결론,http://www.asiatime.co.kr/news/articleView.html?idxno=211153
6767,2018-11-14,삼성바이오로직스매매거래정지가능성에목표가하향SK證,http://news.mt.co.kr/mtview.php?no=2018111408024147263
6768,2018-11-14,스태그플레이션의공포가온다삼성바이오로직스상장폐지코스피코스닥대란경기침체물가폭등,http://www.g-enews.com/ko-kr/news/article/news_all/2018111309410037134a01bf698f_1/article.html
6769,2018-11-14,HotLine삼성바이오로직스증선위서매매정지처분가능성,http://news.mk.co.kr/newsRead.php?year=2018&no=712845
6770,2018-11-14,SK증권삼성바이오로직스매매거래정지가능성목표가↓,http://www.newsis.com/view/?id=NISX20181114_0000472454&cID=10401&pID=10400
6771,2018-11-14,삼성바이오로직스회계불확실성반영목표가↓SK증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111408245041625
6772,2018-11-14,답변하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114015400013&did=1196m
6773,2018-11-14,증선위참석하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114015500013&did=1196m
6774,2018-11-14,포토엘레베이터탄김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408312420158
6775,2018-11-14,삼성바이오로직스오늘증선위결정따라거래정지가능성,http://www.fntimes.com/html/view.php?ud=201811140821296556f09e13944d_18
6776,2018-11-14,휴대전화살펴보는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114015900013&did=1196m
6777,2018-11-14,삼성바이오로직스오늘바로거래정지,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111408302136828
6778,2018-11-14,휴대전화살펴보는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114015800013&did=1196m
6779,2018-11-14,김태한삼성바이오로직스사장굳은표정,http://news1.kr/photos/view/?3389244
6780,2018-11-14,핸드폰보는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3389246
6781,2018-11-14,증선위참석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3389245
6782,2018-11-14,삼성바이오로직스의운명은,http://news1.kr/photos/view/?3389247
6783,2018-11-14,검색받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114016000013&did=1196m
6784,2018-11-14,검색받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114016100013&did=1196m
6785,2018-11-14,포토질문세례받는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408392990532
6786,2018-11-14,서류가방들고증선위참석하는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3389250
6787,2018-11-14,포토김태한삼성바이오로직스대표향한질문,http://view.asiae.co.kr/news/view.htm?idxno=2018111408394293152
6788,2018-11-14,굳은표정의김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3389253
6789,2018-11-14,삼성바이오로직스증선위회계변경고의성여부는,http://news1.kr/photos/view/?3389255
6790,2018-11-14,삼성바이오로직스운명의날,http://news1.kr/photos/view/?3389252
6791,2018-11-14,취재진질문듣는김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3389254
6792,2018-11-14,김태한삼성바이오로직스사장굳은표정으로증선위참석,http://news1.kr/photos/view/?3389256
6793,2018-11-14,포토질문에답변하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408435945918
6794,2018-11-14,포토질문에답변하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408435945918
6795,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114019100013&did=1196m
6796,2018-11-14,답변하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114017800013&did=1196m
6797,2018-11-14,SK증권삼성바이오로직스증선위서매매거래정지가능성목표하향,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00004&news_seq_no=3686207
6798,2018-11-14,질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114017700013&did=1196m
6799,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114019000013&did=1196m
6800,2018-11-14,답변하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114018000013&did=1196m
6801,2018-11-14,증선위삼성바이오로직스분식회계혐의오늘최종결론,http://www.obsnews.co.kr/news/articleView.html?idxno=1125215
6802,2018-11-14,질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114019700013&did=1196m
6803,2018-11-14,증선위향하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114020300013&did=1196m
6804,2018-11-14,투자코멘트실시간종목순위0840삼성바이오로직스셀트리온삼성전자,http://www.fntimes.com/html/view.php?ud=2018111408505920545dfa8273f1_18
6805,2018-11-14,질문받는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114019600013&did=1196m
6806,2018-11-14,증선위향하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114020200013&did=1196m
6807,2018-11-14,오늘의종목삼성바이오로직스매매거래정지리스크목표가↓,http://www.sedaily.com/NewsView/1S76P30NMD
6808,2018-11-14,삼성바이오로직스결전의날고의성판단촉각상폐가능성미미,http://www.seoulwire.com/news/articleView.html?idxno=34220
6809,2018-11-14,포토보안검색받는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408545337755
6810,2018-11-14,포토취재진앞에선김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408550340891
6811,2018-11-14,포토혀내민김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408555052846
6812,2018-11-14,포토증선위향하는김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408564887564
6813,2018-11-14,사진정부청사들어서는김태한삼성바이오로직스대표,http://www.newspim.com/news/view/20181114000212
6814,2018-11-14,포토질문에혀내민김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408561364979
6815,2018-11-14,포토굳은표정의김태한삼성바이오로직스대표,http://view.asiae.co.kr/news/view.htm?idxno=2018111408570696776
6816,2018-11-14,증선위향하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114021000013&did=1196m
6817,2018-11-14,사진답변하는김태한삼성바이오로직스대표,http://www.newspim.com/news/view/20181114000215
6818,2018-11-14,사진증선위출석입굳게다문김태한삼성바이오로직스대표,http://www.newspim.com/news/view/20181114000217
6819,2018-11-14,포토삼성바이오로직스운명의날,http://view.asiae.co.kr/news/view.htm?idxno=2018111409005142600
6820,2018-11-14,사진김태한삼성바이오로직스대표이제그만들어갑시다,http://www.newspim.com/news/view/20181114000223
6821,2018-11-14,사진손사레치는삼성바이오로직스김태한대표,http://www.newspim.com/news/view/20181114000226
6822,2018-11-14,삼성바이오로직스전일대비약5상승한329500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811140092&t=NN
6823,2018-11-14,머니S포토긴장한김태한삼성바이오로직스사장,http://moneys.mt.co.kr/news/mwView.php?no=2018111408578028447
6824,2018-11-14,삼성바이오로직스분식회계결론상장폐지까지는,http://www.namdonews.com/news/articleView.html?idxno=497637
6825,2018-11-14,HotLine운명의날맞은삼성바이오로직스강세출발,http://news.mk.co.kr/newsRead.php?year=2018&no=712977
6826,2018-11-14,삼성바이오로직스운명의날맞아장초반부터무섭게상승셀트리온도강보합,http://www.econonews.co.kr/news/articleView.html?idxno=42244
6827,2018-11-14,특징주삼성바이오로직스증선위앞두고반등,http://www.newsis.com/view/?id=NISX20181114_0000472527&cID=10401&pID=10400
6828,2018-11-14,특징주삼성바이오로직스분식회계혐의최종결론앞두고강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1687149
6829,2018-11-14,특징주삼성바이오로직스운명의날강세무혐의나올까,http://www.asiatime.co.kr/news/articleView.html?idxno=211187
6830,2018-11-14,특징주운명의날맞은삼성바이오로직스상승세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181114037000008&did=1195m
6831,2018-11-14,현장사진증선위불참설헛소문김태한삼성바이오로직스대표이사정부서울청사등장,http://news.imaeil.com/Economy/2018111409092355137
6832,2018-11-14,삼성바이오로직스증선위심판대로,http://news1.kr/photos/view/?3389293
6833,2018-11-14,삼성바이오로직스증선위정례회의결과앞두고상승,http://news.hankyung.com/article/2018111432726
6834,2018-11-14,김태한삼성바이오로직스사장증선위로향하며,http://news1.kr/photos/view/?3389291
6835,2018-11-14,특징주삼성바이오로직스증선위최종결정임박주가는탄력받나,http://www.g-enews.com/ko-kr/news/article/news_all/201811140909247825c642673384_1/article.html
6836,2018-11-14,삼성바이오로직스증선위심판대로,http://news1.kr/photos/view/?3389293
6837,2018-11-14,운명의날삼성바이오로직스증선위분식회계혐의최종결론낸다,http://www.kyeongin.com/main/view.php?key=20181114010004348
6838,2018-11-14,특징주삼성바이오로직스분식회계최종결론앞두고강세,http://www.newspim.com/news/view/20181114000248
6839,2018-11-14,SK증권삼성바이오로직스분식회계결론날경우거래정지가능성”,http://www.kukinews.com/news/article.html?no=603967
6840,2018-11-14,특징주삼성바이오로직스분식회계혐의최종결론앞두고급등,http://www.cstimes.com/?mod=news&act=articleView&idxno=289869
6841,2018-11-14,운명의문통과하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114023400013&did=1196m
6842,2018-11-14,운명의문통과하는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114023300013&did=1196m
6843,2018-11-14,삼성바이오로직스목표주가하향장기간주식거래정지가능성,http://www.businesspost.co.kr/BP?command=article_view&num=102424
6844,2018-11-14,삼성바이오로직스분식회계의혹심의중오늘결론날듯,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10311014
6845,2018-11-14,삼성바이오로직스목표주가하향장기간주식거래정지가능성,http://www.businesspost.co.kr/BP?command=article_view&num=102424
6846,2018-11-14,특징주삼성바이오로직스분식회계결론DDAY장초반상승,http://www.inews24.com/php/news_view.php?g_serial=1139672&g_menu=022300&rrf=nv
6847,2018-11-14,머니S포토삼성바이오로직스최종결론앞둔증선위,http://moneys.mt.co.kr/news/mwView.php?no=2018111409098070253
6848,2018-11-14,특징주삼성바이오로직스증선위정례회의앞두고상승,http://www.edaily.co.kr/news/newspath.asp?newsid=02355046619405720
6849,2018-11-14,특징주삼성바이오로직스증선위최종결론앞두고강세,http://www.fetv.co.kr/news/article.html?no=15474
6850,2018-11-14,삼성바이오로직스운명의날,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114024500013&did=1196m
6851,2018-11-14,삼성바이오로직스운명의날,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114024400013&did=1196m
6852,2018-11-14,특징주운명의날삼성바이오로직스상승세전일대비319↑,http://www.sporbiz.co.kr/news/articleView.html?idxno=288256
6853,2018-11-14,모닝리포트삼성바이오로직스재감리,http://www.fntimes.com/html/view.php?ud=2018111409205958805dfa833dd5_18
6854,2018-11-14,LTE현장연결삼성바이오로직스운명의날증선위개최,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811140067&t=NNv
6855,2018-11-14,특징주삼성바이오로직스증선위최종결론앞두고강세,http://www.ebn.co.kr/news/view/961758
6856,2018-11-14,특징주운명의날맞은삼성바이오로직스장초반강세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111409205516206
6857,2018-11-14,특징주삼성바이오로직스증선위발표앞두고상승,http://www.newsprime.co.kr/news/article.html?no=436158
6858,2018-11-14,현장사진삼성바이오로직스숨통틀어쥔증선위위원장은누구김용범,http://news.imaeil.com/Economy/2018111409331926272
6859,2018-11-14,뉴스워커_외신삼성바이오로직스상장폐지되면이재용부회장타격받을것,http://www.newsworker.co.kr/news/articleView.html?idxno=23315
6860,2018-11-14,오늘의키워드삼성바이오로직스운명의날분식회계결론나면,https://cnbc.sbs.co.kr/article_hub/10000921097?division=NAVER
6861,2018-11-14,포토삼성바이오로직스분식회계증선위최종결론,http://www.dailian.co.kr/news/view/751578/?sc=naver
6862,2018-11-14,삼성바이오로직스증선위결과앞두고2대강세,http://news1.kr/articles/?3476299
6863,2018-11-14,포토증선위출석하는김태한삼성바이오로직스대표,http://www.dailian.co.kr/news/view/751585/?sc=naver
6864,2018-11-14,포토답변하는김태한삼성바이오로직스대표,http://www.dailian.co.kr/news/view/751587/?sc=naver
6865,2018-11-14,운명의날삼성바이오로직스에쏠리는시선,http://www.ftoday.co.kr/news/articleView.html?idxno=104263
6866,2018-11-14,관심주삼성전자SK하이닉스포스코신한지주신라젠CJENM에이치엘비약세셀트리온LG화학SK텔레콤삼성바이오로직스포스코켐텍강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32224
6867,2018-11-14,코스피뉴욕증시하락여파2060선삼성바이오로직스상승세,http://www.seoulwire.com/news/articleView.html?idxno=34242
6868,2018-11-14,특징주삼성바이오로직스증선위발표앞두고주가상승,http://www.mediapen.com/news/view/395647
6869,2018-11-14,속보삼성바이오로직스주가급등김태한대표상장폐지는없다코스피코스닥원달러환율흔들,http://www.g-enews.com/ko-kr/news/article/news_all/2018111409275541264a01bf698f_1/article.html
6870,2018-11-14,금융위원회14일삼성바이오로직스분식회계의혹심의돌입상장폐지여부에쏠리는이목,http://www.topstarnews.net/news/articleView.html?idxno=524297
6871,2018-11-14,삼성바이오로직스분식회계혐의결론앞두고장초반상승세,http://www.kyeongin.com/main/view.php?key=20181114010004373
6872,2018-11-14,포토김태한삼성바이오로직스대표이사증선위참석,http://www.asiatoday.co.kr/view.php?key=20181114010008045
6873,2018-11-14,포토미소짓는김태한삼성바이오로직스대표이사,http://www.asiatoday.co.kr/view.php?key=20181114010008048
6874,2018-11-14,포토오늘증선위로향하는김태한삼성바이오로직스대표,http://www.sisaon.co.kr/news/articleView.html?idxno=79264
6875,2018-11-14,포토증선위회의참석하는김태한삼성바이오로직스대표이사,http://www.asiatoday.co.kr/view.php?key=20181114010008046
6876,2018-11-14,포토미소짓는김태한삼성바이오로직스대표이사,http://www.asiatoday.co.kr/view.php?key=20181114010008048
6877,2018-11-14,아주종목분석증선위발표앞둔삼성바이오로직스상승세,http://www.ajunews.com/view/20181114095704787
6878,2018-11-14,포토삼성바이오로직스결전의날,http://www.asiatoday.co.kr/view.php?key=20181114010008059
6879,2018-11-14,특징주삼성바이오로직스증선위결정앞두고강세,http://moneys.mt.co.kr/news/mwView.php?no=2018111410028086615
6880,2018-11-14,삼성바이오로직스증선위넘어도주가전망은불투명,http://moneys.mt.co.kr/news/mwView.php?no=2018111409548087920
6881,2018-11-14,운명의날에도삼성바이오로직스주식은강세출발,http://news.kmib.co.kr/article/view.asp?arcid=0012840140&code=61141211&cp=nv
6882,2018-11-14,특징주증선위발표앞둔운명의날삼성바이오로직스415급등하며장초반강세,http://www.joongboo.com/news/articleView.html?idxno=1302759
6883,2018-11-14,삼성바이오로직스운명의날상장폐지가능성은,http://www.mediasr.co.kr/news/articleView.html?idxno=50004
6884,2018-11-14,특징주삼성바이오로직스증선위최종발표앞두고이틀째상승,http://www.viva100.com/main/view.php?key=20181114010005123
6885,2018-11-14,삼성바이오로직스의운명의날증선위이후3가지시나리오,http://www.viva100.com/main/view.php?key=20181114010005124
6886,2018-11-14,유삼성바이오로직스전일대비861상승일일회전율은067기록,http://www.sedaily.com/NewsView/1S76PRBKYL
6887,2018-11-14,표삼성바이오로직스사태주요일지,http://www.viva100.com/main/view.php?key=20181114010005115
6888,2018-11-14,운명의날삼성바이오로직스분식회계문제제기부터최종결론까지,http://news.hankyung.com/article/2018111435376
6889,2018-11-14,삼성바이오로직스운명의날세가지시나리오는,http://www.sisajournal-e.com/biz/article/191473
6890,2018-11-14,한경로보뉴스삼성바이오로직스5이상상승증선위결정에따라매매거래정지가능성있어SK증권BUY유지,http://news.hankyung.com/article/201811143944L
6891,2018-11-14,김태한삼성바이오로직스사장회계처리적법성본질봐달라,http://www.newsis.com/view/?id=NISX20181114_0000472656&cID=13001&pID=13000
6892,2018-11-14,운명의날맞은삼성바이오로직스주가는이틀연속반등,http://www.news2day.co.kr/114652
6893,2018-11-14,삼성바이오로직스증선위결과앞두고7대급등,http://news1.kr/articles/?3476424
6894,2018-11-14,최후의날삼성바이오로직스최대쟁점은고의적분식회계,http://www.viva100.com/main/view.php?key=20181114010005089
6895,2018-11-14,삼성바이오로직스거래정지가능성바이오충격파는,http://kormedi.com/?p=1255269
6896,2018-11-14,김태한삼성바이오로직스사장분식회계혐의에회계처리적법성본질봐달라,http://www.segye.com/content/html/2018/11/14/20181114001208.html?OutUrl=naver
6897,2018-11-14,삼성바이오로직스오늘14일운명의날주가는강세,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000071
6898,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648001
6899,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014647996
6900,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648004
6901,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648003
6902,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648010
6903,2018-11-14,청사나서는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648012
6904,2018-11-14,눈감은김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648005
6905,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014647998
6906,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648013
6907,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648003
6908,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648010
6909,2018-11-14,청사나서는김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648012
6910,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014647999
6911,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648011
6912,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648000
6913,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648007
6914,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648000
6915,2018-11-14,증선위원회회의마친김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648004
6916,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648047
6917,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648051
6918,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://www.newsis.com/view/?id=NISI20181114_0014648048
6919,2018-11-14,삼성바이오로직스증선위발표예상시나리오는,http://www.ebn.co.kr/news/view/961778
6920,2018-11-14,김태한증권선물위출석삼성바이오로직스회계처리본질봐야,http://www.businesspost.co.kr/BP?command=article_view&num=102439
6921,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114078300013&did=1196m
6922,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114078200013&did=1196m
6923,2018-11-14,굳은표정의김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114078100013&did=1196m
6924,2018-11-14,사진증선위회의마친김태한삼성바이오로직스대표이사,http://news.mt.co.kr/mtview.php?no=2018111411431098040
6925,2018-11-14,청사나서는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114080400013&did=1196m
6926,2018-11-14,청사나서는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114080600013&did=1196m
6927,2018-11-14,청사나서는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114080200013&did=1196m
6928,2018-11-14,청사나서는김태한삼성바이오로직스대표이사,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114080300013&did=1196m
6929,2018-11-14,증선위마친김태한삼성바이오로직스사장,http://news1.kr/photos/view/?3389829
6930,2018-11-14,삼성바이오로직스증선위결정앞두고5대상승상폐가능성은,http://www.fntimes.com/html/view.php?ud=20181114114221537f09e13944d_18
6931,2018-11-14,삼성바이오로직스의운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114083000013&did=1196m
6932,2018-11-14,삼성바이오로직스고의분식회계혐의심의돌입,http://imnews.imbc.com/replay/2018/nw1200/article/4931537_22606.html
6933,2018-11-14,삼성바이오로직스의운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114082100013&did=1196m
6934,2018-11-14,포토불길한예감굳은표정의김태한삼성바이오로직스대표이사,http://www.betanews.net:8080/article/934788.html
6935,2018-11-14,삼성바이오로직스운명의날회계처리의적법성에대한본질을봐달라,http://www.econonews.co.kr/news/articleView.html?idxno=42285
6936,2018-11-14,삼성바이오로직스분식회계결론묵묵부답주가도답보상태,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181114.99099006033
6937,2018-11-14,삼성바이오로직스매매거래정지가능성목표주가하향SK증권,http://www.ekn.kr/news/article.html?no=397473
6938,2018-11-14,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114105900065&did=1196m
6939,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106000065&did=1196m
6940,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106100065&did=1196m
6941,2018-11-14,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106400065&did=1196m
6942,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114107200065&did=1196m
6943,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106800065&did=1196m
6944,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114107400065&did=1196m
6945,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106700065&did=1196m
6946,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106800065&did=1196m
6947,2018-11-14,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114107100065&did=1196m
6948,2018-11-14,삼성바이오로직스운명은,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114107300065&did=1196m
6949,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106300065&did=1196m
6950,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114107000065&did=1196m
6951,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106200065&did=1196m
6952,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114107500065&did=1196m
6953,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114106600065&did=1196m
6954,2018-11-14,포토운명의날맞이한삼성바이오로직스,http://news.bizwatch.co.kr/article/market/2018/11/14/0005/naver
6955,2018-11-14,삼성바이오로직스운명은,http://news1.kr/photos/view/?3390004
6956,2018-11-14,삼성바이오로직스앞날은,http://news1.kr/photos/view/?3390031
6957,2018-11-14,삼성바이오로직스분식회계혐의심의결과는,http://news1.kr/photos/view/?3390028
6958,2018-11-14,삼성바이오로직스운명의날,http://news1.kr/photos/view/?3390007
6959,2018-11-14,삼성바이오로직스셀트리온대거매수세몰려57↑,http://www.econonews.co.kr/news/articleView.html?idxno=42301
6960,2018-11-14,삼성바이오로직스운명은,http://news1.kr/photos/view/?3390078
6961,2018-11-14,ET투자뉴스삼성바이오로직스증선위결정에따라BUY유지SK증권,http://www.etnews.com/20181114000495
6962,2018-11-14,삼성바이오로직스증선위발표앞두고제약주일제히반등,http://www.ajunews.com/view/20181114140237022
6963,2018-11-14,삼성바이오로직스운명은,http://news1.kr/photos/view/?3390123
6964,2018-11-14,코스피뉴욕증시혼조에엎치락뒤치락셀트리온LG화학SK텔레콤삼성바이오로직스등은상승,http://www.econonews.co.kr/news/articleView.html?idxno=42309
6965,2018-11-14,삼성바이오로직스대표이사최종결론굳은표정,http://www.ggilbo.com/news/articleView.html?idxno=563695
6966,2018-11-14,삼성바이오로직스10급등전일보다31500원상승한345000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811140413&t=NN
6967,2018-11-14,fnRASSI삼성바이오로직스전일대비989상승,http://www.fnnews.com/news/201811141426568198
6968,2018-11-14,이슈진단1삼성바이오로직스DDAY고의성여부에달렸다,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003397763
6969,2018-11-14,잠깐상식삼바삼성바이오로직스준말고의분식회계최종결론14일오후발표예정,http://news.imaeil.com/Economy/2018111414462082777
6970,2018-11-14,삼성바이오로직스증선위결론임박제약바이오주강세,http://www.ebn.co.kr/news/view/961810
6971,2018-11-14,종합삼성바이오로직스최후의날증선위결정과이후파장,http://www.viva100.com/main/view.php?key=20181114010005323
6972,2018-11-14,증선위삼성바이오로직스분식회계결과오후4시30분발표,http://www.g-enews.com/ko-kr/news/article/news_all/201811141506149577c642673384_1/article.html
6973,2018-11-14,삼성바이오로직스고의분식심의앞두고상승세,http://www.kyeongin.com/main/view.php?key=20181114001504061
6974,2018-11-14,분식회계논란삼성바이오로직스향방은오후4시30분결과발표,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811140184&t=NNv
6975,2018-11-14,어차피삼성못건드려”삼성바이오로직스개미탈출無,http://www.mhj21.com/sub_read.html?uid=117511§ion=sc243
6976,2018-11-14,삼성바이오로직스증선위최종결론4시30분발표,http://www.ebn.co.kr/news/view/961820
6977,2018-11-14,특징주삼성바이오로직스분식회계혐의최종결론앞두고강세,http://www.edaily.co.kr/news/newspath.asp?newsid=05011846619405720
6978,2018-11-14,삼성바이오로직스증선위결과4시반이후발표,http://www.asiatime.co.kr/news/articleView.html?idxno=211352
6979,2018-11-14,금융위오후4시30분삼성바이오로직스결과발표,http://www.fetv.co.kr/news/article.html?no=15517
6980,2018-11-14,증선위삼성바이오로직스심의결과4시30분발표,http://www.ajunews.com/view/20181114152743141
6981,2018-11-14,속보증선위삼성바이오로직스분식회계최종결론곧발표증시영향피하기위해장마감이후,http://news.imaeil.com/Finance/2018111415344984550
6982,2018-11-14,삼성바이오로직스증선위결과앞두고670상승마감,http://view.asiae.co.kr/news/view.htm?idxno=2018111415401670790
6983,2018-11-14,삼성바이오로직스증선위분식회계혐의최종결론앞두고67상승마감,http://www.segye.com/content/html/2018/11/14/20181114002751.html?OutUrl=naver
6984,2018-11-14,삼성바이오로직스670상승한33만4500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=563762
6985,2018-11-14,속보오후4시30분금융위증선위삼성바이오로직스분식회계최종결론발표,http://news.imaeil.com/Economy/2018111415480192624
6986,2018-11-14,삼성바이오로직스운명의날주가삼바춤,http://www.dt.co.kr/contents.html?article_no=2018111402109932048012&ref=naver
6987,2018-11-14,삼성바이오로직스증선위분식회계혐의결론앞두고67급등,http://www.sporbiz.co.kr/news/articleView.html?idxno=288404
6988,2018-11-14,베팅매수증선위발표직전장마감삼성바이오로직스주가반등거래량150만건육박,http://news.imaeil.com/Economy/2018111416013123370
6989,2018-11-14,삼성바이오로직스운명의날에도주가는67↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181114037051008&did=1195m
6990,2018-11-14,삼성바이오로직스상폐리스크앞두고도주가훨훨,http://www.sisafocus.co.kr/news/articleView.html?idxno=196238
6991,2018-11-14,금융위삼성바이오로직스삼바분식회계판단결과오후4시30분발표,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000158
6992,2018-11-14,삼성바이오로직스분식회계심의결과4시30분경마무리,http://www.mhj21.com/sub_read.html?uid=117512§ion=sc243
6993,2018-11-14,삼성바이오로직스운명의날에도주가는67↑,http://news.kbs.co.kr/news/view.do?ncd=4073541&ref=A
6994,2018-11-14,증권선물위원회삼성바이오로직스분식회계결론진통,http://view.asiae.co.kr/news/view.htm?idxno=2018111416243918596
6995,2018-11-14,생생경제삼성바이오로직스분식회계혐의운명의날밝았다,https://www.ytn.co.kr/_ln/0102_201811141625369989
6996,2018-11-14,삼성바이오로직스주가개인매수세에급등셀트리온도올라,http://www.businesspost.co.kr/BP?command=article_view&num=102499
6997,2018-11-14,거래소삼성바이오로직스고의분식회계판정시상장폐지는,http://www.asiatime.co.kr/news/articleView.html?idxno=211374
6998,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114165300013&did=1196m
6999,2018-11-14,삼성바이오로직스주가증선위최종결론앞두고반등종합,http://www.newsis.com/view/?id=NISX20181114_0000473327&cID=10401&pID=10400
7000,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114166100013&did=1196m
7001,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114166000013&did=1196m
7002,2018-11-14,생생경제삼성바이오로직스분식회계혐의운명의날밝았다,http://radio.ytn.co.kr/program/?f=2&id=59089&s_mcd=0206&s_hcd=15
7003,2018-11-14,SBSLIVE삼성바이오로직스분식회계혐의최종결론발표,https://news.sbs.co.kr/news/endPage.do?news_id=N1005016630&plink=ORI&cooper=NAVER
7004,2018-11-14,속보증선위삼성바이오로직스당분간거래정지상장폐지심사대상,http://news.imaeil.com/Economy/2018111416294760350
7005,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114165500013&did=1196m
7006,2018-11-14,풀영상삼성바이오로직스고의분식회계결론거래정지,https://news.sbs.co.kr/news/endPage.do?news_id=N1005016813&plink=ORI&cooper=NAVER
7007,2018-11-14,속보증선위삼성바이오로직스2014년회계처리중과실”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141632003&sec_id=564001&pt=nv
7008,2018-11-14,증권선물위원회삼성바이오로직스삼바분식회계고의적결론향후상장폐지되나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181114.99099006183
7009,2018-11-14,증선위삼성바이오로직스거래정지상장실질심사3보,http://news.mt.co.kr/mtview.php?no=2018111416330551973
7010,2018-11-14,삼성바이오로직스고의분식회계결론거래정지,http://news.kbs.co.kr/news/view.do?ncd=4073567&ref=A
7011,2018-11-14,속보증선위삼성바이오로직스2014년회계처리중과실,http://www.newscj.com/news/articleView.html?idxno=572536
7012,2018-11-14,속보증선위삼성바이오로직스2014년회계처리위반,http://www.g-enews.com/ko-kr/news/article/news_all/201811141633224057c642673384_1/article.html
7013,2018-11-14,속보증선위삼성바이오로직스2014년회계처리중과실”,http://www.viva100.com/main/view.php?key=20181114010005412
7014,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114167300013&did=1196m
7015,2018-11-14,삼성바이오로직스고의분식회계맞다1보,http://www.sisafocus.co.kr/news/articleView.html?idxno=196245
7016,2018-11-14,속보삼성바이오로직스2014년회계처리는중과실”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141633003&sec_id=564001&pt=nv
7017,2018-11-14,속보증선위삼성바이오로직스2015년회계처리고의위반,http://www.viva100.com/main/view.php?key=20181114010005414
7018,2018-11-14,속보증선위삼성바이오로직스2014년회계처리중과실”,http://moneys.mt.co.kr/news/mwView.php?no=2018111416358055492
7019,2018-11-14,증선위삼성바이오로직스2014년회계과실1보,http://news.heraldcorp.com/view.php?ud=20181114000763
7020,2018-11-14,속보증선위삼성바이오로직스2015년회계처리고의위반”,http://moneys.mt.co.kr/news/mwView.php?no=2018111416348074546
7021,2018-11-14,2보증선위삼성바이오로직스검찰고발상폐실질심사대상,http://www.newstomato.com/ReadNews.aspx?no=858013
7022,2018-11-14,속보삼성바이오로직스주식당분간거래정지,https://www.ytn.co.kr/_ln/0102_201811141636347541
7023,2018-11-14,1보증선위삼성바이오로직스고의분식으로결론,http://www.newstomato.com/ReadNews.aspx?no=858012
7024,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114169400013&did=1196m
7025,2018-11-14,속보증선위삼성바이오로직스2015년회계처리고의위반”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141634003&sec_id=564001&pt=nv
7026,2018-11-14,속보증선위삼성바이오로직스2015년회계처리고의위반,http://www.newscj.com/news/articleView.html?idxno=572537
7027,2018-11-14,속보증선위김태한삼성바이오로직스대표이사해임권고검찰고발키로,http://news.imaeil.com/Economy/2018111416353603240
7028,2018-11-14,속보증선위삼성바이오로직스삼바2014년회계처리중과실,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000166
7029,2018-11-14,삼성바이오로직스심의결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114170400013&did=1196m
7030,2018-11-14,속보증선위삼성바이오로직스삼바2015년회계처리고의위반,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000167
7031,2018-11-14,삼성바이오로직스거래정지분식회계고의적,http://kormedi.com/?p=1255445
7032,2018-11-14,속보증선위삼성바이오로직스회계처리위반매매거래정지조치,http://www.ekn.kr/news/article.html?no=397651
7033,2018-11-14,삼성바이오로직스의분식회계혐의관련증권선물위원회결과발표,http://www.fnnews.com/news/201811141636104962
7034,2018-11-14,속보삼성바이오로직스고의적분식회계상장폐지검토,https://www.ytn.co.kr/_ln/0102_201811141638229043
7035,2018-11-14,삼성바이오로직스의분식회계혐의관련증권선물위원회결과발표,http://www.fnnews.com/news/201811141636288958
7036,2018-11-14,속보증선위삼성바이오로직스2015년회계처리고위위반벌금80억,http://www.ekn.kr/news/article.html?no=397649
7037,2018-11-14,속보금융당국삼성바이오로직스2015년회계처리고의적분식결론,http://www.vop.co.kr/A00001352599.html
7038,2018-11-14,속보증선위삼성바이오로직스고의분식회계결론檢고발과징금80억,http://moneys.mt.co.kr/news/mwView.php?no=2018111416388097452
7039,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114171600013&did=1196m
7040,2018-11-14,삼성바이오로직스증선위결론에행정소송적극검토속보,http://view.asiae.co.kr/news/view.htm?idxno=2018111416394947169
7041,2018-11-14,증선위2012년부터삼성바이오로직스가지분법회계중단처리사실인지할수있었다,http://view.asiae.co.kr/news/view.htm?idxno=2018111416390539680
7042,2018-11-14,1보증선위삼성바이오로직스고의분식결론거래정지,http://www.newsworks.co.kr/news/articleView.html?idxno=310895
7043,2018-11-14,시황삼성바이오로직스주가67급등코스피↓,https://www.ytn.co.kr/_ln/0102_201811141640519801
7044,2018-11-14,일지증선위삼성바이오로직스분식회계판단일지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181114047500008&did=1195m
7045,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114172000013&did=1196m
7046,2018-11-14,시황삼성바이오로직스주가67급등코스피↓,https://www.ytn.co.kr/_ln/0102_201811141640519801
7047,2018-11-14,속보증선위삼성바이오로직스매매거래정지상장실질심사대상”,http://moneys.mt.co.kr/news/mwView.php?no=2018111416398020773
7048,2018-11-14,속보삼성바이오로직스고의분식회계결론,http://www.kpinews.co.kr/news/articleView.html?idxno=84266
7049,2018-11-14,2보증선위삼성바이오로직스거래정지상장실질심사,http://www.inews24.com/php/news_view.php?g_serial=1139808&g_menu=022300&rrf=nv
7050,2018-11-14,코스피외국인매도공세2060대삼성바이오로직스670↑,http://www.seoulwire.com/news/articleView.html?idxno=34316
7051,2018-11-14,속보증선위삼성바이오로직스삼바주식당분간거래정지대표이사해임권고,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000168
7052,2018-11-14,증선위삼성바이오로직스고의적회계기준위반대표이사해임권고과징금검찰고발의결”,http://www.g-enews.com/ko-kr/news/article/news_all/201811141638033038c642673384_1/article.html
7053,2018-11-14,속보증선위삼성바이오로직스당분간거래정지상장실질심사대상”,http://www.viva100.com/main/view.php?key=20181114010005416
7054,2018-11-14,포토삼성바이오로직스분식회계관련증선위결과브리핑,http://view.asiae.co.kr/news/view.htm?idxno=2018111416412362774
7055,2018-11-14,속보증선위삼성바이오로직스대표이사해임권고과징금80억원부과,http://www.ekn.kr/news/article.html?no=397652
7056,2018-11-14,증선위삼성바이오로직스2015년고의분식회계2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181114141300008&did=1195m
7057,2018-11-14,속보증선위삼성바이오로직스당분간거래정지상장실질심사대상”,http://www.viva100.com/main/view.php?key=20181114010005416
7058,2018-11-14,속보증선위삼성바이오로직스2015년회계처리고의위반,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111416383562757
7059,2018-11-14,삼성바이오로직스삼바분식회계고의적판단상장폐지되나,http://www.ggilbo.com/news/articleView.html?idxno=563793
7060,2018-11-14,증선위삼성바이오로직스분식회계결론주식거래정지,http://www.m-economynews.com/news/article.html?no=23919
7061,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114173500013&did=1196m
7062,2018-11-14,삼성바이오로직스고의분식결론거래재개는언제,http://news.hankyung.com/article/2018111455766
7063,2018-11-14,속보증선위삼성바이오로직스대표이사해임권고검찰고발예정”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141643003&sec_id=564001&pt=nv
7064,2018-11-14,속보삼성바이오로직스대표이사해임권고검찰고발예정,http://www.newscj.com/news/articleView.html?idxno=572550
7065,2018-11-14,속보삼성바이오로직스고의분식회계인정과징금80억,http://www.mhj21.com/sub_read.html?uid=117515§ion=sc243
7066,2018-11-14,삼성바이오로직스증권선물위원회정례회의결과발표,http://www.fnnews.com/news/201811141642560826
7067,2018-11-14,증선위삼성바이오로직스대표이사해임권고검찰고발예정”속보,http://www.viva100.com/main/view.php?key=20181114010005424
7068,2018-11-14,속보증선위삼성바이오로직스2015년고의분식회계”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111416425753640
7069,2018-11-14,삼성바이오로직스분식회계결론뒤집힌삼바회계신산업누가투자하나파장,http://www.fnnews.com/news/201811141520089429
7070,2018-11-14,거래소삼성바이오로직스매매거래정지,http://news.mt.co.kr/mtview.php?no=2018111416431997999
7071,2018-11-14,증선위삼성바이오로직스고의분식회계결론주식거래정지,http://www.kyeongin.com/main/view.php?key=20181114010004632
7072,2018-11-14,속보증선위삼성바이오로직스상장폐지예단할순없어”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141645003&sec_id=564001&pt=nv
7073,2018-11-14,속보거래소삼성바이오로직스주식거래정지,http://www.newsis.com/view/?id=NISX20181114_0000473384&cID=10401&pID=10400
7074,2018-11-14,속보증선위삼성바이오로직스당분간거래정지상장폐지심사대상,http://www.betanews.net:8080/article/934941.html
7075,2018-11-14,삼성바이오로직스주식거래정지거래소상장실질심사대상”,http://www.g-enews.com/ko-kr/news/article/news_all/201811141642347545c642673384_1/article.html
7076,2018-11-14,속보거래소삼성바이오로직스거래정지상장적격심사사유발생,http://www.newscj.com/news/articleView.html?idxno=572556
7077,2018-11-14,삼성바이오로직스증권선물위원회의결정에행정소송제기할것,http://www.fnnews.com/news/201811141646001665
7078,2018-11-14,삼성바이오로직스15일매매거래정지상장실질심사돌입,http://www.ebn.co.kr/news/view/961853
7079,2018-11-14,속보삼성바이오로직스거래정지및상장폐지심사실시,http://www.lawissue.co.kr/view.php?ud=2018111416445095729817d053b9_12
7080,2018-11-14,삼성바이오로직스결과는,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114174400013&did=1196m
7081,2018-11-14,코스피시총5위삼성바이오로직스결국거래정지증선위분식회계결론,http://news.mk.co.kr/newsRead.php?year=2018&no=714756
7082,2018-11-14,삼성바이오로직스결과발표,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114174500013&did=1196m
7083,2018-11-14,속보거래소삼성바이오로직스상장적격심사사유발생거래정지”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141647003&sec_id=564001&pt=nv
7084,2018-11-14,조회공시삼성바이오로직스거래정지회계처리위반검찰통보관련,http://www.newspim.com/news/view/20181114001497
7085,2018-11-14,증권선물위삼성바이오로직스2015년고의분식회계결론,http://www.sedaily.com/NewsView/1S76QDAJ29
7086,2018-11-14,삼성바이오로직스증권위결정매우유감행정소송제기할것,http://www.g-enews.com/ko-kr/news/article/news_all/2018111416463097025b4ac5ede_1/article.html
7087,2018-11-14,증선위삼성바이오로직스2014년까지회계처리중과실,http://www.fntimes.com/html/view.php?ud=201811141638284927f09e13944d_18
7088,2018-11-14,증선위삼성바이오로직스2015년회계처리고의위반”,http://www.fntimes.com/html/view.php?ud=201811141638386998f09e13944d_18
7089,2018-11-14,속보증선위삼성바이오로직스내부문건중요증거로활용”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141648013&sec_id=564001&pt=nv
7090,2018-11-14,삼성바이오로직스증선위결정매우유감행정소송제기,http://www.sedaily.com/NewsView/1S76PXHABH
7091,2018-11-14,증선위김태한삼성바이오로직스대표해임권고,http://www.ebn.co.kr/news/view/961858
7092,2018-11-14,증선위삼성바이오로직스고의분식회계결론주식거래정지종합,http://www.kyeongin.com/main/view.php?key=20181114010004642
7093,2018-11-14,증선위삼성바이오로직스고의분식회계결론주식당분간거래정지,http://www.kpinews.co.kr/news/articleView.html?idxno=84270
7094,2018-11-14,증선위삼성바이오로직스검찰고발등제재조치”,http://www.fntimes.com/html/view.php?ud=201811141640464412f09e13944d_18
7095,2018-11-14,증선위삼성바이오로직스고의적과실판단주식거래정지결정,http://www.medigatenews.com/news/2102760654
7096,2018-11-14,삼성바이오로직스재무제표수정해야삼성물산재무제표에도영향”속보,http://www.sedaily.com/NewsView/1S76PQ0NN8
7097,2018-11-14,증선위삼성바이오로직스대표이사해임권고과징금80억”,http://www.fntimes.com/html/view.php?ud=201811141641494244f09e13944d_18
7098,2018-11-14,조회공시삼성바이오로직스회계처리기준위반검찰보도관련,http://www.etoday.co.kr/news/section/newsview.php?idxno=1687492
7099,2018-11-14,증선위삼성바이오로직스회계처리중과실매매거래정지”1보,http://www.cstimes.com/?mod=news&act=articleView&idxno=289955
7100,2018-11-14,삼성바이오로직스2015년고의분식회계,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10311139
7101,2018-11-14,삼성바이오로직스당분간주식거래정지상장실질심사,http://www.fntimes.com/html/view.php?ud=201811141640431956f09e13944d_18
7102,2018-11-14,삼성바이오로직스분식회계고의상장실질심사대상,http://www.medicaltimes.com/News/1122483
7103,2018-11-14,거래소삼성바이오로직스매매거래정지공시,http://www.sedaily.com/NewsView/1S76QJ8GX4
7104,2018-11-14,거래소회계기준위반삼성바이오로직스매매거래정지,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141652003&sec_id=564001&pt=nv
7105,2018-11-14,거래소삼성바이오로직스매매거래정지공시,http://www.sedaily.com/NewsView/1S76QJ8GX4
7106,2018-11-14,최악의결과받아든삼성바이오로직스증선위대표해임권고및검찰고발예정”,http://www.sedaily.com/NewsView/1S76QKO916
7107,2018-11-14,삼성바이오로직스분식회계고의상장실질심사대상,http://www.medicaltimes.com/News/1122483
7108,2018-11-14,삼성바이오로직스증선위결론매우유감행정소송제기,http://view.asiae.co.kr/news/view.htm?idxno=2018111416540799856
7109,2018-11-14,삼성바이오로직스회계처리위법판단매우유감행정소송제기,http://www.newsis.com/view/?id=NISX20181114_0000473389&cID=13001&pID=13000
7110,2018-11-14,속보증선위삼성바이오로직스상장폐지예단할순없어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111416445683424
7111,2018-11-14,증선위삼성바이오로직스상장폐지예단할수없다1보,http://www.seoulwire.com/news/articleView.html?idxno=34328
7112,2018-11-14,증선위삼성바이오로직스2015년고의분식회계거래정지,http://www.wikitree.co.kr/main/news_view.php?id=382437
7113,2018-11-14,공시거래소삼성바이오로직스에회계위반검찰통보보도조회공시요구,http://www.newsway.co.kr/news/view?tp=1&ud=2018111416533593201
7114,2018-11-14,공시거래소삼성바이오로직스에회계위반검찰통보보도조회공시요구,http://www.newsway.co.kr/news/view?tp=1&ud=2018111416533593201
7115,2018-11-14,속보증선위삼성바이오로직스상장폐지예단할순없어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111416445683424
7116,2018-11-14,거래소고의분식회계삼성바이오로직스삼바매매거래정지,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000195
7117,2018-11-14,삼성바이오로직스증선위판단유감행정소송제기할것,http://www.dailian.co.kr/news/view/751773/?sc=naver
7118,2018-11-14,삼성바이오로직스2015년고의분식회계결론2015년2018년주요사태일지,http://www.ekn.kr/news/article.html?no=397656
7119,2018-11-14,속보삼성바이오로직스증선위결정매우유감회계위반안했다법적대응시사,http://www.viva100.com/main/view.php?key=20181114010005433
7120,2018-11-14,거래소회계기준위반삼성바이오로직스매매거래정지,http://view.asiae.co.kr/news/view.htm?idxno=2018111416572815340
7121,2018-11-14,그래픽뉴스삼성바이오로직스분식회계사태일지,http://news1.kr/photos/view/?3390721
7122,2018-11-14,속보증선위삼성바이오로직스내부문건중요증거로활용”,http://www.viva100.com/main/view.php?key=20181114010005437
7123,2018-11-14,거래소회계처리위반삼성바이오로직스매매거래정지,http://www.viva100.com/main/view.php?key=20181114010005445
7124,2018-11-14,한국거래소삼성바이오로직스매매거래정지,http://www.seoulwire.com/news/articleView.html?idxno=34329
7125,2018-11-14,상장폐지직면한삼성바이오로직스회계처리위반여부행정소송,http://biz.chosun.com/site/data/html_dir/2018/11/14/2018111402589.html
7126,2018-11-14,삼성바이오로직스입장전문행정소송통해회계처리의적법성입증할것,http://www.sporbiz.co.kr/news/articleView.html?idxno=288434
7127,2018-11-14,속보증선위삼성바이오로직스삼바분식규모4조5천억원,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000204
7128,2018-11-14,2년만에고의분식회계결론삼성바이오로직스사태일지,http://www.ggilbo.com/news/articleView.html?idxno=563795
7129,2018-11-14,삼성바이오로직스매매정지등어떤절차밟나,http://news.mt.co.kr/mtview.php?no=2018111416454216681
7130,2018-11-14,증선위삼성바이오로직스2015년고의분식회계결론,http://www.kfm.co.kr/?r=home&m=blog&blog=news&front=list&uid=9328194
7131,2018-11-14,거래소삼성바이오로직스매매거래정지,http://www.dt.co.kr/contents.html?article_no=2018111402109932048018&ref=naver
7132,2018-11-14,거래소회계기준위반삼성바이오로직스매매거래정지,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111416561065015
7133,2018-11-14,속보증선위삼성바이오로직스분식규모4조5000억원”,http://www.sedaily.com/NewsView/1S76PJ04TR
7134,2018-11-14,증선위삼성바이오로직스고의적회계부정했다종합,http://www.nocutnews.co.kr/news/5061121
7135,2018-11-14,속보증선위삼성바이오로직스분식규모4조5000억원,http://www.mediapen.com/news/view/395838
7136,2018-11-14,삼성바이오로직스매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114179300013&did=1196m
7137,2018-11-14,삼성바이오로직스증선위결정매우유감행정소송제기,http://www.inews24.com/php/news_view.php?g_serial=1139818&g_menu=022620&rrf=nv
7138,2018-11-14,삼성바이오로직스거래정지결정에적극대응”,http://www.asiatoday.co.kr/view.php?key=20181114010008563
7139,2018-11-14,삼성바이오로직스회계처리기준자의적해석고의로위반,http://www.g-enews.com/ko-kr/news/article/news_all/201811141654309703c642673384_1/article.html
7140,2018-11-14,1보증선위삼성바이오로직스고의분식회계결론,http://www.ceoscoredaily.com/news/article.html?no=48239
7141,2018-11-14,증선위삼성바이오로직스고의분식회계거래정지후상장폐지심사돌입,http://www.insightkorea.co.kr//news/articleView.html?idxno=32240
7142,2018-11-14,증선위삼성바이오로직스2015년고의분식회계결론,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3686880
7143,2018-11-14,삼성바이오로직스매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114179600013&did=1196m
7144,2018-11-14,코스피시총5위삼성바이오로직스결국거래정지증선위고의분식회계결론종합,http://news.mk.co.kr/newsRead.php?year=2018&no=714833
7145,2018-11-14,전문삼성바이오로직스증선위결정에행정소송제기할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111416541669998
7146,2018-11-14,삼성바이오분식회계사태삼성바이오로직스회계처리적법확신행정소송제기”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1687497
7147,2018-11-14,삼성바이오로직스증선위결정유감행정소송돌입,http://www.ebn.co.kr/news/view/961865
7148,2018-11-14,삼성바이오로직스매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114179900013&did=1196m
7149,2018-11-14,삼성바이오로직스주식매매금지상장폐지실질심사,http://www.weeklytoday.com/news/articleView.html?idxno=69489
7150,2018-11-14,속보증선위삼성바이오로직스분식규모4조5천억원,http://www.sedaily.com/NewsView/1S76QEIM13
7151,2018-11-14,삼성바이오로직스증선위결정유감행정소송제기할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111417012429031
7152,2018-11-14,삼성바이오로직스매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114179800013&did=1196m
7153,2018-11-14,증선위삼성바이오로직스회계처리고의위반상장적격성심사대상,http://www.ekn.kr/news/article.html?no=397663
7154,2018-11-14,삼성바이오로직스증선위결정에행정소송제기글로벌사업타격입나,http://www.fnnews.com/news/201811141703119984
7155,2018-11-14,삼성바이오로직스매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114179800013&did=1196m
7156,2018-11-14,증선위삼성바이오로직스회계처리고의위반상장적격성심사대상,http://www.ekn.kr/news/article.html?no=397663
7157,2018-11-14,삼성바이오로직스결국거래정지증선위고의분식회계맞다,http://daily.hankooki.com/lpage/economy/201811/dh20181114170257138110.htm
7158,2018-11-14,삼성바이오로직스증선위판단매우유감행정소송제기,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811140524&t=NN
7159,2018-11-14,삼성바이오로직스삼바가만히있지않는다행정소송할것회계처리적법,http://news.imaeil.com/Economy/2018111417051921694
7160,2018-11-14,삼성바이오로직스회계기준위반결론주식거래정지,http://moneys.mt.co.kr/news/mwView.php?no=2018111416558041277
7161,2018-11-14,삼성바이오로직스삼바분식회계인정상장폐지가능성은,http://www.newswatch.kr/news/articleView.html?idxno=16372
7162,2018-11-14,삼성바이오로직스회계처리중과실,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114180600013&did=1196m
7163,2018-11-14,삼성바이오로직스증선위에행정소송제기적법함입증,http://biz.newdaily.co.kr/site/data/html/2018/11/14/2018111400174.html
7164,2018-11-14,증선위삼성바이오로직스고의적분식회계결론,http://news1.kr/photos/view/?3390801
7165,2018-11-14,삼성바이오로직스증선위에행정소송제기적법함입증,http://biz.newdaily.co.kr/site/data/html/2018/11/14/2018111400174.html
7166,2018-11-14,삼성바이오로직스행정소송예고회계처리적법성입증하겠다,http://www.fntimes.com/html/view.php?ud=201811141702544015902857eb1a_18
7167,2018-11-14,한국거래소분식회계삼성바이오로직스매매거래정지,http://www.ekn.kr/news/article.html?no=397664
7168,2018-11-14,삼바증선위삼성바이오로직스고의적분식회계결론상폐심사대상종합,http://www.inews24.com/php/news_view.php?g_serial=1139820&g_menu=022300&rrf=nv
7169,2018-11-14,증선위삼성바이오로직스고의분식회계매매거래정지상장실질심사,http://sports.chosun.com/news/ntype.htm?id=201811150100138050010431&servicedate=20181114
7170,2018-11-14,삼성바이오로직스대표이사해임주주총회서결정,http://view.asiae.co.kr/news/view.htm?idxno=2018111417092016829
7171,2018-11-14,삼성바이오로직스회계처리고의위반결론유감행정소송제기,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000207
7172,2018-11-14,증선위삼성바이오로직스2015년고의분식회계,https://news.sbs.co.kr/news/endPage.do?news_id=N1005016960&plink=ORI&cooper=NAVER
7173,2018-11-14,삼성바이오로직스증선위분식회계결론유감행정소송제기,http://www.seoulwire.com/news/articleView.html?idxno=34332
7174,2018-11-14,증선위삼성바이오로직스2015년고의분식회계,https://news.sbs.co.kr/news/endPage.do?news_id=N1005016960&plink=ORI&cooper=NAVER
7175,2018-11-14,삼성바이오로직스결국매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114182400013&did=1196m
7176,2018-11-14,삼성바이오로직스증선위판단유감행정소송불사,http://www.wikitree.co.kr/main/news_view.php?id=382442
7177,2018-11-14,삼성바이오로직스시간외호가하한가몰려마지막거래는상승종합,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111416584913732
7178,2018-11-14,속보증선위삼성바이오로직스분식규모4조5000억원”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141709003&sec_id=564001&pt=nv
7179,2018-11-14,증선위삼성바이오로직스고의분식회계맞다,http://www.sisafocus.co.kr/news/articleView.html?idxno=196249
7180,2018-11-14,삼성바이오로직스결국매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114182500013&did=1196m
7181,2018-11-14,전문삼성바이오로직스증선위결정유감행정소송제기할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111417071989867
7182,2018-11-14,삼성바이오로직스결국매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114183000013&did=1196m
7183,2018-11-14,삼성바이오로직스회계처리적법확신행정소송제기할것”,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141711003&sec_id=564001&pt=nv
7184,2018-11-14,거래정지삼성바이오로직스최근주가흐름은위법결론당일주가는67↑,http://www.kyeongin.com/main/view.php?key=20181114010004665
7185,2018-11-14,삼성바이오로직스주회계처리기준위반검찰통보보도에대한조회공시요구,http://news.kmib.co.kr/article/view.asp?arcid=0012842454&code=61141211&cp=nv
7186,2018-11-14,삼성바이오로직스결국매매거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114183900013&did=1196m
7187,2018-11-14,증권선물위삼성바이오로직스2015년회계처리변경과정에서고의분식회계,http://www.incheonnews.com/news/articleView.html?idxno=113841
7188,2018-11-14,머니S포토삼성바이오로직스회계위반심의결과발표,http://moneys.mt.co.kr/news/mwView.php?no=2018111417058010848
7189,2018-11-14,文정부에날세운삼성바이오로직스매우유감”,http://www.mhj21.com/sub_read.html?uid=117517§ion=sc243
7190,2018-11-14,삼성바이오로직스증선위결정유감행정소송제기”,http://www.kukinews.com/news/article.html?no=604332
7191,2018-11-14,포토삼성바이오로직스회계기준위반결론주식거래정지,http://www.ajunews.com/view/20181114171453283
7192,2018-11-14,증선위삼성바이오로직스고의분식회계인정,http://www.wolyo.co.kr/news/articleView.html?idxno=71686
7193,2018-11-14,삼성바이오로직스기업회계기준위반하지않았다는점에대해확신한다,http://www.econonews.co.kr/news/articleView.html?idxno=42377
7194,2018-11-14,삼성바이오로직스증선위결정에행정소송제기,http://www.fnnews.com/news/201811141712232919
7195,2018-11-14,삼성바이오로직스결국유죄,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114184600013&did=1196m
7196,2018-11-14,브리핑정호진대변인삼성바이오로직스고의분식회계이제이재용부회장경영권승계에초점을맞춰수사해야,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=426&aid=0000006962
7197,2018-11-14,삼성바이오로직스삼바증선위가고의회계처리기준위반판단유감행정소송제기할것,http://www.joongboo.com/news/articleView.html?idxno=1302962
7198,2018-11-14,바이오대표주삼성바이오로직스거래정지증시충격파에촉각,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141715003&sec_id=564001&pt=nv
7199,2018-11-14,번복은없었다증선위삼성바이오로직스2015년고의분식회계결론,http://www.joongboo.com/news/articleView.html?idxno=1302961
7200,2018-11-14,속보삼성바이오로직스당분간거래정지고의분식회계맞다”,http://news.kmib.co.kr/article/view.asp?arcid=0012842477&code=61141111&cp=nv
7201,2018-11-14,삼성바이오로직스결국유죄,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114185000013&did=1196m
7202,2018-11-14,증선위삼성바이오로직스고의분식회계판단상장실질심사대상,http://www.joseilbo.com/news/news_read.php?uid=364493&class=53&grp=
7203,2018-11-14,삼성바이오로직스결국유죄,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114185100013&did=1196m
7204,2018-11-14,금융위삼성바이오로직스주식거래정지,http://www.dailymedi.com/detail.php?number=836926&thread=22r05
7205,2018-11-14,머니S포토증선위삼성바이오로직스심의결과발표,http://moneys.mt.co.kr/news/mwView.php?no=2018111417098081652
7206,2018-11-14,증선위삼성바이오로직스고의위반결론거래정지상보,http://view.asiae.co.kr/news/view.htm?idxno=2018111417204606818
7207,2018-11-14,머니S포토삼성바이오로직스심의종료,http://moneys.mt.co.kr/news/mwView.php?no=2018111417138098318
7208,2018-11-14,고의분식회계삼성바이오로직스물린주주어쩌나거래정지후절차는,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811140540&t=NN
7209,2018-11-14,삼성바이오로직스증선위회계기준위반발표에행정소송제기할것,http://www.sisaon.co.kr/news/articleView.html?idxno=79303
7210,2018-11-14,머니S포토삼성바이오로직스심의결과에이목집중,http://moneys.mt.co.kr/news/mwView.php?no=2018111417168096558
7211,2018-11-14,삼성바이오로직스회계처리중과실,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114185900013&did=1196m
7212,2018-11-14,삼성바이오로직스고의분식회계결론거래정지종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181114141351008&did=1195m
7213,2018-11-14,증선위고의적분식회계삼성바이오로직스에과징금80억처분대표해임권고상보,http://www.newsway.co.kr/news/view?tp=1&ud=2018111417195104891
7214,2018-11-14,삼성바이오로직스의분식회계혐의관련금융위원회심의결과발표,http://www.upinews.kr/news/newsview.php?ncode=1065600292917587
7215,2018-11-14,포토삼성바이오로직스심의결과발표하는김용범증선위원장,http://view.asiae.co.kr/news/view.htm?idxno=2018111417253558657
7216,2018-11-14,종합삼성바이오로직스고의분식회계결론거래정지상폐심사,http://www.kpinews.co.kr/news/articleView.html?idxno=84274
7217,2018-11-14,김용범삼성바이오로직스상장폐지확답어려워,http://www.ebn.co.kr/news/view/961874
7218,2018-11-14,삼성바이오로직스증선위결정유감행정소송제기할것,http://www.newstomato.com/ReadNews.aspx?no=858035
7219,2018-11-14,포토삼성바이오로직스심의결과발표하는증선위원장,http://view.asiae.co.kr/news/view.htm?idxno=2018111417253961573
7220,2018-11-14,포토증선위삼성바이오로직스심의결과발표,http://view.asiae.co.kr/news/view.htm?idxno=2018111417255276471
7221,2018-11-14,증선위삼성바이오로직스2015년회계처리고의위반”매매거래정지,http://www.sisajournal-e.com/biz/article/191509
7222,2018-11-14,삼성바이오로직스분식회계결론유감행정소송으로대응,http://www.ekn.kr/news/article.html?no=397669
7223,2018-11-14,삼성바이오로직스증선위심의결과받아들이기어려워행정소송낼것,http://www.kyeongin.com/main/view.php?key=20181114010004677
7224,2018-11-14,무혐의베팅한삼성바이오로직스투자자들상폐공포확산,http://www.smedaily.co.kr/news/articleView.html?idxno=79535
7225,2018-11-14,삼성바이오로직스증선위제재매우유감행정소송제기,http://moneys.mt.co.kr/news/mwView.php?no=2018111417218060064
7226,2018-11-14,김용범부위원장삼성바이오로직스증선위결과는,http://news1.kr/photos/view/?3390733
7227,2018-11-14,거래소삼성바이오로직스에매매거래정지조치내려,http://www.cstimes.com/?mod=news&act=articleView&idxno=289962
7228,2018-11-14,﻿증권선물위원회vs삼성바이오로직스분식회계”vs기업회계기준위반하지않았다”,http://medicalworldnews.co.kr/news/view.php?idx=1510928217
7229,2018-11-14,오늘Who삼성바이오로직스후폭풍속으로김태한노력물거품,http://www.businesspost.co.kr/BP?command=article_view&num=102517
7230,2018-11-14,삼성바이오로직스증선위심의결과발표하는김용범부위원장,http://news1.kr/photos/view/?3390703
7231,2018-11-14,삼성바이오로직스분식회계혐의결과발표,http://news1.kr/photos/view/?3390709
7232,2018-11-14,증선위삼성바이오로직스분식회계결론→매매거래정지삼바행정소송제기종합,http://www.seoulwire.com/news/articleView.html?idxno=34342
7233,2018-11-14,분식회계위반검찰수사삼성바이오로직스주식거래정지및상장폐지심사도,http://kpenews.com/Board.aspx?BoardNo=21277
7234,2018-11-14,삼성바이오로직스증선위심의결과발표,http://news1.kr/photos/view/?3390685
7235,2018-11-14,포토삼성바이오로직스회계처리위반안건심의결과발표,http://www.dailian.co.kr/news/view/751804/?sc=naver
7236,2018-11-14,증선위삼성바이오로직스고의분식회계결론,http://www.choicenews.co.kr/news/articleView.html?idxno=45988
7237,2018-11-14,삼성바이오로직스주식거래정지대표이사해임권고,http://www.biospectator.com/view/news_view.php?varAtcId=6587
7238,2018-11-14,증권선물위삼성바이오로직스회계놓고고의적분식회계결론,http://www.businesspost.co.kr/BP?command=article_view&num=102516
7239,2018-11-14,사진증선위삼성바이오로직스2015년고의분식회계,http://news.mt.co.kr/mtview.php?no=2018111417331355836
7240,2018-11-14,포토증권선물위원회삼성바이오로직스매매거래정지발표,http://www.metroseoul.co.kr/news/newsview?newscd=2018111400200
7241,2018-11-14,한국거래소삼성바이오로직스주식거래정지15일이내기업심사위심의대상판단,http://www.g-enews.com/ko-kr/news/article/news_all/201811141726037182c642673384_1/article.html
7242,2018-11-14,거래소삼성바이오로직스거래정지상장폐지최악의상황까지가나전문가들가능성희박,http://www.joongboo.com/news/articleView.html?idxno=1302977
7243,2018-11-14,삼성바이오로직스고의분식회계결론거래정지종합2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181114141352008&did=1195m
7244,2018-11-14,정의당삼성바이오로직스분식회계이재용초점맞춰수사해야”,http://view.asiae.co.kr/news/view.htm?idxno=2018111417373639448
7245,2018-11-14,삼성바이오로직스운명은,http://news1.kr/photos/view/?3390127
7246,2018-11-14,금융당국삼성바이오로직스고의적분식회계바이오기업발목잡나일상톡톡플러스,http://www.segye.com/content/html/2018/11/14/20181114004164.html?OutUrl=naver
7247,2018-11-14,증선위삼성바이오로직스회계처리중과실결론판단이유는,http://www.wikitree.co.kr/main/news_view.php?id=382447
7248,2018-11-14,삼성바이오로직스결론나왔다고의분식회계인정,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10311145
7249,2018-11-14,바이오대장주삼성바이오로직스거래정지증시영향은일부증권사불확실성해소긍정적분석도,http://www.kyeongin.com/main/view.php?key=20181114010004694
7250,2018-11-14,증선위삼성바이오로직스분식회계주식거래정지,http://www.isisa.net/news/articleView.html?idxno=112202
7251,2018-11-14,거래소회계위반삼성바이오로직스매매거래정지,http://biz.newdaily.co.kr/site/data/html/2018/11/14/2018111400182.html
7252,2018-11-14,증선위삼성바이오로직스고의분식회계결론상장폐지심사진행,http://www.newscj.com/news/articleView.html?idxno=572601
7253,2018-11-14,바이오대장주삼성바이오로직스고의분식회계로거래정지,http://www.fntimes.com/html/view.php?ud=201811141727525978f09e13944d_18
7254,2018-11-14,포토증선위삼성바이오로직스심의결과발표,http://www.dailian.co.kr/news/view/751818/?sc=naver
7255,2018-11-14,삼성바이오로직스고의분식회계결론날에도주가는급등,http://news.hankyung.com/article/2018111462816
7256,2018-11-14,삼성바이오로직스앞으로어떻게되나,http://www.weeklytoday.com/news/articleView.html?idxno=69490
7257,2018-11-14,삼성바이오로직스2015년고의분식회계매매거래정지,http://www.viva100.com/main/view.php?key=20181114010005484
7258,2018-11-14,증선위삼성바이오로직스2015년회계처리변경은고의분식회계결론,http://www.sedaily.com/NewsView/1S76QOBU2R
7259,2018-11-14,회계위반안했다삼성바이오로직스증선위거래정지처분에행정소송맞불,http://www.viva100.com/main/view.php?key=20181114010005480
7260,2018-11-14,삼성바이오로직스증선위결정유감행정소송제기할것,http://www.newsworks.co.kr/news/articleView.html?idxno=310936
7261,2018-11-14,삼성바이오로직스고의분식회계결론에행정소송제기,http://medipana.com/news/news_viewer.asp?NewsNum=228532&MainKind=A&NewsKind=5&vCount=12&vKind=1
7262,2018-11-14,거래정지삼성바이오로직스상장폐지가능성은,http://kormedi.com/?p=1255510
7263,2018-11-14,머니S포토삼성바이오로직스심의결과발표,http://moneys.mt.co.kr/news/mwView.php?no=2018111417408082037
7264,2018-11-14,삼성바이오로직스증권선물위중징계결정에행정소송대응,http://www.businesspost.co.kr/BP?command=article_view&num=102526
7265,2018-11-14,삼성바이오로직스고의분식회계거래정지및검찰고발,http://www.kwnews.co.kr/view.asp?aid=218111300186&s=801
7266,2018-11-14,삼성바이오로직스분식회계고의위반결론거래정지종합,http://view.asiae.co.kr/news/view.htm?idxno=2018111417504007877
7267,2018-11-14,삼성바이오로직스증선위결정매우유감행정소송제기할것,http://daily.hankooki.com/lpage/economy/201811/dh20181114174941138110.htm
7268,2018-11-14,삼성바이오로직스고의분식회계결론즉각거래정지,http://www.breaknews.com/sub_read.html?uid=614184§ion=sc3
7269,2018-11-14,삼성바이오로직스외국인기관팔때개미만샀다존버외치다폭망각,http://news.donga.com/3/all/20181114/92873362/2
7270,2018-11-14,분식회계결론삼성바이오로직스코스피상장과정살펴보니,http://www.newsis.com/view/?id=NISX20181114_0000473375&cID=10401&pID=10400
7271,2018-11-14,뉴투분석삼성바이오로직스공넘겨받은검찰수사칼끝어디까지겨누나,http://www.news2day.co.kr/114716
7272,2018-11-14,삼성바이오로직스주식상장폐지위기공은거래소로넘어가,http://www.businesspost.co.kr/BP?command=article_view&num=102520
7273,2018-11-14,삼성바이오로직스고의분식으로주식거래올스톱거래재개는언제,http://www.businesskorea.co.kr/news/articleView.html?idxno=26568
7274,2018-11-14,증선위”삼성바이오로직스고의적분식회계거래정지및상장폐지심사실시,http://www.lawissue.co.kr/view.php?ud=2018111417445973269817d053b9_12
7275,2018-11-14,거래소삼성바이오로직스매매거래정지증시영향촉각,http://www.seoulfn.com/news/articleView.html?idxno=324954
7276,2018-11-14,삼성바이오로직스고의분식회계결론거래정지,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3686974
7277,2018-11-14,증선위삼성바이오로직스주식거래중지상장실질심사대상,http://sports.khan.co.kr/news/sk_index.html?art_id=201811141756003&sec_id=561801&pt=nv
7278,2018-11-14,삼성바이오로직스결국유죄,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181114195100013&did=1196m
7279,2018-11-14,쿠키영상증선위삼성바이오로직스분식회계결론주식거래정지삼바상장폐지안되겠지,http://www.kukinews.com/news/article.html?no=604355
7280,2018-11-14,고의분식회계삼성바이오로직스상장폐지가능성촉각향후절차는,http://www.fntimes.com/html/view.php?ud=201811141746329130f09e13944d_18
7281,2018-11-14,OBS뉴스오늘2삼성바이오로직스분식회계논란,http://www.obsnews.co.kr/news/articleView.html?idxno=1125301
7282,2018-11-14,삼성바이오로직스결국고의분식회계거래정지,http://www.newsprime.co.kr/news/article.html?no=436305
7283,2018-11-14,증선위삼성바이오로직스고의분식삼성은반박,http://news.mk.co.kr/newsRead.php?year=2018&no=715116
7284,2018-11-14,증선위삼성바이오로직스고의분식삼성은반박,http://news.mk.co.kr/newsRead.php?year=2018&no=715116
7285,2018-11-14,삼성바이오로직스고의분식결론향후관전포인트는삼성그룹,http://www.sisajournal-e.com/biz/article/191512
7286,2018-11-14,삼성바이오로직스매매거래정지상장실질심사등향후절차는,http://www.dailian.co.kr/news/view/751824/?sc=naver
7287,2018-11-14,포토뉴스삼성바이오로직스감리결과발표하는김용범증선위원장,http://www.tfnews.co.kr/news/article.html?no=56014
7288,2018-11-14,논평증선위원회가삼성바이오로직스의고의분식회계를인정한것은당연한귀결이다자본시장을뒤흔든중대범죄라는점에서후속조치가있어야한다삼성물산의회계처리에대해서도신속하게감리에착수해야한다,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=594&aid=0000000958
7289,2018-11-14,삼성바이오로직스고의분식회계결론결정적증거는내부문건,http://news.donga.com/3/all/20181114/92874014/2
7290,2018-11-14,증선위삼성바이오로직스고의분식인정,http://www.upinews.kr/news/newsview.php?ncode=1065602681909924
7291,2018-11-14,삼성바이오로직스거래정지상장폐지로가지는않을듯,http://news.imaeil.com/Economy/2018111417464524764
7292,2018-11-14,증선위삼성바이오로직스고의분식회계거래정지,https://www.ytn.co.kr/_ln/0102_201811141807443068
7293,2018-11-14,증선위삼성바이오로직스고의분식회계거래정지,http://www.ftoday.co.kr/news/articleView.html?idxno=104301
7294,2018-11-14,분식회계결론삼성바이오로직스주식거래정지향후절차는,http://www.kpinews.co.kr/news/articleView.html?idxno=84284
7295,2018-11-14,오늘의특징주베팅한배짱좋은개미삼성바이오로직스67↑내일부터거래정지,http://www.asiatime.co.kr/news/articleView.html?idxno=211392
7296,2018-11-14,증선위삼성바이오로직스고의분식회계결론,http://it.chosun.com/site/data/html_dir/2018/11/14/2018111402864.html
7297,2018-11-14,삼바증선위결국상폐심사받는삼성바이오로직스향방은,http://www.inews24.com/php/news_view.php?g_serial=1139846&g_menu=022300&rrf=nv
7298,2018-11-14,증선위삼성바이오로직스고의분식회계결론주식거래정지,http://www.rapportian.com/news/articleView.html?idxno=114123
7299,2018-11-14,공시삼성바이오로직스회계처리기준위반으로매매거래정지,http://www.fnnews.com/news/201811141813548493
7300,2018-11-14,증선위삼성바이오로직스고의분식회계분식회계란무엇인가실제보다좋게보이도록재무상태거짓으로부풀려,http://www.joongboo.com/news/articleView.html?idxno=1302995
7301,2018-11-14,증선위삼성바이오로직스분식회계결론매매거래정지,http://www.babytimes.co.kr/news/articleView.html?idxno=23122
7302,2018-11-14,삼성바이오로직스고의분식회계증선위결론,http://www.pressian.com/news/article.html?no=217512&utm_source=naver&utm_medium=search
7303,2018-11-14,한국거래소회계처리기준위반삼성바이오로직스거래정지매매재개얼마나걸릴까,http://www.joongboo.com/news/articleView.html?idxno=1303003
7304,2018-11-14,분식회계있었다”주식거래정지된삼성바이오로직스,http://www.ziksir.com/ziksir/view/7381
7305,2018-11-14,삼성바이오로직스주식매매거래정지상장폐지결론은언제,http://www.sporbiz.co.kr/news/articleView.html?idxno=288484
7306,2018-11-14,삼성바이오로직스고의분식회계결론주식거래정지,http://star.mt.co.kr/stview.php?no=2018111418095469857
7307,2018-11-14,삼성바이오로직스사태2년의기록,http://www.viva100.com/main/view.php?key=20181114010005506
7308,2018-11-14,시총5위삼성바이오로직스분식회계종지부당분간거래정지,http://news.kmib.co.kr/article/view.asp?arcid=0012842823&code=61141211&cp=nv
7309,2018-11-14,삼성바이오로직스고의분식회계결론결국매매거래정지,http://www.mdtoday.co.kr/mdtoday/index.html?no=338702
7310,2018-11-14,고침그래픽삼성바이오로직스분식회계판단일지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=GYH20181114000900044&did=1363m
7311,2018-11-14,일본계외신들삼성바이오로직스삼성미래전략에일격,http://www.choicenews.co.kr/news/articleView.html?idxno=45989
7312,2018-11-14,공시삼성바이오로직스회계처리기준위반으로검찰피고발”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111418355919665
7313,2018-11-14,상장폐지위기놓인삼성바이오로직스거래정지,http://www.mhj21.com/sub_read.html?uid=117521§ion=sc243
7314,2018-11-14,상장폐지위기놓인삼성바이오로직스거래정지,http://www.mhj21.com/sub_read.html?uid=117521§ion=sc243
7315,2018-11-14,증선위삼성바이오로직스고의분식회계결론상장폐지심사진행종합,http://www.newscj.com/news/articleView.html?idxno=572635
7316,2018-11-14,고의분식회계삼성바이오로직스시간외거래서하한가직행,http://www.mediapen.com/news/view/395864
7317,2018-11-14,공시거래소삼성바이오로직스상장적격성실질심사사유발생”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111418383526192
7318,2018-11-14,일지증선위삼성바이오로직스고의분식회계결정까지,http://www.newsis.com/view/?id=NISX20181114_0000473567&cID=10401&pID=10400
7319,2018-11-14,삼성바이오로직스증선위결정유감행정소송제기할것,http://star.mt.co.kr/stview.php?no=2018111418343793988
7320,2018-11-14,거래소삼성바이오로직스매매거래정지,http://www.ajunews.com/view/20181114184033373
7321,2018-11-14,삼성바이오로직스고의분식회계파문이재용대법원재판영향은,http://www.4th.kr/news/articleView.html?idxno=6763
7322,2018-11-14,아주종목분석고의분식회계삼성바이오로직스6대상승,http://www.ajunews.com/view/20181114183951372
7323,2018-11-14,삼성바이오로직스고의분식회계결론거래정지대표이사해임검찰고발종합,http://it.chosun.com/site/data/html_dir/2018/11/14/2018111403068.html
7324,2018-11-14,삼성바이오로직스증선위결과에행정소송예정업계후폭풍예고,http://www.fetv.co.kr/news/article.html?no=15547
7325,2018-11-14,기고삼성바이오로직스분식회계결정상장폐지되면투자자집단소송가능성커,http://news.imaeil.com/Economy/2018111418272289844
7326,2018-11-14,거래정지삼성바이오로직스상장폐지가능성촉각,http://biz.newdaily.co.kr/site/data/html/2018/11/14/2018111400207.html
7327,2018-11-14,박용진삼성바이오로직스분식회계고의위반결정”,http://www.kukinews.com/news/article.html?no=604378
7328,2018-11-14,박용진의삼성내부문건에삼성바이오로직스철벽방어무너지다,http://www.businesspost.co.kr/BP?command=article_view&num=102548
7329,2018-11-14,삼성바이오로직스증선위에행정소송가자,http://it.chosun.com/site/data/html_dir/2018/11/14/2018111403114.html
7330,2018-11-14,삼성바이오로직스고의분식회계결론주식거래정지,http://news.kbs.co.kr/news/view.do?ncd=4073664&ref=A
7331,2018-11-14,삼성바이오로직스2015년고의적분식회계저질러증선위중징계결정,http://news.imaeil.com/Politics/2018111417533538880
7332,2018-11-14,거래소삼성바이오로직스주식거래정지조치내려,http://www.shinailbo.co.kr/news/articleView.html?idxno=1118795
7333,2018-11-14,삼성바이오로직스대표이사해임권고받아들일까,http://www.newsis.com/view/?id=NISX20181114_0000473543&cID=13001&pID=13000
7334,2018-11-14,참여연대한국거래소삼성바이오로직스상장폐지심사엄정해야,http://kormedi.com/?p=1255515
7335,2018-11-14,삼성바이오로직스분식회계당분간주식거래정지최악땐휴짓조각될수도,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000345
7336,2018-11-14,한국거래소삼성바이오로직스관련11개ELW거래도정지,http://news.hankyung.com/article/2018111467336
7337,2018-11-14,특징주삼성바이오로직스시간외에서하한가,http://www.nspna.com/news/?mode=view&newsid=318621
7338,2018-11-14,삼성바이오로직스고의분식회계결론,http://www.nspna.com/news/?mode=view&newsid=318618
7339,2018-11-14,거래소삼성바이오로직스검찰고발상장폐지심사돌입”,http://www.fnnews.com/news/201811141927544180
7340,2018-11-14,삼성바이오로직스증선위결정에반박행정소송서규명,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111419042624011
7341,2018-11-14,삼성바이오로직스고의분식결론주식거래정지,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1197386
7342,2018-11-14,삼성바이오로직스고의분식회계결론이이재용재판에도영향줄까,http://www.businesspost.co.kr/BP?command=article_view&num=102534
7343,2018-11-14,거래소삼성바이오로직스실질심사사유해당,http://www.dt.co.kr/contents.html?article_no=2018111402109932048020&ref=naver
7344,2018-11-14,삼성바이오로직스고의분식회계결론,http://news20.busan.com/controller/newsController.jsp?newsId=20181114000377
7345,2018-11-14,거래소삼성바이오로직스검찰고발실질심사돌입”,https://cnbc.sbs.co.kr/article_hub/10000921206?division=NAVER
7346,2018-11-14,삼성바이오로직스주식거래정지고의분식회계”,http://www.ichannela.com/news/main/news_detailPage.do?publishId=000000121166
7347,2018-11-14,시가총액22조삼성바이오로직스8만투자자충격,http://www.ichannela.com/news/main/news_detailPage.do?publishId=000000121167
7348,2018-11-14,매매거래정지삼성바이오로직스편입ETFETN거래주의,http://www.edaily.co.kr/news/newspath.asp?newsid=09069206619405720
7349,2018-11-14,증선위삼성바이오로직스고의분식회계결론,http://www.sentv.co.kr/news/view/545939
7350,2018-11-14,포토뉴스증선위삼성바이오로직스고의분식회계결론,http://www.sisajournal.com/article/178621
7351,2018-11-14,거래소삼성바이오로직스상장실질심사돌입,http://www.asiatoday.co.kr/view.php?key=20181114010008660
7352,2018-11-14,윤석헌금감원담금질로삼성바이오로직스방패뚫고위상세웠다,http://www.businesspost.co.kr/BP?command=article_view&num=102547
7353,2018-11-14,삼성바이오로직스분식회계삼성물산으로불똥튀나,http://news.imaeil.com/Politics/2018111420033864178
7354,2018-11-14,삼성바이오분식회계사태한국거래소삼성바이오로직스ELW도매매거래정지,http://www.etoday.co.kr/news/section/newsview.php?idxno=1687618
7355,2018-11-14,삼성바이오로직스고의분식회계로결론,http://www.joongboo.com/news/articleView.html?idxno=1302978
7356,2018-11-14,삼성바이오로직스주식매매정지,http://www.ccdn.co.kr/news/articleView.html?idxno=550021
7357,2018-11-14,삼성바이오로직스분식회계파문후폭풍어디까지,http://www.updownnews.co.kr/news/articleView.html?idxno=99104
7358,2018-11-14,삼성바이오로직스매매거래정지,http://www.jjn.co.kr/news/articleView.html?idxno=759275
7359,2018-11-14,증선위삼성바이오로직스고의분식회계결론,http://news.kbs.co.kr/news/view.do?ncd=4073807&ref=A
7360,2018-11-14,김용범금융위부위원장삼성바이오로직스고의분식회계결론발표,http://www.etnews.com/20181114000827
7361,2018-11-14,증권선물위원회삼성바이오로직스당분간매매정지,http://www.kyeonggi.com/news/articleView.html?idxno=2001269
7362,2018-11-14,한국거래소삼성바이오로직스ELW도매매거래정지,http://www.newstomato.com/ReadNews.aspx?no=858084
7363,2018-11-14,삼성바이오로직스고의분식회계결론거래중지,http://www.obsnews.co.kr/news/articleView.html?idxno=1125356
7364,2018-11-14,증선위삼성바이오로직스고의분식회계”주식거래정지,http://news.donga.com/3/all/20181114/92876574/1
7365,2018-11-14,삼성바이오로직스거래정지증시조마조마,http://www.ebn.co.kr/news/view/961906
7366,2018-11-14,삼성바이오로직스고의분식회계2015년거래정지,http://www.kyeongin.com/main/view.php?key=20181114010004737
7367,2018-11-14,박용진삼성바이오로직스고의분식회계이재용부회장승계작업과직결檢철저한수사요구,http://www.newscj.com/news/articleView.html?idxno=572722
7368,2018-11-15,삼성바이오로직스분식회계결론거래정지개미들동요틈타주당00원에살테니쪽지달라,http://www.ajunews.com/view/20181114171845287
7369,2018-11-15,증선위삼성바이오로직스고의분식회계결론,http://news.kbs.co.kr/news/view.do?ncd=4073958&ref=A
7370,2018-11-15,삼성바이오로직스주식거래정지,http://www.incheonilbo.com/news/articleView.html?idxno=912402
7371,2018-11-15,삼성바이오로직스상장폐지가능성낮지만증시에큰충격,http://news.kmib.co.kr/article/view.asp?arcid=0924033805&code=11151200&cp=nv
7372,2018-11-15,기업분석삼성바이오로직스vs엔론Enron분식회계비참한종말상장폐지코스피코스닥원달러환율,http://www.g-enews.com/ko-kr/news/article/news_all/2018111408365252284a01bf698f_1/article.html
7373,2018-11-15,삼성바이오로직스분식회계결론바이오업계산업위축될까우려”,http://www.dailian.co.kr/news/view/751800/?sc=naver
7374,2018-11-15,고의분식회계인정”삼성바이오로직스주식거래정지,http://sports.donga.com/3/all/20181114/92875473/3
7375,2018-11-15,시총22조삼성바이오로직스상폐기로실제가능성은,http://www.medicaltimes.com/News/1122491
7376,2018-11-15,삼성바이오로직스창사최대위기깊은유감적법확신,http://www.asiatoday.co.kr/view.php?key=20181114010008575
7377,2018-11-15,삼성바이오로직스끝날때까지끝난게아니다핵심쟁점은,http://www.g-enews.com/ko-kr/news/article/news_all/201811141714285853c642673384_1/article.html
7378,2018-11-15,뉴욕증시다우지수또와르르삼성바이오로직스쇼크나스닥강타코스피코스닥원달러환율비상,http://www.g-enews.com/ko-kr/news/article/news_all/2018111504131555454a01bf698f_1/article.html
7379,2018-11-15,박용진의원삼성바이오로직스회계분식사건철저수사엄중처벌촉구,http://www.gwangnam.co.kr/read.php3?aid=1542229760310455015
7380,2018-11-15,증선위삼성바이오로직스분식회계고의성인정,http://news.kbs.co.kr/news/view.do?ncd=4074012&ref=A
7381,2018-11-15,브랜드만믿고투자삼성서내돈물어내라주식거래정지개미공포삼성바이오로직스상폐우려눈물,http://www.g-enews.com/ko-kr/news/article/news_all/2018111506231063744e4869c120_1/article.html
7382,2018-11-15,김어준의뉴스공장김경율드디어최종결론삼성바이오로직스고의분식회계로판정,http://www.mediapen.com/news/view/395870
7383,2018-11-15,천지일보이슈종합수능시간표석촌호수실종김정은초청하자고액체납자명단공개이수역폭행양심적병역거부자삼성바이오로직스,http://www.newscj.com/news/articleView.html?idxno=572751
7384,2018-11-15,분식회계삼성바이오로직스주식거래중지,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20181115.010020718500001
7385,2018-11-15,삼성바이오로직스고의분식결론주식거래정지,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1197457
7386,2018-11-15,삼성바이오로직스고의분식회계결론주식거래정지및과징금80억,http://www.topstarnews.net/news/articleView.html?idxno=525089
7387,2018-11-15,삼성바이오로직스사태바이오섹터에미치는영향미미,http://news.hankyung.com/article/2018111572696
7388,2018-11-15,삼성바이오로직스거래정지바이오주악영향거의없어하나금투,http://www.newstomato.com/ReadNews.aspx?no=858087
7389,2018-11-15,삼성바이오로직스이슈펀더멘털요인아냐,http://news.hankyung.com/article/2018111573036
7390,2018-11-15,김어준의뉴스공장김어준삼성바이오로직스삼바분식회계언론들은삼성단어빼고상식적으로생각하자,http://www.topstarnews.net/news/articleView.html?idxno=525082
7391,2018-11-15,초점삼성바이오로직스거래정지충격제약바이오먹구름전망,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062464
7392,2018-11-15,삼성바이오로직스단기적업종투자심리에부정적NH,http://www.fnnews.com/news/201811150741456652
7393,2018-11-15,코스피코스닥14일주요공시거래소회계기준위반삼성바이오로직스매매거래정지등,http://www.betanews.net:8080/article/935064.html
7394,2018-11-15,삼성바이오로직스상장폐지가능성은제한적,http://news.hankyung.com/article/2018111573156
7395,2018-11-15,삼성바이오로직스분식회계이슈펀더멘털요인아냐NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111507441999139
7396,2018-11-15,삼성바이오로직스거래정지제약바이오섹터에미칠영향없어”하나금투,http://www.fntimes.com/html/view.php?ud=201811150756503103f09e13944d_18
7397,2018-11-15,하나금투삼성바이오로직스거래정지제약바이오주영향제한적”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111508082844752
7398,2018-11-15,삼성바이오로직스투자자와고객에게사과증권선물위원회발표유감표명,http://www.m-i.kr/news/articleView.html?idxno=470189
7399,2018-11-15,삼성물산삼성바이오로직스거래정지기간대안주한국,http://news.hankyung.com/article/2018111574186
7400,2018-11-15,삼성바이오로직스거래정지기간불확실성지속NH證,http://news.mt.co.kr/mtview.php?no=2018111508011063844
7401,2018-11-15,삼성바이오로직스모두가승자인게임될수있어,http://news.hankyung.com/article/2018111574406
7402,2018-11-15,거래정지삼성바이오로직스펀드투자자는어쩌나,http://www.sisajournal-e.com/biz/article/191516
7403,2018-11-15,삼성바이오로직스거래정지제약바이오영향미미하나금투,http://news.mt.co.kr/mtview.php?no=2018111508224052036
7404,2018-11-15,삼성바이오로직스거래정지제약∙바이오주영향제한적”,http://www.fntimes.com/html/view.php?ud=2018111508323963971d6f57e61a_18
7405,2018-11-15,대신증권삼성바이오로직스상장폐지가능성제한적,http://www.viva100.com/main/view.php?key=20181115010005564
7406,2018-11-15,삼성바이오로직스상장폐지가능성은제한적한국,http://www.edaily.co.kr/news/newspath.asp?newsid=02007366619406048
7407,2018-11-15,삼성바이오로직스거래정지투자대안은삼성물산”,http://www.fntimes.com/html/view.php?ud=2018111508463558431d6f57e61a_18
7408,2018-11-15,오늘의브릿지경제1면삼성바이오로직스2015년고의분식회계매매거래정지,http://www.viva100.com/main/view.php?key=20181114001725512
7409,2018-11-15,삼성물산삼성바이오로직스의대안주한투,http://www.sedaily.com/NewsView/1S775RVVXN
7410,2018-11-15,대산증권삼성바이오로직스관련상장폐지겪지않을것종합적으로고려하면제한적,http://www.topstarnews.net/news/articleView.html?idxno=525152
7411,2018-11-15,HotLine삼성물산삼성바이오로직스거래정지기간의대안주,http://news.mk.co.kr/newsRead.php?year=2018&no=715919
7412,2018-11-15,삼성바이오로직스거래정지상장폐지가능성희박”,http://www.fntimes.com/html/view.php?ud=2018111508562429691d6f57e61a_18
7413,2018-11-15,삼성물산주가상승가능자회사삼성바이오로직스불확실성해소,http://www.businesspost.co.kr/BP?command=article_view&num=102601
7414,2018-11-15,삼성바이오로직스분식회계가제약바이오주에줄영향거의없어,http://www.businesspost.co.kr/BP?command=article_view&num=102602
7415,2018-11-15,삼성바이오로직스상장폐지가능성제한”,http://www.edaily.co.kr/news/newspath.asp?newsid=02141846619406048
7416,2018-11-15,삼성바이오로직스거래정지국내증시전체비관으로비화할수도”,http://www.fntimes.com/html/view.php?ud=2018111509080460471d6f57e61a_18
7417,2018-11-15,I리포트삼성바이오로직스업종투자심리에부정적영향NH證,http://www.inews24.com/php/news_view.php?g_serial=1139902&g_menu=022300&rrf=nv
7418,2018-11-15,삼성물산삼성바이오로직스거래정지기간의대안주한국투자증권,http://www.ekn.kr/news/article.html?no=397746
7419,2018-11-15,삼성바이오로직스거래중지투자심리냉각우려교보증권,http://www.dt.co.kr/contents.html?article_no=2018111502109932048001&ref=naver
7420,2018-11-15,삼성바이오로직스상장폐지가능성희박대신증권,http://www.dt.co.kr/contents.html?article_no=2018111502109932048002&ref=naver
7421,2018-11-15,증선위삼성바이오로직스분식회계고의주식거래정지,http://www.dailysmart.co.kr/news/articleView.html?idxno=3085
7422,2018-11-15,삼성바이오로직스상폐가능성제한적한국투자증권,http://www.fnnews.com/news/201811150933563387
7423,2018-11-15,SR포커스시가총액22조삼성바이오로직스주식거래정지소액투자자8만명어쩌나,http://www.srtimes.kr/news/articleView.html?idxno=27508
7424,2018-11-15,투자코멘트실시간종목순위0940삼성바이오로직스셀트리온삼성전자,http://www.fntimes.com/html/view.php?ud=2018111509505977985dfa8ac1ac_18
7425,2018-11-15,삼성물산삼성바이오로직스거래정지에대안한국투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111508355163736
7426,2018-11-15,삼성바이오로직스분식회계후폭풍이재용재판으로불똥튀나,http://www.straightnews.co.kr/news/articleView.html?idxno=38448
7427,2018-11-15,1시간늦어진주식시장개장시간기다리는건세계증시하락삼성바이오로직스거래정지여파,http://news.imaeil.com/Economy/2018111509535976670
7428,2018-11-15,고의분식회계삼성바이오로직스거래정지언제풀리나한국항공우주일주일대우조선1년3개월,http://www.ajunews.com/view/20181115094625642
7429,2018-11-15,삼성바이오로직스주식거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076000013&did=1196m
7430,2018-11-15,삼성바이오로직스주식거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115075700013&did=1196m
7431,2018-11-15,삼성바이오로직스주식거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115075900013&did=1196m
7432,2018-11-15,삼성바이오로직스거래정지에도셀트리온장초반상승세,http://www.econonews.co.kr/news/articleView.html?idxno=42420
7433,2018-11-15,삼성바이오로직스거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076800013&did=1196m
7434,2018-11-15,삼성바이오로직스거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076900013&did=1196m
7435,2018-11-15,주식거래정지된삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076700013&did=1196m
7436,2018-11-15,삼성바이오로직스거래정지,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115077200013&did=1196m
7437,2018-11-15,주식거래정지된삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076500013&did=1196m
7438,2018-11-15,주식거래정지된삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076300013&did=1196m
7439,2018-11-15,삼성물산삼성바이오로직스거래정지대안주예상에도장초반부터4대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=42421
7440,2018-11-15,주식거래정지된삼성바이오로직스,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115076200013&did=1196m
7441,2018-11-15,홍남기후보자삼성바이오로직스증선위결정존중,http://news.mt.co.kr/mtview.php?no=2018111510104244099
7442,2018-11-15,위기의삼성바이오로직스상장폐지요건해당할까,http://moneys.mt.co.kr/news/mwView.php?no=2018111510058064280
7443,2018-11-15,삼성바이오로직스바이오대장주꿈2년만에물거품,http://moneys.mt.co.kr/news/mwView.php?no=2018111510048061100
7444,2018-11-15,특징주삼성물산삼성바이오로직스거래정지에약세,http://www.newsis.com/view/?id=NISX20181115_0000474057&cID=10401&pID=10400
7445,2018-11-15,HotLine삼성바이오로직스거래정지에삼성물산약세,http://news.mk.co.kr/newsRead.php?year=2018&no=716235
7446,2018-11-15,특징주삼성물산삼성바이오로직스분식회계결론에약세,http://www.viva100.com/main/view.php?key=20181115010005649
7447,2018-11-15,특징주삼성물산자회사삼성바이오로직스회계처리위반주가된서리,http://www.g-enews.com/ko-kr/news/article/news_all/201811151020556526c642673384_1/article.html
7448,2018-11-15,33만4천5백원종가에거래정지된삼성바이오로직스,http://www.cpbc.co.kr/CMS/news/view_body.php?cid=738962&path=201811
7449,2018-11-15,박용진삼성바이오로직스분식회계사필귀정엄중한처벌이뤄져야,http://www.todaykorea.co.kr/news/view.php?no=258034
7450,2018-11-15,특징주삼성물산자회사삼성바이오로직스분식회계결론에약세,http://www.asiatoday.co.kr/view.php?key=20181115010008966
7451,2018-11-15,삼성바이오로직스45조분식회계결론대표해임검찰고발,http://www.newsrep.co.kr/news/articleView.html?idxno=60289
7452,2018-11-15,삼성바이오로직스그때는맞고지금은틀리다,http://www.nongaek.com/news/articleView.html?idxno=47998
7453,2018-11-15,정준희의최강시사김경률국제회계기준위원회삼성바이오로직스회계처리잘못됐다”,http://news.kbs.co.kr/news/view.do?ncd=4074213&ref=A
7454,2018-11-15,제약바이오주삼성바이오로직스불확실성해소에상승,http://news.hankyung.com/article/2018111583426
7455,2018-11-15,삼성바이오로직스고의분식회계검찰고발이재용소송파장은,http://view.asiae.co.kr/news/view.htm?idxno=2018111510341644881
7456,2018-11-15,삼성바이오로직스주식거래정지에행정소송제기할것”,http://www.cnbnews.com/news/article.html?no=390915
7457,2018-11-15,특징주삼성물산삼성바이오로직스거래정지에약세,http://biz.chosun.com/site/data/html_dir/2018/11/15/2018111501195.html
7458,2018-11-15,그래픽일지증선위삼성바이오로직스고의분식회계결정까지,http://www.newsis.com/view/?id=NISI20181115_0000229963
7459,2018-11-15,특징주바이오株삼성바이오로직스분식회계확정에도강세,http://www.newsis.com/view/?id=NISX20181115_0000474087&cID=10401&pID=10400
7460,2018-11-15,코스피2060대삼성바이오로직스거래정지후삼성물산신저가,http://www.seoulwire.com/news/articleView.html?idxno=34426
7461,2018-11-15,삼성바이오로직스향후15영업일이내심의대상여부결정예상,http://www.sisafocus.co.kr/news/articleView.html?idxno=196291
7462,2018-11-15,박용진삼성바이오로직스사태는사필귀정이재용의혹낱낱히밝혀야,http://www.newsworks.co.kr/news/articleView.html?idxno=311067
7463,2018-11-15,이데일리N삼성바이오로직스고의로분식회계주식거래정지外,http://www.edaily.co.kr/news/newspath.asp?newsid=03037286619406048
7464,2018-11-15,삼성바이오로직스관련기자회견하는심성정의원,http://www.newsis.com/view/?id=NISI20181115_0014651072
7465,2018-11-15,포토삼성바이오로직스고의분식회계관련기자회견,http://view.asiae.co.kr/news/view.htm?idxno=2018111510482217443
7466,2018-11-15,포토심상정삼성바이오로직스분식회계관련기자,http://view.asiae.co.kr/news/view.htm?idxno=2018111510483021155
7467,2018-11-15,채이배삼성바이오로직스분식회계이재용개입여부밝혀야,http://www.weeklytoday.com/news/articleView.html?idxno=69506
7468,2018-11-15,삼성바이오로직스주식거래정지,http://news1.kr/photos/view/?3391907
7469,2018-11-15,심상정의원삼성바이오로직스관련증선위결정은당연,http://news1.kr/photos/view/?3391902
7470,2018-11-15,심상정의원삼성바이오로직스분식회계거래정지환영,http://news1.kr/photos/view/?3391906
7471,2018-11-15,심상정의원삼성바이오로직스분식회계관련증선위결정환영,http://news1.kr/photos/view/?3391904
7472,2018-11-15,심상정의원삼성바이오로직스관련증선위결정환영,http://news1.kr/photos/view/?3391901
7473,2018-11-15,집중분석투자일자리신산업어쩌나삼성바이오로직스사태發산업계후폭풍우려,http://www.viva100.com/main/view.php?key=20181115010005578
7474,2018-11-15,CLSA삼성바이오로직스검찰조사강경진행시불확실성남을것,http://www.choicenews.co.kr/news/articleView.html?idxno=46007
7475,2018-11-15,삼성바이오로직스거래정지에삼성물산개미들삼바때문에피해반등은언제한숨,http://www.g-enews.com/ko-kr/news/article/news_all/2018111510560267784e4869c120_1/article.html
7476,2018-11-15,홍남기후보자삼성바이오로직스관련증선위결정존중,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10311236
7477,2018-11-15,홍영표삼성바이오로직스상장폐지판단까지피해자없도록해야”,http://www.viva100.com/main/view.php?key=20181115010005682
7478,2018-11-15,특징주바이오株삼성바이오로직스분식회계확정에도강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811150245&t=NN
7479,2018-11-15,증권사삼성바이오로직스상장폐지가능성낮다실질심사제도이후상폐없어,http://www.g-enews.com/ko-kr/news/article/news_all/201811151112405147c642673384_1/article.html
7480,2018-11-15,삼성바이오로직스회계이슈최종전돌입3공장수주활동저하걱정,http://www.asiatime.co.kr/news/articleView.html?idxno=211520
7481,2018-11-15,삼성바이오로직스고의분식회계판정상장폐지는안된다는언론의감싸기도문제,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10311248
7482,2018-11-15,삼성바이오로직스분식회계추가의혹제대로밝혀내야,http://moneys.mt.co.kr/news/mwView.php?no=2018111511178071361
7483,2018-11-15,삼성바이오로직스후폭풍묶여버린소액주주8만명거래정지기간은얼마나,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111509305449697
7484,2018-11-15,금융당국vs삼성바이오로직스회계논리차이는,http://news.einfomax.co.kr/news/articleView.html?idxno=4002883
7485,2018-11-15,삼성바이오로직스후폭풍①삼바담은펀드충격파급력어디까지,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111509174683366
7486,2018-11-15,뉴스후삼성바이오로직스후폭풍삼성바이오고의분식회계파장일파만파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111510164154332
7487,2018-11-15,분식회계엔론은붕괴삼성바이오로직스앞날은,http://kormedi.com/?p=1255592
7488,2018-11-15,제약바이오주상승세삼성바이오로직스불확실성해소,http://www.sporbiz.co.kr/news/articleView.html?idxno=288766
7489,2018-11-15,심상정삼성바이오로직스철저히수사해야,http://kormedi.com/?p=1255603
7490,2018-11-15,삼성바이오로직스거래정지후폭풍제약바이오업종전반신뢰하락번지나노심초사,http://news.heraldcorp.com/view.php?ud=20181115000419
7491,2018-11-15,삼성바이오로직스거래정지후폭풍행정소송으로적법성입증”삼성바이오반전카드꺼냈다,http://news.heraldcorp.com/view.php?ud=20181115000416
7492,2018-11-15,삼성바이오로직스분식회계결론후CMO수주고민,http://www.ceoscoredaily.com/news/article.html?no=48274
7493,2018-11-15,삼성바이오로직스거래정지후폭풍바이오제약되살아난악재에공매도먹잇감우려,http://news.heraldcorp.com/view.php?ud=20181115000420
7494,2018-11-15,포토삼성바이오로직스고의분식회계결정기자회견하는심상정의원,http://www.dailian.co.kr/news/view/751984/?sc=naver
7495,2018-11-15,포토심상정삼성바이오로직스고의분식회계결정기자회견,http://www.dailian.co.kr/news/view/751985/?sc=naver
7496,2018-11-15,삼성바이오로직스관련기자회견하는심상정의원,http://www.newscj.com/news/articleView.html?idxno=572941
7497,2018-11-15,포토심상정삼성바이오로직스고의분식회계결정재별개혁이정표”,http://www.dailian.co.kr/news/view/751987/?sc=naver
7498,2018-11-15,삼성바이오로직스거래중지첫날주식시장혼조세,https://www.ytn.co.kr/_ln/0102_201811151146403103
7499,2018-11-15,김태한삼성바이오로직스사장임직원에회계처리문제없다편지,http://www.fnnews.com/news/201811151146412331
7500,2018-11-15,삼성바이오로직스증선위결정관련기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115120800013&did=1196m
7501,2018-11-15,삼성바이오로직스증선위결정관련기자회견,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115120700013&did=1196m
7502,2018-11-15,심상정삼성바이오로직스증권선물위원회결정관련기자회견,http://www.newscj.com/news/articleView.html?idxno=572956
7503,2018-11-15,거래정지된삼성바이오로직스를보는금융권전망은,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062497
7504,2018-11-15,삼성바이오로직스상폐될까공은다시한국거래소로넘어가,http://www.naeil.com/news_view/?id_art=294888
7505,2018-11-15,삼성바이오로직스편입비중상위5개펀드한달새14손실,http://www.dt.co.kr/contents.html?article_no=2018111502109932048007&ref=naver
7506,2018-11-15,삼성바이오로직스상장폐지가능성은희박하다,http://www.newsworks.co.kr/news/articleView.html?idxno=311164
7507,2018-11-15,5스타오후장투자전략삼성바이오로직스거래정지증시영향은,https://cnbc.sbs.co.kr/article_hub/10000921291?division=NAVER
7508,2018-11-15,개미무덤된삼성바이오로직스외인기관매도물량1000억떠안아,http://moneys.mt.co.kr/news/mwView.php?no=2018111514048090387
7509,2018-11-15,삼성물산삼성바이오로직스거래정지영향52주신저가기록,http://www.dailysmart.co.kr/news/articleView.html?idxno=3103
7510,2018-11-15,삼성물산주가삼성바이오로직스회계처리이슈로변동성커져,http://www.businesspost.co.kr/BP?command=article_view&num=102630
7511,2018-11-15,삼성바이오로직스관련기자회견갖는박용진의원,http://www.newscj.com/news/articleView.html?idxno=573001
7512,2018-11-15,박용진삼성바이오로직스관련기자회견,http://www.newscj.com/news/articleView.html?idxno=573002
7513,2018-11-15,삼성바이오로직스상장폐지로휴지조각될까,http://www.ebn.co.kr/news/view/961978
7514,2018-11-15,삼성바이오로직스기자회견하는박용진의원,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115167700013&did=1196m
7515,2018-11-15,삼성바이오로직스기자회견하는박용진의원,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20181115167800013&did=1196m
7516,2018-11-15,거래정지삼성바이오로직스대우조선처럼감자할까,http://www.sisajournal-e.com/biz/article/191530
7517,2018-11-15,삼성바이오로직스관련기자회견하는박용진의원,http://www.newsis.com/view/?id=NISI20181115_0014652091
7518,2018-11-15,박용진의원삼성바이오로직스관련기자회견,http://www.newsis.com/view/?id=NISI20181115_0014652094
7519,2018-11-15,박용진의원삼성바이오로직스관련기자회견,http://www.newsis.com/view/?id=NISI20181115_0014652093
7520,2018-11-15,박용진의원삼성바이오로직스관련기자회견,http://www.newsis.com/view/?id=NISI20181115_0014652095
7521,2018-11-15,삼성바이오로직스관련기자회견하는박용진의원,http://www.newsis.com/view/?id=NISI20181115_0014652092
7522,2018-11-15,삼성바이오로직스관련기자회견하는박용진의원,http://www.newsis.com/view/?id=NISI20181115_0014652090
7523,2018-11-15,삼성바이오로직스회계조작최초제기홍순탁회계사3억아파트로20억번꼴,http://www.segye.com/content/html/2018/11/15/20181115002897.html?OutUrl=naver
7524,2018-11-15,삼성바이오로직스분식회계후폭풍이재용재판에영향미치나,http://www.smedaily.co.kr/news/articleView.html?idxno=79549
7525,2018-11-15,뉴투분석삼성바이오로직스와대우조선해양분식회계의차이는사실과해석,http://www.news2day.co.kr/114777
7526,2018-11-15,삼성물산삼성바이오로직스분식회계불똥튈까,http://news.mk.co.kr/newsRead.php?year=2018&no=717168
7527,2018-11-15,삼성바이오로직스관련답변하는박용진의원,http://news1.kr/photos/view/?3392592
7528,2018-11-15,박용진삼성바이오로직스사건엄중한처벌이있어야,http://news1.kr/photos/view/?3392600
7529,2018-11-15,박용진삼성바이오로직스사건은삼성경영권승계작업의증거이다,http://news1.kr/photos/view/?3392597
7530,2018-11-15,삼성바이오로직스거래정지기간에대한불확실성지속,http://www.newsworks.co.kr/news/articleView.html?idxno=311201
7531,2018-11-15,안팎의위기삼성바이오로직스경영진교체되나,http://news.mt.co.kr/mtview.php?no=2018111510562367834
7532,2018-11-15,외신삼성바이오로직스사태이재용에게끔찍한시점에터졌다,http://www.choicenews.co.kr/news/articleView.html?idxno=46020
7533,2018-11-15,삼성바이오로직스사태의신중하고공정한해결을기대한다윤영석수석대변인논평,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=156&aid=0000024424
7534,2018-11-15,삼성바이오로직스쇼크편입비중상위5개펀드한달새14손실,http://www.g-enews.com/ko-kr/news/article/news_all/201811151438449959a1bf7598da_1/article.html
7535,2018-11-15,시총22조삼성바이오로직스거래정지제2대우그룹될라,http://www.asiatime.co.kr/news/articleView.html?idxno=211605
7536,2018-11-15,김태한삼성바이오로직스사장회계처리위반하지않았다확신,http://www.inews24.com/php/news_view.php?g_serial=1140015&g_menu=022620&rrf=nv
7537,2018-11-15,박용진삼성바이오로직스고의분식회계자본시장근간흔드는중대범죄행위,http://www.mdtoday.co.kr/mdtoday/index.html?no=338825
7538,2018-11-15,거래멈춘삼성바이오로직스,http://news1.kr/photos/view/?3392721
7539,2018-11-15,분식회계결론거래중지된삼성바이오로직스,http://news1.kr/photos/view/?3392724
7540,2018-11-15,삼성바이오로직스거래정지,http://news1.kr/photos/view/?3392723
7541,2018-11-15,삼성바이오로직스거래정지,http://news1.kr/photos/view/?3392726
7542,2018-11-15,거래정지된삼성바이오로직스,http://news1.kr/photos/view/?3392729
7543,2018-11-15,심상정삼성물산합병과삼성바이오로직스분식연관수사해야,http://www.businesspost.co.kr/BP?command=article_view&num=102656
7544,2018-11-15,주식거래정지된삼성바이오로직스,http://news1.kr/photos/view/?3392719
7545,2018-11-15,상폐위기놓인삼성바이오로직스대우조선과같은길걸을까,http://www.sportsseoul.com/news/read/701564
7546,2018-11-15,공감신문입법공감박용진삼성바이오로직스분식회계는박근혜정권최악의금융적폐,http://www.gokorea.kr/news/articleView.html?idxno=56759
7547,2018-11-15,오늘의스트레이트정동영삼성바이오로직스분식회계회계산업의세월호사건,http://www.straightnews.co.kr/news/articleView.html?idxno=38461
7548,2018-11-15,김태한삼성바이오로직스임직원들에게행정소송으로결백입증,http://www.businesspost.co.kr/BP?command=article_view&num=102667
7549,2018-11-15,확실한고의적분식회계삼성바이오로직스15일증권거래중지,http://kpenews.com/Board.aspx?BoardNo=21329
7550,2018-11-15,삼성바이오로직스와관련해기자회견하는박용진포토,http://www.vop.co.kr/A00001353031.html
7551,2018-11-15,공감신문생생국회삼성바이오로직스분식회계기자회견서답변중인박용진의원,http://www.gokorea.kr/news/articleView.html?idxno=56773
7552,2018-11-15,삼성바이오로직스분식회계사태놓고야3당온도차,http://www.sisafocus.co.kr/news/articleView.html?idxno=196339
7553,2018-11-15,삼성바이오로직스사태한국증시대외신인도흔들,http://www.fntimes.com/html/view.php?ud=2018111516235196431d6f57e61a_18
7554,2018-11-15,거래소삼성바이오로직스거래정지상장적격성심사사유발생,http://www.inews24.com/php/news_view.php?g_serial=1139912&g_menu=022300&rrf=nv
7555,2018-11-15,증권가삼성바이오로직스상장폐지가능성적어”,http://www.viva100.com/main/view.php?key=20181115010005807
7556,2018-11-15,분식회계삼성바이오로직스삼성물산감리로번지나,http://www.newsworks.co.kr/news/articleView.html?idxno=311267
7557,2018-11-15,홍남기부총리후보자삼성바이오로직스관련증선위결정존중”,http://news.kbs.co.kr/news/view.do?ncd=4074468&ref=A
7558,2018-11-15,삼성바이오로직스비중상위5개펀드최근한달새14손실”,http://news.kbs.co.kr/news/view.do?ncd=4074469&ref=A
7559,2018-11-15,삼성바이오로직스거래정지제약바이오주불똥증권업계영향거의없을것,http://www.g-enews.com/ko-kr/news/article/news_all/201811151556161197a1bf7598da_1/article.html
7560,2018-11-15,삼바거래정지후폭풍김태한삼성바이오로직스사장임직원에메일국제회계기준에맞게처리,http://www.fnnews.com/news/201811151727122926
7561,2018-11-15,삼성바이오로직스결국상장폐지되나,http://www.finomy.com/news/articleView.html?idxno=60201
7562,2018-11-15,카드뉴스김어준생각삼성바이오로직스상장폐지여부상식적으로생각합시다,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10311357
7563,2018-11-15,심상정삼성바이오로직스재벌개혁이정표,http://www.newsis.com/view/?id=NISX20181115_0000474817&cID=10301&pID=10300
7564,2018-11-15,딜로이트안진삼성바이오로직스분식회계연루돼신뢰회복먹구름,http://www.businesspost.co.kr/BP?command=article_view&num=102681
7565,2018-11-15,상폐심사대상삼성바이오로직스결론최대1년뒤,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181115173356
7566,2018-11-15,거래정지삼성바이오로직스바이오사업타격없다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111516050229883
7567,2018-11-15,오늘Who박용진삼성바이오로직스분식회계싸움멈추지않는다,http://www.businesspost.co.kr/BP?command=article_view&num=102692
7568,2018-11-15,삼성바이오로직스회계엄격성명분은얻었으나실리는모두잃다,http://www.techholic.co.kr/news/articleView.html?idxno=179227
7569,2018-11-15,삼성바이오로직스거래정지첫날제약바이오외려강세,http://www.asiatoday.co.kr/view.php?key=20181115010009480
7570,2018-11-15,증선위의결론은분식회계삼성바이오로직스상장폐지가능성은,http://withinnews.co.kr/news/view.html?section=1&category=163&item=&no=17003
7571,2018-11-15,삼성바이오로직스상장폐지불가라는대마불사원칙이위험하다,http://www.businesspost.co.kr/BP?command=article_view&num=102703
7572,2018-11-15,삼성바이오로직스고의분식회계없었다전직원에이메일,http://www.ggilbo.com/news/articleView.html?idxno=564359
7573,2018-11-15,정동영삼성바이오로직스분식회계사건규명,http://www.jeollailbo.com/news/articleView.html?idxno=555341
7574,2018-11-15,김태한삼성바이오로직스대표직원들에고의분식회계없었다”,http://www.sedaily.com/NewsView/1S776WUBN6
7575,2018-11-15,김태한삼성바이오로직스대표기업회계기준위반하지않았다주장,http://www.ceoscoredaily.com/news/article.html?no=48316
7576,2018-11-15,삼성바이오로직스분식으로삼성생명의삼성전자지분처리에불똥,http://www.businesspost.co.kr/BP?command=article_view&num=102727
7577,2018-11-15,심상정삼성바이오로직스이번결정유지하기위해금융당국이적극적인역할해야”,http://www.hkbs.co.kr/news/articleView.html?idxno=491042
7578,2018-11-15,심상정삼성바이오로직스재벌개혁의이정표생긴것이라생각,http://www.topstarnews.net/news/articleView.html?idxno=525827
7579,2018-11-15,사주스탁삼성바이오로직스15일주식거래정지미치는영향과투자심리생각해라,http://www.fntoday.co.kr/news/articleView.html?idxno=172606
7580,2018-11-15,심상정삼성바이오로직스상장폐지배제할수없어사회적책임답변내놔야,http://www.segye.com/content/html/2018/11/15/20181115005758.html?OutUrl=naver
7581,2018-11-16,기자수첩삼성바이오로직스삼성신뢰하락에국가이미지직격타까지,http://www.g-enews.com/ko-kr/news/article/news_all/20181115163233558725b4ac5ede_1/article.html
7582,2018-11-16,연9신장하는산업서삼성바이오로직스해외신인도충격우려,http://www.asiatoday.co.kr/view.php?key=20181115010009393
7583,2018-11-16,삼성바이오로직스상폐기로거래소보름안에1차관문결판,http://www.asiatoday.co.kr/view.php?key=20181115010009297
7584,2018-11-16,JOB리포트삼성바이오로직스사태로바이오산업투자및고용타격우려,http://www.news2day.co.kr/114804
7585,2018-11-16,김어준의뉴스공장삼성바이오로직스삼바후폭풍엔론은분식회계로파산,http://www.topstarnews.net/news/articleView.html?idxno=526031
7586,2018-11-16,UpDown앤디김vs삼성바이오로직스,http://www.sisajournal.com/article/178628
7587,2018-11-16,인터뷰전문뉴스쇼민주당박용진삼성바이오로직스삼바는금융적폐사건사필귀정,http://www.topstarnews.net/news/articleView.html?idxno=526055
7588,2018-11-16,이데일리N김태한삼성바이오로직스대표고의적분식회계없었다外,http://www.edaily.co.kr/news/newspath.asp?newsid=02118886619406376
7589,2018-11-16,오늘의이투데이DDR5삼성바이오로직스브렉시트가상화폐지스타201811월16일,http://www.etoday.co.kr/news/section/newsview.php?idxno=1688331
7590,2018-11-16,조세금융만평이쁘게칠해주세요삼성바이오로직스분식회계결론,http://www.tfnews.co.kr/news/article.html?no=56127
7591,2018-11-16,더벨삼성바이오로직스가처분여부따라23년장기전도,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201811160100026780001654
7592,2018-11-16,오시영의세상의창최춘희시인의부록처럼삼성바이오로직스의분식회계,http://www.lec.co.kr/news/articleView.html?idxno=49100
7593,2018-11-16,고의성드러난삼성바이오로직스분식회계상장폐지절차돌입하나,http://www.kidd.co.kr/news/205753
7594,2018-11-16,셀트리온은셀트리온의길을간다삼성바이오로직스악재여파벗어나는모습셀트리온제약15이상상승률,http://news.imaeil.com/Economy/2018111611560293328
7595,2018-11-16,정치권엄중한처벌에삼성바이오로직스적법하다반박,http://kormedi.com/?p=1255740
7596,2018-11-16,삼바춤못추고추풍낙엽삼성바이오로직스대체주셀트리온제약등날개짓,http://www.g-enews.com/ko-kr/news/article/news_all/2018111612240064044e4869c120_1/article.html
7597,2018-11-16,셀트리온제약급등세불확실해소삼성바이오로직스대체주지목,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181116.99099007061
7598,2018-11-16,삼성바이오로직스운명가른숨가뻤던6개월분식회계스모킹건은,http://www.iminju.net/news/articleView.html?idxno=40147
7599,2018-11-16,증권업계삼성바이오로직스상장폐지가능성희박,http://www.wolyo.co.kr/news/articleView.html?idxno=71806
7600,2018-11-16,원일희의직설삼성바이오로직스상폐심사를바라보며,https://cnbc.sbs.co.kr/article_hub/10000921427?division=NAVER
7601,2018-11-16,제약바이오주삼성바이오로직스거래정지에도반등,http://www.sporbiz.co.kr/news/articleView.html?idxno=289119
7602,2018-11-16,김태한삼성바이오로직스사장회계기준위반없었다는점확신가지고있어,http://www.econonews.co.kr/news/articleView.html?idxno=42582
7603,2018-11-16,정치권삼성바이오로직스엄중처벌촉구,http://www.kbanker.co.kr/news/articleView.html?idxno=76232
7604,2018-11-17,제약바이오한주간이모저모삼성바이오로직스거래정지,http://www.edaily.co.kr/news/newspath.asp?newsid=01498966619406704
7605,2018-11-17,삼성바이오로직스고의분식회계후폭풍어디까지휘몰아칠까김현주의일상톡톡,http://www.segye.com/content/html/2018/11/16/20181116001057.html?OutUrl=naver
7606,2018-11-17,삼성바이오로직스묶인돈22조거래정지최대1년α,http://www.medicaltimes.com/News/1122555
7607,2018-11-17,서라백의스트레이툰삼성바이오로직스분식회계정경유착쉽지않네,http://www.straightnews.co.kr/news/articleView.html?idxno=38513
7608,2018-11-18,지난주삼성바이오로직스개인은978억원어치순매수,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10311658
7609,2018-11-18,스트레이트뉴스삼성바이오로직스분식회계후폭풍이재용삼성물산운명은,http://www.straightnews.co.kr/news/articleView.html?idxno=38530
7610,2018-11-18,삼성바이오로직스지난해개인투자자4만명증가”,http://www.newsway.co.kr/news/view?tp=1&ud=2018111809411993128
7611,2018-11-18,김태한은삼성바이오로직스분식회계결론에왜결사항전하나,http://www.businesspost.co.kr/BP?command=article_view&num=102906
7612,2018-11-18,삼성바이오로직스새대표로해외영입재무전문가존림급부상,http://www.businesspost.co.kr/BP?command=article_view&num=102907
7613,2018-11-18,마켓포인트코스피주간기관순매도1위삼성바이오로직스,http://www.edaily.co.kr/news/newspath.asp?newsid=01341526619407032
7614,2018-11-18,삼성바이오로직스분식회계논란삼성경영권승계후폭풍거셀듯,http://www.fntoday.co.kr/news/articleView.html?idxno=172731
7615,2018-11-18,이슈분석경영권시련한국기업삼성바이오로직스와경영권총수일가기업의사유화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1119370
7616,2018-11-18,개인투자자외인기관팔때도삼성바이오로직스주식대량매집,http://www.dt.co.kr/contents.html?article_no=2018111802109932048002&ref=naver
7617,2018-11-18,뉴투분석참여연대타깃삼성전자와삼성바이오로직스시가총액56조증발,http://www.news2day.co.kr/114924
7618,2018-11-18,거래정지삼성바이오로직스펀드환매대란오나운용사촉각,http://news.mt.co.kr/mtview.php?no=2018111812493680499
7619,2018-11-18,천지일보주간SNS핫이슈5이수역폭행수능삼성바이오로직스논산여교사혜경궁이재명,http://www.newscj.com/news/articleView.html?idxno=573900
7620,2018-11-19,김어준의뉴스공장김광중삼성바이오로직스고의분식회계후폭풍소액주주손해배상집단소송나선다,http://www.mediapen.com/news/view/396558
7621,2018-11-19,WIKI진단삼성바이오로직스투자자들의울분가라앉지않는증선위금감원고무줄잣대논란,http://www.wikileaks-kr.org/news/articleView.html?idxno=40989
7622,2018-11-19,더벨매니저들은왜삼성바이오로직스를안팔았을까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201811150100025870001601
7623,2018-11-19,삼성바이오로직스개인투자자보유지분가치3조원넘어,http://www.asiatime.co.kr/news/articleView.html?idxno=212005
7624,2018-11-19,검찰서삼성바이오로직스상장당시의혹도규명해야,http://www.choicenews.co.kr/news/articleView.html?idxno=46076
7625,2018-11-19,김어준의뉴스공장삼성바이오로직스삼바분식회계후폭풍소액주주집단소송승소가능성높다,http://www.topstarnews.net/news/articleView.html?idxno=527268
7626,2018-11-19,삼성바이오로직스보유개미주식3조소액투자자만2조원,http://www.viva100.com/main/view.php?key=20181119010006659
7627,2018-11-19,이데일리N국민연금삼성바이오로직스주식203만주보유6790억원外,http://www.edaily.co.kr/news/newspath.asp?newsid=02381286619407360
7628,2018-11-19,삼성바이오로직스소송전돌입장기화예상,http://www.mediasr.co.kr/news/articleView.html?idxno=50046
7629,2018-11-19,국민연금보유삼성바이오로직스주식203만주신속결정해야,http://www.cpbc.co.kr/CMS/news/view_body.php?cid=739131&path=201811
7630,2018-11-19,ISSUEINSIDE삼성바이오로직스거래정지후폭풍45조분식회계충격상장폐지우려도,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=723240
7631,2018-11-19,삼성바이오로직스개미지분3조원대,http://www.ebn.co.kr/news/view/962268
7632,2018-11-19,정동영삼성바이오로직스관련이런식이면증권선물위해체해야,http://www.newsis.com/view/?id=NISX20181119_0000476889&cID=10301&pID=10300
7633,2018-11-19,인터뷰제4공장삼성바이오로직스고의분식회계후폭풍소액주주손해배상집단소송나선다,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10311791
7634,2018-11-19,삼성바이오로직스대마불사통할까,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811180080&t=NNv
7635,2018-11-19,삼성바이오로직스악재떨쳤나제약바이오株상승,http://www.dailymedi.com/detail.php?number=837069&thread=22r05
7636,2018-11-19,주간한국삼성바이오로직스사태후폭풍에피해갈수없는그들,http://daily.hankooki.com/lpage/industry/201811/dh20181119121629147960.htm
7637,2018-11-19,개인이보유한삼성바이오로직스주식은3조원을넘는다,https://www.huffingtonpost.kr/entry/story_kr_5bf21887e4b0f32bd58ab816?utm_id=naver
7638,2018-11-19,시련의이재용삼성바이오로직스분식회계논란,http://www.sisa-news.com/news/article.html?no=116053
7639,2018-11-19,삼성바이오로직스일반인주식투자3조원이상外人보다많아,http://www.m-i.kr/news/articleView.html?idxno=471340
7640,2018-11-19,삼성바이오로직스에투자한개미32조원발동동,http://www.inews24.com/php/news_view.php?g_serial=1140489&g_menu=022620&rrf=nv
7641,2018-11-19,유재중국민연금이삼성바이오로직스주식계속산경위밝혀야”,http://www.businesspost.co.kr/BP?command=article_view&num=102995
7642,2018-11-19,증선위최종결론에도삼성바이오로직스분식회계논란여전강대강법정공방초읽기,http://www.g-enews.com/ko-kr/news/article/news_all/201811191446019916c642673384_1/article.html
7643,2018-11-19,SR포커스증선위의삼성바이오로직스분식회계결정온라인서도치열한논쟁,http://www.srtimes.kr/news/articleView.html?idxno=27734
7644,2018-11-19,삼성바이오로직스분식회계논란여전법적공방확전,http://www.dt.co.kr/contents.html?article_no=2018111902109932048009&ref=naver
7645,2018-11-19,삼성바이오로직스삼바개인투자자주식규모3조대,http://news20.busan.com/controller/newsController.jsp?newsId=20181119000152
7646,2018-11-19,일본언론문재인삼성바이오로직스분식처리놓고선택갈림길,http://www.businesspost.co.kr/BP?command=article_view&num=103030
7647,2018-11-19,삼성바이오로직스상장폐지꼭안된다고볼수도없다,http://www.withinnews.co.kr/news/view.html?section=1&category=163&item=&no=17032
7648,2018-11-19,삼성바이오로직스상장폐지당위론과피해확산현실론줄다리기,http://www.businesspost.co.kr/BP?command=article_view&num=103058
7649,2018-11-19,뉴스워커_화요칼럼이재용삼성바이오로직스사태경영권승계의편법인가,http://www.newsworker.co.kr/news/articleView.html?idxno=23461
7650,2018-11-19,이태희의심호흡참여연대가사살한삼성바이오로직스의미래가치,http://www.news2day.co.kr/115029
7651,2018-11-19,정동영대표증선위삼성바이오로직스회계감사법인솜방망이처벌했다,http://www.jeollailbo.com/news/articleView.html?idxno=555559
7652,2018-11-19,세계는그리고우리는삼성바이오로직스분식회계혐의그쟁점과남은절차,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=214&aid=0000892753
7653,2018-11-19,개미들3조베팅상폐공포부메랑삼성바이오로직스주식개인투자자錢錢긍긍,http://www.kyeonggi.com/news/articleView.html?idxno=2003649
7654,2018-11-19,거래정지삼성바이오로직스개인주식금액3조2천억추산,http://www.kyeongin.com/main/view.php?key=20181119010006250
7655,2018-11-19,기고삼성바이오로직스거래정지보다무서운것,http://www.newsprime.co.kr/news/article.html?no=436827
7656,2018-11-20,삼성바이오로직스증선위에분식회계통보빨리해달라요구,http://www.fnnews.com/news/201811200925577975
7657,2018-11-20,기자수첩삼성바이오로직스사태의의미참여연대가이나라중심인가,http://www.mediapen.com/news/view/396919
7658,2018-11-20,증선위삼성바이오로직스검찰고발,http://www.g-enews.com/ko-kr/news/article/news_all/201811201227272793a218188523_1/article.html
7659,2018-11-20,증선위삼성바이오로직스정식고발,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811200289&t=NN
7660,2018-11-20,증선위고의적분식회계삼성바이오로직스검찰고발,http://www.inews24.com/php/news_view.php?g_serial=1140701&g_menu=022300&rrf=nv
7661,2018-11-20,증선위삼성바이오로직스분식회계혐의검찰고발,http://www.ebn.co.kr/news/view/962429
7662,2018-11-20,증선위고의분식회계삼성바이오로직스검찰고발,http://moneys.mt.co.kr/news/mwView.php?no=2018112014238082110
7663,2018-11-20,증선위삼성바이오로직스검찰에고발삼바집행정지가처분신청할것,http://www.g-enews.com/ko-kr/news/article/news_all/20181120150306164025b4ac5ede_1/article.html
7664,2018-11-20,금융위증선위삼성바이오로직스검찰에고발,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10312037
7665,2018-11-20,이데일리N증선위분식회계삼성바이오로직스오늘검찰에고발外,http://www.edaily.co.kr/news/newspath.asp?newsid=03706406619407688
7666,2018-11-20,이데일리N증선위분식회계삼성바이오로직스오늘검찰에고발外,http://www.edaily.co.kr/news/newspath.asp?newsid=03706406619407688
7667,2018-11-20,증선위삼성바이오로직스정식검찰고발법적공방예고,http://www.mhj21.com/sub_read.html?uid=117655§ion=sc243
7668,2018-11-20,초점국민연금분식회계논란에도삼성바이오로직스사들였나,http://www.inews24.com/php/news_view.php?g_serial=1140745&g_menu=022300&rrf=nv
7669,2018-11-20,증선위분식회계삼성바이오로직스검찰에정식고발,http://www.asiatoday.co.kr/view.php?key=20181120010011803
7670,2018-11-20,증권선물위고의적분식회계삼성바이오로직스검찰에고발,http://www.businesspost.co.kr/BP?command=article_view&num=103194
7671,2018-11-20,증선위고의분식회계혐의삼성바이오로직스검찰에고발,http://www.kpinews.co.kr/news/articleView.html?idxno=84634
7672,2018-11-20,삼바춤그만”증선위삼성바이오로직스분식회계검찰고발거래정지얼마나상장폐지는,http://ilyo.co.kr/?ac=article_view&entry_id=316728
7673,2018-11-20,삼성바이오로직스같은사안에금감원1차감리와재감리입장달라문제제기,http://www.fnnews.com/news/201811201555064776
7674,2018-11-20,증권선물위고의분식회계삼성바이오로직스검찰에정식고발,http://www.mediapen.com/news/view/397005
7675,2018-11-20,증선위삼성바이오로직스검찰에고발,http://www.wsobi.com/news/articleView.html?idxno=67320
7676,2018-11-20,삼성바이오로직스빠지고물만난제약바이오株중장기적상승세,http://www.ekn.kr/news/article.html?no=398740
7677,2018-11-20,삼성바이오로직스2015년회계기준변경미전실결정아냐”,http://biz.chosun.com/site/data/html_dir/2018/11/20/2018112002472.html
7678,2018-11-20,삼성바이오로직스미래전략실보고는회계법인권유따른것,http://kormedi.com/?p=1256146
7679,2018-11-20,증선위삼성바이오로직스오늘검찰정식고발,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003404070
7680,2018-11-20,삼성바이오로직스증선위주장에반박회계처리적절성입증할것”,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=528708
7681,2018-11-20,삼성바이오로직스증선위결정조목조목반박회계처리적절성입증할것,http://www.mediapen.com/news/view/397014
7682,2018-11-20,증선위분식회계삼성바이오로직스검찰에고발,http://imnews.imbc.com/replay/2018/nw1700/article/4942039_23836.html
7683,2018-11-20,증선위분식회계혐의삼성바이오로직스검찰고발,http://news.kbs.co.kr/news/view.do?ncd=4077829&ref=A
7684,2018-11-20,삼성바이오로직스바이오에피스관계회사전환안해도상장가능분식회계필요無”,http://www.g-enews.com/ko-kr/news/article/news_all/2018112017152446725b4ac5ede_1/article.html
7685,2018-11-20,삼성바이오로직스입장전문에피스관계회사전환상장과관계없어회계처리적절”,http://www.sporbiz.co.kr/news/articleView.html?idxno=290200
7686,2018-11-20,삼성바이오로직스증선위결정은중요한사안최선다해회계처리적절성입증해나갈것,http://www.econonews.co.kr/news/articleView.html?idxno=42934
7687,2018-11-20,삼성바이오로직스회계기준변경미래전략실아닌회계법인권유,http://www.inews24.com/php/news_view.php?g_serial=1140787&g_menu=022620&rrf=nv
7688,2018-11-20,증선위분식회계혐의삼성바이오로직스고발검찰수사본격모드로,http://www.updownnews.co.kr/news/articleView.html?idxno=99381
7689,2018-11-20,삼성바이오로직스2015년회계기준변경미전실결정아냐,http://www.dailian.co.kr/news/view/753057/?sc=naver
7690,2018-11-20,증선위삼성바이오로직스검찰고발법적공방본격화,http://www.sporbiz.co.kr/news/articleView.html?idxno=290215
7691,2018-11-20,삼성바이오로직스금감원이입장바꿔정부고무줄잣대조목조목지적,http://www.viva100.com/main/view.php?key=20181120010007603
7692,2018-11-20,삼성바이오로직스에피스지분법전환상장과무관,http://www.dailypharm.com/News/246452
7693,2018-11-20,삼성바이오로직스데이터무결성중시하는기업으로서증선위결정불복적절성입증할것,http://www.g-enews.com/ko-kr/news/article/news_all/20181120175630235825b4ac5ede_1/article.html
7694,2018-11-20,삼성바이오로직스내부문건분식회계정황아니야,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181120165740
7695,2018-11-20,증선위분식회계삼성바이오로직스검찰에고발삼성바이오행정소송계획,http://www.topstarnews.net/news/articleView.html?idxno=528667
7696,2018-11-20,증선위분식회계혐의삼성바이오로직스검찰고발,http://news.kbs.co.kr/news/view.do?ncd=4077938&ref=A
7697,2018-11-20,삼성바이오로직스투자자신뢰걸려있는매우중요한문제적절성입증하겠다,http://www.sisafocus.co.kr/news/articleView.html?idxno=196657
7698,2018-11-20,삼성바이오로직스대우조선해양엔론분식회계와전혀다르다,http://www.businesspost.co.kr/BP?command=article_view&num=103260
7699,2018-11-20,삼성바이오로직스상장시문제점발견못해의견받아”,http://www.econovill.com/news/articleView.html?idxno=350896
7700,2018-11-20,증권선물위원회검찰에삼성바이오로직스정식고발,http://www.kyeongin.com/main/view.php?key=20181120010006728
7701,2018-11-21,금융당국삼성바이오로직스분식회계혐의검찰에정식고발,http://www.techholic.co.kr/news/articleView.html?idxno=179290
7702,2018-11-21,광화문에서김지현삼성바이오로직스차라리한국떠나라,http://news.donga.com/3/all/20181121/92956370/1
7703,2018-11-21,증선위분식회계검찰고발삼성바이오로직스반격,http://www.dailymedi.com/detail.php?number=837142&thread=22r05
7704,2018-11-21,거래정지삼성바이오로직스가해석차이다밝힌배경은,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062659
7705,2018-11-21,삼성바이오로직스악재바이오실적으로넘었다,http://kormedi.com/?p=1256168
7706,2018-11-21,삼성바이오로직스증선위결정에15개항목들어조목조목반박,http://moneys.mt.co.kr/news/mwView.php?no=2018112108438081446
7707,2018-11-21,거래정지삼성바이오로직스ETF로불똥튈까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1689868
7708,2018-11-21,국민연금회계부정논란에도삼성바이오로직스주식매입,http://www.mediasr.co.kr/news/articleView.html?idxno=50073
7709,2018-11-21,이데일리N삼성바이오로직스금감원재감리과정서입장바꿔外,http://www.edaily.co.kr/news/newspath.asp?newsid=02161526619408016
7710,2018-11-21,증선위삼성바이오로직스반박에재반박장외2차전,http://www.sisafocus.co.kr/news/articleView.html?idxno=196667
7711,2018-11-21,포토박용진삼성바이오로직스가치평가관련기자회견,http://www.dailian.co.kr/news/view/753181/?sc=naver
7712,2018-11-21,박용진삼성바이오로직스관련금융위해명은초점흐리기위한동문서답,http://www.gokorea.kr/news/articleView.html?idxno=57630
7713,2018-11-21,박용진삼성바이오로직스가치평가방법해명기자회견,http://www.anewsa.com/detail.php?number=1425662&thread=01r01
7714,2018-11-21,삼성바이오로직스관련기자회견하는박용진포토,http://www.vop.co.kr/A00001354773.html
7715,2018-11-21,삼성바이오로직스삼성때려잡기희생양되나,http://www.mediapen.com/news/view/397129
7716,2018-11-21,삼성바이오로직스증선위창에방패결국고의분식회계,http://www.straightnews.co.kr/news/articleView.html?idxno=38644
7717,2018-11-21,영상금융위저격한박용진삼성바이오로직스관련금융위해명은전형적인초점흐리기,http://facttv.kr/facttvnews/detail.php?number=22801&thread=14r08
7718,2018-11-21,사실은금융위삼성바이오로직스계산법알았다등사실아냐”,http://www.korea.kr/briefing/actuallyView.do?newsId=148855698&call_from=naver_news
7719,2018-11-21,증권선물위삼성바이오로직스는투자자보호에우선힘써야,http://www.businesspost.co.kr/BP?command=article_view&num=103325
7720,2018-11-21,삼성바이오로직스증선위결정에불복공식입장발표,http://www.wsobi.com/news/articleView.html?idxno=67364
7721,2018-11-21,기자수첩국민연금은왜삼성바이오로직스를샀을까,http://kormedi.com/?p=1256273
7722,2018-11-21,검찰삼성바이오로직스고의분식회계사건중앙지검특수2부배당속보,http://view.asiae.co.kr/news/view.htm?idxno=2018112116024895153
7723,2018-11-21,檢삼성바이오로직스분식회계의혹서울중앙지검특수2부배당,http://news.mt.co.kr/mtview.php?no=2018112116018256643
7724,2018-11-21,삼성바이오로직스분식회계사건서울중앙지검특수2부가수사속보,http://yna.kr/AKR20181121129000004?did=1195m
7725,2018-11-21,이데일리N삼성바이오로직스분식회계따른삼성물산감리검토外,http://www.edaily.co.kr/news/newspath.asp?newsid=03821206619408016
7726,2018-11-21,삼성바이오로직스증선위금감원과정면충돌핵심은분식회계목적에초점맞춰야,http://www.kpinews.co.kr/news/articleView.html?idxno=84711
7727,2018-11-21,삼성바이오로직스분식회계고발서울중앙지검특수2부에배당,http://news.kbs.co.kr/news/view.do?ncd=4078688&ref=A
7728,2018-11-21,검찰삼성바이오로직스분식회계수사착수중앙지검특수2부배당,http://www.queen.co.kr/news/articleView.html?idxno=305029
7729,2018-11-21,검찰금융위삼성바이오로직스고발사건중앙지검특수2부배당,http://www.asiatoday.co.kr/view.php?key=20181121010012626
7730,2018-11-21,삼성바이오로직스분식회계사건수사개시특수부배당,http://www.sisajournal-e.com/biz/article/191819
7731,2018-11-21,삼성바이오로직스이르면이번주증선위상대소송제기,http://www.newspim.com/news/view/20181121000640
7732,2018-11-21,삼성바이오로직스분식회계혐의수사개시,http://www.cstimes.com/?mod=news&act=articleView&idxno=290450
7733,2018-11-21,삼성바이오로직스증권위치열한법적공방돌입,http://kormedi.com/?p=1256313
7734,2018-11-21,삼성바이오로직스이르면이번주행정소송제기할것,http://www.viva100.com/main/view.php?key=20181121010008166
7735,2018-11-21,檢삼성바이오로직스분식회계특수2부배당,http://www.obsnews.co.kr/news/articleView.html?idxno=1126433
7736,2018-11-21,검찰삼성바이오로직스분식회계수사착수,http://www.hankookilbo.com/news/npath/201811211771072252?did=NA
7737,2018-11-21,NW포토빨간불켜진삼성바이오로직스검찰수사착수,http://www.newsway.co.kr/news/view?tp=1&ud=2018112118443785489
7738,2018-11-21,NW포토검찰삼성바이오로직스고의회계분식혐의수사착수서울중앙지검특수2부배당,http://www.newsway.co.kr/news/view?tp=1&ud=2018112118432071563
7739,2018-11-21,박용진금융위는안진회계의삼성바이오로직스보고서공개해야,http://www.businesspost.co.kr/BP?command=article_view&num=103382
7740,2018-11-21,NW포토갈림길에선삼성바이오로직스,http://www.newsway.co.kr/news/view?tp=1&ud=2018112118452722053
7741,2018-11-21,삼성바이오로직스분식회계중앙지검특수부배당,http://www.yonhapnewstv.co.kr/MYH20181121016600038/?did=1825m
7742,2018-11-21,이재명혜경궁김씨논란에삼성바이오로직스사건에관심을동문서답,http://www.lawissue.co.kr/view.php?ud=201811201614058917798818e98b_12
7743,2018-11-21,셀트리온갑질삼성바이오로직스분식회계인천바이오맏형들의혹논란,http://www.kyeongin.com/main/view.php?key=20181121010007201
7744,2018-11-21,삼성바이오로직스고의분식회계혐의수사착수,http://www.joongboo.com/news/articleView.html?idxno=1305093
7745,2018-11-22,삼성바이오로직스행정소송쟁점①증선위는결론말고논리도번복했다,http://www.news2day.co.kr/115212
7746,2018-11-22,골룸이건머니151삼성바이오로직스분식회계논란feat김범주의쓴소리,https://news.sbs.co.kr/news/endPage.do?news_id=N1005026779&plink=ORI&cooper=NAVER
7747,2018-11-22,삼성바이오로직스관련질문답변하는최종구금융위원장,http://news1.kr/photos/view/?3401941
7748,2018-11-22,삼성바이오로직스관련질문받는최종구금융위원장,http://news1.kr/photos/view/?3401939
7749,2018-11-22,검찰로넘어간삼성바이오로직스잠재된시한폭탄,http://www.inews24.com/php/news_view.php?g_serial=1141208&g_menu=022300&rrf=nv
7750,2018-11-22,삼성바이오로직스고의분식회계사건최순실특검수사연장선될까,http://www.asiatoday.co.kr/view.php?key=20181122010013401
7751,2018-11-22,삼성바이오로직스분식을둘러싼논란3가지,http://www.edaily.co.kr/news/newspath.asp?newsid=04218086619408344
7752,2018-11-22,김용범삼성바이오로직스주식거래정지불확실성오래안가야,http://www.businesspost.co.kr/BP?command=article_view&num=103554
7753,2018-11-22,삼성바이오로직스에지역기여요청시민이익지킬것,http://www.kyeongin.com/main/view.php?key=20181122002111452
7754,2018-11-23,삼성바이오로직스논란삼성아닌언론의위기다,http://www.choicenews.co.kr/news/articleView.html?idxno=46201
7755,2018-11-23,삼성바이오로직스후폭풍예사롭지않다엘리엇반격기회줄소지커져,http://www.techholic.co.kr/news/articleView.html?idxno=179328
7756,2018-11-23,이데일리N증선위삼성바이오로직스불확실성오래가지않아야外,http://www.edaily.co.kr/news/newspath.asp?newsid=02538726619408672
7757,2018-11-23,이슈진단삼성바이오로직스사태그이후한국바이오산업의숙제는,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003407562
7758,2018-11-23,SR포커스삼성바이오로직스사태외국언론들은어떻게보도하나,http://www.srtimes.kr/news/articleView.html?idxno=28015
7759,2018-11-23,금융위삼성바이오로직스가치평가논란반박권한밖이다”,http://www.g-enews.com/ko-kr/news/article/news_all/201811231452211753a218188523_1/article.html
7760,2018-11-23,삼성채용SDI본사전략기획경력직지원자격및우대사항은삼성바이오로직스삼성전기도채용中,http://www.topstarnews.net/news/articleView.html?idxno=531345
7761,2018-11-23,저널리즘토크쇼J삼성바이오로직스삼바분식회계보도언론이소극적”,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0500&key=20181123.99099010451
7762,2018-11-23,금융위삼성바이오로직스조사권한없었다방관했다는주장반박,http://www.sisafocus.co.kr/news/articleView.html?idxno=196924
7763,2018-11-23,조승현상근부대변인논평삼성은삼성바이오로직스회계분식등자사를둘러싼각종현안에대해법적사회적책임을다해야한다,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=305&aid=0000023876
7764,2018-11-23,금융위회계법인의삼성바이오로직스평가서는금융감독권한밖,http://www.businesspost.co.kr/BP?command=article_view&num=103704
7765,2018-11-24,삼성바이오로직스주식거래이르면11월말12월초재개될듯,http://www.techholic.co.kr/news/articleView.html?idxno=179353
7766,2018-11-24,제2의삼성전자를찾아라④삼성의미래를책임질삼성바이오로직스2021년글로벌1위의바이오의약품위탁생산기업으로도약”,http://monthly.chosun.com/client/news/viw.asp?ctcd=B&nNewsNumb=201812100033
7767,2018-11-25,삼성바이오로직스상장폐지이번주가1차갈림길,http://news.bbsi.co.kr/news/articleView.html?idxno=909724
7768,2018-11-25,삼성바이오로직스상장폐지김용범증선위위원장상장유지조건에부족하지않을것”,http://www.g-enews.com/ko-kr/news/article/news_all/201811251157024128c642673384_1/article.html
7769,2018-11-25,삼성바이오로직스상장폐지심사대상이번주중결정,http://daily.hankooki.com/lpage/economy/201811/dh20181125130007138060.htm
7770,2018-11-25,삼성바이오로직스상장폐지1차심사이번주윤곽,http://news.hankyung.com/article/2018112502357
7771,2018-11-25,삼성바이오로직스상장폐지심의이번주결론난다투명성최대쟁점,http://www.newsway.co.kr/news/view?tp=1&ud=2018112513542526440
7772,2018-11-25,삼성바이오로직스상장폐지심사여부이번주결정,http://news.kbs.co.kr/news/view.do?ncd=4081192&ref=A
7773,2018-11-25,원칙중심회계로본삼성바이오로직스사태,http://www.fnnews.com/news/201811232047406977
7774,2018-11-25,삼성바이오로직스상장폐지1차심사다음주윤곽,http://www.mediapen.com/news/view/397966
7775,2018-11-25,저널리즘토크쇼J삼성바이오로직스삼바분식회계보다폴더블폰이더중요했던언론들,http://www.topstarnews.net/news/articleView.html?idxno=532311
7776,2018-11-25,저널리즘토크쇼J삼성바이오로직스삼바분식회계적발한문재인정부탓언론들의아무말대잔치,http://www.topstarnews.net/news/articleView.html?idxno=532312
7777,2018-11-25,저널리즘토크쇼J삼성바이오로직스삼바분식회계사라진이재용부르면안되는볼드모트,http://www.topstarnews.net/news/articleView.html?idxno=532313
7778,2018-11-26,삼성바이오로직스행정소송쟁점②에피스는원래관계회사라는증선위해석은타당,http://www.news2day.co.kr/115332
7779,2018-11-26,이번주내삼성바이오로직스상장폐지여부결론,http://www.econovill.com/news/articleView.html?idxno=351242
7780,2018-11-26,삼성바이오로직스총구이재용부회장에게로,http://www.mediasr.co.kr/news/articleView.html?idxno=50120
7781,2018-11-26,삼성바이오로직스상폐심의대상여부이번주나온다,http://www.inews24.com/php/news_view.php?g_serial=1141641&g_menu=022300&rrf=nv
7782,2018-11-26,편집국에서대마불사그리고삼성바이오로직스,http://www.joongdo.co.kr/main/view.php?key=20181126010010909
7783,2018-11-26,삼성바이오로직스상장폐지심사여부이르면이번주결정,http://www.kpinews.co.kr/news/articleView.html?idxno=84915
7784,2018-11-26,김병욱삼성바이오로직스분식회계사태교훈과과제토론회,http://www.straightnews.co.kr/news/articleView.html?idxno=38845
7785,2018-11-26,김병욱의원삼성바이오로직스분식회계판정교훈과제토론회주최,http://www.gokorea.kr/news/articleView.html?idxno=58252
7786,2018-11-26,김병욱의원삼성바이오로직스분식회계사태관련토론회주최,http://www.choicenews.co.kr/news/articleView.html?idxno=46263
7787,2018-11-26,삼성바이오로직스상폐여부이번주안에결판날듯,http://www.sisafocus.co.kr/news/articleView.html?idxno=197034
7788,2018-11-27,삼성바이오로직스논란가열분식회계로몰린삼성바이오산업도위기,http://economychosun.com/client/news/view.php?boardName=C08&t_num=13606109
7789,2018-11-27,삼성바이오로직스목표주가하향삼성바이오에피스지분가치하락,http://www.businesspost.co.kr/BP?command=article_view&num=103965
7790,2018-11-27,삼성물산목표주가낮아져삼성바이오로직스불확실성해소필요,http://www.businesspost.co.kr/BP?command=article_view&num=103973
7791,2018-11-27,퀵리포트삼성바이오로직스매수유지목표가15↓50만원KTB證,http://www.itooza.com/common/iview.php?no=2018112708562317194
7792,2018-11-27,삼성바이오로직스목표가15↓50만원제시KTB證,http://www.newspim.com/news/view/20181127000138
7793,2018-11-27,삼성물산주가오르려면삼성바이오로직스불확실성해소돼야목표가↓메리츠종금증권,http://www.fntimes.com/html/view.php?ud=2018112708532959211d6f57e61a_18
7794,2018-11-27,삼성바이오토론회삼성바이오로직스가나스닥에상장되었다면조동근교수주제발표全文,http://www.wikileaks-kr.org/news/articleView.html?idxno=41584
7795,2018-11-27,포토바른사회삼성바이오로직스관련정책토론회개최,http://www.newdaily.co.kr/site/data/html/2018/11/27/2018112700139.html
7796,2018-11-27,삼성바이오토론회불명확한IFRS로벌어진삼성바이오로직스논쟁최준선교수주제발표全文,http://www.wikileaks-kr.org/news/articleView.html?idxno=41595
7797,2018-11-27,삼성바이오로직스판단적절토론회,http://www.newsis.com/view/?id=NISI20181127_0014682598
7798,2018-11-27,삼성바이오로직스판단적절토론회,http://www.newsis.com/view/?id=NISI20181127_0014682600
7799,2018-11-27,삼성바이오로직스의2018년도감사의견은어떻게될까,http://premium.mk.co.kr/view.php?no=24081
7800,2018-11-27,검찰고의분식회계삼성바이오로직스고발내용검토,http://www.sporbiz.co.kr/news/articleView.html?idxno=292135
7801,2018-11-27,조동근삼성바이오로직스코스피아닌나스닥상장했어야,http://www.mediapen.com/news/view/398481
7802,2018-11-27,제10회국제회계포럼포럼시작전부터끝까지삼성바이오로직스,http://www.fnnews.com/news/201811271748338951
7803,2018-11-27,김정동삼성바이오로직스회계판정정치적의도다분,http://www.mediapen.com/news/view/398498
7804,2018-11-28,삼성바이오로직스나스닥이전상장가능성사실상제로,http://www.asiatime.co.kr/news/articleView.html?idxno=213973
7805,2018-11-28,삼성바이오로직스증선위의결에행정소송1보,http://news1.kr/articles/?3487486
7806,2018-11-28,삼성바이오로직스금융위증선위상대로제재취소행정소송,http://news.mt.co.kr/mtview.php?no=2018112807250308326
7807,2018-11-28,속보삼성바이오로직스증선위조치에행정소송및집행정지신청,http://news.heraldcorp.com/view.php?ud=20181128000020
7808,2018-11-28,삼성바이오로직스증선위의결에행정소송집행정지신청,http://www.newspim.com/news/view/20181128000028
7809,2018-11-28,삼성바이오로직스증선위금융위처분에대한행정소송및집행정지신청,http://www.newspim.com/news/view/20181128000029
7810,2018-11-28,삼성바이오로직스증선위의결조치에대한행정소송및집행정지신청,http://www.ekn.kr/news/article.html?no=400178
7811,2018-11-28,삼성바이오로직스고의분식회계결론에또행정소송제기,http://biz.chosun.com/site/data/html_dir/2018/11/28/2018112800414.html
7812,2018-11-28,삼성바이오로직스증선위상대행정소송및집행정지신청,http://www.sedaily.com/NewsView/1S7D48IEGV
7813,2018-11-28,삼성바이오로직스회계처리행정소송CEO해임권고집행정지상보,http://news1.kr/articles/?3487507
7814,2018-11-28,삼성바이오로직스증선위의결조치에대한행정소송및집행정지신청,http://www.fnnews.com/news/201811280803379302
7815,2018-11-28,삼성바이오로직스증선위조치에행정소송집행정지신청,http://www.asiatoday.co.kr/view.php?key=20181128010016066
7816,2018-11-28,삼성바이오로직스증선위조치에행정소송집행정지신청완료,http://www.g-enews.com/ko-kr/news/article/news_all/20181128080813291825b4ac5ede_1/article.html
7817,2018-11-28,분식회계삼성바이오로직스증선위처분에행정소송집행정지신청,http://www.sedaily.com/NewsView/1S7D4WRGBY
7818,2018-11-28,삼성바이오로직스증선위의결에행정소송집행정지신청,http://www.fetv.co.kr/news/article.html?no=16222
7819,2018-11-28,삼성바이오로직스증선위분식회계결론에행정소송제기,http://www.ajunews.com/view/20181128082258097
7820,2018-11-28,삼성바이오로직스증선위의결조치에행정소송집행정지신청,http://www.mediapen.com/news/view/398523
7821,2018-11-28,삼성바이오로직스분식회계의결에행정소송집행정지신청,http://www.sisajournal-e.com/biz/article/192096
7822,2018-11-28,삼성바이오로직스증선위의결조치에행정소송집행정지신청,http://www.inews24.com/php/news_view.php?g_serial=1142098&g_menu=022620&rrf=nv
7823,2018-11-28,삼성바이오로직스증선위상대행정소송,http://news.mt.co.kr/mtview.php?no=2018112808232974951
7824,2018-11-28,삼성바이오로직스증선위고의분식회계의결에행정소송집행정지신청,http://biz.newdaily.co.kr/site/data/html/2018/11/28/2018112800006.html
7825,2018-11-28,분식회계삼성바이오로직스증선위에행정소송집행정지신청,http://www.sisafocus.co.kr/news/articleView.html?idxno=197202
7826,2018-11-28,삼성바이오로직스의반격증선위분식회계의결에행정소송집행정지신청,http://www.viva100.com/main/view.php?key=20181128010010496
7827,2018-11-28,삼성바이오로직스증선위처분에행정소송맞대응,http://www.ceoscoredaily.com/news/article.html?no=48806
7828,2018-11-28,삼성바이오로직스27일서울행정법원에행정소송및집행정지신청,http://www.medigatenews.com/news/375902997
7829,2018-11-28,삼성바이오로직스증선위처분취소소송돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=246754&REFERER=NP
7830,2018-11-28,삼성바이오로직스CEOCFO해임집행정지신청,http://medipana.com/news/news_viewer.asp?NewsNum=229265&MainKind=A&NewsKind=5&vCount=12&vKind=1
7831,2018-11-28,삼성바이오로직스회계처리행정소송CEO해임권고집행정지,http://www.fntoday.co.kr/news/articleView.html?idxno=173408
7832,2018-11-28,삼성바이오로직스증선위분식회계의결에행정소송,http://www.ftoday.co.kr/news/articleView.html?idxno=104699
7833,2018-11-28,삼성바이오로직스증선위분식회계의결에행정소송제기,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181128091855
7834,2018-11-28,삼성바이오로직스증선위고의분식회계결론에행정소송제기,http://www.kpinews.co.kr/news/articleView.html?idxno=85071
7835,2018-11-28,삼성바이오로직스분식회계의결에행정소송집행정지신청,http://daily.hankooki.com/lpage/economy/201811/dh20181128092936138060.htm
7836,2018-11-28,삼성바이오로직스증선위의결조치에행정소송및집행정지신청,http://www.incheonnews.com/news/articleView.html?idxno=114096
7837,2018-11-28,삼성바이오로직스증선위의결관련행정소송집행정지신청,http://www.metroseoul.co.kr/news/newsview?newscd=2018112800014
7838,2018-11-28,삼성바이오로직스고의분식회계의결에행정소송집행정지신청손해예방차원,http://www.topstarnews.net/news/articleView.html?idxno=534530
7839,2018-11-28,삼성바이오로직스증선위의결에행정소송집행정지신청,http://www.mediasr.co.kr/news/articleView.html?idxno=50154
7840,2018-11-28,삼성바이오로직스증권선물위처분에행정소송제기,http://www.businesspost.co.kr/BP?command=article_view&num=104163
7841,2018-11-28,삼성바이오로직스증선위의결조치에대한행정소송및집행정지신청,http://www.m-i.kr/news/articleView.html?idxno=474188
7842,2018-11-28,삼성바이오로직스분식회계의결행정소송CEO해임권고집행정지신청,http://www.fntimes.com/html/view.php?ud=201811280954434668902857eb1a_18
7843,2018-11-28,행정소송꺼내든삼성바이오로직스집행정지신청,http://www.mhj21.com/sub_read.html?uid=117826§ion=sc243
7844,2018-11-28,삼성바이오로직스증선위분식회계의결에행정소송집행정지신청,http://www.kyeongin.com/main/view.php?key=20181128010009251
7845,2018-11-28,삼성바이오로직스분식회계의결처분에행정소송제기정당성입증하겠다,http://www.joongboo.com/news/articleView.html?idxno=1306725
7846,2018-11-28,삼성바이오로직스분식회계관련토론회주최한김병욱의원,http://news1.kr/photos/view/?3409133
7847,2018-11-28,김병욱의원삼성바이오로직스분식회계관련토론회주최,http://news1.kr/photos/view/?3409128
7848,2018-11-28,삼성바이오로직스분식회계논란속하반기공정직채용진행,http://www.ceoscoredaily.com/news/article.html?no=48827
7849,2018-11-28,삼성바이오로직스증선위분식회계의결에행정소송집행정지신청,http://www.segye.com/content/html/2018/11/28/20181128001579.html?OutUrl=naver
7850,2018-11-28,포럼삼성바이오로직스사태본질과바이오산업내치기,http://www.munhwa.com/news/view.html?no=2018112801073911000004
7851,2018-11-28,삼성바이오로직스증선위처분에행정소송집행정지신청,http://news.kbs.co.kr/news/view.do?ncd=4083523&ref=A
7852,2018-11-28,삼성바이오로직스분식회계결론에반발행정소송,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062887
7853,2018-11-28,공감신문입법공감삼성바이오로직스분식회계어떻게진행됐나,http://www.gokorea.kr/news/articleView.html?idxno=58678
7854,2018-11-28,삼성바이오로직스2라운드행정소송집행정지신청,http://www.dailymedi.com/detail.php?number=837426&thread=22r05
7855,2018-11-28,포춘US선정미래유망기업5047위삼성바이오로직스,http://www.sedaily.com/NewsView/1S7D4IZLK6
7856,2018-11-28,경제삼성바이오로직스분식회계삼성이만드는오병이어의기적,https://www.ddanzi.com/ddanziNews/539588911
7857,2018-11-28,삼성바이오로직스분식회계행정소송및집행정지신청,http://www.dailysmart.co.kr/news/articleView.html?idxno=3267
7858,2018-11-28,공시삼성바이오로직스증선위처분효력정지신청,http://www.newsway.co.kr/news/view?tp=1&ud=2018112808192970404
7859,2018-11-28,삼성바이오로직스사태회계업계국제회계기준모호vs고의분식회계,http://news.mk.co.kr/newsRead.php?year=2018&no=744833
7860,2018-11-28,삼성바이오로직스증선위결정에대해해명,http://www.nspna.com/news/?mode=view&newsid=321638
7861,2018-11-28,제2의삼성바이오로직스사태막으려면내부감시기구외부감사인의독립성강화해야”,http://www.fntimes.com/html/view.php?ud=201811281533566394f09e13944d_18
7862,2018-11-28,삼성바이오로직스분식회계3가지쟁점들여다보니,http://www.mediasr.co.kr/news/articleView.html?idxno=50161
7863,2018-11-28,최종구삼성바이오로직스의가처분신청인용되면사태장기화,http://www.businesspost.co.kr/BP?command=article_view&num=104284
7864,2018-11-28,김선동삼성바이오로직스증선위분식회계결정부당성,http://www.mdtoday.co.kr/mdtoday/index.html?no=340017
7865,2018-11-28,삼성바이오로직스증선위분식회계결론에불복해행정소송제기,http://www.techholic.co.kr/news/articleView.html?idxno=179404
7866,2018-11-28,삼성바이오로직스증선위분식회계결정에행정소송제기,http://www.joongboo.com/news/articleView.html?idxno=1306911
7867,2018-11-29,DataScore상폐위기몰린삼성바이오로직스1년새고용62늘려,http://www.ceoscoredaily.com/news/article.html?no=48755
7868,2018-11-29,노출된악재삼성바이오로직스거래정지에도직원들동요없어요,http://www.g-enews.com/ko-kr/news/article/news_all/201811282029532458c642673384_1/article.html
7869,2018-11-29,거래소삼성바이오로직스상폐심사속도,http://www.newstomato.com/ReadNews.aspx?no=860779
7870,2018-11-29,삼성바이오로직스상장폐지여부거래소기심위에상정될듯,http://news.mk.co.kr/newsRead.php?year=2018&no=746097
7871,2018-11-29,김어준의뉴스공장김어준삼성바이오로직스삼바행정소송시간끌기용꼼수,http://www.topstarnews.net/news/articleView.html?idxno=535335
7872,2018-11-29,이슈이슈거래소다음달기심위열어삼성바이오로직스상장폐지여부심사,http://www.viva100.com/main/view.php?key=20181129010010981
7873,2018-11-29,삼성바이오로직스상장폐지거래소기심위가심의,http://www.mhj21.com/sub_read.html?uid=117842§ion=sc243
7874,2018-11-29,삼성바이오로직스상폐여부결정시간더걸린다기업심사위원회정식심의유력,http://www.g-enews.com/ko-kr/news/article/news_all/201811291004305209c642673384_1/article.html
7875,2018-11-29,삼성바이오로직스상장폐지여부기심위정식심의될듯,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10313534
7876,2018-11-29,거래소기업심사위에서삼성바이오로직스상장폐지가릴듯,http://www.businesspost.co.kr/BP?command=article_view&num=104369
7877,2018-11-29,삼성바이오로직스상폐여부거래소기심위심의유력,http://www.newsprime.co.kr/news/article.html?no=438144
7878,2018-11-29,삼성바이오로직스행정소송통해회계처리정당성입증할것,http://www.wsobi.com/news/articleView.html?idxno=67546
7879,2018-11-29,삼성바이오로직스상폐여부기심위서심의거래정지기간길어진다,http://www.fnnews.com/news/201811291442203114
7880,2018-11-29,삼성바이오로직스상폐여부기심위서결론날듯향후시나리오는,http://www.ekn.kr/news/article.html?no=400636
7881,2018-11-29,삼성바이오로직스금융당국분식회계논란본격법정공방내달19일부터1라운드,http://www.joongboo.com/news/articleView.html?idxno=1307353
7882,2018-11-29,삼성바이오로직스과징금집행정지신청다음달심문,https://www.ytn.co.kr/_ln/0103_201811291752577117
7883,2018-11-29,삼성바이오로직스상폐여부거래소기심위에정식상정될듯,http://news.tvchosun.com/site/data/html_dir/2018/11/29/2018112990125.html
7884,2018-11-29,삼성바이오로직스기심위회부가능성높아거래정지기간늘어날듯,http://news.mt.co.kr/mtview.php?no=2018112918320225484
7885,2018-11-29,삼성바이오로직스징계집행정지가처분심문기일12월19일잡혀,http://www.businesspost.co.kr/BP?command=article_view&num=104465
7886,2018-11-30,스트레이트포커스삼성바이오로직스분식회계우리에게무엇을남겼나〈1〉,http://www.straightnews.co.kr/news/articleView.html?idxno=39043
7887,2018-11-30,삼성바이오로직스결국상폐여부가린다일정은,http://www.inews24.com/view/1142745
7888,2018-11-30,삼성바이오로직스거래정지기간늘어나나,http://www.econovill.com/news/articleView.html?idxno=351625
7889,2018-11-30,거래소오늘삼성바이오로직스기심위상정결론낸다,http://www.edaily.co.kr/news/newspath.asp?newsid=02302566619410968
7890,2018-11-30,김태한삼성바이오로직스사장주주들에메일회계적법성인정받겠다,http://www.fnnews.com/news/201811301231445829
7891,2018-11-30,김태한대표삼성바이오로직스조속히주식매매재개노력,http://news1.kr/articles/?3490102
7892,2018-11-30,김태한삼성바이오로직스대표빠른시일내매매거래재개노력중,http://www.mdtoday.co.kr/mdtoday/index.html?no=340220
7893,2018-11-30,김태한삼성바이오로직스대표주식거래조속히재개되도록노력할것”,http://moneys.mt.co.kr/news/mwView.php?no=2018113015008078106
7894,2018-11-30,삼성바이오로직스김태한사장모든회계처리적법확신,http://www.mediasr.co.kr/news/articleView.html?idxno=50209
7895,2018-11-30,한국거래소삼성바이오로직스사건기업심사위회부결정1보,http://news.mt.co.kr/mtview.php?no=2018113016084351466
7896,2018-11-30,삼성바이오로직스기업심사위원회심의대상결정,http://news.hankyung.com/article/2018113013946
7897,2018-11-30,거래소삼성바이오로직스기업심사위원회서심의키로상장폐지여부결정,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201811301614001&code=920100
7898,2018-11-30,거래소삼성바이오로직스기업심사위원회심의대상결정”,http://www.fnnews.com/news/201811301610459089
7899,2018-11-30,한국거래소삼성바이오로직스실질심사관련기심위심의대상결정”,http://www.newsway.co.kr/news/view?tp=1&ud=2018113016154079708
7900,2018-11-30,삼성바이오로직스기심위간다상폐여부연내결론,http://www.newspim.com/news/view/20181130000658
7901,2018-11-30,삼성바이오로직스상폐여부내달결론기심위상정,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003415451
7902,2018-11-30,삼성바이오로직스기업심사위원회심의대상결정,http://view.asiae.co.kr/news/view.htm?idxno=2018113016230315883
7903,2018-11-30,거래소삼성바이오로직스기심위회부키로,http://news.mk.co.kr/newsRead.php?year=2018&no=750720
7904,2018-11-30,거래소삼성바이오로직스기업심사위원회심의대상결정,http://www.asiatoday.co.kr/view.php?key=20181130010018292
7905,2018-11-30,삼성바이오로직스기심위간다김태한대표조속히재개되게노력,http://news.hankyung.com/article/2018113014556
7906,2018-11-30,삼성바이오로직스기심위간다거래소빠른시일내에결론,http://www.etoday.co.kr/news/section/newsview.php?idxno=1694161
7907,2018-11-30,삼성바이오로직스기업심사위원회심의대상결정,http://www.dailian.co.kr/news/view/755496/?sc=naver
7908,2018-11-30,거래소삼성바이오로직스기업심사위원회서상폐여부심의”,http://www.viva100.com/main/view.php?key=20181130010011646
7909,2018-11-30,거래소삼성바이오로직스기업심사위심의대상결정,http://www.weeklytoday.com/news/articleView.html?idxno=69938
7910,2018-11-30,삼성바이오로직스상장폐지일정나왔다기심위12월31일이내에,https://news.imaeil.com/Economy/2018113016365564484
7911,2018-11-30,김태한삼성바이오로직스사장빠른시일내매매거래재개노력,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811300400&t=NN
7912,2018-11-30,분식회계삼성바이오로직스상장폐지심의돌입,http://www.hani.co.kr/arti/economy/finance/872554.html
7913,2018-11-30,김태한삼성바이오로직스사장빠른시일내주식매매재개노력회계기준적법확신,http://www.econonews.co.kr/news/articleView.html?idxno=44130
7914,2018-11-30,삼성바이오로직스결국상폐심사받는다,http://www.econovill.com/news/articleView.html?idxno=351678
7915,2018-11-30,김태한삼성바이오로직스대표회계처리적법조속히주식매매재개노력”,http://www.newsway.co.kr/news/view?tp=1&ud=2018113016434525832
7916,2018-11-30,삼성바이오로직스상장폐지기로한국거래소기심위상정,http://www.seoulwire.com/news/articleView.html?idxno=37113
7917,2018-11-30,삼성바이오로직스상폐여부기심위서가리기로,http://www.newstomato.com/ReadNews.aspx?no=861468
7918,2018-11-30,삼성바이오로직스기업심사위원회심의대상결정,http://www.fntimes.com/html/view.php?ud=2018113016400663091d6f57e61a_18
7919,2018-11-30,삼성바이오로직스거래정지다음달까지연장,http://news.mt.co.kr/mtview.php?no=2018113015094061245
7920,2018-11-30,삼성바이오로직스매매거래정지장기화유감기심위판단기대,http://www.newspim.com/news/view/20181130000706
7921,2018-11-30,거래소기심위서삼성바이오로직스상폐심사,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181130164441
7922,2018-11-30,삼성바이오로직스상장폐지12월결판,http://ilyo.co.kr/?ac=article_view&entry_id=318000
7923,2018-11-30,삼성바이오로직스상폐여부기심위서결론난다,http://www.ekn.kr/news/article.html?no=400891
7924,2018-11-30,거래소삼성바이오로직스기심위서상장폐지여부심의”,http://www.kukinews.com/news/article.html?no=609105
7925,2018-11-30,삼성바이오로직스기업심사위원회서상폐운명가른다,http://www.g-enews.com/ko-kr/news/article/news_all/201811301715009154c642673384_1/article.html
7926,2018-11-30,삼성바이오로직스상폐여부기심위로공넘겨내달중결정,http://www.sisafocus.co.kr/news/articleView.html?idxno=197443
7927,2018-11-30,전문삼성바이오로직스거래정지기간장기화유감기심위현명한판단기대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018113017131755253
7928,2018-11-30,삼성바이오로직스기심위간다상폐여부연내결론,http://www.newsprime.co.kr/news/article.html?no=438287
7929,2018-11-30,거래소삼성바이오로직스상장폐지결정기업심사위원회회부,http://www.4th.kr/news/articleView.html?idxno=7071
7930,2018-11-30,삼성바이오로직스기업심사위원회에상장적격판단기대,http://www.mediapen.com/news/view/399316
7931,2018-11-30,삼성바이오로직스기심위결정유감시장우려해소해달라,http://www.g-enews.com/ko-kr/news/article/news_all/2018113017362279025b4ac5ede_1/article.html
7932,2018-11-30,삼성바이오로직스거래소결정유감,http://www.econovill.com/news/articleView.html?idxno=351684
7933,2018-11-30,거래소삼성바이오로직스상폐여부검토한다,http://moneys.mt.co.kr/news/mwView.php?no=2018113017558051521
7934,2018-11-30,삼성바이오로직스기업심사위시장우려해소시켜줄것,http://moneys.mt.co.kr/news/mwView.php?no=2018113018018063086
7935,2018-11-30,거래소삼성바이오로직스상장폐지여부기업심사위에서결정,http://www.businesspost.co.kr/BP?command=article_view&num=104628
7936,2018-11-30,삼성바이오로직스기업심사위원회심의대상올랐다다음달까지주식거래정지,http://www.sporbiz.co.kr/news/articleView.html?idxno=293252
7937,2018-11-30,삼성바이오로직스기업심사위원회심의대상결정에유감표시,http://www.ceoscoredaily.com/news/article.html?no=49042
7938,2018-11-30,삼성바이오로직스상장폐지심의시장우려해소기대,http://kormedi.com/?p=1257287
7939,2018-11-30,삼성바이오로직스운명결정할기업심사위원회는,http://news.mt.co.kr/mtview.php?no=2018113017205991327
7940,2018-11-30,고의분식회계삼성바이오로직스상장폐지심의돌입,http://www.straightnews.co.kr/news/articleView.html?idxno=39102
7941,2018-11-30,KRX삼성바이오로직스기업심사위원회심의대상결정,http://news20.busan.com/controller/newsController.jsp?newsId=20181130000152
7942,2018-11-30,삼성바이오로직스기업심사위원회심의대상결정에유감표명,http://www.sisaon.co.kr/news/articleView.html?idxno=79917
7943,2018-11-30,삼성바이오로직스상장폐지심사,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201811302037005&code=920301
7944,2018-12-01,스트레이트포커스삼성바이오로직스분식회계우리에게무엇을남겼나〈2〉,http://www.straightnews.co.kr/news/articleView.html?idxno=39111
7945,2018-12-01,삼성바이오로직스결국상폐여부본격적으로심의,http://www.fntoday.co.kr/news/articleView.html?idxno=173624
7946,2018-12-01,거래소삼성바이오로직스기심위회부개미들속타들어간다,http://www.econonews.co.kr/news/articleView.html?idxno=44191
7947,2018-12-02,삼성바이오로직스상폐실질심사이미시장에반영영향제한적증권가전망,http://www.econonews.co.kr/news/articleView.html?idxno=44300
7948,2018-12-02,전문가기고원칙중심주의회계와삼성바이오로직스사태,http://www.ekn.kr/news/article.html?no=401017
7949,2018-12-02,삼성그룹지분승계와삼성바이오로직스,http://www.lecturernews.com/news/articleView.html?idxno=10783
7950,2018-12-03,코스피코스닥30일주요공시거래소삼성바이오로직스상폐여부기심위서심의등,http://www.betanews.net:8080/article/942639.html
7951,2018-12-03,삼성바이오로직스기업심사위원회회부매매거래정지장기화,http://www.mdtoday.co.kr/mdtoday/index.html?no=340330
7952,2018-12-03,스트레이트포커스삼성바이오로직스분식회계우리에게무엇을남겼나〈3〉,http://www.straightnews.co.kr/news/articleView.html?idxno=39141
7953,2018-12-03,삼성바이오로직스회계처리정당성근거나왔다,http://biz.newdaily.co.kr/site/data/html/2018/12/03/2018120300002.html
7954,2018-12-03,삼성바이오로직스분식회계논란둘러싸고다음주치열한법적공방,http://www.mdtoday.co.kr/mdtoday/index.html?no=340360
7955,2018-12-03,김앤장압수수색고객삼성바이오로직스소송에영향있을까,http://www.sisajournal-e.com/biz/article/192321
7956,2018-12-03,셀트리온삼성바이오로직스를넘어섰다,http://www.fnnews.com/news/201812031816333924
7957,2018-12-04,스트레이트포커스삼성바이오로직스분식회계우리에게무엇을남겼나〈4〉,http://www.straightnews.co.kr/news/articleView.html?idxno=39203
7958,2018-12-04,時評삼성바이오로직스사태와한국자본시장퇴행,http://www.munhwa.com/news/view.html?no=2018120401033011000002
7959,2018-12-04,MP그룹상장폐지삼성바이오로직스도혹시,http://www.asiatime.co.kr/news/articleView.html?idxno=215335
7960,2018-12-04,법과사건삼성바이오로직스행정소송앞으로의관전포인트는,http://www.econovill.com/news/articleView.html?idxno=351874
7961,2018-12-04,삼성바이오로직스가처분심문2주앞으로법원결정영향은,http://news.mt.co.kr/mtview.php?no=2018120408471763212
7962,2018-12-05,삼성바이오로직스프랑스생고뱅과부품조달계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=01600646619435568
7963,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약체결,http://news.hankyung.com/article/2018120542886
7964,2018-12-05,삼성바이오로직스프랑스기업생고뱅사와전략적협력확대,http://view.asiae.co.kr/news/view.htm?idxno=2018120508564721347
7965,2018-12-05,삼성바이오로직스생산속도높인다佛기업와원부자재공급계약체결,http://www.g-enews.com/ko-kr/news/article/news_all/20181205085254917025b4ac5ede_1/article.html
7966,2018-12-05,프랑스생고뱅삼성바이오로직스납품위해인천송도에공장설립,http://www.fnnews.com/news/201812050900476613
7967,2018-12-05,삼성바이오로직스프랑스기업생고뱅社와전략적협력확대,http://www.newsway.co.kr/news/view?tp=1&ud=2018120509003800161
7968,2018-12-05,삼성바이오로직스佛생고뱅과바이오의약품개발부품공급계약,http://biz.newdaily.co.kr/site/data/html/2018/12/05/2018120500014.html
7969,2018-12-05,삼성바이오로직스프랑스社생고뱅과전략적협력확대,http://www.metroseoul.co.kr/news/newsview?newscd=2018120500025
7970,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약체결,http://www.ceoscoredaily.com/news/article.html?no=49211
7971,2018-12-05,삼성바이오로직스생고뱅전략적파트너십확대,http://www.ebn.co.kr/news/view/964158
7972,2018-12-05,삼성바이오로직스프랑스기업생고뱅과전략적협력확대,http://www.ekn.kr/news/article.html?no=401621
7973,2018-12-05,삼성바이오로직스와손잡은佛기업국내에공장짓는다,http://news1.kr/articles/?3493532
7974,2018-12-05,삼성바이오로직스佛생고뱅과전략적협력확대,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181205084901
7975,2018-12-05,삼성바이오로직스프랑스기업생고뱅과전략적협력확대,http://www.mediapen.com/news/view/400018
7976,2018-12-05,삼성바이오로직스원부자재공급기간단축시킨다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018120508492865131
7977,2018-12-05,삼성바이오로직스생고뱅싱글유즈공급계약체결,http://www.biospectator.com/view/news_view.php?varAtcId=6735
7978,2018-12-05,삼성바이오로직스프랑스생고뱅과협력확대원부자재조달기간단축,http://www.etoday.co.kr/news/section/newsview.php?idxno=1695687
7979,2018-12-05,삼성바이오로직스프랑스생고뱅과전략적협력확대,http://www.inews24.com/view/1143631
7980,2018-12-05,삼성바이오로직스프랑스생고뱅으로부터싱글유즈원부자재공급받기로,http://news.mk.co.kr/newsRead.php?year=2018&no=759348
7981,2018-12-05,삼성바이오로직스싱글유즈원부자재공급계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=230669&MainKind=A&NewsKind=5&vCount=12&vKind=1
7982,2018-12-05,삼성바이오로직스생고뱅바이오의약품싱글유즈원부자재공급계약체결,http://www.viva100.com/main/view.php?key=20181205010001458
7983,2018-12-05,삼성바이오로직스프랑스생고뱅싱글유즈원부자재공급계약,http://www.asiatoday.co.kr/view.php?key=20181205010002603
7984,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약,http://www.econovill.com/news/articleView.html?idxno=351983
7985,2018-12-05,삼성바이오로직스프랑스기업생고뱅社와전략적협력확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=340636
7986,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약체결,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812050200&t=NN
7987,2018-12-05,삼성바이오로직스프랑스업체생고뱅자재받는다,http://www.ajunews.com/view/20181205101555239
7988,2018-12-05,삼성바이오로직스프랑스생고뱅과전략적협력확대,http://www.dailian.co.kr/news/view/756649/?sc=naver
7989,2018-12-05,삼성바이오로직스바이오산업생태계조성에앞장선다,http://news.heraldcorp.com/view.php?ud=20181205000213
7990,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약체결,http://www.sporbiz.co.kr/news/articleView.html?idxno=294245
7991,2018-12-05,삼성바이오로직스프랑스생고뱅과전략적협력원부자재공급기간4분의1로단축,http://www.fntimes.com/html/view.php?ud=2018120510215830857de3572ddd_18
7992,2018-12-05,삼성바이오로직스의진실은삼성바이오로직스의입장전문공개,http://www.futurekorea.co.kr/news/articleView.html?idxno=113288
7993,2018-12-05,삼성바이오로직스생고뱅자재공급협력,http://www.hankookilbo.com/news/npath/201812051071015621?did=NA
7994,2018-12-05,삼성바이오로직스생고뱅社와바이오의약품싱글유즈원부자재공급계약체결,http://www.m-i.kr/news/articleView.html?idxno=476361
7995,2018-12-05,삼성바이오로직스프랑스기업생고뱅과전략적협력확대,http://www.newsworks.co.kr/news/articleView.html?idxno=316404
7996,2018-12-05,삼성바이오로직스프랑스기업생고뱅社와전략적협력확대,http://news.mk.co.kr/newsRead.php?year=2018&no=759679
7997,2018-12-05,삼성바이오로직스프랑스기업생고뱅과전략적협력확대,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018120511014201248&LinkID=632&objId=A2018120511014201248&portalCode=naver
7998,2018-12-05,삼성바이오로직스프랑스기업생고뱅과원부자재공급계약체결,http://www.sisafocus.co.kr/news/articleView.html?idxno=197701
7999,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약체결,http://www.wolyo.co.kr/news/articleView.html?idxno=73042
8000,2018-12-05,삼성바이오로직스1회용원부자재확대공급계약체결,http://www.bosa.co.kr/news/articleView.html?idxno=2095511
8001,2018-12-05,삼성바이오로직스프랑스생고뱅과싱글유즈원부자재공급계약,http://www.dt.co.kr/contents.html?article_no=2018120502109931102003&ref=naver
8002,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약체결,http://www.asiatime.co.kr/news/articleView.html?idxno=215603
8003,2018-12-05,삼성바이오로직스바이오의약품원부자재안정적공급망확보,http://www.techholic.co.kr/news/articleView.html?idxno=179494
8004,2018-12-05,삼성바이오로직스프랑스생고뱅社와원부자재공급계약체결,http://daily.hankooki.com/lpage/ittech/201812/dh20181205134600145630.htm
8005,2018-12-05,삼성바이오로직스佛생고뱅과바이오의약품원부자재공급계약,http://www.etnews.com/20181205000237
8006,2018-12-05,삼성바이오로직스프랑스기업생고뱅과전략적협력확대,http://www.ftoday.co.kr/news/articleView.html?idxno=104950
8007,2018-12-05,삼성바이오로직스프랑스생고뱅과바이오의약품싱글유즈원부자재공급계약체결,http://mtnews.net/news/view.php?idx=4888
8008,2018-12-05,삼성바이오로직스생고뱅과전략적협력확대국내바이오생태계조성통한성장지원,http://www.segye.com/content/html/2018/12/05/20181205003362.html?OutUrl=naver
8009,2018-12-05,삼성바이오로직스프랑스생고뱅과원부자재공급계약,http://www.seoulfn.com/news/articleView.html?idxno=327014
8010,2018-12-05,금융위삼성바이오로직스과징금80억원의결,http://news.mt.co.kr/mtview.php?no=2018120516084776988
8011,2018-12-05,고의분식회계삼성바이오로직스과징금80억원으로결정,http://www.mediapen.com/news/view/400193
8012,2018-12-05,금융위고의분식회계혐의삼성바이오로직스에과징금80억원부과,http://news.mk.co.kr/newsRead.php?year=2018&no=760794
8013,2018-12-05,금융위삼성바이오로직스과징금80억원부과확정,http://www.asiatoday.co.kr/view.php?key=20181205010003103
8014,2018-12-05,금융위삼성바이오로직스80억과징금의결,http://www.newsis.com/view/?id=NISX20181205_0000493764&cID=10401&pID=10400
8015,2018-12-05,금융위고의분식회계삼성바이오로직스에과징금80억원확정,http://www.newsway.co.kr/news/view?tp=1&ud=2018120516385368331
8016,2018-12-05,금융위삼성바이오로직스과징금80억원확정,http://www.kukinews.com/news/article.html?no=610390
8017,2018-12-05,금융위삼성바이오로직스에과징금80억원부과확정,http://news.hankyung.com/article/2018120567696
8018,2018-12-05,금융위삼성바이오로직스과징금80억의결,http://news.einfomax.co.kr/news/articleView.html?idxno=4006019
8019,2018-12-05,고의분식회계삼성바이오로직스과징금80억원확정,http://www.seoulwire.com/news/articleView.html?idxno=37888
8020,2018-12-05,금융위고의분식회계삼성바이오로직스에과징금80억원확정,http://www.joseilbo.com/news/news_read.php?uid=365885&class=53&grp=
8021,2018-12-05,금융위삼성바이오로직스과징금80억부과확정,http://www.segyefn.com/newsView/20181205003772?OutUrl=naver
8022,2018-12-05,금융위이재용삼성바이오로직스에과징금80억부과확정,https://www.insight.co.kr/news/196070
8023,2018-12-05,삼성바이오로직스회계부정과징금80억원확정,http://www.nocutnews.co.kr/news/5071476
8024,2018-12-05,금융위삼성바이오로직스징계최종의결,http://www.newstomato.com/ReadNews.aspx?no=862364
8025,2018-12-05,금융위분식회계삼성바이오로직스에과징금80억원부과,http://www.newsworks.co.kr/news/articleView.html?idxno=316607
8026,2018-12-05,금융위고의분식회계삼성바이오로직스과징금80억원부과확정,http://www.kyeongin.com/main/view.php?key=20181205010001643
8027,2018-12-05,금융위삼성바이오로직스에과징금80억원부과,http://www.cstimes.com/?mod=news&act=articleView&idxno=291605
8028,2018-12-05,금융위삼성바이오로직스에과징금80억원부과확정,http://www.viva100.com/main/view.php?key=20181205010001802
8029,2018-12-05,금융위삼성바이오로직스과징금80억원확정,http://www.metroseoul.co.kr/news/newsview?newscd=2018120500245
8030,2018-12-05,고의분식회계의혹삼성바이오로직스과징금80억원확정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1124098
8031,2018-12-05,금융위삼성바이오로직스에과징금80억의결,http://biz.newdaily.co.kr/site/data/html/2018/12/05/2018120500168.html
8032,2018-12-05,삼성바이오로직스과징금80억원확정,http://www.fntimes.com/html/view.php?ud=2018120516564640771d6f57e61a_18
8033,2018-12-05,금융위삼성바이오로직스과징금80억원확정,http://news1.kr/articles/?3494215
8034,2018-12-05,금융위삼성바이오로직스과징금80억원의결,http://www.sisajournal-e.com/biz/article/192450
8035,2018-12-05,금융위삼성바이오로직스과징금80억원의결,http://www.seoulfn.com/news/articleView.html?idxno=327028
8036,2018-12-05,금융위삼성바이오로직스에과징금80억원부과확정,http://www.m-i.kr/news/articleView.html?idxno=476642
8037,2018-12-05,분식회계삼성바이오로직스과징금80억원확정,http://www.sisafocus.co.kr/news/articleView.html?idxno=197758
8038,2018-12-05,금융위삼성바이오로직스에80억과징금부과확정,http://www.newsprime.co.kr/news/article.html?no=438863
8039,2018-12-05,금융위삼성바이오로직스80억원과징금의결,http://www.ceoscoredaily.com/news/article.html?no=49264
8040,2018-12-05,금융위삼성바이오로직스에과징금80억확정,http://www.inews24.com/view/1143796
8041,2018-12-05,삼성바이오로직스상장폐지촉각펀드가입자어쩌나,http://www.newsprime.co.kr/news/article.html?no=438857
8042,2018-12-05,삼성바이오로직스프랑스기업과원부자재공급계약체결,http://www.joongboo.com/news/articleView.html?idxno=1308912
8043,2018-12-05,금융위삼성바이오로직스분식회계과징금80억부과확정,http://kormedi.com/?p=1257747
8044,2018-12-05,금융위삼성바이오로직스과징금80억원부과,http://moneys.mt.co.kr/news/mwView.php?no=2018120517428032326
8045,2018-12-05,금융위삼성바이오로직스과징금80억원확정,http://www.dailian.co.kr/news/view/756869/?sc=naver
8046,2018-12-05,금융위원회분식회계삼성바이오로직스삼바과징금80억원부과확정행정소송심문기일은이달중순,http://www.topstarnews.net/news/articleView.html?idxno=539762
8047,2018-12-05,금융위삼성바이오로직스에80억과징금부과의결,http://www.rapportian.com/news/articleView.html?idxno=114694
8048,2018-12-05,삼성바이오로직스금융당국제재절차끝80억과징금의결,http://www.g-enews.com/ko-kr/news/article/news_all/2018120518584495334e4869c120_1/article.html
8049,2018-12-05,금융위고의분식회계삼성바이오로직스에과징금80억확정,http://www.businesspost.co.kr/BP?command=article_view&num=105214
8050,2018-12-05,데일리안오늘뉴스종합광주형일자리합의안조건부의결본래취지퇴색금융위삼성바이오로직스과징금80억원확정등,http://www.dailian.co.kr/news/view/756881/?sc=naver
8051,2018-12-05,금융위삼성바이오로직스에과징금80억원부과의결,http://www.nspna.com/news/?mode=view&newsid=323409
8052,2018-12-05,삼성바이오로직스프랑스기업생고뱅과전략적협력확대,http://www.kyeonggi.com/news/articleView.html?idxno=2013267
8053,2018-12-05,삼성바이오로직스佛생고뱅사와싱글유즈원부자재공급계약체결,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=781117
8054,2018-12-05,삼성바이오로직스佛생고뱅일회성원부자재공급맞손,http://www.kyeongin.com/main/view.php?key=20181205010001572
8055,2018-12-06,금융위삼성바이오로직스과징금80억부과,http://www.mediasr.co.kr/news/articleView.html?idxno=50265
8056,2018-12-06,금융위과징금의결에입다문삼성바이오로직스예정된프로세스일뿐”,http://ilyo.co.kr/?ac=article_view&entry_id=318548
8057,2018-12-06,삼성바이오로직스수사박근혜정권움직인실세A씨겨냥,http://www.updownnews.co.kr/news/articleView.html?idxno=100187
8058,2018-12-06,삼성바이오로직스사태처벌촉구회견,http://yna.kr/PYH20181206098900013?did=1196m
8059,2018-12-06,삼성바이오로직스사태처벌촉구회견,http://yna.kr/PYH20181206099000013?did=1196m
8060,2018-12-06,삼성바이오로직스사태처벌촉구회견,http://yna.kr/PYH20181206099100013?did=1196m
8061,2018-12-06,삼성바이오로직스분식회계사태이유는이재용부회장의경영권승계때문,https://cnbc.sbs.co.kr/article_hub/10000923720?division=NAVER
8062,2018-12-06,삼성바이오로직스분식회계사태이재용재판부터엘리엇까지향후미칠영향은,https://cnbc.sbs.co.kr/article_hub/10000923721?division=NAVER
8063,2018-12-06,삼성바이오로직스분식회계사태그동안솜방망이처벌에그쳐삼바상장폐지이어질까,https://cnbc.sbs.co.kr/article_hub/10000923722?division=NAVER
8064,2018-12-06,삼성바이오로직스회계논란윤석헌금감원장일침기업가치평가때더주의해야,http://www.g-enews.com/ko-kr/news/article/news_all/201812061443242792c642673384_1/article.html
8065,2018-12-06,시민단체삼성바이오로직스분식회계사건책임자이재용구속하라”,http://news.kbs.co.kr/news/view.do?ncd=4089388&ref=A
8066,2018-12-06,삼성바이오로직스집행정지가처분신청결과따른시나리오는,http://biz.newdaily.co.kr/site/data/html/2018/12/06/2018120600125.html
8067,2018-12-06,금융위삼성바이오로직스과징금80억원의결,http://www.mdtoday.co.kr/mdtoday/index.html?no=340778
8068,2018-12-06,금융위삼성바이오로직스과징금80억의결,http://www.wsobi.com/news/articleView.html?idxno=67738
8069,2018-12-06,민주노총삼성바이오로직스분식회계은경영권승계과정의사건,http://www.businesspost.co.kr/BP?command=article_view&num=105369
8070,2018-12-07,삼성바이오로직스반도체이후성장동력정권의감정적보복성뒤집기후진적이언주의원,http://www.greened.kr/news/articleView.html?idxno=86329
8071,2018-12-09,삼성바이오로직스상장폐지본심사초읽기찬반논란증선위원장발언재조명,http://www.g-enews.com/ko-kr/news/article/news_all/201812090838224851c642673384_1/article.html
8072,2018-12-09,삼성바이오로직스상장폐지거래소본심사임박,https://news.sbs.co.kr/news/endPage.do?news_id=N1005049816&plink=ORI&cooper=NAVER
8073,2018-12-09,생사기로앞둔삼성바이오로직스거세진찬반논란,http://news.hankyung.com/article/2018120979457
8074,2018-12-09,삼성바이오로직스상장폐지이르면이번주거래소본심사,http://sports.khan.co.kr/news/sk_index.html?art_id=201812091539023&sec_id=564001&pt=nv
8075,2018-12-10,삼성바이오로직스회계분식사태비시장성자산평가엄격해진다,http://news.mt.co.kr/mtview.php?no=2018121011403329872
8076,2018-12-10,경제삼성바이오로직스분식회계뽀록을실력으로인정한정부,https://www.ddanzi.com/ddanziNews/541042778
8077,2018-12-10,삼성바이오로직스상장폐지여부주목,http://www.naeil.com/news_view/?id_art=297559
8078,2018-12-10,한국거래소삼성바이오로직스기업심사위원회시작,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121014153537567
8079,2018-12-10,거래소삼성바이오로직스기심위진행중,http://www.newstomato.com/ReadNews.aspx?no=863146
8080,2018-12-10,거래소삼성바이오로직스상장폐지여부기심위심사시작,http://news.mk.co.kr/newsRead.php?year=2018&no=769988
8081,2018-12-10,거래소오후2시삼성바이오로직스기업심사위원회개최,http://news.einfomax.co.kr/news/articleView.html?idxno=4006674
8082,2018-12-10,삼성바이오로직스상장폐지결정본심사기심위10일오후2시시작,https://news.imaeil.com/Economy/2018121014341362130
8083,2018-12-10,거래소삼성바이오로직스상폐여부1차기심위개최,http://biz.chosun.com/site/data/html_dir/2018/12/10/2018121001718.html
8084,2018-12-10,삼성바이오로직스상장유지될까오늘기업심사위개최,http://moneys.mt.co.kr/news/mwView.php?no=2018121014478038288
8085,2018-12-10,삼성바이오로직스기업심사위원회오늘오후2시부터상폐여부촉각,http://www.fntimes.com/html/view.php?ud=2018121014393243021d6f57e61a_18
8086,2018-12-10,거래소삼성바이오로직스기업심사위원회진행중,http://www.dailian.co.kr/news/view/757857/?sc=naver
8087,2018-12-10,오늘삼성바이오로직스상폐여부결정바이오업계거래재개무게,http://biz.newdaily.co.kr/site/data/html/2018/12/10/2018121000148.html
8088,2018-12-10,질문의중심은삼성바이오로직스,http://yna.kr/PYH20181210083800013?did=1196m
8089,2018-12-10,질문의중심은삼성바이오로직스,http://yna.kr/PYH20181210083900013?did=1196m
8090,2018-12-10,정지원한국거래소이사장삼성바이오로직스기심위회의오늘개최,http://www.ekn.kr/news/article.html?no=402689
8091,2018-12-10,정지원거래소이사장삼성바이오로직스기심위공정한판단기대”,http://www.fntimes.com/html/view.php?ud=2018121014465868831d6f57e61a_18
8092,2018-12-10,삼성바이오로직스상장폐지피하나기업심사위원회심의돌입,http://www.sisajournal-e.com/biz/article/192635
8093,2018-12-10,삼성바이오로직스기심위첫회의개최올해안결정날것,http://www.sisafocus.co.kr/news/articleView.html?idxno=198060
8094,2018-12-10,삼성바이오로직스상폐여부결론심위심의중,http://www.newsworks.co.kr/news/articleView.html?idxno=317880
8095,2018-12-10,기심위삼성바이오로직스상장폐지여부심사,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=99133
8096,2018-12-10,삼성바이오로직스증시서살아남을까,http://www.ggilbo.com/news/articleView.html?idxno=572448
8097,2018-12-10,삼성바이오로직스상장폐지결론오늘나오나,http://www.econovill.com/news/articleView.html?idxno=352357
8098,2018-12-10,상장폐지냐유지냐삼성바이오로직스심사기로,http://www.mhj21.com/sub_read.html?uid=118081§ion=sc243
8099,2018-12-10,현장사진올해대한민국극한직업CEO는김태한삼성바이오로직스대표10일상폐논의기심위출석,https://news.imaeil.com/Economy/2018121017393004860
8100,2018-12-10,삼성바이오로직스운명의기심위시작시장안정위해빠른시일내결론,http://www.econonews.co.kr/news/articleView.html?idxno=45386
8101,2018-12-10,삼성바이오로직스운명의날한국거래소상장유지or폐지심사시작,http://it.chosun.com/site/data/html_dir/2018/12/10/2018121002945.html
8102,2018-12-10,1보거래소기심위삼성바이오로직스상장유지결정,http://www.newspim.com/news/view/20181210000645
8103,2018-12-10,삼성바이오로직스상장유지내일11일부터거래재개,http://news.donga.com/3/all/20181210/93224573/2
8104,2018-12-10,거래소이사장정지원삼성바이오로직스폐지여부빨리결론내야,http://www.businesspost.co.kr/BP?command=article_view&num=105787
8105,2018-12-10,거래소이사장정지원삼성바이오로직스폐지여부빨리결론내야,http://www.businesspost.co.kr/BP?command=article_view&num=105787
8106,2018-12-10,삼성바이오로직스상장유지결정11일부터거래재개,http://news.hankyung.com/article/2018121029016
8107,2018-12-10,한국거래소삼성바이오로직스상장유지결정,http://www.dailian.co.kr/news/view/757968/?sc=naver
8108,2018-12-10,거래소삼성바이오로직스상장유지결정11일거래재개상보,http://www.edaily.co.kr/news/newspath.asp?newsid=03824486619437208
8109,2018-12-10,거래소삼성바이오로직스상장유지결정11일부터거래재개,http://it.chosun.com/site/data/html_dir/2018/12/10/2018121003195.html
8110,2018-12-10,삼성바이오로직스상장유지결정내일부터거래재개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121019142683101
8111,2018-12-10,속보거래소삼성바이오로직스상장유지결론,http://www.newsis.com/view/?id=NISX20181210_0000498427&cID=10401&pID=10400
8112,2018-12-10,일지삼성바이오로직스분식회계상장유지판단일지,http://yna.kr/AKR20181210139200008?did=1195m
8113,2018-12-10,삼성바이오로직스상폐면했다상장유지결론,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812100638&t=NN
8114,2018-12-10,거래소삼성바이오로직스상장유지11일부터거래재개,http://www.newspost.kr/news/articleView.html?idxno=67372
8115,2018-12-10,거래소삼성바이오로직스상장유지결정,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181210192141
8116,2018-12-10,삼성바이오로직스상장유지결정11일부터거래재개,http://www.inews24.com/view/1144805
8117,2018-12-10,거래소삼성바이오로직스상장유지결정1보,http://www.newsway.co.kr/news/view?tp=1&ud=2018121019274294041
8118,2018-12-10,거래소삼성바이오로직스상장유지결정내일부터거래재개,http://news.hankyung.com/article/2018121029486
8119,2018-12-10,삼성바이오로직스상장유지결정내일부터거래재개,http://news.kbs.co.kr/news/view.do?ncd=4091957&ref=A
8120,2018-12-10,삼성바이오로직스상장유지결정다행,http://www.edaily.co.kr/news/newspath.asp?newsid=03834326619437208
8121,2018-12-10,속보한국거래소삼성바이오로직스상장유지11일거래재개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1697881
8122,2018-12-10,삼성바이오로직스상장유지열한법리공방은어떻게,http://www.ggilbo.com/news/articleView.html?idxno=572536
8123,2018-12-10,거래소삼성바이오로직스상장유지결론종합,http://www.newsis.com/view/?id=NISX20181210_0000498437&cID=10401&pID=10400
8124,2018-12-10,한국거래소삼성바이오로직스상장유지결정,http://www.m-i.kr/news/articleView.html?idxno=478112
8125,2018-12-10,삼성바이오로직스거래재개불확실성제거계기돼야상보,http://www.edaily.co.kr/news/newspath.asp?newsid=03854006619437208
8126,2018-12-10,한국거래소삼성바이오로직스상장유지결정시장불확실성사라져vs금융시장투명성부정,http://www.joongboo.com/news/articleView.html?idxno=1310189
8127,2018-12-10,삼성바이오로직스상장유지내일거래재개,http://news.mt.co.kr/mtview.php?no=2018121019100376457
8128,2018-12-10,거래소삼성바이오로직스상장유지11일매매재개,http://www.asiatoday.co.kr/view.php?key=20181210010006118
8129,2018-12-10,삼성바이오로직스삼바회계처리위반으로상장폐지에해당하지는않아결론,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181210.99099004220
8130,2018-12-10,거래소삼성바이오로직스상장유지결정11일거래재개종합,http://www.newsway.co.kr/news/view?tp=1&ud=2018121019433649402
8131,2018-12-10,거래소삼성바이오로직스상장유지결정11일거래재개,http://www.fnnews.com/news/201812101943563839
8132,2018-12-10,롤러코스터탄삼성바이오로직스경과살펴보니,http://news.hankyung.com/article/2018121029696
8133,2018-12-10,거래소삼성바이오로직스상장유지결정11일거래재개,http://www.ekn.kr/news/article.html?no=402768
8134,2018-12-10,거래소삼성바이오로직스상장유지,http://www.newstomato.com/ReadNews.aspx?no=863315
8135,2018-12-10,삼성바이오로직스거래재개다행경영투명성개선하겠다,http://biz.newdaily.co.kr/site/data/html/2018/12/10/2018121000258.html
8136,2018-12-10,삼성바이오로직스상폐모면내일부터거래재개,http://www.dailypharm.com/Users/News/NewsView.html?ID=247378&REFERER=NP
8137,2018-12-10,삼성바이오로직스상장유지확정오는11일부터거래재개,http://www.segye.com/content/html/2018/12/10/20181210004536.html?OutUrl=naver
8138,2018-12-10,삼성바이오로직스주식거래재개법리공방은현재진행중,http://www.seoulwire.com/news/articleView.html?idxno=38764
8139,2018-12-10,삼성바이오로직스주식매매재개환영행정소송은계속”,http://www.newsway.co.kr/news/view?tp=1&ud=2018121019533879442
8140,2018-12-10,삼성바이오로직스상장유지결정11일부터거래재개,http://www.ceoscoredaily.com/news/article.html?no=49520
8141,2018-12-10,삼성바이오로직스상장유지로경영투명성강화하겠다,http://www.ceoscoredaily.com/news/article.html?no=49521
8142,2018-12-10,한숨돌린삼성바이오로직스한국거래소원칙의구심지속,http://www.econovill.com/news/articleView.html?idxno=352378
8143,2018-12-10,삼성바이오로직스주식거래재개매우다행경영투명성대폭강화,http://www.asiatoday.co.kr/view.php?key=20181210010006138
8144,2018-12-10,거래소삼성바이오로직스상장유지결정내일11일부터거래재개,http://moneys.mt.co.kr/news/mwView.php?no=2018121019598043865
8145,2018-12-10,상장폐지위기벗어난삼성바이오로직스경영투명성강화다짐,http://news1.kr/articles/?3498042
8146,2018-12-10,삼성바이오로직스상장유지결정내일부터거래재개,http://www.mbn.co.kr/pages/news/newsView.php?news_seq_no=3707816
8147,2018-12-10,상폐면한삼성바이오로직스11일거래재개,http://www.ebn.co.kr/news/view/964818
8148,2018-12-10,삼성바이오로직스상장폐지모면11일거래재개,http://news.bizwatch.co.kr/article/market/2018/12/10/0036/naver
8149,2018-12-10,한국거래소삼성바이오로직스상장유지하기로,http://www.ichannela.com/news/main/news_detailPage.do?publishId=000000125086
8150,2018-12-10,삼성바이오로직스주식거래재개다행경영투명성강화,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812100647&t=NN
8151,2018-12-10,삼성바이오로직스거래재개매우다행경영투명성더욱강화할것,http://moneys.mt.co.kr/news/mwView.php?no=2018121020078040374
8152,2018-12-10,거래소삼성바이오로직스상장유지결정김태한직접의견진술,http://www.businesspost.co.kr/BP?command=article_view&num=105828
8153,2018-12-10,삼성바이오로직스주식거래재개환영경영투명성강화,http://www.businesspost.co.kr/BP?command=article_view&num=105830
8154,2018-12-10,삼성바이오로직스의상장은폐지되지않았다,https://www.huffingtonpost.kr/entry/story_kr_5c0e3d9de4b0ab8cf69530e3?utm_id=naver
8155,2018-12-10,삼성바이오로직스상장유지결정11일부터거래재개,http://www.kukinews.com/news/article.html?no=611921
8156,2018-12-10,한국거래소삼성바이오로직스상장유지결정내일부터주식매매거래재개,http://www.topstarnews.net/news/articleView.html?idxno=543063
8157,2018-12-10,삼성바이오로직스상장유지결정행정소송은계속,http://www.news2day.co.kr/116421
8158,2018-12-10,상폐면한삼성바이오로직스기업계속성재무안정감안상장유지로,http://www.sedaily.com/NewsView/1S8EU8FT1T
8159,2018-12-10,삼성바이오로직스주식거래재개삼바경영투명성강화약속”,http://biz.chosun.com/site/data/html_dir/2018/12/10/2018121003279.html
8160,2018-12-10,한숨돌린삼성바이오로직스소송서회계적정성증명할것,http://news.hankyung.com/article/2018121030931
8161,2018-12-10,한국거래소삼성바이오로직스거래재개결정,http://www.babytimes.co.kr/news/articleView.html?idxno=23764
8162,2018-12-10,삼성바이오로직스한국거래소상장유지결정에다행스럽게생각한다환영,http://www.joongboo.com/news/articleView.html?idxno=1310212
8163,2018-12-10,한국거래소삼성바이오로직스상장유지결정내일거래재개,http://news20.busan.com/controller/newsController.jsp?newsId=20181210000369
8164,2018-12-10,한국거래소삼성바이오로직스상장유지결론11일거래재개,http://www.joseilbo.com/news/news_read.php?uid=366178&class=53&grp=
8165,2018-12-10,삼성바이오로직스상장유지11일부터주식거래재개,http://www.newsworks.co.kr/news/articleView.html?idxno=317956
8166,2018-12-10,삼성바이오로직스상장유지11일주식거래재개,http://news.kmib.co.kr/article/view.asp?arcid=0924044948&code=11151200&cp=nv
8167,2018-12-10,거래소삼성바이오로직스상장유지결정기업계속성재무안정성고려”,http://news.donga.com/3/all/20181210/93231719/2
8168,2018-12-10,삼성바이오로직스내일11일거래재개법리공방불가피,http://www.kyeongin.com/main/view.php?key=20181210010003330
8169,2018-12-10,삼성바이오로직스기사회생시초가등관전포인트는,http://www.g-enews.com/ko-kr/news/article/news_all/201812102002535525c642673384_1/article.html
8170,2018-12-10,삼성바이오로직스상장유지11일부터주식거래재개,http://kormedi.com/?p=1258214
8171,2018-12-10,삼성바이오로직스거래재개다행경영투명성한층더개선할것”,http://biz.chosun.com/site/data/html_dir/2018/12/10/2018121003303.html
8172,2018-12-10,삼성바이오로직스상장유지11일부터거래재개,http://www.sisafocus.co.kr/news/articleView.html?idxno=198098
8173,2018-12-10,삼성바이오로직스상장유지결정11일거래재개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123151&REFERER=NP
8174,2018-12-10,삼성바이오로직스상장폐지피했다내일부터거래재개,http://news.kbs.co.kr/news/view.do?ncd=4092134&ref=A
8175,2018-12-10,4조5천억장부조작삼성바이오로직스상장유지거래재개결국면죄부,http://www.vop.co.kr/A00001361264.html
8176,2018-12-10,삼성바이오로직스상장유지결론내일부터바로주식거래재개,http://www.econonews.co.kr/news/articleView.html?idxno=45389
8177,2018-12-10,삼성바이오로직스기사회생11일부터주식거래재개,http://www.fnnews.com/news/201812102141325594
8178,2018-12-10,SR포커스삼성바이오로직스상장유지기심위거래재개최종결론,http://www.srtimes.kr/news/articleView.html?idxno=29112
8179,2018-12-10,삼성바이오로직스상장유지기업의계속성에심각한우려가있지않다예정된수순,http://www.econonews.co.kr/news/articleView.html?idxno=45393
8180,2018-12-10,삼성바이오로직스상장폐지면했다11일부터거래재개,http://www.greened.kr/news/articleView.html?idxno=86661
8181,2018-12-10,삼성바이오로직스주식거래재개다행경영투명성강화,http://www.greened.kr/news/articleView.html?idxno=86662
8182,2018-12-10,삼성바이오로직스주식매매거래재개다행경영투명성강화,http://daily.hankooki.com/lpage/ittech/201812/dh20181210221014145630.htm
8183,2018-12-10,거래소삼성바이오로직스상장유지결정온라인여론은실망감,http://www.fntoday.co.kr/news/articleView.html?idxno=174184
8184,2018-12-10,삼성바이오로직스상장유지한다한국거래소적격성실질심사통과,http://news20.busan.com/controller/newsController.jsp?newsId=20181210000383
8185,2018-12-10,삼성바이오로직스상장유지11일부터거래재개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225290
8186,2018-12-10,삼성바이오로직스코스피상장유지감사기능강화투명경영약속,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=781906
8187,2018-12-10,삼성바이오로직스오늘부터거래재개상장유지결정,http://www.kyeonggi.com/news/articleView.html?idxno=2015730
8188,2018-12-10,기심위삼성바이오로직스거래재개결정3년간경영투명성개선계획이행심사,http://www.techholic.co.kr/news/articleView.html?idxno=179599
8189,2018-12-11,삼성바이오로직스상장유지결정됐지만논란은끝이아니다,http://sports.khan.co.kr/news/sk_index.html?art_id=201812110000073&sec_id=564001&pt=nv
8190,2018-12-11,20일만에돌아오는삼성바이오로직스주가11일얼마나뛸까,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181211.99099004250
8191,2018-12-11,삼성바이오로직스상장유지업다운어느쪽이든 개선이행점검할듯,http://www.ccdn.co.kr/news/articleView.html?idxno=554011
8192,2018-12-11,삼성바이오로직스상장유지업다운어느쪽으로개선이행점검을,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=781928
8193,2018-12-11,삼성바이오로직스11일거래재개심각한우려없었다,http://www.ajunews.com/view/20181211003000912
8194,2018-12-11,시총22조삼성바이오로직스상장유지11일부터주식거래재개,http://www.wikileaks-kr.org/news/articleView.html?idxno=42758
8195,2018-12-11,황교익삼성바이오로직스상장유지에대통령하나바꾸었다고세상이쉽게바뀌겠나,http://news20.busan.com/controller/newsController.jsp?newsId=20181211000009
8196,2018-12-11,삼성바이오로직스기업계속성채무안정성고려한결정,http://www.newstomato.com/ReadNews.aspx?no=863314
8197,2018-12-11,삼성바이오로직스삼바춤다시추기힘들것vs불확실성해소긍정적11일거래재개투자자들설전,http://www.g-enews.com/ko-kr/news/article/news_all/2018121106100291134e4869c120_1/article.html
8198,2018-12-11,삼성바이오로직스삼성바이보상장유지거래재개에셀트리온도관심지난해매출9500억원평균연봉은,http://www.g-enews.com/ko-kr/news/article/news_all/2018121106272955634e4869c120_1/article.html
8199,2018-12-11,삼성그룹삼성바이오로직스삼바상장유지결정에도신중한입장19일심문기일열릴예정,http://www.topstarnews.net/news/articleView.html?idxno=543245
8200,2018-12-11,삼성바이오로직스상장유지에소액주주도안도향후주가는,http://www.ekn.kr/news/article.html?no=402780
8201,2018-12-11,삼성바이오로직스상장유지결정오늘거래재개,http://www.dailymedi.com/detail.php?number=837917&thread=22r05
8202,2018-12-11,상장폐지면한삼성바이오로직스11일오전9시부터거래재개,http://www.sportsseoul.com/news/read/709871
8203,2018-12-11,삼성바이오로직스상장유지오늘부터거래재개,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3707929
8204,2018-12-11,삼성바이오로직스11일거래재개분식회계의혹에도삼성은무적,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181211.99099004267
8205,2018-12-11,삼성바이오로직스상장유지결정주식거래재개,http://www.biospectator.com/view/news_view.php?varAtcId=6768
8206,2018-12-11,삼성바이오로직스불확실성해소다만행정소송지속NH,http://news.hankyung.com/article/2018121136346
8207,2018-12-11,삼성바이오로직스오늘부터거래재개대마불사비판도,http://www.mbn.co.kr/pages/news/newsView.php?news_seq_no=3707916
8208,2018-12-11,삼성바이오로직스오늘부터주식거래재개바이오주등시장영향촉각,http://www.seoulwire.com/news/articleView.html?idxno=38839
8209,2018-12-11,삼성바이오로직스오늘11일거래재개상장폐지까지특이사례,http://www.theceluv.com/article.php?aid=1544479472225954018
8210,2018-12-11,삼성바이오로직스금융당국마찰등영업불확실성목표가↓한국,http://news.hankyung.com/article/2018121136696
8211,2018-12-11,퀵리포트삼성바이오로직스매수유지목표가27↓44만원한투證,http://www.itooza.com/common/iview.php?no=2018121107314270278
8212,2018-12-11,김어준의뉴스공장김어준삼성바이오로직스삼바상장유지한국거래소고민의흔적도없어,http://www.topstarnews.net/news/articleView.html?idxno=543250
8213,2018-12-11,삼성바이오로직스주식거래재개,https://news.sbs.co.kr/news/endPage.do?news_id=N1005052156&plink=ORI&cooper=NAVER
8214,2018-12-11,삼성바이오로직스거래재개로불확실성해소삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01295606619437536
8215,2018-12-11,삼성바이오로직스투자심리개선기대목표가는↓”한국투자증권,http://www.dailian.co.kr/news/view/757989/?sc=naver
8216,2018-12-11,I리포트삼성바이오로직스금융당국마찰부정적목표가↓한투證,http://www.inews24.com/view/1144851
8217,2018-12-11,삼성바이오로직스불확실성해소NH,http://www.fnnews.com/news/201812110737499074
8218,2018-12-11,삼성바이오로직스기사회생상장유지결정에바이오업계안도,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063355
8219,2018-12-11,삼성바이오로직스11일거래재개투자심리개선기대목표주가는하향,http://www.slist.kr/news/articleView.html?idxno=56438
8220,2018-12-11,삼바상장유지거래재개삼성바이오로직스주가반등가능성에촉각,http://www.news2day.co.kr/116423
8221,2018-12-11,삼성바이오로직스목표가51만원유지전일종가33만4500원유안타證,http://www.newspim.com/news/view/20181211000105
8222,2018-12-11,삼성바이오로직스목표가27↓44만원제시한투證,http://www.newspim.com/news/view/20181211000048
8223,2018-12-11,삼성바이오로직스목표가54만원유지삼성證,http://www.newspim.com/news/view/20181211000102
8224,2018-12-11,퀵리포트삼성바이오로직스매수목표가46만원신규제시키움證,http://www.itooza.com/common/iview.php?no=2018121107592516500
8225,2018-12-11,삼성바이오로직스목표가46만원신규제시전일종가33만4500원키움證,http://www.newspim.com/news/view/20181211000051
8226,2018-12-11,HotLine삼성바이오로직스거래재개로최악피했다,http://news.mk.co.kr/newsRead.php?year=2018&no=771578
8227,2018-12-11,삼성바이오로직스금융당국과마찰및시장경쟁심화목표가↓,http://www.asiatoday.co.kr/view.php?key=20181211010006246
8228,2018-12-11,삼성바이오로직스에이어”셀트리온헬스케어분식회계의혹,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181211.99099004287
8229,2018-12-11,삼성바이오로직스상장유지오늘부터거래재개,http://www.namdonews.com/news/articleView.html?idxno=501422
8230,2018-12-11,삼성바이오로직스최악의상황피해소송리스크는남아유안타,http://news.mt.co.kr/mtview.php?no=2018121108053943025
8231,2018-12-11,삼성바이오로직스거래정지불확실성해소NH,http://news.mt.co.kr/mtview.php?no=2018121108093200276
8232,2018-12-11,삼성바이오로직스11일거래재개장기성장성주목,http://www.dt.co.kr/contents.html?article_no=2018121102109932047001&ref=naver
8233,2018-12-11,삼성바이오로직스거래정지해제장기성장성주목”KB증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1697971
8234,2018-12-11,주식매매거래재개삼성바이오로직스경영투명성제고주력키로,http://www.ajunews.com/view/20181211081427990
8235,2018-12-11,삼성바이오로직스경영투명성개선과감사위원회신설해내부통제강화,http://www.m-i.kr/news/articleView.html?idxno=478118
8236,2018-12-11,삼성바이오로직스상장유지오늘부터거래재개,http://www.fntimes.com/html/view.php?ud=2018121108193172911d6f57e61a_18
8237,2018-12-11,삼성바이오로직스삼바상장유지주가향방은증권사마다엇갈려,http://www.seoulwire.com/news/articleView.html?idxno=38844
8238,2018-12-11,KB증권삼성바이오로직스상장불확실성해소장기성장성유효”,http://www.g-enews.com/ko-kr/news/article/news_all/201812110824272708c642673384_1/article.html
8239,2018-12-11,I리포트삼성바이오로직스상폐피했지만소송리스크유안타證,http://www.inews24.com/view/1144859
8240,2018-12-11,삼성바이오로직스거래재개셀트리온헬스케어금감원분식회계감리,http://www.ajunews.com/view/20181211082728010
8241,2018-12-11,삼성바이오로직스목표가50만원유지전일종가33만4500원SK證,http://www.newspim.com/news/view/20181211000080
8242,2018-12-11,퀵리포트삼성바이오로직스매수유지목표가50만원유지SK證,http://www.itooza.com/common/iview.php?no=2018121108304511665
8243,2018-12-11,모닝리포트삼성바이오로직스거래재개,http://www.fntimes.com/html/view.php?ud=2018121108305926225dfa8e9fc3_18
8244,2018-12-11,삼성바이오로직스거래재개제약바이오주투자심리개선기대”한국투자증권,http://www.fntimes.com/html/view.php?ud=201812110820468417f09e13944d_18
8245,2018-12-11,오늘의이투데이경제전망삼성바이오로직스최종구김정은답방카풀12월11일,http://www.etoday.co.kr/news/section/newsview.php?idxno=1697981
8246,2018-12-11,삼성바이오로직스거래재개증권사상장폐지리스크해소매수유지,http://www.ajunews.com/view/20181211082911018
8247,2018-12-11,삼성바이오로직스상장유지오늘부터거래재개,http://www.viva100.com/main/view.php?key=20181211010003432
8248,2018-12-11,키움증권삼성바이오로직스거래재개주가흐름긍정적예상”,http://sports.khan.co.kr/news/sk_index.html?art_id=201812110839003&sec_id=564001&pt=nv
8249,2018-12-11,삼성바이오로직스불확실성털고투자심리개선한국투자,http://www.newstomato.com/ReadNews.aspx?no=863329
8250,2018-12-11,KB증권삼성바이오로직스장기적성장성에주목해야매수”,http://sports.khan.co.kr/news/sk_index.html?art_id=201812110842003&sec_id=564001&pt=nv
8251,2018-12-11,삼성바이오로직스불확실성해소에도목표가↓한투,http://www.sedaily.com/NewsView/1S8F9263GG
8252,2018-12-11,삼성바이오로직스상장유지결정11일부터거래재개,http://www.kukinews.com/news/article.html?no=611936
8253,2018-12-11,SK증권삼성바이오로직스회계이슈불확실성해소”,http://www.newsway.co.kr/news/view?tp=1&ud=2018121108442569356
8254,2018-12-11,삼성바이오로직스불확실성해소긍정적매수유지SK증권,http://www.fntimes.com/html/view.php?ud=2018121108365446481d6f57e61a_18
8255,2018-12-11,삼성바이오로직스불확실성해소펀더멘털반영국면진입전망”NH투자증권,http://www.fntimes.com/html/view.php?ud=201812110835402664f09e13944d_18
8256,2018-12-11,이제는펀더멘털이중요삼성바이오로직스상승기대감키움,http://www.sedaily.com/NewsView/1S8F8OYZKI
8257,2018-12-11,자막뉴스기업심사위가밝힌삼성바이오로직스상장유지이유,https://www.ytn.co.kr/_ln/0102_201812110849182739
8258,2018-12-11,삼성바이오로직스거래재개제약바이오섹터긍정적하이,http://www.ebn.co.kr/news/view/964826
8259,2018-12-11,삼성바이오로직스거래재개제약바이오섹터긍정적하이,http://www.ebn.co.kr/news/view/964826
8260,2018-12-11,투자코멘트실시간종목순위0840삼성바이오로직스아난티셀트리온,http://www.fntimes.com/html/view.php?ud=2018121108510014435dfa8fb997_18
8261,2018-12-11,삼성바이오로직스최악면했지만소송이슈남았다유안타,http://www.sedaily.com/NewsView/1S8F8COLRN
8262,2018-12-11,퀵리포트삼성바이오로직스매수유지목표가54만원유지삼성證,http://www.itooza.com/common/iview.php?no=2018121107370614445
8263,2018-12-11,김어준의뉴스공장김경율회계사삼성바이오로직스삼바상장유지기업심사위이전부터결정된듯,http://www.topstarnews.net/news/articleView.html?idxno=543251
8264,2018-12-11,삼성바이오로직스소송이슈는남아있는리스크유안타증권,http://www.ekn.kr/news/article.html?no=402803
8265,2018-12-11,삼성바이오로직스상장폐지최악피했다펀더멘털위주투자판단필요–유안타증권,http://www.fntimes.com/html/view.php?ud=2018121108422448931d6f57e61a_18
8266,2018-12-11,신문브리핑5삼성바이오로직스상장유지결정배경은외주요기사,http://www.mbn.co.kr/pages/news/newsView.php?news_seq_no=3708112
8267,2018-12-11,퀵리포트삼성바이오로직스매수유지목표가51만원유지유안타證,http://www.itooza.com/common/iview.php?no=2018121107393219071
8268,2018-12-11,삼성바이오로직스4분기영업이익228억원전망,http://www.nspna.com/news/?mode=view&newsid=324583
8269,2018-12-11,한국투자증권삼성바이오로직스투자심리개선기대목표가는하향”,http://www.viva100.com/main/view.php?key=20181211010003445
8270,2018-12-11,삼성바이오로직스유럽시장점유율상승에기대감UPSK,http://www.sedaily.com/NewsView/1S8F8C6DB7
8271,2018-12-11,삼성바이오로직스주가전망엇갈려불확실성해소는일단긍정적,http://www.businesspost.co.kr/BP?command=article_view&num=105840
8272,2018-12-11,삼성바이오로직스상폐피했다이날부터거래재개,http://www.newsprime.co.kr/news/article.html?no=439416
8273,2018-12-11,삼성바이오로직스거래재개는다행‥에피스가치하락은부담,http://news.hankyung.com/article/2018121139606
8274,2018-12-11,삼성바이오로직스거래재개로제약바이오섹터반등기대”대신證,http://www.fntimes.com/html/view.php?ud=201812110850581095f09e13944d_18
8275,2018-12-11,특징주삼성바이오로직스거래재개첫날강세,http://www.newspim.com/news/view/20181211000116
8276,2018-12-11,삼성바이오로직스개장하자마자급등1보,http://www.sedaily.com/NewsView/1S8F8IL3VJ
8277,2018-12-11,특징주삼성바이오로직스거래재개정적VI발동왜,http://www.g-enews.com/ko-kr/news/article/news_all/201812110903397879c642673384_1/article.html
8278,2018-12-11,삼성바이오로직스셀트리온희비엇갈려특히삼성바이오로직스거래재개맞아급등,http://www.econonews.co.kr/news/articleView.html?idxno=45415
8279,2018-12-11,HotLine삼성바이오로직스분식회계논란이영업수주에악영향목표가↓,http://news.mk.co.kr/newsRead.php?year=2018&no=771777
8280,2018-12-11,삼성바이오로직스주식거래재개,http://news.bbsi.co.kr/news/articleView.html?idxno=912299
8281,2018-12-11,삼성바이오로직스39만5000원선분식회계의혹에도상승세,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181211.99099004313
8282,2018-12-11,유삼성바이오로직스현재가514급등,http://www.sedaily.com/NewsView/1S8F8UF24G
8283,2018-12-11,삼성바이오로직스거래재개첫날급등18↑,http://news.hankyung.com/article/2018121140356
8284,2018-12-11,삼성바이오로직스40만원돌파,http://www.sedaily.com/NewsView/1S8F9FRF6V
8285,2018-12-11,특징주삼성바이오로직스거래재개후급등,http://biz.chosun.com/site/data/html_dir/2018/12/11/2018121100845.html
8286,2018-12-11,삼성바이오로직스거래재개에20대급등,http://www.sporbiz.co.kr/news/articleView.html?idxno=295667
8287,2018-12-11,키움증권삼성바이오로직스불확실성해소긍정적주가흐름예상”,http://www.viva100.com/main/view.php?key=20181211010003456
8288,2018-12-11,한경로보뉴스삼성바이오로직스20이상상승,http://news.hankyung.com/article/201812114061L
8289,2018-12-11,특징주삼성바이오로직스거래재개첫날급등,http://yna.kr/AKR20181211034400008?did=1195m
8290,2018-12-11,ET투자뉴스삼성바이오로직스거래재개상장BUYM유안타증권,http://www.etnews.com/20181211000013
8291,2018-12-11,특징주삼성바이오로직스매매거래재개에상승,http://www.ekn.kr/news/article.html?no=402808
8292,2018-12-11,머니e종목삼성바이오로직스급등가장큰불확실성제거,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121109064836007
8293,2018-12-11,특징주삼성바이오로직스거래재개로불확실성해소20↑,http://www.viva100.com/main/view.php?key=20181211010003458
8294,2018-12-11,삼성바이오로직스거래재개20대급등,http://www.kukinews.com/news/article.html?no=611945
8295,2018-12-11,삼성바이오로직스11일거래재개재무안정성고려,http://www.mediasr.co.kr/news/articleView.html?idxno=50329
8296,2018-12-11,코스피소폭상승세삼성바이오로직스20대급등,http://news.mt.co.kr/mtview.php?no=2018121108502168413
8297,2018-12-11,거래재개삼성바이오로직스개장과함께급등,http://www.newsworks.co.kr/news/articleView.html?idxno=317980
8298,2018-12-11,특징주거래재개삼성바이오로직스개장직후급등세,http://www.mediapen.com/news/view/401079
8299,2018-12-11,특징주거래재개삼성바이오로직스개장직후급등세,http://www.mediapen.com/news/view/401079
8300,2018-12-11,특징주삼성바이오로직스거래재개첫날급등세,http://www.fnnews.com/news/201812110910293859
8301,2018-12-11,특징주삼성바이오로직스거래재개첫날급등外人은순매도,http://www.inews24.com/view/1144877
8302,2018-12-11,삼성바이오로직스목표가49만원유지전일종가33만4500원대신證,http://www.newspim.com/news/view/20181211000135
8303,2018-12-11,특징주삼성바이오로직스거래재개첫날20↑,http://www.sentv.co.kr/news/view/546592
8304,2018-12-11,퀵리포트삼성바이오로직스매수유지목표가49만원유지대신證,http://www.itooza.com/common/iview.php?no=2018121109131515240
8305,2018-12-11,삼성바이오로직스급한불껐지만분식혐의벗으려면첩첩산중,http://news1.kr/articles/?3498065
8306,2018-12-11,특징주삼성바이오로직스거래재개첫날20대급등,http://www.seoulfn.com/news/articleView.html?idxno=327593
8307,2018-12-11,22조삼성바이오로직스주식거래재개불확실성여전,http://www.wikitree.co.kr/main/news_view.php?id=388901
8308,2018-12-11,특징주삼성바이오로직스거래재개첫날장초반상한가,http://www.ebn.co.kr/news/view/964845
8309,2018-12-11,거래재개삼성바이오로직스불확실성해소에급등,http://www.segyefn.com/newsView/20181211000512?OutUrl=naver
8310,2018-12-11,삼성바이오로직스목표가52만원유지전일종가33만4500원KB證,http://www.newspim.com/news/view/20181211000137
8311,2018-12-11,삼성바이오로직스불확실성해소실적개선은내년,http://moneys.mt.co.kr/news/mwView.php?no=2018121108598092575
8312,2018-12-11,퀵리포트삼성바이오로직스매수유지목표가52만원유지KB證,http://www.itooza.com/common/iview.php?no=2018121109154218501
8313,2018-12-11,특징주거래재개첫날삼성바이오로직스강세,http://www.newsis.com/view/?id=NISX20181211_0000498689&cID=10401&pID=10400
8314,2018-12-11,상장유지면죄부받은삼성바이오로직스앞으로어떻게되나,http://www.sisafocus.co.kr/news/articleView.html?idxno=198118
8315,2018-12-11,특징주삼성바이오로직스거래재개첫날급등세,http://www.newsprime.co.kr/news/article.html?no=439424
8316,2018-12-11,특징주삼성바이오로직스거래재개직후급등,http://moneys.mt.co.kr/news/mwView.php?no=2018121109088097951
8317,2018-12-11,삼성물산삼성바이오로직스거래재개에동반상승,http://news.hankyung.com/article/2018121141496
8318,2018-12-11,HotLine삼성바이오로직스불확실성해소돼20이상급등,http://news.mk.co.kr/newsRead.php?year=2018&no=771843
8319,2018-12-11,삼성바이오로직스거래재개직후20급등세상장유지결정불확실성해소,http://www.ajunews.com/view/20181211091609094
8320,2018-12-11,ET투자뉴스삼성바이오로직스삼성바이오로직스BUY삼성증권,http://www.etnews.com/20181211000017
8321,2018-12-11,삼성바이오로직스거래재개첫날급등,https://news.sbs.co.kr/news/endPage.do?news_id=N1005052406&plink=ORI&cooper=NAVER
8322,2018-12-11,특징주삼성바이오로직스거래재개후급등,http://www.dailian.co.kr/news/view/758031/?sc=naver
8323,2018-12-11,특징주삼성바이오로직스상장유지결정후거래재개첫날급등,http://www.fetv.co.kr/news/article.html?no=16997
8324,2018-12-11,돌아온삼성바이오로직스주가초강세,http://kormedi.com/?p=1258253
8325,2018-12-11,특징주삼성바이오로직스거래재개첫날급등,http://www.cstimes.com/?mod=news&act=articleView&idxno=292022
8326,2018-12-11,삼성바이오로직스거래재개첫날급등19↑,http://www.segye.com/content/html/2018/12/11/20181211000471.html?OutUrl=naver
8327,2018-12-11,특징주삼성바이오로직스거래재개첫날장초반급등,http://www.asiatoday.co.kr/view.php?key=20181211010006363
8328,2018-12-11,삼성바이오로직스거래재개20대급등불확실성해소,http://www.newsworks.co.kr/news/articleView.html?idxno=317978
8329,2018-12-11,삼성바이오로직스거래재개첫날19이상급등,http://www.sportsseoul.com/news/read/709922
8330,2018-12-11,삼성바이오로직스거래재개첫날부터주가급등,http://www.ceoscoredaily.com/news/article.html?no=49528
8331,2018-12-11,삼성바이오로직스거래재개첫날급등,https://news.sbs.co.kr/news/endPage.do?news_id=N1005052412&plink=ORI&cooper=NAVER
8332,2018-12-11,특징주상장유지삼성바이오로직스거래재개첫날급등세,http://www.kyeongin.com/main/view.php?key=20181211000924095
8333,2018-12-11,거래재개삼성바이오로직스주가20급등,http://news20.busan.com/controller/newsController.jsp?newsId=20181211000029
8334,2018-12-11,특징주삼성물산삼성바이오로직스거래재개영향강세,http://www.viva100.com/main/view.php?key=20181211010003475
8335,2018-12-11,삼성바이오로직스거래재개에급등,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018121109292600597&LinkID=632&objId=A2018121109292600597&portalCode=naver
8336,2018-12-11,삼성바이오로직스주식거래재개다행회계처리적정성증명하겠다,http://www.mediapen.com/news/view/401087
8337,2018-12-11,포토삼성바이오로직스장초반급등,http://view.asiae.co.kr/news/view.htm?idxno=2018121109324064422
8338,2018-12-11,유삼성바이오로직스전일대비1913상승일일회전율은100기록,http://www.sedaily.com/NewsView/1S8F9H2HP1
8339,2018-12-11,실시간분석삼성바이오로직스194상승거래재개,http://www.itooza.com/common/iview.php?no=2018121109032515059
8340,2018-12-11,포토장초반급등하는삼성바이오로직스,http://view.asiae.co.kr/news/view.htm?idxno=2018121109331570770
8341,2018-12-11,거래재개후상승에보이는삼성바이오로직스,http://www.newsis.com/view/?id=NISI20181211_0014721657
8342,2018-12-11,거래재개된삼성바이오로직스,http://www.newsis.com/view/?id=NISI20181211_0014721659
8343,2018-12-11,삼성바이오로직스거래재개,http://www.newsis.com/view/?id=NISI20181211_0014721654
8344,2018-12-11,삼성바이오로직스거래재개첫날급등상한가찍나,http://www.fntimes.com/html/view.php?ud=2018121109215013531d6f57e61a_18
8345,2018-12-11,거래재개후상승에보이는삼성바이오로직스,http://www.newsis.com/view/?id=NISI20181211_0014721655
8346,2018-12-11,거래재개된삼성바이오로직스,http://www.newsis.com/view/?id=NISI20181211_0014721653
8347,2018-12-11,거래재개후상승에보이는삼성바이오로직스,http://www.newsis.com/view/?id=NISI20181211_0014721660
8348,2018-12-11,삼성바이오로직스거래재개,http://www.newsis.com/view/?id=NISI20181211_0014721656
8349,2018-12-11,거래재개된삼성바이오로직스,http://www.newsis.com/view/?id=NISI20181211_0014721659
8350,2018-12-11,특징주삼성물산삼성바이오로직스거래재개에동반강세,http://www.newsis.com/view/?id=NISX20181211_0000498741&cID=10401&pID=10400
8351,2018-12-11,특징주삼성바이오로직스상장유지결정으로불확실성해소,http://www.sisaon.co.kr/news/articleView.html?idxno=80247
8352,2018-12-11,거래재개된삼성바이오로직스,http://yna.kr/PYH20181211025800013?did=1196m
8353,2018-12-11,거래재개된삼성바이오로직스,http://yna.kr/PYH20181211025700013?did=1196m
8354,2018-12-11,거래재개된삼성바이오로직스,http://yna.kr/PYH20181211026700013?did=1196m
8355,2018-12-11,거래재개된삼성바이오로직스,http://yna.kr/PYH20181211026600013?did=1196m
8356,2018-12-11,일단복귀삼성바이오로직스짐효과아난티株시장스포트라이트,http://www.etoday.co.kr/news/section/newsview.php?idxno=1698082
8357,2018-12-11,ET투자뉴스삼성바이오로직스비온뒤에땅이BUY유지KB증권,http://www.etnews.com/20181211000024
8358,2018-12-11,상폐먹구름걷히자마자폭등한삼성바이오로직스,http://news.kmib.co.kr/article/view.asp?arcid=0012909491&code=61141111&cp=nv
8359,2018-12-11,포토삼성바이오로직스부활,http://view.asiae.co.kr/news/view.htm?idxno=2018121109435960295
8360,2018-12-11,급등세보인삼성바이오로직스,http://yna.kr/PYH20181211028700013?did=1196m
8361,2018-12-11,삼성바이오로직스아난티복귀비상청신호로코스피코스닥쌍끌이,http://www.sisunnews.co.kr/news/articleView.html?idxno=94110
8362,2018-12-11,급등세보인삼성바이오로직스,http://yna.kr/PYH20181211028900013?did=1196m
8363,2018-12-11,포토거래재개된삼성바이오로직스급등세,http://www.viva100.com/main/view.php?key=20181211000944082
8364,2018-12-11,삼성바이오로직스거래정지해제이후18대급등세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341177
8365,2018-12-11,이데일리N거래소삼성바이오로직스상장유지오늘거래재개外,http://www.edaily.co.kr/news/newspath.asp?newsid=01813846619437536
8366,2018-12-11,삼성바이오로직스11일거래재개장개장부터20급등,http://medipana.com/news/news_viewer.asp?NewsNum=230981&MainKind=A&NewsKind=5&vCount=12&vKind=1
8367,2018-12-11,삼성바이오로직스거래재개첫날급등불확실성해소”,http://www.sporbiz.co.kr/news/articleView.html?idxno=295678
8368,2018-12-11,삼성바이오로직스거래재개첫날급등세16↑,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3708133
8369,2018-12-11,특징주삼성물산삼성바이오로직스거래재개영향동반강세,http://www.fetv.co.kr/news/article.html?no=17008
8370,2018-12-11,관심주삼성바이오로직스삼성전자SK하이닉스LG화학한국전력강세셀트리온현대차포스코신라젠CJENM약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32789
8371,2018-12-11,결국삼성공화국삼성바이오로직스상장유지,http://www.mhj21.com/sub_read.html?uid=118088§ion=sc243
8372,2018-12-11,삼성바이오로직스거래재개셀트리온회계논란,http://www.kpinews.co.kr/news/articleView.html?idxno=85782
8373,2018-12-11,돌아온삼성바이오로직스거래재개첫날주가급등,http://sports.khan.co.kr/news/sk_index.html?art_id=201812110959003&sec_id=564001&pt=nv
8374,2018-12-11,삼성바이오로직스주식거래재개매우다행회계처리적정성을증명하고사업에도더욱매진,http://www.econonews.co.kr/news/articleView.html?idxno=45444
8375,2018-12-11,핫이슈키워드삼성바이오로직스택시기사분신노벨평화상짐로저스양진호,https://cnbc.sbs.co.kr/article_hub/10000924191?division=NAVER
8376,2018-12-11,삼성바이오로직스거래재개했지만엇갈리는전망,http://www.cstimes.com/?mod=news&act=articleView&idxno=292036
8377,2018-12-11,ET투자뉴스삼성바이오로직스크리스마스보다먼저매수유지한국투자증권,http://www.etnews.com/20181211000048
8378,2018-12-11,삼성바이오로직스거래재개논란앞날은,http://www.straightnews.co.kr/news/articleView.html?idxno=39491
8379,2018-12-11,삼성바이오로직스상장유지결정에네티즌들삼성공화국맞네,http://www.ggilbo.com/news/articleView.html?idxno=572623
8380,2018-12-11,삼성바이오로직스상장유지분식회계혐의벗는시그널,http://news.heraldcorp.com/view.php?ud=20181211000212
8381,2018-12-11,삼성바이오로직스향후주가흐름추이궁금증UP이십육일만에사고파는중분위기엿봤더니,http://www.psnews.co.kr/news/article.html?no=19602
8382,2018-12-11,상폐면한삼성바이오로직스최악면했지만리스크여전,http://www.breaknews.com/620193
8383,2018-12-11,셀트리온헬스케어삼성바이오로직스절차밟나,http://www.ggilbo.com/news/articleView.html?idxno=572632
8384,2018-12-11,외국인이산다삼성바이오로직스17강세종합,http://biz.chosun.com/site/data/html_dir/2018/12/11/2018121101089.html
8385,2018-12-11,삼성바이오로직스경영투명성대폭강화한다,http://www.inews24.com/view/1144900
8386,2018-12-11,상폐위기넘긴삼성바이오로직스거래재개첫날폭등,http://www.dailysmart.co.kr/news/articleView.html?idxno=3474
8387,2018-12-11,삼성바이오로직스종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812110164&t=NN
8388,2018-12-11,삼성바이오로직스상장유지이번에도대마불사논란,http://www.updownnews.co.kr/news/articleView.html?idxno=100395
8389,2018-12-11,삼성바이오로직스상장폐지하라靑국민청원봇물상장유지있을수없는일,http://news20.busan.com/controller/newsController.jsp?newsId=20181211000039
8390,2018-12-11,삼성바이오로직스거래재개에산업계안도,http://www.viva100.com/main/view.php?key=20181211010003540
8391,2018-12-11,삼성바이오로직스거래재개첫날급등세목표주가54만원유지,http://news.donga.com/3/all/20181211/93236403/2
8392,2018-12-11,삼성바이오로직스주가급등셀트리온3총사주가는급락,http://www.businesspost.co.kr/BP?command=article_view&num=105851
8393,2018-12-11,삼성바이오로직스이십육일만에야사고파는중분위기엿봤더니향후주가흐름추이궁금증UP,http://www.ksilbo.co.kr/news/articleView.html?idxno=672731
8394,2018-12-11,ET투자뉴스삼성바이오로직스신속한거래재개로BUY대신증권,http://www.etnews.com/20181211000058
8395,2018-12-11,삼성바이오로직스상장유지주가급등세삼성불패””대마불사,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181211.99099004433
8396,2018-12-11,삼성바이오로직스불확실성해소로급등,http://www.mediasr.co.kr/news/articleView.html?idxno=50333
8397,2018-12-11,ET투자뉴스삼성바이오로직스거래재개로드디어BUYINITIATE키움증권,http://www.etnews.com/20181211000070
8398,2018-12-11,삼성바이오로직스상장유지결정,http://www.wsobi.com/news/articleView.html?idxno=67847
8399,2018-12-11,위기탈출한삼성바이오로직스,http://yna.kr/PYH20181211060800065?did=1196m
8400,2018-12-11,삼성바이오로직스상장유지주식거래재개,http://yna.kr/PYH20181211060200065?did=1196m
8401,2018-12-11,삼성바이오로직스상장유지주식거래재개,http://yna.kr/PYH20181211060100065?did=1196m
8402,2018-12-11,위기탈출한삼성바이오로직스,http://yna.kr/PYH20181211060500065?did=1196m
8403,2018-12-11,삼성바이오로직스상장유지주식거래재개,http://yna.kr/PYH20181211060300065?did=1196m
8404,2018-12-11,위기탈출한삼성바이오로직스,http://yna.kr/PYH20181211060900065?did=1196m
8405,2018-12-11,삼성바이오로직스상장유지주식거래재개,http://yna.kr/PYH20181211060400065?did=1196m
8406,2018-12-11,위기탈출한삼성바이오로직스,http://yna.kr/PYH20181211060600065?did=1196m
8407,2018-12-11,위기탈출한삼성바이오로직스,http://yna.kr/PYH20181211060700065?did=1196m
8408,2018-12-11,특징주삼성바이오로직스거래재개후급등,http://www.finomy.com/news/articleView.html?idxno=61114
8409,2018-12-11,삼성바이오로직스컴백첫날주가급등,http://www.greened.kr/news/articleView.html?idxno=86733
8410,2018-12-11,삼성물산코스피시장서강세보여눈길삼성바이오로직스거래재개영향,http://www.topstarnews.net/news/articleView.html?idxno=543418
8411,2018-12-11,급등세보이는삼성바이오로직스,http://news1.kr/photos/view/?3426802
8412,2018-12-11,삼성바이오로직스거래재개장초반급등,http://news1.kr/photos/view/?3426806
8413,2018-12-11,삼성바이오로직스거래재개장초반급등,http://news1.kr/photos/view/?3426805
8414,2018-12-11,거래재개된삼성바이오로직스급등출발,http://news1.kr/photos/view/?3426808
8415,2018-12-11,삼성바이오로직스거래재개와함께급등세,http://news1.kr/photos/view/?3426804
8416,2018-12-11,삼성바이오로직스거래재개다행회계처리적정성증명할것,http://www.newsworks.co.kr/news/articleView.html?idxno=318079
8417,2018-12-11,뉴스pick거래소가삼성바이오로직스상장유지결정한이유,https://news.sbs.co.kr/news/endPage.do?news_id=N1005052618&plink=ORI&cooper=NAVER
8418,2018-12-11,삼성바이오로직스주식거래재개법과상식뛰어넘는일,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=1&seq_800=10315384
8419,2018-12-11,쿠키영상삼성바이오로직스상장유지거래재개첫날급등셀트리온헬스케어회계감리소식에급락삼성바이오분식회계물타기,http://www.kukinews.com/news/article.html?no=612047
8420,2018-12-11,삼성바이오로직스산넘어산행정소송등과제남아,http://www.kpinews.co.kr/news/articleView.html?idxno=85791
8421,2018-12-11,삼성바이오로직스상장유지효과제약바이오株살아날까,http://www.econonews.co.kr/news/articleView.html?idxno=45488
8422,2018-12-11,﻿삼성바이오로직스상승vs셀트리온헬스케어분식의혹감소세,http://medicalworldnews.co.kr/news/view.php?idx=1510928669
8423,2018-12-11,삼성바이오로직스거래재개후급등,http://www.obsnews.co.kr/news/articleView.html?idxno=1130103
8424,2018-12-11,삼성바이오로직스상장유지거래첫날주가급등시가총액4위,http://www.gokorea.kr/news/articleView.html?idxno=60982
8425,2018-12-11,바이오株희비삼성바이오로직스거래재개급등분식회계의혹셀트리온헬스케어급락,http://www.ajunews.com/view/20181211130200332
8426,2018-12-11,삼성바이오로직스일단상방향여부는변수많아미지수존재,http://www.ccdn.co.kr/news/articleView.html?idxno=554042
8427,2018-12-11,삼성바이오로직스일단상방향지속적여부가변수많아여전히미지수,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=781951
8428,2018-12-11,특징주삼성바이오로직스거래재개첫날급등한때42만원까지주가치솟아전문가들매수의견,http://www.joongboo.com/news/articleView.html?idxno=1310307
8429,2018-12-11,삼성바이오로직스겨누던금감원이번엔셀트리온바람잘날없는바이오시장,http://ilyo.co.kr/?ac=article_view&entry_id=319075
8430,2018-12-11,화려한복귀삼성바이오로직스주가급등증권가전망好好,http://www.viva100.com/main/view.php?key=20181211010003686
8431,2018-12-11,삼성바이오로직스셀트리온희비여전히엇갈려삼성바이오로직스급등셀트리온급락,http://www.econonews.co.kr/news/articleView.html?idxno=45507
8432,2018-12-11,why상장폐지위기넘긴삼성바이오로직스남은쟁점은,https://cnbc.sbs.co.kr/article_hub/10000924227?division=NAVER
8433,2018-12-11,삼성바이오로직스웃고셀트리온울고같은회계분식주제로희비엇갈려,https://news.imaeil.com/Economy/2018121113562732798
8434,2018-12-11,거래재개삼성바이오로직스급등분식회계의혹감리착수셀트리온헬스케어급락,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20181211.990011356361831
8435,2018-12-11,기업분석삼성바이오로직스우선은투자심리회복기대,http://www.ekn.kr/news/article.html?no=402903
8436,2018-12-11,삼성바이오로직스거래재개후주가훨훨CMO사업규모는,http://www.sporbiz.co.kr/news/articleView.html?idxno=295774
8437,2018-12-11,거래재개삼성바이오로직스투자심리개선에급등주가전망은,http://www.sporbiz.co.kr/news/articleView.html?idxno=295776
8438,2018-12-11,고비넘긴삼성바이오로직스글로벌CMO사업등차질없이진행,http://www.etnews.com/20181211000223
8439,2018-12-11,삼성바이오로직스상장유지검찰수사면죄부되기엔역부족,http://www.sisajournal-e.com/biz/article/192675
8440,2018-12-11,삼성바이오로직스일단상방향지속적여부가변수많아여전히미지수수주해소돼,http://www.idjnews.kr/news/articleView.html?idxno=43542
8441,2018-12-11,희비엇갈린삼성바이오로직스셀트리온3형제,http://www.fntimes.com/html/view.php?ud=20181211144113369f09e13944d_18
8442,2018-12-11,삼성바이오로직스상장유지에주식거래재개내부통제강화키로,http://www.newscj.com/news/articleView.html?idxno=581437
8443,2018-12-11,삼성바이오로직스거래재개시민사회단체전형적인삼성봐주기,http://www.seoulwire.com/news/articleView.html?idxno=38922
8444,2018-12-11,삼성바이오로직스향후주가흐름추이궁금증UP분위기엿봤더니무려이십육일만에사고파는중,http://www.economytalk.kr/news/articleView.html?idxno=175244
8445,2018-12-11,삼성바이오로직스이어셀트리온헬스케어쇼크호재악재뒤섞인바이오株,http://www.fntimes.com/html/view.php?ud=201812111516243656f09e13944d_18
8446,2018-12-11,fnRASSI장마감거래소상승종목삼성바이오로직스1779↑,http://www.fnnews.com/news/201812111546479846
8447,2018-12-11,거래재개된삼성바이오로직스1779상승마감,http://www.fnnews.com/news/201812111559049708
8448,2018-12-11,특징주삼성물산삼성바이오로직스거래재개에전일대비335상승마감,http://www.greened.kr/news/articleView.html?idxno=86785
8449,2018-12-11,삼성바이오로직스거래재개첫날1779폭등한39만4000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=572871
8450,2018-12-11,삼성바이오로직스거래재개첫날급등상한가근접종합,http://www.fntimes.com/html/view.php?ud=2018121116031788351d6f57e61a_18
8451,2018-12-11,거래재개된삼성바이오로직스급등,http://yna.kr/PYH20181211161600013?did=1196m
8452,2018-12-11,거래재개된삼성바이오로직스급등,http://yna.kr/PYH20181211161700013?did=1196m
8453,2018-12-11,거래재개된삼성바이오로직스급등,http://yna.kr/PYH20181211161800013?did=1196m
8454,2018-12-11,거래재개된삼성바이오로직스39만4천원거래,http://yna.kr/PYH20181211163800013?did=1196m
8455,2018-12-11,거래재개된삼성바이오로직스39만4천원거래,http://yna.kr/PYH20181211163700013?did=1196m
8456,2018-12-11,삼성바이오로직스이어셀트리온헬스케어감리착수회계처리기준위반의혹,http://www.gokorea.kr/news/articleView.html?idxno=61070
8457,2018-12-11,삼성바이오로직스거래재개후폭등,http://www.etnews.com/20181211000303
8458,2018-12-11,관심주삼성바이오로직스삼성전자LG화학현대차SK텔레콤한국전력상승SK하이닉스셀트리온포스코신라젠에이치엘비하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32806
8459,2018-12-11,삼성바이오로직스주식거래첫날178급등시총8위→4위↑,http://www.kyeongin.com/main/view.php?key=20181211010003625
8460,2018-12-11,셀트리온도분식회계삼성바이오로직스밀어주기의혹,http://www.mhj21.com/sub_read.html?uid=118109§ion=sc243
8461,2018-12-11,삼성바이오로직스화려한컴백주가급등에시총4위껑충,http://www.g-enews.com/ko-kr/news/article/news_all/201812111631455098c642673384_1/article.html
8462,2018-12-11,SR경제라이프거래재개삼성바이오로직스주가급등금감원감리셀트리온주가는급락,http://www.srtimes.kr/news/articleView.html?idxno=29144
8463,2018-12-11,코스피외인매도2050대삼성바이오로직스급등시총4위,http://www.seoulwire.com/news/articleView.html?idxno=38939
8464,2018-12-11,삼성바이오로직스상장폐지위기넘겨불확실성해소했지만남은과제해결해야,http://www.nextdaily.co.kr/news/article.html?id=20181211800038
8465,2018-12-11,삼성바이오로직스상장폐지왜면했을까,http://www.sporbiz.co.kr/news/articleView.html?idxno=295811
8466,2018-12-11,삼성바이오로직스와투자자입은손해정부가보상할것인가,http://www.techholic.co.kr/news/articleView.html?idxno=179619
8467,2018-12-11,경실련삼성바이오로직스상장유지로대마불사또보여줘,http://www.businesspost.co.kr/BP?command=article_view&num=105938
8468,2018-12-11,삼성바이오로직스상장유지불확실성해소돼긍정적매수의견제시,http://www.econonews.co.kr/news/articleView.html?idxno=45593
8469,2018-12-11,삼성바이오로직스거래재개후주식가격급등,http://www.joongboo.com/news/articleView.html?idxno=1310459
8470,2018-12-11,삼성바이오로직스상장유지주식거래풀리자폭등,http://www.dailypop.kr/news/articleView.html?idxno=36766
8471,2018-12-11,KB증권삼성바이오로직스장기적성장성에주목목표주가52만원유지,http://www.sisafocus.co.kr/news/articleView.html?idxno=198185
8472,2018-12-11,논평정의로운나라의기준이삼성바이오로직스의회계부정에대한면죄부인가,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=123&oid=594&aid=0000001065
8473,2018-12-11,기자수첩삼성바이오로직스에한숨돌린바이오업계이번엔셀트리온,http://www.sisajournal-e.com/biz/article/192701
8474,2018-12-11,포토뉴스삼성바이오로직스거래재개개장첫날급등하며장마감,http://www.kidd.co.kr/news/206187
8475,2018-12-11,한국거래소불법분식회계삼성바이오로직스에면죄부,http://www.isisa.net/news/articleView.html?idxno=112512
8476,2018-12-11,거래재개삼성바이오로직스향후투자포인트세가지,http://www.sisajournal-e.com/biz/article/192684
8477,2018-12-11,삼성바이오로직스상장유지결정으로주식거래재개,http://www.betanews.net:8080/article/946981.html
8478,2018-12-11,삼성바이오로직스주가거래재개첫날급등셀트리온3총사는급락,http://www.businesspost.co.kr/BP?command=article_view&num=105969
8479,2018-12-11,삼성바이오로직스상장폐지급한불껐지만檢고발등당면과제산넘어산,http://news20.busan.com/controller/newsController.jsp?newsId=20181211000317
8480,2018-12-11,돌아온삼성바이오로직스,http://www.jjn.co.kr/news/articleView.html?idxno=761429
8481,2018-12-12,삼성바이오로직스화려한복귀식상승세이어질까,http://www.sporbiz.co.kr/news/articleView.html?idxno=295816
8482,2018-12-12,최악면한삼성바이오로직스전화위복열쇠는신뢰회복,http://www.ajunews.com/view/20181211135728387
8483,2018-12-12,삼성바이오로직스상장유지섣부른판단거래소비판목소리,http://www.newstomato.com/ReadNews.aspx?no=863518
8484,2018-12-12,삼성바이오로직스호재덮친셀트리온악재,http://www.newstomato.com/ReadNews.aspx?no=863564
8485,2018-12-12,삼성바이오로직스거래로배당차익거래활성화기대NH,http://news.hankyung.com/article/2018121280526
8486,2018-12-12,화려하게복귀한삼성바이오로직스거래재개첫날주가큰폭상승,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063390
8487,2018-12-12,삼성바이오로직스거래재개배당차익거래활성화기대NH,http://www.fnnews.com/news/201812120801314877
8488,2018-12-12,삼성물산삼성바이오로직스불확실성해소투자의견매수교보證,http://www.fntimes.com/html/view.php?ud=20181212081325453f09e13944d_18
8489,2018-12-12,삼성물산삼성바이오로직스상장유지에불확실성제거교보,http://www.ebn.co.kr/news/view/964985
8490,2018-12-12,NH투자증권삼성바이오로직스배당차익거래활성화기대”,http://www.newsway.co.kr/news/view?tp=1&ud=2018121208462444927
8491,2018-12-12,투자코멘트실시간종목순위0840삼성바이오로직스아난티셀트리온,http://www.fntimes.com/html/view.php?ud=2018121208505944045dfa8fb997_18
8492,2018-12-12,삼성바이오로직스500원013오른394500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812120076&t=NN
8493,2018-12-12,삼성바이오로직스거래재개배당향차익거래활성화기대”NH투자證,http://www.fntimes.com/html/view.php?ud=201812120850143480f09e13944d_18
8494,2018-12-12,삼성바이오로직스셀트리온흐름뒤바뀌어삼성바이오로직스하락셀트리온상승,http://www.econonews.co.kr/news/articleView.html?idxno=45626
8495,2018-12-12,특징주삼성바이오로직스거래재개효과지속되나외인팔자공세에주가주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201812120904255719c642673384_1/article.html
8496,2018-12-12,특징주삼성바이오로직스거래재개하루만에약세전환,http://view.asiae.co.kr/news/view.htm?idxno=2018121209135657001
8497,2018-12-12,특징주삼성바이오로직스거래재개이튿날하락반전,http://www.viva100.com/main/view.php?key=20181212010003971
8498,2018-12-12,특징주삼성바이오로직스외국인매도공세에약세,http://www.inews24.com/view/1145108
8499,2018-12-12,특징주삼성바이오로직스거래재개하루만에약세,http://moneys.mt.co.kr/news/mwView.php?no=2018121209248028134
8500,2018-12-12,특징주삼성바이오로직스거래재개하루만에약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1698618
8501,2018-12-12,HotLine삼성바이오로직스거래재개이후급등피로감에하락,http://news.mk.co.kr/newsRead.php?year=2018&no=774503
8502,2018-12-12,특징주삼성바이오로직스거래재개이튿날약세전환,http://www.seoulfn.com/news/articleView.html?idxno=327714
8503,2018-12-12,특징주삼성바이오로직스약세전환,http://www.sentv.co.kr/news/view/546649
8504,2018-12-12,특징주삼성바이오로직스거래재개하루만에약세,http://www.newsis.com/view/?id=NISX20181212_0000500063&cID=10401&pID=10400
8505,2018-12-12,특징주삼성바이오로직스거래재개하루만에약세,http://www.fetv.co.kr/news/article.html?no=17087
8506,2018-12-12,삼성물산주식저가매수매력적삼성바이오로직스불확실성해소,http://www.businesspost.co.kr/BP?command=article_view&num=105994
8507,2018-12-12,특징주삼성바이오로직스너무많이올랐나하루만에약세,http://www.sporbiz.co.kr/news/articleView.html?idxno=296001
8508,2018-12-12,삼성바이오로직스거래재개급등에이어하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341313
8509,2018-12-12,관심주삼성전자SK하이닉스셀트리온현대차LG화학포스코강세삼성바이오로직스SK텔레콤한국전력약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32815
8510,2018-12-12,삼성바이오로직스거래재개이튿날하락반전거래소삼성봐주기비판도,http://www.kpinews.co.kr/news/articleView.html?idxno=85828
8511,2018-12-12,상장재개후롤러코스터삼성바이오로직스주가,http://www.dailymedi.com/detail.php?number=837997&thread=22r05
8512,2018-12-12,박용진삼성바이오로직스상장유지로경제에더큰부담안겨”,http://www.businesspost.co.kr/BP?command=article_view&num=106026
8513,2018-12-12,삼성바이오로직스거래재개첫날급등후유증둘째날12일주가하락세반전,https://news.imaeil.com/Politics/2018121213454969010
8514,2018-12-12,삼성바이오로직스셀트리온모두소폭상승삼성바이오로직스장내내하락서강보합,http://www.econonews.co.kr/news/articleView.html?idxno=45704
8515,2018-12-12,교보증권삼성물산삼성바이오로직스상장유지로불확실성제거,http://www.econonews.co.kr/news/articleView.html?idxno=45714
8516,2018-12-12,삼성바이오로직스013오른39만4500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=573344
8517,2018-12-12,박용진의원삼성바이오로직스상장유지에대마불사경제에더큰부담,http://www.sisafocus.co.kr/news/articleView.html?idxno=198282
8518,2018-12-12,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학포스코네이버상승SK텔레콤한국전력하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32832
8519,2018-12-12,삼성바이오로직스사태로살펴본금융당국의기업흔들기,http://www.news2day.co.kr/116569
8520,2018-12-12,코스피외국인순매도삼성전자삼성바이오로직스신한지주,http://www.newsway.co.kr/news/view?tp=1&ud=2018121217053629131
8521,2018-12-12,셀트리온3총사주가반등삼성바이오로직스도약간올라,http://www.businesspost.co.kr/BP?command=article_view&num=106119
8522,2018-12-13,퀵리포트삼성바이오로직스매수목표가46만원신규제시NH證,http://www.itooza.com/common/iview.php?no=2018121307332419321
8523,2018-12-13,삼성바이오로직스CMO부문만고려해도2020년까지고성장매수NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1699097
8524,2018-12-13,분식회계논란겪은삼성바이오로직스시총비중늘어,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063411
8525,2018-12-13,I리포트삼성바이오로직스회계이슈해소로상승기대NH證,http://www.inews24.com/view/1145312
8526,2018-12-13,삼성바이오로직스위탁생산만으로도고성장가능,http://www.asiatoday.co.kr/view.php?key=20181213010008048
8527,2018-12-13,삼성바이오로직스목표가46만원신규제시전일종가39만4500원NH證,http://www.newspim.com/news/view/20181213000051
8528,2018-12-13,HotLine삼성바이오로직스CMO만으로도2020년까지고성장,http://news.mk.co.kr/newsRead.php?year=2018&no=777209
8529,2018-12-13,삼성바이오로직스2020년까지고성장가능NH,http://news.hankyung.com/article/2018121323866
8530,2018-12-13,삼성바이오로직스주가오른다상장폐지벗어나신규수주기대,http://www.businesspost.co.kr/BP?command=article_view&num=106155
8531,2018-12-13,삼성바이오로직스종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812120149&t=NN
8532,2018-12-13,삼성바이오로직스CMO시장지위독보적예상시총30조NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01554726619438192
8533,2018-12-13,삼성바이오로직스내년3공장가동으로론자제칠것”NH투자증권,http://www.fnnews.com/news/201812130845259895
8534,2018-12-13,NH투자삼성바이오로직스2020년까지고성장전망,http://yna.kr/AKR20181213030700008?did=1195m
8535,2018-12-13,투자코멘트실시간종목순위0840삼성바이오로직스삼성전자남선알미늄,http://www.fntimes.com/html/view.php?ud=2018121308505928895dfa8b4c62_18
8536,2018-12-13,삼성바이오로직스4500원114오른399000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812130076&t=NN
8537,2018-12-13,하이로우삼성바이오로직스펀더멘털우상향지속목표가46만원NH證,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121308221796825
8538,2018-12-13,삼성바이오로직스고성장기대감사흘째상승,http://news.hankyung.com/article/2018121326146
8539,2018-12-13,삼성바이오로직스셀트리온흐름반대삼성바이오로직스40만원재돌파,http://www.econonews.co.kr/news/articleView.html?idxno=45758
8540,2018-12-13,특징주삼성바이오로직스주가40만원시대다시열렸다외인은공방,http://www.g-enews.com/ko-kr/news/article/news_all/201812130908387356c642673384_1/article.html
8541,2018-12-13,특징주삼성바이오로직스3거래일연속상승40만원대회복,http://www.etoday.co.kr/news/section/newsview.php?idxno=1699169
8542,2018-12-13,삼성바이오로직스바이오업종최선호주NH투자증권,http://www.ekn.kr/news/article.html?no=403313
8543,2018-12-13,특징주삼성바이오로직스거래재개후3거래일연속강세,http://www.newsis.com/view/?id=NISX20181213_0000501333&cID=10401&pID=10400
8544,2018-12-13,특징주삼성바이오로직스40만원선회복3거래일연속강세,http://www.fetv.co.kr/news/article.html?no=17152
8545,2018-12-13,삼성바이오로직스2023년영업가치21조원,http://www.metroseoul.co.kr/news/newsview?newscd=2018121300014
8546,2018-12-13,특징주삼성바이오로직스거래재개3일째상승40만원대회복,http://moneys.mt.co.kr/news/mwView.php?no=2018121309208038404
8547,2018-12-13,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812130134&t=NN
8548,2018-12-13,NH투자증권삼성바이오로직스2020년까지고성장주목,http://www.sisafocus.co.kr/news/articleView.html?idxno=198314
8549,2018-12-13,한경로보뉴스삼성바이오로직스5이상상승거래재개로드디어불확실성해소키움증권BUYInitiate,http://news.hankyung.com/article/201812133041L
8550,2018-12-13,삼성바이오로직스당분간고성장전망에3일째강세,http://www.sedaily.com/NewsView/1S8G5N7UJ2
8551,2018-12-13,특징주삼성바이오로직스사흘째↑내년성장기대,http://www.inews24.com/view/1145389
8552,2018-12-13,관심주삼성전자삼성바이오로직스LG화학포스코한국전력삼성물산강세SK하이닉스셀트리온현대차SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32841
8553,2018-12-13,특징주삼성바이오로직스3일연속상승파죽지세장중한때시총3위,http://www.viva100.com/main/view.php?key=20181213010004483
8554,2018-12-13,특징주삼성바이오로직스고성장전망에40만원대회복,http://www.asiatoday.co.kr/view.php?key=20181213010008352
8555,2018-12-13,실시간분석삼성바이오로직스5상승증권사목표가46만원제시,http://www.itooza.com/common/iview.php?no=2018121310454269015
8556,2018-12-13,삼성바이오로직스3거래일연속상승40만원선회복,http://www.mdtoday.co.kr/mdtoday/index.html?no=341454
8557,2018-12-13,특징주삼성바이오로직스신규수주기대에5대급등장중시총3위,http://www.sporbiz.co.kr/news/articleView.html?idxno=296347
8558,2018-12-13,코스피미중무역전쟁완화기대감에오름세삼성전자삼성바이오로직스LG화학포스코한국전력삼성물산등상승,http://www.econonews.co.kr/news/articleView.html?idxno=45805
8559,2018-12-13,NH투자증권삼성바이오로직스펀더멘털우상향지속2020년까지고성장”,http://www.viva100.com/main/view.php?key=20181213010004429
8560,2018-12-13,삼성바이오로직스15500원393오른410000원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812130396&t=NN
8561,2018-12-13,삼성바이오로직스393오른41만원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=573820
8562,2018-12-13,1보검찰삼성바이오로직스본사압수수색,http://www.sedaily.com/NewsView/1S8G7A6TZC
8563,2018-12-13,속보검찰분식회계삼성바이오로직스압수수색,http://www.newsis.com/view/?id=NISX20181213_0000502060&cID=10201&pID=10200
8564,2018-12-13,1보검찰삼성바이오로직스본사회계법인등압수수색,http://www.newspim.com/news/view/20181213000594
8565,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색1보,http://yna.kr/AKR20181213134900004?did=1195m
8566,2018-12-13,검찰분식회계삼성바이오로직스본사등압수수색속보,http://www.asiatoday.co.kr/view.php?key=20181213010008734
8567,2018-12-13,속보검찰삼성바이오로직스본사압수수색,https://www.ytn.co.kr/_ln/0103_201812131627215880
8568,2018-12-13,속보검찰분식회계삼성바이오로직스압수수색,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201812131626001&code=940301
8569,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://www.joongboo.com/news/articleView.html?idxno=1311177
8570,2018-12-13,속보장마감후검찰삼성바이오로직스압수수색분식회계관련,https://news.imaeil.com/Finance/2018121316273579240
8571,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://www.viva100.com/main/view.php?key=20181213010004770
8572,2018-12-13,검찰분식회계혐의삼성바이오로직스회계법인압수수색속보,http://www.edaily.co.kr/news/newspath.asp?newsid=03463686619438192
8573,2018-12-13,속보검찰삼성바이오로직스압수수색,http://www.newsworker.co.kr/news/articleView.html?idxno=24110
8574,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://sports.khan.co.kr/news/sk_index.html?art_id=201812131627003&sec_id=560901&pt=nv
8575,2018-12-13,속보검찰분식회계의혹삼성바이오로직스회계법인압수수색,http://news.chosun.com/site/data/html_dir/2018/12/13/2018121302403.html?utm_source=naver&utm_medium=original&utm_campaign=news
8576,2018-12-13,속보검찰분식회계고발관련삼성바이오로직스본사압수수색관련회계법인도포함,https://www.ytn.co.kr/_ln/0133_201812131630028836
8577,2018-12-13,속보검찰삼성바이오로직스본사등압수수색,http://www.ekn.kr/news/article.html?no=403530
8578,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://www.newsway.co.kr/news/view?tp=1&ud=2018121316274217189
8579,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색1보,http://news.mk.co.kr/newsRead.php?year=2018&no=779020
8580,2018-12-13,속보검찰삼성바이오로직스압수수색,http://view.asiae.co.kr/news/view.htm?idxno=2018121316303247018
8581,2018-12-13,속보검찰삼성바이오로직스본사압수수색,http://www.mediapen.com/news/view/401771
8582,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://news20.busan.com/controller/newsController.jsp?newsId=20181213000183
8583,2018-12-13,관심주삼성바이오로직스포스코삼성물산LG화학현대차한국전력상승삼성전자SK하이닉스셀트리온SK텔레콤하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32854
8584,2018-12-13,검찰인천송도삼성바이오로직스본사압수수색1보,http://biz.chosun.com/site/data/html_dir/2018/12/13/2018121302407.html
8585,2018-12-13,검찰분식회계삼성바이오로직스본사압수수색속보,http://moneys.mt.co.kr/news/mwView.php?no=2018121316278089979
8586,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://www.kyeonggi.com/news/articleView.html?idxno=2017933
8587,2018-12-13,속보검찰삼성바이오로직스본사회계법인압수수색,http://www.kukinews.com/news/article.html?no=612968
8588,2018-12-13,반등세찬물검찰13일오후삼성바이오로직스압수수색14일주가영향은,https://news.imaeil.com/Finance/2018121316362431307
8589,2018-12-13,1보검찰삼성바이오로직스본사회계법인압수수색,http://www.polinews.co.kr/news/article.html?no=374967
8590,2018-12-13,검찰삼성바이오로직스본사압수수색1보,http://it.chosun.com/site/data/html_dir/2018/12/13/2018121302436.html
8591,2018-12-13,검찰분식회계삼성바이오로직스삼성물산압수수색,http://www.queen.co.kr/news/articleView.html?idxno=306053
8592,2018-12-13,검찰삼성바이오로직스압수수색,http://imnews.imbc.com/news/2018/society/article/5065382_22673.html
8593,2018-12-13,검찰분식회계의혹삼성바이오로직스압수수색2보,http://view.asiae.co.kr/news/view.htm?idxno=2018121316421704945
8594,2018-12-13,검찰분식회계삼성바이오로직스본사회계법인압수수색,http://news20.busan.com/controller/newsController.jsp?newsId=20181213000186
8595,2018-12-13,속보검찰삼성바이오로직스상대로압수수색,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121316411191562
8596,2018-12-13,검찰고의분식회계삼성물산삼성바이오로직스압수수색주가고공행진멈추려나,http://www.anewsa.com/detail.php?number=1443718&thread=09r02
8597,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색1보,http://www.seoulwire.com/news/articleView.html?idxno=39423
8598,2018-12-13,검찰고의분식회계삼성바이오로직스회계법인압수수색,http://www.newspim.com/news/view/20181213000624
8599,2018-12-13,검찰분식회계삼성바이오로직스본사등압수수색,http://www.asiatoday.co.kr/view.php?key=20181213010008753
8600,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색,https://www.ytn.co.kr/_ln/0103_201812131648534215
8601,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색,https://www.ytn.co.kr/_ln/0103_201812131648534215
8602,2018-12-13,검찰고의분식회계의혹삼성바이오로직스삼성물산본사압수수색,http://www.etoday.co.kr/news/section/newsview.php?idxno=1699523
8603,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색,http://news.donga.com/3/all/20181213/93279549/2
8604,2018-12-13,속보검찰삼성바이오로직스전격압수수색,http://kormedi.com/?p=1258572
8605,2018-12-13,검찰분식회계혐의삼성바이오로직스본격수사착수,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=3710567
8606,2018-12-13,검찰분식회계논란삼성바이오로직스압수수색,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063452
8607,2018-12-13,검찰분식회계삼성바이오로직스본사압수수색,http://www.dailypharm.com/Users/News/NewsView.html?ID=247543&REFERER=NP
8608,2018-12-13,檢삼성바이오로직스본사압수수색관련회계법인포함,http://www.newscj.com/news/articleView.html?idxno=582158
8609,2018-12-13,검찰삼성바이오로직스본사압수수색,http://www.inews24.com/view/1145497
8610,2018-12-13,검찰분식회계의혹삼성바이오로직스본사등압수수색,http://www.weeklytoday.com/news/articleView.html?idxno=70318
8611,2018-12-13,검찰삼성바이오로직스본사압수수색,http://www.mhj21.com/sub_read.html?uid=118165§ion=sc243
8612,2018-12-13,검찰삼성바이오로직스본사압수수색,http://www.cstimes.com/?mod=news&act=articleView&idxno=292311
8613,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색,http://medipana.com/news/news_viewer.asp?NewsNum=231142&MainKind=A&NewsKind=5&vCount=12&vKind=1
8614,2018-12-13,검찰삼성바이오로직스압수수색분식회계본격수사,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003428675
8615,2018-12-13,檢분식회계관련삼성바이오로직스전격압수수색,http://www.nocutnews.co.kr/news/5075695
8616,2018-12-13,검찰고의분식회계의혹삼성바이오로직스압수수색,http://www.newstomato.com/ReadNews.aspx?no=864098
8617,2018-12-13,검찰삼성바이오로직스압수수색고의분식회계수사급물살,http://news.bbsi.co.kr/news/articleView.html?idxno=912840
8618,2018-12-13,검찰삼성바이오로직스압수수색증선위고발건후속조치,http://moneys.mt.co.kr/news/mwView.php?no=2018121316548013331
8619,2018-12-13,삼성바이오로직스의끝나지않은롤러코스터검찰삼바삼성물산압수수색,http://ilyo.co.kr/?ac=article_view&entry_id=319374
8620,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색,http://daily.hankooki.com/lpage/economy/201812/dh20181213170242138060.htm
8621,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색,http://imnews.imbc.com/replay/2018/nw1700/article/5065442_23836.html
8622,2018-12-13,검찰삼성바이오로직스본사압수수색,http://www.zdnet.co.kr/ArticleView.asp?artice_id=20181213165009
8623,2018-12-13,검찰분식회계삼성바이오로직스압수수색,http://news.heraldcorp.com/view.php?ud=20181213000797
8624,2018-12-13,검찰삼성바이오로직스압수수색,http://www.asiatime.co.kr/news/articleView.html?idxno=217506
8625,2018-12-13,고의분식회계외혹삼성바이오로직스압수수색,http://news1.kr/photos/view/?3431256
8626,2018-12-13,검찰분식회계의혹삼성바이오로직스본사회계법인압수수색,http://www.fetv.co.kr/news/article.html?no=17205
8627,2018-12-13,검찰삼성바이오로직스압수수색분식회계수사속도,http://www.newsway.co.kr/news/view?tp=1&ud=2018121317161125803
8628,2018-12-13,검찰삼성바이오로직스압수수색수사본격화,http://www.kpinews.co.kr/news/articleView.html?idxno=85971
8629,2018-12-13,고의분식회계의혹삼성바이오로직스압수수색,http://www.hankookilbo.com/news/npath/201812131716340507?did=NA
8630,2018-12-13,검찰삼성바이오로직스본사와회계법인에압수수색,https://cnbc.sbs.co.kr/article_hub/10000924554?division=NAVER
8631,2018-12-13,검찰삼성바이오로직스본사회계법인4곳등압수수색,http://www.hani.co.kr/arti/society/society_general/874322.html
8632,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색,http://www.dailian.co.kr/news/view/758781/?sc=naver
8633,2018-12-13,삼성바이오로직스압수수색증선위고발분식회계의혹본격수사,http://www.g-enews.com/ko-kr/news/article/news_all/20181213173829609c642673384_1/article.html
8634,2018-12-13,검찰삼성바이오로직스분식회계수사본격화삼성물산합병이재용승계연관성규명주목,http://www.4th.kr/news/articleView.html?idxno=7326
8635,2018-12-13,검찰분식회계삼성바이오로직스본사등압수수색종합,http://www.asiatoday.co.kr/view.php?key=20181213010008793
8636,2018-12-13,검찰삼성바이오로직스압수수색고의분식회계의혹수사본격화,http://www.sisajournal-e.com/biz/article/192808
8637,2018-12-13,檢분식회계의혹삼성바이오로직스삼성물산압수수색종합,http://www.nocutnews.co.kr/news/5075802
8638,2018-12-13,종합검찰분식회계의혹삼성바이오로직스삼성물산압수수색삼정안진회계법인도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1699561
8639,2018-12-13,검찰삼성바이오로직스압수수색분식회계혐의수사착수,http://www.newsworks.co.kr/news/articleView.html?idxno=319066
8640,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색종합,http://www.seoulwire.com/news/articleView.html?idxno=39435
8641,2018-12-13,검찰분식회계의혹삼성바이오로직스압수수색,http://www.ebn.co.kr/news/view/965318
8642,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색,http://news.mk.co.kr/newsRead.php?year=2018&no=779447
8643,2018-12-13,분식회계의혹검찰삼성바이오로직스압수수색,http://yna.kr/PYH20181213201700065?did=1196m
8644,2018-12-13,분식회계의혹검찰삼성바이오로직스압수수색,http://yna.kr/PYH20181213201900065?did=1196m
8645,2018-12-13,분식회계의혹검찰삼성바이오로직스압수수색,http://yna.kr/PYH20181213202000065?did=1196m
8646,2018-12-13,분식회계의혹검찰삼성바이오로직스압수수색,http://yna.kr/PYH20181213201800065?did=1196m
8647,2018-12-13,검찰삼성바이오로직스본사압수수색,http://news1.kr/photos/view/?3431369
8648,2018-12-13,삼성바이오로직스본사압수수색,http://news1.kr/photos/view/?3431370
8649,2018-12-13,삼성바이오로직스본사압수수색,http://news1.kr/photos/view/?3431367
8650,2018-12-13,검찰삼성바이오로직스압수수색,http://news1.kr/photos/view/?3431368
8651,2018-12-13,검찰삼성바이오로직스삼성물산압수수색합병승계이슈연관성추적할듯,http://www.joongboo.com/news/articleView.html?idxno=1311298
8652,2018-12-13,검찰분식회계혐의삼성바이오로직스압수수색,http://www.etnews.com/20181213000360
8653,2018-12-13,검찰분식회계삼성바이오로직스압수수색수사본격화,http://news.kbs.co.kr/news/view.do?ncd=4094597&ref=A
8654,2018-12-13,검찰회계기준위반혐의삼성바이오로직스회계법인압수수색,http://www.econovill.com/news/articleView.html?idxno=352650
8655,2018-12-13,검찰고의분식회계의혹삼바본사압수수색불꺼진삼성바이오로직스,http://news1.kr/photos/view/?3431388
8656,2018-12-13,셀트리온3총사주가모두떨어져삼성바이오로직스는급등,http://www.businesspost.co.kr/BP?command=article_view&num=106313
8657,2018-12-13,검찰삼성바이오로직스본사회계법인압수수색,http://www.sentv.co.kr/news/view/546733
8658,2018-12-13,검찰분식회계수사위해삼성바이오로직스삼성물산압수수색,http://www.businesspost.co.kr/BP?command=article_view&num=106297
8659,2018-12-13,검찰삼성바이오로직스압수수색회계법인4곳삼성바이오에피스등도,http://www.ajunews.com/view/20181213194655718
8660,2018-12-13,검찰삼성바이오로직스본사및회계법인압수수색,http://it.chosun.com/site/data/html_dir/2018/12/13/2018121303218.html
8661,2018-12-13,검찰삼성바이오로직스분식회계수사본격화,http://www.yonhapnewstv.co.kr/MYH20181213017100038/?did=1825m
8662,2018-12-13,분식회계삼성바이오로직스압수수색,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201812132134025&code=940301
8663,2018-12-13,셀트리온삼성바이오로직스바이오대장주경쟁치열,http://www.mdtoday.co.kr/mdtoday/index.html?no=341556
8664,2018-12-13,삼성바이오로직스검찰압수수색소식에시간외거래서하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341560
8665,2018-12-13,코스피062오른2095에마감삼성바이오로직스LG화학포스코도↑,http://www.topstarnews.net/news/articleView.html?idxno=545852
8666,2018-12-13,오늘밤김제동최경영기자삼성바이오로직스삼바거래재개김용범금융위부위원장이한국거래소에가이드라인준듯,http://www.topstarnews.net/news/articleView.html?idxno=545858
8667,2018-12-13,오늘밤김제동삼성바이오로직스삼바거래재개결정한한국거래소김앤장변호사가포함,http://www.topstarnews.net/news/articleView.html?idxno=545859
8668,2018-12-14,삼성바이오로직스본사등압수수색,http://news.chosun.com/site/data/html_dir/2018/12/14/2018121400201.html?utm_source=naver&utm_medium=original&utm_campaign=news
8669,2018-12-14,증권가이모저모삼성바이오로직스주주의지난7개월,http://news.einfomax.co.kr/news/articleView.html?idxno=4007407
8670,2018-12-14,김어준의뉴스공장김용범금융위부위원장삼성바이오로직스삼바거래재개가이드라인줬나,http://www.topstarnews.net/news/articleView.html?idxno=545955
8671,2018-12-14,선임기자의시선삼성바이오로직스상장유지검찰은압수수색,http://news.bbsi.co.kr/news/articleView.html?idxno=912878
8672,2018-12-14,투자코멘트실시간종목순위0840삼성바이오로직스삼성전자대아티아이,http://www.fntimes.com/html/view.php?ud=2018121408505938995dfa8a8c51_18
8673,2018-12-14,삼성바이오로직스16000원39내린394000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812140087&t=NN
8674,2018-12-14,삼성바이오로직스삼성물산장초반부터하락세24낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=45913
8675,2018-12-14,특징주삼성바이오로직스분식회계혐의압수수색주가는불똥vs외인은사자,http://www.g-enews.com/ko-kr/news/article/news_all/201812140904538597c642673384_1/article.html
8676,2018-12-14,특징주삼성바이오로직스檢압수수색에주가하락세,http://news.mt.co.kr/mtview.php?no=2018121409050721709
8677,2018-12-14,특징주삼성바이오로직스검찰압수수색에4급락,http://www.inews24.com/view/1145554
8678,2018-12-14,HotLine삼성바이오로직스검찰의분식회계수사착수소식에약세,http://news.mk.co.kr/newsRead.php?year=2018&no=780119
8679,2018-12-14,특징주삼성바이오로직스검찰압수수색에주가하락세,http://www.dailian.co.kr/news/view/758841/?sc=naver
8680,2018-12-14,특징주삼성바이오로직스檢압수수색에40만원선아래로,http://www.newsway.co.kr/news/view?tp=1&ud=2018121409221422288
8681,2018-12-14,특징주삼성바이오로직스검찰압수수색에하락세,http://www.seoulfn.com/news/articleView.html?idxno=327982
8682,2018-12-14,분식회계삼성바이오로직스전방위적압수수색,http://www.hg-times.com/news/articleView.html?idxno=195371
8683,2018-12-14,삼성바이오로직스삼성물산검찰압수수색소식에장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341574
8684,2018-12-14,특징주삼성바이오로직스검찰압수수색소식에하락세,http://www.ebn.co.kr/news/view/965344
8685,2018-12-14,삼성바이오로직스끝나지않은전쟁,http://www.mediasr.co.kr/news/articleView.html?idxno=50373
8686,2018-12-14,검찰삼성바이오로직스분식회계압수수색경영권승계조사할듯,http://www.fntoday.co.kr/news/articleView.html?idxno=174529
8687,2018-12-14,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812140146&t=NN
8688,2018-12-14,관심주포스코현대차LG화학SK텔레콤한국전력강세삼성전자SK하이닉스셀트리온삼성바이오로직스신라젠포스코켐텍메디톡스약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32867
8689,2018-12-14,특징주삼성바이오로직스삼성물산검찰압수수색에3대하락,http://www.viva100.com/main/view.php?key=20181214010004897
8690,2018-12-14,안전진단받은삼성바이오로직스또불,http://www.straightnews.co.kr/news/articleView.html?idxno=39669
8691,2018-12-14,상장유지삼성바이오로직스행정소송논란은남아,http://www.mdtoday.co.kr/mdtoday/index.html?no=341373
8692,2018-12-14,특징주삼성바이오로직스검찰압수수색여파에약세,http://www.asiatoday.co.kr/view.php?key=20181214010008996
8693,2018-12-14,삼성바이오로직스삼성물산삼성전자이재용승계수사확대가능성에주가급락세,http://www.kpinews.co.kr/news/articleView.html?idxno=86003
8694,2018-12-14,코스피개인외국인팔자에내림세삼성전자SK하이닉스셀트리온삼성바이오로직스등하락,http://www.econonews.co.kr/news/articleView.html?idxno=45963
8695,2018-12-14,더벨주가강세삼성바이오로직스매니저뷰바뀌었다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201812130100021770001338
8696,2018-12-14,삼성바이오로직스檢압수수색에거래재개4일만에하락세,http://daily.hankooki.com/lpage/economy/201812/dh20181214114628138110.htm
8697,2018-12-14,조세금융만평삼성바이오로직스거래재개자본시장신뢰는어디에,http://www.tfnews.co.kr/news/article.html?no=57847
8698,2018-12-14,압수수색여파삼성바이오로직스거래재개4일째주가하락전환금융당국칼이커터칼이라면검찰칼은대검,https://news.imaeil.com/Finance/2018121413320460251
8699,2018-12-14,삼성바이오로직스빨간불,http://yna.kr/PYH20181214090800013?did=1196m
8700,2018-12-14,삼성바이오로직스빨간불,http://yna.kr/PYH20181214090700013?did=1196m
8701,2018-12-14,분식회계의혹속삼성바이오로직스,http://yna.kr/PYH20181214091300013?did=1196m
8702,2018-12-14,흔들리는삼성바이오로직스,http://yna.kr/PYH20181214090900013?did=1196m
8703,2018-12-14,분식회계의혹속삼성바이오로직스,http://yna.kr/PYH20181214091100013?did=1196m
8704,2018-12-14,분식회계의혹속삼성바이오로직스,http://yna.kr/PYH20181214091200013?did=1196m
8705,2018-12-14,분식회계의혹속삼성바이오로직스,http://yna.kr/PYH20181214091400013?did=1196m
8706,2018-12-14,삼성바이오로직스셀트리온모두4대낙폭삼성바이오로직스39만원위태,http://www.econonews.co.kr/news/articleView.html?idxno=45989
8707,2018-12-14,삼성바이오로직스18500원451내린391500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812140492&t=NN
8708,2018-12-14,검찰삼성바이오로직스삼성물산수사에서이재용3심이보인다,http://www.sisajournal-e.com/biz/article/192844
8709,2018-12-14,삼성바이오로직스삼성물산검찰압수수색여파에하락세마감,http://www.mdtoday.co.kr/mdtoday/index.html?no=341627
8710,2018-12-14,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학신라젠CJENM포스코켐텍하락포스코한국전력상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=32889
8711,2018-12-14,셀트리온3총사주가모두떨어져삼성바이오로직스도급락,http://www.businesspost.co.kr/BP?command=article_view&num=106466
8712,2018-12-14,박용진의원검찰에삼성바이오로직스신속철저수사촉구,http://www.gokorea.kr/news/articleView.html?idxno=62018
8713,2018-12-14,검찰삼성바이오로직스등압수수색,http://www.mdtoday.co.kr/mdtoday/index.html?no=341648
8714,2018-12-14,박용진검찰의삼성바이오로직스수사철저하게이뤄져야”,http://www.businesspost.co.kr/BP?command=article_view&num=106468
8715,2018-12-14,검찰삼성바이오로직스분식회계수사본격화,http://news.bbsi.co.kr/news/articleView.html?idxno=913070
8716,2018-12-15,큰손주간최다순매수순매도외국인한국전력러브콜vs삼성바이오로직스굿바이,http://www.g-enews.com/ko-kr/news/article/news_all/201812141702055394c642673384_1/article.html
8717,2018-12-15,코스피외국인기관쌍끌이매도2070선붕괴삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학삼성물산등하락,http://www.econonews.co.kr/news/articleView.html?idxno=46071
8718,2018-12-15,기업분석경남제약끝내상장폐지녹십자에서출발국민비타민레모나로폭발같은분식회계삼성바이오로직스차이는,http://www.g-enews.com/ko-kr/news/article/news_all/2018121513082020794a01bf698f_1/article.html
8719,2018-12-15,레모나경남제약상장폐지후폭풍과징금200배삼성바이오로직스는,http://ilyo.co.kr/?ac=article_view&entry_id=319591
8720,2018-12-15,김어준의다스뵈이다한국거래소삼성바이오로직스삼바위해상장규정까지수정했나,http://www.topstarnews.net/news/articleView.html?idxno=546857
8721,2018-12-15,김어준의다스뵈이다김용범금융위부위원장무슨발언했길래삼성바이오로직스삼바거래재개가이드라인논란,http://www.topstarnews.net/news/articleView.html?idxno=546858
8722,2018-12-16,삼성바이오로직스분식회계혐의삼성물산기업가치평가회계법인도압수수색,http://medicalworldnews.co.kr/news/view.php?idx=1510928728
8723,2018-12-16,경남제약상장폐지결정삼성바이오로직스와형평성논란와글경남제약개선계획이행불충분,http://www.kyeongin.com/main/view.php?key=20181216010005046
8724,2018-12-16,일요와이드2부삼성바이오로직스회계기준변경적법성논란쟁점은,http://www.mbn.co.kr/pages/news/newsView.php?news_seq_no=3712236
8725,2018-12-16,경남제약상폐에삼성바이오로직스대마불사형평성논란가열,http://www.g-enews.com/ko-kr/news/article/news_all/201812161108325464c642673384_1/article.html
8726,2018-12-16,경남제약상장폐지삼성바이오로직스와무엇이달랐나,http://www.businesspost.co.kr/BP?command=article_view&num=106547
8727,2018-12-16,경남제약상폐삼성바이오로직스형평성논란확산,http://www.dailymedi.com/detail.php?number=838112&thread=22r05
8728,2018-12-16,분식회계논란삼성바이오로직스셀트리온주가동반하락세,http://www.joongboo.com/news/articleView.html?idxno=1311660
8729,2018-12-16,삼성바이오로직스삼성물산회계법인4곳압수수색,http://www.wsobi.com/news/articleView.html?idxno=67934
8730,2018-12-16,천지일보주간SNS핫이슈5부산대여기숙사괴한침입문우람이태양양진호웹하드카르텔삼성바이오로직스선릉역여성칼부림,http://www.newscj.com/news/articleView.html?idxno=582762
8731,2018-12-16,10대뉴스삼성바이오로직스회계논란⑨,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123200&REFERER=NP
8732,2018-12-16,궁지에몰린삼성바이오로직스공수표만날리고있다,http://www.kyeongin.com/main/view.php?key=20181216010005227
8733,2018-12-17,손혁계명대학교경영대학회계학전공교수삼성바이오로직스사태교훈과과제,http://www.fntimes.com/html/view.php?ud=201812151428374848dd55077bc2_18
8734,2018-12-17,삼성바이오로직스3500원089내린388000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812170079&t=NN
8735,2018-12-17,특징주삼성바이오로직스외국인공방주가는주춤,http://www.g-enews.com/ko-kr/news/article/news_all/201812170911067722c642673384_1/article.html
8736,2018-12-17,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스38만원밑으로,http://www.econonews.co.kr/news/articleView.html?idxno=46207
8737,2018-12-17,박용진한국당유치원3법통과위해책임감있는태도필요삼성바이오로직스가치부풀린과정서불법있다면처벌해야,http://news.bbsi.co.kr/news/articleView.html?idxno=913260
8738,2018-12-17,시선집중경남제약상장폐지결정삼성바이오로직스는안되는데왜경남제약만,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=214&aid=0000900480
8739,2018-12-17,관심주삼성전자LG화학포스코한국전력강세SK하이닉스셀트리온삼성바이오로직스현대차SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32906
8740,2018-12-17,경남제약상장폐지삼성바이오로직스와비교어려워,http://www.mediasr.co.kr/news/articleView.html?idxno=50391
8741,2018-12-17,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812170185&t=NN
8742,2018-12-17,경남제약상장폐지삼성바이오로직스는상장유지그이유는,http://www.ggilbo.com/news/articleView.html?idxno=574583
8743,2018-12-17,특징주삼성바이오로직스檢압수수색후2거래일째하락세,http://www.asiatoday.co.kr/view.php?key=20181217010010121
8744,2018-12-17,삼성바이오로직스검찰압수수색악재에2거래일연속하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341728
8745,2018-12-17,특징주삼성바이오로직스압수수색여파로5하락,http://view.asiae.co.kr/news/view.htm?idxno=2018121710192190404
8746,2018-12-17,특징주삼성바이오로직스압수수색여파에36만원대로6급락,http://www.viva100.com/main/view.php?key=20181217010005586
8747,2018-12-17,코스피개인사자에상승유지삼성전자LG화학포스코한국전력상승vsSK하이닉스셀트리온삼성바이오로직스현대차SK텔레콤하락,http://www.econonews.co.kr/news/articleView.html?idxno=46253
8748,2018-12-17,삼성바이오로직스6대급락으로36만원대셀트리온은강보합,http://www.econonews.co.kr/news/articleView.html?idxno=46264
8749,2018-12-17,삼성바이오로직스압수수색후이틀연속하락거래재개효과단사흘,https://news.imaeil.com/Finance/2018121714085724438
8750,2018-12-17,삼성바이오로직스19000원485내린372500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812170552&t=NN
8751,2018-12-17,삼성바이오로직스485빠진37만2500원으로장마감檢압수수색악재,http://www.ggilbo.com/news/articleView.html?idxno=574845
8752,2018-12-17,코스피미중무역갈등완화기대감에상승삼성바이오로직스2거래일연속4↓,http://www.kukinews.com/news/article.html?no=613842
8753,2018-12-17,관심주삼성전자SK하이닉스셀트리온포스코한국전력삼성물산상승삼성바이오로직스SK텔레콤신라젠포스코켐텍하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32919
8754,2018-12-17,셀트리온주가허쥬마허가덕에급등삼성바이오로직스는급락,http://www.businesspost.co.kr/BP?command=article_view&num=106704
8755,2018-12-17,분식회계들통우려삼성바이오로직스삼정안진기업가치산정보고서국조특위제출누락,http://www.4th.kr/news/articleView.html?idxno=7403
8756,2018-12-17,바이오株연이은악재로투심↓삼성바이오로직스셀트리온헬스케어경남제약,http://www.topstarnews.net/news/articleView.html?idxno=548184
8757,2018-12-18,팩트체크경남제약과삼성바이오로직스간형평성논란은타당한가,http://www.news2day.co.kr/116931
8758,2018-12-18,한경로보뉴스전일기관거래소에서셀트리온313삼성바이오로직스485등순매도,http://news.hankyung.com/article/201812186961L
8759,2018-12-18,투자코멘트실시간종목순위0840아난티삼성전자삼성바이오로직스,http://www.fntimes.com/html/view.php?ud=2018121808505912455dfa85252b_18
8760,2018-12-18,김어준의뉴스공장경남제약상장폐지삼성바이오로직스삼바와형평성논란이유는,http://www.topstarnews.net/news/articleView.html?idxno=548361
8761,2018-12-18,특징주삼성바이오로직스외국인사자우위주가반전주목,http://www.g-enews.com/ko-kr/news/article/news_all/201812180916118886c642673384_1/article.html
8762,2018-12-18,삼성바이오로직스셀트리온소폭이지만희비엇갈려삼성바이오로직스강보합,http://www.econonews.co.kr/news/articleView.html?idxno=46373
8763,2018-12-18,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812180168&t=NN
8764,2018-12-18,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코약세현대차SK텔레콤한국전력바이로메드강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32926
8765,2018-12-18,상장폐지경남기업삼성바이오로직스운명왜엇갈렸나,http://www.ggilbo.com/news/articleView.html?idxno=575081
8766,2018-12-18,삼성바이오로직스가처분신청수용여부촉각,http://www.dailymedi.com/detail.php?number=838184&thread=22r05
8767,2018-12-18,경남제약은안되고삼성바이오로직스는되는수상한주식상장,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=9&seq_800=10316521
8768,2018-12-18,코스피뉴욕증시급락영향하락삼성전자SK하이닉스셀트리온삼성바이오로직스LG화학포스코삼성물산등약세,http://www.econonews.co.kr/news/articleView.html?idxno=46408
8769,2018-12-18,삼성바이오로직스셀트리온모두소폭상승세셀트리온22만원회복눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=46429
8770,2018-12-18,삼성바이오로직스증선위처분불복이유있다,http://www.fnnews.com/news/201812181515589440
8771,2018-12-18,檢삼성바이오로직스압수수색금주까지핵심은이재용경영승계연관성,http://www.4th.kr/news/articleView.html?idxno=7441
8772,2018-12-18,셀트리온주가쌍끌이매수에올라삼성바이오로직스는하락,http://www.businesspost.co.kr/BP?command=article_view&num=106885
8773,2018-12-18,이데일리오늘의경제일정삼성바이오로직스분식회계법정공방시작,http://www.edaily.co.kr/news/newspath.asp?newsid=04611686619439832
8774,2018-12-18,인천모금회삼성바이오로직스로부터기부금4000만원받아,http://news.kmib.co.kr/article/view.asp?arcid=0012929062&code=61121111&cp=nv
8775,2018-12-18,삼성바이오로직스주가널뛰기성급한재개에개인만피해”,http://news.kbs.co.kr/news/view.do?ncd=4097908&ref=A
8776,2018-12-18,경남제약은안되고삼성바이오로직스는되는수상한주식상장삼성바이오로직스봐준밀실안사람들은,http://www.newsfreezone.co.kr/news/articleView.html?idxno=92262
8777,2018-12-18,삼성바이오로직스공동모금회에성금기탁,http://www.kyeongin.com/main/view.php?key=20181218010006004
8778,2018-12-19,삼성바이오로직스법정다툼19일본격시작,http://news.donga.com/3/all/20181219/93363366/1
8779,2018-12-19,이데일리내일의경제일정삼성바이오로직스분식회계법정공방시작,http://www.edaily.co.kr/news/newspath.asp?newsid=01298886619440160
8780,2018-12-19,삼성바이오로직스증선위오늘분식회계법정공방시작,http://www.newspim.com/news/view/20181218000706
8781,2018-12-19,2018년12월19일사회주요일정삼성바이오로직스증선위상대집행정지심문기일등,http://www.betanews.net:8080/article/950199.html
8782,2018-12-19,삼성바이오로직스행정처분집행정지필요오늘법정서공방,http://www.asiatoday.co.kr/view.php?key=20181219010011640
8783,2018-12-19,삼성바이오로직스증선위오늘법정서분식회계공방시작,http://www.asiatime.co.kr/news/articleView.html?idxno=218424
8784,2018-12-19,삼성바이오로직스366500원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812190099&t=NN
8785,2018-12-19,오늘의재판일정삼성바이오로직스증권선물위원회상대집행정지가처분신청심문기일등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1701362
8786,2018-12-19,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스4거래일연속하락,http://www.econonews.co.kr/news/articleView.html?idxno=46530
8787,2018-12-19,특징주삼성바이오로직스법정다툼본격화에하락,http://www.newsis.com/view/?id=NISX20181219_0000506846&cID=10401&pID=10400
8788,2018-12-19,특징주삼성바이오로직스행정소송재판시작주가는불똥,http://www.g-enews.com/ko-kr/news/article/news_all/201812190929279428c642673384_1/article.html
8789,2018-12-19,특징주삼성바이오로직스고의분식회계법정공방본격화주가하락세,http://www.kpinews.co.kr/news/articleView.html?idxno=86223
8790,2018-12-19,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812190183&t=NN
8791,2018-12-19,이데일리N삼성바이오로직스금융당국분식회계법정공방시작外,http://www.edaily.co.kr/news/newspath.asp?newsid=01912246619440160
8792,2018-12-19,삼성바이오로직스증선위분식회계두고오늘법정공방시작,http://www.sisafocus.co.kr/news/articleView.html?idxno=198710
8793,2018-12-19,관심주셀트리온현대차LG화학SK텔레콤한국전력신라젠포스코켐텍강세SK하이닉스삼성바이오로직스포스코삼성물산약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32956
8794,2018-12-19,삼성바이오로직스행정소송19일10시부터법정서공방,http://www.econovill.com/news/articleView.html?idxno=352977
8795,2018-12-19,삼성바이오로직스로경남제약을설명할수있다고,http://www.straightnews.co.kr/news/articleView.html?idxno=39860
8796,2018-12-19,코스피강보합권속상승세SK하이닉스삼성바이오로직스포스코삼성물산하락vs셀트리온현대차LG화학SK텔레콤한국전력상승,http://www.econonews.co.kr/news/articleView.html?idxno=46554
8797,2018-12-19,삼성바이오로직스분식회계법정공방본격시작,http://www.shinailbo.co.kr/news/articleView.html?idxno=1127646
8798,2018-12-19,법정나서는삼성바이오로직스측변호인,http://news1.kr/photos/view/?3437778
8799,2018-12-19,삼성바이오로직스본안소송으로다퉈야vs투자자피해고려,https://www.ytn.co.kr/_ln/0103_201812191336010610
8800,2018-12-19,삼성바이오로직스집행정지소송첫심문서증선위와팽팽한신경전,http://www.asiatoday.co.kr/view.php?key=20181219010012135
8801,2018-12-19,삼성바이오로직스행정처분효력정지법원1월중순늦어도2월초결정”,http://www.econovill.com/news/articleView.html?idxno=353008
8802,2018-12-19,삼성바이오로직스셀트리온상승세이지만삼성바이오로직스오르락내리락,http://www.econonews.co.kr/news/articleView.html?idxno=46593
8803,2018-12-19,삼성바이오로직스증선위법정서첫공방회계기준준수vs콜옵션부채회피의도,http://www.g-enews.com/ko-kr/news/article/news_all/201812191441396950c642673384_1/article.html
8804,2018-12-19,삼성바이오로직스vs금융위원회증선위법정격돌,http://www.dailymedi.com/detail.php?number=838230&thread=22r05
8805,2018-12-19,삼성바이오로직스2079402018년12월19일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=135929
8806,2018-12-19,뉴스인사이트삼성바이오로직스분식회계의혹법정공방본격화,http://news.bbsi.co.kr/news/articleView.html?idxno=913774
8807,2018-12-19,관심주삼성전자셀트리온현대차LG화학삼성바이오로직스포스코SK텔레콤한국전력상승SK하이닉스하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=32972
8808,2018-12-19,﻿윤일규의원국민연금투자대상서삼성바이오로직스등퇴출개정안발의,http://medicalworldnews.co.kr/news/view.php?idx=1510928766
8809,2018-12-19,검찰삼성바이오로직스분식회계의혹에삼성전자압수수색,http://www.kpinews.co.kr/news/articleView.html?idxno=86278
8810,2018-12-19,고의분식삼성바이오로직스제재놓고삼바증선위열띤법정공방,http://www.updownnews.co.kr/news/articleView.html?idxno=100905
8811,2018-12-19,국민연금투자대상에서삼성바이오로직스퇴출시켜야,http://medipana.com/news/news_viewer.asp?NewsNum=232406&MainKind=A&NewsKind=5&vCount=12&vKind=1
8812,2018-12-19,삼성바이오로직스증선위와법정공방,http://www.mediasr.co.kr/news/articleView.html?idxno=50432
8813,2018-12-19,삼성바이오로직스임직원소외청소년을위한BioDreamPlus장학금전달,http://www.joongboo.com/news/articleView.html?idxno=1312713
8814,2018-12-19,오늘Who김태한삼성바이오로직스운명치열한법정공방시작,http://www.businesspost.co.kr/BP?command=article_view&num=106995
8815,2018-12-19,삼성바이오로직스폐업위기몰릴수있다필사적변론분식회계법정공방시작,http://www.4th.kr/news/articleView.html?idxno=7486
8816,2018-12-19,삼성바이오로직스인천사회복지공동모금회에1억2천만원기부,http://www.kyeongin.com/main/view.php?key=20181219010006526
8817,2018-12-19,분식회계삼성바이오로직스법정공방시작법원1월중결론,http://www.yonhapnewstv.co.kr/MYH20181219015100038/?did=1825m
8818,2018-12-19,셀트리온3총사주가급등삼성바이오로직스도소폭올라,http://www.businesspost.co.kr/BP?command=article_view&num=107037
8819,2018-12-19,삼성바이오로직스장학금1억2천만원쾌척,http://www.kgnews.co.kr/news/articleView.html?idxno=535499
8820,2018-12-20,삼성바이오로직스장학금1억2000만원,http://www.incheonilbo.com/news/articleView.html?idxno=919115
8821,2018-12-20,윤일규국민연금투자대상에서삼성바이오로직스퇴출,http://weeklytrade.co.kr/news/view.html?section=1&category=160&item=&no=48158
8822,2018-12-20,출렁이는삼성바이오로직스빠른거래재개가오히려독,http://www.newstomato.com/ReadNews.aspx?no=865117
8823,2018-12-20,삼성바이오로직스집행정지가능성은,http://kormedi.com/?p=1259196
8824,2018-12-20,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스36만원선위태,http://www.econonews.co.kr/news/articleView.html?idxno=46677
8825,2018-12-20,관심주삼성전자SK하이닉스현대차LG화학삼성바이오로직스한국전력포스코SK텔레콤네이버약세셀트리온셀트리온헬스케어에이치엘비강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=32985
8826,2018-12-20,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812200186&t=NN
8827,2018-12-20,국민연금투자대상서삼성바이오로직스퇴출법안추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=342049
8828,2018-12-20,삼성바이오로직스분식회계골드만삭스공매도올해증시10대뉴스,http://news.hankyung.com/article/2018122064626
8829,2018-12-20,2018증시10대뉴스⑧삼성바이오로직스고의적분식회계사건,http://www.inews24.com/view/1146703
8830,2018-12-20,코스피외국인기관팔자에하락세SK하이닉스현대차LG화학삼성바이오로직스한국전력포스코SK텔레콤네이버등약세,http://www.econonews.co.kr/news/articleView.html?idxno=46731
8831,2018-12-20,삼성바이오로직스전일대비약5하락한349500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812200335&t=NN
8832,2018-12-20,삼성바이오로직스셀트리온흐름여전히반대삼성바이오로직스오후들어낙폭커져,http://www.econonews.co.kr/news/articleView.html?idxno=46742
8833,2018-12-20,SR경제라이프미중무역전쟁삼성바이오로직스등올증시10대뉴스,http://www.srtimes.kr/news/articleView.html?idxno=29804
8834,2018-12-20,삼성바이오로직스652폭락한34만4000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=576321
8835,2018-12-20,삼성바이오로직스2079402018년12월20일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=136411
8836,2018-12-20,관심주삼성전자SK하이닉스셀트리온현대차LG화학삼성바이오로직스하락한국전력셀트리온헬스CJENM바이로메드상승,http://www.insightkorea.co.kr//news/articleView.html?idxno=32993
8837,2018-12-20,셀트리온주가쌍끌이매수에도하락삼성바이오로직스는급락,http://www.businesspost.co.kr/BP?command=article_view&num=107222
8838,2018-12-20,주간한국삼성바이오로직스험난했던첫법정공방과전망은,http://daily.hankooki.com/lpage/industry/201812/dh20181220230143147960.htm
8839,2018-12-21,삼성바이오로직스셀트리온모두상승세로삼성바이오로직스35만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=46813
8840,2018-12-21,특징주삼성바이오로직스외국인사자주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201812210914191971c642673384_1/article.html
8841,2018-12-21,특징주삼성바이오로직스하락과도했나2대상승,http://www.viva100.com/main/view.php?key=20181221010007520
8842,2018-12-21,관심주SK하이닉스셀트리온LG화학삼성바이오로직스SK텔레콤강세삼성전자현대차한국전력포스코약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=33000
8843,2018-12-21,특징주삼성바이오로직스너무많이떨어졌나장초반강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=298488
8844,2018-12-21,코스피뉴욕증시급락에약보합세현대차삼성전자우한국전력포스코하락vsSK하이닉스셀트리온LG화학삼성바이오로직스SK텔레콤상승,http://www.econonews.co.kr/news/articleView.html?idxno=46867
8845,2018-12-21,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스↑셀트리온↓,http://www.econonews.co.kr/news/articleView.html?idxno=46887
8846,2018-12-21,뉴스워커_외신삼성바이오로직스스캔들파장한국제약사는국제협력우선순위아니다,http://www.newsworker.co.kr/news/articleView.html?idxno=24333
8847,2018-12-21,삼성바이오로직스2079402018년12월21일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=136967
8848,2018-12-21,셀트리온주가개인매도세에하락삼성바이오로직스는반등,http://www.businesspost.co.kr/BP?command=article_view&num=107359
8849,2018-12-22,코스피기관사자소폭오름세SK하이닉스현대차삼성전자우LG화학삼성바이오로직스SK텔레콤상승vs셀트리온한국전력포스코하락,http://www.econonews.co.kr/news/articleView.html?idxno=47041
8850,2018-12-22,삼성바이오로직스분식회계수사미전실정조준김용관장충기최지성연결고리확보주력,http://www.4th.kr/news/articleView.html?idxno=7570
8851,2018-12-22,김어준의다스뵈이다삼성바이오로직스삼바분식회계취소소송심리에서나온황당한말들,http://www.topstarnews.net/news/articleView.html?idxno=551642
8852,2018-12-23,검찰삼성바이오로직스압수물분석착수,http://www.edaily.co.kr/news/newspath.asp?newsid=01968006619441472
8853,2018-12-24,특징주삼성바이오로직스외국인순매수강화주가꿈틀,http://www.g-enews.com/ko-kr/news/article/news_all/201812240907544177c642673384_1/article.html
8854,2018-12-24,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스전날이어상승,http://www.econonews.co.kr/news/articleView.html?idxno=47184
8855,2018-12-24,관심주삼성전자SK하이닉스셀트리온SK텔레콤한국전력포스코약세현대차LG화학삼성바이오로직스바이로메드강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=33031
8856,2018-12-24,코스피우울한크리스마스이브하락출발SK하이닉스셀트리온삼성전자우SK텔레콤한국전력포스코하락vs현대차LG화학삼성바이오로직스상승,http://www.econonews.co.kr/news/articleView.html?idxno=47217
8857,2018-12-24,삼성바이오로직스셀트리온모두하락세삼성바이오로직스내내상승서약보합으로,http://www.econonews.co.kr/news/articleView.html?idxno=47231
8858,2018-12-24,삼성바이오로직스2079402018년12월24일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=137566
8859,2018-12-24,관심주삼성전자SK하이닉스현대차포스코메디톡스상승셀트리온LG화학삼성바이오로직스한국전력신라젠CJENM하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=33043
8860,2018-12-24,셀트리온주가쌍끌이매수에도급락삼성바이오로직스도약세,http://www.businesspost.co.kr/BP?command=article_view&num=107586
8861,2018-12-25,코스피미국셧다운악재에2050선후퇴삼성전자SK하이닉스현대차포스코상승vs셀트리온삼성전자우LG화학삼성바이오로직스한국전력하락,http://www.econonews.co.kr/news/articleView.html?idxno=47336
8862,2018-12-25,삼성바이오로직스2079402018년12월25일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=138028
8863,2018-12-26,삼성바이오로직스셀트리온모두하락세셀트리온4거래일연속↓,http://www.econonews.co.kr/news/articleView.html?idxno=47431
8864,2018-12-26,관심주삼성전자SK하이닉스셀트리온현대차LG화학삼성바이오로직스SK텔레콤포스코약세한국전력강세,http://www.insightkorea.co.kr//news/articleView.html?idxno=33049
8865,2018-12-26,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812260209&t=NN
8866,2018-12-26,코스피블랙크리스마스여파급락삼성전자SK하이닉스셀트리온현대차LG화학삼성바이오로직스SK텔레콤포스코KB금융등약세,http://www.econonews.co.kr/news/articleView.html?idxno=47466
8867,2018-12-26,삼성바이오로직스셀트리온장초반하락서상승반전하락멈추나,http://www.econonews.co.kr/news/articleView.html?idxno=47480
8868,2018-12-26,주식종목시세삼성바이오로직스주가26일현재352500원,http://www.nbntv.co.kr/news/articleView.html?idxno=147890
8869,2018-12-26,12월26일삼성바이오로직스주식현황129353000원,http://www.nbntv.co.kr/news/articleView.html?idxno=147900
8870,2018-12-26,12월26일삼성바이오로직스주식현재가351000원072,http://www.nbntv.co.kr/news/articleView.html?idxno=147988
8871,2018-12-26,삼성바이오로직스주가12월26일현재360000원주가정보,http://www.cctvnews.co.kr/news/articleView.html?idxno=94918
8872,2018-12-26,2018경제계10대뉴스백두산회동부터삼성바이오로직스분식논란까지,http://weekly.cnbnews.com/news/article.html?no=126470
8873,2018-12-26,삼성바이오로직스주가12월26일현재360000원및증권차트분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=94941
8874,2018-12-26,삼성바이오로직스2079402018년12월26일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=138382
8875,2018-12-26,삼성바이오로직스330오른36만원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=578140
8876,2018-12-26,관심주셀트리온삼성바이오로직스신라젠포스코켐텍상승삼성전자SK하이닉스현대차LG화학SK텔레콤포스코한국전력하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=33061
8877,2018-12-26,오늘Who김태한해외수주로삼성바이오로직스위기돌파추진,http://www.businesspost.co.kr/BP?command=article_view&num=107739
8878,2018-12-26,셀트리온주가쌍끌이매수로급등삼성바이오로직스주가도올라,http://www.businesspost.co.kr/BP?command=article_view&num=107778
8879,2018-12-27,삼성바이오로직스셀트리온모두상승세특히셀트리온전날급등이어5대상승,http://www.econonews.co.kr/news/articleView.html?idxno=47554
8880,2018-12-27,특징주삼성바이오로직스반갑다외국인주가단비,http://www.g-enews.com/ko-kr/news/article/news_all/201812270913136904c642673384_1/article.html
8881,2018-12-27,HotLine셀트리온삼성바이오로직스하락장속이틀째상승세,http://news.mk.co.kr/newsRead.php?year=2018&no=805251
8882,2018-12-27,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812270170&t=NN
8883,2018-12-27,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스포스코네이버강세현대차LG화학SK텔레콤한국전력약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=33076
8884,2018-12-27,특징주삼성바이오로직스외인매수에상승세,http://view.asiae.co.kr/news/view.htm?idxno=2018122711164520977
8885,2018-12-27,코스피뉴욕증시폭등에도찔끔오름세삼성전자SK하이닉스셀트리온삼성바이오로직스포스코상승vs현대차LG화학SK텔레콤한국전력하락,http://www.econonews.co.kr/news/articleView.html?idxno=47611
8886,2018-12-27,삼성바이오로직스주가종목그래프27일현재369000원,http://www.gokorea.kr/news/articleView.html?idxno=65099
8887,2018-12-27,삼성바이오로직스주가그래프27일현재369000원,http://www.nbntv.co.kr/news/articleView.html?idxno=148956
8888,2018-12-27,주식현재가삼성바이오로직스주가27일현재369500원,http://www.nbntv.co.kr/news/articleView.html?idxno=149008
8889,2018-12-27,삼성바이오로직스셀트리온희비엇갈려셀트리온장초반상승서약보합으로,http://www.econonews.co.kr/news/articleView.html?idxno=47626
8890,2018-12-27,12월27일삼성바이오로직스및증권시세및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=65178
8891,2018-12-27,12월27일삼성바이오로직스증권플러스369000원250,http://www.nbntv.co.kr/news/articleView.html?idxno=149245
8892,2018-12-27,삼성바이오로직스주가12월27일현재369500원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=95654
8893,2018-12-27,미디어펜기업경제포럼개최삼성바이오로직스사태법적안정성에관하여,http://www.mediapen.com/news/view/404174
8894,2018-12-27,최종구금융위원장삼성바이오로직스상장유지가이드라인제시한것아냐,http://www.sisafocus.co.kr/news/articleView.html?idxno=199262
8895,2018-12-27,삼성바이오로직스2079402018년12월27일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=138874
8896,2018-12-27,영상이학영금융위이재용과삼성보호중삼성바이오로직스상장유지결정회의록공개해야,http://facttv.kr/facttvnews/detail.php?number=23264&thread=14r08
8897,2018-12-27,코스피배당락에도불구강보합마감SK하이닉스삼성바이오로직스네이버상승삼성전자셀트리온현대차하락마감,http://www.econonews.co.kr/news/articleView.html?idxno=47658
8898,2018-12-27,최종구삼성바이오로직스거래재개공정하게결정,http://www.asiatoday.co.kr/view.php?key=20181227010017155
8899,2018-12-27,셀트리온3총사주가쌍끌이매도에하락삼성바이오로직스급등,http://www.businesspost.co.kr/BP?command=article_view&num=107961
8900,2018-12-27,최종구금융위는삼성바이오로직스상장유지심사관여안했다,http://www.businesspost.co.kr/BP?command=article_view&num=107966
8901,2018-12-27,삼성바이오로직스송도11공구제공타당한가,http://www.obsnews.co.kr/news/articleView.html?idxno=1133430
8902,2018-12-28,삼성바이오로직스6000원162오른377000원에거래시작,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812280086&t=NN
8903,2018-12-28,한경로보뉴스삼성바이오로직스5이상상승,http://news.hankyung.com/article/201812289741L
8904,2018-12-28,삼성바이오로직스셀트리온모두상승세특히삼성바이오로직스4대상승으로39만원눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=47666
8905,2018-12-28,특징주삼성바이오로직스3거래일연속상승3↑,http://view.asiae.co.kr/news/view.htm?idxno=2018122809173532541
8906,2018-12-28,삼성바이오로직스장초반강세,http://www.sedaily.com/NewsView/1S8N2TLM2S
8907,2018-12-28,삼성바이오로직스207940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812280164&t=NN
8908,2018-12-28,관심주삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학포스코한국전력강세SK텔레콤약세,http://www.insightkorea.co.kr//news/articleView.html?idxno=33096
8909,2018-12-28,12월28일삼성바이오로직스증권플러스377385000원,http://www.nbntv.co.kr/news/articleView.html?idxno=151514
8910,2018-12-28,코스피외국인사자에상승유지삼성전자SK하이닉스셀트리온삼성바이오로직스현대차LG화학포스코한국전력등약진,http://www.econonews.co.kr/news/articleView.html?idxno=47713
8911,2018-12-28,삼성바이오로직스주가12월28일현재389500원주가정보,http://www.cctvnews.co.kr/news/articleView.html?idxno=96048
8912,2018-12-28,삼성바이오로직스셀트리온희비엇갈려삼성바이오로직스39만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=47723
8913,2018-12-28,삼성바이오로직스15500원418오른386500원에거래마감,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812280483&t=NN
8914,2018-12-28,12월28일삼성바이오로직스정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=65738
8915,2018-12-28,삼성바이오로직스2079402018년12월28일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=139376
8916,2018-12-28,관심주삼성전자삼성바이오로직스SK텔레콤한국전력포스코신라젠CJENM상승SK하이닉스셀트리온네이버포스코켐텍하락,http://www.insightkorea.co.kr//news/articleView.html?idxno=33109
8917,2018-12-28,코스피기관순매수삼성바이오로직스SK텔레콤호텔신라,http://www.newsway.co.kr/news/view?tp=1&ud=2018122817453089650
8918,2018-12-28,삼성바이오로직스주가기관매수세에급등셀트리온은소폭하락,http://www.businesspost.co.kr/BP?command=article_view&num=108163
8919,2018-12-29,제약∙바이오주이슈분석①삼성바이오로직스상폐위기일단락CMO혁신지속,http://www.fntimes.com/html/view.php?ud=2018122815583128451d6f57e61a_18
8920,2018-12-29,코스피외국인사자상승삼성전자삼성바이오로직스SK텔레콤한국전력포스코강세vsSK하이닉스셀트리온네이버약세,http://www.econonews.co.kr/news/articleView.html?idxno=47987
8921,2018-12-30,국내10대뉴스삼성바이오로직스분식회계논란,http://www.etnews.com/20181228000320
8922,2018-12-30,2018년결산증시넘어산업계관가로번진삼성바이오로직스분식회계논란,http://www.etnews.com/20181228000311
8923,2018-12-30,삼성바이오로직스집행정지소송이르면이달중결론,http://www.dt.co.kr/contents.html?article_no=2019010102101831102001&ref=naver
8924,2018-12-31,삼성바이오로직스매출채권재고자산증가로현금흐름마이너스,http://www.ceoscoredaily.com/news/article.html?no=50307
8925,2018-12-31,실시간주식현황삼성바이오로직스주가31일현재386500원,http://www.nbntv.co.kr/news/articleView.html?idxno=153011
8926,2018-12-31,2018HotLine고의분식삼성바이오로직스투자자냉온탕오가,http://news.mk.co.kr/newsRead.php?year=2018&no=812882
8927,2018-12-31,삼성바이오로직스분식회계논란에1년간주가롤러코스터,http://www.mdtoday.co.kr/mdtoday/index.html?no=342864
8928,2018-12-31,아듀2018유통업계10대뉴스평창롱패딩부터삼성바이오로직스분식회계까지시끌,http://www.ajunews.com/view/20181231090552817
8929,2018-12-31,삼성바이오로직스2079402018년12월31일15시10분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=139849
